data_2mly_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mly _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HA ' HG13 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.647 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.68 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.589 HD13 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.487 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.555 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB3' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 93' ' ' VAL . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.484 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.444 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.409 HG22 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HZ2' HD11 ' A' ' 129' ' ' ILE . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.587 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.457 HD11 ' HZ2' ' A' ' 127' ' ' LYS . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HB ' HD22 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.447 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.445 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.698 ' HG3' HG11 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.683 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.412 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.618 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.618 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.619 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.594 HG23 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.424 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.516 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.426 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 168' ' ' PHE . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.566 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.602 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.585 HG13 ' HE1' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.585 ' HE1' HG13 ' A' ' 270' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.409 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.718 HD21 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 317' ' ' GLN . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.467 ' NE2' HD23 ' A' ' 314' ' ' LEU . 8.7 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.462 HH11 ' HG3' ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 343' ' ' ARG . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.718 HD13 HD21 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 119.928 -0.082 . . . . 15.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.524 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 397' ' ' ASN . 69.7 m-20 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.425 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.454 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD11 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 294' ' ' LEU . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 428' ' ' MET . 20.2 t-20 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.657 ' HG3' HD11 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.428 ' HB2' ' ND2' ' A' ' 425' ' ' ASN . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' HZ2' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.643 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG21 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.45 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.561 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.55 HG22 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.7 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.46 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.674 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.491 HG22 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.47 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.488 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.604 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.465 ' HD3' HG21 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.529 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.674 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.441 ' HA ' HG21 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.601 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.505 ' HA ' ' HZ3' ' A' ' 272' ' ' LYS . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.713 HG22 HD23 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.505 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.7 ' HE2' ' HA ' ' A' ' 137' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.493 HD22 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.449 HG12 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.489 ' HB1' HD23 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.55 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.609 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.439 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.43 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.422 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.609 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 360' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.553 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 398' ' ' MET . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 112.306 0.484 . . . . 15.0 112.306 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 398' ' ' MET . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.665 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.536 HD12 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.527 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 409' ' ' GLU . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.594 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 10.5 t-20 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.594 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.517 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 . . . . . 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.609 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.656 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HE2' HG21 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.463 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.507 HD13 HG22 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.426 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' HB3' HD11 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HE1' HD11 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.54 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.445 HD11 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.636 HG23 HD23 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.506 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.749 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.407 ' HA ' ' HB1' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.581 HG11 HG23 ' A' ' 202' ' ' ILE . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB3' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.559 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.663 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.602 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.414 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.554 HG21 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.581 HG23 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.602 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.658 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.648 HG22 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.597 ' HA ' ' HZ1' ' A' ' 232' ' ' LYS . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.424 ' HE2' HG21 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.554 ' HD3' HG21 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.423 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.597 ' HZ1' ' HA ' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.57 HD23 HG22 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.729 HG23 HD12 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.49 HG12 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.479 ' SD ' HG13 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.636 HD23 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.43 HG12 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 338' ' ' GLU . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.58 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.459 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.514 ' HA ' HD13 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.459 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.467 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.465 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.426 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.365 0.506 . . . . 15.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.47 ' O ' HG22 ' A' ' 401' ' ' VAL . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.653 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.445 ' HD3' HD11 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.745 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.463 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.594 ' HA ' HD12 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.559 HG23 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.52 HG21 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.52 ' HE3' HG21 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.617 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.567 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.684 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.684 HD13 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.534 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.41 ' HA ' HG12 ' A' ' 79' ' ' ILE . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 4.6 t30 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.592 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.422 HG22 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE2' HD12 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.518 HD12 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.695 HG13 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.802 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.53 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.456 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.64 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.681 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.451 HG22 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.444 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.535 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.517 HG21 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.532 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 158' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.535 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.517 ' HD3' HG21 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.442 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG23 ' A' ' 166' ' ' ILE . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.63 ' HG2' HG11 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.695 ' SD ' HG13 ' A' ' 132' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 287' ' ' LYS . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.637 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.466 HD12 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.637 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 341' ' ' ALA . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.547 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.513 HD21 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 112.224 0.453 . . . . 15.0 112.224 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.513 ' SD ' HD21 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.547 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.5 ' HB3' HG23 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.574 ' HA ' HG12 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 3.6 t-20 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.459 HD12 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.7 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 9.1 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 303' ' ' PRO . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.425 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.567 HH12 HG13 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG13 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.48 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.48 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 41.3 t30 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.506 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.705 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.59 HG22 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.562 HG13 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.443 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.556 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.561 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.654 HG13 HG23 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.637 HG23 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.635 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.589 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.635 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.465 HG21 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.654 HG23 HG13 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.445 HD11 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.516 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.619 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.56 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.59 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.403 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.605 ' HB2' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.51 ' HA ' HG23 ' A' ' 166' ' ' ILE . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 164' ' ' VAL . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.548 ' HB2' ' HZ3' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.556 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.421 HG13 ' HE1' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.485 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.473 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . 0.469 HD22 HD22 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.525 HD12 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.503 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB2' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.43 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.405 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.525 ' HE3' HD12 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.416 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.626 HD13 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.409 ' HA ' HD13 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.705 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . 0.467 ' HG1' ' HB2' ' A' ' 426' ' ' GLU . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.836 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 21.4 m120 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.467 ' HB2' ' HG1' ' A' ' 423' ' ' THR . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.836 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.559 HG13 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.715 HD11 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.449 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.434 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 HG21 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.602 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.602 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.715 ' HB3' HD11 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' A' ' 19' ' ' ILE . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.436 HD13 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.53 ' HG2' HD12 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.725 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.564 HG11 HG23 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.471 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.485 HD22 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.428 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.564 HG23 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.635 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 226' ' ' LEU . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HZ2' ' HB2' ' A' ' 214' ' ' ASP . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.489 ' HA ' HG22 ' A' ' 166' ' ' ILE . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.725 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.484 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.612 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.562 HG22 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.53 ' HE3' ' HA ' ' A' ' 137' ' ' VAL . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.608 HD13 ' HE2' ' A' ' 428' ' ' MET . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.429 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.586 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.469 HD13 HG12 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.472 ' HB1' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.472 HD22 ' HB1' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.552 ' HG3' HG22 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.462 HD21 ' HE1' ' A' ' 398' ' ' MET . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 119.068 -0.492 . . . . 15.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.467 ' HA ' HD13 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.469 HG12 HD13 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.436 ' HD3' HD13 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.461 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.765 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.452 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG13 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.469 ' O ' HG21 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.564 ' NH2' HG13 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HB3' HG23 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.54 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.597 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.514 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.634 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 HG22 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.58 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 HG22 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 140' ' ' MET . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.796 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.607 ' HA ' HG22 ' A' ' 240' ' ' VAL . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.543 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.532 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.577 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.492 HG23 HG13 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 237' ' ' LEU . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.619 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.486 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.438 ' HE2' HG23 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.576 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.486 ' HZ3' ' HB2' ' A' ' 214' ' ' ASP . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.701 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.563 HD21 HG22 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.796 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.512 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.44 ' HA2' HG13 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.705 ' HA ' ' HZ3' ' A' ' 272' ' ' LYS . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.582 HG12 ' HE3' ' A' ' 274' ' ' MET . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.705 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.582 ' HE3' HG12 ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.435 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 332' ' ' LEU . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD21 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.413 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.685 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.519 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 340' ' ' GLN . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.519 HG21 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.492 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.426 ' O ' HD11 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.461 HD13 ' HB1' ' A' ' 407' ' ' ALA . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.522 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 112.097 0.406 . . . . 15.0 112.097 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.455 ' HE2' ' HA ' ' A' ' 395' ' ' MET . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.561 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.574 ' HA ' HG13 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' HD13 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.634 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.495 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.59 ' HG3' HD11 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.59 HD11 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.495 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.567 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.548 HG23 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.419 HG21 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.419 ' HE3' HG21 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD11 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG23 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.428 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.679 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.508 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.708 HG22 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.405 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.641 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.631 HG22 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.507 ' HG3' ' HB1' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 237' ' ' LEU . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.583 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.533 HG23 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.788 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.788 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.537 HG22 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.545 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 168' ' ' PHE . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.631 HD21 HG22 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.483 HG21 ' HB ' ' A' ' 258' ' ' VAL . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.454 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 253' ' ' ILE . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 264' ' ' GLU . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.531 HG11 ' HE1' ' A' ' 274' ' ' MET . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.531 ' HE1' HG11 ' A' ' 270' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.413 HD12 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.494 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.416 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.708 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.655 HD12 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.421 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.474 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.563 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.45 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.437 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.496 ' HA ' ' HE3' ' A' ' 395' ' ' MET . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.648 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.578 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.622 HG23 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.648 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.555 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.645 HG12 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.56 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.645 ' HG2' HG12 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.622 ' HB3' HG23 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.555 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.578 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.511 HG11 HD11 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.45 HG22 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.522 HD23 HG22 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.638 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.641 HG11 HG23 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.67 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.53 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.493 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.54 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.67 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.513 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 166' ' ' ILE . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.599 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.638 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.555 HG23 HD12 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.443 HG11 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.443 ' HA2' HG11 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.555 HD12 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.54 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 405' ' ' GLU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.547 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.511 HD11 HG11 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.493 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.526 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.497 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.419 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.419 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.443 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 407' ' ' ALA . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.627 HH12 HD13 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.627 HD13 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 119.273 -0.394 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.465 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.525 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.464 ' HA ' HD11 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG23 ' A' ' 66' ' ' VAL . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.464 ' HA ' HG21 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.471 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.458 HG12 ' HE2' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.743 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.552 ' HA ' HD11 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 141' ' ' LEU . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.668 ' HG3' HG11 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.583 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.478 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.549 ' HG3' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.476 ' N ' ' SD ' ' A' ' 194' ' ' MET . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.534 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.492 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.442 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.443 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.442 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.558 ' HA ' HG23 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' A' ' 154' ' ' LYS . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.544 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.743 ' HE1' ' SD ' ' A' ' 140' ' ' MET . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.628 HD12 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 346' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.531 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.558 ' HB2' HG22 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.593 -0.151 . . . . 15.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 404' ' ' GLU . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.8 t-20 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 130' ' ' VAL . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.554 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HA ' HG13 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.647 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.68 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HE3' HG21 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HD2' HD13 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.589 HD13 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.487 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.555 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.555 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.421 ' HG3' HD11 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB3' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 93' ' ' VAL . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.484 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.444 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.409 HG22 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HZ2' HD11 ' A' ' 129' ' ' ILE . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.587 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.457 HD11 ' HZ2' ' A' ' 127' ' ' LYS . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HB ' HD22 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' B' ' 127' ' ' SER . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.447 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.445 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.698 ' HG3' HG11 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.683 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.412 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.618 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.507 ' HE1' ' HA ' ' B' ' 14' ' ' LEU . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.618 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.619 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.594 HG23 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.424 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' HB2' HD11 ' B' ' 10' ' ' LEU . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.516 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.426 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 168' ' ' PHE . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.566 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.602 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.585 HG13 ' HE1' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' B' ' 130' ' ' ALA . 0.9 OUTLIER -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.585 ' HE1' HG13 ' A' ' 270' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 377' ' ' ALA . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.409 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.718 HD21 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 317' ' ' GLN . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.467 ' NE2' HD23 ' A' ' 314' ' ' LEU . 8.7 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.462 HH11 ' HG3' ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.533 HG13 ' HG ' ' B' ' 111' ' ' LEU . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.718 HD13 HD21 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.539 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -68.21 -33.87 75.22 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.435 ' HG2' ' HE1' ' B' ' 94' ' ' PHE . 56.5 ttp -70.84 -44.06 67.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.385 0.612 . . . . 15.0 109.953 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -84.3 -6.53 59.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.172 0.989 . . . . 15.0 111.945 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -59.64 -20.33 55.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.112 0.965 . . . . 15.0 112.346 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 276' ' ' ARG . . . -63.32 -33.24 75.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.3 0.64 . . . . 15.0 110.932 171.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.7 156.98 18.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.523 0.729 . . . . 15.0 110.028 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -31.96 16.8 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.894 0.878 . . . . 15.0 110.052 175.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -150.56 87.5 4.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.49 49.63 1.85 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.821 3.014 . . . . 15.0 114.003 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -55.48 -38.16 68.75 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.853 0.861 . . . . 15.0 111.452 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.579 ' HG3' HG23 ' A' ' 384' ' ' VAL . 6.1 pt-20 -49.41 -49.44 44.84 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.624 1.17 . . . . 15.0 111.832 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.579 HG23 ' HG3' ' A' ' 383' ' ' GLU . 91.5 t -71.89 -52.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 C-N-CA 123.98 0.912 . . . . 15.0 109.91 -172.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.76 -45.28 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.914 0.886 . . . . 15.0 110.921 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.42 -35.6 79.58 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.161 -0.472 . . . . 15.0 111.024 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.503 ' CD1' HG21 ' B' ' 97' ' ' ILE . 13.9 t80 -64.17 -38.26 90.42 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 119.469 -0.301 . . . . 15.0 110.403 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.58 -58.46 8.44 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 120.863 0.363 . . . . 15.0 110.972 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 22.1 p -66.17 -14.6 62.13 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 113.067 0.766 . . . . 15.0 113.067 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.24 4.19 13.5 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.608 0.763 . . . . 15.0 111.442 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -151.12 90.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.558 -1.275 . . . . 15.0 107.558 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -74.71 -16.74 60.74 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.708 -1.133 . . . . 15.0 111.026 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.524 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.539 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 397' ' ' ASN . 69.7 m-20 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.425 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.454 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD11 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 294' ' ' LEU . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 428' ' ' MET . 20.2 t-20 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.657 ' HG3' HD11 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.528 ' SD ' ' HB1' ' B' ' 126' ' ' ALA . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -42.32 -31.56 0.42 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . 0.451 HE22 ' HA ' ' B' ' 122' ' ' THR . 77.8 mt-30 -104.86 117.48 34.15 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.979 0.512 . . . . 15.0 111.551 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -117.51 -19.1 9.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.93 0.892 . . . . 15.0 109.569 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 C-N-CA 123.492 0.717 . . . . 15.0 109.806 -177.475 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' B' ' 9' ' ' ALA . 36.7 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.441 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 22.4 tptm -156.87 92.52 1.28 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -162.01 165.14 27.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.237 1.015 . . . . 0.0 109.403 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -61.34 -43.83 98.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.078 0.951 . . . . 0.0 112.442 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.8 m -71.07 77.05 0.67 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.978 0.911 . . . . 0.0 111.806 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.572 HG22 HD13 ' B' ' 10' ' ' LEU . 2.6 mp 32.79 -95.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 127.429 2.292 . . . . 0.0 113.101 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.15 31.32 13.72 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.04 0.936 . . . . 0.0 113.253 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp 49.93 17.12 0.26 Allowed 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.252 1.821 . . . . 0.0 114.489 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.539 ' HB3' ' HG3' ' B' ' 1' ' ' MET . . . -76.42 -32.44 58.48 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.792 0.837 . . . . 0.0 110.831 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.572 HD13 HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -86.68 -11.53 50.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.84 0.856 . . . . 0.0 112.409 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -167.58 108.19 0.6 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.906 0.882 . . . . 0.0 108.993 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.58 112.16 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.85 2.367 . . . . 0.0 111.075 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.49 -40.07 85.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 110.407 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.507 ' HA ' ' HE1' ' A' ' 194' ' ' MET . 0.0 OUTLIER -85.98 117.29 24.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 169.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.24 0.26 45.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.43 0.692 . . . . 0.0 111.944 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -114.18 87.67 13.69 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.98 -58.39 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.644 2.229 . . . . 0.0 111.573 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.53 HG11 ' H ' ' B' ' 20' ' ' LYS . 85.0 t 65.01 -67.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.444 1.498 . . . . 0.0 111.292 -172.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.3 p 57.78 16.65 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.036 1.734 . . . . 0.0 112.927 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.53 ' H ' HG11 ' B' ' 18' ' ' VAL . 62.8 mttm 58.44 23.46 10.67 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.143 1.377 . . . . 0.0 112.365 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.52 4.87 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 62.28 63.0 1.1 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 124.539 1.149 . . . . 0.0 109.658 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.526 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 98.9 m -54.18 118.61 16.46 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.517 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -16.0 82.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.419 1 C-N-CA 126.568 4.845 . . . . 0.0 117.67 -168.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 23' ' ' THR . 27.3 mt-10 -105.22 -75.95 0.61 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.557 1.143 . . . . 0.0 107.965 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 85.2 mtp -96.99 -43.0 0.25 Allowed Pre-proline 0 CA--C 1.559 1.29 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.375 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.43 73.74 2.16 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 122.273 1.982 . . . . 0.0 112.255 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.25 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.322 1.449 . . . . 0.0 108.915 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.31 130.77 53.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.426 1.09 . . . . 0.0 110.056 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -83.68 133.81 34.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.425 0.69 . . . . 0.0 109.405 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.467 HD22 ' HB3' ' B' ' 35' ' ' GLN . 2.2 t-20 -80.05 4.49 16.98 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.849 0.86 . . . . 0.0 111.003 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 74.48 -76.37 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.379 1.872 . . . . 0.0 111.688 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.68 30.61 4.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.649 0.78 . . . . 0.0 110.181 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' B' ' 37' ' ' ASP . . . 60.76 67.81 0.8 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.571 1.149 . . . . 0.0 111.537 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.467 ' HB3' HD22 ' B' ' 31' ' ' ASN . 6.0 tp-100 -62.25 -53.2 58.57 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.028 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.61 22.01 29.22 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.646 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' B' ' 34' ' ' ALA . 33.2 t70 -130.75 169.0 16.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.114 0.566 . . . . 0.0 110.616 -173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.7 mt 77.11 -67.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.366 1.866 . . . . 0.0 110.114 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -109.61 -75.43 0.63 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . 179.54 -52.13 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.356 1.462 . . . . 0.0 109.476 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 77.1 Cg_endo -101.07 111.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 123.164 2.576 . . . . 0.0 112.886 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.15 76.37 2.24 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.254 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.34 -79.19 0.22 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.24 -176.7 6.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.857 0.863 . . . . 0.0 109.743 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -99.58 -42.64 6.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.466 0.707 . . . . 0.0 109.611 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 69.96 -65.66 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.763 1.625 . . . . 0.0 112.714 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.442 HD12 HG21 ' B' ' 68' ' ' ILE . 50.9 tp 78.12 -15.16 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.34 1.456 . . . . 0.0 112.504 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -88.24 6.78 35.19 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.437 0.695 . . . . 0.0 111.861 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.68 47.32 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.88 -16.42 58.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.495 0.718 . . . . 0.0 111.964 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.98 -54.94 23.86 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.01 0.924 . . . . 0.0 110.251 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -70.35 -24.39 62.97 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.66 -43.26 59.89 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.295 0.638 . . . . 0.0 111.383 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -172.37 -66.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.799 0.84 . . . . 0.0 110.934 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' B' ' 57' ' ' ASP . 2.6 pt? -129.48 167.14 18.29 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.16 0.584 . . . . 0.0 111.343 -168.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' B' ' 56' ' ' ARG . 0.1 OUTLIER -127.06 15.01 7.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.779 0.832 . . . . 0.0 109.255 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.529 ' HB2' HD12 ' B' ' 55' ' ' LEU . 3.3 m-20 -93.59 55.23 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.813 1.245 . . . . 0.0 109.571 -170.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.448 ' HB3' HD11 ' B' ' 68' ' ' ILE . 86.7 p 56.12 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.888 1.675 . . . . 0.0 111.625 -173.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -168.11 -57.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.0 m -147.03 -76.53 0.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -156.01 -65.15 0.11 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.396 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 mptt 37.18 168.31 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.061 0 C-N-CA 126.008 1.723 . . . . 0.0 115.504 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.28 129.46 19.18 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 123.127 2.551 . . . . 0.0 114.399 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.29 28.19 13.83 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.326 1.45 . . . . 0.0 112.127 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.55 ' HZ3' ' HB2' ' B' ' 65' ' ' LYS . 0.1 OUTLIER 61.14 49.21 5.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.491 1.116 . . . . 0.0 109.774 -177.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 65.45 -176.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.46 1.104 . . . . 0.0 110.54 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -87.05 61.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 122.755 1.264 . . . . 0.0 110.466 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' B' ' 58' ' ' SER . 24.4 pt -120.79 2.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.451 -0.78 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 128.26 36.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.33 -47.93 82.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.688 0.795 . . . . 0.0 112.163 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.38 133.53 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -173.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.76 55.02 0.09 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -79.87 -35.04 38.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.374 0.67 . . . . 0.0 110.758 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.7 81.96 1.1 Allowed Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.041 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.7 -22.0 64.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.489 0.715 . . . . 0.0 111.325 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.94 11.53 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 168.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 74.04 -24.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.125 1.37 . . . . 0.0 114.488 166.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -69.64 -44.84 69.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.431 0.692 . . . . 0.0 111.257 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -93.27 -72.09 0.62 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.806 0.442 . . . . 0.0 110.13 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 9.8 tp -162.35 -30.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.677 0.391 . . . . 0.0 110.827 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 28.8 m -59.5 135.17 57.58 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 123.252 0.621 . . . . 0.0 109.892 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 79.64 -49.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.644 1.578 . . . . 0.0 111.256 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.52 -66.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.377 1.471 . . . . 0.0 110.574 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -130.32 104.45 7.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.41 115.27 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.244 1.017 . . . . 0.0 110.387 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' B' ' 90' ' ' ALA . 32.9 m-85 80.3 -42.24 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.554 1.542 . . . . 0.0 112.111 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.6 48.4 9.58 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.477 1.111 . . . . 0.0 111.234 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 76.16 -57.43 0.56 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.112 1.765 . . . . 0.0 112.901 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.603 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . -80.38 1.23 82.38 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' B' ' 86' ' ' TYR . . . 62.77 24.01 14.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.31 1.044 . . . . 0.0 111.642 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.46 -65.79 3.6 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -168.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.7 -91.71 0.27 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 122.8 0.238 . . . . 0.0 112.998 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -158.13 -70.37 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.435 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 48.4 t80 -77.08 -40.35 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.258 0.623 . . . . 0.0 110.641 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.615 ' HD2' ' HA2' ' B' ' 134' ' ' GLY . 0.3 OUTLIER -58.7 -28.21 65.57 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.542 0.526 . . . . 0.0 110.662 174.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.81 -79.48 0.21 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.503 HG21 ' CD1' ' A' ' 387' ' ' PHE . 0.0 OUTLIER 176.88 -35.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.143 0.977 . . . . 0.0 109.647 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.2 148.58 47.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 113.113 -162.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.44 -24.39 5.0 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.952 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.18 108.64 0.9 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.18 -85.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.023 1.815 . . . . 0.0 112.121 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.676 HD21 ' HG3' ' B' ' 113' ' ' LYS . 85.2 mt 60.66 -173.58 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.83 1.252 . . . . 0.0 113.336 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 17.6 m -140.11 90.86 2.41 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.25 90.13 0.08 OUTLIER Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -81.98 119.52 24.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.439 ' H ' ' ND2' ' A' ' 400' ' ' ASN . 82.2 m-85 71.39 26.43 3.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.37 1.468 . . . . 0.0 111.807 -175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -82.25 167.39 18.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.21 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -135.08 11.15 3.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.504 0.722 . . . . 0.0 110.502 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -86.51 23.39 1.64 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 0.0 110.131 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.9 -100.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.77 0.828 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.533 ' HG ' HG13 ' A' ' 347' ' ' VAL . 3.2 mm? 51.73 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.88 1.272 . . . . 0.0 112.953 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.405 ' HA ' ' OG1' ' B' ' 115' ' ' THR . 9.8 m120 -92.63 82.41 4.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.543 0.687 . . . . 0.0 111.862 -171.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.676 ' HG3' HD21 ' B' ' 102' ' ' LEU . 0.0 OUTLIER -157.24 37.86 0.29 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.153 -1.385 . . . . 0.0 107.598 162.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -176.93 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.683 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' B' ' 112' ' ' ASN . 7.0 m -64.81 -34.0 77.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.631 0.772 . . . . 0.0 111.071 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.49 ' HA2' ' H ' ' B' ' 121' ' ' VAL . . . 90.19 -66.69 2.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -67.4 143.33 97.18 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.832 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -1.64 66.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.453 1 C-N-CA 126.701 4.934 . . . . 0.0 116.369 -154.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.82 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.846 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.72 -90.6 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 109.816 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.601 HG23 HG22 ' B' ' 122' ' ' THR . 12.8 p -174.63 141.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.519 1.528 . . . . 0.0 108.074 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.601 HG22 HG23 ' B' ' 121' ' ' VAL . 56.7 p 60.25 176.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.699 1.6 . . . . 0.0 114.287 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.95 71.99 1.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.669 0.788 . . . . 0.0 109.582 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t 76.12 -51.18 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.295 1.438 . . . . 0.0 111.848 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.32 41.59 16.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.17 0.988 . . . . 0.0 109.626 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.528 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -73.97 9.02 1.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.806 -170.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.486 ' HB3' ' SD ' ' A' ' 140' ' ' MET . 26.8 m -59.74 86.58 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 123.573 0.749 . . . . 0.0 110.001 169.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.96 -76.04 0.07 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.89 1.676 . . . . 0.0 111.99 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.0 m 61.44 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.023 1.329 . . . . 0.0 109.372 -166.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 273' ' ' ASN . . . 58.8 -171.98 0.11 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 124.648 1.179 . . . . 0.0 114.04 170.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.466 ' HH2' HD13 ' A' ' 144' ' ' LEU . 3.6 p90 47.28 31.17 1.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.386 1.874 . . . . 0.0 114.966 166.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 51.3 p -87.83 61.51 6.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.745 0.818 . . . . 0.0 109.853 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -84.45 65.52 8.98 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.827 1.298 . . . . 0.0 110.54 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' B' ' 95' ' ' LYS . . . 79.12 -95.43 1.41 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 80.6 t 63.71 113.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.072 1.349 . . . . 0.0 111.749 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.35 82.56 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.043 0.925 . . . . 0.0 109.623 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -107.96 3.91 24.66 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.827 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.69 -175.83 3.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.02 0.928 . . . . 0.0 109.515 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.25 136.52 57.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.313 0.645 . . . . 0.0 112.285 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -142.12 88.54 0.18 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.64 17.94 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.498 0.719 . . . . 0.0 110.168 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.16 -177.2 5.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.637 1.175 . . . . 0.0 109.442 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.86 -78.97 1.76 Allowed Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.1 122.66 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.849 0.859 . . . . 0.0 109.85 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.82 168.89 18.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.136 1.375 . . . . 0.0 108.834 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.538 HG12 ' H ' ' B' ' 147' ' ' HIS . 12.8 tt 30.15 -141.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 125.831 1.652 . . . . 0.0 111.781 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . 0.538 ' H ' HG12 ' B' ' 146' ' ' ILE . 85.2 t60 -65.66 90.24 0.11 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.396 1.907 . . . . 0.0 110.348 169.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 27.15 79.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.549 2.34 . . . . 0.0 115.814 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.3 157.68 44.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t0 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.883 0.873 . . . . 0.0 108.723 170.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HG3' ' HZ2' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.643 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG21 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.441 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.45 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.561 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.55 HG22 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.7 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.46 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.674 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.491 HG22 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.47 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.591 ' HA2' HD23 ' B' ' 8' ' ' LEU . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' B' ' 30' ' ' GLU . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.488 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.604 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.465 ' HD3' HG21 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.677 ' HH ' HG23 ' B' ' 6' ' ' ILE . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.472 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.4 ' HB3' HD12 ' B' ' 6' ' ' ILE . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.529 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.674 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.441 ' HA ' HG21 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.601 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.551 ' HD2' ' HB2' ' B' ' 138' ' ' TYR . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.594 ' HA3' ' HB ' ' B' ' 133' ' ' THR . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.505 ' HA ' ' HZ3' ' A' ' 272' ' ' LYS . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.713 HG22 HD23 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.505 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.7 ' HE2' ' HA ' ' A' ' 137' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.618 ' HG2' ' HA ' ' B' ' 128' ' ' ALA . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.493 HD22 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.449 HG12 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.489 ' HB1' HD23 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.55 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.609 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.439 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.43 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.422 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.609 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.486 HD13 HD21 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 360' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.553 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 398' ' ' MET . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.08 -43.44 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.511 ' SD ' HD11 ' B' ' 97' ' ' ILE . 41.2 ttp -80.48 -50.98 9.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.547 1.539 . . . . 15.0 111.202 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.47 -15.08 60.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.872 0.869 . . . . 15.0 112.321 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.6 t -67.66 -3.18 8.32 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.413 0.685 . . . . 15.0 111.383 171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.15 -14.62 63.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.118 0.567 . . . . 15.0 111.336 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -137.24 161.76 35.34 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.889 1.276 . . . . 15.0 109.915 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.72 -35.41 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.357 0.663 . . . . 15.0 110.212 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.51 85.64 55.96 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -101.73 34.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.568 2.845 . . . . 15.0 112.847 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -56.49 -40.55 75.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.87 0.868 . . . . 15.0 111.091 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.57 -32.6 73.6 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 123.957 0.786 . . . . 15.0 111.533 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.29 -51.77 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.16 -42.97 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.784 0.834 . . . . 15.0 110.51 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.47 -43.57 76.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.748 0.819 . . . . 15.0 110.995 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -57.37 -37.79 73.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.957 0.503 . . . . 15.0 110.964 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.34 -71.7 0.23 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.481 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 73.2 p -55.35 -34.65 64.44 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.673 0.99 . . . . 15.0 113.673 -168.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.79 -26.2 59.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.758 0.651 . . . . 15.0 112.758 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 393' ' ' GLU . 62.1 t30 -153.62 151.03 29.25 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.585 0.629 . . . . 15.0 112.329 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt -61.8 -15.43 41.54 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.869 1.268 . . . . 15.0 112.306 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.414 ' HB2' ' ND2' ' A' ' 391' ' ' ASN . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 398' ' ' MET . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.665 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.536 HD12 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.527 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 409' ' ' GLU . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.594 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 10.5 t-20 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.594 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' B' ' 126' ' ' ALA . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -65.05 -0.11 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.72 103.79 15.69 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 15.0 110.126 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -96.74 -35.6 10.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.481 0.712 . . . . 15.0 109.457 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.383 1.073 . . . . 15.0 108.243 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 tttm 70.89 -2.17 2.4 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.745 1.218 . . . . 0.0 112.647 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 61.28 18.49 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.552 1.141 . . . . 0.0 111.885 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -81.18 -4.77 56.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.709 0.804 . . . . 0.0 110.183 171.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 52.4 p -59.05 138.6 57.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.949 1.3 . . . . 0.0 110.373 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.677 HG23 ' HH ' ' A' ' 221' ' ' TYR . 17.2 tt -69.28 117.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.423 0.689 . . . . 0.0 111.292 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 99.51 11.91 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.712 HD21 HD11 ' B' ' 13' ' ' LEU . 1.3 pp -70.89 155.76 40.41 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.48 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.997 0.919 . . . . 0.0 108.574 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.76 -25.56 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.72 157.51 88.37 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.382 1.073 . . . . 0.0 112.411 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 222' ' ' HIS . 49.9 Cg_exo -60.5 116.25 3.21 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.391 2.728 . . . . 0.0 114.154 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.712 HD11 HD21 ' B' ' 8' ' ' LEU . 6.4 tt -168.67 -62.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.37 84.26 6.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -77.76 83.81 4.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.814 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -145.65 122.45 6.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.21 -40.97 71.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.244 2.63 . . . . 0.0 113.056 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.92 166.19 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.647 0.779 . . . . 0.0 110.849 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -83.56 113.36 20.76 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.552 0.691 . . . . 0.0 110.073 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -106.42 11.42 30.84 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.804 0.842 . . . . 0.0 110.678 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.07 -175.52 5.58 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.68 0.792 . . . . 0.0 110.185 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -85.21 64.07 8.46 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 45.4 p 27.71 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.911 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -165.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 71.3 Cg_exo -45.51 90.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.366 2.044 . . . . 0.0 114.149 168.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.559 ' HG2' ' HD2' ' B' ' 27' ' ' PRO . 30.0 tt0 -170.23 146.62 2.97 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.222 1.409 . . . . 0.0 108.19 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.43 ' HE1' ' HA ' ' B' ' 26' ' ' MET . 4.0 tpt -73.96 -51.36 4.98 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.425 -0.798 . . . . 0.0 112.749 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.559 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 36.2 Cg_endo -66.44 99.58 0.44 Allowed 'Trans proline' 0 C--N 1.39 2.717 0 CA-C-N 121.079 1.421 . . . . 0.0 110.685 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -79.77 65.82 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 122.663 1.221 . . . . 0.0 110.334 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.4 13.81 6.21 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 183' ' ' SER . 31.6 tt0 82.16 -45.13 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.071 1.748 . . . . 0.0 112.799 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 70.63 -100.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.129 1.372 . . . . 0.0 108.016 -170.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' B' ' 30' ' ' GLU . 9.2 mpt_? 49.08 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.704 1.202 . . . . 0.0 111.988 -177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.33 7.11 17.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.892 0.877 . . . . 0.0 112.043 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.5 84.4 1.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.262 0.625 . . . . 0.0 109.358 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -162.15 -174.37 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.324 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.47 -45.37 1.14 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.33 79.42 1.84 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 mp 61.24 -91.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.607 1.163 . . . . 0.0 108.552 -172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 55.3 m -170.5 -63.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.3 145.61 11.2 Favored Pre-proline 0 C--O 1.245 0.861 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.122 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.65 102.44 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.749 2.299 . . . . 0.0 111.338 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.12 -37.29 0.53 Allowed Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.1 166.46 21.94 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.59 -49.94 6.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.883 0.473 . . . . 0.0 110.383 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 67.63 1.38 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.579 0.751 . . . . 0.0 110.685 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 65.13 -174.36 0.18 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.566 1.146 . . . . 0.0 111.362 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.72 91.59 7.04 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' B' ' 53' ' ' ALA . 38.1 p 63.95 -67.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 127.153 2.181 . . . . 0.0 112.648 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 -1.55 6.62 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.44 -72.84 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.563 1.545 . . . . 0.0 111.716 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -38.85 74.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.764 0.826 . . . . 0.0 111.245 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.5 m -64.61 -69.5 0.28 Allowed 'General case' 0 C--N 1.36 1.033 0 C-N-CA 122.943 0.497 . . . . 0.0 110.721 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.529 ' HB2' ' HB ' ' B' ' 48' ' ' THR . . . -107.12 -51.21 2.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.081 0.553 . . . . 0.0 111.157 -171.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 75.18 -176.18 0.14 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.706 1.203 . . . . 0.0 111.14 -172.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.45 -26.71 64.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.698 0.799 . . . . 0.0 110.688 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -82.99 -6.45 59.49 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 0.0 112.286 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.421 ' HA ' ' HB1' ' B' ' 53' ' ' ALA . 29.9 t70 62.81 13.12 6.23 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.607 1.163 . . . . 0.0 112.092 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -125.99 119.48 27.81 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.509 1.123 . . . . 0.0 109.246 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 158.45 25.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.028 0.931 . . . . 0.0 110.566 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.6 p -88.99 146.86 24.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.228 0.611 . . . . 0.0 110.355 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 65.3 -173.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.533 1.133 . . . . 0.0 112.254 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.464 ' HD2' ' HD2' ' B' ' 63' ' ' PRO . 20.7 tptm -79.54 123.21 84.33 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.464 ' HD2' ' HD2' ' B' ' 62' ' ' LYS . 58.8 Cg_endo -71.35 72.45 2.27 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.777 2.318 . . . . 0.0 113.013 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.25 122.95 0.22 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.83 58.48 3.85 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.803 0.811 . . . . 0.0 111.889 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.99 2.93 21.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.777 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.29 151.88 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 109.135 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . 0.28 9.6 tt 68.74 -50.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 127.993 2.517 . . . . 0.0 113.859 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -89.94 71.59 7.51 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.97 -66.99 1.01 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.89 -174.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.073 1.349 . . . . 0.0 109.287 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.4 -83.5 1.1 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.37 94.56 7.41 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.81 60.64 0.51 Allowed Glycine 0 C--O 1.244 0.761 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.1 ttt -77.21 94.38 4.1 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.05 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' B' ' 79' ' ' GLU . . . -78.45 163.61 50.3 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.532 171.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.29 -69.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.6 m -99.99 -8.11 24.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.685 0.794 . . . . 0.0 110.151 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.52 ' HB2' ' HA3' ' B' ' 76' ' ' GLY . 1.8 mp0 -75.9 -16.83 59.97 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.296 0.638 . . . . 0.0 111.055 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 tt -82.58 -22.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.507 0.723 . . . . 0.0 110.957 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.2 m -143.73 105.14 4.28 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.247 0.619 . . . . 0.0 110.605 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.08 -168.56 3.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.026 0.93 . . . . 0.0 109.768 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.51 168.83 5.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 0.0 111.112 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -74.02 83.26 1.75 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 110.692 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -124.54 -28.56 3.58 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.593 1.157 . . . . 0.0 109.623 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.76 83.25 5.73 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.413 0.685 . . . . 0.0 110.268 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.7 -68.95 0.16 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -175.8 123.68 0.2 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.4 -101.2 0.25 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.51 -65.73 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.261 1.424 . . . . 0.0 111.66 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 115.23 7.13 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 123.3 0.476 . . . . 0.0 113.027 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.89 12.32 47.06 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-O 119.95 -0.361 . . . . 0.0 112.415 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' B' ' 131' ' ' TRP . 4.0 m-85 69.49 -77.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.026 1.33 . . . . 0.0 111.474 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -120.66 140.93 50.88 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -148.32 152.28 36.81 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.35 -78.83 1.88 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.528 HG23 ' H ' ' B' ' 98' ' ' ASP . 4.9 tp -175.24 -81.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 C-N-CA 124.518 1.127 . . . . 0.0 110.864 164.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.528 ' H ' HG23 ' B' ' 97' ' ' ILE . 26.4 t0 67.32 151.98 0.07 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.489 1.515 . . . . 0.0 111.898 -166.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.47 -156.0 0.68 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.184 0.594 . . . . 0.0 111.136 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -61.43 -175.5 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.127 0 C-N-CA 125.0 1.32 . . . . 0.0 113.355 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' B' ' 100' ' ' LEU . 32.2 Cg_exo -26.96 -19.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.392 1 C-N-CA 126.674 4.916 . . . . 0.0 119.653 167.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.88 84.67 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.012 1.325 . . . . 0.0 108.129 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -63.05 1.24 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.502 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.74 -129.01 9.75 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.078 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -83.17 95.59 8.16 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.394 0.678 . . . . 0.0 110.249 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 75.0 t80 58.86 -91.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.056 1.342 . . . . 0.0 110.502 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 p 38.78 37.73 0.22 Allowed 'General case' 0 C--N 1.38 1.91 0 C-N-CA 125.242 1.417 . . . . 0.0 113.779 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -81.34 13.45 2.93 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.057 -165.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.614 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 82.9 m-85 -86.16 108.46 18.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.053 0.941 . . . . 0.0 109.322 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 344' ' ' ARG . . . 67.33 100.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.918 1.287 . . . . 0.0 112.072 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.49 40.92 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.89 0.876 . . . . 0.0 110.486 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -147.12 33.89 0.9 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.216 1.406 . . . . 0.0 108.361 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -73.78 -42.1 61.47 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.279 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -160.82 -169.61 2.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.857 0.863 . . . . 0.0 109.651 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 72.4 m 62.04 97.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.063 1.345 . . . . 0.0 112.472 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.65 -70.39 3.12 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.771 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.622 ' HB2' ' HZ2' ' B' ' 117' ' ' LYS . 4.7 ttmp? -123.38 81.91 52.9 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.341 0.656 . . . . 0.0 111.067 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.6 -62.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.661 2.241 . . . . 0.0 110.609 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.74 170.45 1.96 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.906 1.682 . . . . 0.0 108.28 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 90.9 t80 63.76 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.715 1.206 . . . . 0.0 113.3 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.67 -45.92 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.071 . . . . 0.0 112.59 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m 65.87 140.9 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.965 1.306 . . . . 0.0 112.216 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -73.62 -174.27 1.69 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.568 1.147 . . . . 0.0 111.448 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 45.0 t -68.89 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.688 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 277' ' ' GLU . . . 63.57 -70.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.699 1.199 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.561 ' HB3' ' HG2' ' A' ' 428' ' ' MET . . . -112.96 148.34 35.23 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.785 0.834 . . . . 0.0 110.651 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 4.4 m 70.61 -1.45 2.57 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.901 1.68 . . . . 0.0 112.846 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.618 ' HA ' ' HG2' ' A' ' 277' ' ' GLU . . . 65.25 146.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.019 1.328 . . . . 0.0 114.304 173.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 13.6 t -76.66 -11.01 59.79 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.837 166.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 72.0 -74.84 0.08 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.103 1.761 . . . . 0.0 110.269 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.466 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . 6.0 m-90 -137.08 110.11 7.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.833 0.853 . . . . 0.0 109.111 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -93.54 -6.75 45.99 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.384 0.674 . . . . 0.0 111.865 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.594 ' HB ' ' HA3' ' A' ' 257' ' ' GLY . 88.0 m -59.99 -57.13 14.19 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 123.722 0.639 . . . . 0.0 110.033 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.3 -78.75 0.43 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.761 0.663 . . . . 0.0 113.161 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.01 114.31 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.896 0.878 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -141.37 121.21 13.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.0 m -57.02 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.131 0.973 . . . . 0.0 111.934 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . 0.551 ' HB2' ' HD2' ' A' ' 255' ' ' ARG . 77.0 t80 -98.81 -55.53 2.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.824 0.85 . . . . 0.0 109.916 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.511 HD22 ' HB3' ' B' ' 148' ' ' GLU . 86.4 m-20 74.52 -53.9 0.67 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.497 1.519 . . . . 0.0 112.372 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.53 -46.42 2.35 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 77.37 -24.69 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.732 1.613 . . . . 0.0 113.454 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt 59.06 22.39 10.46 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.73 -119.38 4.03 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.56 98.78 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.349 0.66 . . . . 0.0 109.955 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -168.59 142.76 3.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.5 pt -144.62 72.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.317 1.047 . . . . 0.0 110.095 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -97.99 92.5 5.82 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.186 0.993 . . . . 0.0 108.655 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.536 ' HG3' ' H ' ' B' ' 149' ' ' LYS . 5.6 pt-20 -163.68 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.051 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.536 ' H ' ' HG3' ' B' ' 148' ' ' GLU . 0.0 OUTLIER -132.05 77.21 1.75 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.497 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.609 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.656 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HE2' HG21 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.463 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.507 HD13 HG22 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.426 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' HB3' HD11 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HE1' HD11 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.54 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.445 HD11 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.488 HG22 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.636 HG23 HD23 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.506 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.598 HD12 ' HB2' ' B' ' 128' ' ' ALA . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.749 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.407 ' HA ' ' HB1' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.581 HG11 HG23 ' A' ' 202' ' ' ILE . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB3' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.559 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.663 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.602 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' B' ' 23' ' ' THR . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.414 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.554 HG21 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.581 HG23 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.602 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.658 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.648 HG22 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.597 ' HA ' ' HZ1' ' A' ' 232' ' ' LYS . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.424 ' HE2' HG21 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.554 ' HD3' HG21 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' B' ' 5' ' ' THR . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.597 ' HZ1' ' HA ' ' A' ' 214' ' ' ASP . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.57 HD23 HG22 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.729 HG23 HD12 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.49 HG12 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.479 ' SD ' HG13 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.636 HD23 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.43 HG12 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.435 HG23 HG11 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 338' ' ' GLU . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.58 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' B' ' 118' ' ' PRO . 6.1 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.524 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.459 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.514 ' HA ' HD13 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.459 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.467 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.465 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.526 HD21 HG12 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.622 ' HB3' ' HE2' ' B' ' 108' ' ' HIS . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.426 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 384' ' ' VAL . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -70.28 -31.5 68.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttp -65.87 -48.87 70.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.701 0.4 . . . . 15.0 109.955 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.24 58.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.107 0.963 . . . . 15.0 112.093 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.2 t -55.81 -31.18 62.44 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.223 0.609 . . . . 15.0 111.379 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 4.49 53.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.591 0.756 . . . . 15.0 112.497 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -167.13 103.04 0.54 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.81 12.27 0.54 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.7 1.37 . . . . 15.0 114.7 -164.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' B' ' 139' ' ' ASN . 20.4 t70 -110.69 96.81 30.07 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 168.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.75 -4.84 9.9 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.125 1.883 . . . . 15.0 111.725 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -62.79 -38.02 89.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.677 0.791 . . . . 15.0 112.594 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -37.41 70.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 123.428 0.455 . . . . 15.0 110.47 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 371' ' ' ILE . 36.1 t -75.19 -62.22 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.594 0.758 . . . . 15.0 109.762 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.92 -46.28 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.678 0.791 . . . . 15.0 110.405 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.83 -34.35 64.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 118.669 -0.681 . . . . 15.0 112.224 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.58 -44.81 95.79 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.078 0.854 . . . . 15.0 110.084 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 3.2 m-30 -67.26 -56.14 11.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.296 -0.865 . . . . 15.0 110.856 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 36.0 p -60.68 -30.44 69.93 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.522 0.729 . . . . 15.0 112.261 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -93.87 -12.09 29.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.115 0.566 . . . . 15.0 112.07 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.19 123.89 8.52 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.429 0.559 . . . . 15.0 110.664 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -58.29 -26.57 63.14 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.593 1.157 . . . . 15.0 112.365 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' B' ' 99' ' ' ALA . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' B' ' 102' ' ' LEU . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.653 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.445 ' HD3' HD11 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.454 ' HE2' ' H ' ' B' ' 127' ' ' SER . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -95.38 31.76 1.91 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -92.86 132.48 36.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.168 0.987 . . . . 15.0 109.806 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.28 -46.69 22.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.807 0.843 . . . . 15.0 109.589 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.524 1.129 . . . . 15.0 108.372 178.163 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? 61.41 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.579 1.552 . . . . 0.0 109.985 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -130.21 -165.19 1.51 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.683 1.193 . . . . 0.0 110.03 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p 53.57 36.59 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.103 1.361 . . . . 0.0 112.253 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' A' ' 223' ' ' ALA . 27.6 p -125.16 -57.37 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.382 1.073 . . . . 0.0 108.244 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.69 86.93 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.338 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.43 55.86 1.79 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' B' ' 12' ' ' PRO . 13.1 mt -76.3 -170.51 1.48 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.454 -158.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.73 -61.15 0.5 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.837 1.655 . . . . 0.0 112.035 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.528 ' HB2' ' NE2' ' B' ' 35' ' ' GLN . 3.8 pp -65.68 -23.15 66.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.42 ' HB3' ' HD3' ' B' ' 12' ' ' PRO . 2.3 tm? -168.84 -58.91 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.999 174.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' B' ' 8' ' ' LEU . 83.1 Cg_exo -51.08 -19.01 5.28 Favored 'Trans proline' 0 C--N 1.404 3.484 0 C-N-CA 123.434 2.756 . . . . 0.0 116.958 -167.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' B' ' 8' ' ' LEU . 1.1 tt -145.63 72.53 1.31 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -174.78 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.78 5.36 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.828 1.651 . . . . 0.0 114.37 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 83.5 m -114.85 90.87 23.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.001 0.92 . . . . 0.0 109.937 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -96.48 17.52 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.393 2.728 . . . . 0.0 112.394 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.03 144.31 31.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 124.181 0.992 . . . . 0.0 109.001 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.1 p -85.61 118.51 25.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.252 0.621 . . . . 0.0 110.785 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 52.77 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.715 1.606 . . . . 0.0 114.958 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.25 -65.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -161.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -69.15 146.85 52.13 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -161.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.58 ' HA ' ' NH2' ' A' ' 193' ' ' ARG . 92.4 m -105.79 110.25 63.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.889 1.276 . . . . 0.0 110.839 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.56 -86.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.793 2.329 . . . . 0.0 111.24 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.3 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.376 1.47 . . . . 0.0 113.286 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.9 ttp 55.36 73.77 0.82 Allowed Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.617 1.167 . . . . 0.0 111.07 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.38 141.15 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.748 2.298 . . . . 0.0 113.157 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.2 133.87 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.54 0.736 . . . . 0.0 109.164 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.94 -159.39 0.27 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.945 0.898 . . . . 0.0 110.254 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.63 -178.94 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.777 0.831 . . . . 0.0 109.842 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -99.36 21.3 12.24 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 0.0 109.914 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 11.05 22.52 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.904 0.882 . . . . 0.0 111.401 -172.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.09 -17.05 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.804 1.242 . . . . 0.0 113.512 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 74.64 -172.97 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.153 1.381 . . . . 0.0 111.606 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' B' ' 10' ' ' LEU . 10.3 pt20 -142.17 -177.52 5.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.17 0.988 . . . . 0.0 110.701 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.94 -40.21 2.13 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.406 ' O ' HG23 ' B' ' 38' ' ' ILE . 24.2 t70 -72.59 151.13 42.53 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.406 HG23 ' O ' ' B' ' 37' ' ' ASP . 5.7 tt 57.63 6.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 126.728 2.011 . . . . 0.0 113.122 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.472 HG21 HD21 ' B' ' 10' ' ' LEU . 28.3 m -89.67 131.7 35.52 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.382 0.673 . . . . 0.0 109.482 -176.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.15 69.97 1.37 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.553 1.141 . . . . 0.0 110.846 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.98 22.4 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.358 2.705 . . . . 0.0 112.346 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.98 -167.86 31.9 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.39 147.66 14.42 Favored Glycine 0 N--CA 1.463 0.487 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.92 70.12 6.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.756 0.789 . . . . 0.0 109.294 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -64.13 124.27 21.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.351 1.06 . . . . 0.0 110.72 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.28 9.19 6.93 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.439 1.096 . . . . 0.0 112.303 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.79 42.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.17 0.588 . . . . 0.0 112.529 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -65.49 150.68 47.97 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.203 0.601 . . . . 0.0 111.716 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.48 152.16 42.66 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.66 -8.61 57.23 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -69.38 -84.81 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 122.76 0.424 . . . . 0.0 111.163 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.4 m -111.28 -80.96 0.58 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.09 -61.32 1.73 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.307 1.043 . . . . 0.0 108.427 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.02 103.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.226 1.411 . . . . 0.0 112.531 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.85 -20.27 46.39 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.892 0.877 . . . . 0.0 110.994 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -135.86 128.26 30.34 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.325 1.05 . . . . 0.0 108.939 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 62.22 -167.77 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.806 1.242 . . . . 0.0 112.122 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 54.9 m -132.18 177.2 7.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 109.587 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 40.08 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.494 1.918 . . . . 0.0 114.084 -174.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.9 m -147.38 94.07 2.33 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.26 150.41 45.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.696 0.399 . . . . 0.0 110.212 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -135.38 86.79 29.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.629 1.172 . . . . 0.0 109.183 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -82.07 -170.63 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.947 2.432 . . . . 0.0 112.092 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.5 -35.69 65.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.881 0.872 . . . . 0.0 111.455 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -66.45 93.34 0.23 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.431 0.692 . . . . 0.0 109.837 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -91.4 158.01 16.76 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.474 0.709 . . . . 0.0 109.702 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.23 162.84 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.801 0.841 . . . . 0.0 112.324 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.96 133.54 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.938 0.895 . . . . 0.0 109.023 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.03 124.11 32.09 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.3 136.97 41.18 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.882 0.473 . . . . 0.0 109.951 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp 77.78 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 125.627 1.571 . . . . 0.0 111.704 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.44 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 123.116 0.388 . . . . 0.0 113.412 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -57.94 -57.65 11.87 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.197 0.999 . . . . 0.0 110.892 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.82 123.38 0.67 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.0 ttt -84.03 77.67 9.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.904 0.852 . . . . 0.0 110.213 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.24 57.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 55.78 -171.07 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.938 1.295 . . . . 0.0 112.619 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.3 p -83.52 -63.31 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.024 0.529 . . . . 0.0 110.751 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -40.61 5.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.781 0.432 . . . . 0.0 110.988 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.83 87.16 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 122.215 1.007 . . . . 0.0 110.271 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 45.9 p -97.9 -54.29 3.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.761 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.63 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.828 1.651 . . . . 0.0 114.355 169.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.85 86.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.448 0.699 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 20.1 ptt85 -66.81 -56.16 11.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.097 0.959 . . . . 0.0 111.247 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 171.44 151.59 0.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.797 1.639 . . . . 0.0 108.29 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -111.82 81.15 1.41 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.493 ' HB1' ' HA2' ' B' ' 91' ' ' GLY . . . -172.88 108.57 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.386 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -85.09 107.42 17.17 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.24 72.28 1.0 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.42 128.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.509 1.524 . . . . 0.0 111.494 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.493 ' HA2' ' HB1' ' B' ' 87' ' ' ALA . . . -63.44 -69.66 1.26 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.44 0.462 . . . . 0.0 112.912 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.79 -61.39 4.75 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 122.983 0.325 . . . . 0.0 112.32 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.738 ' HB3' ' HA3' ' B' ' 134' ' ' GLY . 97.1 m-85 63.24 17.03 9.91 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.781 1.232 . . . . 0.0 112.319 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -178.05 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 155.22 4.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.348 1.059 . . . . 0.0 110.169 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -95.07 149.33 19.31 Favored Glycine 0 C--O 1.244 0.748 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 163.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.83 78.58 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-O 123.04 1.4 . . . . 0.0 109.102 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.55 -64.03 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.014 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.475 ' HB2' HD13 ' A' ' 394' ' ' LEU . . . 52.41 -156.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.499 1.12 . . . . 0.0 111.6 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.422 HD23 ' O ' ' B' ' 110' ' ' ALA . 5.6 mp -63.26 141.14 97.78 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 123.798 0.839 . . . . 0.0 109.773 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.495 ' HB3' ' HA2' ' B' ' 116' ' ' GLY . 94.6 Cg_endo -88.35 137.55 3.67 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.727 2.285 . . . . 0.0 113.539 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' B' ' 105' ' ' GLN . 0.0 OUTLIER -68.35 103.49 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 168.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' B' ' 109' ' ' TYR . 42.7 m -75.07 95.9 3.13 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.323 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.85 -71.08 2.92 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.603 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 16.0 tp60 -170.99 -154.12 0.09 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.603 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 89.8 t80 -58.29 99.45 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.617 0.644 . . . . 0.0 109.884 164.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -140.23 -1.09 1.56 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.14 0.976 . . . . 0.0 109.752 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 351' ' ' LEU . 86.4 t60 61.75 75.78 0.39 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.715 1.206 . . . . 0.0 110.674 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.438 ' HB3' ' HB ' ' B' ' 103' ' ' THR . 6.2 t80 -155.63 64.77 0.6 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.422 ' O ' HD23 ' B' ' 100' ' ' LEU . . . -94.18 -26.1 16.82 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.336 172.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.471 HD13 ' N ' ' B' ' 112' ' ' ASN . 0.9 OUTLIER -64.82 144.73 57.06 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.471 ' N ' HD13 ' B' ' 111' ' ' LEU . 18.8 t30 80.66 140.44 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.747 1.28 . . . . 0.0 109.877 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 44.83 100.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.887 2.075 . . . . 0.0 112.38 -168.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.72 -30.87 70.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.173 0.989 . . . . 0.0 112.234 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.1 p -125.25 166.39 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.077 0.551 . . . . 0.0 110.679 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' B' ' 101' ' ' PRO . . . -63.38 -33.16 86.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.665 0.603 . . . . 0.0 111.779 171.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -63.46 145.37 97.26 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.813 0.845 . . . . 0.0 110.004 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.439 ' HB3' ' HG3' ' A' ' 317' ' ' GLN . 42.2 Cg_exo -42.14 131.69 4.63 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.968 3.112 . . . . 0.0 113.652 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -87.3 176.71 7.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.211 0.529 . . . . 0.0 111.831 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.92 148.24 7.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 32.5 t -80.2 71.75 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.8 0.809 . . . . 0.0 110.046 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 98.1 m -158.79 104.98 1.78 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.106 1.762 . . . . 0.0 106.547 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -139.04 162.16 35.61 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.2 t 70.13 116.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.132 1.373 . . . . 0.0 111.303 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.44 35.99 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.525 1.13 . . . . 0.0 110.749 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.94 -170.17 1.82 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.958 0.903 . . . . 0.0 111.391 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.454 ' H ' ' HE2' ' A' ' 428' ' ' MET . 36.4 m 70.19 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.595 1.558 . . . . 0.0 108.303 -164.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.598 ' HB2' HD12 ' A' ' 144' ' ' LEU . . . -164.66 -169.01 1.62 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.854 0.862 . . . . 0.0 109.931 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m 62.15 44.09 8.11 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.106 0.955 . . . . 0.0 109.282 -171.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.29 -75.6 0.09 Allowed 'General case' 0 C--N 1.355 0.812 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.339 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 5.4 m95 50.45 31.35 5.41 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.814 1.246 . . . . 0.0 112.36 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m -80.19 -6.48 57.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -162.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.4 p -82.72 94.02 7.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' B' ' 93' ' ' PHE . . . -115.76 145.04 18.63 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.474 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 48.3 t 64.14 -76.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.315 1.446 . . . . 0.0 110.446 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.615 ' HG2' ' H ' ' B' ' 138' ' ' TYR . 22.8 ttmm 178.43 155.05 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.889 1.676 . . . . 0.0 107.726 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.3 p -66.32 -24.59 66.56 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.124 0.42 . . . . 0.0 110.84 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . 0.615 ' H ' ' HG2' ' B' ' 136' ' ' LYS . 65.1 t80 65.94 173.06 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.356 1.462 . . . . 0.0 111.369 170.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 14.1 t-20 84.53 -53.88 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.757 1.623 . . . . 0.0 110.229 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 76.27 45.65 14.46 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 92.98 0.9 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.283 0.633 . . . . 0.0 110.11 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.471 HD23 ' H ' ' B' ' 142' ' ' LEU . 2.3 pt? -76.67 -9.75 58.89 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.717 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.17 74.23 0.85 Allowed Glycine 0 C--N 1.358 1.77 0 O-C-N 123.571 0.544 . . . . 0.0 112.544 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 p -158.57 97.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.714 1.205 . . . . 0.0 108.164 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.09 147.95 46.24 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.192 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.11 140.59 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 121.064 0.459 . . . . 0.0 110.984 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -118.43 78.18 1.24 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.076 0.95 . . . . 0.0 108.968 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.88 142.97 15.44 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' B' ' 149' ' ' LYS . 0.6 OUTLIER -70.34 91.12 0.73 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -178.227 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.541 0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.631 176.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.745 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.463 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 ' HA ' HD12 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.559 HG23 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.52 HG21 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.617 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.52 ' HE3' HG21 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.617 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.567 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.684 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.684 HD13 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.534 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.41 ' HA ' HG12 ' A' ' 79' ' ' ILE . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 4.6 t30 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.592 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.422 HG22 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE2' HD12 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.518 HD12 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG13 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.802 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.53 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.64 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.681 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.448 ' HE2' HD13 ' B' ' 13' ' ' LEU . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.451 HG22 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.444 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.558 ' HE1' ' HB ' ' B' ' 16' ' ' THR . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.54 HG11 HG21 ' B' ' 18' ' ' VAL . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.535 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.517 HG21 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.532 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 158' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.535 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.517 ' HD3' HG21 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.426 ' HE1' HD13 ' B' ' 6' ' ' ILE . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.442 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG23 ' A' ' 166' ' ' ILE . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.63 ' HG2' HG11 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.695 ' SD ' HG13 ' A' ' 132' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.477 HG13 HD12 ' B' ' 111' ' ' LEU . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.591 ' HG2' ' HH ' ' B' ' 109' ' ' TYR . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.637 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.466 HD12 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.637 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.688 HH12 ' HB2' ' B' ' 118' ' ' PRO . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.494 HG11 ' HE1' ' B' ' 109' ' ' TYR . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.733 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.547 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.513 HD21 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.25 -39.8 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 46.5 ttp -63.59 -41.72 98.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.6 -46.43 89.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.798 -1.092 . . . . 15.0 111.056 176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.0 t -62.78 -29.26 70.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.928 0.891 . . . . 15.0 111.103 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.07 -32.72 65.2 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.881 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -80.99 174.62 11.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.17 0.986 . . . . 15.0 111.491 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -83.49 -21.74 32.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.555 -1.657 . . . . 15.0 109.572 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -160.95 139.04 7.17 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.483 0.713 . . . . 15.0 110.668 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.658 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 27.3 Cg_endo -102.29 0.3 0.44 Allowed 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.347 2.698 . . . . 15.0 115.422 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.1 -37.33 74.32 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -168.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -55.76 -45.22 78.12 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.522 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 10.8 t -71.24 -56.86 9.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.939 -1.028 . . . . 15.0 108.993 -170.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 381' ' ' PRO . 1.7 mp -64.04 -64.0 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.725 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.45 -36.77 83.49 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -90.54 -35.23 15.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.534 0.606 . . . . 15.0 111.977 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.522 ' HD2' ' HA ' ' A' ' 384' ' ' VAL . 55.6 m-85 -102.51 -42.08 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.357 1.243 . . . . 15.0 114.357 -171.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.7 p -67.45 -19.13 65.31 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.947 0.794 . . . . 15.0 111.843 -170.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.34 -5.24 59.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.765 0.826 . . . . 15.0 112.186 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -148.27 130.94 15.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -59.17 -21.33 59.23 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.558 0.743 . . . . 15.0 112.224 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.513 ' SD ' HD21 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' B' ' 106' ' ' TYR . 75.0 m-20 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' B' ' 101' ' ' PRO . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.547 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.5 ' HB3' HG23 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.574 ' HA ' HG12 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 3.6 t-20 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.459 HD12 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.7 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.457 ' HA ' HE22 ' A' ' 431' ' ' GLN . 43.6 t-20 -80.39 51.45 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -127.32 88.89 2.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.829 1.251 . . . . 15.0 108.315 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . 0.457 HE22 ' HA ' ' A' ' 429' ' ' ASN . 20.8 mp0 -97.87 -73.74 0.6 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 15.0 109.728 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.943 0.897 . . . . 15.0 108.607 -178.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.463 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 23.6 tptm -129.19 -67.04 0.79 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.146 0.578 . . . . 0.0 110.313 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -129.44 148.39 51.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.503 0.721 . . . . 0.0 110.656 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -128.06 68.11 1.34 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 14.5 t -71.21 143.47 50.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.809 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.426 HD13 ' HE1' ' A' ' 222' ' ' HIS . 5.2 tt -78.41 111.11 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.213 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.14 89.82 6.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 166.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -86.08 143.44 28.07 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -161.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.09 170.22 12.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.197 -1.82 . . . . 0.0 108.297 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . 0.256 0.0 OUTLIER 25.35 96.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.289 1.835 . . . . 0.0 115.516 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.67 65.87 1.97 Allowed Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.793 1.237 . . . . 0.0 112.094 -173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -102.86 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.716 2.277 . . . . 0.0 111.324 158.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.448 HD13 ' HE2' ' A' ' 168' ' ' PHE . 75.7 mt -134.5 135.97 42.79 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.761 1.624 . . . . 0.0 106.868 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 70.16 100.44 0.06 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -160.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -138.04 49.12 1.96 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.952 1.358 . . . . 0.0 107.527 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.558 ' HB ' ' HE1' ' A' ' 185' ' ' PHE . 87.6 m -153.74 128.72 4.88 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.402 -172.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.74 109.86 1.34 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.787 1.658 . . . . 0.0 110.508 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.54 HG21 HG11 ' A' ' 186' ' ' VAL . 7.6 p -75.12 86.05 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-O 122.432 1.11 . . . . 0.0 110.044 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.1 m -117.68 88.36 2.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.885 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.53 92.24 1.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.178 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.95 159.97 29.98 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.431 0.692 . . . . 0.0 109.232 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 67.15 105.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.544 1.138 . . . . 0.0 109.892 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 p -81.74 145.81 55.03 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.415 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.96 93.07 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.301 2.667 . . . . 0.0 112.384 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.48 128.97 37.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.021 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -61.71 -37.15 37.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 117.841 -1.075 . . . . 0.0 112.583 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.69 -27.69 43.4 Favored 'Trans proline' 0 C--N 1.41 3.78 0 C-N-CA 122.387 2.058 . . . . 0.0 113.625 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.523 HG11 ' H ' ' B' ' 29' ' ' LEU 0.271 7.7 p 48.64 -75.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 126.986 2.114 . . . . 0.0 113.827 175.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.523 ' H ' HG11 ' B' ' 28' ' ' VAL . 1.7 tm? 55.66 -89.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.201 1.801 . . . . 0.0 112.052 171.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.0 -29.2 69.54 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.23 1.012 . . . . 0.0 111.716 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.63 108.34 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.526 0.73 . . . . 0.0 109.17 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -80.58 87.3 5.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.21 81.27 3.71 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.988 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.6 -62.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.061 1.344 . . . . 0.0 107.731 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.9 140.39 4.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.041 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.28 53.5 3.86 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.19 165.91 34.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.105 0.962 . . . . 0.0 109.106 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.9 mt 76.35 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.524 1.53 . . . . 0.0 110.221 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.0 m -75.04 -17.82 60.43 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.463 0.705 . . . . 0.0 111.017 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.35 138.35 85.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.43 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 124.024 3.149 . . . . 0.0 114.497 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.32 64.48 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.551 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.18 55.06 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-O 119.924 -0.375 . . . . 0.0 113.486 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.42 -2.83 51.26 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.631 0.772 . . . . 0.0 111.198 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' B' ' 45' ' ' ARG . 1.8 mmp_? -68.06 75.65 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.144 0.977 . . . . 0.0 110.715 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 59.2 -96.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.84 1.256 . . . . 0.0 110.804 -164.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' B' ' 53' ' ' ALA . 3.5 mm? 56.84 168.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.488 1.115 . . . . 0.0 111.7 -167.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.531 ' H ' ' HB2' ' B' ' 53' ' ' ALA . 55.3 m 73.35 -36.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.649 1.58 . . . . 0.0 112.851 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.26 46.48 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.54 0.59 . . . . 0.0 114.528 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.526 ' HB3' HG22 ' B' ' 52' ' ' THR . 14.1 t70 -147.31 160.65 42.27 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.482 0.713 . . . . 0.0 109.56 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -63.18 -15.25 56.28 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.173 0.989 . . . . 0.0 112.963 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.526 HG22 ' HB3' ' B' ' 50' ' ' ASP . 11.7 t -66.09 -10.23 38.63 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.7 0.8 . . . . 0.0 111.629 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.673 ' HA ' HD11 ' B' ' 47' ' ' LEU . . . -67.1 -20.77 65.84 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 123.515 0.726 . . . . 0.0 112.154 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.77 47.0 6.51 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.588 1.155 . . . . 0.0 110.378 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 tt 67.04 92.08 0.08 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 109.38 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -143.74 26.18 1.58 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.789 0.836 . . . . 0.0 108.935 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.479 ' HA ' HG23 ' B' ' 48' ' ' THR . 4.1 m-20 -59.0 -44.97 91.73 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.759 0.824 . . . . 0.0 111.551 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -148.2 149.11 31.35 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.401 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 74.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.0 m -78.15 78.41 4.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.78 -51.45 0.56 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.235 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.77 150.84 82.02 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.81 118.83 5.77 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.405 2.07 . . . . 0.0 110.979 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 84.4 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.638 0.775 . . . . 0.0 111.415 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -123.41 91.07 3.4 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.7 -17.09 28.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.111 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tp -68.94 90.96 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.069 0.937 . . . . 0.0 110.623 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.57 143.01 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -100.09 105.62 17.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.94 -48.56 0.13 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.019 0.528 . . . . 0.0 110.334 -172.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -74.79 92.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.711 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.79 -12.4 82.95 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.426 171.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t70 69.21 -77.97 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.912 1.685 . . . . 0.0 111.564 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 170.55 118.26 0.45 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.7 mmt -90.49 -13.18 35.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.938 0.495 . . . . 0.0 110.433 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.29 -138.4 7.67 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -169.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . 5.0 p-10 50.47 -69.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.814 2.046 . . . . 0.0 115.389 166.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 41.6 m -61.8 -45.9 91.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.734 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.13 -53.29 2.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.604 0.762 . . . . 0.0 110.814 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mm -84.05 122.62 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -53.87 110.11 0.55 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.819 0.848 . . . . 0.0 112.696 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' B' ' 77' ' ' ASP . . . -153.09 -60.63 0.14 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 0.0 109.382 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' B' ' 77' ' ' ASP . . . -119.77 100.8 7.46 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.451 ' H ' ' HB3' ' B' ' 87' ' ' ALA . 40.8 ttm180 -161.63 150.14 15.54 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 109.311 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.4 t30 61.52 71.29 0.56 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.325 1.05 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . 0.4 ' H ' ' HB1' ' B' ' 90' ' ' ALA . 78.5 m-85 74.72 -5.4 2.14 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.149 1.38 . . . . 0.0 112.685 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' B' ' 84' ' ' ARG . . . -77.29 -33.46 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.066 0.546 . . . . 0.0 110.013 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.69 -30.56 14.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.894 0.878 . . . . 0.0 110.813 170.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.81 -55.25 0.44 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.4 ' HB1' ' H ' ' B' ' 86' ' ' TYR . . . 61.06 -76.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.597 1.559 . . . . 0.0 112.152 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.75 75.89 0.14 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.0 78.23 0.15 Allowed Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.745 0.688 . . . . 0.0 114.382 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.525 ' HB3' ' HZ1' ' B' ' 136' ' ' LYS . 90.8 t80 -176.41 92.95 0.05 OUTLIER 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.7 16.8 16.41 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.901 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . 0.275 0.3 OUTLIER 63.09 -8.7 0.13 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.903 2.081 . . . . 0.0 116.604 165.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.97 33.66 64.25 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.766 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 35.3 pt 37.39 -172.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 C-N-CA 126.236 1.815 . . . . 0.0 115.524 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -166.55 109.42 0.73 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.89 164.02 22.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.22 0.533 . . . . 0.0 110.533 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.02 -48.08 0.8 Allowed Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.351 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.533 ' HG2' ' HB ' ' A' ' 401' ' ' VAL . 27.8 Cg_exo -64.96 -76.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 121.988 1.792 . . . . 0.0 114.006 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 115' ' ' THR . 4.5 mm? 57.23 -134.15 1.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.579 1.152 . . . . 0.0 111.134 -174.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 4.1 m 60.93 28.13 17.93 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.959 0.904 . . . . 0.0 110.357 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.11 -112.9 5.38 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.822 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.06 86.63 2.96 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.497 ' HE1' ' HB2' ' B' ' 110' ' ' ALA . 88.1 t80 -65.32 101.46 0.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.824 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -83.22 20.47 1.27 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.075 0.95 . . . . 0.0 111.058 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 t60 78.25 -28.18 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.026 1.731 . . . . 0.0 111.551 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.591 ' HH ' ' HG2' ' A' ' 310' ' ' GLU . 82.5 t80 -74.23 89.03 2.01 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.869 1.268 . . . . 0.0 110.336 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.681 ' HB1' ' HB3' ' B' ' 113' ' ' LYS . . . -176.69 -58.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 108.058 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.477 HD12 HG13 ' A' ' 291' ' ' ILE . 1.6 tm? 63.93 -80.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.528 1.531 . . . . 0.0 110.88 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' B' ' 118' ' ' PRO . 27.5 t-20 -72.47 -20.65 61.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.762 1.225 . . . . 0.0 111.122 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.681 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 37.2 ttmt -82.56 93.94 7.4 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.623 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.41 ' HZ1' ' HA ' ' B' ' 122' ' ' THR . 0.0 OUTLIER -95.53 101.41 13.12 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.307 0.643 . . . . 0.0 110.76 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.492 HG22 ' HB2' ' B' ' 102' ' ' LEU . 54.5 p 49.82 33.37 6.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.492 1.517 . . . . 0.0 113.869 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 99.15 -12.1 62.03 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.298 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 96.8 6.58 Favored Pre-proline 0 N--CA 1.477 0.885 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 170.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.688 ' HB2' HH12 ' A' ' 344' ' ' ARG . 10.1 Cg_endo -93.51 -60.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.922 2.415 . . . . 0.0 113.495 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.58 77.48 3.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.148 1.379 . . . . 0.0 111.579 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -166.42 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.783 1.233 . . . . 0.0 108.697 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.431 HG23 ' H ' ' B' ' 123' ' ' ASP . 10.5 m 53.26 -175.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 126.53 1.932 . . . . 0.0 112.868 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.41 ' HA ' ' HZ1' ' B' ' 114' ' ' LYS . 28.2 p -74.83 -31.38 61.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.664 0.786 . . . . 0.0 111.696 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.431 ' H ' HG23 ' B' ' 121' ' ' VAL . 3.7 m-20 -56.2 129.39 40.0 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.128 0.971 . . . . 0.0 113.109 -172.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 12.2 p -93.36 -176.77 4.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.726 1.21 . . . . 0.0 110.216 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.0 81.78 0.67 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 0.0 110.292 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -66.4 -54.08 28.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.157 0.983 . . . . 0.0 112.012 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -66.81 89.32 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.19 99.16 1.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.252 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.6 m -66.2 -37.5 85.73 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 160.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 75.58 -70.44 0.15 Allowed 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.997 1.719 . . . . 0.0 113.444 162.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -90.4 149.09 22.41 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.347 0.659 . . . . 0.0 111.837 -163.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 71.0 m -151.03 11.59 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.109 0.963 . . . . 0.0 110.86 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 53.2 p -93.37 27.86 2.43 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.589 0.755 . . . . 0.0 111.966 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.02 -7.04 83.88 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 114.404 0.521 . . . . 0.0 114.404 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 34.8 m -78.18 -6.19 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.909 0.883 . . . . 0.0 112.056 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.525 ' HZ1' ' HB3' ' B' ' 93' ' ' PHE . 99.5 mttt -73.31 77.76 1.34 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.749 0.819 . . . . 0.0 111.906 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.9 m -179.18 -42.18 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.982 2.113 . . . . 0.0 106.991 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -111.0 155.65 22.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.453 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.48 115.09 3.32 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.663 0.785 . . . . 0.0 109.496 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.2 55.75 2.84 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.93 7.84 6.45 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.47 1.508 . . . . 0.0 113.194 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -89.06 93.91 9.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.013 0.925 . . . . 0.0 109.474 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.71 60.65 1.14 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.14 154.12 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.429 1.092 . . . . 0.0 108.324 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -113.36 165.3 12.58 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.559 0.744 . . . . 0.0 109.028 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.69 149.23 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.454 0.702 . . . . 0.0 110.222 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -66.73 132.56 48.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.285 0.634 . . . . 0.0 111.098 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.9 166.02 16.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.673 0.389 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -85.64 139.97 30.95 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.803 0.841 . . . . 0.0 111.41 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 9.1 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 303' ' ' PRO . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.631 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.425 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.567 HH12 HG13 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG13 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.48 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 41.3 t30 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.506 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.705 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.59 HG22 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.562 HG13 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.443 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.556 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.521 HG23 HE21 ' A' ' 431' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.561 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.654 HG13 HG23 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.637 HG23 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.635 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.589 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.59 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.635 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.458 ' HB3' HD12 ' B' ' 14' ' ' LEU . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.401 ' HE2' ' O ' ' B' ' 13' ' ' LEU . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.465 HG21 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.654 HG23 HG13 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.445 HD11 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.516 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.619 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.56 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.59 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.403 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.605 ' HB2' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.51 ' HA ' HG23 ' A' ' 166' ' ' ILE . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 164' ' ' VAL . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.548 ' HB2' ' HZ3' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.556 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.421 HG13 ' HE1' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.485 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.473 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.469 HD22 HD22 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.525 HD12 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.529 ' HB3' HD21 ' B' ' 112' ' ' ASN . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.503 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 113' ' ' LYS . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB2' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.43 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.405 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.525 ' HE3' HD12 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' B' ' 112' ' ' ASN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.416 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.626 HD13 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -35.29 80.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.7 ttp -72.33 -41.98 65.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.629 -0.714 . . . . 15.0 110.82 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.703 ' HA ' HG22 ' A' ' 384' ' ' VAL . . . -67.85 -46.92 70.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.906 0.882 . . . . 15.0 111.765 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 27.5 t -65.07 -18.23 65.13 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.997 -1.001 . . . . 15.0 112.245 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.62 61.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.569 0.748 . . . . 15.0 111.553 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -104.39 -178.51 3.68 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.379 0.672 . . . . 15.0 110.798 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.58 -52.64 60.09 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.709 0.804 . . . . 15.0 111.356 -169.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 19.4 t70 -145.02 126.02 7.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.389 -0.823 . . . . 15.0 109.483 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 380' ' ' ASP . 31.8 Cg_exo -60.9 -22.54 74.52 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.512 2.808 . . . . 15.0 115.196 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.67 -32.91 67.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.01 0.524 . . . . 15.0 112.201 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 14.9 pt-20 -58.47 -45.78 87.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.006 -0.739 . . . . 15.0 109.006 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 375' ' ' ALA . 19.3 t -69.71 -59.43 3.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.966 0.906 . . . . 15.0 109.727 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.21 -54.59 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.35 -1.295 . . . . 15.0 110.468 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.68 -32.72 62.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.078 0.399 . . . . 15.0 112.078 -169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.18 -53.35 31.19 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 110.123 -0.325 . . . . 15.0 110.123 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.96 -32.81 57.56 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.185 1.18 . . . . 15.0 114.185 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.1 p -60.17 -27.34 67.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.008 0.433 . . . . 15.0 111.304 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -109.68 8.48 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 15.0 111.365 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -117.7 99.67 7.11 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.252 -0.647 . . . . 15.0 109.252 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -47.22 -42.89 21.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.418 1.487 . . . . 15.0 112.576 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.589 ' HA ' HD21 ' B' ' 102' ' ' LEU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.409 ' HA ' HD13 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.705 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . 0.467 ' HG1' ' HB2' ' A' ' 426' ' ' GLU . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.836 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 21.4 m120 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.467 ' HB2' ' HG1' ' A' ' 423' ' ' THR . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.836 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -68.26 2.86 1.96 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.94 71.62 10.49 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 119.8 1.182 . . . . 15.0 111.447 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . 0.521 HE21 HG23 ' A' ' 143' ' ' THR . 9.7 mp0 -125.66 -58.59 1.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.325 1.05 . . . . 15.0 108.61 170.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 123.843 0.857 . . . . 15.0 109.382 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -142.61 -168.11 2.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.423 1.089 . . . . 0.0 109.129 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.72 163.58 39.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.523 0.729 . . . . 0.0 110.16 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -140.96 144.23 35.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 0.0 109.884 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.1 t -150.5 171.57 16.85 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.2 148.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.739 0.816 . . . . 0.0 110.982 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.21 -30.69 10.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.631 0.772 . . . . 0.0 109.693 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp 54.95 157.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.831 2.452 . . . . 0.0 114.875 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.34 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.038 1.335 . . . . 0.0 107.935 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -4.91 59.25 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.443 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -155.88 100.82 2.16 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.152 0.581 . . . . 0.0 109.66 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.1 146.84 6.58 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.707 2.271 . . . . 0.0 112.001 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.401 ' O ' ' HE2' ' A' ' 194' ' ' MET . 9.4 mp -73.65 -23.98 59.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.186 0.594 . . . . 0.0 111.697 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.604 HD11 ' H ' ' B' ' 14' ' ' LEU . 0.0 OUTLIER -82.68 68.64 9.23 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.407 -174.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -70.03 -20.27 63.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.814 0.846 . . . . 0.0 112.548 -173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -94.35 111.39 53.44 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.033 0.533 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.45 171.34 8.77 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.028 2.485 . . . . 0.0 112.082 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.98 95.83 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 122.11 0.957 . . . . 0.0 109.448 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -73.9 -47.21 39.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.967 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -108.23 120.64 42.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.597 0.759 . . . . 0.0 109.53 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.23 90.08 2.49 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.725 0.81 . . . . 0.0 109.53 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -123.57 103.39 8.4 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 57.6 p -80.89 149.21 66.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 167.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -37.73 103.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.521 3.481 . . . . 0.0 115.593 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' B' ' 23' ' ' THR . 0.0 OUTLIER -136.85 169.25 18.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.327 1.051 . . . . 0.0 109.907 174.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -110.59 142.77 26.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.591 0.757 . . . . 0.0 109.59 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.11 103.95 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.533 2.155 . . . . 0.0 111.093 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.77 97.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 CA-C-O 121.651 0.738 . . . . 0.0 109.811 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.2 tp -135.35 116.28 14.16 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -94.26 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.701 0.626 . . . . 0.0 110.924 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 56.7 23.34 7.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.823 1.249 . . . . 0.0 111.215 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -86.37 78.99 9.16 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.95 73.39 10.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.621 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.81 -68.47 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.83 -73.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.812 1.645 . . . . 0.0 111.943 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.63 -137.59 3.67 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -162.1 148.6 13.54 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.404 1.082 . . . . 0.0 109.007 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -101.27 -8.05 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.364 0.666 . . . . 0.0 112.657 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m 59.23 77.73 0.3 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.66 1.184 . . . . 0.0 110.51 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.29 125.27 31.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.323 0.649 . . . . 0.0 110.91 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.26 -28.33 70.95 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 167.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.24 -121.31 6.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.22 52.82 0.02 OUTLIER Glycine 0 C--O 1.24 0.491 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.02 104.5 0.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.863 0.865 . . . . 0.0 111.078 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -98.82 -153.76 0.44 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.447 1.099 . . . . 0.0 110.295 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -62.92 91.8 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.613 0.765 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp 70.95 -13.11 0.52 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.777 1.631 . . . . 0.0 114.205 165.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m 65.07 -75.75 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.463 1.505 . . . . 0.0 111.158 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.04 81.87 0.06 OUTLIER Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -125.86 -44.73 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.295 0.638 . . . . 0.0 111.004 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' B' ' 52' ' ' THR . 15.0 pt20 -50.65 -69.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.082 0.953 . . . . 0.0 112.844 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' B' ' 51' ' ' GLN . 80.6 m -108.21 -85.13 0.53 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.24 -71.33 0.75 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 171.87 173.21 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.473 1.909 . . . . 0.0 108.52 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.9 mt 64.02 -168.48 0.2 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 0.0 113.131 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -133.98 99.84 4.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.957 0.903 . . . . 0.0 109.424 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.18 97.56 7.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.331 1.052 . . . . 0.0 109.571 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -98.07 175.34 6.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.268 0.627 . . . . 0.0 110.293 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.71 150.77 45.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.09 0.956 . . . . 0.0 109.559 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 62.4 p -93.39 105.9 17.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.46 -46.89 11.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.066 0.547 . . . . 0.0 110.253 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -172.04 165.95 3.87 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.786 0.834 . . . . 0.0 110.395 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -37.11 -40.6 0.65 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 124.708 3.606 . . . . 0.0 115.673 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.99 -79.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.142 1.377 . . . . 0.0 112.402 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -122.73 -44.58 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.659 0.784 . . . . 0.0 110.181 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.02 152.19 33.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.321 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.98 68.53 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.579 1.181 . . . . 0.0 108.97 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.45 169.39 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.315 1.446 . . . . 0.0 108.14 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -97.01 -58.44 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt 61.57 -166.45 0.21 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.544 1.152 . . . . 0.0 110.562 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tp 49.99 23.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 C-N-CA 125.68 1.592 . . . . 0.0 113.838 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.63 -107.26 0.37 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.43 -167.92 0.17 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.474 1.11 . . . . 0.0 112.675 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 168.56 30.23 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 67.2 mtt -102.77 94.23 5.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.252 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.83 80.3 1.22 Allowed Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.62 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.576 1.15 . . . . 0.0 110.895 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -102.52 -73.39 0.66 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.714 0.805 . . . . 0.0 109.423 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.86 -72.72 0.71 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.6 mm 61.21 -76.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.642 1.577 . . . . 0.0 112.154 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 25.8 m 62.38 -78.54 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.842 1.257 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.34 -91.33 0.42 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 174.47 165.48 0.23 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.951 1.3 . . . . 0.0 109.453 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 63.62 111.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.743 1.217 . . . . 0.0 111.607 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.598 ' HB3' ' HA3' ' B' ' 140' ' ' GLY . 3.7 p-10 -72.0 107.84 4.92 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -76.94 82.31 3.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.24 134.37 0.08 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 126.213 1.805 . . . . 0.0 106.883 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.22 90.22 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.62 -48.88 2.25 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.9 -44.46 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.886 1.274 . . . . 0.0 108.951 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.84 -83.02 0.54 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.58 -73.35 0.78 Allowed Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.433 0.54 . . . . 0.0 113.349 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -67.3 -20.58 65.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.197 1.399 . . . . 0.0 111.03 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.647 ' HE1' HG21 ' A' ' 384' ' ' VAL . 84.3 t80 -134.96 152.77 52.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.818 0.847 . . . . 0.0 109.324 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -145.72 145.62 30.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.454 1.101 . . . . 0.0 109.475 178.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.19 89.75 0.64 Allowed Glycine 0 C--N 1.345 1.07 0 O-C-N 123.774 0.672 . . . . 0.0 112.232 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.79 137.29 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 122.209 -0.583 . . . . 0.0 110.904 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.18 -68.76 0.19 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.772 1.229 . . . . 0.0 108.773 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.55 29.17 6.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.259 1.424 . . . . 0.0 112.991 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.38 88.54 0.12 Allowed Pre-proline 0 C--N 1.363 1.169 0 C-N-CA 124.599 1.159 . . . . 0.0 109.158 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.85 99.95 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.273 1.982 . . . . 0.0 112.328 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 401' ' ' VAL . 10.9 mp -82.43 -156.44 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.684 0.794 . . . . 0.0 109.02 169.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 63.9 p -64.58 121.97 15.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.223 0.609 . . . . 0.0 109.707 172.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.11 -17.61 55.93 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 -168.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.583 HE21 ' HA ' ' B' ' 105' ' ' GLN . 0.0 OUTLIER -126.57 -179.38 4.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.028 0.531 . . . . 0.0 110.491 175.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -65.48 95.71 0.22 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 122.894 0.477 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 11.1 m -142.96 21.26 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.199 1.0 . . . . 0.0 109.682 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -75.96 85.28 2.87 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.356 0.598 . . . . 0.0 109.71 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -139.79 -28.33 0.75 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.694 1.198 . . . . 0.0 108.127 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.65 127.3 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.103 1.361 . . . . 0.0 108.278 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.503 HD11 ' H ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -78.92 1.4 23.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.493 0.717 . . . . 0.0 111.806 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.529 HD21 ' HB3' ' A' ' 310' ' ' GLU . 34.8 t30 -70.6 81.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.253 1.021 . . . . 0.0 110.619 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' A' ' 313' ' ' VAL . 4.1 ptpp? 174.73 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.691 1.596 . . . . 0.0 109.3 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -81.25 95.54 6.99 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p 52.56 -78.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.577 1.951 . . . . 0.0 114.211 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.15 146.76 11.78 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.25 0.452 . . . . 0.0 113.625 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -81.63 -50.17 0.91 Allowed Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.303 1.041 . . . . 0.0 111.991 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.02 -6.63 17.56 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 121.63 1.554 . . . . 0.0 112.209 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.31 -32.24 24.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.238 1.015 . . . . 0.0 109.548 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 67.59 96.03 0.06 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 124.985 1.314 . . . . 0.0 111.332 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.81 -33.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.058 0.943 . . . . 0.0 108.774 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.5 m 81.53 -55.24 0.27 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.211 1.805 . . . . 0.0 112.039 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 71.91 -66.24 0.31 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.574 1.55 . . . . 0.0 110.392 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -157.51 142.94 17.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.8 27.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.203 0.601 . . . . 0.0 109.95 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.667 ' HB2' ' SD ' ' A' ' 428' ' ' MET . . . -74.49 179.59 4.56 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.049 0.54 . . . . 0.0 112.263 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 3.1 m 79.74 29.85 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.541 1.937 . . . . 0.0 110.593 -164.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.09 85.51 0.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.729 1.212 . . . . 0.0 112.325 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 46.8 m -70.66 138.77 50.98 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 158.95 26.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.419 0.628 . . . . 0.0 111.75 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -110.8 -74.32 0.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.068 -147.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' B' ' 135' ' ' VAL . 81.3 p 47.38 82.38 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.56 1.544 . . . . 0.0 112.435 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 3.1 m -68.58 -43.28 76.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.821 0.848 . . . . 0.0 110.592 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.46 -5.99 64.7 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.504 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.582 ' HA ' ' HB2' ' B' ' 132' ' ' SER . 5.7 m 56.63 4.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 127.236 2.214 . . . . 0.0 114.63 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.451 ' HG2' ' HG1' ' B' ' 137' ' ' THR . 66.1 tttp 64.43 136.32 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.789 1.636 . . . . 0.0 112.238 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.451 ' HG1' ' HG2' ' B' ' 136' ' ' LYS . 23.4 m 77.27 -22.2 0.29 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.032 1.333 . . . . 0.0 113.496 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -57.07 128.16 35.58 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.696 0.68 . . . . 0.0 112.827 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -174.87 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.393 1.477 . . . . 0.0 109.323 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' B' ' 85' ' ' ASN . . . 99.11 -51.28 1.14 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.459 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 -152.3 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.674 1.189 . . . . 0.0 111.512 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 mt 68.14 13.73 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.202 1.001 . . . . 0.0 111.586 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.25 32.37 12.27 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.575 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -82.99 60.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.406 1.098 . . . . 0.0 110.572 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.51 103.85 4.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.101 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.55 HD12 ' HD3' ' B' ' 149' ' ' LYS . 27.2 pt -123.35 150.21 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.598 0.759 . . . . 0.0 109.351 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.16 176.73 8.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.737 0.815 . . . . 0.0 110.815 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 40.3 32.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.495 1.918 . . . . 0.0 113.893 -172.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.55 ' HD3' HD12 ' B' ' 146' ' ' ILE . 89.1 tttt -125.38 102.08 7.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 123.742 0.817 . . . . 0.0 109.918 -178.571 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG13 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.715 HD11 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.449 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.449 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.434 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 HG21 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.602 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.602 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.715 ' HB3' HD11 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' A' ' 19' ' ' ILE . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.436 HD13 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG22 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.53 ' HG2' HD12 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' HA ' ' HE3' ' A' ' 274' ' ' MET . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.485 HD12 ' CZ2' ' B' ' 131' ' ' TRP . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.725 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.564 HG11 HG23 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.471 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.485 HD22 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.428 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.564 HG23 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.635 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.467 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.566 ' HB2' HD22 ' B' ' 10' ' ' LEU . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.496 ' HB2' HG12 ' B' ' 6' ' ' ILE . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 226' ' ' LEU . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HZ2' ' HB2' ' A' ' 214' ' ' ASP . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.489 ' HA ' HG22 ' A' ' 166' ' ' ILE . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.765 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.725 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.484 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.612 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.562 HG22 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.53 ' HE3' ' HA ' ' A' ' 137' ' ' VAL . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.608 HD13 ' HE2' ' A' ' 428' ' ' MET . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.429 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.586 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.469 HD13 HG12 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.472 ' HB1' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.472 HD22 ' HB1' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.552 ' HG3' HG22 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.462 HD21 ' HE1' ' A' ' 398' ' ' MET . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 -58.39 -42.02 86.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 43.3 ttp -75.78 -33.05 60.14 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.999 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -77.19 -9.73 58.96 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.746 0.818 . . . . 15.0 111.26 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 47.5 t -58.64 -22.44 56.62 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 122.826 0.45 . . . . 15.0 111.271 167.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.07 -11.22 53.35 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.753 0.821 . . . . 15.0 111.905 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -130.86 116.65 18.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.821 0.848 . . . . 15.0 110.821 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.55 -38.0 85.86 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.846 0.858 . . . . 15.0 109.501 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -133.94 88.36 32.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 114.73 -1.123 . . . . 15.0 108.544 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.42 47.29 2.15 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.63 2.887 . . . . 15.0 114.847 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -53.24 -48.42 68.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.466 0.706 . . . . 15.0 110.992 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.59 -33.45 63.95 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.979 0.799 . . . . 15.0 111.791 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.84 -62.81 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.32 -42.83 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.534 -0.757 . . . . 15.0 109.884 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.92 -51.21 58.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.636 -0.697 . . . . 15.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -54.7 -42.98 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.302 0.501 . . . . 15.0 111.406 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.93 -62.07 2.14 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.793 0.437 . . . . 15.0 110.819 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 90.4 p -67.67 -8.49 35.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.437 0.903 . . . . 15.0 113.437 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.94 -19.02 13.65 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.383 0.673 . . . . 15.0 111.795 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -139.11 124.12 18.86 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -54.47 -46.04 73.27 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.132 0.973 . . . . 15.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.558 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' B' ' 106' ' ' TYR . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.467 ' HA ' HD13 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.469 HG12 HD13 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.436 ' HD3' HD13 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.461 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.765 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.49 16.48 0.48 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -106.49 102.21 11.62 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -90.53 -61.13 1.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.978 0.911 . . . . 15.0 109.483 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-N 115.647 -0.706 . . . . 15.0 109.52 -178.108 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -64.08 -57.36 9.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.655 0.782 . . . . 0.0 109.128 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -100.31 173.54 6.55 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.293 167.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -71.57 91.04 1.04 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.838 0.855 . . . . 0.0 109.631 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -79.9 78.34 6.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.749 0.819 . . . . 0.0 110.611 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 223' ' ' ALA . 3.5 mp -123.22 114.06 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.06 36.9 0.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.825 1.25 . . . . 0.0 111.384 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.834 HD21 HD21 ' B' ' 13' ' ' LEU . 1.2 pp 46.03 11.64 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 126.643 1.977 . . . . 0.0 115.608 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.52 -8.55 48.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.336 0.655 . . . . 0.0 112.329 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 222' ' ' HIS . 0.1 OUTLIER -66.32 -70.79 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 179.01 -64.31 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 124.472 1.109 . . . . 0.0 109.385 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.545 ' HD2' HD11 ' B' ' 10' ' ' LEU . 93.0 Cg_endo -72.86 146.13 41.81 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 121.909 1.74 . . . . 0.0 113.831 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.834 HD21 HD21 ' B' ' 8' ' ' LEU . 30.3 tp 169.4 -58.33 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.079 1.752 . . . . 0.0 108.277 164.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.527 ' H ' HD21 ' B' ' 14' ' ' LEU . 2.4 pt? -86.33 -44.64 11.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.418 -174.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.426 ' O ' ' HD2' ' B' ' 17' ' ' PRO . 90.1 m-85 57.69 -160.49 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.741 0.816 . . . . 0.0 111.277 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . 0.306 13.1 m 87.45 -89.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.287 0 CA-C-O 116.292 -1.813 . . . . 0.0 112.269 171.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 86.9 Cg_endo -77.76 -20.07 12.21 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 124.789 2.746 . . . . 0.0 111.941 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.47 HG13 HG22 ' B' ' 19' ' ' THR . 12.0 p -90.91 164.21 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 125.299 1.439 . . . . 0.0 110.309 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.47 HG22 HG13 ' B' ' 18' ' ' VAL . 10.9 t 50.05 82.59 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 126.452 1.901 . . . . 0.0 114.376 170.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.72 105.96 16.5 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 101.86 0.86 Allowed 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.483 1.113 . . . . 0.0 110.778 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 57.41 67.83 0.93 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.711 1.257 . . . . 0.0 109.175 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 m -141.59 115.12 6.77 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.74 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.21 150.04 36.74 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.34 2.027 . . . . 0.0 111.323 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.32 -44.87 50.75 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 96.5 mmm 53.9 79.86 0.32 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.885 1.366 . . . . 0.0 111.316 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.33 -74.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.796 1.664 . . . . 0.0 112.108 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -179.65 -32.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.895 1.278 . . . . 0.0 108.811 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 75.12 -61.34 0.49 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 125.967 1.707 . . . . 0.0 110.576 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.36 163.55 37.18 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.153 0.981 . . . . 0.0 109.043 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.39 -153.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.554 0.742 . . . . 0.0 110.655 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 68.56 93.69 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -171.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 76.26 121.4 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.181 1.393 . . . . 0.0 108.889 -164.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 75.33 143.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.089 1.356 . . . . 0.0 110.906 -167.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -66.25 -63.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.003 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.7 11.2 0.1 Allowed Glycine 0 N--CA 1.468 0.771 0 O-C-N 123.432 0.458 . . . . 0.0 112.641 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.48 145.69 19.17 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.352 1.061 . . . . 0.0 109.118 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 20.7 tt -170.09 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.853 0.861 . . . . 0.0 110.631 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m 59.15 -90.46 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 111.727 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.68 94.46 13.22 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.256 0.622 . . . . 0.0 109.527 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.24 22.75 0.84 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 123.572 2.848 . . . . 0.0 112.886 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.74 -138.1 26.7 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.513 0.508 . . . . 0.0 112.338 -175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.48 58.26 3.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.25 153.89 29.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.394 0.678 . . . . 0.0 110.782 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -81.57 -12.39 58.8 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.614 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 73.92 -46.93 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.786 1.634 . . . . 0.0 110.724 -170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.8 96.43 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 34.7 p -84.14 83.51 7.94 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.506 1.123 . . . . 0.0 110.263 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.03 75.28 0.11 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.216 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.15 160.49 31.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.35 1.06 . . . . 0.0 111.059 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.65 -35.54 80.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.754 0.822 . . . . 0.0 112.338 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.8 m -106.79 -84.24 0.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.76 0.424 . . . . 0.0 110.818 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.65 -71.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.99 0.916 . . . . 0.0 110.034 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.64 -59.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.05 174.28 0.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.072 1.349 . . . . 0.0 113.803 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -117.46 -26.14 6.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.881 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.61 47.09 25.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.63 1.172 . . . . 0.0 110.333 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -54.51 110.72 0.67 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.834 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.595 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -76.75 179.4 6.1 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.236 176.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m 70.16 118.52 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.54 1.136 . . . . 0.0 110.302 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 34.7 t70 75.5 -7.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.537 1.135 . . . . 0.0 111.833 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.557 ' HZ1' ' HB2' ' B' ' 62' ' ' LYS . 0.1 OUTLIER -67.76 108.18 2.45 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.893 0.877 . . . . 0.0 110.149 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -85.31 126.99 3.26 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.576 2.184 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 159.49 32.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.7 162.05 13.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.233 0.613 . . . . 0.0 110.135 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -59.95 -34.82 73.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.015 0.926 . . . . 0.0 111.007 -174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.441 HG21 HG23 ' B' ' 68' ' ' ILE . 8.9 tp -166.86 -44.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.816 173.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.441 HG23 HG21 ' B' ' 67' ' ' ILE . 9.6 tp 176.7 -22.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.899 1.279 . . . . 0.0 109.655 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp 77.97 94.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.834 1.654 . . . . 0.0 109.144 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.6 tp -152.54 62.04 0.81 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.694 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 -20.26 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.427 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.82 41.56 0.06 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -104.71 146.85 28.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.532 1.133 . . . . 0.0 110.986 -168.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 171.55 37.21 Favored Glycine 0 C--O 1.244 0.771 0 C-N-CA 123.487 0.565 . . . . 0.0 111.774 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -89.58 62.05 5.75 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.89 76.77 0.07 OUTLIER Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.202 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -176.41 -67.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.676 1.19 . . . . 0.0 109.484 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 49.3 m -94.48 -21.71 18.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.508 0.723 . . . . 0.0 112.015 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.15 -24.58 65.91 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.34 -13.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -127.44 147.02 50.29 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 110.328 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.79 79.15 6.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.966 0.907 . . . . 0.0 108.621 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.41 82.89 8.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.301 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -97.56 114.59 26.52 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 169.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.551 ' HB3' ' HB1' ' B' ' 90' ' ' ALA . 40.5 t-20 -124.09 120.19 31.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -69.44 -30.49 68.42 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.763 0.825 . . . . 0.0 110.837 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.14 -175.51 5.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.246 1.018 . . . . 0.0 112.107 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -61.85 -36.95 82.7 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.67 1.188 . . . . 0.0 113.343 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.12 73.1 1.56 Allowed Glycine 0 C--N 1.35 1.352 0 O-C-N 123.944 0.778 . . . . 0.0 114.167 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' B' ' 85' ' ' ASN . . . -162.08 90.04 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.404 1.082 . . . . 0.0 108.809 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.64 121.93 5.19 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.591 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.83 -41.02 95.82 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -114.45 -64.8 1.26 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 167.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -154.59 -79.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' B' ' 95' ' ' LYS . 32.5 ttmt 179.79 -61.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.74 0.816 . . . . 0.0 109.016 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.71 85.41 0.06 OUTLIER Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 pt -132.46 147.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.4 1.08 . . . . 0.0 109.377 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.31 130.4 28.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.561 1.144 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.1 160.57 21.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.612 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 6.5 mt -64.98 -50.88 59.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 O-C-N 123.307 0.38 . . . . 0.0 110.004 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 52.9 Cg_endo -99.2 154.84 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.316 2.011 . . . . 0.0 110.543 153.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.34 176.52 9.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 110.341 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 71.4 p 54.8 76.01 0.27 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 113.404 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.38 166.08 24.83 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.722 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.1 -17.64 42.39 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.237 1.015 . . . . 0.0 110.66 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.441 ' HD2' ' HB2' ' A' ' 404' ' ' GLU . 1.5 m-85 73.02 153.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.971 1.308 . . . . 0.0 111.421 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 14.3 t -160.8 9.18 0.09 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.387 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 73.35 -46.85 0.65 Allowed 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 125.136 1.374 . . . . 0.0 112.282 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.64 -35.41 74.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.917 1.287 . . . . 0.0 111.815 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.72 25.42 11.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.08 0.952 . . . . 0.0 111.825 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.95 -21.25 60.9 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.945 0.402 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -105.8 157.56 17.37 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.723 1.209 . . . . 0.0 109.211 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 68.54 170.2 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.37 1.468 . . . . 0.0 112.03 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.594 ' HD2' HG22 ' B' ' 115' ' ' THR . 1.6 tmmt? 69.08 -75.93 0.06 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.826 1.25 . . . . 0.0 110.172 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.594 HG22 ' HD2' ' B' ' 114' ' ' LYS . 7.5 p -100.52 -7.65 23.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.361 0.665 . . . . 0.0 110.655 171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.05 -35.86 64.44 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.85 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' B' ' 118' ' ' PRO . 99.2 mttt 61.86 -153.38 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.558 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' B' ' 117' ' ' LYS . 21.4 Cg_exo -41.8 95.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 123.39 2.246 . . . . 0.0 113.5 158.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.96 -17.27 64.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.73 1.212 . . . . 0.0 112.624 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -74.07 -28.43 61.39 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.929 0.491 . . . . 0.0 112.247 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.11 -26.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.576 0.35 . . . . 0.0 110.664 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.3 p 50.42 -86.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.763 1.625 . . . . 0.0 113.22 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -152.22 169.78 21.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.91 1.284 . . . . 0.0 109.359 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m 74.17 -77.57 0.05 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.573 1.549 . . . . 0.0 111.856 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.96 -34.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.014 1.326 . . . . 0.0 111.691 -171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.707 ' HB2' ' SD ' ' A' ' 428' ' ' MET . . . 75.36 -172.8 0.11 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.435 1.094 . . . . 0.0 111.541 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m 57.48 43.27 23.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.518 1.127 . . . . 0.0 110.788 -161.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 78.33 -44.24 0.38 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.083 1.753 . . . . 0.0 112.44 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 24.8 m 60.83 -87.13 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.917 1.287 . . . . 0.0 108.866 -169.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.94 -162.73 0.14 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.488 1.115 . . . . 0.0 113.827 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.485 ' CZ2' HD12 ' A' ' 144' ' ' LEU . 6.0 m95 77.21 148.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.97 1.708 . . . . 0.0 113.979 163.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t 71.58 108.04 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.401 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -66.57 130.9 44.71 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.82 8.01 58.42 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 38.6 t 58.21 69.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.141 0 C-N-CA 125.13 1.372 . . . . 0.0 110.886 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 76.51 -33.02 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.521 1.529 . . . . 0.0 113.926 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 34.8 p 51.76 -151.28 0.26 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.144 1.378 . . . . 0.0 110.868 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.39 -173.69 4.59 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.51 HD22 ' HB3' ' B' ' 142' ' ' LEU . 25.3 t30 65.64 -101.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.907 0.883 . . . . 0.0 110.672 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.93 -44.19 1.52 Allowed Glycine 0 CA--C 1.543 1.797 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.77 -16.22 62.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.51 ' HB3' HD22 ' B' ' 139' ' ' ASN . 5.2 tt -84.98 107.23 17.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.7 -71.45 1.15 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 124.002 0.814 . . . . 0.0 111.927 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 p -168.63 153.12 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 0.0 110.464 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -88.09 142.12 28.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.511 1.125 . . . . 0.0 110.219 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.33 115.58 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.056 0.943 . . . . 0.0 109.66 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -157.33 92.05 1.21 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 163.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -165.73 173.64 10.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.376 0.67 . . . . 0.0 110.277 -169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.6 80.09 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.202 1.001 . . . . 0.0 110.348 166.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG13 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.452 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG13 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG13 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.469 ' O ' HG21 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.564 ' NH2' HG13 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HB3' HG23 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.54 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.597 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.514 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.634 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 HG22 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.58 ' HA ' ' HE2' ' A' ' 274' ' ' MET . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.408 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 HG22 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' B' ' 128' ' ' ALA . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.796 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.607 ' HA ' HG22 ' A' ' 240' ' ' VAL . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.543 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.532 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.436 ' HB3' HE21 ' B' ' 3' ' ' GLN . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.538 ' HA2' HD21 ' B' ' 13' ' ' LEU . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.479 ' HG2' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.577 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.492 HG23 HG13 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 237' ' ' LEU . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.619 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.486 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.438 ' HE2' HG23 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.577 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.546 ' NE2' ' HB3' ' B' ' 11' ' ' LEU . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.576 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.486 ' HZ3' ' HB2' ' A' ' 214' ' ' ASP . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.701 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.563 HD21 HG22 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.796 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' B' ' 134' ' ' GLY . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.512 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.44 ' HA2' HG13 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.705 ' HA ' ' HZ3' ' A' ' 272' ' ' LYS . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.582 HG12 ' HE3' ' A' ' 274' ' ' MET . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.705 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.582 ' HE3' HG12 ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.508 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.435 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 332' ' ' LEU . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD21 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.413 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.685 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.519 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.682 ' HG2' ' HE3' ' B' ' 113' ' ' LYS . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.519 HG21 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.492 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.426 ' O ' HD11 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.461 HD13 ' HB1' ' A' ' 407' ' ' ALA . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.522 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 -60.99 -55.82 28.36 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.4 ttp -59.4 -40.47 86.72 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.461 -1.245 . . . . 15.0 110.733 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -65.77 -38.9 90.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.021 0.928 . . . . 15.0 112.905 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.1 t -63.77 -15.39 58.55 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.848 0.859 . . . . 15.0 112.369 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.97 63.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.076 0.55 . . . . 15.0 112.182 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -95.31 -170.86 2.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.956 0.502 . . . . 15.0 110.554 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -79.88 -27.68 39.99 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 15.0 110.378 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -148.05 131.33 8.16 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.262 0.625 . . . . 15.0 110.873 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.581 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 88.3 Cg_endo -76.04 -29.75 6.37 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.653 2.235 . . . . 15.0 113.19 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -59.3 -32.44 70.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.358 0.663 . . . . 15.0 111.309 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.6 -53.99 13.13 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.675 1.235 . . . . 15.0 110.059 170.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 375' ' ' ALA . 24.8 t -73.4 -54.08 16.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 CA-C-N 114.182 -1.372 . . . . 15.0 110.806 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.76 -54.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 124.548 1.155 . . . . 15.0 109.315 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.48 -40.95 76.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 119.199 -0.429 . . . . 15.0 111.825 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -59.14 -53.82 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.679 0.392 . . . . 15.0 111.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.564 ' HH ' ' HB3' ' B' ' 94' ' ' PHE . 33.1 m-85 -77.51 -32.88 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.351 0.871 . . . . 15.0 113.351 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.0 p -61.77 -29.06 69.88 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.749 0.309 . . . . 15.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.5 -13.73 60.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.412 0.685 . . . . 15.0 111.835 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -122.48 114.28 20.48 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 110.039 -0.356 . . . . 15.0 110.039 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt -62.3 -19.13 62.97 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.696 1.198 . . . . 15.0 112.097 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.455 ' HE2' ' HA ' ' A' ' 395' ' ' MET . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.561 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.574 ' HA ' HG13 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' B' ' 105' ' ' GLN . 71.5 m-20 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.623 ' HA ' ' HE1' ' B' ' 108' ' ' HIS . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' HD13 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.634 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.495 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.59 ' HG3' HD11 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.59 HD11 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.504 ' HG2' ' HB1' ' B' ' 126' ' ' ALA . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.21 48.32 0.86 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -123.29 39.74 3.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.791 0.836 . . . . 15.0 109.756 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . 0.418 HE22 HD22 ' A' ' 425' ' ' ASN . 26.5 mp0 -76.04 119.25 19.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.246 0.618 . . . . 15.0 110.31 174.104 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.02 130.27 6.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 178' ' ' GLU . 13.7 pt20 -67.55 98.2 0.65 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.432 0.458 . . . . 0.0 110.035 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.3 t 69.93 -79.92 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.219 1.407 . . . . 0.0 111.945 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.1 t -161.94 -154.8 0.35 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.283 0.633 . . . . 0.0 110.458 -164.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' ' 223' ' ' ALA 0.251 1.7 mp 71.84 -76.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.445 0 C-N-CA 125.596 1.558 . . . . 0.0 110.521 -173.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.11 48.11 23.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.655 0.782 . . . . 0.0 111.305 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.87 133.28 51.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.956 -166.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.46 170.04 16.79 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.491 1.117 . . . . 0.0 108.84 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tm? 72.12 -69.8 0.18 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.622 1.569 . . . . 0.0 109.408 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.546 ' HB3' ' NE2' ' A' ' 222' ' ' HIS . 30.0 tp -126.28 109.17 23.96 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.558 1.143 . . . . 0.0 109.025 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.29 -162.85 0.2 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 124.076 3.184 . . . . 0.0 111.434 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.538 HD21 ' HA2' ' A' ' 180' ' ' GLY . 3.8 mm? -64.96 -2.23 2.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.607 0.763 . . . . 0.0 112.736 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 mt -86.85 80.54 8.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.521 0.729 . . . . 0.0 109.716 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 194' ' ' MET . 31.4 m-85 -82.93 -8.4 59.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.4 m -74.47 -54.47 3.09 Favored Pre-proline 0 CA--C 1.573 1.853 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.465 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.417 ' HB2' HG21 ' B' ' 19' ' ' THR . 94.4 Cg_endo -78.59 -30.27 3.21 Favored 'Trans proline' 0 C--N 1.392 2.823 0 CA-C-N 121.521 1.579 . . . . 0.0 114.026 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.507 HG12 HD13 ' B' ' 11' ' ' LEU . 30.1 m 38.51 57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 125.786 1.635 . . . . 0.0 113.377 -174.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.417 HG21 ' HB2' ' B' ' 17' ' ' PRO . 47.4 p -85.09 120.99 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.223 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.53 159.53 33.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.079 0.952 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.49 103.14 4.03 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.572 0.749 . . . . 0.0 110.055 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -123.46 -174.83 3.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.152 0.981 . . . . 0.0 110.534 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -62.77 143.82 96.74 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-O 117.75 -1.119 . . . . 0.0 109.68 167.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.66 97.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 1 C-N-CA 125.621 4.214 . . . . 0.0 114.971 -171.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.25 88.67 0.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.54 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.554 ' HG3' HG12 ' B' ' 28' ' ' VAL . 26.9 ptm -159.73 167.73 13.52 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.343 1.057 . . . . 0.0 109.172 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' B' ' 26' ' ' MET . 24.6 Cg_endo -61.21 85.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.472 2.115 . . . . 0.0 113.035 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.554 HG12 ' HG3' ' B' ' 26' ' ' MET . 19.0 m -121.59 -26.41 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.598 1.159 . . . . 0.0 109.749 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.57 109.99 2.17 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 48.95 30.8 2.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.704 1.602 . . . . 0.0 112.988 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . 0.255 5.5 p30 46.25 -75.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.155 1.782 . . . . 0.0 111.789 -164.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.6 -22.8 0.09 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.179 0.591 . . . . 0.0 111.281 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -160.31 -47.0 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.15 85.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.354 0.662 . . . . 0.0 111.983 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 63.07 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.898 1.279 . . . . 0.0 110.193 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.76 26.94 0.02 OUTLIER Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -95.09 157.29 15.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.136 0.975 . . . . 0.0 110.093 -175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -66.18 89.8 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.758 0.789 . . . . 0.0 111.651 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -68.82 142.95 54.72 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.75 81.64 0.23 Allowed Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -161.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.03 -18.15 56.39 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.328 2.686 . . . . 0.0 113.472 -170.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.31 5.02 64.91 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.547 0.529 . . . . 0.0 113.103 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.32 48.0 11.73 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.32 0.486 . . . . 0.0 112.048 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.76 176.56 0.27 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.695 1.198 . . . . 0.0 112.396 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -82.77 72.42 9.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.763 0.825 . . . . 0.0 110.081 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -88.03 -62.87 1.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.253 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.602 HD23 ' H ' ' B' ' 47' ' ' LEU . 1.5 pt? -84.52 107.23 16.64 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.742 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 12.7 m -102.64 59.07 0.79 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.002 0.906 . . . . 0.0 109.252 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.33 146.45 6.75 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.791 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.61 95.19 7.7 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.124 0.487 . . . . 0.0 110.969 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -112.64 -24.26 9.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.058 0.943 . . . . 0.0 110.841 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.9 m -79.74 -15.04 58.24 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.591 0.756 . . . . 0.0 112.261 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.14 -17.71 56.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.691 -0.631 . . . . 0.0 111.432 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.35 -174.24 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.887 1.275 . . . . 0.0 111.981 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 pp -166.16 153.98 10.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.691 0.797 . . . . 0.0 110.602 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 61.61 12.01 4.25 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.908 1.283 . . . . 0.0 113.88 170.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.7 107.82 20.34 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.8 p 56.05 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.727 1.611 . . . . 0.0 112.119 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp 67.64 -80.08 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.482 1.513 . . . . 0.0 111.47 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.3 p -161.38 165.09 29.46 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.772 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.26 -61.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.319 1.447 . . . . 0.0 111.218 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' B' ' 63' ' ' PRO . 2.6 tppp? -54.78 125.62 55.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.134 1.374 . . . . 0.0 110.506 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' B' ' 62' ' ' LYS . 20.8 Cg_exo -35.26 91.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 125.3 4.0 . . . . 0.0 115.305 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.07 -158.55 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 106.955 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 tttp 62.11 21.54 12.47 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.758 0.823 . . . . 0.0 111.401 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 18.5 m120 65.14 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 0.0 110.798 -169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.5 mt 59.95 -85.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.984 1.313 . . . . 0.0 111.47 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -83.57 -25.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.787 0.835 . . . . 0.0 110.021 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.8 mt -71.85 81.47 0.9 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.634 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.23 4.81 1.84 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.428 1.491 . . . . 0.0 108.558 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.52 132.22 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.974 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.99 1.41 Allowed Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.49 -149.22 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.707 1.203 . . . . 0.0 110.654 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.42 97.62 0.05 OUTLIER Glycine 0 C--N 1.361 1.935 0 O-C-N 123.403 0.439 . . . . 0.0 112.748 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' B' ' 82' ' ' ALA . 54.3 tpp 58.72 92.52 0.04 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.384 1.474 . . . . 0.0 110.437 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.66 ' HA2' ' HB ' ' B' ' 80' ' ' ILE . . . -160.61 103.02 0.22 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.336 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.61 -72.29 0.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.276 0.63 . . . . 0.0 109.341 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -96.86 -71.97 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -105.74 -78.8 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.66 ' HB ' ' HA2' ' B' ' 76' ' ' GLY . 38.7 mm 52.94 -76.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 125.962 1.705 . . . . 0.0 112.303 -171.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 38.6 p 57.45 82.48 0.12 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.976 1.71 . . . . 0.0 110.809 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' B' ' 75' ' ' MET . . . -85.07 12.01 8.55 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.003 -0.436 . . . . 0.0 111.932 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.74 156.81 26.01 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.883 0.873 . . . . 0.0 111.036 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 62.86 82.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.139 0.976 . . . . 0.0 111.668 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -137.44 -61.99 0.63 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.434 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 57.38 174.77 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.351 1.461 . . . . 0.0 113.71 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.72 -174.3 1.56 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.854 1.262 . . . . 0.0 108.257 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -125.75 86.72 2.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.04 107.41 2.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.144 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.07 178.96 6.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.751 0.821 . . . . 0.0 109.947 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.24 97.36 0.27 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.28 -21.04 75.66 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.736 0.316 . . . . 0.0 113.699 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.41 -5.91 57.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.414 0.686 . . . . 0.0 110.896 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.564 ' HB3' ' HH ' ' A' ' 388' ' ' TYR . 77.2 t80 77.31 162.17 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.048 1.739 . . . . 0.0 111.426 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -59.2 152.3 20.94 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.053 1.741 . . . . 0.0 113.237 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.07 -82.22 0.18 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 124.565 1.166 . . . . 0.0 115.04 165.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.512 HG22 HD11 ' B' ' 100' ' ' LEU . 37.3 mm 77.13 140.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.826 1.65 . . . . 0.0 111.835 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.64 -73.17 0.55 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.544 0.738 . . . . 0.0 110.801 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' A' ' 401' ' ' VAL . . . -101.98 -81.28 0.49 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.315 0.646 . . . . 0.0 110.823 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.512 HD11 HG22 ' B' ' 97' ' ' ILE . 9.0 mp 65.97 -173.82 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 117.854 -1.07 . . . . 0.0 112.383 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 77.4 Cg_exo -50.7 29.54 0.02 OUTLIER 'Trans proline' 1 C--N 1.415 4.043 0 C-N-CA 123.897 3.065 . . . . 0.0 118.81 172.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 120' ' ' TYR . 7.8 tt -50.54 -41.76 54.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.283 1.033 . . . . 0.0 108.864 155.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.538 HG22 HD13 ' B' ' 111' ' ' LEU . 66.0 p -105.58 156.32 18.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.461 1.105 . . . . 0.0 109.707 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.28 -128.8 1.71 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.438 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 9.7 mp0 -100.01 -171.22 2.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.36 74.19 0.23 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.111 1.365 . . . . 0.0 110.417 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -146.95 -54.07 0.23 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.431 1.093 . . . . 0.0 109.912 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . 0.623 ' HE1' ' HA ' ' A' ' 404' ' ' GLU . 76.9 m-70 81.54 -13.7 0.87 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 126.549 1.939 . . . . 0.0 112.392 -171.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -69.36 -33.22 72.75 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.02 -8.99 58.23 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.69 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.538 HD13 HG22 ' B' ' 103' ' ' THR . 60.3 tp -66.1 102.7 0.85 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -80.5 143.94 32.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.682 ' HE3' ' HG2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -149.96 122.79 8.7 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.768 0.258 . . . . 0.0 111.09 -173.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.699 ' HG2' ' HA ' ' B' ' 119' ' ' ASP . 44.3 mmtm -67.98 179.29 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.496 0.665 . . . . 0.0 111.095 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -65.47 96.31 0.24 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 121.929 0.871 . . . . 0.0 108.898 165.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.65 -37.97 2.03 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 288' ' ' SER 0.34 4.2 ptpp? 110.22 -26.56 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 128.455 2.702 . . . . 0.0 116.019 169.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.83 99.42 0.97 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 CA-C-N 123.618 2.328 . . . . 0.0 111.277 168.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.699 ' HA ' ' HG2' ' B' ' 114' ' ' LYS . 9.0 t70 -93.44 -31.41 14.61 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 122.778 0.431 . . . . 0.0 111.611 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.448 ' HB3' ' HG ' ' B' ' 102' ' ' LEU . 30.1 p90 -51.47 125.81 15.52 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.588 1.18 . . . . 0.0 111.713 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -71.6 83.31 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.288 1.035 . . . . 0.0 109.431 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.8 m -147.38 114.76 6.29 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.69 78.81 1.53 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.467 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 47.5 t -81.6 85.25 6.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.219 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.06 -28.5 64.41 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.017 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 428' ' ' MET . . . 71.82 -57.3 0.62 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 125.167 1.542 . . . . 0.0 111.276 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 31.7 m -64.09 102.56 0.51 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 122.789 0.436 . . . . 0.0 109.835 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 144' ' ' LEU . . . 80.15 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.081 1.752 . . . . 0.0 111.922 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.3 m 57.09 26.18 11.73 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.056 0.942 . . . . 0.0 111.339 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.3 22.34 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.241 1.016 . . . . 0.0 112.752 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -100.79 3.98 42.55 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.29 1.036 . . . . 0.0 109.96 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 10.5 m -60.25 -43.28 96.25 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.826 1.25 . . . . 0.0 113.784 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -91.15 -7.36 51.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.04 0.536 . . . . 0.0 111.859 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 257' ' ' GLY . . . -122.81 -165.14 12.31 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.678 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.5 t 50.26 43.1 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 122.644 1.211 . . . . 0.0 109.513 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -137.28 56.8 1.77 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.947 -167.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 40.7 m -120.53 123.59 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.238 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.1 -11.09 4.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 111.983 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -70.94 -21.66 62.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.895 0.478 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.47 -75.87 2.09 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.459 ' HB1' HG13 ' B' ' 144' ' ' VAL . . . -146.03 136.7 24.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.24 0.616 . . . . 0.0 110.813 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.7 124.41 50.5 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.577 1.151 . . . . 0.0 108.565 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.7 -63.55 4.25 Favored Glycine 0 C--N 1.347 1.152 0 O-C-N 123.455 0.472 . . . . 0.0 112.295 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.459 HG13 ' HB1' ' B' ' 141' ' ' ALA . 3.7 p -67.29 104.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.391 0.615 . . . . 0.0 110.006 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -138.22 145.27 41.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.685 0.794 . . . . 0.0 109.173 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.72 107.17 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 109.355 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -157.36 75.64 0.81 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.623 0.725 . . . . 0.0 110.942 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.35 159.6 25.57 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.058 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -86.84 80.62 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 124.334 1.054 . . . . 0.0 111.311 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.567 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.548 HG23 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG21 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' HE3' HG21 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.429 ' HA ' HG21 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD11 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG23 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.428 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.679 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.508 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.708 HG22 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.53 ' HE2' ' HB2' ' B' ' 127' ' ' SER . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.641 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.631 HG22 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.507 ' HG3' ' HB1' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.568 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 237' ' ' LEU . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.583 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.401 ' HZ ' HD21 ' B' ' 13' ' ' LEU . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.417 ' HA ' ' HD1' ' B' ' 15' ' ' PHE . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.4 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.533 HG23 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.788 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.788 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.537 HG22 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.545 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.411 ' O ' HD23 ' B' ' 11' ' ' LEU . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' B' ' 13' ' ' LEU . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 168' ' ' PHE . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.631 HD21 HG22 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.483 HG21 ' HB ' ' A' ' 258' ' ' VAL . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.454 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' B' ' 132' ' ' SER . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 253' ' ' ILE . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 264' ' ' GLU . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.531 HG11 ' HE1' ' A' ' 274' ' ' MET . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.531 ' HE1' HG11 ' A' ' 270' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.413 HD12 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.494 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.416 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.708 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.655 HD12 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.421 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.474 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.563 ' O ' HG22 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.45 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' B' ' 112' ' ' ASN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.437 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.509 ' HA ' ' HE2' ' A' ' 374' ' ' MET . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 -63.72 -44.58 93.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' B' ' 98' ' ' ASP . 32.5 ttp -58.51 -51.3 70.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.498 -1.228 . . . . 15.0 110.271 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.415 ' HA ' HG22 ' A' ' 384' ' ' VAL . . . -65.04 -40.32 94.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.297 1.039 . . . . 15.0 112.699 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.7 t -64.17 -24.44 67.68 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 15.0 111.78 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.18 -11.76 59.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.363 0.665 . . . . 15.0 111.659 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -100.65 159.24 15.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.961 0.886 . . . . 15.0 112.156 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -6.42 50.34 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.226 -1.807 . . . . 15.0 111.668 174.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -152.1 112.8 2.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.387 -0.598 . . . . 15.0 109.387 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.54 -30.65 9.66 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.232 2.622 . . . . 15.0 113.008 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -56.28 -43.18 78.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.504 0.721 . . . . 15.0 111.547 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.71 -36.35 83.35 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.78 0.675 . . . . 15.0 111.12 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 375' ' ' ALA . 28.4 t -67.97 -47.46 78.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 109.005 -0.739 . . . . 15.0 109.005 -172.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.12 -55.48 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.822 -1.081 . . . . 15.0 109.185 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.93 -4.78 34.23 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.34 -45.68 6.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.722 0.409 . . . . 15.0 110.601 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -95.41 -33.91 12.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.115 1.524 . . . . 15.0 115.115 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 81.6 p -55.93 -39.25 71.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 112.913 0.708 . . . . 15.0 112.913 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -111.98 14.96 20.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.804 0.842 . . . . 15.0 110.923 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -94.14 97.69 10.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.655 0.782 . . . . 15.0 108.953 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -47.82 -43.06 27.63 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.206 1.403 . . . . 15.0 111.817 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.496 ' HA ' ' HE3' ' A' ' 395' ' ' MET . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.407 ' HB3' HG23 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.572 HD11 ' NE2' ' A' ' 430' ' ' GLN . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.619 ' HG3' ' HB3' ' B' ' 127' ' ' SER . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.26 33.86 1.5 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . 0.572 ' NE2' HD11 ' A' ' 427' ' ' LEU . 41.5 mt-30 -90.23 80.97 6.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.031 0.533 . . . . 15.0 110.039 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.27 -70.74 0.73 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 107.177 -1.416 . . . . 15.0 107.177 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.801 0.841 . . . . 15.0 108.997 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -175.31 156.3 2.01 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.799 0.84 . . . . 0.0 109.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -70.51 86.25 0.63 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -142.85 12.82 1.87 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.532 1.133 . . . . 0.0 109.048 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.574 HG23 HG13 ' B' ' 6' ' ' ILE . 88.0 m -148.38 142.99 26.52 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.364 1.465 . . . . 0.0 107.334 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.574 HG13 HG23 ' B' ' 5' ' ' THR . 5.4 mt 65.34 75.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.433 1.093 . . . . 0.0 110.061 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.6 34.26 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.822 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . 0.252 1.2 pp 33.83 58.51 0.57 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.326 1.85 . . . . 0.0 114.168 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.16 127.76 53.06 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.5 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.08 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.245 1.418 . . . . 0.0 111.166 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 220' ' ' GLU . 28.3 tp 60.86 66.04 1.85 Allowed Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 123.988 0.915 . . . . 0.0 109.016 -171.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.41 179.89 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.119 2.546 . . . . 0.0 112.568 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.428 HD23 ' CE1' ' A' ' 233' ' ' PHE . 17.2 tp -85.81 58.94 5.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.005 0.907 . . . . 0.0 109.685 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 174.62 78.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.417 ' HD1' ' HA ' ' A' ' 194' ' ' MET . 4.1 m-85 -91.57 -1.37 57.52 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.466 ' N ' ' HD2' ' B' ' 17' ' ' PRO . 46.8 m -69.85 -41.67 16.19 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 16' ' ' THR . 8.5 Cg_endo -44.59 -70.54 0.07 OUTLIER 'Trans proline' 1 C--N 1.424 4.508 0 C-N-CA 123.656 2.904 . . . . 0.0 113.256 -169.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t 51.55 -79.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 125.182 1.393 . . . . 0.0 111.976 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m 79.13 -44.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.636 1.974 . . . . 0.0 112.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.409 ' HB3' ' HZ3' ' B' ' 20' ' ' LYS . 6.4 mtpm? 67.93 -77.22 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.002 1.321 . . . . 0.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.66 87.96 0.05 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.918 1.287 . . . . 0.0 111.623 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' B' ' 22' ' ' ARG . 1.9 mmp_? -127.51 103.72 7.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.665 0.786 . . . . 0.0 110.615 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -70.74 165.82 42.67 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.263 1.025 . . . . 0.0 109.275 167.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.45 ' HG3' ' HG3' ' B' ' 41' ' ' PRO . 10.5 Cg_endo -50.23 106.82 0.13 Allowed 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.106 2.538 . . . . 0.0 112.004 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.43 77.88 1.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.961 0.905 . . . . 0.0 110.338 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.403 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 64.8 mtt -94.17 -33.9 0.3 Allowed Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 117.179 -1.391 . . . . 0.0 112.941 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' B' ' 26' ' ' MET . 1.9 Cg_exo -33.49 101.62 0.03 OUTLIER 'Trans proline' 1 C--N 1.42 4.304 0 C-N-CA 124.407 3.404 . . . . 0.0 115.749 176.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' B' ' 34' ' ' ALA . 13.8 p -144.7 157.58 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 125.022 1.329 . . . . 0.0 108.808 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -142.62 -56.18 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -120.52 179.99 4.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 0.0 110.528 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 72.22 166.37 0.3 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.511 1.525 . . . . 0.0 112.077 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -83.37 -171.72 3.74 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.228 174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 73.29 -66.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.404 1.482 . . . . 0.0 110.121 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . 55.49 87.87 0.05 OUTLIER 'General case' 0 C--N 1.366 1.32 0 C-N-CA 125.357 1.463 . . . . 0.0 111.779 173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 77.98 -48.56 0.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.415 1.486 . . . . 0.0 110.82 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.28 -74.23 2.5 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -143.76 103.98 4.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.771 0.828 . . . . 0.0 109.133 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.02 172.94 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.744 1.217 . . . . 0.0 109.342 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -138.51 166.49 24.15 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.989 0.916 . . . . 0.0 109.02 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.56 103.95 4.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.795 0.838 . . . . 0.0 109.099 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.45 ' HG3' ' HG3' ' B' ' 24' ' ' PRO . 29.5 Cg_endo -93.16 169.57 2.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.6 2.2 . . . . 0.0 113.1 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.64 -108.02 2.18 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.829 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.05 -31.8 82.07 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 124.137 0.551 . . . . 0.0 112.312 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.14 -78.11 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.214 1.406 . . . . 0.0 112.437 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.798 ' HG3' ' HA ' ' B' ' 63' ' ' PRO . 8.2 tmm_? 62.39 -82.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.196 1.398 . . . . 0.0 110.173 -171.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' B' ' 46' ' ' ARG . 2.5 tpm_? 176.17 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.019 0.928 . . . . 0.0 109.702 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.03 70.36 1.44 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.0 m -66.78 -48.25 69.62 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.201 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.57 63.39 0.01 OUTLIER Glycine 0 C--O 1.244 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 62.12 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.456 1.502 . . . . 0.0 109.798 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -103.99 -72.95 0.69 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 166.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -111.2 -62.53 1.53 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.46 -48.83 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -161.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 106.24 0.9 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 -167.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.41 89.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.039 0.936 . . . . 0.0 111.941 -173.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.432 ' NH2' HD21 ' B' ' 59' ' ' LEU . 62.2 ttt180 65.59 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.699 1.2 . . . . 0.0 112.574 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.33 -37.66 13.89 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.72 1.208 . . . . 0.0 109.064 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -146.62 172.34 13.74 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.892 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.432 HD21 ' NH2' ' B' ' 56' ' ' ARG . 38.3 tp -132.2 -19.63 2.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.907 0.483 . . . . 0.0 111.519 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.29 -0.12 16.04 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.73 92.54 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.431 1.093 . . . . 0.0 110.637 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -66.28 151.93 95.06 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.482 1.113 . . . . 0.0 110.749 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.798 ' HA ' ' HG3' ' B' ' 45' ' ' ARG . 69.9 Cg_exo -40.27 -56.12 1.61 Allowed 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 124.255 3.304 . . . . 0.0 114.711 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.76 -169.96 3.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.714 0.806 . . . . 0.0 109.382 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 43.08 75.39 0.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.122 1.769 . . . . 0.0 114.03 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -86.15 141.32 29.45 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.907 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.9 pp -62.27 -29.96 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 123.209 0.603 . . . . 0.0 112.605 -172.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.473 ' HA ' ' HB3' ' B' ' 73' ' ' ASP . 23.6 pt 41.13 29.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.95 2.1 . . . . 0.0 115.477 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.77 25.98 6.08 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.539 0.736 . . . . 0.0 109.302 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -163.16 112.42 1.32 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.441 HG22 ' H ' ' B' ' 72' ' ' GLY 0.265 13.9 tt 42.5 -76.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 127.179 2.192 . . . . 0.0 115.121 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.441 ' H ' HG22 ' B' ' 71' ' ' ILE . . . -126.25 -62.91 0.16 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.473 ' HB3' ' HA ' ' B' ' 68' ' ' ILE . 15.0 t70 65.67 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.705 1.202 . . . . 0.0 111.152 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.14 61.23 0.4 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 28.0 ttt -138.92 106.76 5.65 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.524 0.729 . . . . 0.0 109.78 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.43 146.64 17.3 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . 0.271 2.0 p30 49.59 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.208 1.403 . . . . 0.0 111.758 -167.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.5 t -102.65 -79.5 0.53 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.497 1.119 . . . . 0.0 108.016 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.417 ' HG2' HG21 ' B' ' 80' ' ' ILE . 29.1 tt0 -113.75 -56.84 2.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.884 0.873 . . . . 0.0 108.678 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.417 HG21 ' HG2' ' B' ' 79' ' ' GLU . 13.4 tt -173.99 105.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.829 0.852 . . . . 0.0 110.96 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.3 m -76.08 110.32 10.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.7 -87.46 0.18 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.63 -166.66 1.22 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.91 0.484 . . . . 0.0 110.675 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 68.08 73.58 0.3 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.08 1.352 . . . . 0.0 110.095 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.83 -49.41 25.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -154.08 -53.26 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.75 0.42 . . . . 0.0 110.756 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 119.41 3.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.877 0.871 . . . . 0.0 109.401 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -172.68 142.93 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.363 1.065 . . . . 0.0 108.562 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.1 -106.62 0.64 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' B' ' 135' ' ' VAL . . . -160.87 120.02 2.61 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.893 0.877 . . . . 0.0 109.28 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.27 -160.89 52.72 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.699 0.625 . . . . 0.0 112.596 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.16 167.2 11.63 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 64.79 -78.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.426 1.49 . . . . 0.0 111.303 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -125.15 145.01 50.15 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.239 1.016 . . . . 0.0 109.65 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.39 106.73 18.69 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.3 -132.5 14.89 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.656 0.598 . . . . 0.0 111.906 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.82 -40.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 374' ' ' MET . 14.9 t70 71.49 -63.12 0.43 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.17 1.788 . . . . 0.0 112.154 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.41 134.86 57.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.653 0.781 . . . . 0.0 110.367 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -94.79 107.27 29.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.82 0.848 . . . . 0.0 110.797 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -76.47 -31.23 4.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.25 2.633 . . . . 0.0 113.05 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.418 ' HB2' HG21 ' B' ' 107' ' ' THR . 6.2 mp 56.4 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.524 1.53 . . . . 0.0 110.945 -170.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.443 ' HB ' ' HA ' ' B' ' 107' ' ' THR . 25.8 m -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.873 . . . . 0.0 110.514 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.34 145.03 10.34 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 62.23 -85.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.572 1.149 . . . . 0.0 110.115 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -120.68 110.41 16.37 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.443 ' HA ' ' HB ' ' B' ' 103' ' ' THR . 6.9 m -78.55 -18.57 54.47 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.61 0.764 . . . . 0.0 112.909 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.72 1.13 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.625 0.77 . . . . 0.0 112.229 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 63.66 82.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.712 1.205 . . . . 0.0 109.646 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.436 ' HB2' ' HD3' ' B' ' 113' ' ' LYS . . . 61.57 68.03 0.73 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.129 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 132.48 48.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 171.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.521 ' O ' ' HD3' ' A' ' 344' ' ' ARG . 10.5 t30 60.68 102.88 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.234 0.959 . . . . 0.0 109.379 -163.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' B' ' 110' ' ' ALA . 40.4 pttt -147.64 98.95 3.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt 58.42 74.37 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.08 1.352 . . . . 0.0 110.393 -170.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.422 ' H ' ' HA ' ' B' ' 119' ' ' ASP . 78.6 m -86.4 95.03 9.54 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.238 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.03 3.76 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.418 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.409 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 22.1 tptm -108.23 -50.29 0.09 OUTLIER Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 124.219 1.008 . . . . 0.0 112.039 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.409 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 57.8 Cg_endo -67.49 -22.31 45.17 Favored 'Trans proline' 0 C--N 1.396 3.061 0 CA-C-N 121.478 1.563 . . . . 0.0 113.571 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.422 ' HA ' ' H ' ' B' ' 115' ' ' THR . 42.7 t0 62.08 24.89 14.87 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.313 1.53 . . . . 0.0 110.37 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -168.93 172.98 7.28 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.676 -1.602 . . . . 0.0 107.312 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t 70.15 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 124.051 0.941 . . . . 0.0 110.911 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.4 m -66.97 -34.64 78.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.075 0.95 . . . . 0.0 110.898 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.22 -129.45 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.095 0.958 . . . . 0.0 108.95 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 52.6 p -159.81 -54.0 0.06 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.934 1.243 . . . . 0.0 111.314 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.62 -10.54 7.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.786 0.835 . . . . 0.0 111.747 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.488 ' HB2' ' SD ' ' A' ' 428' ' ' MET . . . 72.64 -60.92 0.52 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.629 1.572 . . . . 0.0 113.818 172.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.619 ' HB3' ' HG3' ' A' ' 428' ' ' MET . 22.0 p -101.77 -41.74 6.42 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.751 -0.593 . . . . 0.0 112.541 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.32 90.3 2.78 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.0 0.429 . . . . 0.0 111.954 -169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.2 p -86.97 8.17 24.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.694 0.798 . . . . 0.0 111.143 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 61.89 -144.72 0.42 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.423 1.089 . . . . 0.0 109.95 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 256' ' ' PHE . 35.4 p90 -153.36 154.46 34.55 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.385 0.674 . . . . 0.0 110.259 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 32.9 t -162.95 148.17 11.78 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.01 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 34.9 m -67.85 151.39 47.24 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.53 24.39 Favored Glycine 0 N--CA 1.482 1.756 0 O-C-N 123.475 0.484 . . . . 0.0 113.787 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' B' ' 90' ' ' ALA . 7.4 p -160.55 123.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.111 0.964 . . . . 0.0 108.906 169.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -179.94 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.528 1.131 . . . . 0.0 108.889 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 37.0 p -68.82 131.18 44.71 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.985 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 71.18 -62.09 0.46 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.754 1.622 . . . . 0.0 111.842 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.11 83.98 0.72 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.646 0.779 . . . . 0.0 109.339 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.39 46.92 1.07 Allowed Glycine 0 C--N 1.336 0.577 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.39 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.072 0.949 . . . . 0.0 109.928 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 55.1 tp 64.86 -80.54 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.875 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.01 -69.77 1.23 Allowed Glycine 0 C--N 1.36 1.879 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.43 75.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.94 92.44 0.92 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.52 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 9.3 tp -111.2 137.2 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -101.74 158.33 16.19 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 72.2 142.49 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.403 1.481 . . . . 0.0 113.057 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -111.02 173.91 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.879 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.551 1.0 0 C-N-CA 123.819 0.847 . . . . 0.0 109.022 167.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.648 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.578 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.622 HG23 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.648 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.555 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.645 HG12 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.56 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.645 ' HG2' HG12 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.622 ' HB3' HG23 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.555 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.578 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.511 HG11 HD11 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.45 HG22 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.522 HD23 HG22 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' B' ' 128' ' ' ALA . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.638 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.641 HG11 HG23 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.666 HG23 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.67 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' B' ' 8' ' ' LEU . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.604 ' HA2' HD21 ' B' ' 13' ' ' LEU . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.53 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.56 ' HA ' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.493 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.54 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' B' ' 7' ' ' ALA . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' B' ' 7' ' ' ALA . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.67 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.513 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 166' ' ' ILE . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.599 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.638 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.555 HG23 HD12 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' B' ' 135' ' ' VAL . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.443 HG11 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.443 ' HA2' HG11 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.555 HD12 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.493 HD22 ' HB ' ' B' ' 133' ' ' THR . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.54 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.728 ' HE2' HD12 ' B' ' 111' ' ' LEU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.547 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.547 ' HB2' HD23 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.511 HD11 HG11 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.493 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.526 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.497 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.419 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.419 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.477 ' HG3' HH21 ' B' ' 46' ' ' ARG . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.443 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.511 ' HA ' HD13 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.754 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 407' ' ' ALA . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.627 HH12 HD13 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.627 HD13 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -32.31 73.93 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 47.2 ttp -74.11 -62.71 1.41 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.841 0.456 . . . . 15.0 110.551 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.68 -37.31 82.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.718 0.807 . . . . 15.0 113.067 -168.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.1 t -63.07 -27.7 69.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.939 0.495 . . . . 15.0 111.45 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.76 64.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.098 0.559 . . . . 15.0 111.688 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.32 179.32 7.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 15.0 112.223 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -59.89 -45.87 91.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.895 1.678 . . . . 15.0 110.694 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.88 108.22 4.33 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.15 -30.79 37.6 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.56 2.174 . . . . 15.0 112.418 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.74 -36.65 79.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.543 0.737 . . . . 15.0 112.734 -166.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -68.47 -30.49 69.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.254 0.622 . . . . 15.0 111.163 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.12 -46.06 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.299 -1.0 . . . . 15.0 108.299 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.46 -41.12 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.244 1.018 . . . . 15.0 110.374 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.96 -38.53 91.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.335 0.654 . . . . 15.0 110.624 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.7 -41.35 99.08 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.422 0.451 . . . . 15.0 110.714 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 395' ' ' MET . 93.4 m-85 -62.93 -58.03 8.75 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.458 0.647 . . . . 15.0 110.706 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 74.2 p -65.4 -23.51 66.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.455 0.909 . . . . 15.0 113.455 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.47 -1.15 21.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.327 0.651 . . . . 15.0 111.844 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -151.47 126.76 9.94 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 120.875 0.369 . . . . 15.0 110.116 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -77.04 -13.01 60.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.314 0.646 . . . . 15.0 111.643 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.41 ' HA ' ' HD1' ' A' ' 388' ' ' TYR . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.465 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.581 HG21 HD23 ' B' ' 102' ' ' LEU . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.525 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.464 ' HA ' HD11 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' B' ' 126' ' ' ALA . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.36 -10.15 58.63 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.32 86.37 5.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.177 0.991 . . . . 15.0 110.568 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.77 -72.77 0.53 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.531 -0.915 . . . . 15.0 108.531 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.922 0.889 . . . . 15.0 109.056 178.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -150.32 -161.6 1.38 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.368 0.667 . . . . 0.0 110.441 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -66.56 87.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.612 0.765 . . . . 0.0 111.791 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.6 t -92.27 78.58 5.11 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 32.1 p -127.32 120.29 28.23 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.523 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -74.8 -171.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.415 0.626 . . . . 0.0 110.884 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.488 ' HA ' ' HB1' ' A' ' 223' ' ' ALA . . . -151.08 -7.47 0.25 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.46 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.521 HD21 ' O ' ' B' ' 12' ' ' PRO . 1.1 pp -160.33 159.25 31.01 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.554 -162.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -71.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.935 0.772 . . . . 0.0 109.927 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 -18.9 60.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.51 0.724 . . . . 0.0 110.504 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.7 145.82 37.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.23 1.012 . . . . 0.0 109.36 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.521 ' O ' HD21 ' B' ' 8' ' ' LEU . 25.0 Cg_exo -64.95 -40.59 20.28 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.604 HD21 ' HA2' ' A' ' 180' ' ' GLY . 16.7 tp 175.14 -45.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.569 1.548 . . . . 0.0 108.073 169.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 142.72 55.91 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' A' ' 194' ' ' MET . 93.7 m-85 -107.58 25.55 11.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.903 0.881 . . . . 0.0 110.731 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.528 ' N ' ' HD3' ' B' ' 17' ' ' PRO . 1.0 OUTLIER -114.18 23.08 0.08 OUTLIER Pre-proline 0 CA--C 1.588 2.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -174.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' B' ' 16' ' ' THR . 4.2 Cg_exo -78.47 85.93 1.76 Allowed 'Trans proline' 0 C--N 1.405 3.522 0 CA-C-N 123.698 2.356 . . . . 0.0 111.617 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t 44.65 -74.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 127.127 2.171 . . . . 0.0 115.119 168.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -69.77 -32.98 71.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.473 ' HZ1' ' HB2' ' B' ' 20' ' ' LYS . 3.0 ttmp? -63.35 115.92 5.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.938 0.495 . . . . 0.0 111.569 -174.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.24 34.23 18.78 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.455 1.097 . . . . 0.0 111.408 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.497 ' HG3' HG22 ' B' ' 23' ' ' THR . 10.1 tpt180 -58.8 -65.9 0.59 Allowed 'General case' 0 C--N 1.357 0.933 0 C-N-CA 123.913 0.885 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.497 HG22 ' HG3' ' B' ' 22' ' ' ARG . 3.7 t -169.77 102.22 0.46 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.222 1.009 . . . . 0.0 109.379 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.59 42.94 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.123 2.549 . . . . 0.0 112.533 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -153.7 -34.34 0.11 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.244 1.418 . . . . 0.0 109.184 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 41.44 86.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -53.01 104.56 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.392 2.728 . . . . 0.0 112.692 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.525 HG13 ' H ' ' B' ' 29' ' ' LEU 0.267 7.6 p 43.28 -79.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 126.505 1.922 . . . . 0.0 113.454 -171.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.525 ' H ' HG13 ' B' ' 28' ' ' VAL . 96.2 mt -134.57 125.44 27.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.681 1.192 . . . . 0.0 108.109 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.1 102.56 4.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.138 0.575 . . . . 0.0 110.04 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 60.4 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.067 1.347 . . . . 0.0 113.04 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -88.37 118.81 28.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.151 0.981 . . . . 0.0 110.13 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.73 47.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.318 0.647 . . . . 0.0 110.65 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.344 1.458 . . . . 0.0 111.842 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 69.85 -60.26 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.873 1.669 . . . . 0.0 112.927 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.89 64.26 1.0 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.45 103.31 15.4 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.911 0.884 . . . . 0.0 110.718 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.87 -45.06 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -152.37 114.47 4.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.314 1.046 . . . . 0.0 108.805 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.75 73.81 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.13 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.4 88.19 0.5 Allowed 'Trans proline' 0 C--N 1.39 2.759 0 CA-C-N 120.951 1.375 . . . . 0.0 110.844 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.53 -168.87 35.2 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.096 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -54.75 4.6 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.22 173.35 16.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.495 1.118 . . . . 0.0 109.845 173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -64.36 -56.96 10.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.581 0.752 . . . . 0.0 109.998 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.477 HH21 ' HG3' ' A' ' 326' ' ' GLU . 20.2 ttm180 65.94 -84.28 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.311 1.044 . . . . 0.0 110.983 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.51 175.78 7.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.11 1.364 . . . . 0.0 108.941 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.4 m 68.34 83.85 0.16 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 112.232 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.7 99.82 0.7 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -55.98 108.23 0.43 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.978 0.911 . . . . 0.0 111.933 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.28 -9.91 59.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.939 0.896 . . . . 0.0 111.182 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 43.0 p -62.83 -25.56 68.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.839 0.856 . . . . 0.0 111.366 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 -22.23 65.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.289 1.036 . . . . 0.0 111.54 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.08 98.22 7.38 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.904 0.882 . . . . 0.0 109.052 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.13 83.71 1.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.569 0.748 . . . . 0.0 109.421 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.67 -16.11 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.244 1.018 . . . . 0.0 110.761 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.76 6.8 4.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.17 1.388 . . . . 0.0 114.291 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 72.1 p -90.57 18.18 6.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.558 0.743 . . . . 0.0 110.893 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.43 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -118.65 145.24 45.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.4 t 54.92 46.71 23.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.851 0.86 . . . . 0.0 109.472 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -47.51 -45.97 26.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.359 1.464 . . . . 0.0 113.276 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -102.28 126.48 33.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 -18.64 32.89 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 124.224 3.283 . . . . 0.0 115.249 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.72 -13.43 62.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.814 0.445 . . . . 0.0 112.14 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.91 8.84 34.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.533 0.733 . . . . 0.0 111.714 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.4 -170.26 2.88 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp 44.57 56.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 125.478 1.511 . . . . 0.0 112.006 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.429 HG12 HD11 ' B' ' 71' ' ' ILE . 38.7 pt -85.93 9.98 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.59 -170.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt 77.29 123.25 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.704 1.602 . . . . 0.0 109.099 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 44.6 tp 80.71 -51.74 0.32 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.052 1.741 . . . . 0.0 113.015 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.429 HD11 HG12 ' B' ' 68' ' ' ILE . 37.3 mm 58.72 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.919 0.887 . . . . 0.0 109.045 -166.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.46 -163.7 37.12 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.343 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -151.07 -35.88 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.484 0.714 . . . . 0.0 109.721 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.97 87.79 0.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.401 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -87.45 -163.51 0.94 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.557 171.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 16.48 -133.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.08 -174.72 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.418 1.487 . . . . 0.0 109.463 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -52.16 -46.45 65.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.407 1.083 . . . . 0.0 112.461 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -87.03 -13.36 44.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.424 0.69 . . . . 0.0 112.338 -173.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt 52.3 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 126.39 1.876 . . . . 0.0 114.357 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -83.32 -61.41 1.86 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.698 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -167.71 -51.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.84 10.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.716 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.48 163.03 12.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 110.962 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -158.3 -47.33 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.774 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 69.07 -72.06 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.308 1.443 . . . . 0.0 109.992 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.52 80.59 0.22 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.814 1.246 . . . . 0.0 113.12 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 90' ' ' ALA . 34.7 tt0 -172.09 153.85 3.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.284 1.034 . . . . 0.0 109.476 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.63 -36.26 82.66 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.41 ' H ' ' HG2' ' B' ' 88' ' ' GLU . . . 67.85 -6.31 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 168.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.69 -47.78 3.87 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 122.909 0.29 . . . . 0.0 113.472 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.37 -6.35 75.32 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -70.55 105.24 3.03 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.94 83.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.993 0.917 . . . . 0.0 110.974 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -151.78 -46.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.487 1.515 . . . . 0.0 107.385 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.09 82.0 1.57 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.99 102.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.19 -19.92 52.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.14 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.604 1.562 . . . . 0.0 111.548 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 pp -159.93 177.32 2.11 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.542 0.737 . . . . 0.0 110.215 -168.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.14 107.17 0.24 Allowed 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.155 1.903 . . . . 0.0 112.24 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.581 HD23 HG21 ' A' ' 401' ' ' VAL . 2.6 pp -159.76 151.18 19.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.18 0.992 . . . . 0.0 108.979 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.8 p -139.83 25.9 2.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.435 0.694 . . . . 0.0 109.597 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -53.83 119.59 11.76 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.615 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -156.39 -64.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.248 1.019 . . . . 0.0 108.402 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -156.66 -58.58 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.794 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.9 p -64.34 -58.3 6.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.159 0.584 . . . . 0.0 110.128 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 p80 36.16 42.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 126.627 1.971 . . . . 0.0 113.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.754 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 0.2 OUTLIER -89.87 27.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.312 -172.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 344' ' ' ARG . . . -168.89 75.9 0.1 Allowed 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.971 0.909 . . . . 0.0 109.4 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.728 HD12 ' HE2' ' A' ' 287' ' ' LYS . 8.4 tt -54.18 -39.66 66.81 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.819 1.248 . . . . 0.0 111.235 -176.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -85.23 128.51 34.71 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.482 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' B' ' 114' ' ' LYS . 11.0 tppt? -174.49 -161.89 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.63 ' H ' ' HG3' ' B' ' 113' ' ' LYS . 32.0 mmtp 87.83 140.77 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.016 2.126 . . . . 0.0 112.03 164.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.7 t -61.08 -52.93 62.85 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.212 1.005 . . . . 0.0 111.489 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.14 47.35 1.99 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.091 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.619 ' HB3' ' HB2' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -167.98 116.53 0.64 Allowed Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.152 0.581 . . . . 0.0 109.55 -174.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.17 161.49 19.46 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.858 2.372 . . . . 0.0 112.564 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -82.03 6.19 16.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.921 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.28 167.27 20.69 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.582 0.753 . . . . 0.0 109.348 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.55 95.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.1 0.952 . . . . 0.0 111.515 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.576 HG22 ' H ' ' B' ' 123' ' ' ASP . 1.8 m -133.75 -164.98 1.57 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.576 ' H ' HG22 ' B' ' 122' ' ' THR . 6.5 m-20 73.75 -70.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.793 1.637 . . . . 0.0 110.694 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 91.76 0.69 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.237 1.015 . . . . 0.0 112.063 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.6 94.51 2.51 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.547 ' N ' ' SD ' ' A' ' 428' ' ' MET . . . -51.97 -21.08 2.74 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.751 1.221 . . . . 0.0 113.372 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -57.84 93.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 144' ' ' LEU . . . 74.54 -19.41 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.48 1.512 . . . . 0.0 114.637 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 8.5 m -77.68 90.05 3.98 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.44 27.61 5.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.141 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -105.44 15.38 27.25 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.212 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 33.2 t -72.87 -12.94 61.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.493 ' HB ' HD22 ' A' ' 273' ' ' ASN . 14.3 t -67.8 -18.48 64.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.442 0.697 . . . . 0.0 110.534 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.2 127.39 5.62 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 41.4 t -73.99 81.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -70.04 -40.34 75.2 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.81 -170.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m 55.05 30.55 14.45 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 124.106 0.879 . . . . 0.0 111.1 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -60.73 -30.81 70.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.722 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -117.88 105.84 12.35 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.09 179.98 42.61 Favored Glycine 0 C--N 1.34 0.777 0 O-C-N 123.288 0.367 . . . . 0.0 113.033 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.14 100.65 3.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.28 1.032 . . . . 0.0 110.046 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp 63.69 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.086 1.354 . . . . 0.0 112.14 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.01 -75.73 1.49 Allowed Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 m -126.2 120.96 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 109.018 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.62 176.46 5.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.813 0.845 . . . . 0.0 110.605 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.85 99.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -125.91 173.54 9.04 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.685 0.794 . . . . 0.0 109.225 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 75.68 -68.92 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.22 129.83 35.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.119 0.568 . . . . 0.0 109.688 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 110.403 177.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG23 ' A' ' 66' ' ' VAL . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.464 ' HA ' HG21 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.471 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' HE1' HD12 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.458 HG12 ' HE2' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.743 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.552 ' HA ' HD11 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' B' ' 128' ' ' ALA . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.668 ' HG3' HG11 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.558 HG23 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.583 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.478 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.661 ' HA2' HD22 ' B' ' 13' ' ' LEU . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' B' ' 17' ' ' PRO . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.549 ' HG3' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' B' ' 13' ' ' LEU . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.534 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.644 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.492 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.442 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.443 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.442 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.558 ' HA ' HG23 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' A' ' 154' ' ' LYS . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.544 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.743 ' HE1' ' SD ' ' A' ' 140' ' ' MET . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 377' ' ' ALA . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.628 HD12 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 346' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.531 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.558 ' HB2' HG22 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -68.79 -38.48 80.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.473 ' SD ' HG21 ' B' ' 97' ' ' ILE . 53.6 ttp -73.04 -35.94 66.83 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.897 0.879 . . . . 15.0 110.461 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 384' ' ' VAL . . . -67.97 -45.55 73.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.21 0.604 . . . . 15.0 110.392 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -61.44 -31.56 71.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.222 1.009 . . . . 15.0 110.942 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 276' ' ' ARG . . . -71.09 -33.74 70.47 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.923 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.3 174.17 10.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.81 0.444 . . . . 15.0 110.299 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.44 -34.57 74.61 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.694 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 14.3 t70 -159.0 126.49 2.7 Favored Pre-proline 0 C--O 1.21 -1.022 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.6 -31.78 41.62 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 123.642 2.895 . . . . 15.0 115.377 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -53.21 -40.35 64.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.264 0.626 . . . . 15.0 112.0 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.3 pt-20 -58.84 -36.91 75.32 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 122.923 0.489 . . . . 15.0 111.116 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 375' ' ' ALA . 69.6 t -73.11 -51.64 25.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 123.822 0.849 . . . . 15.0 109.817 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.68 -41.25 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 CA-C-N 115.624 -0.716 . . . . 15.0 110.754 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.29 -34.76 75.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.649 0.78 . . . . 15.0 111.422 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.488 ' HB2' ' HE1' ' B' ' 94' ' ' PHE . 29.5 t80 -60.55 -54.61 43.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.909 -0.404 . . . . 15.0 109.909 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -54.2 -49.71 68.77 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.274 0.63 . . . . 15.0 112.294 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.7 p -64.5 -14.28 56.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.88 2.26 11.55 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.102 -0.475 . . . . 15.0 111.463 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -142.74 101.44 3.86 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 15.0 111.372 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.72 -31.07 68.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.15 0.98 . . . . 15.0 110.593 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 404' ' ' GLU . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.8 t-20 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 130' ' ' VAL . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.554 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.38 7.23 10.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -105.1 86.9 2.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.884 0.874 . . . . 15.0 110.056 -176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -96.45 -10.19 28.06 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.46 0.704 . . . . 15.0 110.718 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.472 1.109 . . . . 15.0 108.321 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.53 ' HB2' ' HZ2' ' B' ' 2' ' ' LYS . 4.1 ttmp? 56.84 32.02 20.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.733 1.213 . . . . 0.0 111.259 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.85 144.59 49.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.021 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.2 m -121.5 79.65 1.57 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -77.72 81.35 4.16 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -87.98 141.59 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 109.446 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.07 65.29 5.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.367 1.079 . . . . 0.0 109.354 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -85.89 10.93 12.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.382 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.41 -9.84 45.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.116 0.967 . . . . 0.0 111.385 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.95 -150.86 0.46 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 125.179 1.392 . . . . 0.0 107.805 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.588 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 3.4 pp 59.42 177.3 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.412 1.485 . . . . 0.0 113.007 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' B' ' 11' ' ' LEU . 37.8 Cg_endo -64.82 74.01 0.22 Allowed 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 122.013 1.809 . . . . 0.0 114.699 171.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.661 HD22 ' HA2' ' A' ' 180' ' ' GLY . 62.3 tp -128.79 -34.77 1.94 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.347 1.059 . . . . 0.0 108.657 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.65 -59.2 1.02 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.969 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 51.42 76.15 0.18 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.512 0.725 . . . . 0.0 111.7 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -91.81 140.97 25.08 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.555 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 186' ' ' VAL . 50.9 Cg_exo -55.41 -52.88 6.7 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.478 2.119 . . . . 0.0 111.205 171.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.99 136.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.093 1.357 . . . . 0.0 108.545 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 35.8 p -72.22 113.85 9.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 69.61 -73.16 0.09 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.379 1.472 . . . . 0.0 112.06 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.5 -80.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.026 1.33 . . . . 0.0 110.176 -171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -166.55 76.81 0.2 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.615 1.166 . . . . 0.0 108.116 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 13.2 p -70.22 125.34 91.96 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.094 173.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 7.0 Cg_exo -75.39 14.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.206 2.604 . . . . 0.0 114.251 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.4 -45.95 84.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.697 0.799 . . . . 0.0 109.234 167.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -110.38 98.67 37.17 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.23 123.56 10.73 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.341 2.027 . . . . 0.0 111.332 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.67 90.71 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -78.66 89.17 4.55 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.054 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -80.97 139.78 35.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.682 0.793 . . . . 0.0 108.945 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -141.57 90.63 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 52.26 14.09 0.33 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 126.388 1.875 . . . . 0.0 115.062 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.06 -9.88 27.19 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.092 0.557 . . . . 0.0 110.205 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.17 146.31 35.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.767 0.827 . . . . 0.0 110.466 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -117.05 171.9 7.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.834 0.854 . . . . 0.0 109.923 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.63 173.77 35.62 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.868 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.422 ' O ' HG22 ' B' ' 38' ' ' ILE . 20.6 t70 -58.98 120.93 10.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.799 0.84 . . . . 0.0 109.627 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.422 HG22 ' O ' ' B' ' 37' ' ' ASP . 6.7 tp 60.63 -0.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.454 1.902 . . . . 0.0 112.962 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m 51.45 -83.09 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.616 1.567 . . . . 0.0 112.043 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.09 107.91 27.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 109.508 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.96 10.98 3.41 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.624 2.216 . . . . 0.0 113.196 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.42 -85.4 0.73 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -172.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.02 22.09 59.95 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 124.234 0.608 . . . . 0.0 114.525 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.69 72.37 3.33 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.785 0.802 . . . . 0.0 109.437 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -168.43 -38.14 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.131 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 70.89 -46.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.547 1.539 . . . . 0.0 111.767 -169.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.38 178.19 9.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.181 0.993 . . . . 0.0 110.134 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.2 m -139.29 -53.3 0.56 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.68 -160.7 35.87 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.476 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.01 84.13 6.55 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 122.14 0.972 . . . . 0.0 111.017 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' B' ' 55' ' ' LEU . 0.4 OUTLIER -112.14 6.89 19.37 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.444 1.497 . . . . 0.0 110.168 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -57.04 -64.74 0.78 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.79 0.836 . . . . 0.0 113.027 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.98 -24.42 30.62 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.084 0.553 . . . . 0.0 111.623 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.61 78.29 1.78 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.48 0.712 . . . . 0.0 109.251 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.44 ' HA ' ' HG3' ' B' ' 51' ' ' GLN . 2.8 tm? -72.5 -61.44 1.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -169.18 163.47 10.98 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.587 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.06 71.57 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.884 0.85 . . . . 0.0 108.783 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m -75.5 -60.9 2.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.985 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 57.29 -78.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.17 1.388 . . . . 0.0 113.019 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t 68.91 25.38 6.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.258 1.023 . . . . 0.0 110.288 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 63.11 83.13 0.17 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.447 1.499 . . . . 0.0 110.829 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -127.27 143.16 46.18 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.54 79.74 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.631 2.221 . . . . 0.0 110.649 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -11.78 59.86 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.989 0.915 . . . . 0.0 111.254 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 66.25 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.413 1.485 . . . . 0.0 111.287 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -101.27 95.28 6.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.611 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -84.01 71.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.204 1.002 . . . . 0.0 109.02 177.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.16 -58.04 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.485 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt 60.32 -177.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.634 1.174 . . . . 0.0 111.721 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.532 ' HA ' ' HG3' ' B' ' 75' ' ' MET . 50.4 mt -71.63 -24.16 61.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.371 174.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 40.8 mt -98.61 101.3 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.613 0.765 . . . . 0.0 109.072 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.06 -131.47 1.35 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.17 -66.91 0.89 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.313 0.557 . . . . 0.0 109.666 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.21 -143.84 0.46 Allowed Glycine 0 C--N 1.348 1.224 0 O-C-N 124.174 0.921 . . . . 0.0 113.972 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.532 ' HG3' ' HA ' ' B' ' 70' ' ' LEU . 25.7 mmt 75.74 -57.57 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.038 1.335 . . . . 0.0 111.598 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.52 73.73 2.34 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.397 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' B' ' 80' ' ' ILE . 15.6 t70 74.77 156.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.769 1.628 . . . . 0.0 111.488 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -63.11 -67.22 0.44 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.372 1.069 . . . . 0.0 111.635 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.84 -14.7 59.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.125 0.57 . . . . 0.0 110.354 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' B' ' 77' ' ' ASP . 75.5 mt 66.6 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 125.387 1.475 . . . . 0.0 109.616 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.7 m -158.08 -45.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.134 1.374 . . . . 0.0 107.301 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.89 127.82 0.03 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.411 1.484 . . . . 0.0 110.642 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.82 4.68 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 123.537 0.523 . . . . 0.0 109.883 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.84 106.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.64 74.06 4.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.785 0.802 . . . . 0.0 110.861 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -79.03 -38.41 36.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.78 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.85 23.0 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.358 1.063 . . . . 0.0 109.615 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -72.97 94.78 1.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.08 -58.72 0.69 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.83 66.54 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.459 0.703 . . . . 0.0 111.645 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.79 3.36 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.613 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.16 152.81 21.12 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -114.75 142.4 46.57 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.92 0.888 . . . . 0.0 110.615 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.488 ' HE1' ' HB2' ' A' ' 387' ' ' PHE . 42.1 p90 -69.69 -47.29 63.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -165.92 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.23 157.62 9.92 Favored Glycine 0 N--CA 1.479 1.537 0 CA-C-O 119.883 -0.399 . . . . 0.0 112.853 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 384' ' ' VAL . 21.3 mt -123.65 132.85 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.483 0.713 . . . . 0.0 111.149 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.23 130.79 39.51 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.29 73.45 10.45 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.489 0.716 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . 0.292 3.1 mm? 61.07 -91.09 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.446 0 CA-C-O 116.336 -1.792 . . . . 0.0 112.224 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 -12.02 12.22 Favored 'Trans proline' 0 C--N 1.412 3.893 0 CA-C-N 125.38 2.957 . . . . 0.0 111.907 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 36.9 tp 53.87 84.89 0.06 Allowed 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.77 1.628 . . . . 0.0 111.05 -171.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -65.11 143.21 58.04 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.348 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.28 164.01 29.88 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.232 0.333 . . . . 0.0 113.308 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -63.5 103.51 0.53 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.355 0.662 . . . . 0.0 110.546 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 60.59 22.44 12.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.569 1.548 . . . . 0.0 111.713 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.9 m -85.71 52.61 2.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.777 1.275 . . . . 0.0 108.629 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.5 -14.51 45.76 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.143 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.63 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 68.9 m-85 -87.57 8.14 26.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.616 1.167 . . . . 0.0 111.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.69 -44.8 0.24 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.719 0.807 . . . . 0.0 109.876 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt 66.07 -78.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.245 1.418 . . . . 0.0 108.781 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.02 132.21 35.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 108.259 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 179.63 -20.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.219 0.608 . . . . 0.0 110.892 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.74 -42.31 91.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.101 0.96 . . . . 0.0 112.562 -163.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -91.46 -22.5 20.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.752 0.421 . . . . 0.0 110.364 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.26 71.74 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.934 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -167.33 -66.12 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.525 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.464 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 68.5 Cg_endo -83.63 -55.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.39 2.757 0 CA-C-N 121.169 1.453 . . . . 0.0 113.776 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.58 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.588 1.555 . . . . 0.0 112.356 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.464 ' HE1' ' HB2' ' B' ' 118' ' ' PRO . 25.0 p90 35.28 -82.96 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 125.952 1.701 . . . . 0.0 114.696 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.3 m -144.86 171.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.861 1.664 . . . . 0.0 108.082 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -148.72 139.72 23.03 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.922 -0.486 . . . . 0.0 111.376 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 69.81 -67.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.11 1.764 . . . . 0.0 113.346 173.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -58.73 98.47 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.324 1.05 . . . . 0.0 112.335 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.52 ' HB2' ' HB ' ' B' ' 129' ' ' THR . . . -81.36 97.08 7.54 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.78 -13.54 15.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.684 1.194 . . . . 0.0 113.493 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 71.1 m -60.74 -46.23 91.22 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.293 0.637 . . . . 0.0 111.754 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.564 ' HB3' ' HG ' ' A' ' 144' ' ' LEU . . . -176.55 -41.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' B' ' 125' ' ' ALA . 21.4 m -67.33 115.24 6.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.329 0.651 . . . . 0.0 111.376 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.49 -150.28 0.3 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.873 0.869 . . . . 0.0 110.49 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.465 ' HH2' HD13 ' A' ' 144' ' ' LEU . 8.1 m-90 78.84 160.49 0.19 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.277 1.831 . . . . 0.0 112.854 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.2 p -168.87 90.59 0.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.154 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 9.3 t -70.47 139.65 51.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.855 0.462 . . . . 0.0 110.839 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.77 21.24 0.04 OUTLIER Glycine 0 N--CA 1.472 1.048 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.401 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.53 141.9 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.683 0.793 . . . . 0.0 110.015 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -10.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.241 0.616 . . . . 0.0 111.26 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 6.2 t 48.39 -159.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 126.094 1.757 . . . . 0.0 111.91 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -104.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.639 -0.663 . . . . 0.0 110.055 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.521 HD22 HD11 ' B' ' 142' ' ' LEU . 28.5 t-20 -58.97 -47.87 83.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.154 0.982 . . . . 0.0 110.468 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 60.7 57.55 18.33 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 124.007 0.817 . . . . 0.0 114.1 168.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.99 41.39 14.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.541 1.136 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.521 HD11 HD22 ' B' ' 139' ' ' ASN . 3.9 mm? 60.42 34.37 20.58 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.393 1.077 . . . . 0.0 110.178 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.78 119.57 16.87 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.972 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 23.1 t -67.44 89.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.501 0.721 . . . . 0.0 109.694 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.59 95.31 5.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.781 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.9 112.11 37.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -70.04 87.27 0.56 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.387 1.075 . . . . 0.0 110.15 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 60.21 87.94 0.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.277 1.431 . . . . 0.0 111.547 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -64.97 92.85 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 124.135 0.974 . . . . 0.0 108.514 -177.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.603 HD12 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.685 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.459 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB2' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.448 HD12 ' HD3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 HG23 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.598 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.506 ' HB ' HD21 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 136' ' ' ASP . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 133' ' ' THR . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.627 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.629 HG21 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 3.0 m-20 -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.556 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.448 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.483 ' HE3' HG23 ' A' ' 137' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB2' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.469 HD23 ' NE2' ' A' ' 317' ' ' GLN . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.469 ' NE2' HD23 ' A' ' 314' ' ' LEU . 8.7 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.436 ' HA ' HD11 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.553 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 119.928 -0.082 . . . . 15.0 111.026 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.516 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.553 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 397' ' ' ASN . 69.7 m-20 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.461 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 407' ' ' ALA . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.448 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 14.9 t30 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.67 ' HG3' HD12 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.554 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.596 ' HA ' HD12 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.557 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.532 ' HB ' HD21 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.693 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 235' ' ' ILE . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.497 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.46 HG23 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.497 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.637 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.493 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.693 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.4 m120 -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.693 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.443 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.594 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.455 ' HG2' HG13 ' A' ' 258' ' ' VAL . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 132' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.522 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 285' ' ' ARG . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.557 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.619 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.47 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 319' ' ' ALA . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.575 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.619 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.536 HD13 HD22 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.552 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 112.306 0.484 . . . . 15.0 112.306 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 394' ' ' LEU . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.653 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 408' ' ' VAL . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 290' ' ' ALA . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.404 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 10.5 t-20 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.627 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 . . . . . 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 51' ' ' MET . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.432 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HD13 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.474 ' HE1' HD13 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.722 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.551 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.45 HD12 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG23 ' SD ' ' A' ' 274' ' ' MET . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.62 HD13 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 237' ' ' LEU . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG21 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.659 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.659 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.609 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.565 HG23 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.588 HG22 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.609 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.69 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 236' ' ' ASN . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 210' ' ' GLU . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.755 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 251' ' ' GLU . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 249' ' ' THR . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.754 HG23 HD13 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.484 ' SD ' HG11 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 408' ' ' VAL . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.486 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.434 HG21 HG13 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 307' ' ' ILE . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.615 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.506 HD21 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.506 ' NH1' HD21 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.618 HG22 HG21 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 407' ' ' ALA . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.682 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.365 0.506 . . . . 15.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 401' ' ' VAL . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.682 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 355' ' ' ILE . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.45 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 130' ' ' VAL . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.729 HD12 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.491 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.1 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' VAL . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.533 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 11' ' ' LEU . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.603 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.422 HG23 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.528 HD11 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.817 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.509 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.663 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.64 HG11 HG22 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.444 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.523 HG23 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 164' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.632 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.523 ' HD3' HG23 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.455 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 2.1 m120 -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.817 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.633 ' HG2' HG13 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.733 ' HE1' ' HA ' ' A' ' 137' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 287' ' ' LYS . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.504 HG11 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' VAL . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.516 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.436 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.462 HD13 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.7 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.462 HE22 HD13 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 341' ' ' ALA . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.418 HD12 HG12 ' A' ' 347' ' ' VAL . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.732 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.5 ttmt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 112.224 0.453 . . . . 15.0 112.224 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG2' HG21 ' A' ' 367' ' ' VAL . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.576 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.416 ' HA ' HD12 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.483 HG22 HD13 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.583 ' HA ' HG13 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 3.6 t-20 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.725 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.2 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.6 HH12 HG11 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' HG22 ' A' ' 54' ' ' VAL . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG11 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.433 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.582 HG23 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 123' ' ' ILE . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.569 HG11 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.56 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.457 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 207' ' ' ALA . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.513 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.692 HG22 HG11 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.672 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.51 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.627 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.412 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.4 m120 -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.423 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG11 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.423 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.52 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.582 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.503 HD21 HD21 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.507 ' HB3' HD22 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.481 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.575 HD11 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.54 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.54 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.423 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.575 ' HE3' HD11 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.408 HH11 ' HB3' ' A' ' 363' ' ' ASP . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 398' ' ' MET . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.631 ' SD ' HD11 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 355' ' ' ILE . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.859 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 21.4 m120 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.859 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.5 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.628 ' HA ' HG21 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 53' ' ' ILE . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.1 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.628 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG11 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.44 HD12 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.497 HG11 HG13 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.562 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 141' ' ' LEU . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.735 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.626 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.548 HG23 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.486 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.548 ' CE1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.434 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.41 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.557 HG22 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.626 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.489 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.5 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.407 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.1 m-20 -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 158' ' ' VAL . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.78 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.655 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.597 HG21 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.497 HG13 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.585 HG21 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 311' ' ' ILE . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.585 ' HG3' HG21 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 119.068 -0.492 . . . . 15.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.586 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.44 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.484 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.795 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.484 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.562 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.653 HG12 HG12 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG11 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.611 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' NH2' HG11 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 28' ' ' VAL . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.403 HG12 ' HD2' ' A' ' 109' ' ' PHE . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.526 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.413 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.561 HD21 HG21 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 140' ' ' MET . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 237' ' ' LEU . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.59 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.401 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.599 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.656 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.656 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.435 ' HE2' HG22 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.599 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.55 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 232' ' ' LYS . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 258' ' ' VAL . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.413 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 258' ' ' VAL . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.561 HG21 HD21 ' A' ' 141' ' ' LEU . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.475 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 287' ' ' LYS . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 345' ' ' VAL . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.409 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 336' ' ' LEU . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.707 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 340' ' ' GLN . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 112.097 0.406 . . . . 15.0 112.097 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.57 ' HA ' HG12 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.525 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.448 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.522 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 5' ' ' VAL . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.548 HG21 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG22 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG21 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.729 HG23 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.47 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.495 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.584 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 177' ' ' PHE . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CE1' HG23 ' A' ' 172' ' ' VAL . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.805 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.805 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.565 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.445 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.479 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.606 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.703 HG12 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.432 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 266' ' ' LEU . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.546 ' H ' ' HA ' ' A' ' 254' ' ' LYS . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.493 HD13 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 137' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.419 HD13 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.552 HD12 HG11 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.729 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.461 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.678 HD11 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.435 ' O ' HD13 ' A' ' 311' ' ' ILE . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.433 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 330' ' ' LEU . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.407 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.426 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.529 ' HB1' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 355' ' ' ILE . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 287' ' ' LYS . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.657 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.518 HG12 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.612 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.584 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.658 ' HG2' HG11 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 97' ' ' TYR . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.499 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.629 ' HB3' HG21 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.442 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.612 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.528 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.532 ' HG2' HD11 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG23 HD22 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.708 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 HG22 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.54 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 191' ' ' GLN . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.587 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 158' ' ' VAL . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.708 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.66 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.576 HD13 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.513 HD22 HG23 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 405' ' ' GLU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.528 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.527 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.41 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.421 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.641 HH12 HD12 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.641 HD12 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 119.273 -0.394 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.489 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 396' ' ' ASP . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.54 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 407' ' ' ALA . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.505 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.468 ' HA ' HD12 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.418 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.532 HD11 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.676 HG12 HG12 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD13 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 63' ' ' ARG . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG22 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.526 ' HE1' HD13 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 117' ' ' LEU . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.501 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.458 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 141' ' ' LEU . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.673 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.58 HD13 HD11 ' A' ' 202' ' ' ILE . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.587 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.587 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.566 ' HG3' HD21 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.476 ' N ' ' SD ' ' A' ' 194' ' ' MET . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.538 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.525 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.554 ' HA ' HG22 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.572 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.644 HD11 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.501 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 346' ' ' VAL . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 115' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.571 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.566 ' HB2' HG23 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 355' ' ' ILE . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 398' ' ' MET . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.593 -0.151 . . . . 15.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.41 ' HG3' HG13 ' A' ' 367' ' ' VAL . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 287' ' ' LYS . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.4 t30 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.603 HD12 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.685 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.459 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB2' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.448 HD12 ' HD3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 HG23 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.598 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.506 ' HB ' HD21 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 136' ' ' ASP . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 133' ' ' THR . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.537 HG23 ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.526 HD13 ' HH2' ' B' ' 131' ' ' TRP . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.627 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.629 HG21 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.463 ' HB2' HD13 ' B' ' 10' ' ' LEU . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 3.0 m-20 -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.556 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.448 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 273' ' ' ASN . 0.9 OUTLIER -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.537 ' HE3' HG23 ' A' ' 137' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 377' ' ' ALA . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB2' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.432 HD21 ' HE ' ' A' ' 344' ' ' ARG . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.411 HE21 HH22 ' A' ' 321' ' ' ARG . 59.8 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.411 HH22 HE21 ' A' ' 317' ' ' GLN . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.436 ' HA ' HD11 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.519 HG11 ' HG ' ' B' ' 111' ' ' LEU . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.553 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -68.21 -33.87 75.22 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.442 ' HG2' ' HE1' ' B' ' 94' ' ' PHE . 56.5 ttp -70.84 -44.06 67.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.385 0.612 . . . . 15.0 109.953 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -84.3 -6.53 59.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.172 0.989 . . . . 15.0 111.945 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -59.64 -20.33 55.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.112 0.965 . . . . 15.0 112.346 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.442 ' HB2' ' HG2' ' A' ' 276' ' ' ARG . . . -63.32 -33.24 75.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.3 0.64 . . . . 15.0 110.932 171.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.7 156.98 18.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.523 0.729 . . . . 15.0 110.028 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -31.96 16.8 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.894 0.878 . . . . 15.0 110.052 175.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -150.56 87.5 4.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.49 49.63 1.85 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.821 3.014 . . . . 15.0 114.003 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -55.48 -38.16 68.75 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.853 0.861 . . . . 15.0 111.452 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 384' ' ' VAL . 6.1 pt-20 -49.41 -49.44 44.84 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.624 1.17 . . . . 15.0 111.832 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 383' ' ' GLU . 91.5 t -71.89 -52.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 C-N-CA 123.98 0.912 . . . . 15.0 109.91 -172.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.76 -45.28 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.914 0.886 . . . . 15.0 110.921 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.42 -35.6 79.58 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.161 -0.472 . . . . 15.0 111.024 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' B' ' 97' ' ' ILE . 13.9 t80 -64.17 -38.26 90.42 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 119.469 -0.301 . . . . 15.0 110.403 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.58 -58.46 8.44 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 120.863 0.363 . . . . 15.0 110.972 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 22.1 p -66.17 -14.6 62.13 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 113.067 0.766 . . . . 15.0 113.067 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.24 4.19 13.5 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.608 0.763 . . . . 15.0 111.442 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -151.12 90.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.558 -1.275 . . . . 15.0 107.558 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -74.71 -16.74 60.74 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.708 -1.133 . . . . 15.0 111.026 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.553 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.461 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 407' ' ' ALA . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.448 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 14.9 t30 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.67 ' HG3' HD12 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' B' ' 126' ' ' ALA . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -42.32 -31.56 0.42 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLN . . . . . 0.493 HE22 ' HA ' ' B' ' 122' ' ' THR . 77.8 mt-30 -104.86 117.48 34.15 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.979 0.512 . . . . 15.0 111.551 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 -19.1 9.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.93 0.892 . . . . 15.0 109.569 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 C-N-CA 123.492 0.717 . . . . 15.0 109.806 -177.475 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.555 ' HG3' ' HB2' ' B' ' 9' ' ' ALA . 36.7 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 22.4 tptm -156.87 92.52 1.28 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -162.01 165.14 27.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.237 1.015 . . . . 0.0 109.403 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -61.34 -43.83 98.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.078 0.951 . . . . 0.0 112.442 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.8 m -71.07 77.05 0.67 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.978 0.911 . . . . 0.0 111.806 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.583 HG23 HD11 ' B' ' 10' ' ' LEU . 2.6 mp 32.79 -95.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 127.429 2.292 . . . . 0.0 113.101 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.15 31.32 13.72 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.04 0.936 . . . . 0.0 113.253 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp 49.93 17.12 0.26 Allowed 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.252 1.821 . . . . 0.0 114.489 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HG3' ' B' ' 1' ' ' MET . . . -76.42 -32.44 58.48 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.792 0.837 . . . . 0.0 110.831 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.583 HD11 HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -86.68 -11.53 50.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.84 0.856 . . . . 0.0 112.409 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -167.58 108.19 0.6 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.906 0.882 . . . . 0.0 108.993 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.58 112.16 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.85 2.367 . . . . 0.0 111.075 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.49 -40.07 85.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 110.407 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.98 117.29 24.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 169.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.24 0.26 45.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.43 0.692 . . . . 0.0 111.944 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -114.18 87.67 13.69 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.98 -58.39 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.644 2.229 . . . . 0.0 111.573 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.608 HG12 ' H ' ' B' ' 20' ' ' LYS . 85.0 t 65.01 -67.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.444 1.498 . . . . 0.0 111.292 -172.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.3 p 57.78 16.65 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.036 1.734 . . . . 0.0 112.927 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.608 ' H ' HG12 ' B' ' 18' ' ' VAL . 62.8 mttm 58.44 23.46 10.67 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.143 1.377 . . . . 0.0 112.365 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.52 4.87 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 62.28 63.0 1.1 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 124.539 1.149 . . . . 0.0 109.658 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 98.9 m -54.18 118.61 16.46 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.517 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -16.0 82.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.419 1 C-N-CA 126.568 4.845 . . . . 0.0 117.67 -168.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 23' ' ' THR . 27.3 mt-10 -105.22 -75.95 0.61 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.557 1.143 . . . . 0.0 107.965 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 85.2 mtp -96.99 -43.0 0.25 Allowed Pre-proline 0 CA--C 1.559 1.29 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.375 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.43 73.74 2.16 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 122.273 1.982 . . . . 0.0 112.255 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.25 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.322 1.449 . . . . 0.0 108.915 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.31 130.77 53.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.426 1.09 . . . . 0.0 110.056 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -83.68 133.81 34.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.425 0.69 . . . . 0.0 109.405 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.487 HD21 ' HB3' ' B' ' 35' ' ' GLN . 2.2 t-20 -80.05 4.49 16.98 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.849 0.86 . . . . 0.0 111.003 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 74.48 -76.37 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.379 1.872 . . . . 0.0 111.688 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.68 30.61 4.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.649 0.78 . . . . 0.0 110.181 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.76 67.81 0.8 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.571 1.149 . . . . 0.0 111.537 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.487 ' HB3' HD21 ' B' ' 31' ' ' ASN . 6.0 tp-100 -62.25 -53.2 58.57 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.028 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.61 22.01 29.22 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.646 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.75 169.0 16.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.114 0.566 . . . . 0.0 110.616 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.7 mt 77.11 -67.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.366 1.866 . . . . 0.0 110.114 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.424 HG21 HD13 ' B' ' 67' ' ' ILE . 24.3 p -109.61 -75.43 0.63 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.488 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . 179.54 -52.13 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.356 1.462 . . . . 0.0 109.476 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 77.1 Cg_endo -101.07 111.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 123.164 2.576 . . . . 0.0 112.886 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.15 76.37 2.24 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.254 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.34 -79.19 0.22 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.24 -176.7 6.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.857 0.863 . . . . 0.0 109.743 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -99.58 -42.64 6.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.466 0.707 . . . . 0.0 109.611 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 69.96 -65.66 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.763 1.625 . . . . 0.0 112.714 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 68' ' ' ILE . 50.9 tp 78.12 -15.16 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.34 1.456 . . . . 0.0 112.504 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -88.24 6.78 35.19 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.437 0.695 . . . . 0.0 111.861 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.68 47.32 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.88 -16.42 58.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.495 0.718 . . . . 0.0 111.964 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.98 -54.94 23.86 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.01 0.924 . . . . 0.0 110.251 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -70.35 -24.39 62.97 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.66 -43.26 59.89 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.295 0.638 . . . . 0.0 111.383 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -172.37 -66.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.799 0.84 . . . . 0.0 110.934 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' B' ' 57' ' ' ASP . 2.6 pt? -129.48 167.14 18.29 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.16 0.584 . . . . 0.0 111.343 -168.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.56 ' HD3' ' H ' ' B' ' 56' ' ' ARG . 0.1 OUTLIER -127.06 15.01 7.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.779 0.832 . . . . 0.0 109.255 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' B' ' 55' ' ' LEU . 3.3 m-20 -93.59 55.23 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.813 1.245 . . . . 0.0 109.571 -170.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.512 ' HB3' HD13 ' B' ' 68' ' ' ILE . 86.7 p 56.12 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.888 1.675 . . . . 0.0 111.625 -173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -168.11 -57.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.0 m -147.03 -76.53 0.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -156.01 -65.15 0.11 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.396 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 mptt 37.18 168.31 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.061 0 C-N-CA 126.008 1.723 . . . . 0.0 115.504 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.28 129.46 19.18 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 123.127 2.551 . . . . 0.0 114.399 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.29 28.19 13.83 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.326 1.45 . . . . 0.0 112.127 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.14 49.21 5.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.491 1.116 . . . . 0.0 109.774 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 17.5 m120 65.45 -176.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.46 1.104 . . . . 0.0 110.54 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.424 HD13 HG21 ' B' ' 39' ' ' THR . 15.0 tt -87.05 61.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 122.755 1.264 . . . . 0.0 110.466 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 58' ' ' SER . 24.4 pt -120.79 2.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.451 -0.78 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 128.26 36.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.33 -47.93 82.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.688 0.795 . . . . 0.0 112.163 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.38 133.53 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -173.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.76 55.02 0.09 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -79.87 -35.04 38.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.374 0.67 . . . . 0.0 110.758 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.7 81.96 1.1 Allowed Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.041 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.7 -22.0 64.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.489 0.715 . . . . 0.0 111.325 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.94 11.53 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 168.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 74.04 -24.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.125 1.37 . . . . 0.0 114.488 166.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -69.64 -44.84 69.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.431 0.692 . . . . 0.0 111.257 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -93.27 -72.09 0.62 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.806 0.442 . . . . 0.0 110.13 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 9.8 tp -162.35 -30.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.677 0.391 . . . . 0.0 110.827 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 28.8 m -59.5 135.17 57.58 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 123.252 0.621 . . . . 0.0 109.892 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 79.64 -49.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.644 1.578 . . . . 0.0 111.256 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.52 -66.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.377 1.471 . . . . 0.0 110.574 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -130.32 104.45 7.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.41 115.27 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.244 1.017 . . . . 0.0 110.387 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' B' ' 90' ' ' ALA . 32.9 m-85 80.3 -42.24 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.554 1.542 . . . . 0.0 112.111 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.6 48.4 9.58 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.477 1.111 . . . . 0.0 111.234 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 76.16 -57.43 0.56 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.112 1.765 . . . . 0.0 112.901 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.58 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . -80.38 1.23 82.38 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' B' ' 86' ' ' TYR . . . 62.77 24.01 14.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.31 1.044 . . . . 0.0 111.642 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.46 -65.79 3.6 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -168.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.7 -91.71 0.27 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 122.8 0.238 . . . . 0.0 112.998 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -158.13 -70.37 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.442 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 48.4 t80 -77.08 -40.35 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.258 0.623 . . . . 0.0 110.641 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.64 ' HD2' ' HA2' ' B' ' 134' ' ' GLY . 0.3 OUTLIER -58.7 -28.21 65.57 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.542 0.526 . . . . 0.0 110.662 174.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.81 -79.48 0.21 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 387' ' ' PHE . 0.0 OUTLIER 176.88 -35.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.143 0.977 . . . . 0.0 109.647 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.2 148.58 47.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 113.113 -162.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.44 -24.39 5.0 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.952 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.18 108.64 0.9 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.18 -85.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.023 1.815 . . . . 0.0 112.121 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.695 HD21 ' HG3' ' B' ' 113' ' ' LYS . 85.2 mt 60.66 -173.58 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.83 1.252 . . . . 0.0 113.336 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 17.6 m -140.11 90.86 2.41 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.25 90.13 0.08 OUTLIER Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -81.98 119.52 24.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 71.39 26.43 3.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.37 1.468 . . . . 0.0 111.807 -175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -82.25 167.39 18.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.21 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -135.08 11.15 3.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.504 0.722 . . . . 0.0 110.502 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -86.51 23.39 1.64 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 0.0 110.131 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' B' ' 113' ' ' LYS . . . -79.9 -100.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.77 0.828 . . . . 0.0 109.384 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.519 ' HG ' HG11 ' A' ' 347' ' ' VAL . 3.2 mm? 51.73 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.88 1.272 . . . . 0.0 112.953 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -92.63 82.41 4.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.543 0.687 . . . . 0.0 111.862 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.695 ' HG3' HD21 ' B' ' 102' ' ' LEU . 0.0 OUTLIER -157.24 37.86 0.29 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.153 -1.385 . . . . 0.0 107.598 162.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -176.93 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.683 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.0 m -64.81 -34.0 77.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.631 0.772 . . . . 0.0 111.071 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.537 ' HA2' ' H ' ' B' ' 121' ' ' VAL . . . 90.19 -66.69 2.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -67.4 143.33 97.18 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.832 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -1.64 66.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.453 1 C-N-CA 126.701 4.934 . . . . 0.0 116.369 -154.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.82 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.846 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.72 -90.6 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 109.816 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.622 HG22 HG23 ' B' ' 122' ' ' THR . 12.8 p -174.63 141.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.519 1.528 . . . . 0.0 108.074 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.622 HG23 HG22 ' B' ' 121' ' ' VAL . 56.7 p 60.25 176.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.699 1.6 . . . . 0.0 114.287 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.95 71.99 1.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.669 0.788 . . . . 0.0 109.582 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t 76.12 -51.18 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.295 1.438 . . . . 0.0 111.848 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.32 41.59 16.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.17 0.988 . . . . 0.0 109.626 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 428' ' ' MET . . . -73.97 9.02 1.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.806 -170.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' A' ' 140' ' ' MET . 26.8 m -59.74 86.58 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 123.573 0.749 . . . . 0.0 110.001 169.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.96 -76.04 0.07 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.89 1.676 . . . . 0.0 111.99 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.0 m 61.44 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.023 1.329 . . . . 0.0 109.372 -166.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.8 -171.98 0.11 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 124.648 1.179 . . . . 0.0 114.04 170.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.526 ' HH2' HD13 ' A' ' 144' ' ' LEU . 3.6 p90 47.28 31.17 1.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.386 1.874 . . . . 0.0 114.966 166.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 51.3 p -87.83 61.51 6.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.745 0.818 . . . . 0.0 109.853 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -84.45 65.52 8.98 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.827 1.298 . . . . 0.0 110.54 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLY . . . . . 0.64 ' HA2' ' HD2' ' B' ' 95' ' ' LYS . . . 79.12 -95.43 1.41 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 80.6 t 63.71 113.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.072 1.349 . . . . 0.0 111.749 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.35 82.56 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.043 0.925 . . . . 0.0 109.623 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -107.96 3.91 24.66 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.827 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.69 -175.83 3.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.02 0.928 . . . . 0.0 109.515 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -62.25 136.52 57.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.313 0.645 . . . . 0.0 112.285 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -142.12 88.54 0.18 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.64 17.94 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.498 0.719 . . . . 0.0 110.168 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.16 -177.2 5.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.637 1.175 . . . . 0.0 109.442 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.86 -78.97 1.76 Allowed Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.1 122.66 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.849 0.859 . . . . 0.0 109.85 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.82 168.89 18.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.136 1.375 . . . . 0.0 108.834 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.565 HG12 ' H ' ' B' ' 147' ' ' HIS . 12.8 tt 30.15 -141.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 125.831 1.652 . . . . 0.0 111.781 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' HIS . . . . . 0.565 ' H ' HG12 ' B' ' 146' ' ' ILE . 85.2 t60 -65.66 90.24 0.11 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.396 1.907 . . . . 0.0 110.348 169.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 27.15 79.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.549 2.34 . . . . 0.0 115.814 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.3 157.68 44.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t0 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.883 0.873 . . . . 0.0 108.723 170.785 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.554 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.596 ' HA ' HD12 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.557 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.532 ' HB ' HD21 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.693 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 235' ' ' ILE . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.615 ' HA2' HD21 ' B' ' 8' ' ' LEU . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' B' ' 30' ' ' GLU . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.497 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.46 HG23 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.497 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.637 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' OH ' HD12 ' B' ' 13' ' ' LEU . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.503 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.493 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.693 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.4 m120 -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.693 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.443 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.594 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.561 ' HD2' ' HB2' ' B' ' 138' ' ' TYR . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.588 ' HA3' ' HB ' ' B' ' 133' ' ' THR . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.455 ' HG2' HG13 ' A' ' 258' ' ' VAL . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 132' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.599 ' HG2' ' HA ' ' B' ' 128' ' ' ALA . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.522 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 285' ' ' ARG . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.557 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.619 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.47 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 319' ' ' ALA . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.575 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.619 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.536 HD13 HD22 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.552 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 398' ' ' MET . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.08 -43.44 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.519 ' SD ' HD11 ' B' ' 97' ' ' ILE . 41.2 ttp -80.48 -50.98 9.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.547 1.539 . . . . 15.0 111.202 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.47 -15.08 60.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.872 0.869 . . . . 15.0 112.321 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.6 t -67.66 -3.18 8.32 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.413 0.685 . . . . 15.0 111.383 171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.15 -14.62 63.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.118 0.567 . . . . 15.0 111.336 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -137.24 161.76 35.34 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.889 1.276 . . . . 15.0 109.915 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.72 -35.41 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.357 0.663 . . . . 15.0 110.212 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.51 85.64 55.96 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -101.73 34.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.568 2.845 . . . . 15.0 112.847 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -56.49 -40.55 75.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.87 0.868 . . . . 15.0 111.091 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.57 -32.6 73.6 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 123.957 0.786 . . . . 15.0 111.533 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.29 -51.77 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.16 -42.97 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.784 0.834 . . . . 15.0 110.51 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.47 -43.57 76.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.748 0.819 . . . . 15.0 110.995 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -57.37 -37.79 73.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.957 0.503 . . . . 15.0 110.964 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.34 -71.7 0.23 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.481 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 73.2 p -55.35 -34.65 64.44 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.673 0.99 . . . . 15.0 113.673 -168.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.79 -26.2 59.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.758 0.651 . . . . 15.0 112.758 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 393' ' ' GLU . 62.1 t30 -153.62 151.03 29.25 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.585 0.629 . . . . 15.0 112.329 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt -61.8 -15.43 41.54 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.869 1.268 . . . . 15.0 112.306 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 391' ' ' ASN . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 394' ' ' LEU . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.653 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 408' ' ' VAL . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 290' ' ' ALA . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.404 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 8.8 t30 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.627 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.567 ' HG2' ' HB1' ' B' ' 126' ' ' ALA . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -65.05 -0.11 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.72 103.79 15.69 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 15.0 110.126 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.74 -35.6 10.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.481 0.712 . . . . 15.0 109.457 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.383 1.073 . . . . 15.0 108.243 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 tttm 70.89 -2.17 2.4 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.745 1.218 . . . . 0.0 112.647 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 61.28 18.49 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.552 1.141 . . . . 0.0 111.885 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -81.18 -4.77 56.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.709 0.804 . . . . 0.0 110.183 171.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 52.4 p -59.05 138.6 57.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.949 1.3 . . . . 0.0 110.373 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 223' ' ' ALA . 17.2 tt -69.28 117.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.423 0.689 . . . . 0.0 111.292 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 99.51 11.91 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.719 HD23 HD13 ' B' ' 13' ' ' LEU . 1.3 pp -70.89 155.76 40.41 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.48 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.997 0.919 . . . . 0.0 108.574 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.76 -25.56 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.72 157.51 88.37 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.382 1.073 . . . . 0.0 112.411 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 222' ' ' HIS . 49.9 Cg_exo -60.5 116.25 3.21 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.391 2.728 . . . . 0.0 114.154 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.719 HD13 HD23 ' B' ' 8' ' ' LEU . 6.4 tt -168.67 -62.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.37 84.26 6.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -77.76 83.81 4.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.814 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -145.65 122.45 6.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.21 -40.97 71.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.244 2.63 . . . . 0.0 113.056 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.92 166.19 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.647 0.779 . . . . 0.0 110.849 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -83.56 113.36 20.76 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.552 0.691 . . . . 0.0 110.073 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -106.42 11.42 30.84 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.804 0.842 . . . . 0.0 110.678 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.07 -175.52 5.58 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.68 0.792 . . . . 0.0 110.185 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -85.21 64.07 8.46 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 45.4 p 27.71 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.911 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -165.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 71.3 Cg_exo -45.51 90.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.366 2.044 . . . . 0.0 114.149 168.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' HD2' ' B' ' 27' ' ' PRO . 30.0 tt0 -170.23 146.62 2.97 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.222 1.409 . . . . 0.0 108.19 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 4.0 tpt -73.96 -51.36 4.98 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.425 -0.798 . . . . 0.0 112.749 -173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.551 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 36.2 Cg_endo -66.44 99.58 0.44 Allowed 'Trans proline' 0 C--N 1.39 2.717 0 CA-C-N 121.079 1.421 . . . . 0.0 110.685 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -79.77 65.82 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 122.663 1.221 . . . . 0.0 110.334 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.4 13.81 6.21 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 183' ' ' SER . 31.6 tt0 82.16 -45.13 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.071 1.748 . . . . 0.0 112.799 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 70.63 -100.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.129 1.372 . . . . 0.0 108.016 -170.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.45 ' HD3' ' HG2' ' B' ' 30' ' ' GLU . 9.2 mpt_? 49.08 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.704 1.202 . . . . 0.0 111.988 -177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.33 7.11 17.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.892 0.877 . . . . 0.0 112.043 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.5 84.4 1.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.262 0.625 . . . . 0.0 109.358 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.15 -174.37 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.324 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.47 -45.37 1.14 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.33 79.42 1.84 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 mp 61.24 -91.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.607 1.163 . . . . 0.0 108.552 -172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 55.3 m -170.5 -63.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.3 145.61 11.2 Favored Pre-proline 0 C--O 1.245 0.861 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.122 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.65 102.44 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.749 2.299 . . . . 0.0 111.338 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.12 -37.29 0.53 Allowed Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.1 166.46 21.94 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.59 -49.94 6.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.883 0.473 . . . . 0.0 110.383 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 67.63 1.38 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.579 0.751 . . . . 0.0 110.685 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 65.13 -174.36 0.18 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.566 1.146 . . . . 0.0 111.362 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.72 91.59 7.04 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 53' ' ' ALA . 38.1 p 63.95 -67.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 127.153 2.181 . . . . 0.0 112.648 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 -1.55 6.62 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.44 -72.84 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.563 1.545 . . . . 0.0 111.716 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -57.28 -38.85 74.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.764 0.826 . . . . 0.0 111.245 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.5 m -64.61 -69.5 0.28 Allowed 'General case' 0 C--N 1.36 1.033 0 C-N-CA 122.943 0.497 . . . . 0.0 110.721 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' B' ' 48' ' ' THR . . . -107.12 -51.21 2.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.081 0.553 . . . . 0.0 111.157 -171.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 75.18 -176.18 0.14 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.706 1.203 . . . . 0.0 111.14 -172.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.45 -26.71 64.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.698 0.799 . . . . 0.0 110.688 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -82.99 -6.45 59.49 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 0.0 112.286 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.463 ' HA ' ' HB1' ' B' ' 53' ' ' ALA . 29.9 t70 62.81 13.12 6.23 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.607 1.163 . . . . 0.0 112.092 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -125.99 119.48 27.81 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.509 1.123 . . . . 0.0 109.246 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 158.45 25.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.028 0.931 . . . . 0.0 110.566 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.6 p -88.99 146.86 24.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.228 0.611 . . . . 0.0 110.355 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 65.3 -173.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.533 1.133 . . . . 0.0 112.254 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HD2' ' B' ' 63' ' ' PRO . 20.7 tptm -79.54 123.21 84.33 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.474 ' HD2' ' HD2' ' B' ' 62' ' ' LYS . 58.8 Cg_endo -71.35 72.45 2.27 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.777 2.318 . . . . 0.0 113.013 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.25 122.95 0.22 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.83 58.48 3.85 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.803 0.811 . . . . 0.0 111.889 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.99 2.93 21.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.777 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.29 151.88 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 109.135 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . 0.28 9.6 tt 68.74 -50.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 127.993 2.517 . . . . 0.0 113.859 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -89.94 71.59 7.51 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.97 -66.99 1.01 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.89 -174.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.073 1.349 . . . . 0.0 109.287 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.4 -83.5 1.1 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.37 94.56 7.41 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.81 60.64 0.51 Allowed Glycine 0 C--O 1.244 0.761 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.1 ttt -77.21 94.38 4.1 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.05 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' B' ' 79' ' ' GLU . . . -78.45 163.61 50.3 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.532 171.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.29 -69.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.6 m -99.99 -8.11 24.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.685 0.794 . . . . 0.0 110.151 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.53 ' HB2' ' HA3' ' B' ' 76' ' ' GLY . 1.8 mp0 -75.9 -16.83 59.97 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.296 0.638 . . . . 0.0 111.055 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 tt -82.58 -22.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.507 0.723 . . . . 0.0 110.957 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.2 m -143.73 105.14 4.28 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.247 0.619 . . . . 0.0 110.605 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' B' ' 86' ' ' TYR . . . -150.08 -168.56 3.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.026 0.93 . . . . 0.0 109.768 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.51 168.83 5.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 0.0 111.112 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -74.02 83.26 1.75 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 110.692 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -124.54 -28.56 3.58 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.593 1.157 . . . . 0.0 109.623 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' B' ' 82' ' ' ALA . 50.2 m-85 -79.76 83.25 5.73 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.413 0.685 . . . . 0.0 110.268 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.7 -68.95 0.16 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -175.8 123.68 0.2 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.4 -101.2 0.25 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.51 -65.73 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.261 1.424 . . . . 0.0 111.66 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 115.23 7.13 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 123.3 0.476 . . . . 0.0 113.027 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.89 12.32 47.06 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-O 119.95 -0.361 . . . . 0.0 112.415 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.467 ' CZ ' ' HA ' ' B' ' 131' ' ' TRP . 4.0 m-85 69.49 -77.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.026 1.33 . . . . 0.0 111.474 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -120.66 140.93 50.88 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -148.32 152.28 36.81 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.35 -78.83 1.88 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.558 HG23 ' H ' ' B' ' 98' ' ' ASP . 4.9 tp -175.24 -81.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 C-N-CA 124.518 1.127 . . . . 0.0 110.864 164.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.558 ' H ' HG23 ' B' ' 97' ' ' ILE . 26.4 t0 67.32 151.98 0.07 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.489 1.515 . . . . 0.0 111.898 -166.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.47 -156.0 0.68 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.184 0.594 . . . . 0.0 111.136 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.514 ' HB2' ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -61.43 -175.5 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.127 0 C-N-CA 125.0 1.32 . . . . 0.0 113.355 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 100' ' ' LEU . 32.2 Cg_exo -26.96 -19.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.392 1 C-N-CA 126.674 4.916 . . . . 0.0 119.653 167.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.88 84.67 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.012 1.325 . . . . 0.0 108.129 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -63.05 1.24 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.502 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.74 -129.01 9.75 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.078 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 392' ' ' LYS . 81.2 mm-40 -83.17 95.59 8.16 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.394 0.678 . . . . 0.0 110.249 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 75.0 t80 58.86 -91.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.056 1.342 . . . . 0.0 110.502 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 p 38.78 37.73 0.22 Allowed 'General case' 0 C--N 1.38 1.91 0 C-N-CA 125.242 1.417 . . . . 0.0 113.779 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -81.34 13.45 2.93 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.057 -165.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.638 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 82.9 m-85 -86.16 108.46 18.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.053 0.941 . . . . 0.0 109.322 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 344' ' ' ARG . . . 67.33 100.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.918 1.287 . . . . 0.0 112.072 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.455 HD13 ' H ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -88.49 40.92 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.89 0.876 . . . . 0.0 110.486 174.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -147.12 33.89 0.9 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.216 1.406 . . . . 0.0 108.361 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -73.78 -42.1 61.47 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.279 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -160.82 -169.61 2.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.857 0.863 . . . . 0.0 109.651 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 72.4 m 62.04 97.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.063 1.345 . . . . 0.0 112.472 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.65 -70.39 3.12 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.771 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.434 ' HZ2' ' HB2' ' B' ' 117' ' ' LYS . 4.7 ttmp? -123.38 81.91 52.9 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.341 0.656 . . . . 0.0 111.067 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.6 -62.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.661 2.241 . . . . 0.0 110.609 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.74 170.45 1.96 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.906 1.682 . . . . 0.0 108.28 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 90.9 t80 63.76 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.715 1.206 . . . . 0.0 113.3 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.67 -45.92 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.071 . . . . 0.0 112.59 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m 65.87 140.9 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.965 1.306 . . . . 0.0 112.216 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -73.62 -174.27 1.69 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.568 1.147 . . . . 0.0 111.448 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 45.0 t -68.89 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.688 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 277' ' ' GLU . . . 63.57 -70.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.699 1.199 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.567 ' HB1' ' HG2' ' A' ' 428' ' ' MET . . . -112.96 148.34 35.23 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.785 0.834 . . . . 0.0 110.651 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 4.4 m 70.61 -1.45 2.57 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.901 1.68 . . . . 0.0 112.846 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.599 ' HA ' ' HG2' ' A' ' 277' ' ' GLU . . . 65.25 146.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.019 1.328 . . . . 0.0 114.304 173.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 13.6 t -76.66 -11.01 59.79 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.837 166.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 72.0 -74.84 0.08 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.103 1.761 . . . . 0.0 110.269 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . 6.0 m-90 -137.08 110.11 7.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.833 0.853 . . . . 0.0 109.111 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -93.54 -6.75 45.99 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.384 0.674 . . . . 0.0 111.865 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.588 ' HB ' ' HA3' ' A' ' 257' ' ' GLY . 88.0 m -59.99 -57.13 14.19 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 123.722 0.639 . . . . 0.0 110.033 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.3 -78.75 0.43 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.761 0.663 . . . . 0.0 113.161 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.01 114.31 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.896 0.878 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -141.37 121.21 13.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.0 m -57.02 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.131 0.973 . . . . 0.0 111.934 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 255' ' ' ARG . 77.0 t80 -98.81 -55.53 2.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.824 0.85 . . . . 0.0 109.916 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 m120 74.52 -53.9 0.67 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.497 1.519 . . . . 0.0 112.372 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.53 -46.42 2.35 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 77.37 -24.69 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.732 1.613 . . . . 0.0 113.454 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt 59.06 22.39 10.46 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.73 -119.38 4.03 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.56 98.78 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.349 0.66 . . . . 0.0 109.955 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -168.59 142.76 3.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.5 pt -144.62 72.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.317 1.047 . . . . 0.0 110.095 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -97.99 92.5 5.82 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.186 0.993 . . . . 0.0 108.655 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' B' ' 149' ' ' LYS . 5.6 pt-20 -163.68 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.051 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.544 ' H ' ' HG3' ' B' ' 148' ' ' GLU . 0.0 OUTLIER -132.05 77.21 1.75 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.497 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 51' ' ' MET . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.432 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HD13 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.474 ' HE1' HD13 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.722 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.551 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.45 HD12 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG23 ' SD ' ' A' ' 274' ' ' MET . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.62 HD13 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.609 HD11 ' HB1' ' B' ' 128' ' ' ALA . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 237' ' ' LEU . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG21 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.659 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.659 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.609 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' B' ' 23' ' ' THR . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.565 HG23 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.588 HG22 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.609 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.69 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 236' ' ' ASN . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.611 ' HA ' ' HB ' ' B' ' 5' ' ' THR . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 210' ' ' GLU . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.755 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 251' ' ' GLU . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 249' ' ' THR . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.754 HG23 HD13 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.484 ' SD ' HG11 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 408' ' ' VAL . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.486 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.434 HG21 HG13 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 307' ' ' ILE . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.615 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.506 HD21 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' B' ' 118' ' ' PRO . 40.2 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.506 ' NH1' HD21 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.618 HG22 HG21 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 407' ' ' ALA . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.682 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 384' ' ' VAL . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -70.28 -31.5 68.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttp -65.87 -48.87 70.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.701 0.4 . . . . 15.0 109.955 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.24 58.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.107 0.963 . . . . 15.0 112.093 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.2 t -55.81 -31.18 62.44 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.223 0.609 . . . . 15.0 111.379 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 4.49 53.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.591 0.756 . . . . 15.0 112.497 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -167.13 103.04 0.54 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.81 12.27 0.54 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.7 1.37 . . . . 15.0 114.7 -164.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' B' ' 139' ' ' ASN . 20.4 t70 -110.69 96.81 30.07 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 168.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.75 -4.84 9.9 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.125 1.883 . . . . 15.0 111.725 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -62.79 -38.02 89.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.677 0.791 . . . . 15.0 112.594 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -37.41 70.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 123.428 0.455 . . . . 15.0 110.47 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.451 HG11 HG23 ' A' ' 371' ' ' ILE . 36.1 t -75.19 -62.22 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.594 0.758 . . . . 15.0 109.762 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.92 -46.28 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.678 0.791 . . . . 15.0 110.405 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.83 -34.35 64.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 118.669 -0.681 . . . . 15.0 112.224 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.58 -44.81 95.79 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.078 0.854 . . . . 15.0 110.084 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.521 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 3.2 m-30 -67.26 -56.14 11.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.296 -0.865 . . . . 15.0 110.856 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 36.0 p -60.68 -30.44 69.93 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.522 0.729 . . . . 15.0 112.261 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -93.87 -12.09 29.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.115 0.566 . . . . 15.0 112.07 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.19 123.89 8.52 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.429 0.559 . . . . 15.0 110.664 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -58.29 -26.57 63.14 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.593 1.157 . . . . 15.0 112.365 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 99' ' ' ALA . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' B' ' 102' ' ' LEU . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.682 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' B' ' 106' ' ' TYR . 49.6 m-80 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 355' ' ' ILE . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.45 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 130' ' ' VAL . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.464 ' HE3' ' H ' ' B' ' 127' ' ' SER . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -95.38 31.76 1.91 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -92.86 132.48 36.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.168 0.987 . . . . 15.0 109.806 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.28 -46.69 22.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.807 0.843 . . . . 15.0 109.589 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.524 1.129 . . . . 15.0 108.372 178.163 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? 61.41 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.579 1.552 . . . . 0.0 109.985 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -130.21 -165.19 1.51 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.683 1.193 . . . . 0.0 110.03 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p 53.57 36.59 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.103 1.361 . . . . 0.0 112.253 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 223' ' ' ALA . 27.6 p -125.16 -57.37 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.382 1.073 . . . . 0.0 108.244 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.69 86.93 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.338 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.43 55.86 1.79 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 12' ' ' PRO . 13.1 mt -76.3 -170.51 1.48 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.454 -158.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.73 -61.15 0.5 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.837 1.655 . . . . 0.0 112.035 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.534 ' HB2' ' NE2' ' B' ' 35' ' ' GLN . 3.8 pp -65.68 -23.15 66.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' HB3' ' HD3' ' B' ' 12' ' ' PRO . 2.3 tm? -168.84 -58.91 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.999 174.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.642 ' HB2' HD23 ' B' ' 8' ' ' LEU . 83.1 Cg_exo -51.08 -19.01 5.28 Favored 'Trans proline' 0 C--N 1.404 3.484 0 C-N-CA 123.434 2.756 . . . . 0.0 116.958 -167.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' B' ' 8' ' ' LEU . 1.1 tt -145.63 72.53 1.31 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -174.78 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.78 5.36 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.828 1.651 . . . . 0.0 114.37 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 83.5 m -114.85 90.87 23.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.001 0.92 . . . . 0.0 109.937 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -96.48 17.52 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.393 2.728 . . . . 0.0 112.394 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.03 144.31 31.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 124.181 0.992 . . . . 0.0 109.001 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.1 p -85.61 118.51 25.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.252 0.621 . . . . 0.0 110.785 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 52.77 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.715 1.606 . . . . 0.0 114.958 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.25 -65.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -161.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -69.15 146.85 52.13 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -161.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.571 ' HA ' ' NH2' ' A' ' 193' ' ' ARG . 92.4 m -105.79 110.25 63.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.889 1.276 . . . . 0.0 110.839 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.56 -86.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.793 2.329 . . . . 0.0 111.24 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.3 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.376 1.47 . . . . 0.0 113.286 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.9 ttp 55.36 73.77 0.82 Allowed Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.617 1.167 . . . . 0.0 111.07 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.38 141.15 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.748 2.298 . . . . 0.0 113.157 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.2 133.87 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.54 0.736 . . . . 0.0 109.164 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.94 -159.39 0.27 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.945 0.898 . . . . 0.0 110.254 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.63 -178.94 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.777 0.831 . . . . 0.0 109.842 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -99.36 21.3 12.24 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 0.0 109.914 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 11.05 22.52 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.904 0.882 . . . . 0.0 111.401 -172.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.09 -17.05 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.804 1.242 . . . . 0.0 113.512 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 74.64 -172.97 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.153 1.381 . . . . 0.0 111.606 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.534 ' NE2' ' HB2' ' B' ' 10' ' ' LEU . 10.3 pt20 -142.17 -177.52 5.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.17 0.988 . . . . 0.0 110.701 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.94 -40.21 2.13 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.59 151.13 42.53 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 tt 57.63 6.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 126.728 2.011 . . . . 0.0 113.122 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.516 HG21 HD21 ' B' ' 10' ' ' LEU . 28.3 m -89.67 131.7 35.52 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.382 0.673 . . . . 0.0 109.482 -176.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.15 69.97 1.37 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.553 1.141 . . . . 0.0 110.846 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.98 22.4 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.358 2.705 . . . . 0.0 112.346 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.98 -167.86 31.9 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.39 147.66 14.42 Favored Glycine 0 N--CA 1.463 0.487 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.92 70.12 6.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.756 0.789 . . . . 0.0 109.294 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -64.13 124.27 21.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.351 1.06 . . . . 0.0 110.72 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.28 9.19 6.93 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.439 1.096 . . . . 0.0 112.303 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.79 42.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.17 0.588 . . . . 0.0 112.529 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -65.49 150.68 47.97 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.203 0.601 . . . . 0.0 111.716 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.48 152.16 42.66 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.66 -8.61 57.23 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -69.38 -84.81 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 122.76 0.424 . . . . 0.0 111.163 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.4 m -111.28 -80.96 0.58 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.09 -61.32 1.73 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.307 1.043 . . . . 0.0 108.427 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.02 103.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.226 1.411 . . . . 0.0 112.531 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.85 -20.27 46.39 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.892 0.877 . . . . 0.0 110.994 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -135.86 128.26 30.34 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.325 1.05 . . . . 0.0 108.939 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 62.22 -167.77 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.806 1.242 . . . . 0.0 112.122 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 54.9 m -132.18 177.2 7.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 109.587 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 40.08 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.494 1.918 . . . . 0.0 114.084 -174.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.9 m -147.38 94.07 2.33 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.26 150.41 45.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.696 0.399 . . . . 0.0 110.212 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -135.38 86.79 29.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.629 1.172 . . . . 0.0 109.183 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -82.07 -170.63 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.947 2.432 . . . . 0.0 112.092 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.5 -35.69 65.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.881 0.872 . . . . 0.0 111.455 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -66.45 93.34 0.23 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.431 0.692 . . . . 0.0 109.837 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -91.4 158.01 16.76 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.474 0.709 . . . . 0.0 109.702 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.23 162.84 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.801 0.841 . . . . 0.0 112.324 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.96 133.54 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.938 0.895 . . . . 0.0 109.023 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.03 124.11 32.09 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.3 136.97 41.18 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.882 0.473 . . . . 0.0 109.951 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp 77.78 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 125.627 1.571 . . . . 0.0 111.704 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.44 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 123.116 0.388 . . . . 0.0 113.412 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -57.94 -57.65 11.87 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.197 0.999 . . . . 0.0 110.892 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.82 123.38 0.67 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.0 ttt -84.03 77.67 9.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.904 0.852 . . . . 0.0 110.213 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.24 57.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 55.78 -171.07 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.938 1.295 . . . . 0.0 112.619 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.3 p -83.52 -63.31 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.024 0.529 . . . . 0.0 110.751 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -40.61 5.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.781 0.432 . . . . 0.0 110.988 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.83 87.16 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 122.215 1.007 . . . . 0.0 110.271 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 45.9 p -97.9 -54.29 3.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.761 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.63 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.828 1.651 . . . . 0.0 114.355 169.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.85 86.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.448 0.699 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 20.1 ptt85 -66.81 -56.16 11.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.097 0.959 . . . . 0.0 111.247 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 171.44 151.59 0.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.797 1.639 . . . . 0.0 108.29 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -111.82 81.15 1.41 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HA2' ' B' ' 91' ' ' GLY . . . -172.88 108.57 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.386 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -85.09 107.42 17.17 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.24 72.28 1.0 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.42 128.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.509 1.524 . . . . 0.0 111.494 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' B' ' 87' ' ' ALA . . . -63.44 -69.66 1.26 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.44 0.462 . . . . 0.0 112.912 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.79 -61.39 4.75 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 122.983 0.325 . . . . 0.0 112.32 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.747 ' HB3' ' HA3' ' B' ' 134' ' ' GLY . 97.1 m-85 63.24 17.03 9.91 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.781 1.232 . . . . 0.0 112.319 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -178.05 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 155.22 4.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.348 1.059 . . . . 0.0 110.169 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -95.07 149.33 19.31 Favored Glycine 0 C--O 1.244 0.748 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 163.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.83 78.58 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-O 123.04 1.4 . . . . 0.0 109.102 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.55 -64.03 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.014 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 394' ' ' LEU . . . 52.41 -156.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.499 1.12 . . . . 0.0 111.6 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.439 HD23 ' O ' ' B' ' 110' ' ' ALA . 5.6 mp -63.26 141.14 97.78 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 123.798 0.839 . . . . 0.0 109.773 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.493 ' HB3' ' HA2' ' B' ' 116' ' ' GLY . 94.6 Cg_endo -88.35 137.55 3.67 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.727 2.285 . . . . 0.0 113.539 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -68.35 103.49 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 168.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 109' ' ' TYR . 42.7 m -75.07 95.9 3.13 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.323 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.85 -71.08 2.92 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.624 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 16.0 tp60 -170.99 -154.12 0.09 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.624 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 89.8 t80 -58.29 99.45 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.617 0.644 . . . . 0.0 109.884 164.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -140.23 -1.09 1.56 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.14 0.976 . . . . 0.0 109.752 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 61.75 75.78 0.39 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.715 1.206 . . . . 0.0 110.674 -172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' B' ' 103' ' ' THR . 6.2 t80 -155.63 64.77 0.6 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.439 ' O ' HD23 ' B' ' 100' ' ' LEU . . . -94.18 -26.1 16.82 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.336 172.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 112' ' ' ASN . 0.9 OUTLIER -64.82 144.73 57.06 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.517 ' N ' HD13 ' B' ' 111' ' ' LEU . 18.8 t30 80.66 140.44 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.747 1.28 . . . . 0.0 109.877 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 44.83 100.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.887 2.075 . . . . 0.0 112.38 -168.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.72 -30.87 70.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.173 0.989 . . . . 0.0 112.234 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.1 p -125.25 166.39 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.077 0.551 . . . . 0.0 110.679 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' B' ' 101' ' ' PRO . . . -63.38 -33.16 86.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.665 0.603 . . . . 0.0 111.779 171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -63.46 145.37 97.26 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.813 0.845 . . . . 0.0 110.004 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.452 ' HB3' ' HG3' ' A' ' 317' ' ' GLN . 42.2 Cg_exo -42.14 131.69 4.63 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.968 3.112 . . . . 0.0 113.652 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -87.3 176.71 7.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.211 0.529 . . . . 0.0 111.831 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.92 148.24 7.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 32.5 t -80.2 71.75 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.8 0.809 . . . . 0.0 110.046 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 98.1 m -158.79 104.98 1.78 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.106 1.762 . . . . 0.0 106.547 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -139.04 162.16 35.61 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.2 t 70.13 116.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.132 1.373 . . . . 0.0 111.303 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.44 35.99 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.525 1.13 . . . . 0.0 110.749 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.94 -170.17 1.82 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.958 0.903 . . . . 0.0 111.391 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.464 ' H ' ' HE3' ' A' ' 428' ' ' MET . 36.4 m 70.19 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.595 1.558 . . . . 0.0 108.303 -164.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -164.66 -169.01 1.62 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.854 0.862 . . . . 0.0 109.931 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m 62.15 44.09 8.11 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.106 0.955 . . . . 0.0 109.282 -171.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.29 -75.6 0.09 Allowed 'General case' 0 C--N 1.355 0.812 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.339 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 5.4 m95 50.45 31.35 5.41 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.814 1.246 . . . . 0.0 112.36 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m -80.19 -6.48 57.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -162.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.4 p -82.72 94.02 7.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLY . . . . . 0.747 ' HA3' ' HB3' ' B' ' 93' ' ' PHE . . . -115.76 145.04 18.63 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.474 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 48.3 t 64.14 -76.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.315 1.446 . . . . 0.0 110.446 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' B' ' 138' ' ' TYR . 22.8 ttmm 178.43 155.05 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.889 1.676 . . . . 0.0 107.726 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.3 p -66.32 -24.59 66.56 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.124 0.42 . . . . 0.0 110.84 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' TYR . . . . . 0.676 ' H ' ' HG2' ' B' ' 136' ' ' LYS . 65.1 t80 65.94 173.06 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.356 1.462 . . . . 0.0 111.369 170.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 14.1 t-20 84.53 -53.88 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.757 1.623 . . . . 0.0 110.229 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 76.27 45.65 14.46 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 92.98 0.9 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.283 0.633 . . . . 0.0 110.11 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.517 ' H ' HD23 ' B' ' 142' ' ' LEU . 2.3 pt? -76.67 -9.75 58.89 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.717 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.17 74.23 0.85 Allowed Glycine 0 C--N 1.358 1.77 0 O-C-N 123.571 0.544 . . . . 0.0 112.544 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 p -158.57 97.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.714 1.205 . . . . 0.0 108.164 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.09 147.95 46.24 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.192 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.11 140.59 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 121.064 0.459 . . . . 0.0 110.984 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -118.43 78.18 1.24 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.076 0.95 . . . . 0.0 108.968 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.88 142.97 15.44 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' B' ' 149' ' ' LYS . 0.6 OUTLIER -70.34 91.12 0.73 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -178.227 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.541 0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.631 176.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.729 HD12 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.491 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.1 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' VAL . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.533 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 11' ' ' LEU . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.603 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.422 HG23 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.528 HD11 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.817 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.509 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.663 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.64 HG11 HG22 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.444 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.531 ' HE1' ' HB ' ' B' ' 16' ' ' THR . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.552 HG12 HG23 ' B' ' 18' ' ' VAL . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.523 HG23 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 164' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.632 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.523 ' HD3' HG23 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.439 ' HE1' HD11 ' B' ' 6' ' ' ILE . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.455 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 2.1 m120 -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.817 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.633 ' HG2' HG13 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.733 ' HE1' ' HA ' ' A' ' 137' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.502 HG13 HD11 ' B' ' 111' ' ' LEU . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.504 HG11 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' VAL . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.516 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.436 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.462 HD13 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.7 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.462 HE22 HD13 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.708 HH12 ' HB2' ' B' ' 118' ' ' PRO . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.505 HG13 ' HE1' ' B' ' 109' ' ' TYR . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.418 HD12 HG12 ' A' ' 347' ' ' VAL . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.732 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.25 -39.8 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 46.5 ttp -63.59 -41.72 98.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.6 -46.43 89.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.798 -1.092 . . . . 15.0 111.056 176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.0 t -62.78 -29.26 70.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.928 0.891 . . . . 15.0 111.103 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.07 -32.72 65.2 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.881 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -80.99 174.62 11.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.17 0.986 . . . . 15.0 111.491 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -83.49 -21.74 32.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.555 -1.657 . . . . 15.0 109.572 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -160.95 139.04 7.17 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.483 0.713 . . . . 15.0 110.668 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.662 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 27.3 Cg_endo -102.29 0.3 0.44 Allowed 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.347 2.698 . . . . 15.0 115.422 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.1 -37.33 74.32 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -168.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -55.76 -45.22 78.12 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.507 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 10.8 t -71.24 -56.86 9.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.939 -1.028 . . . . 15.0 108.993 -170.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 381' ' ' PRO . 1.7 mp -64.04 -64.0 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.725 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.45 -36.77 83.49 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -90.54 -35.23 15.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.534 0.606 . . . . 15.0 111.977 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 384' ' ' VAL . 55.6 m-85 -102.51 -42.08 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.357 1.243 . . . . 15.0 114.357 -171.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.7 p -67.45 -19.13 65.31 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.947 0.794 . . . . 15.0 111.843 -170.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.34 -5.24 59.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.765 0.826 . . . . 15.0 112.186 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -148.27 130.94 15.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.5 ttmt -59.17 -21.33 59.23 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.558 0.743 . . . . 15.0 112.224 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG2' HG21 ' A' ' 367' ' ' VAL . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' B' ' 106' ' ' TYR . 11.8 m120 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.548 ' HB ' ' HG2' ' B' ' 101' ' ' PRO . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.576 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.416 ' HA ' HD12 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.483 HG22 HD13 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.583 ' HA ' HG13 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 5.5 t30 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.725 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.39 51.45 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -127.32 88.89 2.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.829 1.251 . . . . 15.0 108.315 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.87 -73.74 0.6 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 15.0 109.728 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.943 0.897 . . . . 15.0 108.607 -178.622 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.477 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 23.6 tptm -129.19 -67.04 0.79 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.146 0.578 . . . . 0.0 110.313 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -129.44 148.39 51.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.503 0.721 . . . . 0.0 110.656 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -128.06 68.11 1.34 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 14.5 t -71.21 143.47 50.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.809 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.439 HD11 ' HE1' ' A' ' 222' ' ' HIS . 5.2 tt -78.41 111.11 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.213 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.14 89.82 6.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 166.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -86.08 143.44 28.07 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -161.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.09 170.22 12.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.197 -1.82 . . . . 0.0 108.297 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . 0.256 0.0 OUTLIER 25.35 96.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.289 1.835 . . . . 0.0 115.516 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.67 65.87 1.97 Allowed Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.793 1.237 . . . . 0.0 112.094 -173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -102.86 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.716 2.277 . . . . 0.0 111.324 158.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.463 HD13 ' HE2' ' A' ' 168' ' ' PHE . 75.7 mt -134.5 135.97 42.79 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.761 1.624 . . . . 0.0 106.868 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 2.1 tm? 70.16 100.44 0.06 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -160.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -138.04 49.12 1.96 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.952 1.358 . . . . 0.0 107.527 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.531 ' HB ' ' HE1' ' A' ' 185' ' ' PHE . 87.6 m -153.74 128.72 4.88 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.402 -172.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.74 109.86 1.34 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.787 1.658 . . . . 0.0 110.508 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.552 HG23 HG12 ' A' ' 186' ' ' VAL . 7.6 p -75.12 86.05 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-O 122.432 1.11 . . . . 0.0 110.044 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.1 m -117.68 88.36 2.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.885 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.53 92.24 1.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.178 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.95 159.97 29.98 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.431 0.692 . . . . 0.0 109.232 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 67.15 105.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.544 1.138 . . . . 0.0 109.892 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 p -81.74 145.81 55.03 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.415 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.96 93.07 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.301 2.667 . . . . 0.0 112.384 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.48 128.97 37.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.021 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -61.71 -37.15 37.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 117.841 -1.075 . . . . 0.0 112.583 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.69 -27.69 43.4 Favored 'Trans proline' 0 C--N 1.41 3.78 0 C-N-CA 122.387 2.058 . . . . 0.0 113.625 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.559 HG13 ' H ' ' B' ' 29' ' ' LEU 0.271 7.7 p 48.64 -75.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 126.986 2.114 . . . . 0.0 113.827 175.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.559 ' H ' HG13 ' B' ' 28' ' ' VAL . 1.7 tm? 55.66 -89.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.201 1.801 . . . . 0.0 112.052 171.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.0 -29.2 69.54 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.23 1.012 . . . . 0.0 111.716 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.63 108.34 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.526 0.73 . . . . 0.0 109.17 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -80.58 87.3 5.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.21 81.27 3.71 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.988 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.6 -62.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.061 1.344 . . . . 0.0 107.731 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.9 140.39 4.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.041 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.28 53.5 3.86 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.19 165.91 34.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.105 0.962 . . . . 0.0 109.106 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.9 mt 76.35 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.524 1.53 . . . . 0.0 110.221 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.0 m -75.04 -17.82 60.43 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.463 0.705 . . . . 0.0 111.017 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.35 138.35 85.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.43 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 124.024 3.149 . . . . 0.0 114.497 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.32 64.48 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.551 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.18 55.06 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-O 119.924 -0.375 . . . . 0.0 113.486 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.42 -2.83 51.26 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.631 0.772 . . . . 0.0 111.198 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' B' ' 45' ' ' ARG . 1.8 mmp_? -68.06 75.65 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.144 0.977 . . . . 0.0 110.715 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 59.2 -96.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.84 1.256 . . . . 0.0 110.804 -164.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' ' 53' ' ' ALA . 3.5 mm? 56.84 168.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.488 1.115 . . . . 0.0 111.7 -167.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' B' ' 53' ' ' ALA . 55.3 m 73.35 -36.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.649 1.58 . . . . 0.0 112.851 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.26 46.48 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.54 0.59 . . . . 0.0 114.528 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.553 ' HB3' HG22 ' B' ' 52' ' ' THR . 14.1 t70 -147.31 160.65 42.27 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.482 0.713 . . . . 0.0 109.56 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -63.18 -15.25 56.28 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.173 0.989 . . . . 0.0 112.963 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.553 HG22 ' HB3' ' B' ' 50' ' ' ASP . 11.7 t -66.09 -10.23 38.63 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.7 0.8 . . . . 0.0 111.629 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' B' ' 47' ' ' LEU . . . -67.1 -20.77 65.84 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 123.515 0.726 . . . . 0.0 112.154 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.77 47.0 6.51 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.588 1.155 . . . . 0.0 110.378 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 tt 67.04 92.08 0.08 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 109.38 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -143.74 26.18 1.58 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.789 0.836 . . . . 0.0 108.935 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.51 ' HA ' HG23 ' B' ' 48' ' ' THR . 4.1 m-20 -59.0 -44.97 91.73 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.759 0.824 . . . . 0.0 111.551 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -148.2 149.11 31.35 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.401 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.6 OUTLIER -141.03 74.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.0 m -78.15 78.41 4.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.78 -51.45 0.56 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.235 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.77 150.84 82.02 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.81 118.83 5.77 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.405 2.07 . . . . 0.0 110.979 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 84.4 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.638 0.775 . . . . 0.0 111.415 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -123.41 91.07 3.4 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.7 -17.09 28.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.111 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tp -68.94 90.96 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.069 0.937 . . . . 0.0 110.623 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.433 ' H ' HD13 ' B' ' 68' ' ' ILE . 0.2 OUTLIER -112.57 143.01 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 175.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -100.09 105.62 17.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.94 -48.56 0.13 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.019 0.528 . . . . 0.0 110.334 -172.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -74.79 92.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.711 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.79 -12.4 82.95 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.426 171.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t70 69.21 -77.97 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.912 1.685 . . . . 0.0 111.564 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 170.55 118.26 0.45 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.7 mmt -90.49 -13.18 35.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.938 0.495 . . . . 0.0 110.433 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.29 -138.4 7.67 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -169.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.61 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . 5.0 p-10 50.47 -69.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.814 2.046 . . . . 0.0 115.389 166.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 41.6 m -61.8 -45.9 91.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.734 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.13 -53.29 2.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.604 0.762 . . . . 0.0 110.814 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mm -84.05 122.62 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -53.87 110.11 0.55 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.819 0.848 . . . . 0.0 112.696 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' B' ' 77' ' ' ASP . . . -153.09 -60.63 0.14 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 0.0 109.382 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' B' ' 77' ' ' ASP . . . -119.77 100.8 7.46 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.48 ' H ' ' HB3' ' B' ' 87' ' ' ALA . 40.8 ttm180 -161.63 150.14 15.54 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 109.311 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.4 t30 61.52 71.29 0.56 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.325 1.05 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 74.72 -5.4 2.14 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.149 1.38 . . . . 0.0 112.685 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.48 ' HB3' ' H ' ' B' ' 84' ' ' ARG . . . -77.29 -33.46 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.066 0.546 . . . . 0.0 110.013 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.69 -30.56 14.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.894 0.878 . . . . 0.0 110.813 170.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.81 -55.25 0.44 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.06 -76.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.597 1.559 . . . . 0.0 112.152 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.75 75.89 0.14 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.0 78.23 0.15 Allowed Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.745 0.688 . . . . 0.0 114.382 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -176.41 92.95 0.05 OUTLIER 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.7 16.8 16.41 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.901 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . 0.275 0.3 OUTLIER 63.09 -8.7 0.13 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.903 2.081 . . . . 0.0 116.604 165.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.97 33.66 64.25 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.766 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 35.3 pt 37.39 -172.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 C-N-CA 126.236 1.815 . . . . 0.0 115.524 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -166.55 109.42 0.73 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.89 164.02 22.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.22 0.533 . . . . 0.0 110.533 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.02 -48.08 0.8 Allowed Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.351 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 401' ' ' VAL . 27.8 Cg_exo -64.96 -76.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 121.988 1.792 . . . . 0.0 114.006 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 115' ' ' THR . 4.5 mm? 57.23 -134.15 1.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.579 1.152 . . . . 0.0 111.134 -174.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 4.1 m 60.93 28.13 17.93 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.959 0.904 . . . . 0.0 110.357 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.11 -112.9 5.38 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.822 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.06 86.63 2.96 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.499 ' HE1' ' HB3' ' B' ' 110' ' ' ALA . 88.1 t80 -65.32 101.46 0.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.824 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -83.22 20.47 1.27 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.075 0.95 . . . . 0.0 111.058 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 t60 78.25 -28.18 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.026 1.731 . . . . 0.0 111.551 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE1' HG13 ' A' ' 345' ' ' VAL . 82.5 t80 -74.23 89.03 2.01 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.869 1.268 . . . . 0.0 110.336 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' B' ' 113' ' ' LYS . . . -176.69 -58.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 108.058 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 291' ' ' ILE . 1.6 tm? 63.93 -80.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.528 1.531 . . . . 0.0 110.88 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 118' ' ' PRO . 27.5 t-20 -72.47 -20.65 61.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.762 1.225 . . . . 0.0 111.122 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.7 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 37.2 ttmt -82.56 93.94 7.4 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.623 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 101.41 13.12 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.307 0.643 . . . . 0.0 110.76 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.485 HG22 ' HB2' ' B' ' 102' ' ' LEU . 54.5 p 49.82 33.37 6.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.492 1.517 . . . . 0.0 113.869 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 99.15 -12.1 62.03 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.298 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 96.8 6.58 Favored Pre-proline 0 N--CA 1.477 0.885 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 170.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.708 ' HB2' HH12 ' A' ' 344' ' ' ARG . 10.1 Cg_endo -93.51 -60.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.922 2.415 . . . . 0.0 113.495 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.58 77.48 3.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.148 1.379 . . . . 0.0 111.579 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -166.42 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.783 1.233 . . . . 0.0 108.697 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.497 HG23 ' H ' ' B' ' 123' ' ' ASP . 10.5 m 53.26 -175.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 126.53 1.932 . . . . 0.0 112.868 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p -74.83 -31.38 61.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.664 0.786 . . . . 0.0 111.696 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.497 ' H ' HG23 ' B' ' 121' ' ' VAL . 3.7 m-20 -56.2 129.39 40.0 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.128 0.971 . . . . 0.0 113.109 -172.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 12.2 p -93.36 -176.77 4.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.726 1.21 . . . . 0.0 110.216 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.0 81.78 0.67 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 0.0 110.292 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -66.4 -54.08 28.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.157 0.983 . . . . 0.0 112.012 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -66.81 89.32 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.19 99.16 1.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.252 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.6 m -66.2 -37.5 85.73 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 160.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 75.58 -70.44 0.15 Allowed 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.997 1.719 . . . . 0.0 113.444 162.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.43 ' HZ2' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -90.4 149.09 22.41 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.347 0.659 . . . . 0.0 111.837 -163.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 71.0 m -151.03 11.59 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.109 0.963 . . . . 0.0 110.86 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 53.2 p -93.37 27.86 2.43 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.589 0.755 . . . . 0.0 111.966 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.02 -7.04 83.88 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 114.404 0.521 . . . . 0.0 114.404 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 34.8 m -78.18 -6.19 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.909 0.883 . . . . 0.0 112.056 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.31 77.76 1.34 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.749 0.819 . . . . 0.0 111.906 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.9 m -179.18 -42.18 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.982 2.113 . . . . 0.0 106.991 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -111.0 155.65 22.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.453 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.48 115.09 3.32 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.663 0.785 . . . . 0.0 109.496 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.2 55.75 2.84 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.93 7.84 6.45 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.47 1.508 . . . . 0.0 113.194 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -89.06 93.91 9.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.013 0.925 . . . . 0.0 109.474 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.71 60.65 1.14 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.14 154.12 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.429 1.092 . . . . 0.0 108.324 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -113.36 165.3 12.58 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.559 0.744 . . . . 0.0 109.028 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.69 149.23 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.454 0.702 . . . . 0.0 110.222 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -66.73 132.56 48.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.285 0.634 . . . . 0.0 111.098 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.9 166.02 16.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.673 0.389 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -85.64 139.97 30.95 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.803 0.841 . . . . 0.0 111.41 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.2 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.6 HH12 HG11 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' HG22 ' A' ' 54' ' ' VAL . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG11 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.433 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.582 HG23 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 123' ' ' ILE . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG11 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.56 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.457 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 207' ' ' ALA . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' B' ' 14' ' ' LEU . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.692 HG22 HG11 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.672 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.51 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.627 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.412 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.4 m120 -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.423 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG11 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.423 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.52 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.582 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.503 HD21 HD21 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.507 ' HB3' HD22 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.481 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.575 HD11 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.566 ' HB3' HD22 ' B' ' 112' ' ' ASN . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.54 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' B' ' 113' ' ' LYS . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.54 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.423 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.575 ' HE3' HD11 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' B' ' 112' ' ' ASN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.408 HH11 ' HB3' ' A' ' 363' ' ' ASP . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 398' ' ' MET . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -35.29 80.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.7 ttp -72.33 -41.98 65.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.629 -0.714 . . . . 15.0 110.82 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.703 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -67.85 -46.92 70.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.906 0.882 . . . . 15.0 111.765 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 27.5 t -65.07 -18.23 65.13 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.997 -1.001 . . . . 15.0 112.245 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.62 61.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.569 0.748 . . . . 15.0 111.553 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -104.39 -178.51 3.68 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.379 0.672 . . . . 15.0 110.798 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.58 -52.64 60.09 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.709 0.804 . . . . 15.0 111.356 -169.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 381' ' ' PRO . 19.4 t70 -145.02 126.02 7.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.389 -0.823 . . . . 15.0 109.483 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 380' ' ' ASP . 31.8 Cg_exo -60.9 -22.54 74.52 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.512 2.808 . . . . 15.0 115.196 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.67 -32.91 67.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.01 0.524 . . . . 15.0 112.201 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 14.9 pt-20 -58.47 -45.78 87.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.006 -0.739 . . . . 15.0 109.006 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 375' ' ' ALA . 19.3 t -69.71 -59.43 3.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.966 0.906 . . . . 15.0 109.727 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.21 -54.59 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.35 -1.295 . . . . 15.0 110.468 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.68 -32.72 62.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.078 0.399 . . . . 15.0 112.078 -169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.18 -53.35 31.19 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 110.123 -0.325 . . . . 15.0 110.123 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.96 -32.81 57.56 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.185 1.18 . . . . 15.0 114.185 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.1 p -60.17 -27.34 67.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.008 0.433 . . . . 15.0 111.304 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -109.68 8.48 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 15.0 111.365 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -117.7 99.67 7.11 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.252 -0.647 . . . . 15.0 109.252 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -47.22 -42.89 21.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.418 1.487 . . . . 15.0 112.576 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.631 ' SD ' HD11 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.599 ' HA ' HD22 ' B' ' 102' ' ' LEU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 355' ' ' ILE . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.859 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 54.6 m-80 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.859 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -68.26 2.86 1.96 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.94 71.62 10.49 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 119.8 1.182 . . . . 15.0 111.447 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.66 -58.59 1.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.325 1.05 . . . . 15.0 108.61 170.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 123.843 0.857 . . . . 15.0 109.382 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -142.61 -168.11 2.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.423 1.089 . . . . 0.0 109.129 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -152.72 163.58 39.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.523 0.729 . . . . 0.0 110.16 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -140.96 144.23 35.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 0.0 109.884 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.1 t -150.5 171.57 16.85 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.2 148.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.739 0.816 . . . . 0.0 110.982 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.21 -30.69 10.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.631 0.772 . . . . 0.0 109.693 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp 54.95 157.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.831 2.452 . . . . 0.0 114.875 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.34 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.038 1.335 . . . . 0.0 107.935 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -4.91 59.25 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.443 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -155.88 100.82 2.16 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.152 0.581 . . . . 0.0 109.66 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.1 146.84 6.58 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.707 2.271 . . . . 0.0 112.001 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.65 -23.98 59.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.186 0.594 . . . . 0.0 111.697 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.688 HD13 ' H ' ' B' ' 14' ' ' LEU . 0.0 OUTLIER -82.68 68.64 9.23 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.407 -174.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -70.03 -20.27 63.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.814 0.846 . . . . 0.0 112.548 -173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -94.35 111.39 53.44 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.033 0.533 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.45 171.34 8.77 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.028 2.485 . . . . 0.0 112.082 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.98 95.83 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 122.11 0.957 . . . . 0.0 109.448 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -73.9 -47.21 39.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.967 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -108.23 120.64 42.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.597 0.759 . . . . 0.0 109.53 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.23 90.08 2.49 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.725 0.81 . . . . 0.0 109.53 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -123.57 103.39 8.4 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 57.6 p -80.89 149.21 66.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 167.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -37.73 103.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.521 3.481 . . . . 0.0 115.593 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 23' ' ' THR . 0.0 OUTLIER -136.85 169.25 18.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.327 1.051 . . . . 0.0 109.907 174.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -110.59 142.77 26.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.591 0.757 . . . . 0.0 109.59 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.11 103.95 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.533 2.155 . . . . 0.0 111.093 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.77 97.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 CA-C-O 121.651 0.738 . . . . 0.0 109.811 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.2 tp -135.35 116.28 14.16 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -94.26 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.701 0.626 . . . . 0.0 110.924 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 66.8 t30 56.7 23.34 7.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.823 1.249 . . . . 0.0 111.215 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -86.37 78.99 9.16 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.95 73.39 10.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.621 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.81 -68.47 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.83 -73.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.812 1.645 . . . . 0.0 111.943 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.63 -137.59 3.67 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -162.1 148.6 13.54 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.404 1.082 . . . . 0.0 109.007 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -101.27 -8.05 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.364 0.666 . . . . 0.0 112.657 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m 59.23 77.73 0.3 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.66 1.184 . . . . 0.0 110.51 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.29 125.27 31.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.323 0.649 . . . . 0.0 110.91 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.26 -28.33 70.95 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 167.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.24 -121.31 6.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.22 52.82 0.02 OUTLIER Glycine 0 C--O 1.24 0.491 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.02 104.5 0.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.863 0.865 . . . . 0.0 111.078 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -98.82 -153.76 0.44 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.447 1.099 . . . . 0.0 110.295 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -62.92 91.8 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.613 0.765 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp 70.95 -13.11 0.52 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.777 1.631 . . . . 0.0 114.205 165.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m 65.07 -75.75 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.463 1.505 . . . . 0.0 111.158 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.04 81.87 0.06 OUTLIER Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -125.86 -44.73 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.295 0.638 . . . . 0.0 111.004 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' B' ' 52' ' ' THR . 15.0 pt20 -50.65 -69.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.082 0.953 . . . . 0.0 112.844 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' B' ' 51' ' ' GLN . 80.6 m -108.21 -85.13 0.53 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.24 -71.33 0.75 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 171.87 173.21 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.473 1.909 . . . . 0.0 108.52 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.9 mt 64.02 -168.48 0.2 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 0.0 113.131 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -133.98 99.84 4.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.957 0.903 . . . . 0.0 109.424 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.18 97.56 7.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.331 1.052 . . . . 0.0 109.571 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -98.07 175.34 6.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.268 0.627 . . . . 0.0 110.293 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.71 150.77 45.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.09 0.956 . . . . 0.0 109.559 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 62.4 p -93.39 105.9 17.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.46 -46.89 11.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.066 0.547 . . . . 0.0 110.253 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -172.04 165.95 3.87 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.786 0.834 . . . . 0.0 110.395 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -37.11 -40.6 0.65 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 124.708 3.606 . . . . 0.0 115.673 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.99 -79.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.142 1.377 . . . . 0.0 112.402 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -122.73 -44.58 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.659 0.784 . . . . 0.0 110.181 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -78.02 152.19 33.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.321 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.98 68.53 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.579 1.181 . . . . 0.0 108.97 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.45 169.39 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.315 1.446 . . . . 0.0 108.14 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -97.01 -58.44 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt 61.57 -166.45 0.21 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.544 1.152 . . . . 0.0 110.562 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tp 49.99 23.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 C-N-CA 125.68 1.592 . . . . 0.0 113.838 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.63 -107.26 0.37 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.43 -167.92 0.17 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.474 1.11 . . . . 0.0 112.675 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 168.56 30.23 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 67.2 mtt -102.77 94.23 5.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.252 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.83 80.3 1.22 Allowed Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.62 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.576 1.15 . . . . 0.0 110.895 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -102.52 -73.39 0.66 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.714 0.805 . . . . 0.0 109.423 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.86 -72.72 0.71 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.6 mm 61.21 -76.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.642 1.577 . . . . 0.0 112.154 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 25.8 m 62.38 -78.54 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.842 1.257 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.34 -91.33 0.42 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 174.47 165.48 0.23 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.951 1.3 . . . . 0.0 109.453 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 63.62 111.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.743 1.217 . . . . 0.0 111.607 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.624 ' HB3' ' HA3' ' B' ' 140' ' ' GLY . 3.7 p-10 -72.0 107.84 4.92 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -76.94 82.31 3.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.24 134.37 0.08 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 126.213 1.805 . . . . 0.0 106.883 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.22 90.22 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.62 -48.88 2.25 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.9 -44.46 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.886 1.274 . . . . 0.0 108.951 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.84 -83.02 0.54 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.58 -73.35 0.78 Allowed Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.433 0.54 . . . . 0.0 113.349 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -67.3 -20.58 65.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.197 1.399 . . . . 0.0 111.03 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG22 ' A' ' 384' ' ' VAL . 84.3 t80 -134.96 152.77 52.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.818 0.847 . . . . 0.0 109.324 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -145.72 145.62 30.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.454 1.101 . . . . 0.0 109.475 178.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.19 89.75 0.64 Allowed Glycine 0 C--N 1.345 1.07 0 O-C-N 123.774 0.672 . . . . 0.0 112.232 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.79 137.29 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 122.209 -0.583 . . . . 0.0 110.904 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.18 -68.76 0.19 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.772 1.229 . . . . 0.0 108.773 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.55 29.17 6.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.259 1.424 . . . . 0.0 112.991 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.38 88.54 0.12 Allowed Pre-proline 0 C--N 1.363 1.169 0 C-N-CA 124.599 1.159 . . . . 0.0 109.158 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.85 99.95 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.273 1.982 . . . . 0.0 112.328 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 401' ' ' VAL . 10.9 mp -82.43 -156.44 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.684 0.794 . . . . 0.0 109.02 169.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 63.9 p -64.58 121.97 15.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.223 0.609 . . . . 0.0 109.707 172.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.11 -17.61 55.93 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 -168.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -126.57 -179.38 4.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.028 0.531 . . . . 0.0 110.491 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -65.48 95.71 0.22 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 122.894 0.477 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 11.1 m -142.96 21.26 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.199 1.0 . . . . 0.0 109.682 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -75.96 85.28 2.87 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.356 0.598 . . . . 0.0 109.71 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -139.79 -28.33 0.75 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.694 1.198 . . . . 0.0 108.127 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.65 127.3 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.103 1.361 . . . . 0.0 108.278 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.57 HD13 ' H ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -78.92 1.4 23.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.493 0.717 . . . . 0.0 111.806 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.566 HD22 ' HB3' ' A' ' 310' ' ' GLU . 34.8 t30 -70.6 81.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.253 1.021 . . . . 0.0 110.619 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.42 ' HB3' HG11 ' A' ' 313' ' ' VAL . 4.1 ptpp? 174.73 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.691 1.596 . . . . 0.0 109.3 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -81.25 95.54 6.99 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p 52.56 -78.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.577 1.951 . . . . 0.0 114.211 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.15 146.76 11.78 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.25 0.452 . . . . 0.0 113.625 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -81.63 -50.17 0.91 Allowed Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.303 1.041 . . . . 0.0 111.991 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.02 -6.63 17.56 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 121.63 1.554 . . . . 0.0 112.209 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.31 -32.24 24.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.238 1.015 . . . . 0.0 109.548 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 67.59 96.03 0.06 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 124.985 1.314 . . . . 0.0 111.332 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.81 -33.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.058 0.943 . . . . 0.0 108.774 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.5 m 81.53 -55.24 0.27 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.211 1.805 . . . . 0.0 112.039 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 71.91 -66.24 0.31 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.574 1.55 . . . . 0.0 110.392 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -157.51 142.94 17.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.8 27.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.203 0.601 . . . . 0.0 109.95 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.711 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -74.49 179.59 4.56 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.049 0.54 . . . . 0.0 112.263 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 3.1 m 79.74 29.85 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.541 1.937 . . . . 0.0 110.593 -164.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.09 85.51 0.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.729 1.212 . . . . 0.0 112.325 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 46.8 m -70.66 138.77 50.98 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 158.95 26.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.419 0.628 . . . . 0.0 111.75 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -110.8 -74.32 0.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.068 -147.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' B' ' 135' ' ' VAL . 81.3 p 47.38 82.38 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.56 1.544 . . . . 0.0 112.435 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 3.1 m -68.58 -43.28 76.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.821 0.848 . . . . 0.0 110.592 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.46 -5.99 64.7 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.504 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.597 ' HA ' ' HB2' ' B' ' 132' ' ' SER . 5.7 m 56.63 4.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 127.236 2.214 . . . . 0.0 114.63 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 tttp 64.43 136.32 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.789 1.636 . . . . 0.0 112.238 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.4 m 77.27 -22.2 0.29 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.032 1.333 . . . . 0.0 113.496 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -57.07 128.16 35.58 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.696 0.68 . . . . 0.0 112.827 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -174.87 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.393 1.477 . . . . 0.0 109.323 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLY . . . . . 0.624 ' HA3' ' HB3' ' B' ' 85' ' ' ASN . . . 99.11 -51.28 1.14 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.459 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 -152.3 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.674 1.189 . . . . 0.0 111.512 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 mt 68.14 13.73 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.202 1.001 . . . . 0.0 111.586 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.25 32.37 12.27 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.575 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -82.99 60.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.406 1.098 . . . . 0.0 110.572 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.51 103.85 4.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.101 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.569 HD12 ' HD3' ' B' ' 149' ' ' LYS . 27.2 pt -123.35 150.21 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.598 0.759 . . . . 0.0 109.351 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.16 176.73 8.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.737 0.815 . . . . 0.0 110.815 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 40.3 32.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.495 1.918 . . . . 0.0 113.893 -172.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.569 ' HD3' HD12 ' B' ' 146' ' ' ILE . 89.1 tttt -125.38 102.08 7.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 123.742 0.817 . . . . 0.0 109.918 -178.571 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.5 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.628 ' HA ' HG21 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 53' ' ' ILE . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.1 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.628 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG11 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.44 HD12 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.497 HG11 HG13 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.562 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.527 HD11 ' CZ2' ' B' ' 131' ' ' TRP . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.735 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.626 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.548 HG23 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.486 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.548 ' CE1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.434 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.557 HG22 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.626 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.489 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.585 ' HB2' HD22 ' B' ' 10' ' ' LEU . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' B' ' 6' ' ' ILE . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.5 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.407 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.1 m-20 -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 158' ' ' VAL . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.78 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.655 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.597 HG21 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.497 HG13 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.585 HG21 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 311' ' ' ILE . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.585 ' HG3' HG21 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 -58.39 -42.02 86.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 43.3 ttp -75.78 -33.05 60.14 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.999 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -77.19 -9.73 58.96 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.746 0.818 . . . . 15.0 111.26 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 47.5 t -58.64 -22.44 56.62 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 122.826 0.45 . . . . 15.0 111.271 167.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.07 -11.22 53.35 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.753 0.821 . . . . 15.0 111.905 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -130.86 116.65 18.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.821 0.848 . . . . 15.0 110.821 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.55 -38.0 85.86 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.846 0.858 . . . . 15.0 109.501 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -133.94 88.36 32.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 114.73 -1.123 . . . . 15.0 108.544 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.42 47.29 2.15 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.63 2.887 . . . . 15.0 114.847 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -53.24 -48.42 68.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.466 0.706 . . . . 15.0 110.992 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.59 -33.45 63.95 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.979 0.799 . . . . 15.0 111.791 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.84 -62.81 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.32 -42.83 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.534 -0.757 . . . . 15.0 109.884 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.92 -51.21 58.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.636 -0.697 . . . . 15.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -54.7 -42.98 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.302 0.501 . . . . 15.0 111.406 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.93 -62.07 2.14 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.793 0.437 . . . . 15.0 110.819 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 90.4 p -67.67 -8.49 35.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.437 0.903 . . . . 15.0 113.437 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.94 -19.02 13.65 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.383 0.673 . . . . 15.0 111.795 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -139.11 124.12 18.86 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -54.47 -46.04 73.27 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.132 0.973 . . . . 15.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.586 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' B' ' 106' ' ' TYR . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.44 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.484 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.795 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.484 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.562 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.49 16.48 0.48 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -106.49 102.21 11.62 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -90.53 -61.13 1.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.978 0.911 . . . . 15.0 109.483 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-N 115.647 -0.706 . . . . 15.0 109.52 -178.108 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -64.08 -57.36 9.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.655 0.782 . . . . 0.0 109.128 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -100.31 173.54 6.55 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.293 167.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -71.57 91.04 1.04 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.838 0.855 . . . . 0.0 109.631 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -79.9 78.34 6.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.749 0.819 . . . . 0.0 110.611 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 223' ' ' ALA . 3.5 mp -123.22 114.06 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.06 36.9 0.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.825 1.25 . . . . 0.0 111.384 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.859 HD23 HD23 ' B' ' 13' ' ' LEU . 1.2 pp 46.03 11.64 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 126.643 1.977 . . . . 0.0 115.608 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.52 -8.55 48.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.336 0.655 . . . . 0.0 112.329 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 222' ' ' HIS . 0.1 OUTLIER -66.32 -70.79 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 179.01 -64.31 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 124.472 1.109 . . . . 0.0 109.385 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.573 ' HD2' HD13 ' B' ' 10' ' ' LEU . 93.0 Cg_endo -72.86 146.13 41.81 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 121.909 1.74 . . . . 0.0 113.831 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.859 HD23 HD23 ' B' ' 8' ' ' LEU . 30.3 tp 169.4 -58.33 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.079 1.752 . . . . 0.0 108.277 164.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 14' ' ' LEU . 2.4 pt? -86.33 -44.64 11.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.418 -174.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.442 ' O ' ' HD2' ' B' ' 17' ' ' PRO . 90.1 m-85 57.69 -160.49 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.741 0.816 . . . . 0.0 111.277 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . 0.306 13.1 m 87.45 -89.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.287 0 CA-C-O 116.292 -1.813 . . . . 0.0 112.269 171.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 86.9 Cg_endo -77.76 -20.07 12.21 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 124.789 2.746 . . . . 0.0 111.941 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.483 HG13 HG22 ' B' ' 19' ' ' THR . 12.0 p -90.91 164.21 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 125.299 1.439 . . . . 0.0 110.309 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.483 HG22 HG13 ' B' ' 18' ' ' VAL . 10.9 t 50.05 82.59 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 126.452 1.901 . . . . 0.0 114.376 170.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.72 105.96 16.5 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 101.86 0.86 Allowed 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.483 1.113 . . . . 0.0 110.778 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 57.41 67.83 0.93 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.711 1.257 . . . . 0.0 109.175 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 m -141.59 115.12 6.77 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.74 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.21 150.04 36.74 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.34 2.027 . . . . 0.0 111.323 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.32 -44.87 50.75 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 96.5 mmm 53.9 79.86 0.32 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.885 1.366 . . . . 0.0 111.316 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.33 -74.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.796 1.664 . . . . 0.0 112.108 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -179.65 -32.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.895 1.278 . . . . 0.0 108.811 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 75.12 -61.34 0.49 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 125.967 1.707 . . . . 0.0 110.576 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.36 163.55 37.18 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.153 0.981 . . . . 0.0 109.043 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -73.39 -153.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.554 0.742 . . . . 0.0 110.655 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 68.56 93.69 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -171.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 76.26 121.4 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.181 1.393 . . . . 0.0 108.889 -164.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 75.33 143.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.089 1.356 . . . . 0.0 110.906 -167.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -66.25 -63.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.003 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.7 11.2 0.1 Allowed Glycine 0 N--CA 1.468 0.771 0 O-C-N 123.432 0.458 . . . . 0.0 112.641 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.48 145.69 19.17 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.352 1.061 . . . . 0.0 109.118 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 20.7 tt -170.09 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.853 0.861 . . . . 0.0 110.631 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m 59.15 -90.46 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 111.727 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.68 94.46 13.22 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.256 0.622 . . . . 0.0 109.527 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.24 22.75 0.84 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 123.572 2.848 . . . . 0.0 112.886 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.74 -138.1 26.7 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.513 0.508 . . . . 0.0 112.338 -175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.48 58.26 3.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.25 153.89 29.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.394 0.678 . . . . 0.0 110.782 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -81.57 -12.39 58.8 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.614 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 73.92 -46.93 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.786 1.634 . . . . 0.0 110.724 -170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.8 96.43 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 34.7 p -84.14 83.51 7.94 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.506 1.123 . . . . 0.0 110.263 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.03 75.28 0.11 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.216 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.15 160.49 31.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.35 1.06 . . . . 0.0 111.059 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.65 -35.54 80.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.754 0.822 . . . . 0.0 112.338 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.8 m -106.79 -84.24 0.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.76 0.424 . . . . 0.0 110.818 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.65 -71.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.99 0.916 . . . . 0.0 110.034 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.64 -59.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.05 174.28 0.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.072 1.349 . . . . 0.0 113.803 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -117.46 -26.14 6.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.881 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.61 47.09 25.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.63 1.172 . . . . 0.0 110.333 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -54.51 110.72 0.67 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.834 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.697 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -76.75 179.4 6.1 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.236 176.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m 70.16 118.52 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.54 1.136 . . . . 0.0 110.302 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 34.7 t70 75.5 -7.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.537 1.135 . . . . 0.0 111.833 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 108.18 2.45 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.893 0.877 . . . . 0.0 110.149 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -85.31 126.99 3.26 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.576 2.184 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 159.49 32.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.7 162.05 13.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.233 0.613 . . . . 0.0 110.135 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -59.95 -34.82 73.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.015 0.926 . . . . 0.0 111.007 -174.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 HG22 ' B' ' 68' ' ' ILE . 8.9 tp -166.86 -44.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.816 173.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.415 HG22 HG23 ' B' ' 67' ' ' ILE . 9.6 tp 176.7 -22.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.899 1.279 . . . . 0.0 109.655 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp 77.97 94.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.834 1.654 . . . . 0.0 109.144 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.6 tp -152.54 62.04 0.81 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.694 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 -20.26 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.427 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.82 41.56 0.06 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -104.71 146.85 28.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.532 1.133 . . . . 0.0 110.986 -168.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 171.55 37.21 Favored Glycine 0 C--O 1.244 0.771 0 C-N-CA 123.487 0.565 . . . . 0.0 111.774 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -89.58 62.05 5.75 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.89 76.77 0.07 OUTLIER Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.202 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -176.41 -67.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.676 1.19 . . . . 0.0 109.484 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 49.3 m -94.48 -21.71 18.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.508 0.723 . . . . 0.0 112.015 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.15 -24.58 65.91 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.34 -13.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -127.44 147.02 50.29 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 110.328 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.79 79.15 6.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.966 0.907 . . . . 0.0 108.621 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.41 82.89 8.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.301 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -97.56 114.59 26.52 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 169.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 40.5 t-20 -124.09 120.19 31.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -69.44 -30.49 68.42 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.763 0.825 . . . . 0.0 110.837 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.14 -175.51 5.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.246 1.018 . . . . 0.0 112.107 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -61.85 -36.95 82.7 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.67 1.188 . . . . 0.0 113.343 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.12 73.1 1.56 Allowed Glycine 0 C--N 1.35 1.352 0 O-C-N 123.944 0.778 . . . . 0.0 114.167 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' B' ' 85' ' ' ASN . . . -162.08 90.04 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.404 1.082 . . . . 0.0 108.809 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.64 121.93 5.19 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.591 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.83 -41.02 95.82 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -114.45 -64.8 1.26 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 167.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -154.59 -79.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' B' ' 95' ' ' LYS . 32.5 ttmt 179.79 -61.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.74 0.816 . . . . 0.0 109.016 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.71 85.41 0.06 OUTLIER Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 pt -132.46 147.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.4 1.08 . . . . 0.0 109.377 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.31 130.4 28.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.561 1.144 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.1 160.57 21.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.62 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 6.5 mt -64.98 -50.88 59.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 O-C-N 123.307 0.38 . . . . 0.0 110.004 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 52.9 Cg_endo -99.2 154.84 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.316 2.011 . . . . 0.0 110.543 153.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.34 176.52 9.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 110.341 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 71.4 p 54.8 76.01 0.27 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 113.404 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.38 166.08 24.83 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.722 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.1 -17.64 42.39 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.237 1.015 . . . . 0.0 110.66 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.435 ' HD2' ' HB2' ' A' ' 404' ' ' GLU . 1.5 m-85 73.02 153.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.971 1.308 . . . . 0.0 111.421 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 14.3 t -160.8 9.18 0.09 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.387 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 73.35 -46.85 0.65 Allowed 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 125.136 1.374 . . . . 0.0 112.282 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.64 -35.41 74.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.917 1.287 . . . . 0.0 111.815 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.72 25.42 11.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.08 0.952 . . . . 0.0 111.825 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.95 -21.25 60.9 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.945 0.402 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -105.8 157.56 17.37 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.723 1.209 . . . . 0.0 109.211 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 68.54 170.2 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.37 1.468 . . . . 0.0 112.03 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' B' ' 115' ' ' THR . 1.6 tmmt? 69.08 -75.93 0.06 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.826 1.25 . . . . 0.0 110.172 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.613 HG23 ' HD2' ' B' ' 114' ' ' LYS . 7.5 p -100.52 -7.65 23.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.361 0.665 . . . . 0.0 110.655 171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.05 -35.86 64.44 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.85 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.643 ' HB3' ' HD2' ' B' ' 118' ' ' PRO . 99.2 mttt 61.86 -153.38 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.558 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' B' ' 117' ' ' LYS . 21.4 Cg_exo -41.8 95.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 123.39 2.246 . . . . 0.0 113.5 158.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.96 -17.27 64.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.73 1.212 . . . . 0.0 112.624 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -74.07 -28.43 61.39 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.929 0.491 . . . . 0.0 112.247 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.11 -26.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.576 0.35 . . . . 0.0 110.664 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.3 p 50.42 -86.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.763 1.625 . . . . 0.0 113.22 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -152.22 169.78 21.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.91 1.284 . . . . 0.0 109.359 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m 74.17 -77.57 0.05 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.573 1.549 . . . . 0.0 111.856 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.96 -34.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.014 1.326 . . . . 0.0 111.691 -171.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.712 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . 75.36 -172.8 0.11 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.435 1.094 . . . . 0.0 111.541 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m 57.48 43.27 23.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.518 1.127 . . . . 0.0 110.788 -161.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 78.33 -44.24 0.38 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.083 1.753 . . . . 0.0 112.44 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 24.8 m 60.83 -87.13 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.917 1.287 . . . . 0.0 108.866 -169.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.94 -162.73 0.14 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.488 1.115 . . . . 0.0 113.827 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.527 ' CZ2' HD11 ' A' ' 144' ' ' LEU . 6.0 m95 77.21 148.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.97 1.708 . . . . 0.0 113.979 163.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t 71.58 108.04 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.401 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -66.57 130.9 44.71 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.82 8.01 58.42 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 38.6 t 58.21 69.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.141 0 C-N-CA 125.13 1.372 . . . . 0.0 110.886 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 76.51 -33.02 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.521 1.529 . . . . 0.0 113.926 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 34.8 p 51.76 -151.28 0.26 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.144 1.378 . . . . 0.0 110.868 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.39 -173.69 4.59 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.542 HD21 ' HB3' ' B' ' 142' ' ' LEU . 25.3 t30 65.64 -101.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.907 0.883 . . . . 0.0 110.672 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.93 -44.19 1.52 Allowed Glycine 0 CA--C 1.543 1.797 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.77 -16.22 62.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.542 ' HB3' HD21 ' B' ' 139' ' ' ASN . 5.2 tt -84.98 107.23 17.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.7 -71.45 1.15 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 124.002 0.814 . . . . 0.0 111.927 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 p -168.63 153.12 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 0.0 110.464 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -88.09 142.12 28.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.511 1.125 . . . . 0.0 110.219 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.33 115.58 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.056 0.943 . . . . 0.0 109.66 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -157.33 92.05 1.21 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 163.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -165.73 173.64 10.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.376 0.67 . . . . 0.0 110.277 -169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.6 80.09 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.202 1.001 . . . . 0.0 110.348 166.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.653 HG12 HG12 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG11 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.611 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' NH2' HG11 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 28' ' ' VAL . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.403 HG12 ' HD2' ' A' ' 109' ' ' PHE . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.526 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.413 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' B' ' 127' ' ' SER . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.561 HD21 HG21 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 128' ' ' ALA . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 237' ' ' LEU . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.59 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.585 ' HA2' HD23 ' B' ' 13' ' ' LEU . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.441 ' HB3' HE21 ' A' ' 191' ' ' GLN . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.401 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.599 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.656 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.656 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.435 ' HE2' HG22 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.599 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.55 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' B' ' 11' ' ' LEU . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 232' ' ' LYS . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.461 ' HA2' ' HA3' ' B' ' 134' ' ' GLY . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 258' ' ' VAL . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.413 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 258' ' ' VAL . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.561 HG21 HD21 ' A' ' 141' ' ' LEU . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.475 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.424 HH21 ' HB2' ' A' ' 377' ' ' ALA . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 287' ' ' LYS . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 345' ' ' VAL . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.406 HE22 ' NH2' ' A' ' 344' ' ' ARG . 10.2 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.409 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 336' ' ' LEU . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.707 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.696 ' HG2' ' HE3' ' B' ' 113' ' ' LYS . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 375' ' ' ALA . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 -60.99 -55.82 28.36 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.4 ttp -59.4 -40.47 86.72 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.461 -1.245 . . . . 15.0 110.733 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.53 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -65.77 -38.9 90.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.021 0.928 . . . . 15.0 112.905 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.1 t -63.77 -15.39 58.55 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.848 0.859 . . . . 15.0 112.369 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.424 ' HB2' HH21 ' A' ' 276' ' ' ARG . . . -71.59 -27.97 63.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.076 0.55 . . . . 15.0 112.182 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -95.31 -170.86 2.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.956 0.502 . . . . 15.0 110.554 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -79.88 -27.68 39.99 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 15.0 110.378 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -148.05 131.33 8.16 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.262 0.625 . . . . 15.0 110.873 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 88.3 Cg_endo -76.04 -29.75 6.37 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.653 2.235 . . . . 15.0 113.19 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -59.3 -32.44 70.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.358 0.663 . . . . 15.0 111.309 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.6 -53.99 13.13 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.675 1.235 . . . . 15.0 110.059 170.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 375' ' ' ALA . 24.8 t -73.4 -54.08 16.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 CA-C-N 114.182 -1.372 . . . . 15.0 110.806 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.76 -54.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 124.548 1.155 . . . . 15.0 109.315 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.48 -40.95 76.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 119.199 -0.429 . . . . 15.0 111.825 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -59.14 -53.82 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.679 0.392 . . . . 15.0 111.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -77.51 -32.88 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.351 0.871 . . . . 15.0 113.351 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.0 p -61.77 -29.06 69.88 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.749 0.309 . . . . 15.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.5 -13.73 60.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.412 0.685 . . . . 15.0 111.835 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -122.48 114.28 20.48 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 110.039 -0.356 . . . . 15.0 110.039 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt -62.3 -19.13 62.97 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.696 1.198 . . . . 15.0 112.097 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' B' ' 100' ' ' LEU . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.57 ' HA ' HG12 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.623 ' HA ' ' HE1' ' B' ' 108' ' ' HIS . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.525 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.448 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.583 ' HG2' ' HB1' ' B' ' 126' ' ' ALA . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.515 ' HA ' HE22 ' A' ' 431' ' ' GLN . 85.7 m-20 -79.21 48.32 0.86 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -123.29 39.74 3.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.791 0.836 . . . . 15.0 109.756 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.515 HE22 ' HA ' ' A' ' 429' ' ' ASN . 2.2 mp0 -76.04 119.25 19.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.246 0.618 . . . . 15.0 110.31 174.104 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.02 130.27 6.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -67.55 98.2 0.65 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.432 0.458 . . . . 0.0 110.035 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.3 t 69.93 -79.92 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.219 1.407 . . . . 0.0 111.945 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.1 t -161.94 -154.8 0.35 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.283 0.633 . . . . 0.0 110.458 -164.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 223' ' ' ALA 0.251 1.7 mp 71.84 -76.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.445 0 C-N-CA 125.596 1.558 . . . . 0.0 110.521 -173.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.11 48.11 23.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.655 0.782 . . . . 0.0 111.305 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.87 133.28 51.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.956 -166.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.46 170.04 16.79 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.491 1.117 . . . . 0.0 108.84 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tm? 72.12 -69.8 0.18 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.622 1.569 . . . . 0.0 109.408 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.553 ' HB3' ' NE2' ' A' ' 222' ' ' HIS . 30.0 tp -126.28 109.17 23.96 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.558 1.143 . . . . 0.0 109.025 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.29 -162.85 0.2 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 124.076 3.184 . . . . 0.0 111.434 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.585 HD23 ' HA2' ' A' ' 180' ' ' GLY . 3.8 mm? -64.96 -2.23 2.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.607 0.763 . . . . 0.0 112.736 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 mt -86.85 80.54 8.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.521 0.729 . . . . 0.0 109.716 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 194' ' ' MET . 31.4 m-85 -82.93 -8.4 59.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.4 m -74.47 -54.47 3.09 Favored Pre-proline 0 CA--C 1.573 1.853 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.465 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.418 ' HB2' HG23 ' B' ' 19' ' ' THR . 94.4 Cg_endo -78.59 -30.27 3.21 Favored 'Trans proline' 0 C--N 1.392 2.823 0 CA-C-N 121.521 1.579 . . . . 0.0 114.026 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.528 HG12 HD13 ' B' ' 11' ' ' LEU . 30.1 m 38.51 57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 125.786 1.635 . . . . 0.0 113.377 -174.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.418 HG23 ' HB2' ' B' ' 17' ' ' PRO . 47.4 p -85.09 120.99 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.223 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.53 159.53 33.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.079 0.952 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.49 103.14 4.03 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.572 0.749 . . . . 0.0 110.055 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -123.46 -174.83 3.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.152 0.981 . . . . 0.0 110.534 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -62.77 143.82 96.74 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-O 117.75 -1.119 . . . . 0.0 109.68 167.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.66 97.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 1 C-N-CA 125.621 4.214 . . . . 0.0 114.971 -171.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.25 88.67 0.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.54 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.558 ' HG3' HG13 ' B' ' 28' ' ' VAL . 26.9 ptm -159.73 167.73 13.52 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.343 1.057 . . . . 0.0 109.172 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' B' ' 26' ' ' MET . 24.6 Cg_endo -61.21 85.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.472 2.115 . . . . 0.0 113.035 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' B' ' 26' ' ' MET . 19.0 m -121.59 -26.41 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.598 1.159 . . . . 0.0 109.749 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.57 109.99 2.17 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 48.95 30.8 2.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.704 1.602 . . . . 0.0 112.988 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . 0.255 5.5 p30 46.25 -75.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.155 1.782 . . . . 0.0 111.789 -164.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.6 -22.8 0.09 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.179 0.591 . . . . 0.0 111.281 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -160.31 -47.0 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.15 85.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.354 0.662 . . . . 0.0 111.983 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 63.07 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.898 1.279 . . . . 0.0 110.193 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.76 26.94 0.02 OUTLIER Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -95.09 157.29 15.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.136 0.975 . . . . 0.0 110.093 -175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -66.18 89.8 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.758 0.789 . . . . 0.0 111.651 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -68.82 142.95 54.72 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.75 81.64 0.23 Allowed Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -161.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.03 -18.15 56.39 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.328 2.686 . . . . 0.0 113.472 -170.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.31 5.02 64.91 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.547 0.529 . . . . 0.0 113.103 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.32 48.0 11.73 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.32 0.486 . . . . 0.0 112.048 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.76 176.56 0.27 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.695 1.198 . . . . 0.0 112.396 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -82.77 72.42 9.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.763 0.825 . . . . 0.0 110.081 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -88.03 -62.87 1.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.253 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.681 HD23 ' H ' ' B' ' 47' ' ' LEU . 1.5 pt? -84.52 107.23 16.64 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.742 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 12.7 m -102.64 59.07 0.79 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.002 0.906 . . . . 0.0 109.252 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.33 146.45 6.75 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.791 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.61 95.19 7.7 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.124 0.487 . . . . 0.0 110.969 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -112.64 -24.26 9.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.058 0.943 . . . . 0.0 110.841 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.9 m -79.74 -15.04 58.24 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.591 0.756 . . . . 0.0 112.261 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.14 -17.71 56.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.691 -0.631 . . . . 0.0 111.432 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.35 -174.24 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.887 1.275 . . . . 0.0 111.981 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 pp -166.16 153.98 10.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.691 0.797 . . . . 0.0 110.602 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 61.61 12.01 4.25 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.908 1.283 . . . . 0.0 113.88 170.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.7 107.82 20.34 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.8 p 56.05 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.727 1.611 . . . . 0.0 112.119 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp 67.64 -80.08 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.482 1.513 . . . . 0.0 111.47 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.3 p -161.38 165.09 29.46 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.772 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.26 -61.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.319 1.447 . . . . 0.0 111.218 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' B' ' 63' ' ' PRO . 2.6 tppp? -54.78 125.62 55.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.134 1.374 . . . . 0.0 110.506 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' B' ' 62' ' ' LYS . 20.8 Cg_exo -35.26 91.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 125.3 4.0 . . . . 0.0 115.305 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.07 -158.55 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 106.955 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 tttp 62.11 21.54 12.47 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.758 0.823 . . . . 0.0 111.401 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 18.5 m120 65.14 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 0.0 110.798 -169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.5 mt 59.95 -85.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.984 1.313 . . . . 0.0 111.47 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -83.57 -25.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.787 0.835 . . . . 0.0 110.021 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.8 mt -71.85 81.47 0.9 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.634 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.23 4.81 1.84 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.428 1.491 . . . . 0.0 108.558 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.52 132.22 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.974 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.99 1.41 Allowed Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.49 -149.22 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.707 1.203 . . . . 0.0 110.654 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.42 97.62 0.05 OUTLIER Glycine 0 C--N 1.361 1.935 0 O-C-N 123.403 0.439 . . . . 0.0 112.748 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' B' ' 82' ' ' ALA . 54.3 tpp 58.72 92.52 0.04 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.384 1.474 . . . . 0.0 110.437 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.673 ' HA2' ' HB ' ' B' ' 80' ' ' ILE . . . -160.61 103.02 0.22 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.336 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.61 -72.29 0.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.276 0.63 . . . . 0.0 109.341 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -96.86 -71.97 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -105.74 -78.8 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.673 ' HB ' ' HA2' ' B' ' 76' ' ' GLY . 38.7 mm 52.94 -76.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 125.962 1.705 . . . . 0.0 112.303 -171.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 38.6 p 57.45 82.48 0.12 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.976 1.71 . . . . 0.0 110.809 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' B' ' 75' ' ' MET . . . -85.07 12.01 8.55 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.003 -0.436 . . . . 0.0 111.932 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.74 156.81 26.01 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.883 0.873 . . . . 0.0 111.036 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 62.86 82.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.139 0.976 . . . . 0.0 111.668 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -137.44 -61.99 0.63 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.434 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 57.38 174.77 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.351 1.461 . . . . 0.0 113.71 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.72 -174.3 1.56 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.854 1.262 . . . . 0.0 108.257 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -125.75 86.72 2.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.04 107.41 2.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.144 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.07 178.96 6.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.751 0.821 . . . . 0.0 109.947 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.24 97.36 0.27 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.28 -21.04 75.66 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.736 0.316 . . . . 0.0 113.699 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.41 -5.91 57.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.414 0.686 . . . . 0.0 110.896 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 77.2 t80 77.31 162.17 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.048 1.739 . . . . 0.0 111.426 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -59.2 152.3 20.94 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.053 1.741 . . . . 0.0 113.237 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.07 -82.22 0.18 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 124.565 1.166 . . . . 0.0 115.04 165.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.504 HG23 HD13 ' B' ' 100' ' ' LEU . 37.3 mm 77.13 140.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.826 1.65 . . . . 0.0 111.835 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.64 -73.17 0.55 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.544 0.738 . . . . 0.0 110.801 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 401' ' ' VAL . . . -101.98 -81.28 0.49 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.315 0.646 . . . . 0.0 110.823 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.504 HD13 HG23 ' B' ' 97' ' ' ILE . 9.0 mp 65.97 -173.82 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 117.854 -1.07 . . . . 0.0 112.383 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 77.4 Cg_exo -50.7 29.54 0.02 OUTLIER 'Trans proline' 1 C--N 1.415 4.043 0 C-N-CA 123.897 3.065 . . . . 0.0 118.81 172.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' B' ' 120' ' ' TYR . 7.8 tt -50.54 -41.76 54.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.283 1.033 . . . . 0.0 108.864 155.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.539 HG22 HD13 ' B' ' 111' ' ' LEU . 66.0 p -105.58 156.32 18.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.461 1.105 . . . . 0.0 109.707 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.28 -128.8 1.71 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -100.01 -171.22 2.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.36 74.19 0.23 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.111 1.365 . . . . 0.0 110.417 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -146.95 -54.07 0.23 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.431 1.093 . . . . 0.0 109.912 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' HIS . . . . . 0.623 ' HE1' ' HA ' ' A' ' 404' ' ' GLU . 76.9 m-70 81.54 -13.7 0.87 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 126.549 1.939 . . . . 0.0 112.392 -171.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -69.36 -33.22 72.75 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.02 -8.99 58.23 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.69 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.539 HD13 HG22 ' B' ' 103' ' ' THR . 60.3 tp -66.1 102.7 0.85 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -80.5 143.94 32.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.696 ' HE3' ' HG2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -149.96 122.79 8.7 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.768 0.258 . . . . 0.0 111.09 -173.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' B' ' 119' ' ' ASP . 44.3 mmtm -67.98 179.29 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.496 0.665 . . . . 0.0 111.095 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -65.47 96.31 0.24 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 121.929 0.871 . . . . 0.0 108.898 165.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.65 -37.97 2.03 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -171.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 288' ' ' SER 0.34 4.2 ptpp? 110.22 -26.56 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 128.455 2.702 . . . . 0.0 116.019 169.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.83 99.42 0.97 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 CA-C-N 123.618 2.328 . . . . 0.0 111.277 168.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASP . . . . . 0.716 ' HA ' ' HG2' ' B' ' 114' ' ' LYS . 9.0 t70 -93.44 -31.41 14.61 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 122.778 0.431 . . . . 0.0 111.611 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.462 ' HB3' ' HG ' ' B' ' 102' ' ' LEU . 30.1 p90 -51.47 125.81 15.52 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.588 1.18 . . . . 0.0 111.713 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -71.6 83.31 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.288 1.035 . . . . 0.0 109.431 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.8 m -147.38 114.76 6.29 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.69 78.81 1.53 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.467 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 47.5 t -81.6 85.25 6.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.219 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.06 -28.5 64.41 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.017 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 428' ' ' MET . . . 71.82 -57.3 0.62 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 125.167 1.542 . . . . 0.0 111.276 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.417 ' HA ' ' SD ' ' A' ' 140' ' ' MET . 31.7 m -64.09 102.56 0.51 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 122.789 0.436 . . . . 0.0 109.835 167.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 144' ' ' LEU . . . 80.15 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.081 1.752 . . . . 0.0 111.922 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.3 m 57.09 26.18 11.73 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.056 0.942 . . . . 0.0 111.339 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.3 22.34 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.241 1.016 . . . . 0.0 112.752 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -100.79 3.98 42.55 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.29 1.036 . . . . 0.0 109.96 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 10.5 m -60.25 -43.28 96.25 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.826 1.25 . . . . 0.0 113.784 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -91.15 -7.36 51.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.04 0.536 . . . . 0.0 111.859 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLY . . . . . 0.461 ' HA3' ' HA2' ' A' ' 257' ' ' GLY . . . -122.81 -165.14 12.31 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.678 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.5 t 50.26 43.1 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 122.644 1.211 . . . . 0.0 109.513 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -137.28 56.8 1.77 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.947 -167.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 40.7 m -120.53 123.59 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.238 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.1 -11.09 4.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 111.983 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -70.94 -21.66 62.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.895 0.478 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.47 -75.87 2.09 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' B' ' 144' ' ' VAL . . . -146.03 136.7 24.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.24 0.616 . . . . 0.0 110.813 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.7 124.41 50.5 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.577 1.151 . . . . 0.0 108.565 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.7 -63.55 4.25 Favored Glycine 0 C--N 1.347 1.152 0 O-C-N 123.455 0.472 . . . . 0.0 112.295 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.478 HG13 ' HB1' ' B' ' 141' ' ' ALA . 3.7 p -67.29 104.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.391 0.615 . . . . 0.0 110.006 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -138.22 145.27 41.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.685 0.794 . . . . 0.0 109.173 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.72 107.17 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 109.355 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -157.36 75.64 0.81 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.623 0.725 . . . . 0.0 110.942 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.35 159.6 25.57 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.058 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -86.84 80.62 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 124.334 1.054 . . . . 0.0 111.311 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 5' ' ' VAL . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.548 HG21 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG22 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG21 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.729 HG23 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.47 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.495 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.584 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 177' ' ' PHE . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.421 ' HZ ' HD23 ' B' ' 13' ' ' LEU . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.406 ' HA ' ' HD1' ' B' ' 15' ' ' PHE . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.805 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.805 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.565 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.445 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.423 ' O ' HD21 ' B' ' 11' ' ' LEU . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.479 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.606 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' B' ' 13' ' ' LEU . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.703 HG12 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.432 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 266' ' ' LEU . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 132' ' ' SER . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.546 ' H ' ' HA ' ' A' ' 254' ' ' LYS . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.493 HD13 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 137' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.419 HD13 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.552 HD12 HG11 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.729 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.461 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.678 HD11 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.435 ' O ' HD13 ' A' ' 311' ' ' ILE . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.433 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 330' ' ' LEU . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.407 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.426 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 112' ' ' ASN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 -63.72 -44.58 93.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.606 ' HG3' ' HB3' ' B' ' 98' ' ' ASP . 32.5 ttp -58.51 -51.3 70.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.498 -1.228 . . . . 15.0 110.271 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -65.04 -40.32 94.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.297 1.039 . . . . 15.0 112.699 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.7 t -64.17 -24.44 67.68 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 15.0 111.78 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.18 -11.76 59.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.363 0.665 . . . . 15.0 111.659 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -100.65 159.24 15.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.961 0.886 . . . . 15.0 112.156 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -6.42 50.34 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.226 -1.807 . . . . 15.0 111.668 174.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -152.1 112.8 2.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.387 -0.598 . . . . 15.0 109.387 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.54 -30.65 9.66 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.232 2.622 . . . . 15.0 113.008 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -56.28 -43.18 78.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.504 0.721 . . . . 15.0 111.547 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.71 -36.35 83.35 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.78 0.675 . . . . 15.0 111.12 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 375' ' ' ALA . 28.4 t -67.97 -47.46 78.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 109.005 -0.739 . . . . 15.0 109.005 -172.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.12 -55.48 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.822 -1.081 . . . . 15.0 109.185 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.93 -4.78 34.23 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.34 -45.68 6.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.722 0.409 . . . . 15.0 110.601 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -95.41 -33.91 12.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.115 1.524 . . . . 15.0 115.115 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 81.6 p -55.93 -39.25 71.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 112.913 0.708 . . . . 15.0 112.913 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -111.98 14.96 20.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.804 0.842 . . . . 15.0 110.923 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -94.14 97.69 10.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.655 0.782 . . . . 15.0 108.953 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -47.82 -43.06 27.63 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.206 1.403 . . . . 15.0 111.817 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.529 ' HB1' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 355' ' ' ILE . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 287' ' ' LYS . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.58 HD12 ' NE2' ' A' ' 430' ' ' GLN . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.635 ' SD ' ' HB1' ' B' ' 126' ' ' ALA . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.26 33.86 1.5 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLN . . . . . 0.58 ' NE2' HD12 ' A' ' 427' ' ' LEU . 41.5 mt-30 -90.23 80.97 6.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.031 0.533 . . . . 15.0 110.039 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.27 -70.74 0.73 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 107.177 -1.416 . . . . 15.0 107.177 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.801 0.841 . . . . 15.0 108.997 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -175.31 156.3 2.01 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.799 0.84 . . . . 0.0 109.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -70.51 86.25 0.63 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -142.85 12.82 1.87 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.532 1.133 . . . . 0.0 109.048 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.563 HG22 HG13 ' B' ' 6' ' ' ILE . 88.0 m -148.38 142.99 26.52 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.364 1.465 . . . . 0.0 107.334 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.563 HG13 HG22 ' B' ' 5' ' ' THR . 5.4 mt 65.34 75.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.433 1.093 . . . . 0.0 110.061 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.6 34.26 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.822 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . 0.252 1.2 pp 33.83 58.51 0.57 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.326 1.85 . . . . 0.0 114.168 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.16 127.76 53.06 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.5 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.08 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.245 1.418 . . . . 0.0 111.166 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.423 HD21 ' O ' ' A' ' 220' ' ' GLU . 28.3 tp 60.86 66.04 1.85 Allowed Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 123.988 0.915 . . . . 0.0 109.016 -171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.41 179.89 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.119 2.546 . . . . 0.0 112.568 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 233' ' ' PHE . 17.2 tp -85.81 58.94 5.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.005 0.907 . . . . 0.0 109.685 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 174.62 78.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.406 ' HD1' ' HA ' ' A' ' 194' ' ' MET . 4.1 m-85 -91.57 -1.37 57.52 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.479 ' N ' ' HD2' ' B' ' 17' ' ' PRO . 46.8 m -69.85 -41.67 16.19 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 16' ' ' THR . 8.5 Cg_endo -44.59 -70.54 0.07 OUTLIER 'Trans proline' 1 C--N 1.424 4.508 0 C-N-CA 123.656 2.904 . . . . 0.0 113.256 -169.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t 51.55 -79.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 125.182 1.393 . . . . 0.0 111.976 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m 79.13 -44.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.636 1.974 . . . . 0.0 112.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 67.93 -77.22 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.002 1.321 . . . . 0.0 109.965 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.66 87.96 0.05 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.918 1.287 . . . . 0.0 111.623 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' B' ' 22' ' ' ARG . 1.9 mmp_? -127.51 103.72 7.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.665 0.786 . . . . 0.0 110.615 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -70.74 165.82 42.67 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.263 1.025 . . . . 0.0 109.275 167.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.475 ' HG3' ' HG3' ' B' ' 41' ' ' PRO . 10.5 Cg_endo -50.23 106.82 0.13 Allowed 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.106 2.538 . . . . 0.0 112.004 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.43 77.88 1.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.961 0.905 . . . . 0.0 110.338 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 64.8 mtt -94.17 -33.9 0.3 Allowed Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 117.179 -1.391 . . . . 0.0 112.941 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 26' ' ' MET . 1.9 Cg_exo -33.49 101.62 0.03 OUTLIER 'Trans proline' 1 C--N 1.42 4.304 0 C-N-CA 124.407 3.404 . . . . 0.0 115.749 176.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' B' ' 34' ' ' ALA . 13.8 p -144.7 157.58 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 125.022 1.329 . . . . 0.0 108.808 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -142.62 -56.18 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -120.52 179.99 4.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 0.0 110.528 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.8 m120 72.22 166.37 0.3 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.511 1.525 . . . . 0.0 112.077 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -83.37 -171.72 3.74 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.228 174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 73.29 -66.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.404 1.482 . . . . 0.0 110.121 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' B' ' 28' ' ' VAL . . . 55.49 87.87 0.05 OUTLIER 'General case' 0 C--N 1.366 1.32 0 C-N-CA 125.357 1.463 . . . . 0.0 111.779 173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 77.98 -48.56 0.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.415 1.486 . . . . 0.0 110.82 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.28 -74.23 2.5 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -143.76 103.98 4.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.771 0.828 . . . . 0.0 109.133 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.452 HD13 ' H ' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -138.02 172.94 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.744 1.217 . . . . 0.0 109.342 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -138.51 166.49 24.15 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.989 0.916 . . . . 0.0 109.02 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.56 103.95 4.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.795 0.838 . . . . 0.0 109.099 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.475 ' HG3' ' HG3' ' B' ' 24' ' ' PRO . 29.5 Cg_endo -93.16 169.57 2.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.6 2.2 . . . . 0.0 113.1 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.64 -108.02 2.18 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.829 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.05 -31.8 82.07 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 124.137 0.551 . . . . 0.0 112.312 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.14 -78.11 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.214 1.406 . . . . 0.0 112.437 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.806 ' HG3' ' HA ' ' B' ' 63' ' ' PRO . 8.2 tmm_? 62.39 -82.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.196 1.398 . . . . 0.0 110.173 -171.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' B' ' 46' ' ' ARG . 2.5 tpm_? 176.17 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.019 0.928 . . . . 0.0 109.702 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.03 70.36 1.44 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.0 m -66.78 -48.25 69.62 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.201 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.57 63.39 0.01 OUTLIER Glycine 0 C--O 1.244 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 62.12 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.456 1.502 . . . . 0.0 109.798 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -103.99 -72.95 0.69 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 166.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -111.2 -62.53 1.53 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.46 -48.83 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -161.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 106.24 0.9 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 -167.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.41 89.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.039 0.936 . . . . 0.0 111.941 -173.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.44 ' NH2' HD22 ' B' ' 59' ' ' LEU . 62.2 ttt180 65.59 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.699 1.2 . . . . 0.0 112.574 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.33 -37.66 13.89 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.72 1.208 . . . . 0.0 109.064 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -146.62 172.34 13.74 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.892 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.44 HD22 ' NH2' ' B' ' 56' ' ' ARG . 38.3 tp -132.2 -19.63 2.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.907 0.483 . . . . 0.0 111.519 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.29 -0.12 16.04 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.73 92.54 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.431 1.093 . . . . 0.0 110.637 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -66.28 151.93 95.06 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.482 1.113 . . . . 0.0 110.749 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.806 ' HA ' ' HG3' ' B' ' 45' ' ' ARG . 69.9 Cg_exo -40.27 -56.12 1.61 Allowed 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 124.255 3.304 . . . . 0.0 114.711 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.76 -169.96 3.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.714 0.806 . . . . 0.0 109.382 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 43.08 75.39 0.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.122 1.769 . . . . 0.0 114.03 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -86.15 141.32 29.45 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.907 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.437 HD12 ' H ' ' B' ' 69' ' ' LEU . 2.9 pp -62.27 -29.96 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 123.209 0.603 . . . . 0.0 112.605 -172.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' B' ' 73' ' ' ASP . 23.6 pt 41.13 29.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.95 2.1 . . . . 0.0 115.477 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.437 ' H ' HD12 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -98.77 25.98 6.08 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.539 0.736 . . . . 0.0 109.302 -177.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -163.16 112.42 1.32 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.484 HG23 ' H ' ' B' ' 72' ' ' GLY 0.265 13.9 tt 42.5 -76.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 127.179 2.192 . . . . 0.0 115.121 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.484 ' H ' HG23 ' B' ' 71' ' ' ILE . . . -126.25 -62.91 0.16 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' B' ' 68' ' ' ILE . 15.0 t70 65.67 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.705 1.202 . . . . 0.0 111.152 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.14 61.23 0.4 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 28.0 ttt -138.92 106.76 5.65 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.524 0.729 . . . . 0.0 109.78 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.43 146.64 17.3 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . 0.271 2.0 p30 49.59 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.208 1.403 . . . . 0.0 111.758 -167.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.5 t -102.65 -79.5 0.53 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.497 1.119 . . . . 0.0 108.016 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' B' ' 80' ' ' ILE . 29.1 tt0 -113.75 -56.84 2.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.884 0.873 . . . . 0.0 108.678 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.434 HG22 ' HG2' ' B' ' 79' ' ' GLU . 13.4 tt -173.99 105.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.829 0.852 . . . . 0.0 110.96 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.3 m -76.08 110.32 10.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.7 -87.46 0.18 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.63 -166.66 1.22 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.91 0.484 . . . . 0.0 110.675 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 68.08 73.58 0.3 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.08 1.352 . . . . 0.0 110.095 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.83 -49.41 25.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -154.08 -53.26 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.75 0.42 . . . . 0.0 110.756 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 119.41 3.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.877 0.871 . . . . 0.0 109.401 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -172.68 142.93 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.363 1.065 . . . . 0.0 108.562 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.1 -106.62 0.64 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' HB3' HG11 ' B' ' 135' ' ' VAL . . . -160.87 120.02 2.61 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.893 0.877 . . . . 0.0 109.28 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.27 -160.89 52.72 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.699 0.625 . . . . 0.0 112.596 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.16 167.2 11.63 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 64.79 -78.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.426 1.49 . . . . 0.0 111.303 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -125.15 145.01 50.15 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.239 1.016 . . . . 0.0 109.65 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.39 106.73 18.69 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.3 -132.5 14.89 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.656 0.598 . . . . 0.0 111.906 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.82 -40.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.606 ' HB3' ' HG3' ' A' ' 374' ' ' MET . 14.9 t70 71.49 -63.12 0.43 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.17 1.788 . . . . 0.0 112.154 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.41 134.86 57.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.653 0.781 . . . . 0.0 110.367 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -94.79 107.27 29.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.82 0.848 . . . . 0.0 110.797 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -76.47 -31.23 4.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.25 2.633 . . . . 0.0 113.05 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' B' ' 107' ' ' THR . 6.2 mp 56.4 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.524 1.53 . . . . 0.0 110.945 -170.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' B' ' 107' ' ' THR . 25.8 m -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.873 . . . . 0.0 110.514 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.34 145.03 10.34 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 62.23 -85.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.572 1.149 . . . . 0.0 110.115 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -120.68 110.41 16.37 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' ' 102' ' ' LEU . 6.9 m -78.55 -18.57 54.47 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.61 0.764 . . . . 0.0 112.909 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.72 1.13 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.625 0.77 . . . . 0.0 112.229 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 63.66 82.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.712 1.205 . . . . 0.0 109.646 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.57 68.03 0.73 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.129 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 132.48 48.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 171.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 344' ' ' ARG . 10.5 t30 60.68 102.88 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.234 0.959 . . . . 0.0 109.379 -163.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -147.64 98.95 3.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt 58.42 74.37 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.08 1.352 . . . . 0.0 110.393 -170.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.506 ' H ' ' HA ' ' B' ' 119' ' ' ASP . 78.6 m -86.4 95.03 9.54 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.238 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.03 3.76 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.418 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 22.1 tptm -108.23 -50.29 0.09 OUTLIER Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 124.219 1.008 . . . . 0.0 112.039 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 57.8 Cg_endo -67.49 -22.31 45.17 Favored 'Trans proline' 0 C--N 1.396 3.061 0 CA-C-N 121.478 1.563 . . . . 0.0 113.571 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASP . . . . . 0.506 ' HA ' ' H ' ' B' ' 115' ' ' THR . 42.7 t0 62.08 24.89 14.87 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.313 1.53 . . . . 0.0 110.37 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -168.93 172.98 7.28 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.676 -1.602 . . . . 0.0 107.312 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t 70.15 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 124.051 0.941 . . . . 0.0 110.911 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.4 m -66.97 -34.64 78.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.075 0.95 . . . . 0.0 110.898 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.22 -129.45 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.095 0.958 . . . . 0.0 108.95 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 52.6 p -159.81 -54.0 0.06 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.934 1.243 . . . . 0.0 111.314 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.62 -10.54 7.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.786 0.835 . . . . 0.0 111.747 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.635 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . 72.64 -60.92 0.52 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.629 1.572 . . . . 0.0 113.818 172.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.613 ' HB3' ' HG3' ' A' ' 428' ' ' MET . 22.0 p -101.77 -41.74 6.42 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.751 -0.593 . . . . 0.0 112.541 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.32 90.3 2.78 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.0 0.429 . . . . 0.0 111.954 -169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.2 p -86.97 8.17 24.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.694 0.798 . . . . 0.0 111.143 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 61.89 -144.72 0.42 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.423 1.089 . . . . 0.0 109.95 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.461 ' NE1' ' HB2' ' A' ' 256' ' ' PHE . 35.4 p90 -153.36 154.46 34.55 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.385 0.674 . . . . 0.0 110.259 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 32.9 t -162.95 148.17 11.78 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.01 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 34.9 m -67.85 151.39 47.24 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.53 24.39 Favored Glycine 0 N--CA 1.482 1.756 0 O-C-N 123.475 0.484 . . . . 0.0 113.787 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' B' ' 90' ' ' ALA . 7.4 p -160.55 123.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.111 0.964 . . . . 0.0 108.906 169.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -179.94 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.528 1.131 . . . . 0.0 108.889 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 37.0 p -68.82 131.18 44.71 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.985 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 71.18 -62.09 0.46 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.754 1.622 . . . . 0.0 111.842 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.11 83.98 0.72 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.646 0.779 . . . . 0.0 109.339 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.39 46.92 1.07 Allowed Glycine 0 C--N 1.336 0.577 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.39 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.072 0.949 . . . . 0.0 109.928 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 55.1 tp 64.86 -80.54 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.875 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.01 -69.77 1.23 Allowed Glycine 0 C--N 1.36 1.879 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.43 75.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.94 92.44 0.92 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.52 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 9.3 tp -111.2 137.2 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -101.74 158.33 16.19 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 72.2 142.49 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.403 1.481 . . . . 0.0 113.057 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -111.02 173.91 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.879 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.551 1.0 0 C-N-CA 123.819 0.847 . . . . 0.0 109.022 167.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.657 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.518 HG12 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.612 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.584 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.658 ' HG2' HG11 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 97' ' ' TYR . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.629 ' HB3' HG21 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.442 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.612 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.528 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.532 ' HG2' HD11 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG23 HD22 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD21 ' HB1' ' B' ' 128' ' ' ALA . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.708 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 HG22 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' B' ' 8' ' ' LEU . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.617 ' HA2' HD22 ' B' ' 13' ' ' LEU . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.54 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 191' ' ' GLN . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.521 ' HA ' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.587 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' OH ' ' HB1' ' B' ' 7' ' ' ALA . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 7' ' ' ALA . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 158' ' ' VAL . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.708 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.66 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' B' ' 135' ' ' VAL . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.576 HD13 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.476 HD21 ' HB ' ' B' ' 133' ' ' THR . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.513 HD22 HG23 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.755 ' HE2' HD11 ' B' ' 111' ' ' LEU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.528 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.527 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.41 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.485 ' HG3' HH21 ' B' ' 46' ' ' ARG . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.421 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.641 HH12 HD12 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.641 HD12 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -32.31 73.93 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 47.2 ttp -74.11 -62.71 1.41 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.841 0.456 . . . . 15.0 110.551 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.68 -37.31 82.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.718 0.807 . . . . 15.0 113.067 -168.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.1 t -63.07 -27.7 69.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.939 0.495 . . . . 15.0 111.45 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.76 64.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.098 0.559 . . . . 15.0 111.688 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.32 179.32 7.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 15.0 112.223 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -59.89 -45.87 91.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.895 1.678 . . . . 15.0 110.694 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.88 108.22 4.33 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.15 -30.79 37.6 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.56 2.174 . . . . 15.0 112.418 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.74 -36.65 79.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.543 0.737 . . . . 15.0 112.734 -166.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -68.47 -30.49 69.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.254 0.622 . . . . 15.0 111.163 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.12 -46.06 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.299 -1.0 . . . . 15.0 108.299 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.46 -41.12 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.244 1.018 . . . . 15.0 110.374 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.96 -38.53 91.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.335 0.654 . . . . 15.0 110.624 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.7 -41.35 99.08 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.422 0.451 . . . . 15.0 110.714 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 395' ' ' MET . 93.4 m-85 -62.93 -58.03 8.75 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.458 0.647 . . . . 15.0 110.706 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 74.2 p -65.4 -23.51 66.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.455 0.909 . . . . 15.0 113.455 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.47 -1.15 21.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.327 0.651 . . . . 15.0 111.844 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -151.47 126.76 9.94 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 120.875 0.369 . . . . 15.0 110.116 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -77.04 -13.01 60.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.314 0.646 . . . . 15.0 111.643 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.411 ' HA ' ' HD1' ' A' ' 388' ' ' TYR . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.489 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 396' ' ' ASP . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.564 HG21 HD22 ' B' ' 102' ' ' LEU . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.54 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 407' ' ' ALA . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.505 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.468 ' HA ' HD12 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.418 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.532 HD11 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' B' ' 126' ' ' ALA . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.36 -10.15 58.63 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.32 86.37 5.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.177 0.991 . . . . 15.0 110.568 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.77 -72.77 0.53 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.531 -0.915 . . . . 15.0 108.531 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.922 0.889 . . . . 15.0 109.056 178.487 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -150.32 -161.6 1.38 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.368 0.667 . . . . 0.0 110.441 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -66.56 87.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.612 0.765 . . . . 0.0 111.791 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.6 t -92.27 78.58 5.11 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 32.1 p -127.32 120.29 28.23 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.523 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -74.8 -171.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.415 0.626 . . . . 0.0 110.884 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 223' ' ' ALA . . . -151.08 -7.47 0.25 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.46 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 179' ' ' GLY . 1.1 pp -160.33 159.25 31.01 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.554 -162.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -71.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.935 0.772 . . . . 0.0 109.927 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 -18.9 60.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.51 0.724 . . . . 0.0 110.504 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.477 HD13 ' H ' ' B' ' 11' ' ' LEU . 0.0 OUTLIER -117.7 145.82 37.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.23 1.012 . . . . 0.0 109.36 174.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.546 ' O ' HD22 ' B' ' 8' ' ' LEU . 25.0 Cg_exo -64.95 -40.59 20.28 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.617 HD22 ' HA2' ' A' ' 180' ' ' GLY . 16.7 tp 175.14 -45.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.569 1.548 . . . . 0.0 108.073 169.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 142.72 55.91 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 194' ' ' MET . 93.7 m-85 -107.58 25.55 11.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.903 0.881 . . . . 0.0 110.731 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' B' ' 17' ' ' PRO . 1.0 OUTLIER -114.18 23.08 0.08 OUTLIER Pre-proline 0 CA--C 1.588 2.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -174.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' B' ' 16' ' ' THR . 4.2 Cg_exo -78.47 85.93 1.76 Allowed 'Trans proline' 0 C--N 1.405 3.522 0 CA-C-N 123.698 2.356 . . . . 0.0 111.617 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t 44.65 -74.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 127.127 2.171 . . . . 0.0 115.119 168.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -69.77 -32.98 71.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -63.35 115.92 5.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.938 0.495 . . . . 0.0 111.569 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.24 34.23 18.78 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.455 1.097 . . . . 0.0 111.408 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.506 ' HG3' HG22 ' B' ' 23' ' ' THR . 10.1 tpt180 -58.8 -65.9 0.59 Allowed 'General case' 0 C--N 1.357 0.933 0 C-N-CA 123.913 0.885 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.506 HG22 ' HG3' ' B' ' 22' ' ' ARG . 3.7 t -169.77 102.22 0.46 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.222 1.009 . . . . 0.0 109.379 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.59 42.94 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.123 2.549 . . . . 0.0 112.533 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -153.7 -34.34 0.11 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.244 1.418 . . . . 0.0 109.184 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 41.44 86.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -53.01 104.56 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.392 2.728 . . . . 0.0 112.692 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.566 HG13 ' H ' ' B' ' 29' ' ' LEU 0.267 7.6 p 43.28 -79.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 126.505 1.922 . . . . 0.0 113.454 -171.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.566 ' H ' HG13 ' B' ' 28' ' ' VAL . 96.2 mt -134.57 125.44 27.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.681 1.192 . . . . 0.0 108.109 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.1 102.56 4.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.138 0.575 . . . . 0.0 110.04 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 60.4 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.067 1.347 . . . . 0.0 113.04 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -88.37 118.81 28.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.151 0.981 . . . . 0.0 110.13 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.73 47.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.318 0.647 . . . . 0.0 110.65 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.344 1.458 . . . . 0.0 111.842 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 69.85 -60.26 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.873 1.669 . . . . 0.0 112.927 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.89 64.26 1.0 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.45 103.31 15.4 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.911 0.884 . . . . 0.0 110.718 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.87 -45.06 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -152.37 114.47 4.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.314 1.046 . . . . 0.0 108.805 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.75 73.81 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.13 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.4 88.19 0.5 Allowed 'Trans proline' 0 C--N 1.39 2.759 0 CA-C-N 120.951 1.375 . . . . 0.0 110.844 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.53 -168.87 35.2 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.096 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -54.75 4.6 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.22 173.35 16.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.495 1.118 . . . . 0.0 109.845 173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -64.36 -56.96 10.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.581 0.752 . . . . 0.0 109.998 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 326' ' ' GLU . 20.2 ttm180 65.94 -84.28 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.311 1.044 . . . . 0.0 110.983 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.51 175.78 7.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.11 1.364 . . . . 0.0 108.941 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.4 m 68.34 83.85 0.16 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 112.232 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.7 99.82 0.7 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -55.98 108.23 0.43 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.978 0.911 . . . . 0.0 111.933 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.28 -9.91 59.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.939 0.896 . . . . 0.0 111.182 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 43.0 p -62.83 -25.56 68.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.839 0.856 . . . . 0.0 111.366 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 -22.23 65.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.289 1.036 . . . . 0.0 111.54 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.08 98.22 7.38 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.904 0.882 . . . . 0.0 109.052 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.13 83.71 1.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.569 0.748 . . . . 0.0 109.421 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.67 -16.11 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.244 1.018 . . . . 0.0 110.761 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.76 6.8 4.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.17 1.388 . . . . 0.0 114.291 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 72.1 p -90.57 18.18 6.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.558 0.743 . . . . 0.0 110.893 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.55 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -118.65 145.24 45.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.4 t 54.92 46.71 23.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.851 0.86 . . . . 0.0 109.472 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -47.51 -45.97 26.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.359 1.464 . . . . 0.0 113.276 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 63' ' ' PRO . 49.0 mtmt -102.28 126.48 33.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 62' ' ' LYS . 45.3 Cg_exo -57.5 -18.64 32.89 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 124.224 3.283 . . . . 0.0 115.249 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.72 -13.43 62.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.814 0.445 . . . . 0.0 112.14 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.91 8.84 34.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.533 0.733 . . . . 0.0 111.714 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.4 -170.26 2.88 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp 44.57 56.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 125.478 1.511 . . . . 0.0 112.006 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.441 HG12 HD13 ' B' ' 71' ' ' ILE . 38.7 pt -85.93 9.98 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.59 -170.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt 77.29 123.25 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.704 1.602 . . . . 0.0 109.099 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 44.6 tp 80.71 -51.74 0.32 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.052 1.741 . . . . 0.0 113.015 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 68' ' ' ILE . 37.3 mm 58.72 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.919 0.887 . . . . 0.0 109.045 -166.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.46 -163.7 37.12 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.343 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -151.07 -35.88 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.484 0.714 . . . . 0.0 109.721 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.97 87.79 0.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.401 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -87.45 -163.51 0.94 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.557 171.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 16.48 -133.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.08 -174.72 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.418 1.487 . . . . 0.0 109.463 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -52.16 -46.45 65.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.407 1.083 . . . . 0.0 112.461 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -87.03 -13.36 44.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.424 0.69 . . . . 0.0 112.338 -173.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt 52.3 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 126.39 1.876 . . . . 0.0 114.357 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -83.32 -61.41 1.86 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.698 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -167.71 -51.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.84 10.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.716 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.48 163.03 12.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 110.962 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -158.3 -47.33 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.774 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 69.07 -72.06 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.308 1.443 . . . . 0.0 109.992 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.52 80.59 0.22 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.814 1.246 . . . . 0.0 113.12 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' B' ' 90' ' ' ALA . 34.7 tt0 -172.09 153.85 3.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.284 1.034 . . . . 0.0 109.476 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.63 -36.26 82.66 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' H ' ' HG2' ' B' ' 88' ' ' GLU . . . 67.85 -6.31 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 168.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.69 -47.78 3.87 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 122.909 0.29 . . . . 0.0 113.472 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.37 -6.35 75.32 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -70.55 105.24 3.03 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.94 83.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.993 0.917 . . . . 0.0 110.974 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -151.78 -46.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.487 1.515 . . . . 0.0 107.385 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.09 82.0 1.57 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.99 102.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.19 -19.92 52.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.14 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.604 1.562 . . . . 0.0 111.548 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 pp -159.93 177.32 2.11 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.542 0.737 . . . . 0.0 110.215 -168.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.14 107.17 0.24 Allowed 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.155 1.903 . . . . 0.0 112.24 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 401' ' ' VAL . 2.6 pp -159.76 151.18 19.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.18 0.992 . . . . 0.0 108.979 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.8 p -139.83 25.9 2.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.435 0.694 . . . . 0.0 109.597 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -53.83 119.59 11.76 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.615 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -156.39 -64.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.248 1.019 . . . . 0.0 108.402 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -156.66 -58.58 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.794 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.9 p -64.34 -58.3 6.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.159 0.584 . . . . 0.0 110.128 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 p80 36.16 42.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 126.627 1.971 . . . . 0.0 113.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.749 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 0.2 OUTLIER -89.87 27.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.312 -172.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 344' ' ' ARG . . . -168.89 75.9 0.1 Allowed 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.971 0.909 . . . . 0.0 109.4 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.755 HD11 ' HE2' ' A' ' 287' ' ' LYS . 8.4 tt -54.18 -39.66 66.81 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.819 1.248 . . . . 0.0 111.235 -176.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -85.23 128.51 34.71 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.482 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.66 ' HG3' ' H ' ' B' ' 114' ' ' LYS . 11.0 tppt? -174.49 -161.89 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.66 ' H ' ' HG3' ' B' ' 113' ' ' LYS . 32.0 mmtp 87.83 140.77 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.016 2.126 . . . . 0.0 112.03 164.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.7 t -61.08 -52.93 62.85 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.212 1.005 . . . . 0.0 111.489 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.14 47.35 1.99 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.091 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -167.98 116.53 0.64 Allowed Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.152 0.581 . . . . 0.0 109.55 -174.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.17 161.49 19.46 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.858 2.372 . . . . 0.0 112.564 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -82.03 6.19 16.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.921 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.28 167.27 20.69 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.582 0.753 . . . . 0.0 109.348 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.55 95.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.1 0.952 . . . . 0.0 111.515 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 123' ' ' ASP . 1.8 m -133.75 -164.98 1.57 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.59 ' H ' HG22 ' B' ' 122' ' ' THR . 6.5 m-20 73.75 -70.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.793 1.637 . . . . 0.0 110.694 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 91.76 0.69 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.237 1.015 . . . . 0.0 112.063 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.6 94.51 2.51 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.547 ' N ' ' SD ' ' A' ' 428' ' ' MET . . . -51.97 -21.08 2.74 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.751 1.221 . . . . 0.0 113.372 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -57.84 93.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 144' ' ' LEU . . . 74.54 -19.41 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.48 1.512 . . . . 0.0 114.637 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 8.5 m -77.68 90.05 3.98 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 273' ' ' ASN . . . -130.44 27.61 5.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.141 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -105.44 15.38 27.25 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.212 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 33.2 t -72.87 -12.94 61.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.476 ' HB ' HD21 ' A' ' 273' ' ' ASN . 14.3 t -67.8 -18.48 64.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.442 0.697 . . . . 0.0 110.534 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.2 127.39 5.62 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 41.4 t -73.99 81.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -70.04 -40.34 75.2 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.81 -170.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m 55.05 30.55 14.45 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 124.106 0.879 . . . . 0.0 111.1 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -60.73 -30.81 70.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.722 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -117.88 105.84 12.35 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.09 179.98 42.61 Favored Glycine 0 C--N 1.34 0.777 0 O-C-N 123.288 0.367 . . . . 0.0 113.033 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.14 100.65 3.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.28 1.032 . . . . 0.0 110.046 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp 63.69 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.086 1.354 . . . . 0.0 112.14 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.01 -75.73 1.49 Allowed Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -173.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 m -126.2 120.96 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 109.018 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.62 176.46 5.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.813 0.845 . . . . 0.0 110.605 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.85 99.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -125.91 173.54 9.04 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.685 0.794 . . . . 0.0 109.225 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 75.68 -68.92 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.22 129.83 35.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.119 0.568 . . . . 0.0 109.688 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 110.403 177.373 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.676 HG12 HG12 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD13 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 63' ' ' ARG . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG22 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.526 ' HE1' HD13 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 117' ' ' LEU . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.501 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.458 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HG ' ' HB1' ' B' ' 128' ' ' ALA . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.673 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.58 HD13 HD11 ' A' ' 202' ' ' ILE . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.587 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.693 ' HA2' HD21 ' B' ' 13' ' ' LEU . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.587 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' B' ' 17' ' ' PRO . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.566 ' HG3' HD21 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' B' ' 13' ' ' LEU . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.538 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.525 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.554 ' HA ' HG22 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.572 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 377' ' ' ALA . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.644 HD11 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.501 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 346' ' ' VAL . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 115' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.571 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.566 ' HB2' HG23 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 355' ' ' ILE . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 398' ' ' MET . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -68.79 -38.48 80.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.468 ' SD ' HG23 ' B' ' 97' ' ' ILE . 53.6 ttp -73.04 -35.94 66.83 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.897 0.879 . . . . 15.0 110.461 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -67.97 -45.55 73.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.21 0.604 . . . . 15.0 110.392 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -61.44 -31.56 71.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.222 1.009 . . . . 15.0 110.942 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' A' ' 276' ' ' ARG . . . -71.09 -33.74 70.47 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.923 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.407 ' HE2' HG12 ' B' ' 97' ' ' ILE . 5.2 m-30 -84.3 174.17 10.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.81 0.444 . . . . 15.0 110.299 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.44 -34.57 74.61 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.694 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 14.3 t70 -159.0 126.49 2.7 Favored Pre-proline 0 C--O 1.21 -1.022 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.6 -31.78 41.62 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 123.642 2.895 . . . . 15.0 115.377 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -53.21 -40.35 64.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.264 0.626 . . . . 15.0 112.0 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.3 pt-20 -58.84 -36.91 75.32 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 122.923 0.489 . . . . 15.0 111.116 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' B' ' 97' ' ' ILE . 69.6 t -73.11 -51.64 25.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 123.822 0.849 . . . . 15.0 109.817 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.68 -41.25 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 CA-C-N 115.624 -0.716 . . . . 15.0 110.754 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.29 -34.76 75.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.649 0.78 . . . . 15.0 111.422 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.477 ' HB2' ' HE1' ' B' ' 94' ' ' PHE . 29.5 t80 -60.55 -54.61 43.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.909 -0.404 . . . . 15.0 109.909 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -54.2 -49.71 68.77 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.274 0.63 . . . . 15.0 112.294 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.7 p -64.5 -14.28 56.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.88 2.26 11.55 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.102 -0.475 . . . . 15.0 111.463 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -142.74 101.44 3.86 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 15.0 111.372 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.72 -31.07 68.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.15 0.98 . . . . 15.0 110.593 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.41 ' HG3' HG13 ' A' ' 367' ' ' VAL . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 287' ' ' LYS . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.4 t30 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -80.38 7.23 10.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -105.1 86.9 2.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.884 0.874 . . . . 15.0 110.056 -176.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -96.45 -10.19 28.06 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.46 0.704 . . . . 15.0 110.718 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.472 1.109 . . . . 15.0 108.321 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? 56.84 32.02 20.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.733 1.213 . . . . 0.0 111.259 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.85 144.59 49.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.021 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.2 m -121.5 79.65 1.57 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -77.72 81.35 4.16 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -87.98 141.59 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 109.446 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.07 65.29 5.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.367 1.079 . . . . 0.0 109.354 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -85.89 10.93 12.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.382 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.41 -9.84 45.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.116 0.967 . . . . 0.0 111.385 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.95 -150.86 0.46 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 125.179 1.392 . . . . 0.0 107.805 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.611 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 3.4 pp 59.42 177.3 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.412 1.485 . . . . 0.0 113.007 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' HB2' ' B' ' 11' ' ' LEU . 37.8 Cg_endo -64.82 74.01 0.22 Allowed 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 122.013 1.809 . . . . 0.0 114.699 171.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.693 HD21 ' HA2' ' A' ' 180' ' ' GLY . 62.3 tp -128.79 -34.77 1.94 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.347 1.059 . . . . 0.0 108.657 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' A' ' 194' ' ' MET . 2.2 pt? -130.65 -59.2 1.02 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.969 -175.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 51.42 76.15 0.18 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.512 0.725 . . . . 0.0 111.7 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -91.81 140.97 25.08 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.555 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 186' ' ' VAL . 50.9 Cg_exo -55.41 -52.88 6.7 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.478 2.119 . . . . 0.0 111.205 171.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.99 136.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.093 1.357 . . . . 0.0 108.545 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 35.8 p -72.22 113.85 9.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 69.61 -73.16 0.09 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.379 1.472 . . . . 0.0 112.06 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.5 -80.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.026 1.33 . . . . 0.0 110.176 -171.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -166.55 76.81 0.2 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.615 1.166 . . . . 0.0 108.116 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 13.2 p -70.22 125.34 91.96 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.094 173.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 7.0 Cg_exo -75.39 14.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.206 2.604 . . . . 0.0 114.251 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.4 -45.95 84.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.697 0.799 . . . . 0.0 109.234 167.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -110.38 98.67 37.17 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.23 123.56 10.73 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.341 2.027 . . . . 0.0 111.332 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.67 90.71 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -78.66 89.17 4.55 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.054 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -80.97 139.78 35.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.682 0.793 . . . . 0.0 108.945 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -141.57 90.63 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 52.26 14.09 0.33 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 126.388 1.875 . . . . 0.0 115.062 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.06 -9.88 27.19 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.092 0.557 . . . . 0.0 110.205 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.17 146.31 35.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.767 0.827 . . . . 0.0 110.466 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -117.05 171.9 7.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.834 0.854 . . . . 0.0 109.923 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.63 173.77 35.62 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.868 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 38' ' ' ILE . 20.6 t70 -58.98 120.93 10.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.799 0.84 . . . . 0.0 109.627 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.421 HG22 ' O ' ' B' ' 37' ' ' ASP . 6.7 tp 60.63 -0.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.454 1.902 . . . . 0.0 112.962 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m 51.45 -83.09 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.616 1.567 . . . . 0.0 112.043 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.09 107.91 27.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 109.508 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.96 10.98 3.41 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.624 2.216 . . . . 0.0 113.196 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.42 -85.4 0.73 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -172.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.02 22.09 59.95 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 124.234 0.608 . . . . 0.0 114.525 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.69 72.37 3.33 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.785 0.802 . . . . 0.0 109.437 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -168.43 -38.14 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.131 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 70.89 -46.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.547 1.539 . . . . 0.0 111.767 -169.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.38 178.19 9.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.181 0.993 . . . . 0.0 110.134 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.2 m -139.29 -53.3 0.56 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.68 -160.7 35.87 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.476 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.01 84.13 6.55 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 122.14 0.972 . . . . 0.0 111.017 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.455 ' HG3' ' HA ' ' B' ' 55' ' ' LEU . 0.4 OUTLIER -112.14 6.89 19.37 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.444 1.497 . . . . 0.0 110.168 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -57.04 -64.74 0.78 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.79 0.836 . . . . 0.0 113.027 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.98 -24.42 30.62 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.084 0.553 . . . . 0.0 111.623 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.61 78.29 1.78 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.48 0.712 . . . . 0.0 109.251 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.455 ' HA ' ' HG3' ' B' ' 51' ' ' GLN . 2.8 tm? -72.5 -61.44 1.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -169.18 163.47 10.98 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.587 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.06 71.57 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.884 0.85 . . . . 0.0 108.783 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m -75.5 -60.9 2.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.985 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 57.29 -78.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.17 1.388 . . . . 0.0 113.019 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t 68.91 25.38 6.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.258 1.023 . . . . 0.0 110.288 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 63.11 83.13 0.17 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.447 1.499 . . . . 0.0 110.829 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -127.27 143.16 46.18 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.54 79.74 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.631 2.221 . . . . 0.0 110.649 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -11.78 59.86 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.989 0.915 . . . . 0.0 111.254 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 66.25 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.413 1.485 . . . . 0.0 111.287 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -101.27 95.28 6.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -84.01 71.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.204 1.002 . . . . 0.0 109.02 177.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.16 -58.04 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.485 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt 60.32 -177.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.634 1.174 . . . . 0.0 111.721 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.536 ' HA ' ' HG3' ' B' ' 75' ' ' MET . 50.4 mt -71.63 -24.16 61.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.371 174.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 40.8 mt -98.61 101.3 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.613 0.765 . . . . 0.0 109.072 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.06 -131.47 1.35 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.17 -66.91 0.89 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.313 0.557 . . . . 0.0 109.666 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.21 -143.84 0.46 Allowed Glycine 0 C--N 1.348 1.224 0 O-C-N 124.174 0.921 . . . . 0.0 113.972 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' B' ' 70' ' ' LEU . 25.7 mmt 75.74 -57.57 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.038 1.335 . . . . 0.0 111.598 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.52 73.73 2.34 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.397 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' B' ' 80' ' ' ILE . 15.6 t70 74.77 156.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.769 1.628 . . . . 0.0 111.488 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -63.11 -67.22 0.44 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.372 1.069 . . . . 0.0 111.635 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.84 -14.7 59.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.125 0.57 . . . . 0.0 110.354 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.5 ' HA ' ' HB3' ' B' ' 77' ' ' ASP . 75.5 mt 66.6 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 125.387 1.475 . . . . 0.0 109.616 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.7 m -158.08 -45.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.134 1.374 . . . . 0.0 107.301 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.89 127.82 0.03 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.411 1.484 . . . . 0.0 110.642 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.82 4.68 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 123.537 0.523 . . . . 0.0 109.883 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.84 106.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.64 74.06 4.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.785 0.802 . . . . 0.0 110.861 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -79.03 -38.41 36.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.78 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.85 23.0 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.358 1.063 . . . . 0.0 109.615 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -72.97 94.78 1.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.08 -58.72 0.69 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.83 66.54 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.459 0.703 . . . . 0.0 111.645 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.79 3.36 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.613 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.16 152.81 21.12 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -114.75 142.4 46.57 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.92 0.888 . . . . 0.0 110.615 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.477 ' HE1' ' HB2' ' A' ' 387' ' ' PHE . 42.1 p90 -69.69 -47.29 63.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -165.92 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.23 157.62 9.92 Favored Glycine 0 N--CA 1.479 1.537 0 CA-C-O 119.883 -0.399 . . . . 0.0 112.853 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 384' ' ' VAL . 21.3 mt -123.65 132.85 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.483 0.713 . . . . 0.0 111.149 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.23 130.79 39.51 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.29 73.45 10.45 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.489 0.716 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . 0.292 3.1 mm? 61.07 -91.09 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.446 0 CA-C-O 116.336 -1.792 . . . . 0.0 112.224 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 -12.02 12.22 Favored 'Trans proline' 0 C--N 1.412 3.893 0 CA-C-N 125.38 2.957 . . . . 0.0 111.907 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 36.9 tp 53.87 84.89 0.06 Allowed 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.77 1.628 . . . . 0.0 111.05 -171.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -65.11 143.21 58.04 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.348 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.28 164.01 29.88 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.232 0.333 . . . . 0.0 113.308 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -63.5 103.51 0.53 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.355 0.662 . . . . 0.0 110.546 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 60.59 22.44 12.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.569 1.548 . . . . 0.0 111.713 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.9 m -85.71 52.61 2.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.777 1.275 . . . . 0.0 108.629 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.5 -14.51 45.76 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.143 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 68.9 m-85 -87.57 8.14 26.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.616 1.167 . . . . 0.0 111.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.69 -44.8 0.24 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.719 0.807 . . . . 0.0 109.876 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt 66.07 -78.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.245 1.418 . . . . 0.0 108.781 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.02 132.21 35.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 108.259 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 179.63 -20.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.219 0.608 . . . . 0.0 110.892 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.74 -42.31 91.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.101 0.96 . . . . 0.0 112.562 -163.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -91.46 -22.5 20.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.752 0.421 . . . . 0.0 110.364 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.26 71.74 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.934 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -167.33 -66.12 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.525 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.471 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 68.5 Cg_endo -83.63 -55.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.39 2.757 0 CA-C-N 121.169 1.453 . . . . 0.0 113.776 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.58 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.588 1.555 . . . . 0.0 112.356 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.471 ' HE1' ' HB2' ' B' ' 118' ' ' PRO . 25.0 p90 35.28 -82.96 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 125.952 1.701 . . . . 0.0 114.696 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.3 m -144.86 171.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.861 1.664 . . . . 0.0 108.082 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -148.72 139.72 23.03 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.922 -0.486 . . . . 0.0 111.376 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 69.81 -67.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.11 1.764 . . . . 0.0 113.346 173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -58.73 98.47 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.324 1.05 . . . . 0.0 112.335 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 129' ' ' THR . . . -81.36 97.08 7.54 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.78 -13.54 15.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.684 1.194 . . . . 0.0 113.493 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 71.1 m -60.74 -46.23 91.22 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.293 0.637 . . . . 0.0 111.754 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.654 ' HB1' ' HG ' ' A' ' 144' ' ' LEU . . . -176.55 -41.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' B' ' 125' ' ' ALA . 21.4 m -67.33 115.24 6.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.329 0.651 . . . . 0.0 111.376 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.49 -150.28 0.3 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.873 0.869 . . . . 0.0 110.49 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.483 ' HH2' HD13 ' A' ' 144' ' ' LEU . 8.1 m-90 78.84 160.49 0.19 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.277 1.831 . . . . 0.0 112.854 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.2 p -168.87 90.59 0.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.154 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 9.3 t -70.47 139.65 51.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.855 0.462 . . . . 0.0 110.839 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.77 21.24 0.04 OUTLIER Glycine 0 N--CA 1.472 1.048 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.401 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.53 141.9 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.683 0.793 . . . . 0.0 110.015 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -10.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.241 0.616 . . . . 0.0 111.26 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 6.2 t 48.39 -159.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 126.094 1.757 . . . . 0.0 111.91 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -104.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.639 -0.663 . . . . 0.0 110.055 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.535 HD21 HD13 ' B' ' 142' ' ' LEU . 28.5 t-20 -58.97 -47.87 83.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.154 0.982 . . . . 0.0 110.468 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 60.7 57.55 18.33 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 124.007 0.817 . . . . 0.0 114.1 168.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.99 41.39 14.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.541 1.136 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.535 HD13 HD21 ' B' ' 139' ' ' ASN . 3.9 mm? 60.42 34.37 20.58 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.393 1.077 . . . . 0.0 110.178 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.78 119.57 16.87 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.972 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 23.1 t -67.44 89.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.501 0.721 . . . . 0.0 109.694 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.59 95.31 5.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.781 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.9 112.11 37.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -70.04 87.27 0.56 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.387 1.075 . . . . 0.0 110.15 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 60.21 87.94 0.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.277 1.431 . . . . 0.0 111.547 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -64.97 92.85 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 124.135 0.974 . . . . 0.0 108.514 -177.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.603 HD12 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.685 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.459 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB2' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.448 HD12 ' HD3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 HG23 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.598 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.506 ' HB ' HD21 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 136' ' ' ASP . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 133' ' ' THR . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.627 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.629 HG21 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.556 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.448 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 273' ' ' ASN . 0.9 OUTLIER -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.483 ' HE3' HG23 ' A' ' 137' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB2' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.469 HD23 ' NE2' ' A' ' 317' ' ' GLN . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.469 ' NE2' HD23 ' A' ' 314' ' ' LEU . 8.7 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.436 ' HA ' HD11 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.553 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 119.928 -0.082 . . . . 15.0 111.026 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.516 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.553 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 397' ' ' ASN . 69.7 m-20 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.461 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 407' ' ' ALA . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.448 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 20.2 t-20 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.67 ' HG3' HD12 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.554 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.596 ' HA ' HD12 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.557 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.532 ' HB ' HD21 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.693 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 235' ' ' ILE . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.497 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.46 HG23 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.497 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.637 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.493 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.693 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.693 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.443 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.594 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.455 ' HG2' HG13 ' A' ' 258' ' ' VAL . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 132' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.522 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 285' ' ' ARG . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.557 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.619 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.47 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 319' ' ' ALA . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.575 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.619 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.536 HD13 HD22 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.552 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 112.306 0.484 . . . . 15.0 112.306 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 394' ' ' LEU . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.653 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 408' ' ' VAL . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 290' ' ' ALA . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.404 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 10.5 t-20 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.627 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 . . . . . 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 51' ' ' MET . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.432 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HD13 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.474 ' HE1' HD13 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.722 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.551 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.45 HD12 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG23 ' SD ' ' A' ' 274' ' ' MET . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.62 HD13 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 237' ' ' LEU . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG21 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.659 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.659 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.609 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.565 HG23 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.588 HG22 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.609 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.69 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 236' ' ' ASN . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 210' ' ' GLU . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.755 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 251' ' ' GLU . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 249' ' ' THR . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.754 HG23 HD13 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.484 ' SD ' HG11 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 408' ' ' VAL . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.486 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.434 HG21 HG13 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 307' ' ' ILE . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.615 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.506 HD21 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.506 ' NH1' HD21 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.618 HG22 HG21 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 407' ' ' ALA . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.682 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.365 0.506 . . . . 15.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 401' ' ' VAL . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.682 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 355' ' ' ILE . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.45 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 130' ' ' VAL . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.729 HD12 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.491 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' VAL . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.533 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 4.6 t30 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 11' ' ' LEU . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.603 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.422 HG23 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.528 HD11 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.817 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.509 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.663 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.64 HG11 HG22 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.444 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.523 HG23 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 164' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.632 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.523 ' HD3' HG23 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.455 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.817 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.633 ' HG2' HG13 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.733 ' HE1' ' HA ' ' A' ' 137' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 287' ' ' LYS . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.504 HG11 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' VAL . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.516 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.436 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.462 HD13 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.7 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.462 HE22 HD13 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 341' ' ' ALA . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.418 HD12 HG12 ' A' ' 347' ' ' VAL . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.732 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.5 ttmt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 112.224 0.453 . . . . 15.0 112.224 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG2' HG21 ' A' ' 367' ' ' VAL . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.576 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.416 ' HA ' HD12 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.483 HG22 HD13 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.583 ' HA ' HG13 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 3.6 t-20 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.725 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 9.1 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.6 HH12 HG11 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' HG22 ' A' ' 54' ' ' VAL . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG11 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.433 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 41.3 t30 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.582 HG23 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 123' ' ' ILE . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.569 HG11 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.56 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.457 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 207' ' ' ALA . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.513 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.692 HG22 HG11 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.672 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.51 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.627 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.412 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.423 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG11 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.423 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.52 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.582 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.503 HD21 HD21 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.507 ' HB3' HD22 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.481 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.575 HD11 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.54 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.54 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.423 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.575 ' HE3' HD11 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.408 HH11 ' HB3' ' A' ' 363' ' ' ASP . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 398' ' ' MET . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.631 ' SD ' HD11 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 355' ' ' ILE . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.859 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 21.4 m120 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.859 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.628 ' HA ' HG21 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 53' ' ' ILE . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.628 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG11 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.44 HD12 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.497 HG11 HG13 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.562 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 141' ' ' LEU . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.735 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.626 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.548 HG23 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.486 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.548 ' CE1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.434 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.41 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.557 HG22 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.626 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.489 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.5 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.407 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 158' ' ' VAL . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.78 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.655 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.597 HG21 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.497 HG13 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.585 HG21 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 311' ' ' ILE . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.585 ' HG3' HG21 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 119.068 -0.492 . . . . 15.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.586 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.44 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.484 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.795 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.484 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.562 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.653 HG12 HG12 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG11 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.611 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' NH2' HG11 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 28' ' ' VAL . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.403 HG12 ' HD2' ' A' ' 109' ' ' PHE . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.526 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.413 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.561 HD21 HG21 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 140' ' ' MET . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 237' ' ' LEU . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.59 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.441 ' HB3' HE21 ' A' ' 191' ' ' GLN . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.401 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.599 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.656 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.656 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.435 ' HE2' HG22 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.599 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.55 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 232' ' ' LYS . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 258' ' ' VAL . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.413 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 258' ' ' VAL . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.561 HG21 HD21 ' A' ' 141' ' ' LEU . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.475 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 287' ' ' LYS . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 345' ' ' VAL . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.406 HE22 ' NH2' ' A' ' 344' ' ' ARG . 10.2 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.409 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 336' ' ' LEU . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.707 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 340' ' ' GLN . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 112.097 0.406 . . . . 15.0 112.097 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.57 ' HA ' HG12 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.525 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.448 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.522 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 5' ' ' VAL . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.548 HG21 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG22 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG21 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.729 HG23 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.47 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.495 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.584 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 177' ' ' PHE . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CE1' HG23 ' A' ' 172' ' ' VAL . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.805 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.805 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.565 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.445 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.479 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.606 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.703 HG12 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.432 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 266' ' ' LEU . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.546 ' H ' ' HA ' ' A' ' 254' ' ' LYS . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.493 HD13 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 137' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.419 HD13 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.552 HD12 HG11 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.729 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.461 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.678 HD11 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.435 ' O ' HD13 ' A' ' 311' ' ' ILE . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.433 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 330' ' ' LEU . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.407 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.426 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.529 ' HB1' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 355' ' ' ILE . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 287' ' ' LYS . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.657 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.518 HG12 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.612 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.584 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.658 ' HG2' HG11 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 97' ' ' TYR . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.499 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.629 ' HB3' HG21 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.442 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.612 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.528 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.532 ' HG2' HD11 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG23 HD22 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.708 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 HG22 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.54 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 191' ' ' GLN . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.587 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.9 OUTLIER -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 158' ' ' VAL . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.708 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.66 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.576 HD13 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.513 HD22 HG23 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 405' ' ' GLU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.528 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.527 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.41 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.421 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.641 HH12 HD12 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.641 HD12 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 119.273 -0.394 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.489 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 396' ' ' ASP . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.54 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 407' ' ' ALA . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.505 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.468 ' HA ' HD12 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.418 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.532 HD11 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.676 HG12 HG12 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD13 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 63' ' ' ARG . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG22 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.526 ' HE1' HD13 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 117' ' ' LEU . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.501 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.458 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 141' ' ' LEU . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.673 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.58 HD13 HD11 ' A' ' 202' ' ' ILE . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.587 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.587 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.566 ' HG3' HD21 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.476 ' N ' ' SD ' ' A' ' 194' ' ' MET . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.538 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.525 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.554 ' HA ' HG22 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.572 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.644 HD11 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.501 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 346' ' ' VAL . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 115' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.571 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.4 HE21 ' HA ' ' A' ' 314' ' ' LEU . 8.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.566 ' HB2' HG23 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 355' ' ' ILE . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 398' ' ' MET . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.593 -0.151 . . . . 15.0 110.593 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.41 ' HG3' HG13 ' A' ' 367' ' ' VAL . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 287' ' ' LYS . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.8 t-20 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 20.5 ptm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.918 -0.401 . . . . 15.0 109.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.18 116.34 19.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.188 0.595 . . . . 15.0 110.029 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 17' ' ' ILE . 33.7 m -130.51 150.69 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.238 0.615 . . . . 15.0 109.876 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.1 p -136.35 97.98 3.72 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.464 0.706 . . . . 15.0 109.606 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.39 132.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.589 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -138.37 121.08 16.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.082 0.953 . . . . 15.0 108.434 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 m -71.17 103.56 2.81 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.2 p -101.65 -73.19 0.66 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.947 0.499 . . . . 15.0 112.034 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -91.14 58.41 3.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.061 0.545 . . . . 15.0 110.475 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.98 -97.86 0.39 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.906 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.43 -30.64 60.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.666 0.786 . . . . 15.0 109.494 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 96.13 0.27 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 114.858 -1.064 . . . . 15.0 112.785 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -93.45 131.55 38.55 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.098 0.959 . . . . 15.0 110.526 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 36.5 ttm180 -95.53 89.45 5.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.003 1.321 . . . . 15.0 110.21 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.43 96.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 28.3 m -78.44 89.33 4.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.676 -0.693 . . . . 15.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 3' ' ' VAL . 45.3 mt -78.13 142.37 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.357 -0.838 . . . . 15.0 109.308 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.5 m -122.9 102.32 7.95 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.797 -1.186 . . . . 15.0 107.797 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 70' ' ' LEU . 71.8 mt -82.54 122.92 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.25 149.18 50.74 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.509 0.724 . . . . 15.0 111.942 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.94 67.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.123 0.969 . . . . 15.0 112.754 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.35 -36.38 71.48 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.012 0.525 . . . . 15.0 110.702 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -66.58 -39.82 88.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.429 0.692 . . . . 15.0 110.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' VAL . 46.2 mt -69.02 -50.09 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.165 -0.925 . . . . 15.0 109.53 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.83 -36.86 75.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.12 0.968 . . . . 15.0 111.35 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -70.38 -47.02 62.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.16 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.6 -34.97 76.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG21 ' HD3' ' A' ' 63' ' ' ARG . 96.0 t -67.73 -46.55 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.282 0.633 . . . . 15.0 109.498 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -63.45 -36.07 82.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.035 -0.984 . . . . 15.0 111.026 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.0 m -71.34 -31.53 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.129 0.972 . . . . 15.0 110.436 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.19 -38.16 66.23 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.668 0.387 . . . . 15.0 110.764 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 87.6 mt -65.97 -35.84 81.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.234 0.614 . . . . 15.0 111.899 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.7 p -72.83 -28.09 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.217 0.323 . . . . 15.0 110.513 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -64.0 -45.63 88.11 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.144 0.497 . . . . 15.0 109.89 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.93 -38.06 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.06 -0.973 . . . . 15.0 110.159 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.48 95.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.368 0.667 . . . . 15.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.464 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.5 mttt -71.81 -39.39 69.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.873 0.469 . . . . 15.0 110.816 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.09 -48.54 79.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.83 0.852 . . . . 15.0 111.116 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.43 -0.9 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 123.805 0.842 . . . . 15.0 110.503 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 70.5 13.68 7.39 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.267 1.427 . . . . 15.0 112.595 175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mt -63.56 -23.31 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.655 1.182 . . . . 15.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.35 -36.19 82.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.678 0.791 . . . . 15.0 110.687 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -34.6 43.73 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.878 -0.601 . . . . 15.0 112.151 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.0 -0.28 48.1 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.258 0.623 . . . . 15.0 111.448 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -68.85 117.05 10.04 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.72 -15.64 53.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 15.0 111.474 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.11 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.516 0.51 . . . . 15.0 114.013 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -93.97 -20.65 19.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.378 0.671 . . . . 15.0 109.822 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.9 t -98.35 113.43 64.08 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 108.52 -0.918 . . . . 15.0 108.52 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.3 Cg_exo -56.92 148.24 68.8 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.112 2.541 . . . . 15.0 113.068 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.8 tpt -75.19 -28.54 60.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 15.0 111.88 -170.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -62.73 -33.78 75.82 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.144 0.578 . . . . 15.0 111.3 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.603 HD12 ' HD2' ' A' ' 50' ' ' PRO . 26.6 mt -67.46 -49.75 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.14 0.976 . . . . 15.0 110.722 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 23.8 m -71.2 -22.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 111.462 0.171 . . . . 15.0 111.462 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -67.04 -42.86 84.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 15.0 111.986 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -85.53 -43.96 13.08 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.747 -0.661 . . . . 15.0 111.433 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.66 -58.83 3.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.97 0.508 . . . . 15.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 58.8 m-85 -82.88 -31.76 27.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.31 0.644 . . . . 15.0 110.187 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.91 -1.27 87.16 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.323 -0.853 . . . . 15.0 113.645 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.87 -34.24 69.54 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.916 0.886 . . . . 15.0 111.657 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -68.81 -42.1 77.74 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.868 0.867 . . . . 15.0 111.073 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 66' ' ' VAL . 20.0 t -80.62 -15.62 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.85 0.86 . . . . 15.0 111.709 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.685 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -46.67 -46.66 20.14 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.4 1.08 . . . . 15.0 112.066 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -57.0 -54.17 49.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.911 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.9 -32.55 73.88 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.256 -0.884 . . . . 15.0 111.38 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 28' ' ' VAL . 83.8 t -70.92 -38.05 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.051 -0.522 . . . . 15.0 110.454 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 95.5 mt -58.9 -51.52 69.66 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.729 0.412 . . . . 15.0 110.38 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -36.4 92.68 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.845 0.716 . . . . 15.0 113.321 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.01 -48.94 78.08 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.973 0.909 . . . . 15.0 111.021 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.6 mt -63.55 -38.53 91.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.013 -0.994 . . . . 15.0 110.895 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 59.1 mtm -60.97 -38.15 84.95 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.063 0.545 . . . . 15.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -71.73 -41.4 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.231 -0.895 . . . . 15.0 111.054 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.84 -22.33 43.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.344 0.658 . . . . 15.0 111.951 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -85.99 -24.87 26.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.5 0.72 . . . . 15.0 110.099 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.52 -58.04 7.5 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.559 0.537 . . . . 15.0 110.289 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -63.61 -33.79 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.504 -0.771 . . . . 15.0 110.806 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.18 -45.73 90.39 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.317 0.647 . . . . 15.0 110.831 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.05 -57.24 9.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.566 0.747 . . . . 15.0 111.631 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 86' ' ' PRO . 32.9 pt -56.17 -30.03 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 113.36 0.874 . . . . 15.0 113.36 -172.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.4 mt -71.97 -55.86 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.493 0.717 . . . . 15.0 110.464 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.459 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 17.0 ptpt -71.64 -31.48 66.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.583 0.353 . . . . 15.0 111.467 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.82 -8.33 59.59 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.513 0.725 . . . . 15.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 65.74 25.59 11.41 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.568 1.147 . . . . 15.0 111.801 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 143.63 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.509 0.724 . . . . 15.0 109.727 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 57.6 t30 -102.51 89.86 1.93 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 79' ' ' ILE . 88.7 Cg_endo -74.37 167.4 27.24 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.129 2.553 . . . . 15.0 113.548 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.12 169.58 15.99 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.8 1.24 . . . . 15.0 109.178 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.805 ' HA2' ' HB2' ' A' ' 305' ' ' ALA . . . 74.48 -179.98 42.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.405 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.66 114.79 56.03 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.07 99.22 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.46 2.107 . . . . 15.0 110.815 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 19.1 m -65.12 85.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.765 0.826 . . . . 15.0 109.918 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -72.14 91.18 1.25 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.81 98.95 0.4 Allowed Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.57 115.19 2.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.065 2.51 . . . . 15.0 111.384 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.94 169.17 46.12 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.571 -0.612 . . . . 15.0 111.571 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.8 117.23 8.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.074 0.55 . . . . 15.0 111.398 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -76.46 99.46 4.91 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.338 0.59 . . . . 15.0 109.941 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.0 mttt -82.73 116.19 21.98 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.81 -1.182 . . . . 15.0 107.81 171.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.91 100.54 0.31 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.582 0.753 . . . . 15.0 110.264 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.6 -18.69 9.25 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.667 -0.697 . . . . 15.0 112.901 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.9 mt-10 -109.71 178.88 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.884 0.874 . . . . 15.0 110.88 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.12 140.76 37.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.62 0.768 . . . . 15.0 111.094 -172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -91.67 95.82 10.11 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.531 0.732 . . . . 15.0 109.838 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.2 m -86.41 137.91 32.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.637 0.775 . . . . 15.0 109.626 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.4 p90 -157.94 144.32 17.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.645 0.778 . . . . 15.0 109.468 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 66.0 m -98.84 109.18 21.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.072 0.949 . . . . 15.0 110.931 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.34 95.48 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 26.4 mt-10 -90.34 97.41 11.17 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -123.74 148.84 46.24 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.031 -0.729 . . . . 15.0 109.031 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -77.18 174.13 11.07 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.702 0.626 . . . . 15.0 109.929 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.75 154.46 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 21.7 m-85 -85.19 111.72 38.39 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.86 114.9 4.14 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.882 1.722 . . . . 15.0 108.966 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.33 141.93 58.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.803 0.441 . . . . 15.0 109.899 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 350' ' ' LEU . 45.5 t -77.53 109.0 11.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.761 -164.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -69.63 81.19 0.42 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.066 0.946 . . . . 15.0 109.091 171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.96 111.62 3.9 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -86.69 -165.47 1.29 Allowed 'General case' 0 C--O 1.245 0.862 0 C-N-CA 124.241 1.016 . . . . 15.0 109.801 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.49 115.24 7.44 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.137 0.273 . . . . 15.0 112.783 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.448 HD12 ' HD3' ' A' ' 414' ' ' LYS . 79.0 mt -82.99 -0.11 47.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.463 0.705 . . . . 15.0 110.616 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -67.97 -27.53 66.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.966 1.306 . . . . 15.0 110.137 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.925 0.89 . . . . 15.0 111.843 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 HG23 ' HA3' ' A' ' 293' ' ' GLY . 45.4 mt -71.5 135.63 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.43 1.092 . . . . 15.0 109.575 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.8 119.08 22.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.38 151.77 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.646 1.179 . . . . 15.0 108.796 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.83 134.14 55.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -118.53 87.52 31.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.518 1.127 . . . . 15.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.598 ' HB2' HG21 ' A' ' 422' ' ' THR . 93.6 Cg_endo -87.4 106.26 0.62 Allowed 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.115 1.877 . . . . 15.0 112.496 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.17 93.32 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.488 1.115 . . . . 15.0 109.84 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.506 ' HB ' HD21 ' A' ' 278' ' ' LEU . 58.7 t -78.18 107.46 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.599 0.76 . . . . 15.0 109.879 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.62 144.13 26.25 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.331 0.653 . . . . 15.0 109.929 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -124.81 139.39 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 107.952 -1.129 . . . . 15.0 107.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 136' ' ' ASP . 67.7 p -127.32 -177.72 4.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.58 0.752 . . . . 15.0 109.699 172.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 4.1 m-20 -63.16 -35.05 79.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.167 0.587 . . . . 15.0 111.409 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.0 74.02 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.888 0.475 . . . . 15.0 111.049 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 133' ' ' THR . 68.8 m-20 -75.03 -47.04 30.97 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.877 -0.602 . . . . 15.0 111.132 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.537 HG23 ' HE3' ' A' ' 274' ' ' MET . 14.1 p -66.72 -41.78 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.261 0.351 . . . . 15.0 110.077 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.96 -37.98 79.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.376 0.67 . . . . 15.0 110.873 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.84 -38.06 92.72 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.767 0.667 . . . . 15.0 112.539 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.5 tpp -69.54 -44.46 70.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.528 0.331 . . . . 15.0 110.516 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 144' ' ' LEU . 83.0 mt -59.41 -36.83 76.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.661 0.785 . . . . 15.0 110.632 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.89 -46.21 90.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.562 1.145 . . . . 15.0 110.305 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 29.0 m -58.57 -42.96 89.18 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.687 0.617 . . . . 15.0 111.357 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.526 HD13 ' HH2' ' B' ' 131' ' ' TRP . 41.3 mt -66.06 -37.21 85.26 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.079 0.952 . . . . 15.0 110.88 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 64.7 mtp85 -69.73 -27.1 64.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.817 -1.083 . . . . 15.0 110.461 175.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.556 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.8 mttt -79.75 -28.09 40.46 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.386 0.674 . . . . 15.0 111.717 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 143' ' ' THR . 94.0 mt-30 -69.2 -41.48 77.05 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 171.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -103.91 29.93 5.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.114 0.966 . . . . 15.0 110.786 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.86 134.71 36.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.106 0.562 . . . . 15.0 110.867 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.3 m -85.55 106.77 17.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -78.15 140.92 39.0 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.125 0.57 . . . . 15.0 110.156 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -152.28 151.63 31.16 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.873 -1.058 . . . . 15.0 108.838 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.53 149.69 38.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.33 1.062 . . . . 15.0 112.594 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.5 pttt -138.48 -177.74 4.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.763 -2.017 . . . . 15.0 107.601 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -147.01 132.58 18.75 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.012 0.434 . . . . 15.0 110.227 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.36 -129.03 7.4 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 114.773 -1.103 . . . . 15.0 111.375 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.99 115.97 10.73 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.439 0.696 . . . . 15.0 112.015 -171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 237' ' ' LEU . 25.1 t -70.47 145.51 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.918 0.887 . . . . 15.0 110.288 170.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.98 162.33 19.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.835 1.254 . . . . 15.0 108.594 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.42 7.42 9.78 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.84 12.91 5.8 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.324 0.65 . . . . 15.0 110.97 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.14 -176.39 6.31 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.891 0.853 . . . . 15.0 111.397 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.91 50.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 160.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 240' ' ' VAL . 33.2 m -135.45 -178.37 2.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.003 0.43 . . . . 15.0 111.172 -168.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.5 m -120.55 109.06 14.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.942 -1.026 . . . . 15.0 108.485 167.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 34.8 pt -107.93 -174.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.216 0.531 . . . . 15.0 111.828 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 39.4 t0 -156.62 89.88 1.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 106.72 -1.585 . . . . 15.0 106.72 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 36.8 p90 -100.67 153.75 19.17 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.408 0.521 . . . . 15.0 112.408 -168.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.9 m -100.63 105.95 17.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.174 0.989 . . . . 15.0 109.274 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -70.09 111.81 4.02 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.726 0.641 . . . . 15.0 112.167 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 19.6 m -135.69 144.98 46.26 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.196 0.598 . . . . 15.0 110.997 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.05 125.15 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.279 . . . . 15.0 108.069 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 64.62 21.49 12.43 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.825 0.85 . . . . 15.0 111.279 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.79 7.66 88.15 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.277 -0.419 . . . . 15.0 113.173 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -102.54 105.08 15.55 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.893 -0.78 . . . . 15.0 108.893 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.9 114.49 3.69 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.153 0.501 . . . . 15.0 110.31 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -88.5 151.46 22.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -72.25 142.78 48.93 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.431 0.693 . . . . 15.0 110.962 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.52 -21.31 9.08 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 -166.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.8 71.61 1.97 Allowed Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.644 0.64 . . . . 15.0 112.131 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -156.2 -179.74 8.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.639 1.576 . . . . 15.0 107.214 171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -166.19 120.74 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 162.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.0 p -102.35 131.6 48.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.975 1.31 . . . . 15.0 109.683 -173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.18 25.22 13.6 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.751 1.262 . . . . 15.0 109.665 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -71.77 115.04 10.5 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.809 -1.087 . . . . 15.0 110.223 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 6.3 p -80.57 110.89 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.538 -0.755 . . . . 15.0 109.517 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 46.4 tp -108.08 133.63 52.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.402 -0.817 . . . . 15.0 110.214 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -113.47 148.12 36.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.814 0.846 . . . . 15.0 109.942 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.627 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 38.2 mtt -96.08 163.35 13.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.957 0.903 . . . . 15.0 110.709 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.37 -48.28 3.89 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.736 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 7.9 pt20 -63.22 120.83 12.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.353 0.661 . . . . 15.0 111.035 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.72 33.02 3.81 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.602 -0.726 . . . . 15.0 114.014 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -81.99 -33.43 30.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.111 0.564 . . . . 15.0 110.177 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 86.0 mmm -81.57 -170.91 3.03 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.368 1.067 . . . . 15.0 110.708 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 61.4 mt -68.48 131.92 91.45 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.185 -0.672 . . . . 15.0 109.185 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.63 117.71 4.54 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.888 2.392 . . . . 15.0 111.546 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.81 -14.33 61.75 Favored Glycine 0 C--O 1.218 -0.893 0 CA-C-N 115.922 -0.581 . . . . 15.0 112.926 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 86.9 t80 -61.95 -34.84 76.86 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 117.98 0.89 . . . . 15.0 111.755 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.4 -23.63 63.74 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.435 0.694 . . . . 15.0 111.955 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.3 t70 -50.96 -50.93 57.03 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.736 1.214 . . . . 15.0 112.591 -171.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.98 -40.97 91.97 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 124.249 0.968 . . . . 15.0 113.71 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.1 mp -59.15 -46.03 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 123.64 0.776 . . . . 15.0 110.741 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 52.6 mtpt -68.12 -2.04 7.14 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.147 1.536 . . . . 15.0 115.147 -164.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -144.15 36.36 1.5 Allowed Glycine 0 C--N 1.342 0.895 0 CA-C-N 118.098 0.408 . . . . 15.0 112.121 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -138.98 -168.21 2.38 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.725 0.81 . . . . 15.0 110.085 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.01 168.26 9.49 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.089 0.956 . . . . 15.0 109.96 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -79.15 7.88 6.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.602 0.761 . . . . 15.0 111.95 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.79 49.34 0.93 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.039 -0.825 . . . . 15.0 111.039 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.35 154.09 35.55 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.948 0.88 . . . . 15.0 112.539 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -144.3 125.38 14.5 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.515 -1.675 . . . . 15.0 106.923 171.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -163.04 155.73 18.86 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 123.722 0.639 . . . . 15.0 110.445 -171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 45.2 m -115.02 117.99 32.15 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.887 0.875 . . . . 15.0 108.763 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.629 HG21 ' HA3' ' A' ' 201' ' ' GLY . 41.0 pt -102.42 150.66 6.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.315 0.579 . . . . 15.0 111.273 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.27 96.4 7.72 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.357 -1.292 . . . . 15.0 108.129 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.72 138.42 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.671 0.748 . . . . 15.0 110.843 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 72.5 m -83.7 132.57 34.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.891 -1.504 . . . . 15.0 109.957 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -53.29 163.32 0.97 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 124.55 1.14 . . . . 15.0 112.166 172.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.18 152.77 24.3 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.632 1.555 . . . . 15.0 109.509 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.3 mt-10 -74.46 -4.75 38.53 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.814 0.34 . . . . 15.0 110.698 169.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.83 -5.08 56.07 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.312 1.045 . . . . 15.0 111.42 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -60.79 141.85 56.6 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.956 0.502 . . . . 15.0 110.063 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.463 ' HB2' HD13 ' B' ' 10' ' ' LEU . 30.6 m170 -83.52 31.69 0.46 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.192 0.812 . . . . 15.0 113.192 -170.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -143.31 116.91 9.18 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 107.993 -1.114 . . . . 15.0 107.993 175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 44.3 tt0 -61.19 -43.63 98.57 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.942 0.897 . . . . 15.0 112.108 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.4 -11.0 60.32 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.387 -0.824 . . . . 15.0 111.784 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 82.9 mt -116.97 -11.13 10.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.439 0.696 . . . . 15.0 112.214 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.5 ptpt -77.27 122.07 24.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.429 1.013 . . . . 15.0 108.801 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.64 31.13 73.08 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.817 -0.629 . . . . 15.0 112.794 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -104.06 133.7 48.56 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.1 -1.074 . . . . 15.0 108.1 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 116.25 9.99 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.219 0.608 . . . . 15.0 110.594 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.19 166.85 11.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 15.0 111.441 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.4 mmpt? -109.66 137.51 47.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.127 0.971 . . . . 15.0 109.321 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.439 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 94.5 m-85 -139.98 109.2 6.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.65 80.92 5.0 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 121.596 0.713 . . . . 15.0 110.218 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.43 104.98 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.908 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -89.86 78.57 6.8 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.291 -0.633 . . . . 15.0 109.291 173.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 158' ' ' VAL . 25.0 tp -69.32 93.33 0.63 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.907 1.283 . . . . 15.0 110.393 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -94.47 -27.54 15.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.439 0.696 . . . . 15.0 112.546 -171.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.465 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.4 mmmt -145.42 158.53 43.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.423 0.689 . . . . 15.0 110.66 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 154' ' ' LYS . 7.0 p -132.61 140.41 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.485 1.114 . . . . 15.0 108.489 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -125.8 131.04 52.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.9 0.88 . . . . 15.0 109.738 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.94 150.52 30.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 15.0 110.257 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.556 HH11 ' HB3' ' A' ' 146' ' ' LYS . 20.2 ptp180 -77.47 142.06 39.35 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.33 -0.619 . . . . 15.0 109.33 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -102.37 110.65 22.67 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.448 ' HB3' HH21 ' A' ' 145' ' ' ARG . 96.0 mt -55.1 105.8 0.58 Allowed Pre-proline 0 C--N 1.354 0.791 0 N-CA-C 107.643 -1.243 . . . . 15.0 107.643 168.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 37.6 Cg_endo -59.84 170.48 3.6 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 123.713 2.942 . . . . 15.0 112.82 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.5 129.49 40.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.531 -0.759 . . . . 15.0 110.123 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.46 24.9 0.93 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.329 0.652 . . . . 15.0 110.106 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 m -53.99 133.79 43.38 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.97 1.308 . . . . 15.0 110.284 171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.71 -35.79 61.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.359 1.064 . . . . 15.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 50.4 mt-10 -69.6 -32.45 71.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.442 0.697 . . . . 15.0 111.967 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.18 -41.62 57.58 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.631 HG23 HD13 ' A' ' 266' ' ' LEU . 60.9 mt -52.51 -53.97 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.235 1.014 . . . . 15.0 109.811 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 20.1 ptmt -76.04 -6.16 49.78 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -65.33 -33.33 75.72 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.37 0.605 . . . . 15.0 109.865 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.07 -25.19 64.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.52 -1.218 . . . . 15.0 111.151 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.7 14.28 8.85 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-N 116.142 -0.481 . . . . 15.0 112.225 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.63 98.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.988 -1.116 . . . . 15.0 107.988 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.68 96.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.399 -0.819 . . . . 15.0 110.845 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -87.61 68.62 9.59 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 168.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.0 50.44 3.03 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.011 0.765 . . . . 15.0 115.011 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 48.4 m -107.47 -173.51 2.3 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 170.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.19 -67.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.429 0.559 . . . . 15.0 110.218 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 0.0 OUTLIER -58.64 -26.54 63.85 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.253 0.621 . . . . 15.0 110.336 169.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.09 91.44 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.266 0.979 . . . . 15.0 113.412 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.631 HD13 HG23 ' A' ' 253' ' ' ILE . 53.1 tp -67.89 -50.03 58.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.38 -0.97 . . . . 15.0 108.38 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 34.1 mtp85 -56.81 -47.69 79.67 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.281 -1.327 . . . . 15.0 110.983 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.29 -47.11 62.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.389 0.675 . . . . 15.0 111.869 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -65.0 -48.98 72.02 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.602 0.564 . . . . 15.0 110.752 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' MET . 93.3 t -64.61 -35.67 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.718 -0.673 . . . . 15.0 110.406 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -57.2 -55.91 28.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.675 0.79 . . . . 15.0 112.367 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -67.14 -25.14 66.03 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.713 0.405 . . . . 15.0 111.616 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 273' ' ' ASN . 0.9 OUTLIER -75.78 -36.94 59.64 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.774 0.43 . . . . 15.0 111.066 171.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.537 ' HE3' HG23 ' A' ' 137' ' ' VAL . 49.8 mtt -58.12 -49.73 75.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.875 0.87 . . . . 15.0 109.637 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.39 -31.14 71.72 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.496 1.122 . . . . 15.0 111.96 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 377' ' ' ALA . 11.9 tpp180 -75.07 -40.16 60.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.676 0.391 . . . . 15.0 110.703 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.93 -39.62 72.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.215 -0.448 . . . . 15.0 109.839 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 130' ' ' VAL . 64.8 tp -66.96 -26.33 66.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.301 1.04 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -59.98 -54.43 46.13 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-O 121.809 0.814 . . . . 15.0 109.676 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 t -70.78 -32.93 70.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.674 -1.148 . . . . 15.0 110.733 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.58 74.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.382 0.673 . . . . 15.0 110.764 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 10.0 tp -71.96 -34.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 12.9 tpt180 -61.45 -47.28 86.41 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.375 173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.65 -29.72 69.09 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.331 0.653 . . . . 15.0 111.181 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -65.19 -59.66 3.85 Favored 'General case' 0 C--O 1.25 1.128 0 C-N-CA 123.531 0.732 . . . . 15.0 109.962 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.12 -40.0 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.744 -1.116 . . . . 15.0 110.191 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.6 tttt -67.06 -43.96 81.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.67 0.388 . . . . 15.0 111.205 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.3 p -66.31 -40.69 90.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.147 0.179 . . . . 15.0 110.943 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.01 -31.06 65.85 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.587 0.554 . . . . 15.0 111.318 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -61.51 -48.75 79.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.167 0.587 . . . . 15.0 111.217 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 287' ' ' LYS . 27.3 mm -68.92 -40.23 80.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.119 0.968 . . . . 15.0 110.83 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.56 -52.98 62.74 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.124 -0.944 . . . . 15.0 109.7 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.29 -31.48 74.49 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 114.299 -1.318 . . . . 15.0 113.525 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 350' ' ' LEU . 0.5 OUTLIER -63.08 -51.22 67.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.831 0.852 . . . . 15.0 109.753 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.44 -31.96 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 15.0 109.79 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -62.33 -25.55 67.95 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.921 0.391 . . . . 15.0 110.466 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.43 -22.33 23.78 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.88 0.872 . . . . 15.0 112.52 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.45 139.49 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.388 0.54 . . . . 15.0 111.931 -165.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -130.14 138.89 50.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.606 0.763 . . . . 15.0 109.649 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tt -155.21 130.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.632 0.773 . . . . 15.0 109.529 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 14.8 m-20 -87.15 110.97 20.49 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.525 -0.917 . . . . 15.0 108.525 174.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 345' ' ' VAL . 23.9 t -81.56 145.17 54.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.831 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.0 147.41 26.47 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.805 2.337 . . . . 15.0 111.712 165.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.62 -33.44 60.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.025 1.33 . . . . 15.0 112.803 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.805 ' HB2' ' HA2' ' A' ' 88' ' ' GLY . . . -49.19 -62.27 1.63 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 15.0 112.673 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -41.89 88.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.215 0.606 . . . . 15.0 111.809 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 311' ' ' ILE . 51.7 mt -61.1 -49.13 85.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.589 0.556 . . . . 15.0 109.785 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.13 -25.1 62.43 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.559 0.743 . . . . 15.0 112.492 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.0 m -63.43 -51.46 65.62 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -62.67 -37.17 85.37 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.366 -0.834 . . . . 15.0 111.547 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 35.0 mm -55.83 -54.11 30.16 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.8 -44.66 90.82 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.047 0.842 . . . . 15.0 112.048 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -57.28 -46.04 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.059 0.543 . . . . 15.0 110.766 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.469 HD23 ' NE2' ' A' ' 317' ' ' GLN . 43.8 mt -72.49 -28.07 62.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.097 0.959 . . . . 15.0 111.464 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 58.1 mtm180 -68.87 -43.99 74.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.133 0.573 . . . . 15.0 109.501 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -69.66 -40.93 76.14 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.731 0.644 . . . . 15.0 110.488 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.469 ' NE2' HD23 ' A' ' 314' ' ' LEU . 8.7 tt0 -61.84 -38.14 87.11 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.348 1.059 . . . . 15.0 110.864 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -72.39 -58.68 3.2 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.562 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.92 67.37 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 15.0 112.256 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -52.5 -45.44 66.22 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.799 1.239 . . . . 15.0 111.148 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -94.33 -28.84 15.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.157 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -85.21 68.83 10.65 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 95.23 -50.9 1.88 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 114.543 -1.208 . . . . 15.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 80.68 25.47 56.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.128 -0.389 . . . . 15.0 112.128 -171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -82.09 161.04 23.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.598 0.759 . . . . 15.0 110.597 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -51.86 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.559 1.318 . . . . 15.0 114.559 -172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 59.13 27.89 17.01 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.757 1.223 . . . . 15.0 113.41 164.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -61.7 -22.52 65.41 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.029 0.932 . . . . 15.0 111.43 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -52.0 25.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.552 1.541 . . . . 15.0 112.365 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.52 -17.46 63.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.416 -0.811 . . . . 15.0 112.572 -168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -95.69 -15.07 22.92 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.1 123.06 76.41 Favored Pre-proline 0 N--CA 1.481 1.118 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -60.43 153.98 56.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.392 2.728 . . . . 15.0 113.47 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -56.36 -45.34 80.5 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.458 0.703 . . . . 15.0 109.568 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.83 -14.72 35.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.899 -1.046 . . . . 15.0 113.079 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.82 -33.17 75.03 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -125.75 -11.32 6.67 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.924 -0.56 . . . . 15.0 112.453 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.436 ' HA ' HD11 ' A' ' 311' ' ' ILE . 42.6 tt0 -46.44 -47.91 18.97 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.935 1.294 . . . . 15.0 114.252 -164.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.28 -54.62 43.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.952 0.783 . . . . 15.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.97 -23.56 48.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.958 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -73.98 -47.78 34.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.658 0.783 . . . . 15.0 109.603 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.8 tttt -54.26 -46.3 72.62 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 114.726 -1.125 . . . . 15.0 109.469 170.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.22 -47.82 77.65 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.586 1.154 . . . . 15.0 110.399 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 344' ' ' ARG . 39.0 mtt85 -54.84 -50.89 67.52 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.368 1.067 . . . . 15.0 111.598 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.676 HG11 HG11 ' A' ' 302' ' ' VAL . 38.8 t -66.78 -35.61 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.343 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 37.1 t -58.72 -46.45 90.58 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.519 HG11 ' HG ' ' B' ' 111' ' ' LEU . 16.9 t -58.62 -43.13 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 123.852 0.72 . . . . 15.0 110.888 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -33.34 83.64 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.466 -0.788 . . . . 15.0 113.742 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.33 -38.11 35.98 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.648 0.779 . . . . 15.0 110.634 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.74 HD13 HD22 ' A' ' 294' ' ' LEU . 92.6 mt -61.24 -56.28 22.45 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.005 0.922 . . . . 15.0 109.941 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.8 -33.2 73.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.042 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.15 96.69 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 112.071 -0.412 . . . . 15.0 112.071 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.93 -34.57 69.15 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.594 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.7 t -61.22 -44.39 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.554 0.342 . . . . 15.0 110.253 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.7 mp -57.15 -50.48 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.341 0.656 . . . . 15.0 109.969 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.09 -62.28 1.44 Allowed 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 111.612 0.226 . . . . 15.0 111.612 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 88.1 m -50.45 -53.63 28.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.91 1.284 . . . . 15.0 112.276 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.66 10.12 19.17 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.897 0.479 . . . . 15.0 110.833 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 43.72 36.15 1.21 Allowed 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.485 1.514 . . . . 15.0 112.37 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 8.8 tt -77.78 113.38 15.59 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 113.592 -1.64 . . . . 15.0 110.33 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 162.77 13.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.322 1.049 . . . . 15.0 110.815 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.21 113.02 6.18 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.689 -0.687 . . . . 15.0 109.525 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -84.66 131.65 34.56 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.66 0.384 . . . . 15.0 110.979 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.48 -25.0 63.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.471 0.709 . . . . 15.0 112.593 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.43 -20.73 50.41 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.251 0.344 . . . . 15.0 110.669 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -81.57 -36.45 29.04 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.229 -0.656 . . . . 15.0 109.229 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.553 HG13 ' HG3' ' A' ' 398' ' ' MET . 70.5 t -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.798 0.839 . . . . 15.0 109.74 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -53.5 -60.74 2.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.942 0.897 . . . . 15.0 110.491 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.56 93.24 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 124.146 0.903 . . . . 15.0 113.342 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.31 -55.18 23.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.573 0.749 . . . . 15.0 109.84 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 73.6 mt -57.02 -48.68 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.66 0.784 . . . . 15.0 111.159 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.87 -43.76 78.67 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.606 0.566 . . . . 15.0 111.199 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -68.21 -33.87 75.22 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 111.868 0.322 . . . . 15.0 111.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.442 ' HG2' ' HE1' ' B' ' 94' ' ' PHE . 56.5 ttp -70.84 -44.06 67.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.385 0.612 . . . . 15.0 109.953 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -84.3 -6.53 59.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.172 0.989 . . . . 15.0 111.945 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -59.64 -20.33 55.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.112 0.965 . . . . 15.0 112.346 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.442 ' HB2' ' HG2' ' A' ' 276' ' ' ARG . . . -63.32 -33.24 75.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.3 0.64 . . . . 15.0 110.932 171.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.7 156.98 18.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.523 0.729 . . . . 15.0 110.028 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -31.96 16.8 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.894 0.878 . . . . 15.0 110.052 175.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -150.56 87.5 4.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.49 49.63 1.85 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.821 3.014 . . . . 15.0 114.003 -172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -55.48 -38.16 68.75 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.853 0.861 . . . . 15.0 111.452 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 384' ' ' VAL . 6.1 pt-20 -49.41 -49.44 44.84 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.624 1.17 . . . . 15.0 111.832 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 383' ' ' GLU . 91.5 t -71.89 -52.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 C-N-CA 123.98 0.912 . . . . 15.0 109.91 -172.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.76 -45.28 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.914 0.886 . . . . 15.0 110.921 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.42 -35.6 79.58 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.161 -0.472 . . . . 15.0 111.024 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' B' ' 97' ' ' ILE . 13.9 t80 -64.17 -38.26 90.42 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 119.469 -0.301 . . . . 15.0 110.403 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -58.58 -58.46 8.44 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 120.863 0.363 . . . . 15.0 110.972 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 22.1 p -66.17 -14.6 62.13 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 113.067 0.766 . . . . 15.0 113.067 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.24 4.19 13.5 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.608 0.763 . . . . 15.0 111.442 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -151.12 90.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.558 -1.275 . . . . 15.0 107.558 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -74.71 -16.74 60.74 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.708 -1.133 . . . . 15.0 111.026 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.39 -27.68 66.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.306 0.642 . . . . 15.0 110.625 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tt -92.3 -34.21 14.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 15.0 109.089 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 10.8 tpt -66.29 -36.21 82.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -32.22 62.06 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.516 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 65.8 t30 -69.58 -26.58 64.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.669 0.788 . . . . 15.0 110.894 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.553 ' HG3' HG13 ' A' ' 367' ' ' VAL . 24.5 tpp -64.99 -37.76 88.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.967 0.907 . . . . 15.0 109.529 170.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -76.33 -30.45 57.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.571 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 397' ' ' ASN . 69.7 m-20 -67.81 -43.4 79.72 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.273 0.629 . . . . 15.0 111.244 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 7.7 p -69.05 -39.68 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.995 -0.372 . . . . 15.0 109.995 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.82 79.23 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.445 0.698 . . . . 15.0 111.204 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 56.5 tp -63.28 -45.66 90.4 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.98 1.312 . . . . 15.0 109.674 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.6 tt0 -68.27 -36.16 78.98 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.978 -1.01 . . . . 15.0 111.528 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 56.6 mm-40 -66.89 -43.19 84.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.511 0.324 . . . . 15.0 110.946 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.461 HE21 ' HG ' ' A' ' 360' ' ' LEU . 27.1 tt0 -67.14 -36.93 82.92 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.568 -0.742 . . . . 15.0 110.418 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.1 -50.59 70.62 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.995 0.81 . . . . 15.0 110.931 173.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 404' ' ' GLU . 74.0 t -56.71 -49.7 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.229 0.956 . . . . 15.0 110.805 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.8 mt-10 -61.58 -34.53 75.77 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.42 64.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.207 0.603 . . . . 15.0 111.342 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 407' ' ' ALA . 78.4 t -84.97 -35.5 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.899 0.879 . . . . 15.0 109.282 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.8 mt -63.25 -34.36 77.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.456 1.103 . . . . 15.0 110.385 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -51.38 -35.85 40.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.214 1.006 . . . . 15.0 112.422 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.448 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.5 mtpp -96.37 -22.79 16.96 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.835 0.854 . . . . 15.0 111.859 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -76.52 155.53 33.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.816 0.846 . . . . 15.0 112.374 -174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.53 77.37 4.05 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.932 0.893 . . . . 15.0 109.664 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -93.82 95.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -75.73 159.31 31.22 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.705 -0.68 . . . . 15.0 109.617 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -138.95 143.38 38.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -150.16 143.94 25.35 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.287 0.367 . . . . 15.0 110.108 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.15 110.85 19.29 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 128' ' ' PRO . 14.7 t -114.78 171.29 7.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 15.0 110.716 -169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -73.51 167.84 20.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.716 0.807 . . . . 15.0 111.503 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -61.09 -52.23 65.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.071 0.948 . . . . 15.0 112.664 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 20.2 t-20 -79.51 6.64 9.87 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 112.401 0.519 . . . . 15.0 112.401 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.67 ' HG3' HD12 ' A' ' 427' ' ' LEU . 9.6 tp10 -45.42 -64.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.475 1.11 . . . . 15.0 112.142 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.67 HD12 ' HG3' ' A' ' 426' ' ' GLU . 11.2 mp -83.08 -10.31 58.78 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 122.94 0.496 . . . . 15.0 111.886 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' B' ' 126' ' ' ALA . 5.7 mmt -89.67 37.81 0.89 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.603 0.761 . . . . 15.0 109.781 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -42.32 -31.56 0.42 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 126.884 2.074 . . . . 15.0 114.939 -170.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . 0.493 HE22 ' HA ' ' B' ' 122' ' ' THR . 77.8 mt-30 -104.86 117.48 34.15 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.979 0.512 . . . . 15.0 111.551 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -117.51 -19.1 9.59 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.93 0.892 . . . . 15.0 109.569 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 C-N-CA 123.492 0.717 . . . . 15.0 109.806 -177.475 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.555 ' HG3' ' HB2' ' B' ' 9' ' ' ALA . 36.7 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 22.4 tptm -156.87 92.52 1.28 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -162.01 165.14 27.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.237 1.015 . . . . 0.0 109.403 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -61.34 -43.83 98.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.078 0.951 . . . . 0.0 112.442 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 29.8 m -71.07 77.05 0.67 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.978 0.911 . . . . 0.0 111.806 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.583 HG23 HD11 ' B' ' 10' ' ' LEU . 2.6 mp 32.79 -95.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 127.429 2.292 . . . . 0.0 113.101 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.15 31.32 13.72 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.04 0.936 . . . . 0.0 113.253 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp 49.93 17.12 0.26 Allowed 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.252 1.821 . . . . 0.0 114.489 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.555 ' HB2' ' HG3' ' B' ' 1' ' ' MET . . . -76.42 -32.44 58.48 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.792 0.837 . . . . 0.0 110.831 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.583 HD11 HG23 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -86.68 -11.53 50.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.84 0.856 . . . . 0.0 112.409 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -167.58 108.19 0.6 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.906 0.882 . . . . 0.0 108.993 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.58 112.16 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.85 2.367 . . . . 0.0 111.075 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.49 -40.07 85.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 110.407 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.98 117.29 24.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 169.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.24 0.26 45.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.43 0.692 . . . . 0.0 111.944 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -114.18 87.67 13.69 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.98 -58.39 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.644 2.229 . . . . 0.0 111.573 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.608 HG12 ' H ' ' B' ' 20' ' ' LYS . 85.0 t 65.01 -67.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.444 1.498 . . . . 0.0 111.292 -172.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.3 p 57.78 16.65 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.036 1.734 . . . . 0.0 112.927 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.608 ' H ' HG12 ' B' ' 18' ' ' VAL . 62.8 mttm 58.44 23.46 10.67 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.143 1.377 . . . . 0.0 112.365 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.5 103.52 4.87 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 62.28 63.0 1.1 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 124.539 1.149 . . . . 0.0 109.658 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.533 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 98.9 m -54.18 118.61 16.46 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.517 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -16.0 82.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.419 1 C-N-CA 126.568 4.845 . . . . 0.0 117.67 -168.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' B' ' 23' ' ' THR . 27.3 mt-10 -105.22 -75.95 0.61 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.557 1.143 . . . . 0.0 107.965 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 85.2 mtp -96.99 -43.0 0.25 Allowed Pre-proline 0 CA--C 1.559 1.29 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.375 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.43 73.74 2.16 Favored 'Trans proline' 0 C--N 1.399 3.201 0 C-N-CA 122.273 1.982 . . . . 0.0 112.255 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.25 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.322 1.449 . . . . 0.0 108.915 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 8.1 tt -105.31 130.77 53.36 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.426 1.09 . . . . 0.0 110.056 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -83.68 133.81 34.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.425 0.69 . . . . 0.0 109.405 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.487 HD21 ' HB3' ' B' ' 35' ' ' GLN . 2.2 t-20 -80.05 4.49 16.98 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.849 0.86 . . . . 0.0 111.003 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 74.48 -76.37 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.379 1.872 . . . . 0.0 111.688 169.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.68 30.61 4.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.649 0.78 . . . . 0.0 110.181 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.76 67.81 0.8 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.571 1.149 . . . . 0.0 111.537 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.487 ' HB3' HD21 ' B' ' 31' ' ' ASN . 6.0 tp-100 -62.25 -53.2 58.57 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.028 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.61 22.01 29.22 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.646 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.75 169.0 16.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.114 0.566 . . . . 0.0 110.616 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.7 mt 77.11 -67.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.366 1.866 . . . . 0.0 110.114 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.424 HG21 HD13 ' B' ' 67' ' ' ILE . 24.3 p -109.61 -75.43 0.63 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.488 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . 179.54 -52.13 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 125.356 1.462 . . . . 0.0 109.476 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 77.1 Cg_endo -101.07 111.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 123.164 2.576 . . . . 0.0 112.886 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.15 76.37 2.24 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.254 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.34 -79.19 0.22 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.24 -176.7 6.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.857 0.863 . . . . 0.0 109.743 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -99.58 -42.64 6.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.466 0.707 . . . . 0.0 109.611 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 69.96 -65.66 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.763 1.625 . . . . 0.0 112.714 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 68' ' ' ILE . 50.9 tp 78.12 -15.16 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.34 1.456 . . . . 0.0 112.504 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -88.24 6.78 35.19 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.437 0.695 . . . . 0.0 111.861 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.68 47.32 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.88 -16.42 58.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.495 0.718 . . . . 0.0 111.964 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.98 -54.94 23.86 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.01 0.924 . . . . 0.0 110.251 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.4 t -70.35 -24.39 62.97 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.66 -43.26 59.89 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.295 0.638 . . . . 0.0 111.383 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -172.37 -66.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.799 0.84 . . . . 0.0 110.934 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' B' ' 57' ' ' ASP . 2.6 pt? -129.48 167.14 18.29 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.16 0.584 . . . . 0.0 111.343 -168.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.56 ' HD3' ' H ' ' B' ' 56' ' ' ARG . 0.1 OUTLIER -127.06 15.01 7.35 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.779 0.832 . . . . 0.0 109.255 179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' B' ' 55' ' ' LEU . 3.3 m-20 -93.59 55.23 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.813 1.245 . . . . 0.0 109.571 -170.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.512 ' HB3' HD13 ' B' ' 68' ' ' ILE . 86.7 p 56.12 -80.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.888 1.675 . . . . 0.0 111.625 -173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -168.11 -57.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 51.0 m -147.03 -76.53 0.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -156.01 -65.15 0.11 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.396 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 mptt 37.18 168.31 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.061 0 C-N-CA 126.008 1.723 . . . . 0.0 115.504 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -48.28 129.46 19.18 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 123.127 2.551 . . . . 0.0 114.399 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.29 28.19 13.83 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.326 1.45 . . . . 0.0 112.127 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.14 49.21 5.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.491 1.116 . . . . 0.0 109.774 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 65.45 -176.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.46 1.104 . . . . 0.0 110.54 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.424 HD13 HG21 ' B' ' 39' ' ' THR . 15.0 tt -87.05 61.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 122.755 1.264 . . . . 0.0 110.466 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 58' ' ' SER . 24.4 pt -120.79 2.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.451 -0.78 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 128.26 36.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.33 -47.93 82.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.688 0.795 . . . . 0.0 112.163 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.38 133.53 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -173.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.76 55.02 0.09 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -79.87 -35.04 38.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.374 0.67 . . . . 0.0 110.758 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.7 81.96 1.1 Allowed Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.041 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.7 -22.0 64.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.489 0.715 . . . . 0.0 111.325 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.79 -141.94 11.53 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 168.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 74.04 -24.85 0.2 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.125 1.37 . . . . 0.0 114.488 166.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.1 t -69.64 -44.84 69.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.431 0.692 . . . . 0.0 111.257 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -93.27 -72.09 0.62 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.806 0.442 . . . . 0.0 110.13 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 9.8 tp -162.35 -30.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.677 0.391 . . . . 0.0 110.827 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 28.8 m -59.5 135.17 57.58 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 123.252 0.621 . . . . 0.0 109.892 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 79.64 -49.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.644 1.578 . . . . 0.0 111.256 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.52 -66.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.377 1.471 . . . . 0.0 110.574 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -130.32 104.45 7.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.41 115.27 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.244 1.017 . . . . 0.0 110.387 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' B' ' 90' ' ' ALA . 32.9 m-85 80.3 -42.24 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.554 1.542 . . . . 0.0 112.111 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.6 48.4 9.58 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.477 1.111 . . . . 0.0 111.234 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 76.16 -57.43 0.56 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.112 1.765 . . . . 0.0 112.901 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.58 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . -80.38 1.23 82.38 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' B' ' 86' ' ' TYR . . . 62.77 24.01 14.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.31 1.044 . . . . 0.0 111.642 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.46 -65.79 3.6 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -168.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.7 -91.71 0.27 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 122.8 0.238 . . . . 0.0 112.998 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -158.13 -70.37 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.442 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 48.4 t80 -77.08 -40.35 46.39 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.258 0.623 . . . . 0.0 110.641 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.64 ' HD2' ' HA2' ' B' ' 134' ' ' GLY . 0.3 OUTLIER -58.7 -28.21 65.57 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.542 0.526 . . . . 0.0 110.662 174.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.81 -79.48 0.21 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 387' ' ' PHE . 0.0 OUTLIER 176.88 -35.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.143 0.977 . . . . 0.0 109.647 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.2 148.58 47.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 113.113 -162.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.44 -24.39 5.0 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.952 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.18 108.64 0.9 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.18 -85.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.023 1.815 . . . . 0.0 112.121 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.695 HD21 ' HG3' ' B' ' 113' ' ' LYS . 85.2 mt 60.66 -173.58 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.83 1.252 . . . . 0.0 113.336 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 17.6 m -140.11 90.86 2.41 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.25 90.13 0.08 OUTLIER Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -81.98 119.52 24.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.48 ' H ' ' ND2' ' A' ' 400' ' ' ASN . 82.2 m-85 71.39 26.43 3.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.37 1.468 . . . . 0.0 111.807 -175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -82.25 167.39 18.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.21 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -135.08 11.15 3.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.504 0.722 . . . . 0.0 110.502 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -86.51 23.39 1.64 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 0.0 110.131 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' B' ' 113' ' ' LYS . . . -79.9 -100.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.77 0.828 . . . . 0.0 109.384 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.519 ' HG ' HG11 ' A' ' 347' ' ' VAL . 3.2 mm? 51.73 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.88 1.272 . . . . 0.0 112.953 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -92.63 82.41 4.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.543 0.687 . . . . 0.0 111.862 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.695 ' HG3' HD21 ' B' ' 102' ' ' LEU . 0.0 OUTLIER -157.24 37.86 0.29 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.153 -1.385 . . . . 0.0 107.598 162.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -176.93 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.683 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.0 m -64.81 -34.0 77.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.631 0.772 . . . . 0.0 111.071 -173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.537 ' HA2' ' H ' ' B' ' 121' ' ' VAL . . . 90.19 -66.69 2.69 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -67.4 143.33 97.18 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.832 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -1.64 66.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.453 1 C-N-CA 126.701 4.934 . . . . 0.0 116.369 -154.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.82 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.846 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.72 -90.6 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 109.816 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.622 HG22 HG23 ' B' ' 122' ' ' THR . 12.8 p -174.63 141.95 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.519 1.528 . . . . 0.0 108.074 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.622 HG23 HG22 ' B' ' 121' ' ' VAL . 56.7 p 60.25 176.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.699 1.6 . . . . 0.0 114.287 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.95 71.99 1.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.669 0.788 . . . . 0.0 109.582 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t 76.12 -51.18 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.295 1.438 . . . . 0.0 111.848 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.32 41.59 16.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.17 0.988 . . . . 0.0 109.626 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 428' ' ' MET . . . -73.97 9.02 1.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.806 -170.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.474 ' HB3' ' SD ' ' A' ' 140' ' ' MET . 26.8 m -59.74 86.58 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 123.573 0.749 . . . . 0.0 110.001 169.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.96 -76.04 0.07 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.89 1.676 . . . . 0.0 111.99 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.0 m 61.44 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.023 1.329 . . . . 0.0 109.372 -166.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 58.8 -171.98 0.11 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 124.648 1.179 . . . . 0.0 114.04 170.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.526 ' HH2' HD13 ' A' ' 144' ' ' LEU . 3.6 p90 47.28 31.17 1.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.386 1.874 . . . . 0.0 114.966 166.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 51.3 p -87.83 61.51 6.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.745 0.818 . . . . 0.0 109.853 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.8 t -84.45 65.52 8.98 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.827 1.298 . . . . 0.0 110.54 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . 0.64 ' HA2' ' HD2' ' B' ' 95' ' ' LYS . . . 79.12 -95.43 1.41 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 80.6 t 63.71 113.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.072 1.349 . . . . 0.0 111.749 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.35 82.56 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.043 0.925 . . . . 0.0 109.623 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -107.96 3.91 24.66 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.827 -172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.69 -175.83 3.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.02 0.928 . . . . 0.0 109.515 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.25 136.52 57.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.313 0.645 . . . . 0.0 112.285 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -142.12 88.54 0.18 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.64 17.94 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.498 0.719 . . . . 0.0 110.168 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.16 -177.2 5.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.637 1.175 . . . . 0.0 109.442 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.86 -78.97 1.76 Allowed Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.1 122.66 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.849 0.859 . . . . 0.0 109.85 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.82 168.89 18.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.136 1.375 . . . . 0.0 108.834 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.565 HG12 ' H ' ' B' ' 147' ' ' HIS . 12.8 tt 30.15 -141.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 125.831 1.652 . . . . 0.0 111.781 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . 0.565 ' H ' HG12 ' B' ' 146' ' ' ILE . 85.2 t60 -65.66 90.24 0.11 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.396 1.907 . . . . 0.0 110.348 169.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 27.15 79.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.549 2.34 . . . . 0.0 115.814 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.3 157.68 44.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t0 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.883 0.873 . . . . 0.0 108.723 170.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.508 0.67 . . . . 15.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.59 96.95 7.63 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.76 -0.655 . . . . 15.0 109.817 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 17' ' ' ILE . 32.6 m -89.86 151.39 3.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 115.707 -0.679 . . . . 15.0 109.958 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 p -152.52 108.42 3.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.655 0.382 . . . . 15.0 110.522 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 131.04 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.203 0.601 . . . . 15.0 110.413 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -130.96 97.67 4.38 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.794 0.838 . . . . 15.0 109.236 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 10' ' ' GLY . 97.9 m -62.9 97.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.15 0.5 . . . . 15.0 109.966 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.3 p -92.55 -64.1 1.15 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.79 54.99 0.69 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.555 0.742 . . . . 15.0 110.373 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 7' ' ' THR . . . 68.57 -96.28 0.42 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.485 -0.325 . . . . 15.0 112.596 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.44 -34.44 70.27 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.76 88.4 0.04 OUTLIER Glycine 0 C--N 1.351 1.378 0 CA-C-N 114.786 -1.097 . . . . 15.0 112.904 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -93.63 124.86 37.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.298 1.039 . . . . 15.0 110.718 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -88.59 91.1 8.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.147 1.379 . . . . 15.0 110.316 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.5 93.09 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 90.3 m -76.85 109.38 10.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.479 -1.237 . . . . 15.0 109.811 175.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 3' ' ' VAL . 53.0 mt -103.62 137.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.613 0.765 . . . . 15.0 109.719 -176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.7 m -117.33 94.68 4.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.153 -1.055 . . . . 15.0 108.153 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.8 mt -79.9 135.02 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.65 128.38 36.44 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 123.057 0.543 . . . . 15.0 109.946 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.06 73.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.433 1.093 . . . . 15.0 112.141 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -65.16 -34.55 78.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.779 0.432 . . . . 15.0 111.078 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -77.02 -29.86 55.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.381 0.672 . . . . 15.0 110.826 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.13 -47.13 88.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 N-CA-C 109.124 -0.695 . . . . 15.0 109.124 172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 17.0 tp10 -57.54 -39.43 76.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.621 1.168 . . . . 15.0 111.399 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -61.25 -46.55 89.91 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.146 0.978 . . . . 15.0 111.336 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 -39.23 69.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.714 -0.675 . . . . 15.0 111.838 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 66' ' ' VAL . 81.6 t -63.87 -41.3 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.0 0.92 . . . . 15.0 110.205 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 5.0 ttmp? -60.85 -42.93 98.78 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.204 1.002 . . . . 15.0 111.073 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -64.09 -34.87 79.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.583 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.4 tp10 -71.48 -41.44 69.33 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.798 -0.637 . . . . 15.0 111.647 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -64.82 -38.96 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.198 0.599 . . . . 15.0 112.486 -172.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.53 -32.25 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 123.205 0.316 . . . . 15.0 110.235 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -73.55 -30.35 63.0 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.267 0.627 . . . . 15.0 111.281 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.1 t -67.4 -40.22 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 174.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.08 85.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.228 0.611 . . . . 15.0 110.6 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.77 -36.68 73.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.372 0.669 . . . . 15.0 111.456 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -65.79 -43.83 87.55 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.103 0.961 . . . . 15.0 110.75 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 6.4 t -87.63 -0.66 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-N 115.685 -0.689 . . . . 15.0 109.961 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 70.17 14.82 7.64 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 125.461 1.505 . . . . 15.0 113.205 172.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.77 4.57 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 C-N-CA 124.175 0.99 . . . . 15.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.01 -34.56 73.51 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.652 1.181 . . . . 15.0 113.018 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.28 -23.69 74.87 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.254 0.346 . . . . 15.0 112.467 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -91.12 4.17 52.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.564 1.145 . . . . 15.0 111.6 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -71.47 101.14 2.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.069 -1.085 . . . . 15.0 108.069 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -71.78 -30.83 65.97 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.331 -0.85 . . . . 15.0 111.512 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.65 68.79 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.587 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -69.52 -49.68 52.29 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.552 0.741 . . . . 15.0 109.518 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.28 129.98 28.13 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 115.319 -0.855 . . . . 15.0 108.766 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.95 145.45 24.55 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.445 2.764 . . . . 15.0 113.629 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.5 tpt -68.34 -32.13 72.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.831 0.852 . . . . 15.0 111.552 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 9.7 p30 -62.7 -33.37 74.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.636 0.375 . . . . 15.0 111.31 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.46 -51.25 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.509 0.724 . . . . 15.0 110.464 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 51' ' ' MET . 28.2 m -67.48 -28.14 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 112.259 0.466 . . . . 15.0 112.259 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -49.56 77.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 -172.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -79.28 -1.99 39.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.379 0.511 . . . . 15.0 112.379 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.55 -55.22 2.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.11 0.564 . . . . 15.0 111.113 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.66 -30.67 52.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.871 0.468 . . . . 15.0 110.545 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 62' ' ' VAL . . . -93.54 6.08 74.28 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 118.902 -0.943 . . . . 15.0 113.286 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.81 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.378 0.671 . . . . 15.0 111.615 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -98.24 -19.95 17.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 15.0 110.916 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HA2' ' A' ' 59' ' ' GLY . 43.1 t -95.24 73.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.183 0.992 . . . . 15.0 109.119 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -117.8 -39.34 3.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.328 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -58.29 -41.74 85.04 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.535 1.134 . . . . 15.0 112.15 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.8 -39.41 71.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.998 0.919 . . . . 15.0 110.456 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 28' ' ' VAL . 16.6 t -84.43 -23.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 114.436 -1.256 . . . . 15.0 111.008 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.1 mt -68.57 -26.16 65.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.532 0.333 . . . . 15.0 110.48 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.14 -26.43 70.38 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.241 -0.436 . . . . 15.0 112.303 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -81.98 -55.27 4.69 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.295 1.038 . . . . 15.0 109.907 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.76 -61.54 1.83 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.302 1.041 . . . . 15.0 112.605 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.9 mtm -56.3 -31.25 63.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.212 0.605 . . . . 15.0 111.47 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -77.3 -49.99 13.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.649 0.78 . . . . 15.0 111.686 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtm105 -71.83 -45.16 62.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 111.881 0.326 . . . . 15.0 111.881 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -64.64 -13.15 52.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.045 0.538 . . . . 15.0 111.725 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -87.68 -66.15 0.94 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.501 0.721 . . . . 15.0 110.446 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 tt -60.53 -35.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.252 1.021 . . . . 15.0 112.301 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.46 -52.3 58.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.461 0.704 . . . . 15.0 110.415 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -53.77 44.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.407 -0.815 . . . . 15.0 111.933 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 HD12 ' HD3' ' A' ' 86' ' ' PRO . 44.6 pt -64.39 -41.76 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.298 0.481 . . . . 15.0 112.298 -171.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.79 -38.03 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.789 0.436 . . . . 15.0 111.133 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -73.14 -17.08 61.43 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.564 -0.162 . . . . 15.0 110.564 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -95.88 10.13 38.25 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.579 0.752 . . . . 15.0 111.296 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 65.12 16.27 10.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.18 1.392 . . . . 15.0 113.2 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.93 101.54 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.109 0.964 . . . . 15.0 109.216 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -101.22 122.11 49.53 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 123.451 0.7 . . . . 15.0 109.734 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' HD3' HD12 ' A' ' 79' ' ' ILE . 65.5 Cg_endo -72.6 119.97 6.42 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.435 2.756 . . . . 15.0 113.249 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.86 124.81 34.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.004 0.922 . . . . 15.0 109.626 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.18 -101.48 2.81 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.542 -0.623 . . . . 15.0 111.542 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -157.84 136.52 7.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.53 0.732 . . . . 15.0 110.049 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 3.9 Cg_exo -79.68 125.03 5.95 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.642 2.895 . . . . 15.0 113.489 -175.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -89.7 95.07 10.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.601 0.76 . . . . 15.0 109.881 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -72.04 127.1 31.51 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.457 0.703 . . . . 15.0 109.969 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.54 87.48 41.36 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.503 0.721 . . . . 15.0 109.227 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -90.49 111.86 0.42 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.195 2.597 . . . . 15.0 110.673 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.08 87.69 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 116.761 -0.2 . . . . 15.0 113.11 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -166.05 143.26 5.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.216 1.007 . . . . 15.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.1 139.35 33.26 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 110.144 -0.317 . . . . 15.0 110.144 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -137.07 157.45 46.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.73 0.812 . . . . 15.0 111.085 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.09 145.5 51.27 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.307 -1.368 . . . . 15.0 107.307 170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.76 -53.07 4.79 Favored Glycine 0 N--CA 1.473 1.136 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.71 140.12 30.78 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.46 124.07 21.31 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.954 . . . . 15.0 111.25 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -76.58 106.35 8.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.747 0.819 . . . . 15.0 110.495 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.2 m -101.04 141.4 33.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 15.0 109.585 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -155.96 138.9 15.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.553 0.741 . . . . 15.0 109.736 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 64.9 m -100.71 110.88 23.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.008 0.923 . . . . 15.0 110.855 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.4 t -98.03 105.93 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -95.35 121.02 36.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.376 0.67 . . . . 15.0 110.029 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.554 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.6 p90 -151.32 148.4 28.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.856 0.862 . . . . 15.0 108.864 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -78.66 161.88 26.61 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 174.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.26 157.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 15.0 109.811 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -71.46 119.46 74.02 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.044 0.537 . . . . 15.0 110.185 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.82 150.72 8.55 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.617 2.211 . . . . 15.0 112.071 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.55 118.13 16.14 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.596 ' HA ' HD12 ' A' ' 300' ' ' ILE . 31.6 t -81.35 135.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.007 0.523 . . . . 15.0 109.739 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.999 0.52 . . . . 15.0 110.378 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -119.83 105.74 11.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.323 1.049 . . . . 15.0 109.243 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.89 -179.19 2.15 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.177 0.991 . . . . 15.0 109.695 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 116.1 6.75 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.521 0.513 . . . . 15.0 112.312 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 70.7 mt -73.07 -8.57 56.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.445 0.698 . . . . 15.0 110.623 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -58.51 -32.96 69.31 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.687 1.595 . . . . 15.0 111.039 167.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.2 64.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.843 0.857 . . . . 15.0 112.657 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.557 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.9 mt -81.24 130.61 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.057 0.943 . . . . 15.0 108.614 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 44.4 mt-10 -120.08 117.4 27.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.611 0.764 . . . . 15.0 109.606 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' A' ' 286' ' ' VAL . 60.3 t -118.8 149.75 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.471 1.109 . . . . 15.0 108.415 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.04 133.6 53.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.428 -0.953 . . . . 15.0 108.428 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -118.08 84.53 21.94 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.471 1.108 . . . . 15.0 108.169 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 427' ' ' LEU . 1.2 Cg_endo -85.46 108.07 1.04 Allowed 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.0 1.8 . . . . 15.0 112.114 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.1 mm -65.19 116.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.866 0.866 . . . . 15.0 109.098 170.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.532 ' HB ' HD21 ' A' ' 278' ' ' LEU . 86.2 t -104.82 117.94 51.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.339 0.656 . . . . 15.0 109.886 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.88 125.04 34.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 274' ' ' MET . 23.8 t -111.82 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.493 -1.299 . . . . 15.0 107.493 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.0 p -105.18 176.0 5.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.786 -0.82 . . . . 15.0 108.786 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.15 -24.51 66.68 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.079 0.552 . . . . 15.0 111.191 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -43.04 94.45 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.644 0.778 . . . . 15.0 109.652 172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -68.94 -40.67 78.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.388 0.675 . . . . 15.0 111.102 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.01 -50.83 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.761 0.424 . . . . 15.0 110.697 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.16 -48.93 77.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.439 1.096 . . . . 15.0 110.403 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.78 -33.39 84.04 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.737 -1.12 . . . . 15.0 113.099 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 7.3 tpt -68.75 -42.79 77.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.923 0.489 . . . . 15.0 110.517 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 270' ' ' VAL . 42.0 mt -59.51 -40.33 86.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.133 0.573 . . . . 15.0 111.215 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.57 -38.28 90.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.916 0.886 . . . . 15.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -61.84 -47.51 84.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.08 0.552 . . . . 15.0 109.912 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 140' ' ' MET . 79.3 mt -62.52 -37.52 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.896 0.879 . . . . 15.0 110.379 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.4 mtp85 -81.41 -10.55 59.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.655 0.782 . . . . 15.0 112.814 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -94.22 -26.39 16.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.67 -0.644 . . . . 15.0 111.52 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -78.13 -37.64 45.67 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.215 0.531 . . . . 15.0 109.63 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -105.21 34.68 3.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.43 1.092 . . . . 15.0 109.62 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.89 137.43 55.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.756 0.822 . . . . 15.0 111.598 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -80.66 108.82 14.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.734 0.814 . . . . 15.0 109.337 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -79.07 144.85 34.2 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.803 0.811 . . . . 15.0 111.497 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 25.7 ttpt -151.3 155.76 39.4 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.74 1.616 . . . . 15.0 107.276 -173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -77.52 152.74 33.95 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.963 0.801 . . . . 15.0 111.632 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.693 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.6 pttt -146.62 177.47 9.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.81 -1.541 . . . . 15.0 108.711 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -140.95 131.27 25.07 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.375 -1.342 . . . . 15.0 107.375 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.73 -155.51 17.75 Favored Glycine 0 N--CA 1.465 0.58 0 O-C-N 124.014 0.821 . . . . 15.0 111.86 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.83 117.78 5.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.007 0.923 . . . . 15.0 112.741 -167.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.538 HG21 HD21 ' A' ' 237' ' ' LEU . 34.5 t -70.49 135.73 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.839 1.256 . . . . 15.0 110.345 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.66 166.76 11.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.55 4.36 11.4 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.13 0.972 . . . . 15.0 112.755 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.78 4.87 6.66 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.565 1.146 . . . . 15.0 110.727 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -89.92 -179.58 5.75 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.81 0.814 . . . . 15.0 111.611 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -117.82 162.39 18.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.599 -1.63 . . . . 15.0 106.599 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 202' ' ' ILE . 35.8 m -147.11 179.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.597 0.713 . . . . 15.0 111.495 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 82.6 m -130.26 107.03 8.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.728 -1.578 . . . . 15.0 107.364 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.4 pt -105.49 -177.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.898 1.333 . . . . 15.0 111.327 174.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -130.78 167.72 18.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 104.077 -2.564 . . . . 15.0 104.077 161.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 235' ' ' ILE . 37.7 p90 -162.48 148.43 12.76 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.613 0.642 . . . . 15.0 111.042 170.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 64.6 m -97.47 101.33 12.84 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.214 -1.357 . . . . 15.0 108.48 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -66.35 118.9 11.62 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.201 -0.908 . . . . 15.0 111.908 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 14.1 m -135.87 143.93 45.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.147 0.579 . . . . 15.0 110.675 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.11 112.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.861 1.264 . . . . 15.0 107.67 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 63.09 21.42 12.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.517 1.127 . . . . 15.0 111.535 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.06 -17.93 53.12 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-O 119.915 -0.38 . . . . 15.0 112.727 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.42 104.65 12.87 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.411 -0.589 . . . . 15.0 109.411 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -64.12 85.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.778 0.831 . . . . 15.0 112.038 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' A' ' 180' ' ' GLY . 41.8 p90 -64.46 144.95 56.81 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.777 -176.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.59 140.34 42.59 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.832 -0.622 . . . . 15.0 111.471 -170.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.92 -32.49 4.57 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.542 -0.753 . . . . 15.0 111.564 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.615 ' HA2' HD21 ' B' ' 8' ' ' LEU . . . -85.4 70.68 3.04 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.879 -0.488 . . . . 15.0 111.879 -171.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.4 mptt -150.83 151.99 33.09 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.279 -1.748 . . . . 15.0 106.279 174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.49 139.8 42.56 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' B' ' 30' ' ' GLU . 9.8 p -128.75 120.36 26.26 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.754 1.222 . . . . 15.0 108.938 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.5 t70 67.94 31.42 5.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.904 1.282 . . . . 15.0 109.961 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.52 122.36 21.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.015 0.926 . . . . 15.0 110.211 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.58 122.55 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 123.067 0.547 . . . . 15.0 109.732 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 tp -121.37 133.43 55.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.242 0.617 . . . . 15.0 109.66 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.08 148.18 43.32 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 15.0 110.2 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.497 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 33.9 mtt -106.72 171.67 7.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.965 0.906 . . . . 15.0 110.558 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.46 4.58 87.38 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.141 -0.936 . . . . 15.0 112.033 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -145.4 133.78 21.85 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.41 1.084 . . . . 15.0 108.96 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.24 46.67 3.05 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.446 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -93.21 57.48 2.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.86 0.864 . . . . 15.0 109.233 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.89 177.81 4.83 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.697 177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 91.8 mt -58.3 125.81 76.41 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.492 167.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -60.35 116.34 3.26 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.758 2.306 . . . . 15.0 111.358 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.78 -10.86 52.91 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.095 -0.502 . . . . 15.0 112.947 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.515 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 45.7 t80 -66.99 -43.76 82.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.83 0.852 . . . . 15.0 110.225 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -20.32 65.33 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.611 -1.177 . . . . 15.0 112.454 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -49.6 -51.86 34.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.982 1.313 . . . . 15.0 112.552 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.65 -30.14 73.94 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 124.224 0.953 . . . . 15.0 113.555 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.46 HG23 HG11 ' A' ' 164' ' ' VAL . 3.4 mp -72.35 -44.33 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.368 0.667 . . . . 15.0 110.326 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.497 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.0 mtpt -59.22 -12.09 4.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.042 1.867 . . . . 15.0 116.042 -166.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -148.88 43.0 0.81 Allowed Glycine 0 N--CA 1.466 0.655 0 CA-C-N 118.585 0.63 . . . . 15.0 111.779 -171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -136.01 -167.37 2.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.122 0.969 . . . . 15.0 108.615 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -128.09 164.44 22.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.314 0.646 . . . . 15.0 110.224 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.66 45.37 0.88 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.795 1.238 . . . . 15.0 113.086 -168.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.1 0.73 Allowed Glycine 0 N--CA 1.462 0.409 0 CA-C-O 119.866 -0.408 . . . . 15.0 112.84 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.86 153.82 29.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.437 1.273 . . . . 15.0 114.437 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -118.88 122.4 42.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 111.567 -2.56 . . . . 15.0 107.465 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -157.76 150.39 22.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.133 0.573 . . . . 15.0 109.972 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 32.5 m -118.94 112.36 19.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.139 -1.06 . . . . 15.0 108.139 -174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.637 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.8 pt -100.09 151.25 5.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 CA-C-O 121.326 0.584 . . . . 15.0 111.876 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -96.88 104.77 16.81 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.488 -1.233 . . . . 15.0 109.295 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 198' ' ' PHE . 33.7 m -116.41 -176.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.44 0.638 . . . . 15.0 110.381 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 56.1 m -140.8 127.21 19.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.267 -1.333 . . . . 15.0 108.56 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -55.59 159.43 4.91 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.841 1.256 . . . . 15.0 112.596 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 195' ' ' ILE . 37.7 Cg_endo -77.23 161.68 31.95 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.403 2.069 . . . . 15.0 110.215 173.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 45.4 mt-10 -83.47 -7.2 59.59 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.253 0.549 . . . . 15.0 110.681 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.38 -2.34 57.96 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.672 0.789 . . . . 15.0 111.234 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' OH ' HD12 ' B' ' 13' ' ' LEU . 26.3 t80 -58.42 132.32 53.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.17 0.988 . . . . 15.0 109.951 169.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.503 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 84.9 t60 -60.49 -48.87 79.88 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.126 0.891 . . . . 15.0 112.133 -171.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' B' ' 6' ' ' ILE . . . -68.04 111.28 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.51 -32.55 72.6 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.611 0.569 . . . . 15.0 111.61 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.78 -12.21 61.45 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.168 0.987 . . . . 15.0 110.963 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.21 1.15 9.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.838 0.855 . . . . 15.0 111.979 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.2 ptpt -77.72 126.07 30.31 Favored 'General case' 0 CA--C 1.546 0.788 0 CA-C-N 119.511 1.05 . . . . 15.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.91 22.27 75.63 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.349 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -100.64 138.02 38.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.058 0.943 . . . . 15.0 109.314 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.11 120.81 17.22 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.439 0.696 . . . . 15.0 111.573 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.35 167.58 11.42 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.694 0.798 . . . . 15.0 111.387 -174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 9.8 mmpt? -116.25 136.41 53.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.669 1.188 . . . . 15.0 107.96 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.493 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 63.0 m-85 -136.57 110.38 8.15 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.825 -0.806 . . . . 15.0 108.825 173.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.77 81.02 4.22 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 168' ' ' PHE . 7.5 mm -73.12 112.27 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.913 -1.494 . . . . 15.0 110.212 -175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.693 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -97.45 83.26 3.23 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.538 HD21 HG21 ' A' ' 158' ' ' VAL . 21.7 tp -64.3 99.27 0.27 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.619 -1.173 . . . . 15.0 110.03 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -88.69 -45.33 9.91 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 123.322 0.649 . . . . 15.0 110.687 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 26.6 mmmt -136.78 156.08 48.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.977 0.911 . . . . 15.0 110.171 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.693 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.3 p -129.48 136.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.22 1.008 . . . . 15.0 108.489 168.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.01 129.73 51.64 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.043 0.937 . . . . 15.0 110.358 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 25.3 tt0 -90.55 135.11 33.91 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.619 1.568 . . . . 15.0 111.055 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -81.94 131.18 35.25 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.703 -1.221 . . . . 15.0 107.703 165.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -116.21 140.73 49.0 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.1 mt -58.45 114.65 9.24 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.279 -1.008 . . . . 15.0 108.279 168.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 23.3 Cg_endo -58.18 -169.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 124.983 3.789 . . . . 15.0 114.474 -170.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.443 ' HB2' ' CD2' ' A' ' 252' ' ' PHE . 28.9 mt-10 -59.09 134.14 56.72 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.559 0.743 . . . . 15.0 110.96 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.81 10.43 34.51 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.862 -0.792 . . . . 15.0 108.862 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -51.77 132.51 31.39 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 124.819 1.247 . . . . 15.0 110.083 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.538 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -57.42 -42.8 83.04 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.769 0.668 . . . . 15.0 112.314 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.71 -24.32 66.96 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.269 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 247' ' ' GLU . 91.4 t80 -88.37 -44.39 10.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.928 0.491 . . . . 15.0 110.781 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 250' ' ' ALA . 7.1 tt -61.96 -36.94 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.504 0.721 . . . . 15.0 109.599 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.594 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.2 ptmt -81.56 -14.88 56.3 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.02 0.748 . . . . 15.0 113.02 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.561 ' HD2' ' HB2' ' B' ' 138' ' ' TYR . 11.9 tpp180 -67.48 -28.73 68.1 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.711 0.804 . . . . 15.0 111.725 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.19 -29.82 70.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.628 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.588 ' HA3' ' HB ' ' B' ' 133' ' ' THR . . . 121.12 32.86 1.02 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.488 -0.778 . . . . 15.0 112.285 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 22.0 t -88.43 108.23 18.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.238 -1.764 . . . . 15.0 106.238 170.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -64.28 -48.02 77.3 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.78 0.675 . . . . 15.0 110.673 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -101.71 68.9 1.18 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.207 1.403 . . . . 15.0 108.249 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 254' ' ' LYS . . . -74.98 50.03 2.23 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 115.887 1.115 . . . . 15.0 115.887 -169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.2 p -93.6 -176.05 3.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.773 -0.825 . . . . 15.0 108.773 164.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.34 -57.55 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.64 -31.08 71.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.984 0.514 . . . . 15.0 110.444 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.67 -30.16 72.82 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.93 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 253' ' ' ILE . 53.1 tp -72.46 -44.49 62.28 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -57.24 -48.07 79.78 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.033 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.44 72.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.682 0.793 . . . . 15.0 111.707 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.455 ' HG2' HG13 ' A' ' 258' ' ' VAL . 12.0 tp10 -56.7 -62.18 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.688 -0.856 . . . . 15.0 108.688 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 141' ' ' LEU . 57.8 t -63.04 -31.41 52.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-N 114.691 -1.14 . . . . 15.0 111.269 -177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -60.67 -56.04 26.04 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.673 0.389 . . . . 15.0 111.554 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.98 -27.0 65.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 120.476 0.179 . . . . 15.0 110.985 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.45 -39.14 77.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.485 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 132' ' ' VAL . 42.6 mtt -62.27 -55.17 30.89 Favored 'General case' 0 C--O 1.204 -1.315 0 O-C-N 123.934 0.771 . . . . 15.0 109.79 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.7 -41.76 91.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.218 0.949 . . . . 15.0 111.982 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -64.9 -45.23 86.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.996 0.919 . . . . 15.0 110.966 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.599 ' HG2' ' HA ' ' B' ' 128' ' ' ALA . 7.0 tp10 -70.28 -32.18 69.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.182 0.993 . . . . 15.0 110.772 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.532 HD21 ' HB ' ' A' ' 130' ' ' VAL . 46.3 tp -80.64 -37.13 31.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.46 1.104 . . . . 15.0 110.694 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.42 -36.89 76.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.277 -0.638 . . . . 15.0 109.277 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.0 t -75.14 -32.5 61.34 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 123.851 0.86 . . . . 15.0 111.08 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -52.75 63.91 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.27 -43.07 95.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.72 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.522 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 19.1 tpt180 -63.6 -49.13 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.103 0.41 . . . . 15.0 110.769 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -69.51 -32.72 71.76 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.484 -0.78 . . . . 15.0 110.803 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 285' ' ' ARG . 8.7 tpp85 -56.14 -60.11 3.97 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.427 0.691 . . . . 15.0 110.521 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 125' ' ' VAL . 95.5 t -66.55 -40.43 86.35 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.717 -172.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -68.26 -43.56 77.55 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 119.187 -0.435 . . . . 15.0 110.874 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -67.18 -37.47 83.76 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 118.219 0.463 . . . . 15.0 111.496 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -74.23 -29.97 61.95 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.378 0.424 . . . . 15.0 111.386 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.06 -45.38 93.79 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.214 0.321 . . . . 15.0 110.345 170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 42.5 mm -61.92 -48.48 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.788 0.835 . . . . 15.0 110.244 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.35 -52.43 63.53 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.553 1.158 . . . . 15.0 110.147 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.557 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -71.28 -34.05 64.31 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 114.988 -1.005 . . . . 15.0 113.823 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 350' ' ' LEU . 0.4 OUTLIER -65.58 -50.27 65.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.337 0.655 . . . . 15.0 109.751 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.619 HG11 ' HG3' ' A' ' 343' ' ' ARG . 84.5 t -65.57 -43.31 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.694 -0.684 . . . . 15.0 109.759 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -58.3 -34.37 70.49 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.185 0.594 . . . . 15.0 111.052 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.97 -28.29 55.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.7 0.8 . . . . 15.0 112.009 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -133.24 135.1 44.78 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 112.402 0.519 . . . . 15.0 112.402 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -140.33 144.02 36.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.955 0.902 . . . . 15.0 109.422 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 115' ' ' VAL . 7.2 tt -147.98 152.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.288 1.035 . . . . 15.0 109.041 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.05 90.69 0.46 Allowed 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 170.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.25 132.29 84.33 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 114.258 -1.337 . . . . 15.0 109.123 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.76 126.65 21.81 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.607 2.205 . . . . 15.0 110.67 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.52 -37.83 65.82 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.167 0.987 . . . . 15.0 110.959 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.57 65.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.804 1.241 . . . . 15.0 111.993 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.25 -44.26 88.69 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.117 0.567 . . . . 15.0 110.552 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 311' ' ' ILE . 60.8 mt -62.37 -42.83 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.147 -0.933 . . . . 15.0 109.988 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.78 -27.93 61.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.805 0.842 . . . . 15.0 111.791 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.3 m -58.88 -52.09 67.23 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 167.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.97 -33.09 74.93 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.759 -1.11 . . . . 15.0 112.658 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 50.5 mm -59.88 -56.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 N-CA-C 108.418 -0.956 . . . . 15.0 108.418 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.47 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.9 t70 -59.84 -43.03 94.81 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.3 1.0 . . . . 15.0 111.933 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.01 -45.56 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.36 0.664 . . . . 15.0 111.032 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.09 -24.82 64.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.757 0.423 . . . . 15.0 111.903 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 53.4 mtm180 -71.68 -42.19 67.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.196 0.598 . . . . 15.0 110.331 175.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -64.53 -41.3 96.45 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.353 0.597 . . . . 15.0 110.744 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 7.9 tt0 -70.46 -35.59 73.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.788 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.68 95.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.882 0.473 . . . . 15.0 109.994 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 325' ' ' ASN . . . -53.67 -51.01 64.58 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 124.056 0.847 . . . . 15.0 110.495 174.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -55.63 -31.08 62.0 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 124.637 1.211 . . . . 15.0 111.429 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 99.5 mtt180 -84.5 -35.29 23.03 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.964 0.412 . . . . 15.0 110.751 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 325' ' ' ASN . 33.3 t80 -88.79 36.41 0.8 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.88 0.872 . . . . 15.0 110.0 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.72 67.43 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 115.419 -0.81 . . . . 15.0 114.195 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.81 62.12 1.71 Allowed Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.032 0.348 . . . . 15.0 112.811 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 322' ' ' PHE . 59.1 t30 -67.01 95.7 0.4 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.457 0.703 . . . . 15.0 109.601 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.62 121.62 27.06 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.201 1.0 . . . . 15.0 109.078 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 69.82 -54.79 0.6 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 126.172 1.789 . . . . 15.0 113.856 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -59.34 -21.57 59.99 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.793 0.837 . . . . 15.0 112.777 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 319' ' ' ALA . . . -63.31 -50.74 68.84 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 123.325 0.65 . . . . 15.0 110.6 171.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.1 -14.25 62.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.167 -0.469 . . . . 15.0 110.519 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -90.56 -11.59 39.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.212 1.005 . . . . 15.0 111.184 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.6 mt -54.77 135.5 65.08 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 123.118 0.567 . . . . 15.0 110.446 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 74.1 Cg_endo -70.65 154.94 63.88 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.555 2.17 . . . . 15.0 111.861 -173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HG13 ' A' ' 311' ' ' ILE . 27.3 ttt-85 -55.7 -45.17 77.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.444 0.698 . . . . 15.0 109.7 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.575 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 13.3 pt-20 -52.8 -26.73 15.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.287 1.435 . . . . 15.0 113.214 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -31.67 72.78 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.105 0.562 . . . . 15.0 109.66 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -125.35 -6.8 7.02 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 118.2 -0.905 . . . . 15.0 112.243 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 311' ' ' ILE . 36.1 tt0 -51.28 -53.41 35.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.973 1.101 . . . . 15.0 113.973 -166.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.62 -52.88 48.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.648 0.779 . . . . 15.0 111.155 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 22.1 pt20 -63.35 -37.81 88.73 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.417 0.448 . . . . 15.0 111.516 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -69.0 -43.87 73.94 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.938 0.895 . . . . 15.0 110.625 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 79.3 tttt -56.93 -47.91 79.51 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.037 0.836 . . . . 15.0 109.689 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.619 ' HG3' HG11 ' A' ' 295' ' ' VAL . 26.3 ttt180 -57.29 -42.64 82.11 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 124.17 0.919 . . . . 15.0 110.938 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 80.2 mtt-85 -60.21 -43.01 96.32 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.722 0.639 . . . . 15.0 111.146 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 341' ' ' ALA . 38.7 t -64.32 -42.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 123.359 0.412 . . . . 15.0 110.286 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 82.5 t -60.72 -36.27 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.747 0.819 . . . . 15.0 110.689 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.3 t -57.27 -45.78 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.093 0.473 . . . . 15.0 109.981 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -74.09 -26.96 67.34 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.143 -0.935 . . . . 15.0 113.789 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.18 -45.33 41.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.122 0.569 . . . . 15.0 110.182 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.536 HD13 HD22 ' A' ' 294' ' ' LEU . 94.1 mt -70.14 -51.51 30.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.721 0.808 . . . . 15.0 110.411 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 355' ' ' ILE . 47.4 mt -73.57 -8.37 55.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.581 0.352 . . . . 15.0 111.681 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -82.71 -37.05 14.35 Favored Glycine 0 N--CA 1.469 0.839 0 N-CA-C 110.31 -1.116 . . . . 15.0 110.31 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.5 -35.18 60.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.507 0.723 . . . . 15.0 112.6 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 56.7 t -57.8 -42.47 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.715 0.769 . . . . 15.0 109.147 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -63.79 -51.17 73.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 CA-C-N 114.135 -1.393 . . . . 15.0 110.21 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -62.24 -57.03 12.96 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 123.684 0.615 . . . . 15.0 110.955 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 87.6 m -51.55 -49.43 62.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.899 1.28 . . . . 15.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.552 ' HB3' ' HG ' ' A' ' 360' ' ' LEU . 3.1 t30 -94.88 8.59 42.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 111.628 0.233 . . . . 15.0 111.628 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 42.42 38.93 1.34 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.958 1.303 . . . . 15.0 112.86 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 83.6 mt -58.58 132.53 54.08 Favored 'General case' 0 C--N 1.361 1.105 0 C-N-CA 123.742 0.817 . . . . 15.0 111.676 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 159.96 33.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.428 1.091 . . . . 15.0 108.112 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.7 86.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.459 0.703 . . . . 15.0 109.731 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.9 142.89 57.74 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.273 1.029 . . . . 15.0 109.987 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -55.52 -34.73 64.91 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.215 0.947 . . . . 15.0 112.235 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.48 -36.98 85.54 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.429 0.692 . . . . 15.0 111.763 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -87.41 -28.99 21.81 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 119.402 -0.332 . . . . 15.0 111.2 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.74 -56.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.468 -0.938 . . . . 15.0 108.468 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -59.26 -41.43 88.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.682 0.793 . . . . 15.0 110.914 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.62 -42.24 96.05 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.854 0.721 . . . . 15.0 113.23 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 398' ' ' MET . 4.4 tt -68.93 -41.72 77.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.143 0.577 . . . . 15.0 109.624 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.55 -44.9 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.444 0.698 . . . . 15.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.05 -49.79 63.99 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.461 0.704 . . . . 15.0 110.257 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.08 -43.44 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.246 1.418 . . . . 15.0 111.471 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.519 ' SD ' HD11 ' B' ' 97' ' ' ILE . 41.2 ttp -80.48 -50.98 9.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.547 1.539 . . . . 15.0 111.202 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.47 -15.08 60.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.872 0.869 . . . . 15.0 112.321 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.6 t -67.66 -3.18 8.32 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.413 0.685 . . . . 15.0 111.383 171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.15 -14.62 63.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.118 0.567 . . . . 15.0 111.336 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -137.24 161.76 35.34 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.889 1.276 . . . . 15.0 109.915 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -85.72 -35.41 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.357 0.663 . . . . 15.0 110.212 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.51 85.64 55.96 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -101.73 34.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.568 2.845 . . . . 15.0 112.847 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -56.49 -40.55 75.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.87 0.868 . . . . 15.0 111.091 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.57 -32.6 73.6 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 123.957 0.786 . . . . 15.0 111.533 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.29 -51.77 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.16 -42.97 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.784 0.834 . . . . 15.0 110.51 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.47 -43.57 76.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.748 0.819 . . . . 15.0 110.995 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -57.37 -37.79 73.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.957 0.503 . . . . 15.0 110.964 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -70.34 -71.7 0.23 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.481 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 73.2 p -55.35 -34.65 64.44 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.673 0.99 . . . . 15.0 113.673 -168.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.79 -26.2 59.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.758 0.651 . . . . 15.0 112.758 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 393' ' ' GLU . 62.1 t30 -153.62 151.03 29.25 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.585 0.629 . . . . 15.0 112.329 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 31.9 ttmt -61.8 -15.43 41.54 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.869 1.268 . . . . 15.0 112.306 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 391' ' ' ASN . 8.9 tp10 -27.3 -65.97 0.07 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 127.262 2.225 . . . . 15.0 113.807 -176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 394' ' ' LEU . 6.7 tt -101.92 -22.65 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 14.8 tpt -57.97 -25.24 60.75 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.58 0.752 . . . . 15.0 112.837 -168.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.431 ' HB3' ' HG2' ' A' ' 392' ' ' LYS . 23.6 p-10 -71.57 -47.4 55.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.575 0.35 . . . . 15.0 111.454 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.84 -10.35 59.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.683 -0.488 . . . . 15.0 109.683 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.653 ' HA ' HG12 ' A' ' 401' ' ' VAL . 11.5 tpp -72.54 -38.45 68.02 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 123.475 0.71 . . . . 15.0 109.769 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 395' ' ' MET . 81.6 mtm180 -61.49 -46.88 88.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 173.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.88 -51.53 68.91 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.035 0.834 . . . . 15.0 111.292 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.1 p -69.87 -34.07 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 118.658 0.663 . . . . 15.0 111.785 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.08 -46.59 83.62 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.556 -0.535 . . . . 15.0 109.556 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 355' ' ' ILE . 57.9 tp -62.27 -39.41 92.84 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.168 -0.923 . . . . 15.0 111.9 175.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 408' ' ' VAL . 28.5 tt0 -74.54 -47.54 32.17 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.645 1.178 . . . . 15.0 110.088 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.522 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 15.8 mm-40 -64.24 -43.15 95.84 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.864 0.728 . . . . 15.0 110.762 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -57.28 -43.34 83.02 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.273 0.629 . . . . 15.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -62.32 -51.18 68.66 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 78.8 t -57.41 -47.24 85.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 O-C-N 124.308 1.005 . . . . 15.0 110.056 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.9 mt-10 -67.54 -27.78 67.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.722 0.809 . . . . 15.0 112.398 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.55 62.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.994 0.518 . . . . 15.0 110.546 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.0 t -81.58 -32.9 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.634 0.774 . . . . 15.0 109.13 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 290' ' ' ALA . 91.1 mt -71.87 -34.84 69.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.533 1.133 . . . . 15.0 110.39 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.79 63.0 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.0 0.813 . . . . 15.0 111.53 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -100.99 -28.53 12.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 111.685 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -77.24 150.42 35.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.691 0.796 . . . . 15.0 111.902 -177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.4 mttt -72.63 77.63 1.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.926 0.89 . . . . 15.0 110.182 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 125' ' ' VAL . 43.1 t -89.77 81.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -74.23 109.75 7.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.406 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.1 146.64 30.48 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.675 -0.693 . . . . 15.0 109.576 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -145.01 142.13 29.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.003 -0.74 . . . . 15.0 109.003 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -97.98 124.87 42.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -153.86 179.81 8.53 Favored 'General case' 0 C--O 1.247 0.928 0 C-N-CA 123.451 0.7 . . . . 15.0 110.332 -164.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -83.21 -176.08 6.15 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.09 0.956 . . . . 15.0 112.894 -172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.404 ' HD1' HG22 ' A' ' 132' ' ' VAL . 83.8 t80 -61.59 -66.15 0.58 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.662 1.585 . . . . 15.0 112.872 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 10.5 t-20 -82.08 9.06 9.19 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.425 0.69 . . . . 15.0 112.616 -167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.627 ' HG2' HG21 ' A' ' 422' ' ' THR . 14.2 tp10 -49.26 -51.99 30.13 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.618 1.167 . . . . 15.0 113.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 128' ' ' PRO . 5.2 mp -86.91 -9.35 55.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.397 0.679 . . . . 15.0 110.906 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.567 ' HG2' ' HB1' ' B' ' 126' ' ' ALA . 38.1 mtt -104.34 36.54 2.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.425 1.09 . . . . 15.0 111.136 -162.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -65.05 -0.11 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.931 0.892 . . . . 15.0 113.146 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -95.72 103.79 15.69 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 15.0 110.126 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -96.74 -35.6 10.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.481 0.712 . . . . 15.0 109.457 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.383 1.073 . . . . 15.0 108.243 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 56.1 tttm 70.89 -2.17 2.4 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.745 1.218 . . . . 0.0 112.647 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 61.28 18.49 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.552 1.141 . . . . 0.0 111.885 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -81.18 -4.77 56.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.709 0.804 . . . . 0.0 110.183 171.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 52.4 p -59.05 138.6 57.47 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.949 1.3 . . . . 0.0 110.373 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 223' ' ' ALA . 17.2 tt -69.28 117.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.423 0.689 . . . . 0.0 111.292 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 99.51 11.91 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.719 HD23 HD13 ' B' ' 13' ' ' LEU . 1.3 pp -70.89 155.76 40.41 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.48 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.997 0.919 . . . . 0.0 108.574 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.76 -25.56 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 110.71 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.72 157.51 88.37 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.382 1.073 . . . . 0.0 112.411 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 222' ' ' HIS . 49.9 Cg_exo -60.5 116.25 3.21 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.391 2.728 . . . . 0.0 114.154 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.719 HD13 HD23 ' B' ' 8' ' ' LEU . 6.4 tt -168.67 -62.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.37 84.26 6.44 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -77.76 83.81 4.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.814 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -145.65 122.45 6.03 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.21 -40.97 71.68 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.244 2.63 . . . . 0.0 113.056 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.92 166.19 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.647 0.779 . . . . 0.0 110.849 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -83.56 113.36 20.76 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.552 0.691 . . . . 0.0 110.073 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -106.42 11.42 30.84 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.804 0.842 . . . . 0.0 110.678 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.07 -175.52 5.58 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.68 0.792 . . . . 0.0 110.185 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -85.21 64.07 8.46 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 45.4 p 27.71 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.911 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -165.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 71.3 Cg_exo -45.51 90.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.366 2.044 . . . . 0.0 114.149 168.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' HD2' ' B' ' 27' ' ' PRO . 30.0 tt0 -170.23 146.62 2.97 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.222 1.409 . . . . 0.0 108.19 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 4.0 tpt -73.96 -51.36 4.98 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.425 -0.798 . . . . 0.0 112.749 -173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.551 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 36.2 Cg_endo -66.44 99.58 0.44 Allowed 'Trans proline' 0 C--N 1.39 2.717 0 CA-C-N 121.079 1.421 . . . . 0.0 110.685 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -79.77 65.82 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 122.663 1.221 . . . . 0.0 110.334 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.4 13.81 6.21 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.201 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 183' ' ' SER . 31.6 tt0 82.16 -45.13 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.071 1.748 . . . . 0.0 112.799 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 70.63 -100.5 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.129 1.372 . . . . 0.0 108.016 -170.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.45 ' HD3' ' HG2' ' B' ' 30' ' ' GLU . 9.2 mpt_? 49.08 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.704 1.202 . . . . 0.0 111.988 -177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.33 7.11 17.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.892 0.877 . . . . 0.0 112.043 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.5 84.4 1.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.262 0.625 . . . . 0.0 109.358 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -162.15 -174.37 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.324 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.47 -45.37 1.14 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.33 79.42 1.84 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 mp 61.24 -91.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.607 1.163 . . . . 0.0 108.552 -172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 55.3 m -170.5 -63.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.3 145.61 11.2 Favored Pre-proline 0 C--O 1.245 0.861 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.122 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.65 102.44 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.749 2.299 . . . . 0.0 111.338 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.12 -37.29 0.53 Allowed Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.1 166.46 21.94 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.59 -49.94 6.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.883 0.473 . . . . 0.0 110.383 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 67.63 1.38 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.579 0.751 . . . . 0.0 110.685 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 65.13 -174.36 0.18 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.566 1.146 . . . . 0.0 111.362 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.72 91.59 7.04 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 53' ' ' ALA . 38.1 p 63.95 -67.23 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 127.153 2.181 . . . . 0.0 112.648 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 -1.55 6.62 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.44 -72.84 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.563 1.545 . . . . 0.0 111.716 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -38.85 74.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.764 0.826 . . . . 0.0 111.245 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 73.5 m -64.61 -69.5 0.28 Allowed 'General case' 0 C--N 1.36 1.033 0 C-N-CA 122.943 0.497 . . . . 0.0 110.721 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' B' ' 48' ' ' THR . . . -107.12 -51.21 2.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.081 0.553 . . . . 0.0 111.157 -171.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 75.18 -176.18 0.14 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.706 1.203 . . . . 0.0 111.14 -172.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -69.45 -26.71 64.72 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.698 0.799 . . . . 0.0 110.688 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -82.99 -6.45 59.49 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 0.0 112.286 174.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.463 ' HA ' ' HB1' ' B' ' 53' ' ' ALA . 29.9 t70 62.81 13.12 6.23 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.607 1.163 . . . . 0.0 112.092 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.5 m -125.99 119.48 27.81 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.509 1.123 . . . . 0.0 109.246 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 158.45 25.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.028 0.931 . . . . 0.0 110.566 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.6 p -88.99 146.86 24.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.228 0.611 . . . . 0.0 110.355 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 65.3 -173.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.533 1.133 . . . . 0.0 112.254 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HD2' ' B' ' 63' ' ' PRO . 20.7 tptm -79.54 123.21 84.33 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.474 ' HD2' ' HD2' ' B' ' 62' ' ' LYS . 58.8 Cg_endo -71.35 72.45 2.27 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.777 2.318 . . . . 0.0 113.013 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.25 122.95 0.22 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -90.83 58.48 3.85 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.803 0.811 . . . . 0.0 111.889 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.99 2.93 21.64 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.777 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.29 151.88 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 109.135 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . 0.28 9.6 tt 68.74 -50.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 127.993 2.517 . . . . 0.0 113.859 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -89.94 71.59 7.51 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.97 -66.99 1.01 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.89 -174.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.073 1.349 . . . . 0.0 109.287 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.4 -83.5 1.1 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.37 94.56 7.41 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.81 60.64 0.51 Allowed Glycine 0 C--O 1.244 0.761 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.1 ttt -77.21 94.38 4.1 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.71 -0.745 . . . . 0.0 110.05 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' B' ' 79' ' ' GLU . . . -78.45 163.61 50.3 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.532 171.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -73.29 -69.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.6 m -99.99 -8.11 24.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.685 0.794 . . . . 0.0 110.151 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.53 ' HB2' ' HA3' ' B' ' 76' ' ' GLY . 1.8 mp0 -75.9 -16.83 59.97 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.296 0.638 . . . . 0.0 111.055 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 tt -82.58 -22.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.507 0.723 . . . . 0.0 110.957 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.2 m -143.73 105.14 4.28 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.247 0.619 . . . . 0.0 110.605 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' B' ' 86' ' ' TYR . . . -150.08 -168.56 3.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.026 0.93 . . . . 0.0 109.768 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.51 168.83 5.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 0.0 111.112 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -74.02 83.26 1.75 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 110.692 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -124.54 -28.56 3.58 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.593 1.157 . . . . 0.0 109.623 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' B' ' 82' ' ' ALA . 50.2 m-85 -79.76 83.25 5.73 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.413 0.685 . . . . 0.0 110.268 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.7 -68.95 0.16 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -175.8 123.68 0.2 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.4 -101.2 0.25 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.51 -65.73 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.261 1.424 . . . . 0.0 111.66 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.45 115.23 7.13 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 123.3 0.476 . . . . 0.0 113.027 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.89 12.32 47.06 Favored Glycine 0 N--CA 1.471 1.03 0 CA-C-O 119.95 -0.361 . . . . 0.0 112.415 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.467 ' CZ ' ' HA ' ' B' ' 131' ' ' TRP . 4.0 m-85 69.49 -77.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.026 1.33 . . . . 0.0 111.474 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -120.66 140.93 50.88 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -148.32 152.28 36.81 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.35 -78.83 1.88 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.558 HG23 ' H ' ' B' ' 98' ' ' ASP . 4.9 tp -175.24 -81.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 C-N-CA 124.518 1.127 . . . . 0.0 110.864 164.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.558 ' H ' HG23 ' B' ' 97' ' ' ILE . 26.4 t0 67.32 151.98 0.07 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.489 1.515 . . . . 0.0 111.898 -166.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.47 -156.0 0.68 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.184 0.594 . . . . 0.0 111.136 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.514 ' HB2' ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -61.43 -175.5 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.127 0 C-N-CA 125.0 1.32 . . . . 0.0 113.355 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 100' ' ' LEU . 32.2 Cg_exo -26.96 -19.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.392 1 C-N-CA 126.674 4.916 . . . . 0.0 119.653 167.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.88 84.67 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.012 1.325 . . . . 0.0 108.129 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -63.05 1.24 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.502 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.74 -129.01 9.75 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.078 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.446 HE22 ' HD3' ' A' ' 392' ' ' LYS . 81.2 mm-40 -83.17 95.59 8.16 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.394 0.678 . . . . 0.0 110.249 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 75.0 t80 58.86 -91.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.056 1.342 . . . . 0.0 110.502 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 p 38.78 37.73 0.22 Allowed 'General case' 0 C--N 1.38 1.91 0 C-N-CA 125.242 1.417 . . . . 0.0 113.779 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -81.34 13.45 2.93 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.057 -165.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.638 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 82.9 m-85 -86.16 108.46 18.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.053 0.941 . . . . 0.0 109.322 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 344' ' ' ARG . . . 67.33 100.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.918 1.287 . . . . 0.0 112.072 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.455 HD13 ' H ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -88.49 40.92 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.89 0.876 . . . . 0.0 110.486 174.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -147.12 33.89 0.9 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.216 1.406 . . . . 0.0 108.361 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -73.78 -42.1 61.47 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.279 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -160.82 -169.61 2.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.857 0.863 . . . . 0.0 109.651 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 72.4 m 62.04 97.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.063 1.345 . . . . 0.0 112.472 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.65 -70.39 3.12 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.771 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.434 ' HZ2' ' HB2' ' B' ' 117' ' ' LYS . 4.7 ttmp? -123.38 81.91 52.9 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.341 0.656 . . . . 0.0 111.067 -172.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.6 -62.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.661 2.241 . . . . 0.0 110.609 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.74 170.45 1.96 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.906 1.682 . . . . 0.0 108.28 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 90.9 t80 63.76 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.715 1.206 . . . . 0.0 113.3 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.67 -45.92 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.071 . . . . 0.0 112.59 -171.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m 65.87 140.9 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.965 1.306 . . . . 0.0 112.216 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -73.62 -174.27 1.69 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.568 1.147 . . . . 0.0 111.448 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 45.0 t -68.89 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.688 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 277' ' ' GLU . . . 63.57 -70.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.699 1.199 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.567 ' HB1' ' HG2' ' A' ' 428' ' ' MET . . . -112.96 148.34 35.23 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.785 0.834 . . . . 0.0 110.651 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 4.4 m 70.61 -1.45 2.57 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.901 1.68 . . . . 0.0 112.846 -172.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.599 ' HA ' ' HG2' ' A' ' 277' ' ' GLU . . . 65.25 146.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.019 1.328 . . . . 0.0 114.304 173.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 13.6 t -76.66 -11.01 59.79 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.837 166.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 72.0 -74.84 0.08 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.103 1.761 . . . . 0.0 110.269 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CZ ' ' B' ' 93' ' ' PHE . 6.0 m-90 -137.08 110.11 7.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.833 0.853 . . . . 0.0 109.111 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -93.54 -6.75 45.99 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.384 0.674 . . . . 0.0 111.865 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.588 ' HB ' ' HA3' ' A' ' 257' ' ' GLY . 88.0 m -59.99 -57.13 14.19 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 123.722 0.639 . . . . 0.0 110.033 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.3 -78.75 0.43 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.761 0.663 . . . . 0.0 113.161 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 5.9 p -61.01 114.31 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.896 0.878 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -141.37 121.21 13.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.0 m -57.02 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.131 0.973 . . . . 0.0 111.934 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 255' ' ' ARG . 77.0 t80 -98.81 -55.53 2.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.824 0.85 . . . . 0.0 109.916 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.556 HD21 ' HB3' ' B' ' 148' ' ' GLU . 86.4 m-20 74.52 -53.9 0.67 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.497 1.519 . . . . 0.0 112.372 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.53 -46.42 2.35 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 77.37 -24.69 0.21 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.732 1.613 . . . . 0.0 113.454 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt 59.06 22.39 10.46 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.124 . . . . 0.0 111.498 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.73 -119.38 4.03 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.56 98.78 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.349 0.66 . . . . 0.0 109.955 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -168.59 142.76 3.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.537 1.135 . . . . 0.0 109.484 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.5 pt -144.62 72.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.317 1.047 . . . . 0.0 110.095 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -97.99 92.5 5.82 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.186 0.993 . . . . 0.0 108.655 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.556 ' HB3' HD21 ' B' ' 139' ' ' ASN . 5.6 pt-20 -163.68 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.051 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.544 ' H ' ' HG3' ' B' ' 148' ' ' GLU . 0.0 OUTLIER -132.05 77.21 1.75 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 169.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.497 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.848 -0.427 . . . . 15.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -88.54 113.9 24.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 22.5 m -125.45 154.85 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.99 0.516 . . . . 15.0 110.555 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.7 p -144.06 142.99 30.96 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.344 1.058 . . . . 15.0 108.653 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.94 143.13 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.007 0.432 . . . . 15.0 110.402 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.7 mt-10 -133.7 155.36 49.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.031 1.332 . . . . 15.0 108.284 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.2 m -130.53 96.4 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.197 -1.038 . . . . 15.0 108.197 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.3 p -104.57 -29.1 10.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 15.0 112.358 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 58.2 tp60 -128.72 31.36 4.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.68 0.792 . . . . 15.0 110.134 -173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.41 -96.83 0.83 Allowed Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.348 -0.701 . . . . 15.0 111.348 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 -37.29 85.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.738 -0.838 . . . . 15.0 108.738 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 9' ' ' GLN . . . -66.98 93.03 0.21 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 114.913 -1.039 . . . . 15.0 113.124 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -102.22 173.72 6.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.047 0.939 . . . . 15.0 110.753 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.5 ttm180 -146.14 106.94 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.578 0.751 . . . . 15.0 109.732 -170.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.89 90.01 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.513 -0.921 . . . . 15.0 108.513 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 84.8 m -73.3 100.76 3.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.821 0.848 . . . . 15.0 109.967 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -98.11 117.02 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.884 0.874 . . . . 15.0 109.991 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -88.7 108.02 19.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 109.065 -0.716 . . . . 15.0 109.065 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' A' ' 103' ' ' PHE . 59.3 mt -78.4 102.64 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 167.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 157.53 33.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.946 0.498 . . . . 15.0 111.703 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.36 69.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.37 1.068 . . . . 15.0 112.897 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.66 -35.69 72.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.978 0.511 . . . . 15.0 110.261 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.1 m -72.79 -32.08 65.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.776 0.83 . . . . 15.0 110.669 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 28' ' ' VAL . 80.1 mt -70.85 -46.93 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.396 -0.82 . . . . 15.0 109.63 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.29 -39.06 72.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.865 0.866 . . . . 15.0 111.378 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -67.54 -47.25 70.44 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.582 -0.736 . . . . 15.0 110.605 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.73 77.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.491 -0.777 . . . . 15.0 112.81 -172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 24' ' ' ILE . 42.2 t -59.81 -47.92 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.678 0.611 . . . . 15.0 109.583 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' A' ' 51' ' ' MET . 4.5 ttmp? -56.56 -43.27 79.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.692 -1.14 . . . . 15.0 111.646 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.6 m -78.13 -16.66 57.75 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.298 -0.864 . . . . 15.0 111.748 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.92 -34.65 14.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.737 0.415 . . . . 15.0 111.449 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 85.1 mt -73.32 -32.31 64.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.33 0.652 . . . . 15.0 111.548 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HE2' ' A' ' 37' ' ' LYS . 11.7 p -66.52 -26.12 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.511 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -69.71 -38.5 76.94 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 15.0 110.776 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -65.8 -44.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.35 95.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.891 -1.049 . . . . 15.0 111.717 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 33' ' ' VAL . 67.2 mttm -69.97 -43.0 72.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.331 0.652 . . . . 15.0 111.364 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.48 -42.53 99.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.494 0.718 . . . . 15.0 111.367 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 t -91.05 -6.0 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.385 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 71.92 11.82 6.16 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.792 1.637 . . . . 15.0 113.104 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.57 -31.04 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.616 1.166 . . . . 15.0 111.575 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.94 -36.38 76.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.785 0.834 . . . . 15.0 111.174 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.99 -22.57 77.79 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.817 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.98 -9.24 31.6 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.555 0.742 . . . . 15.0 111.776 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -74.71 111.67 10.14 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -80.98 22.44 0.62 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.973 1.309 . . . . 15.0 112.097 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.56 22.8 75.27 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 123.023 0.344 . . . . 15.0 112.891 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -72.11 -61.79 1.66 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.859 0.463 . . . . 15.0 110.281 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.39 112.52 55.74 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 53' ' ' ILE . 23.3 Cg_exo -64.54 154.61 71.02 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.718 2.279 . . . . 15.0 112.379 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.593 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 56.5 tpp -73.29 -10.23 59.53 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.059 0.944 . . . . 15.0 112.086 -169.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 28.1 p-10 -77.37 -42.08 37.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.093 -0.38 . . . . 15.0 110.614 172.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.5 mt -67.63 -37.28 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.275 0.63 . . . . 15.0 111.128 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.4 -39.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 120.381 0.134 . . . . 15.0 111.229 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.73 66.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.581 0.752 . . . . 15.0 112.451 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.71 -2.65 18.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.23 0.455 . . . . 15.0 112.23 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -130.91 -66.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.336 0.517 . . . . 15.0 111.402 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -72.84 -12.7 61.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.496 0.718 . . . . 15.0 111.838 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -134.29 23.1 3.69 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.564 -0.576 . . . . 15.0 112.277 174.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.42 69.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.327 0.651 . . . . 15.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 p -82.69 -22.95 34.37 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.231 1.012 . . . . 15.0 111.738 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -79.05 87.42 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.973 -0.751 . . . . 15.0 108.973 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -108.61 -26.52 10.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.901 0.88 . . . . 15.0 110.089 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -56.27 -64.14 0.96 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.232 1.413 . . . . 15.0 111.927 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.16 -32.81 72.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 15.0 110.797 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.48 -67.09 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.31 1.044 . . . . 15.0 110.636 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.2 mt -66.47 -33.05 74.82 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.5 -0.773 . . . . 15.0 110.892 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.32 -45.0 97.35 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 123.033 0.208 . . . . 15.0 112.835 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.25 -49.29 74.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.306 1.043 . . . . 15.0 111.023 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 19' ' ' ILE . 98.3 mt -61.27 -56.2 23.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.145 -0.934 . . . . 15.0 111.574 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.432 ' HA ' ' OH ' ' A' ' 105' ' ' TYR . 70.2 mtm -56.65 -38.05 71.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 15.0 111.985 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.5 t -65.94 -50.78 63.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.279 0.987 . . . . 15.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -75.24 -37.09 61.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.968 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HD13 ' A' ' 17' ' ' ILE . 94.8 m-20 -58.89 -31.16 68.35 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.941 0.496 . . . . 15.0 111.281 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -67.66 -53.47 27.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.091 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.1 tt -68.84 -37.29 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 123.039 0.212 . . . . 15.0 111.041 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.04 -45.09 87.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.116 0.567 . . . . 15.0 110.672 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.65 -57.41 12.81 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 124.037 0.835 . . . . 15.0 111.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.33 -27.24 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -171.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.9 mt -69.0 -53.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.745 0.418 . . . . 15.0 110.265 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.97 -33.33 63.82 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.532 0.333 . . . . 15.0 111.53 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.17 -9.55 57.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.539 0.736 . . . . 15.0 111.321 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 60.76 36.23 19.35 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.271 1.028 . . . . 15.0 111.21 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.41 129.24 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.761 -0.829 . . . . 15.0 108.761 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -108.27 93.3 11.08 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.84 155.72 26.92 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.206 2.604 . . . . 15.0 112.998 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.03 98.6 11.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.325 0.65 . . . . 15.0 109.777 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.41 -130.42 29.06 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.797 0.686 . . . . 15.0 113.489 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.47 131.83 31.64 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.76 0.824 . . . . 15.0 110.665 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.47 164.36 10.91 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.926 2.418 . . . . 15.0 113.263 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.8 m -104.48 99.66 9.35 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.747 0.819 . . . . 15.0 109.664 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -76.85 97.69 4.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.8 0.84 . . . . 15.0 108.956 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.94 104.55 6.17 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.481 0.712 . . . . 15.0 109.652 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -74.87 119.93 5.89 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.681 2.254 . . . . 15.0 111.639 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.99 -68.22 1.74 Allowed Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.136 -0.786 . . . . 15.0 111.136 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.93 154.86 5.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.959 0.903 . . . . 15.0 110.026 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.474 ' HE1' HD13 ' A' ' 24' ' ' ILE . 84.0 t80 -112.7 146.01 39.47 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.315 0.646 . . . . 15.0 109.977 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.722 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.6 mttt -132.35 132.91 43.37 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.925 -1.139 . . . . 15.0 107.925 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.8 115.37 8.95 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.932 0.893 . . . . 15.0 110.684 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.95 87.72 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.406 0.441 . . . . 15.0 112.904 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -126.62 176.38 7.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.142 0.977 . . . . 15.0 109.584 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.27 129.84 39.38 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.687 0.795 . . . . 15.0 111.306 -172.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.551 ' HD2' HD12 ' A' ' 19' ' ' ILE . 28.5 t80 -87.45 146.17 25.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.723 0.809 . . . . 15.0 109.131 169.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -140.55 136.03 32.44 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' A' ' 71' ' ' MET . 8.4 p90 -149.91 140.67 22.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.901 0.88 . . . . 15.0 109.333 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.2 m -101.6 107.28 18.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.698 1.199 . . . . 15.0 110.734 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.74 96.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -93.85 128.44 40.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.274 0.63 . . . . 15.0 110.189 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -161.41 158.59 27.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.372 1.069 . . . . 15.0 109.012 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 46.2 mt-10 -105.1 141.13 37.2 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -99.24 172.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.453 0.701 . . . . 15.0 110.746 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -87.16 134.96 35.48 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.119 0.568 . . . . 15.0 110.563 174.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.45 160.74 6.7 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.274 . . . . 15.0 112.65 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -82.39 102.93 11.58 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG11 HD23 ' A' ' 350' ' ' LEU . 40.6 t -75.65 123.45 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.51 0.724 . . . . 15.0 110.486 -172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -89.65 93.9 9.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.39 0.676 . . . . 15.0 110.516 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HA ' ' OD1' ' A' ' 298' ' ' ASN . 92.7 mt -70.83 109.1 4.81 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.44 -174.28 3.26 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.994 0.918 . . . . 15.0 110.546 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.16 119.61 19.17 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.638 0.586 . . . . 15.0 113.718 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.45 HD12 ' HD3' ' A' ' 414' ' ' LYS . 66.2 mt -83.07 3.79 29.0 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.466 0.707 . . . . 15.0 110.809 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -75.26 -23.37 57.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.791 1.236 . . . . 15.0 110.243 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.86 66.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.024 0.93 . . . . 15.0 111.792 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HA3' ' A' ' 293' ' ' GLY . 21.2 mt -73.76 129.79 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 109.094 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 32.4 mt-10 -122.61 84.7 2.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 286' ' ' VAL . 60.1 t -84.38 140.59 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.623 1.169 . . . . 15.0 110.625 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -94.1 141.16 28.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.394 0.677 . . . . 15.0 109.428 172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 84.2 tttt -115.56 93.35 36.48 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 107.809 -1.182 . . . . 15.0 107.809 171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.18 108.77 2.05 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.701 2.267 . . . . 15.0 111.807 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -75.8 88.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.693 -0.854 . . . . 15.0 108.693 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 427' ' ' LEU . 28.3 t -107.2 147.02 12.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 114.462 -1.245 . . . . 15.0 108.535 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -145.65 133.67 21.43 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.496 -0.927 . . . . 15.0 108.496 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 278' ' ' LEU . 30.8 t -97.0 88.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.431 -0.952 . . . . 15.0 108.431 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.5 p -77.9 179.33 6.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.975 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' NH2' ' A' ' 267' ' ' ARG . 3.4 m-20 -53.48 -48.79 68.6 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.366 1.066 . . . . 15.0 112.138 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -42.9 88.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.79 0.436 . . . . 15.0 111.409 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -58.92 -57.04 14.84 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.861 0.726 . . . . 15.0 110.332 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG23 ' SD ' ' A' ' 274' ' ' MET . 12.4 p -63.58 -44.27 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.006 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.05 -49.42 76.05 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.556 0.742 . . . . 15.0 111.236 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.06 93.91 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.576 -0.738 . . . . 15.0 112.911 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.0 ttp -73.06 -25.52 60.94 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.942 0.897 . . . . 15.0 111.822 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.62 HD13 ' HG ' ' A' ' 266' ' ' LEU . 45.9 mt -73.53 -40.01 64.33 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.888 0.875 . . . . 15.0 110.048 173.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.6 -30.33 68.06 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.826 -0.624 . . . . 15.0 110.572 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.3 m -64.24 -42.94 96.3 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.857 0.463 . . . . 15.0 109.762 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.609 HD11 ' HB1' ' B' ' 128' ' ' ALA . 91.2 mt -56.92 -42.46 80.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.019 0.528 . . . . 15.0 110.632 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -68.04 -27.11 66.24 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.224 0.609 . . . . 15.0 111.398 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.92 -32.07 51.45 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.512 0.725 . . . . 15.0 111.629 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -78.17 -24.87 47.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.3 0.64 . . . . 15.0 110.6 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -108.05 29.56 7.18 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.223 1.009 . . . . 15.0 109.814 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -86.44 139.8 30.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 15.0 111.656 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.2 m -75.57 115.53 15.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 15.0 110.12 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -77.03 148.28 36.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.671 0.748 . . . . 15.0 110.875 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -153.87 141.16 19.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.1 -1.409 . . . . 15.0 108.234 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 40.8 mt-10 -74.49 158.51 33.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.847 0.832 . . . . 15.0 111.532 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HG3' HG13 ' A' ' 240' ' ' VAL . 53.6 pttt -156.59 174.85 14.84 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.069 -1.423 . . . . 15.0 110.002 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 21.8 m-20 -134.37 129.45 35.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.362 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.08 -159.88 20.48 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.986 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.65 110.25 0.55 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.265 1.026 . . . . 15.0 112.841 -167.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 237' ' ' LEU . 48.0 t -63.84 131.24 29.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 124.454 1.101 . . . . 15.0 111.495 172.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 30.1 tt0 -97.11 152.38 18.85 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.873 -0.788 . . . . 15.0 108.873 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -74.87 10.09 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.791 1.404 . . . . 15.0 114.791 -169.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 11.0 pt-20 -130.01 7.5 5.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.375 0.67 . . . . 15.0 110.984 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -77.98 159.38 28.83 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.831 0.824 . . . . 15.0 110.613 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -94.55 148.9 21.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.865 -1.902 . . . . 15.0 105.865 162.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG21 HG21 ' A' ' 202' ' ' ILE . 25.1 m -142.46 179.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.945 0.793 . . . . 15.0 110.981 -174.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 89.3 m -132.26 112.13 11.98 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.591 -1.186 . . . . 15.0 109.52 170.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.0 pt -112.1 -172.76 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.305 0.574 . . . . 15.0 111.94 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -157.16 93.31 1.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.369 1.468 . . . . 15.0 107.464 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.2 p90 -105.34 151.42 24.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.099 0.407 . . . . 15.0 112.099 -168.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 27.1 m -98.45 113.7 25.8 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.416 -0.811 . . . . 15.0 109.621 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.659 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -69.3 115.22 6.25 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.777 0.673 . . . . 15.0 114.119 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 232' ' ' LYS . 3.6 m -137.47 137.85 39.13 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.814 0.846 . . . . 15.0 109.447 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 177' ' ' PHE . 79.3 t -104.43 121.18 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.85 -1.167 . . . . 15.0 107.85 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.81 8.31 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 O-C-N 124.238 0.961 . . . . 15.0 112.104 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.5 -10.35 28.32 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 122.896 0.284 . . . . 15.0 113.456 -175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -99.45 113.8 26.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.959 0.904 . . . . 15.0 109.075 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 147.61 53.14 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.966 0.412 . . . . 15.0 111.033 176.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 172' ' ' VAL . 34.4 p90 -141.19 152.03 44.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.731 0.812 . . . . 15.0 109.776 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.72 145.78 46.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.162 0.585 . . . . 15.0 111.497 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.48 -25.55 12.72 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 115.798 -0.637 . . . . 15.0 112.896 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.36 -2.78 88.09 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 115.066 0.786 . . . . 15.0 115.066 -164.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.659 ' HG3' ' H ' ' A' ' 170' ' ' GLY . 8.6 mptt -102.22 144.89 30.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.515 0.726 . . . . 15.0 109.375 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -141.4 118.2 11.09 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 123.528 0.517 . . . . 15.0 109.907 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 p -102.27 131.96 48.52 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.902 1.281 . . . . 15.0 109.676 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.9 t70 63.5 28.43 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.355 1.074 . . . . 15.0 109.634 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -71.89 121.95 19.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.207 -1.361 . . . . 15.0 110.75 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.75 122.95 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-N 115.466 -0.788 . . . . 15.0 110.148 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' A' ' 194' ' ' MET . 54.8 tp -124.66 135.78 53.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.541 0.736 . . . . 15.0 110.506 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -120.46 151.13 39.74 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.038 0.935 . . . . 15.0 109.759 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.609 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 45.7 mtt -106.47 154.42 20.87 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.87 0.868 . . . . 15.0 112.922 -166.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.49 1.4 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.056 -0.974 . . . . 15.0 113.288 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -128.98 145.74 51.16 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.959 0.903 . . . . 15.0 110.28 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.81 51.41 4.56 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.088 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' B' ' 23' ' ' THR . 28.7 ttm180 -104.34 26.73 8.55 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.685 0.755 . . . . 15.0 109.435 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -167.8 -172.19 1.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.501 1.12 . . . . 15.0 108.881 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.565 HG23 ' HD3' ' A' ' 218' ' ' PRO . 90.9 mt -65.03 118.73 52.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.238 1.015 . . . . 15.0 108.824 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.97 105.86 0.41 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.953 2.435 . . . . 15.0 112.576 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.14 10.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.527 -0.761 . . . . 15.0 112.092 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.563 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 65.0 t80 -63.84 -37.07 86.01 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.322 1.049 . . . . 15.0 111.182 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.58 -24.66 67.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 15.0 112.717 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -46.86 -47.02 21.36 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.504 1.522 . . . . 15.0 113.219 -172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.92 -45.53 95.97 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.853 -1.067 . . . . 15.0 113.636 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.588 HG22 HG11 ' A' ' 158' ' ' VAL . 4.3 mp -60.34 -38.17 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.279 0.632 . . . . 15.0 110.474 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.609 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 56.4 mtpt -70.95 10.09 0.59 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.108 1.363 . . . . 15.0 114.404 -169.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.05 37.54 0.86 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 118.281 0.491 . . . . 15.0 112.257 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.66 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 66.8 m80 -143.76 -164.48 1.89 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.054 0.942 . . . . 15.0 108.876 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 171.51 11.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.997 0.919 . . . . 15.0 110.519 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.69 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -81.85 38.93 0.53 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.874 0.87 . . . . 15.0 113.103 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.11 50.97 0.52 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 109.408 -1.477 . . . . 15.0 109.408 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 21.9 mm-40 -129.07 162.6 27.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.703 1.001 . . . . 15.0 113.703 -167.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 236' ' ' ASN . 19.4 tt0 -157.28 128.69 6.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 112.994 -1.912 . . . . 15.0 108.027 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -164.63 157.16 16.57 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.609 0.764 . . . . 15.0 110.527 -170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 40.0 m -117.31 112.63 21.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.29 0.636 . . . . 15.0 109.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 201' ' ' GLY . 36.6 pt -98.53 148.01 6.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 121.293 0.568 . . . . 15.0 112.243 -171.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.82 103.96 16.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.6 -1.182 . . . . 15.0 108.683 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 198' ' ' PHE . 15.7 m -121.21 -179.27 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.775 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.6 m -137.96 133.75 34.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.571 -1.195 . . . . 15.0 108.32 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HE2' HG22 ' A' ' 172' ' ' VAL . 50.0 m-85 -58.54 161.82 7.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.23 1.012 . . . . 15.0 111.899 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 195' ' ' ILE . 62.2 Cg_endo -81.63 156.18 18.55 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.376 2.051 . . . . 15.0 110.599 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 40.8 mt-10 -78.8 1.69 22.4 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.7 0.4 . . . . 15.0 111.546 172.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.08 0.29 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.294 1.038 . . . . 15.0 110.914 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.84 141.56 48.7 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.379 0.672 . . . . 15.0 111.049 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -59.49 -47.44 85.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.321 1.048 . . . . 15.0 111.691 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.611 ' HA ' ' HB ' ' B' ' 5' ' ' THR . . . -76.03 111.26 11.24 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.188 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -71.23 -27.1 63.24 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.49 0.494 . . . . 15.0 110.911 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -57.98 -28.24 64.19 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.968 0.907 . . . . 15.0 111.063 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 65.3 mt -115.6 -4.46 12.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.312 1.045 . . . . 15.0 112.119 -171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.3 ptpt -72.77 118.63 15.94 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.623 1.101 . . . . 15.0 110.335 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.47 69.62 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 115.539 -0.755 . . . . 15.0 112.77 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -96.86 135.65 38.54 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.05 116.48 11.4 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.82 160.69 17.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.811 0.844 . . . . 15.0 111.701 -172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 0.0 OUTLIER -116.78 123.04 46.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.463 -1.244 . . . . 15.0 108.469 174.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -126.45 113.4 16.79 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.16 -0.681 . . . . 15.0 109.16 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -79.34 79.74 5.76 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.68 0.752 . . . . 15.0 109.744 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.91 108.19 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 113.621 -1.627 . . . . 15.0 110.993 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 210' ' ' GLU . 27.2 t-20 -93.77 85.98 4.98 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.238 -1.023 . . . . 15.0 108.238 171.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 158' ' ' VAL . 23.6 tp -68.54 102.64 1.5 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.659 1.184 . . . . 15.0 110.299 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.77 -45.12 8.17 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.366 0.666 . . . . 15.0 111.013 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.5 mmmt -136.47 153.18 51.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 15.0 110.478 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.755 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.3 p -129.71 140.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 169.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 33.3 mt-10 -120.06 122.52 41.28 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.054 0.941 . . . . 15.0 110.737 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -93.53 147.67 22.77 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 15.0 111.015 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -87.64 140.73 29.22 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.576 -0.898 . . . . 15.0 108.576 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -119.7 125.0 47.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.031 0.533 . . . . 15.0 110.04 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.05 113.28 6.17 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.347 1.059 . . . . 15.0 110.263 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 56.4 Cg_endo -67.79 172.27 10.88 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.403 2.068 . . . . 15.0 111.016 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.55 139.32 58.75 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.536 -0.757 . . . . 15.0 110.864 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -91.08 30.38 1.24 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.879 0.872 . . . . 15.0 109.428 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 251' ' ' GLU . 40.9 m -55.39 140.66 39.1 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.057 1.343 . . . . 15.0 110.833 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.95 -38.4 50.33 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.033 0.933 . . . . 15.0 112.147 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 249' ' ' THR . 36.6 mt-10 -64.24 -36.29 83.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.54 1.136 . . . . 15.0 111.5 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -73.67 -50.68 19.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.629 0.772 . . . . 15.0 109.158 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.754 HG23 HD13 ' A' ' 266' ' ' LEU . 58.3 mt -48.57 -52.38 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.05 1.34 . . . . 15.0 110.958 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -79.18 -11.61 59.97 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.65 -0.705 . . . . 15.0 112.399 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -62.47 -30.42 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.465 0.65 . . . . 15.0 110.217 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -80.45 -26.78 38.16 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.689 -1.141 . . . . 15.0 111.414 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 121.02 69.15 0.28 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 123.155 0.284 . . . . 15.0 112.725 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.81 110.32 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.567 -0.901 . . . . 15.0 108.567 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -50.32 69.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.149 0.579 . . . . 15.0 111.173 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -90.73 64.49 5.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.89 49.48 4.22 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.41 -0.813 . . . . 15.0 114.938 -167.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -95.27 -174.67 3.27 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.002 -0.74 . . . . 15.0 109.002 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.02 -62.01 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.96 -30.7 66.21 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 15.0 110.421 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.6 -30.33 62.23 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.0 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 253' ' ' ILE . 58.8 tp -70.99 -47.91 56.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.862 -1.162 . . . . 15.0 107.862 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 134' ' ' ASP . 30.4 mtp85 -55.23 -53.08 60.61 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.639 -1.164 . . . . 15.0 111.226 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.19 -50.48 47.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.553 0.741 . . . . 15.0 112.226 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -66.53 -44.69 81.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.471 0.709 . . . . 15.0 110.722 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 141' ' ' LEU . 76.9 t -71.49 -37.38 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-O 117.845 -1.074 . . . . 15.0 111.247 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 274' ' ' MET . 12.0 ptm180 -68.72 -32.33 72.04 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.146 1.339 . . . . 15.0 110.392 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -57.32 -52.24 66.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.887 0.875 . . . . 15.0 110.382 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -71.72 -29.89 65.03 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.835 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.484 ' SD ' HG11 ' A' ' 132' ' ' VAL . 44.1 mtt -69.05 -37.11 78.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.138 0.575 . . . . 15.0 110.374 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.01 -31.15 23.63 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.724 0.81 . . . . 15.0 110.926 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -60.36 -44.69 95.36 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.381 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -76.21 -28.43 57.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.049 -0.978 . . . . 15.0 111.316 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 132' ' ' VAL . 32.7 tp -65.51 -50.25 65.98 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 123.536 0.734 . . . . 15.0 110.589 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -65.5 -28.97 69.57 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.544 0.527 . . . . 15.0 110.517 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.5 t -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.316 0.646 . . . . 15.0 110.323 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.11 44.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.74 0.816 . . . . 15.0 111.096 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.69 -40.78 90.24 Favored 'Isoleucine or valine' 0 C--N 1.364 1.208 0 N-CA-C 108.257 -1.016 . . . . 15.0 108.257 168.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -63.15 -45.42 91.97 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 122.827 0.451 . . . . 15.0 109.962 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -61.47 -45.87 92.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.671 0.789 . . . . 15.0 110.407 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.34 -58.5 8.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.663 0.785 . . . . 15.0 110.981 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 125' ' ' VAL . 73.8 t -61.44 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.638 1.175 . . . . 15.0 111.267 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 408' ' ' VAL . 84.8 tttt -67.17 -42.32 84.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -69.02 -36.41 77.75 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.485 0.314 . . . . 15.0 111.42 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -69.64 -37.97 76.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.576 0.351 . . . . 15.0 110.869 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -58.84 -48.85 79.91 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.674 0.608 . . . . 15.0 110.702 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 287' ' ' LYS . 25.3 mm -64.74 -51.57 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.464 1.106 . . . . 15.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -57.32 -50.12 73.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.124 0.97 . . . . 15.0 110.492 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.485 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.96 -36.59 91.22 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 114.952 -1.022 . . . . 15.0 113.185 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 3.5 tt -61.05 -54.09 49.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.618 0.767 . . . . 15.0 109.418 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 347' ' ' VAL . 60.3 t -63.87 -44.69 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.278 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -56.1 -38.92 71.37 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.922 0.889 . . . . 15.0 111.261 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.6 -18.17 61.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 15.0 112.711 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.486 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 42.1 m-80 -120.89 159.08 26.26 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.485 0.66 . . . . 15.0 112.569 -169.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -123.54 147.44 47.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.462 -1.245 . . . . 15.0 109.153 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.434 HG21 HG13 ' A' ' 346' ' ' VAL . 7.5 tt -167.66 143.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 15.0 109.812 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -104.91 116.61 32.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.849 -1.167 . . . . 15.0 107.849 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 307' ' ' ILE . 58.2 t -92.49 127.13 49.75 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.47 0.708 . . . . 15.0 110.035 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.47 145.46 97.98 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.387 2.058 . . . . 15.0 111.007 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.56 64.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.997 1.319 . . . . 15.0 113.546 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -39.08 -56.65 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.351 1.46 . . . . 15.0 114.272 -170.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.46 -39.24 85.32 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.196 0.598 . . . . 15.0 112.073 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 311' ' ' ILE . 65.3 mt -60.93 -50.88 78.73 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.3 -28.48 68.04 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.233 0.958 . . . . 15.0 112.297 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 313' ' ' VAL . 54.6 m -59.78 -54.9 40.88 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.632 -0.507 . . . . 15.0 109.632 168.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.8 -28.36 68.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.801 -0.636 . . . . 15.0 112.197 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 34.9 mm -60.34 -55.35 24.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.701 -1.222 . . . . 15.0 107.701 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.615 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 38.6 t70 -58.5 -44.0 89.3 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 124.515 1.135 . . . . 15.0 111.518 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 309' ' ' SER . 87.9 t -56.16 -47.52 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 123.742 0.651 . . . . 15.0 110.975 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.506 HD21 ' NH1' ' A' ' 344' ' ' ARG . 96.0 mt -72.93 -25.18 60.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.474 0.709 . . . . 15.0 112.859 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.4 mtm180 -72.65 -45.54 58.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.814 0.445 . . . . 15.0 109.943 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 17.2 mtm180 -62.94 -44.97 94.62 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.749 0.655 . . . . 15.0 109.698 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' B' ' 118' ' ' PRO . 6.1 tt0 -53.63 -49.79 67.11 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.074 1.35 . . . . 15.0 112.184 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.05 -58.16 8.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.945 0.778 . . . . 15.0 110.776 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.0 -42.05 65.23 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.103 0.877 . . . . 15.0 111.879 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.92 -33.56 73.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.363 1.065 . . . . 15.0 112.499 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -106.42 -63.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.149 0.5 . . . . 15.0 110.385 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -72.05 84.03 0.99 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.163 -0.926 . . . . 15.0 110.05 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 110.59 -49.38 0.85 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 114.908 -1.042 . . . . 15.0 113.575 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 90.75 40.62 5.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 109.959 -1.257 . . . . 15.0 109.959 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 77.2 m-20 -65.9 114.09 4.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.969 0.907 . . . . 15.0 110.741 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.04 88.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.26 1.424 . . . . 15.0 111.941 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm 64.83 5.75 2.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.045 1.338 . . . . 15.0 112.981 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 28.7 mm-40 -67.45 -17.39 64.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.472 0.709 . . . . 15.0 110.364 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.01 -58.29 3.28 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.35 1.46 . . . . 15.0 111.313 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.063 0.945 . . . . 15.0 111.689 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -94.9 -20.05 19.74 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.646 0.779 . . . . 15.0 112.112 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 88.6 mt -56.78 134.05 78.81 Favored Pre-proline 0 N--CA 1.495 1.825 0 CA-C-N 117.965 0.348 . . . . 15.0 110.545 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.93 150.48 71.97 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.082 2.521 . . . . 15.0 113.943 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -53.75 -52.02 61.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.713 0.805 . . . . 15.0 109.645 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.13 -10.68 24.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.391 -1.277 . . . . 15.0 113.283 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -33.13 75.23 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HD1' HE21 ' A' ' 340' ' ' GLN . 91.4 m-85 -127.43 -6.27 5.86 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 118.668 -0.682 . . . . 15.0 112.546 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 311' ' ' ILE . 32.1 tt0 -51.88 -38.82 57.61 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -171.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 41.4 tt0 -55.11 -56.87 14.94 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.581 0.551 . . . . 15.0 111.142 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HD1' ' A' ' 337' ' ' PHE . 18.0 pt20 -75.54 -39.96 57.56 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 119.149 -0.453 . . . . 15.0 111.305 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 344' ' ' ARG . . . -63.62 -48.96 75.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.728 0.811 . . . . 15.0 110.968 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.4 tttt -59.62 -45.21 92.63 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 114.754 -1.112 . . . . 15.0 110.606 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -59.05 -41.47 87.95 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.196 0.998 . . . . 15.0 110.264 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.506 ' NH1' HD21 ' A' ' 314' ' ' LEU . 38.7 mtt180 -60.98 -47.1 88.0 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.629 1.172 . . . . 15.0 110.678 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.1 t -63.76 -39.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.774 -0.648 . . . . 15.0 111.072 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 342' ' ' LYS . 52.3 t -55.85 -47.4 79.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 C-N-CA 123.806 0.842 . . . . 15.0 109.233 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.618 HG22 HG21 ' A' ' 295' ' ' VAL . 21.6 t -54.65 -51.35 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.865 0.728 . . . . 15.0 111.358 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.14 -27.45 72.35 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.828 0.705 . . . . 15.0 113.694 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.4 mt -83.0 -32.99 26.66 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.9 0.48 . . . . 15.0 111.567 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 115' ' ' VAL . 96.6 mt -70.55 -47.59 59.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 407' ' ' ALA . 56.2 mt -67.66 -35.45 78.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.865 0.866 . . . . 15.0 110.543 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.41 -36.15 92.09 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.818 -0.513 . . . . 15.0 111.818 172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -73.5 -36.2 65.72 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.815 -0.692 . . . . 15.0 111.039 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 350' ' ' LEU . 91.3 t -58.56 -43.71 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.3 mp -64.57 -46.86 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.534 -0.757 . . . . 15.0 110.876 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -66.91 -68.04 0.41 Allowed 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.293 0.37 . . . . 15.0 110.063 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 m -53.43 -44.11 68.55 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.672 1.189 . . . . 15.0 113.336 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.71 15.51 28.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.357 0.263 . . . . 15.0 110.879 -174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 44.14 41.79 4.47 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.536 1.534 . . . . 15.0 113.21 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.0 tt -79.5 110.22 14.6 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.111 -0.949 . . . . 15.0 109.521 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.23 170.07 12.46 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.37 1.068 . . . . 15.0 111.447 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.16 170.99 14.39 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.234 0.614 . . . . 15.0 110.407 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 7.9 t0 -131.2 95.92 3.9 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.29 -29.03 70.43 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.906 0.882 . . . . 15.0 111.655 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.53 -25.38 57.16 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.343 -0.844 . . . . 15.0 110.106 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -88.19 -24.23 23.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.008 -0.738 . . . . 15.0 109.008 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 398' ' ' MET . 44.0 t -58.85 -52.5 59.61 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 166.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -56.5 -53.16 60.7 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 115.115 -0.948 . . . . 15.0 111.165 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.59 64.77 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 124.175 0.922 . . . . 15.0 113.497 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.682 HD23 ' SD ' ' A' ' 398' ' ' MET . 56.7 tp -60.14 -52.74 64.02 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.928 0.891 . . . . 15.0 111.321 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.451 HG23 HG11 ' A' ' 384' ' ' VAL . 85.2 mt -61.49 -39.95 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.436 0.694 . . . . 15.0 111.644 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -79.49 -32.83 42.54 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.946 0.498 . . . . 15.0 111.58 -173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -70.28 -31.5 68.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.107 0.163 . . . . 15.0 110.878 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttp -65.87 -48.87 70.1 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.701 0.4 . . . . 15.0 109.955 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.24 58.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.107 0.963 . . . . 15.0 112.093 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.2 t -55.81 -31.18 62.44 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.223 0.609 . . . . 15.0 111.379 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 4.49 53.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.591 0.756 . . . . 15.0 112.497 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -167.13 103.04 0.54 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.81 12.27 0.54 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.7 1.37 . . . . 15.0 114.7 -164.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' B' ' 139' ' ' ASN . 20.4 t70 -110.69 96.81 30.07 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 168.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.75 -4.84 9.9 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.125 1.883 . . . . 15.0 111.725 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -62.79 -38.02 89.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.677 0.791 . . . . 15.0 112.594 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -37.41 70.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 123.428 0.455 . . . . 15.0 110.47 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.451 HG11 HG23 ' A' ' 371' ' ' ILE . 36.1 t -75.19 -62.22 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.594 0.758 . . . . 15.0 109.762 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.92 -46.28 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.678 0.791 . . . . 15.0 110.405 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -73.83 -34.35 64.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 118.669 -0.681 . . . . 15.0 112.224 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.58 -44.81 95.79 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.078 0.854 . . . . 15.0 110.084 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.521 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 3.2 m-30 -67.26 -56.14 11.05 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.296 -0.865 . . . . 15.0 110.856 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 36.0 p -60.68 -30.44 69.93 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.522 0.729 . . . . 15.0 112.261 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -93.87 -12.09 29.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.115 0.566 . . . . 15.0 112.07 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.19 123.89 8.52 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.429 0.559 . . . . 15.0 110.664 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -58.29 -26.57 63.14 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.593 1.157 . . . . 15.0 112.365 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -33.01 -67.11 0.13 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.585 1.954 . . . . 15.0 113.713 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 99' ' ' ALA . 13.6 tp -102.91 -3.6 25.95 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.025 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 5.0 tpt -70.29 -62.04 1.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.126 0.57 . . . . 15.0 110.778 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.57 84.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' B' ' 102' ' ' LEU . 25.3 t-20 -58.59 -46.21 87.45 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 124.501 1.126 . . . . 15.0 110.869 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.682 ' SD ' HD23 ' A' ' 370' ' ' LEU . 37.3 tpp -58.67 -29.21 66.41 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.365 0.416 . . . . 15.0 111.642 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.5 mtm105 -80.88 -31.56 35.2 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.154 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' B' ' 106' ' ' TYR . 49.6 m-80 -64.66 -33.11 75.18 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 15.0 110.345 168.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.0 t -72.34 -44.91 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.726 . . . . 15.0 109.316 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.64 69.68 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.023 0.529 . . . . 15.0 111.032 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 355' ' ' ILE . 39.9 tp -68.79 -37.25 79.13 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.001 0.92 . . . . 15.0 110.234 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -71.32 -41.11 70.29 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.217 1.007 . . . . 15.0 109.848 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 7.1 mm-40 -63.17 -49.54 73.87 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.726 -1.124 . . . . 15.0 109.937 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 10.5 tt0 -72.09 -26.91 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.022 0.826 . . . . 15.0 110.986 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -57.95 -51.74 68.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.903 0.481 . . . . 15.0 109.836 169.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 287' ' ' LYS . 83.4 t -62.27 -40.21 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.281 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 5.2 mm-40 -58.2 -42.7 86.76 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.306 0.503 . . . . 15.0 110.878 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.76 71.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.839 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 407' ' ' ALA . 73.4 t -77.56 -33.5 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.4 -31.06 62.2 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.933 . . . . 15.0 110.67 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.86 -22.33 66.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.573 0.749 . . . . 15.0 111.33 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.45 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.6 mtpp -104.57 -34.17 8.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.358 1.063 . . . . 15.0 111.283 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.46 169.96 15.79 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.991 0.917 . . . . 15.0 111.092 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 94.6 mttt -78.94 115.83 18.87 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 52.4 t -111.89 78.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 107.448 -1.315 . . . . 15.0 107.448 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -78.98 107.65 11.89 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.377 -0.829 . . . . 15.0 110.7 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 39.8 tt0 -76.43 132.34 39.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.557 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -153.17 131.31 11.9 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.814 0.846 . . . . 15.0 109.857 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 43.6 mt-10 -67.09 130.3 42.69 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.666 0.604 . . . . 15.0 109.763 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.419 ' HB ' HG22 ' A' ' 130' ' ' VAL . 27.4 m -133.42 140.47 47.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.054 0.942 . . . . 15.0 108.674 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 81.3 p -64.77 164.53 12.06 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.548 0.339 . . . . 15.0 110.806 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -50.83 -54.38 24.19 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.424 1.089 . . . . 15.0 112.653 -170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -22.3 21.15 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 119.059 -0.496 . . . . 15.0 111.744 -172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -54.35 -31.87 55.49 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 123.799 0.84 . . . . 15.0 112.781 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.51 ' HB2' HG21 ' A' ' 130' ' ' VAL . 48.3 tp -57.17 -48.7 78.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.959 0.904 . . . . 15.0 111.565 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.464 ' HE3' ' H ' ' B' ' 127' ' ' SER . 0.0 OUTLIER -121.66 31.4 6.28 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.569 0.748 . . . . 15.0 111.538 -173.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -95.38 31.76 1.91 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.914 0.864 . . . . 15.0 109.201 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -92.86 132.48 36.98 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.168 0.987 . . . . 15.0 109.806 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.28 -46.69 22.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.807 0.843 . . . . 15.0 109.589 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.524 1.129 . . . . 15.0 108.372 178.163 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? 61.41 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.579 1.552 . . . . 0.0 109.985 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -130.21 -165.19 1.51 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.683 1.193 . . . . 0.0 110.03 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p 53.57 36.59 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.103 1.361 . . . . 0.0 112.253 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 223' ' ' ALA . 27.6 p -125.16 -57.37 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.382 1.073 . . . . 0.0 108.244 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.69 86.93 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.338 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.43 55.86 1.79 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 12' ' ' PRO . 13.1 mt -76.3 -170.51 1.48 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.928 -1.487 . . . . 0.0 113.454 -158.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.73 -61.15 0.5 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.837 1.655 . . . . 0.0 112.035 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.534 ' HB2' ' NE2' ' B' ' 35' ' ' GLN . 3.8 pp -65.68 -23.15 66.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' HB3' ' HD3' ' B' ' 12' ' ' PRO . 2.3 tm? -168.84 -58.91 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.999 174.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.642 ' HB2' HD23 ' B' ' 8' ' ' LEU . 83.1 Cg_exo -51.08 -19.01 5.28 Favored 'Trans proline' 0 C--N 1.404 3.484 0 C-N-CA 123.434 2.756 . . . . 0.0 116.958 -167.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' B' ' 8' ' ' LEU . 1.1 tt -145.63 72.53 1.31 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 tt -174.78 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.78 5.36 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.828 1.651 . . . . 0.0 114.37 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 83.5 m -114.85 90.87 23.98 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.001 0.92 . . . . 0.0 109.937 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -96.48 17.52 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.393 2.728 . . . . 0.0 112.394 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.03 144.31 31.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 124.181 0.992 . . . . 0.0 109.001 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.1 p -85.61 118.51 25.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.252 0.621 . . . . 0.0 110.785 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 52.77 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.715 1.606 . . . . 0.0 114.958 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.25 -65.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -161.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -69.15 146.85 52.13 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -161.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.571 ' HA ' ' NH2' ' A' ' 193' ' ' ARG . 92.4 m -105.79 110.25 63.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.889 1.276 . . . . 0.0 110.839 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.56 -86.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.793 2.329 . . . . 0.0 111.24 170.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.3 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.376 1.47 . . . . 0.0 113.286 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.9 ttp 55.36 73.77 0.82 Allowed Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.617 1.167 . . . . 0.0 111.07 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.38 141.15 5.68 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.748 2.298 . . . . 0.0 113.157 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.2 133.87 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.54 0.736 . . . . 0.0 109.164 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.94 -159.39 0.27 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.945 0.898 . . . . 0.0 110.254 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.63 -178.94 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.777 0.831 . . . . 0.0 109.842 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -99.36 21.3 12.24 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 0.0 109.914 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 11.05 22.52 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.904 0.882 . . . . 0.0 111.401 -172.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.09 -17.05 36.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.804 1.242 . . . . 0.0 113.512 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 74.64 -172.97 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.153 1.381 . . . . 0.0 111.606 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.534 ' NE2' ' HB2' ' B' ' 10' ' ' LEU . 10.3 pt20 -142.17 -177.52 5.28 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.17 0.988 . . . . 0.0 110.701 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.94 -40.21 2.13 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.59 151.13 42.53 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 5.7 tt 57.63 6.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 126.728 2.011 . . . . 0.0 113.122 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.516 HG21 HD21 ' B' ' 10' ' ' LEU . 28.3 m -89.67 131.7 35.52 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.382 0.673 . . . . 0.0 109.482 -176.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.15 69.97 1.37 Allowed Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.553 1.141 . . . . 0.0 110.846 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.98 22.4 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.358 2.705 . . . . 0.0 112.346 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.98 -167.86 31.9 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.39 147.66 14.42 Favored Glycine 0 N--CA 1.463 0.487 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.92 70.12 6.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.756 0.789 . . . . 0.0 109.294 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -64.13 124.27 21.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.351 1.06 . . . . 0.0 110.72 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.28 9.19 6.93 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 124.439 1.096 . . . . 0.0 112.303 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.79 42.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.17 0.588 . . . . 0.0 112.529 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -65.49 150.68 47.97 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.203 0.601 . . . . 0.0 111.716 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.48 152.16 42.66 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -75.66 -8.61 57.23 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -69.38 -84.81 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 122.76 0.424 . . . . 0.0 111.163 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.4 m -111.28 -80.96 0.58 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.09 -61.32 1.73 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.307 1.043 . . . . 0.0 108.427 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.02 103.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.226 1.411 . . . . 0.0 112.531 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.85 -20.27 46.39 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.892 0.877 . . . . 0.0 110.994 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -135.86 128.26 30.34 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.325 1.05 . . . . 0.0 108.939 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 62.22 -167.77 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.806 1.242 . . . . 0.0 112.122 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 54.9 m -132.18 177.2 7.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.511 1.124 . . . . 0.0 109.587 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER 40.08 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.494 1.918 . . . . 0.0 114.084 -174.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 50.9 m -147.38 94.07 2.33 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.26 150.41 45.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.696 0.399 . . . . 0.0 110.212 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -135.38 86.79 29.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.629 1.172 . . . . 0.0 109.183 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -82.07 -170.63 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.947 2.432 . . . . 0.0 112.092 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.5 -35.69 65.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.881 0.872 . . . . 0.0 111.455 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -66.45 93.34 0.23 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.431 0.692 . . . . 0.0 109.837 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -91.4 158.01 16.76 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.474 0.709 . . . . 0.0 109.702 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.23 162.84 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.801 0.841 . . . . 0.0 112.324 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.96 133.54 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.938 0.895 . . . . 0.0 109.023 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.03 124.11 32.09 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.3 136.97 41.18 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.882 0.473 . . . . 0.0 109.951 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp 77.78 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 125.627 1.571 . . . . 0.0 111.704 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.44 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 123.116 0.388 . . . . 0.0 113.412 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -57.94 -57.65 11.87 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.197 0.999 . . . . 0.0 110.892 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.82 123.38 0.67 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 27.0 ttt -84.03 77.67 9.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.904 0.852 . . . . 0.0 110.213 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.24 57.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 55.78 -171.07 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.938 1.295 . . . . 0.0 112.619 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 33.3 p -83.52 -63.31 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.024 0.529 . . . . 0.0 110.751 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -40.61 5.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.781 0.432 . . . . 0.0 110.988 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 tp -79.83 87.16 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 122.215 1.007 . . . . 0.0 110.271 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 45.9 p -97.9 -54.29 3.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.761 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.63 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.828 1.651 . . . . 0.0 114.355 169.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.85 86.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.448 0.699 . . . . 0.0 110.8 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 20.1 ptt85 -66.81 -56.16 11.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.097 0.959 . . . . 0.0 111.247 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 171.44 151.59 0.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.797 1.639 . . . . 0.0 108.29 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -111.82 81.15 1.41 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HA2' ' B' ' 91' ' ' GLY . . . -172.88 108.57 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.386 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -85.09 107.42 17.17 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.24 72.28 1.0 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.42 128.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.509 1.524 . . . . 0.0 111.494 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' B' ' 87' ' ' ALA . . . -63.44 -69.66 1.26 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.44 0.462 . . . . 0.0 112.912 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.79 -61.39 4.75 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 122.983 0.325 . . . . 0.0 112.32 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.747 ' HB3' ' HA3' ' B' ' 134' ' ' GLY . 97.1 m-85 63.24 17.03 9.91 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.781 1.232 . . . . 0.0 112.319 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -178.05 -69.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.7 155.22 4.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.348 1.059 . . . . 0.0 110.169 170.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -95.07 149.33 19.31 Favored Glycine 0 C--O 1.244 0.748 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 163.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.83 78.58 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-O 123.04 1.4 . . . . 0.0 109.102 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.55 -64.03 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.014 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 394' ' ' LEU . . . 52.41 -156.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.499 1.12 . . . . 0.0 111.6 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.439 HD23 ' O ' ' B' ' 110' ' ' ALA . 5.6 mp -63.26 141.14 97.78 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 123.798 0.839 . . . . 0.0 109.773 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.493 ' HB3' ' HA2' ' B' ' 116' ' ' GLY . 94.6 Cg_endo -88.35 137.55 3.67 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.727 2.285 . . . . 0.0 113.539 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -68.35 103.49 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 168.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 109' ' ' TYR . 42.7 m -75.07 95.9 3.13 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.323 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.85 -71.08 2.92 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.624 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 16.0 tp60 -170.99 -154.12 0.09 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.624 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 89.8 t80 -58.29 99.45 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 118.617 0.644 . . . . 0.0 109.884 164.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 8.8 m -140.23 -1.09 1.56 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.14 0.976 . . . . 0.0 109.752 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 61.75 75.78 0.39 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.715 1.206 . . . . 0.0 110.674 -172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' B' ' 103' ' ' THR . 6.2 t80 -155.63 64.77 0.6 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.439 ' O ' HD23 ' B' ' 100' ' ' LEU . . . -94.18 -26.1 16.82 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.336 172.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 112' ' ' ASN . 0.9 OUTLIER -64.82 144.73 57.06 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.517 ' N ' HD13 ' B' ' 111' ' ' LEU . 18.8 t30 80.66 140.44 0.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.747 1.28 . . . . 0.0 109.877 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 44.83 100.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.887 2.075 . . . . 0.0 112.38 -168.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.72 -30.87 70.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.173 0.989 . . . . 0.0 112.234 -171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.1 p -125.25 166.39 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.077 0.551 . . . . 0.0 110.679 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' B' ' 101' ' ' PRO . . . -63.38 -33.16 86.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.665 0.603 . . . . 0.0 111.779 171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -63.46 145.37 97.26 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.813 0.845 . . . . 0.0 110.004 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.452 ' HB3' ' HG3' ' A' ' 317' ' ' GLN . 42.2 Cg_exo -42.14 131.69 4.63 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.968 3.112 . . . . 0.0 113.652 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -87.3 176.71 7.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.211 0.529 . . . . 0.0 111.831 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.92 148.24 7.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 32.5 t -80.2 71.75 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.8 0.809 . . . . 0.0 110.046 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 98.1 m -158.79 104.98 1.78 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.106 1.762 . . . . 0.0 106.547 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -139.04 162.16 35.61 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.2 t 70.13 116.63 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.132 1.373 . . . . 0.0 111.303 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.44 35.99 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.525 1.13 . . . . 0.0 110.749 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.94 -170.17 1.82 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.958 0.903 . . . . 0.0 111.391 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.464 ' H ' ' HE3' ' A' ' 428' ' ' MET . 36.4 m 70.19 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.595 1.558 . . . . 0.0 108.303 -164.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -164.66 -169.01 1.62 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.854 0.862 . . . . 0.0 109.931 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m 62.15 44.09 8.11 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.106 0.955 . . . . 0.0 109.282 -171.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.29 -75.6 0.09 Allowed 'General case' 0 C--N 1.355 0.812 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.339 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 5.4 m95 50.45 31.35 5.41 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.814 1.246 . . . . 0.0 112.36 172.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m -80.19 -6.48 57.87 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -162.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.4 p -82.72 94.02 7.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . 0.747 ' HA3' ' HB3' ' B' ' 93' ' ' PHE . . . -115.76 145.04 18.63 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.474 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 48.3 t 64.14 -76.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.315 1.446 . . . . 0.0 110.446 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.676 ' HG2' ' H ' ' B' ' 138' ' ' TYR . 22.8 ttmm 178.43 155.05 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.889 1.676 . . . . 0.0 107.726 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.3 p -66.32 -24.59 66.56 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.124 0.42 . . . . 0.0 110.84 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . 0.676 ' H ' ' HG2' ' B' ' 136' ' ' LYS . 65.1 t80 65.94 173.06 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.356 1.462 . . . . 0.0 111.369 170.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 14.1 t-20 84.53 -53.88 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.757 1.623 . . . . 0.0 110.229 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 76.27 45.65 14.46 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 92.98 0.9 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.283 0.633 . . . . 0.0 110.11 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.517 ' H ' HD23 ' B' ' 142' ' ' LEU . 2.3 pt? -76.67 -9.75 58.89 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.717 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.17 74.23 0.85 Allowed Glycine 0 C--N 1.358 1.77 0 O-C-N 123.571 0.544 . . . . 0.0 112.544 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 p -158.57 97.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.714 1.205 . . . . 0.0 108.164 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.09 147.95 46.24 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.192 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.11 140.59 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 121.064 0.459 . . . . 0.0 110.984 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -118.43 78.18 1.24 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.076 0.95 . . . . 0.0 108.968 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.88 142.97 15.44 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' B' ' 149' ' ' LYS . 0.6 OUTLIER -70.34 91.12 0.73 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -178.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.541 0.597 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.631 176.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.385 0.612 . . . . 15.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.2 tt0 -66.14 89.24 0.12 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.146 -0.933 . . . . 15.0 110.36 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.68 138.32 20.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.523 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 46.8 m -141.62 88.65 2.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.906 -0.775 . . . . 15.0 108.906 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.63 124.2 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 41.5 mt-10 -131.67 89.26 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -62.93 100.05 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.898 -0.592 . . . . 15.0 109.871 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -72.53 -42.97 64.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.227 1.011 . . . . 15.0 110.476 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -157.66 87.72 0.96 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.126 0.571 . . . . 15.0 109.928 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.21 0.07 OUTLIER Glycine 0 C--N 1.357 1.728 0 O-C-N 123.911 0.757 . . . . 15.0 114.079 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.4 mp -66.32 -41.17 90.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.478 0.711 . . . . 15.0 110.106 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.78 104.77 1.07 Allowed Glycine 0 C--N 1.351 1.386 0 O-C-N 123.738 0.649 . . . . 15.0 112.588 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.48 120.11 37.11 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.192 0.997 . . . . 15.0 109.658 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.3 ttm180 -84.46 91.18 7.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.805 0.842 . . . . 15.0 109.403 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.11 88.65 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 108.6 -0.889 . . . . 15.0 108.6 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.2 m -78.67 106.43 10.65 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.893 -1.049 . . . . 15.0 110.039 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -100.22 122.98 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.548 0.739 . . . . 15.0 109.544 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 86.3 m -108.44 104.45 13.81 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.343 -0.984 . . . . 15.0 108.343 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.82 124.27 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.701 0.8 . . . . 15.0 109.736 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.89 41.43 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 123.478 0.711 . . . . 15.0 110.922 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.25 -24.87 65.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.562 1.145 . . . . 15.0 114.025 -170.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.64 -38.7 80.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.416 0.286 . . . . 15.0 110.65 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -76.91 -30.42 56.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.535 0.734 . . . . 15.0 110.742 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 70' ' ' LEU . 66.8 mt -64.92 -50.38 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.727 -0.669 . . . . 15.0 109.441 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.85 -44.16 97.35 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.222 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -63.69 -45.14 91.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.394 0.677 . . . . 15.0 110.846 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.03 -47.87 82.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.183 0.593 . . . . 15.0 111.363 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 66' ' ' VAL . 87.9 t -65.57 -39.32 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.573 -0.74 . . . . 15.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.86 -34.36 73.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.824 0.449 . . . . 15.0 111.351 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.1 m -63.42 -26.67 68.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 15.0 110.594 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -86.36 -35.09 20.02 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.588 0.755 . . . . 15.0 110.84 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.25 -37.22 86.38 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.341 0.656 . . . . 15.0 111.37 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.5 p -69.25 -31.02 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 123.468 0.48 . . . . 15.0 110.538 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -70.41 -48.79 54.42 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.256 0.622 . . . . 15.0 110.253 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.12 -32.88 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.275 -0.875 . . . . 15.0 109.884 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.83 -50.91 70.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.064 0.546 . . . . 15.0 110.849 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.3 mttt -66.75 -50.45 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.002 0.521 . . . . 15.0 111.704 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.76 -43.01 99.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.692 1.197 . . . . 15.0 111.709 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.97 12.04 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.511 0.725 . . . . 15.0 109.999 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 66.8 10.3 7.43 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.375 1.47 . . . . 15.0 113.467 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.621 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 47.4 mt -62.13 -33.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.109 1.363 . . . . 15.0 111.031 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.67 -32.89 74.51 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.203 1.001 . . . . 15.0 111.503 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.28 -44.32 52.82 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.836 0.71 . . . . 15.0 112.132 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -70.79 -19.74 62.66 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.026 0.53 . . . . 15.0 111.07 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' NH2' ' SD ' ' A' ' 51' ' ' MET . 34.8 ttt180 -70.47 129.24 38.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.23 0.612 . . . . 15.0 110.283 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.96 33.63 4.9 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.253 0.621 . . . . 15.0 112.205 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 -37.56 3.08 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 113.904 0.322 . . . . 15.0 113.904 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -55.52 -34.17 64.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.564 1.146 . . . . 15.0 111.324 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 45' ' ' ARG . 66.5 t -77.65 109.2 8.91 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.64 1.176 . . . . 15.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 53' ' ' ILE . 1.3 Cg_endo -89.38 137.98 3.14 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.489 2.793 . . . . 15.0 111.845 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.575 ' SD ' ' NH2' ' A' ' 45' ' ' ARG . 2.7 mpp? -68.32 -29.64 68.44 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.791 0.836 . . . . 15.0 111.763 -172.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -71.55 -43.93 65.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.026 0.531 . . . . 15.0 111.273 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.729 HD12 ' HG2' ' A' ' 50' ' ' PRO . 20.8 mt -69.91 -40.7 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.774 0.829 . . . . 15.0 111.444 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.3 m -70.73 -24.8 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 111.914 0.338 . . . . 15.0 111.914 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.14 9.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.395 0.678 . . . . 15.0 111.158 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.491 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -69.49 -44.13 71.73 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.891 -1.05 . . . . 15.0 111.896 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.0 mtt180 -91.73 -73.28 0.55 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.888 0.475 . . . . 15.0 111.094 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -81.32 -7.93 59.66 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.187 -162.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.71 38.47 2.7 Favored Glycine 0 C--N 1.345 1.041 0 N-CA-C 111.483 -0.647 . . . . 15.0 111.483 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.18 -27.33 68.63 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.832 0.853 . . . . 15.0 111.785 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -71.87 -43.25 65.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.628 0.771 . . . . 15.0 110.331 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' VAL . 13.3 t -68.51 -22.71 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.845 0.858 . . . . 15.0 111.186 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.533 HH21 ' HB ' ' A' ' 28' ' ' VAL . 1.6 mmp_? -53.92 -44.92 71.0 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.803 0.841 . . . . 15.0 110.133 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.23 -52.3 24.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.644 1.178 . . . . 15.0 111.54 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -42.46 78.17 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.594 0.758 . . . . 15.0 112.712 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 28' ' ' VAL . 4.8 t -87.6 4.85 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 121.378 0.609 . . . . 15.0 111.03 -173.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 70' ' ' LEU . 94.7 mt -70.9 -25.11 62.64 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.799 -0.563 . . . . 15.0 109.729 164.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.63 -40.69 97.72 Favored Glycine 0 C--N 1.358 1.757 0 O-C-N 123.478 0.486 . . . . 15.0 111.917 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.58 -43.74 84.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.64 1.176 . . . . 15.0 110.878 172.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 24' ' ' ILE . 81.4 mt -65.52 -50.82 63.82 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.404 -0.816 . . . . 15.0 111.349 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -67.85 -17.9 64.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.188 0.595 . . . . 15.0 111.843 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -88.62 -59.47 2.22 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.096 0.558 . . . . 15.0 110.776 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -67.94 -42.34 81.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.797 0.439 . . . . 15.0 111.476 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -74.34 -18.16 60.73 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.429 0.292 . . . . 15.0 110.985 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.24 -56.59 6.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 110.153 -0.314 . . . . 15.0 110.153 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 tt -64.98 -32.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.416 0.447 . . . . 15.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -65.88 -42.27 90.53 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.476 0.71 . . . . 15.0 110.307 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.6 29.93 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.468 0.707 . . . . 15.0 111.3 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 32.2 pt -61.06 -31.34 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.871 0.468 . . . . 15.0 111.818 -173.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.72 -48.59 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.521 0.729 . . . . 15.0 110.872 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -72.73 -31.34 64.88 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.793 0.33 . . . . 15.0 111.252 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -87.14 -9.69 54.63 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.319 1.047 . . . . 15.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 63.28 22.71 13.46 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.516 1.127 . . . . 15.0 111.808 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.1 mt -92.32 112.74 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.543 1.137 . . . . 15.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 4.6 t30 -79.16 119.56 77.55 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.78 160.61 37.41 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.397 2.064 . . . . 15.0 113.717 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.99 158.41 37.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.546 1.138 . . . . 15.0 109.325 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.52 -158.39 43.35 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.406 -0.361 . . . . 15.0 113.642 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.54 108.28 30.19 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 39.9 Cg_endo -66.85 98.94 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.127 1.885 . . . . 15.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 56.9 m -78.49 93.09 4.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.195 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.84 109.5 15.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.343 -0.614 . . . . 15.0 109.343 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.96 95.53 47.1 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -63.08 96.55 0.18 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.084 2.523 . . . . 15.0 111.9 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.57 84.57 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.704 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.88 171.15 13.03 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.797 0.839 . . . . 15.0 110.785 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -153.42 111.56 3.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.562 1.145 . . . . 15.0 107.91 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -124.26 113.31 18.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.497 0.719 . . . . 15.0 109.311 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.92 121.95 17.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 15.0 109.248 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.32 -21.23 33.55 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.861 -0.495 . . . . 15.0 111.861 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.31 -89.97 0.58 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.426 0.69 . . . . 15.0 111.34 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -148.96 179.2 8.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -147.95 94.16 2.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.208 1.403 . . . . 15.0 108.335 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 m -89.32 128.47 35.88 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.986 0.514 . . . . 15.0 109.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -145.21 125.31 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.387 0.675 . . . . 15.0 109.976 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 49.0 m -83.73 119.09 24.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.043 0.937 . . . . 15.0 109.553 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 t -103.81 105.8 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 108.926 -0.768 . . . . 15.0 108.926 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 38.8 mt-10 -104.89 112.58 25.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.321 0.648 . . . . 15.0 110.707 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 38.6 p90 -147.41 155.04 41.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.981 0.912 . . . . 15.0 109.472 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -78.57 -178.87 6.08 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.926 0.491 . . . . 15.0 110.507 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 11' ' ' LEU . 24.7 m -124.86 163.63 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.159 0.583 . . . . 15.0 110.555 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 35.9 m-85 -108.38 97.09 20.96 Favored Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 166.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -172.37 1.12 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.893 2.395 . . . . 15.0 111.534 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.46 126.91 30.98 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.08 127.21 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.894 0.477 . . . . 15.0 110.022 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -74.94 79.92 2.16 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.719 0.808 . . . . 15.0 109.707 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.1 106.43 14.9 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.62 -176.69 6.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.023 0.929 . . . . 15.0 109.979 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.7 115.39 7.53 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 113.789 0.276 . . . . 15.0 113.789 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.603 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 95.3 mt -90.55 3.14 54.85 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.182 0.993 . . . . 15.0 110.526 172.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.96 -21.52 37.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.326 1.05 . . . . 15.0 110.781 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -11.63 59.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.829 0.852 . . . . 15.0 112.081 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.422 HG23 ' HA3' ' A' ' 293' ' ' GLY . 49.4 mt -73.37 135.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.559 0.744 . . . . 15.0 110.049 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -122.07 108.28 13.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.066 0.946 . . . . 15.0 108.613 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -101.89 126.82 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.779 0.832 . . . . 15.0 109.077 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.09 127.63 35.72 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.192 0.597 . . . . 15.0 109.438 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.7 tttt -115.72 88.72 21.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.721 -0.844 . . . . 15.0 108.721 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.8 Cg_endo -91.15 107.38 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 123.076 2.517 . . . . 15.0 111.382 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.528 HD11 ' HE2' ' A' ' 127' ' ' LYS . 43.9 mm -76.84 110.33 12.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.647 1.179 . . . . 15.0 109.724 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 278' ' ' LEU . 87.3 t -78.28 111.84 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.268 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.53 110.91 22.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.826 -0.805 . . . . 15.0 108.826 171.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 274' ' ' MET . 22.0 t -96.82 126.24 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.446 -0.946 . . . . 15.0 108.446 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -100.39 171.89 7.48 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 122.926 0.491 . . . . 15.0 109.838 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.73 -24.71 67.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.347 0.659 . . . . 15.0 110.791 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.04 95.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.23 0.612 . . . . 15.0 110.499 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -70.98 -30.74 67.08 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.062 0.545 . . . . 15.0 110.961 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 71.6 t -60.51 -53.05 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 172.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.817 ' HB2' HH22 ' A' ' 267' ' ' ARG . 20.4 t70 -63.8 -36.27 83.33 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.224 -0.898 . . . . 15.0 110.463 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.14 -43.69 79.65 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.132 -0.94 . . . . 15.0 113.09 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.509 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 76.8 mtp -66.1 -40.58 90.88 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.929 0.365 . . . . 15.0 110.543 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 270' ' ' VAL . 80.3 mt -58.7 -40.66 84.31 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.551 0.532 . . . . 15.0 111.415 175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.81 -43.63 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.291 0.636 . . . . 15.0 110.487 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.9 m -67.89 -28.1 67.23 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.808 0.843 . . . . 15.0 111.488 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 89.7 mt -74.91 -46.79 33.56 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.39 0.676 . . . . 15.0 109.556 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.18 -27.98 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.16 0.584 . . . . 15.0 110.683 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.39 -36.83 60.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.647 1.179 . . . . 15.0 110.728 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.92 -29.45 68.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.903 0.881 . . . . 15.0 110.058 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 20.0 mm-40 -87.77 42.64 1.06 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.891 0.876 . . . . 15.0 109.646 172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -55.99 98.38 0.03 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.231 1.413 . . . . 15.0 112.41 -173.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.9 m -90.45 94.02 9.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -77.23 133.79 38.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.3 0.571 . . . . 15.0 111.754 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -148.06 140.25 24.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.36 -1.291 . . . . 15.0 108.873 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -64.17 138.6 58.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.923 0.868 . . . . 15.0 112.891 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.663 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -129.31 -178.81 4.81 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.188 -1.824 . . . . 15.0 108.911 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -135.65 145.97 47.36 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.0 -138.3 11.62 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.156 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.91 128.72 33.68 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.102 0.561 . . . . 15.0 112.058 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.64 HG11 HG22 ' A' ' 202' ' ' ILE . 28.3 t -76.7 142.0 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 15.0 110.065 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -112.8 167.97 10.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.341 1.056 . . . . 15.0 109.057 174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.34 5.01 13.56 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.669 0.989 . . . . 15.0 113.669 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.69 8.67 5.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.948 0.899 . . . . 15.0 110.752 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -85.87 170.86 11.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.149 0.976 . . . . 15.0 112.048 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -116.45 143.44 45.57 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 105.885 -1.894 . . . . 15.0 105.885 165.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 240' ' ' VAL . 22.8 m -134.85 -171.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 118.074 0.397 . . . . 15.0 111.371 -167.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.9 m -141.79 106.59 4.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.303 1.041 . . . . 15.0 108.576 170.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 237' ' ' LEU . 30.0 pt -108.88 -176.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.332 0.587 . . . . 15.0 111.233 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 32.7 t0 -155.11 95.62 1.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.054 -1.832 . . . . 15.0 106.054 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.5 p90 -107.69 146.91 31.44 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.985 -0.447 . . . . 15.0 111.989 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 90.9 m -95.24 113.71 25.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.101 -0.954 . . . . 15.0 108.717 168.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -72.73 111.39 3.52 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 123.794 0.684 . . . . 15.0 112.406 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 15.9 m -126.1 146.15 50.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.796 0.839 . . . . 15.0 109.363 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 177' ' ' PHE . 84.4 t -111.44 119.81 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.444 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 39.0 t70 64.98 8.35 4.63 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.713 0.805 . . . . 15.0 112.553 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.42 -16.33 11.6 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 121.907 -0.496 . . . . 15.0 113.366 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 12.5 pt-20 -105.27 115.34 30.1 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.438 0.619 . . . . 15.0 109.83 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 0.0 OUTLIER -66.84 143.85 56.63 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.285 -0.416 . . . . 15.0 110.311 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 172' ' ' VAL . 48.3 p90 -125.13 164.56 19.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.367 0.667 . . . . 15.0 110.723 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.64 138.86 56.7 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.88 0.738 . . . . 15.0 112.275 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.38 -13.16 5.02 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.811 -0.632 . . . . 15.0 114.633 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.96 71.05 0.91 Allowed Glycine 0 C--O 1.213 -1.212 0 N-CA-C 111.414 -0.674 . . . . 15.0 111.414 -167.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 9.2 mptt -145.81 175.15 10.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 173.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.5 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -160.66 129.41 4.72 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.97 -0.382 . . . . 15.0 109.97 163.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 p -108.61 133.44 52.72 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.289 1.435 . . . . 15.0 109.408 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 t70 63.86 29.73 14.55 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.91 1.338 . . . . 15.0 109.49 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.531 ' HE1' ' HB ' ' B' ' 16' ' ' THR . 10.9 t80 -71.17 102.27 2.47 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.79 -1.55 . . . . 15.0 110.4 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.552 HG12 HG23 ' B' ' 18' ' ' VAL . 7.3 p -77.69 86.33 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 122.467 1.127 . . . . 15.0 110.176 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.65 131.71 34.08 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.785 -1.098 . . . . 15.0 110.37 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.34 138.94 47.18 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.004 0.922 . . . . 15.0 109.472 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 35.4 mtt -88.32 -12.07 44.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.43 0.692 . . . . 15.0 110.755 177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -70.7 -11.1 68.56 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.89 174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 121.43 40.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.946 0.898 . . . . 15.0 109.087 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.45 2.54 Favored Glycine 0 N--CA 1.47 0.92 0 CA-C-N 115.916 -0.584 . . . . 15.0 112.02 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -96.51 -22.54 17.04 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.978 0.911 . . . . 15.0 111.084 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 177.86 3.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.98 0.912 . . . . 15.0 110.171 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.523 HG23 ' HD3' ' A' ' 218' ' ' PRO . 77.7 mt -54.06 120.16 23.25 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 109.102 -0.703 . . . . 15.0 109.102 170.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.72 105.43 0.43 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.714 2.276 . . . . 15.0 112.133 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.59 -17.59 8.85 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.652 -0.704 . . . . 15.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 46.0 t80 -65.89 -55.28 17.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.037 0.935 . . . . 15.0 110.72 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -24.58 66.0 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.697 -1.138 . . . . 15.0 112.102 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.556 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 16.2 t70 -44.23 -50.8 8.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.73 1.612 . . . . 15.0 112.209 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -60.5 -30.29 71.41 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.967 1.417 . . . . 15.0 114.638 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 164' ' ' VAL . 4.9 mp -77.64 -38.18 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 122.623 0.369 . . . . 15.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 57.3 mtpt -62.82 -5.71 3.06 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.86 1.8 . . . . 15.0 115.86 -161.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -151.43 41.99 0.73 Allowed Glycine 0 N--CA 1.469 0.841 0 N-CA-C 111.386 -0.686 . . . . 15.0 111.386 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -133.64 -177.29 4.48 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.12 0.968 . . . . 15.0 108.761 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -105.73 156.88 17.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.456 0.702 . . . . 15.0 111.102 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.632 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.53 21.28 0.28 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.951 1.463 . . . . 15.0 114.951 -163.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -152.21 35.46 0.83 Allowed Glycine 0 N--CA 1.475 1.295 0 N-CA-C 111.515 -0.634 . . . . 15.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -111.6 134.52 53.12 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 121.189 0.519 . . . . 15.0 112.361 -168.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -92.85 129.24 38.84 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.483 1.113 . . . . 15.0 108.32 166.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -163.69 153.41 14.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.705 0.802 . . . . 15.0 110.529 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.5 m -114.77 127.11 55.55 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.323 -0.991 . . . . 15.0 108.323 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.6 pt -105.83 145.81 13.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.277 0.561 . . . . 15.0 111.379 -176.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.91 96.92 10.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.228 -1.351 . . . . 15.0 108.305 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.16 -175.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.556 0.693 . . . . 15.0 110.508 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.0 m -139.22 139.49 37.49 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.461 -1.245 . . . . 15.0 108.629 171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -64.27 164.88 16.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.191 0.997 . . . . 15.0 111.866 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.523 ' HD3' HG23 ' A' ' 195' ' ' ILE . 88.7 Cg_endo -85.96 163.79 10.27 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.501 2.134 . . . . 15.0 110.56 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 46.6 mt-10 -84.95 2.09 44.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.764 0.316 . . . . 15.0 111.424 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -97.23 -1.89 43.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.546 0.739 . . . . 15.0 110.627 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -62.95 112.79 2.73 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.071 0.548 . . . . 15.0 109.723 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.439 ' HE1' HD11 ' B' ' 6' ' ' ILE . 5.8 p80 -49.11 -31.26 7.78 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.761 1.624 . . . . 15.0 114.954 -176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.13 107.55 11.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.988 -1.115 . . . . 15.0 107.988 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 15.8 tt0 -74.88 -27.46 60.25 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.461 0.476 . . . . 15.0 111.859 -173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.07 -16.18 64.18 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.968 -0.56 . . . . 15.0 110.6 172.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.51 -15.11 11.5 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.175 0.99 . . . . 15.0 112.213 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 16.4 ptpt -68.81 121.93 17.55 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.896 1.225 . . . . 15.0 110.444 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.83 26.0 74.0 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.125 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.1 tmtm? -104.44 141.37 36.48 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.757 -1.201 . . . . 15.0 107.757 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.13 129.82 40.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.219 0.608 . . . . 15.0 111.62 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.83 153.97 41.72 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.836 0.854 . . . . 15.0 111.394 -172.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 171' ' ' SER . 10.9 mmpt? -110.16 116.6 31.82 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.634 1.173 . . . . 15.0 108.709 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.455 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 21.9 m-85 -117.97 108.93 15.87 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.105 0.866 . . . . 15.0 109.923 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.25 78.72 3.78 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.749 0.82 . . . . 15.0 110.124 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 168' ' ' PHE . 11.6 mm -71.06 107.31 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 113.691 -1.595 . . . . 15.0 110.6 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.8 82.88 6.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 170.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 14.7 tp -67.61 93.7 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.867 0.867 . . . . 15.0 108.928 176.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 167' ' ' ASP . 49.1 mtmt -96.34 -24.09 16.33 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.53 0.732 . . . . 15.0 112.473 -169.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.7 mmmt -148.47 156.93 43.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.785 0.834 . . . . 15.0 110.265 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 164' ' ' VAL . 8.5 p -132.85 143.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.103 -1.073 . . . . 15.0 108.103 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -109.17 167.61 9.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.406 1.082 . . . . 15.0 109.26 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.01 142.75 24.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.821 0.849 . . . . 15.0 109.091 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -74.51 150.93 39.61 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.158 0.583 . . . . 15.0 109.619 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 132.72 50.93 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 68.3 mt -83.85 103.92 3.47 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.97 170.53 8.74 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.18 2.586 . . . . 15.0 112.935 -172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.49 139.85 47.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.108 0.963 . . . . 15.0 113.248 -167.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.64 13.25 20.53 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.234 172.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -59.06 132.12 53.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.895 1.278 . . . . 15.0 109.772 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.79 72.6 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.262 1.025 . . . . 15.0 113.077 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.41 -23.83 64.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.303 1.041 . . . . 15.0 112.008 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -102.56 -25.65 13.51 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.192 0.597 . . . . 15.0 110.617 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 47.7 mt -58.91 -43.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.971 -0.751 . . . . 15.0 108.971 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -68.23 -15.23 63.49 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.548 -0.751 . . . . 15.0 112.556 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -66.66 -32.16 73.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.224 0.535 . . . . 15.0 110.076 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -68.05 -22.12 64.97 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.74 -1.118 . . . . 15.0 110.714 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.35 20.42 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.668 0.605 . . . . 15.0 112.735 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.633 HG13 ' HG2' ' A' ' 269' ' ' GLU . 61.1 t -66.69 110.24 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.148 -0.686 . . . . 15.0 109.148 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.95 -48.74 70.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.616 1.166 . . . . 15.0 109.943 -172.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -88.88 67.15 8.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.432 -1.322 . . . . 15.0 107.432 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.67 51.7 3.08 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 114.818 -1.083 . . . . 15.0 115.212 -172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 50.4 p -111.13 -170.49 1.65 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.373 -0.973 . . . . 15.0 108.373 166.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.6 t -81.98 -61.44 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.51 -35.06 71.67 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.685 0.794 . . . . 15.0 111.002 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.94 -26.11 72.0 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 114.719 -1.128 . . . . 15.0 112.999 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.1 tp -71.91 -42.99 66.05 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.817 HH22 ' HB2' ' A' ' 138' ' ' ASP . 11.4 mmm180 -57.62 -51.32 69.97 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.318 0.58 . . . . 15.0 110.004 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.14 -42.39 94.77 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.41 -1.268 . . . . 15.0 111.055 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.633 ' HG2' HG13 ' A' ' 258' ' ' VAL . 6.4 tp10 -56.75 -56.59 19.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.466 1.106 . . . . 15.0 111.075 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 266' ' ' LEU . 23.9 t -64.22 -45.31 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.722 -0.672 . . . . 15.0 109.696 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.451 ' NH1' ' HB ' ' A' ' 132' ' ' VAL . 15.5 tpt180 -59.77 -47.31 86.21 Favored 'General case' 0 C--O 1.252 1.201 0 O-C-N 123.564 0.54 . . . . 15.0 111.873 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 62.6 pttt -72.9 -32.41 65.33 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.381 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.55 -34.28 69.85 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.521 0.728 . . . . 15.0 110.769 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.733 ' HE1' ' HA ' ' A' ' 137' ' ' VAL . 26.3 mtt -57.39 -61.98 2.1 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.93 -34.54 69.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.14 0.9 . . . . 15.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LYS . 8.8 tpp85 -61.13 -52.01 66.69 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.369 1.067 . . . . 15.0 110.189 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.4 -20.47 37.05 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.173 -0.921 . . . . 15.0 111.104 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.682 HD11 ' HB ' ' A' ' 130' ' ' VAL . 50.3 tp -75.98 -42.98 46.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.458 0.703 . . . . 15.0 110.789 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.75 -35.34 74.38 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -69.87 -37.47 76.1 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.791 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.54 77.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.18 0.592 . . . . 15.0 110.812 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.74 -40.85 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.372 0.669 . . . . 15.0 109.97 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -58.27 -51.76 68.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 15.0 111.087 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -72.85 -27.97 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.24 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -61.73 -57.79 10.53 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.368 0.667 . . . . 15.0 110.319 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 80.6 t -61.47 -41.61 90.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.957 -1.02 . . . . 15.0 110.13 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.488 ' O ' HG12 ' A' ' 291' ' ' ILE . 85.9 tttt -65.05 -47.82 76.02 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 116.293 -0.412 . . . . 15.0 110.981 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.2 p -61.71 -39.17 90.54 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 117.853 0.297 . . . . 15.0 111.619 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -76.48 -30.41 57.26 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.444 0.297 . . . . 15.0 111.633 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.76 99.9 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.455 0.302 . . . . 15.0 110.633 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.502 HG13 HD11 ' B' ' 111' ' ' LEU . 35.1 mm -77.94 -42.22 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.903 0.881 . . . . 15.0 110.545 -175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -57.9 -49.57 76.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.724 0.81 . . . . 15.0 109.515 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.55 -32.75 79.47 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 114.525 -1.216 . . . . 15.0 113.032 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.19 -52.47 65.16 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.794 0.837 . . . . 15.0 110.502 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.504 HG11 ' HG3' ' A' ' 343' ' ' ARG . 38.4 t -68.98 -36.78 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 123.383 0.427 . . . . 15.0 110.039 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -61.5 -28.82 69.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.145 0.578 . . . . 15.0 111.522 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.66 -3.75 48.87 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.964 0.906 . . . . 15.0 112.302 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -140.86 145.2 35.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -167.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -145.29 128.76 16.97 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.75 134.58 24.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.61 0.764 . . . . 15.0 109.32 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.05 103.6 1.91 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 169.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 75.5 t -80.22 138.94 52.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 115.074 -0.967 . . . . 15.0 111.004 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' VAL . 9.3 Cg_endo -50.98 120.2 6.36 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.13 2.553 . . . . 15.0 110.991 164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.67 65.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.203 1.001 . . . . 15.0 111.988 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -46.1 -54.56 8.36 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.208 1.403 . . . . 15.0 112.044 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.45 -43.56 80.79 Favored 'General case' 0 C--O 1.25 1.087 0 CA-C-N 114.056 -1.429 . . . . 15.0 111.017 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.516 ' O ' HG12 ' A' ' 311' ' ' ILE . 59.9 mt -55.2 -53.55 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.328 -0.851 . . . . 15.0 109.229 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.53 -30.19 70.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.211 1.005 . . . . 15.0 112.364 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 313' ' ' VAL . 51.5 m -59.57 -54.01 51.47 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.63 -31.45 72.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 118.909 -0.567 . . . . 15.0 112.11 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 338' ' ' GLU . 45.1 mm -57.21 -56.1 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.074 -1.084 . . . . 15.0 108.074 175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.436 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.3 t70 -65.27 -35.76 82.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.885 -1.052 . . . . 15.0 111.491 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 309' ' ' SER . 79.1 t -57.65 -50.76 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.462 HD13 HE22 ' A' ' 340' ' ' GLN . 78.1 mt -69.01 -28.78 66.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.176 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 59.2 mtm180 -70.17 -54.83 11.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.146 0.578 . . . . 15.0 110.413 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 16.7 mtm180 -55.98 -48.67 75.41 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.242 0.964 . . . . 15.0 109.817 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -54.39 -52.59 61.22 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.477 1.111 . . . . 15.0 111.639 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.29 -60.64 3.46 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.241 0.963 . . . . 15.0 110.516 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.99 -33.57 74.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.919 0.762 . . . . 15.0 111.726 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 48.9 tt0 -64.93 -30.07 71.04 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.789 0.835 . . . . 15.0 111.199 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -94.25 -20.52 19.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.626 0.37 . . . . 15.0 110.368 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -83.77 36.66 0.56 Allowed 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.039 0.936 . . . . 15.0 110.353 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.85 -14.63 63.78 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.696 -0.684 . . . . 15.0 113.416 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 80.6 43.28 9.32 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.595 0.698 . . . . 15.0 112.163 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -65.6 158.54 26.91 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.073 0.949 . . . . 15.0 112.789 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.96 98.27 1.25 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.543 1.137 . . . . 15.0 110.46 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 54.99 17.0 1.68 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.655 1.582 . . . . 15.0 114.977 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -65.68 -22.66 66.65 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.929 0.492 . . . . 15.0 111.115 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -55.03 -56.71 16.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.692 1.197 . . . . 15.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.19 -21.3 66.12 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.846 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -94.77 -12.58 26.86 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.659 0.783 . . . . 15.0 112.018 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 56.5 mt -61.3 131.93 92.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.14 153.66 74.27 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.573 2.182 . . . . 15.0 111.727 -175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -57.48 -46.59 83.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.762 0.425 . . . . 15.0 109.982 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -56.3 -22.72 32.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.079 -0.964 . . . . 15.0 112.942 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -36.92 73.85 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.83 -5.86 6.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 118.392 -0.813 . . . . 15.0 111.938 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.7 ' HA ' HD11 ' A' ' 311' ' ' ILE . 24.1 tt0 -50.37 -59.32 4.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 113.958 1.096 . . . . 15.0 113.958 -164.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.5 -47.28 86.11 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 123.908 0.755 . . . . 15.0 112.094 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.462 HE22 HD13 ' A' ' 314' ' ' LEU . 1.0 OUTLIER -74.21 -36.66 63.99 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.172 0.589 . . . . 15.0 111.807 -176.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -68.55 -47.81 65.9 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.255 0.55 . . . . 15.0 109.626 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.9 tttt -52.25 -42.15 63.39 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 114.344 -1.298 . . . . 15.0 110.524 170.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.9 ttt180 -60.17 -45.73 92.11 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.953 0.783 . . . . 15.0 110.387 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.708 HH12 ' HB2' ' B' ' 118' ' ' PRO . 30.4 mtt180 -56.44 -44.28 80.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.779 0.674 . . . . 15.0 110.32 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.505 HG13 ' HE1' ' B' ' 109' ' ' TYR . 45.8 t -67.45 -37.94 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.557 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 342' ' ' LYS . 46.2 t -57.26 -47.19 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 343' ' ' ARG . 28.7 t -60.72 -44.38 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.904 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.63 -34.0 88.76 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.229 -0.441 . . . . 15.0 113.673 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -77.73 -48.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.497 0.719 . . . . 15.0 110.754 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 68.1 mt -64.29 -45.01 89.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.325 0.65 . . . . 15.0 110.927 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.418 HD12 HG12 ' A' ' 347' ' ' VAL . 37.1 mt -68.52 -34.39 75.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.81 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.35 -35.19 91.29 Favored Glycine 0 N--CA 1.477 1.389 0 CA-C-O 121.542 0.523 . . . . 15.0 111.877 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.26 -32.3 62.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.254 0.622 . . . . 15.0 110.748 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 92.9 t -62.09 -42.76 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.06 -0.719 . . . . 15.0 109.06 170.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.732 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -59.14 -45.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.333 0.653 . . . . 15.0 110.873 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -70.47 -61.32 1.82 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 120.523 0.202 . . . . 15.0 111.236 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 64.0 m -57.73 -38.84 76.01 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.65 1.18 . . . . 15.0 113.039 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 28.8 t-20 -96.67 6.32 48.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.37 0.668 . . . . 15.0 111.27 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 47.04 34.82 2.99 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.358 1.463 . . . . 15.0 111.719 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.732 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.7 tt -73.67 121.36 20.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.909 -1.496 . . . . 15.0 108.704 -172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 172.51 12.9 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.303 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.22 104.34 2.61 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.933 -1.03 . . . . 15.0 109.588 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.97 132.93 33.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.222 0.609 . . . . 15.0 110.957 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.17 -43.84 92.16 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.06 0.944 . . . . 15.0 111.19 -174.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -73.73 -16.75 61.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.976 -1.011 . . . . 15.0 110.887 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.576 HH21 ' HB2' ' A' ' 405' ' ' GLU . 59.4 ttt85 -85.64 -34.15 21.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 110.047 -0.353 . . . . 15.0 110.047 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.1 t -63.63 -47.91 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -52.52 -49.7 64.3 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.821 0.848 . . . . 15.0 110.55 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.14 -53.22 47.36 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.13 -0.941 . . . . 15.0 112.654 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 398' ' ' MET . 5.9 tt -60.16 -53.32 59.12 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.587 0.755 . . . . 15.0 110.039 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.29 -53.66 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.541 0.737 . . . . 15.0 111.334 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -76.68 -29.04 56.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.606 0.595 . . . . 15.0 112.606 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.25 -39.8 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.478 0.311 . . . . 15.0 110.786 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 46.5 ttp -63.59 -41.72 98.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.6 -46.43 89.89 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.798 -1.092 . . . . 15.0 111.056 176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.0 t -62.78 -29.26 70.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.928 0.891 . . . . 15.0 111.103 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.07 -32.72 65.2 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.881 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -80.99 174.62 11.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.17 0.986 . . . . 15.0 111.491 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -83.49 -21.74 32.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.555 -1.657 . . . . 15.0 109.572 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -160.95 139.04 7.17 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.483 0.713 . . . . 15.0 110.668 -169.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.662 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 27.3 Cg_endo -102.29 0.3 0.44 Allowed 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.347 2.698 . . . . 15.0 115.422 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.1 -37.33 74.32 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -168.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -55.76 -45.22 78.12 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.507 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 10.8 t -71.24 -56.86 9.08 Favored 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.939 -1.028 . . . . 15.0 108.993 -170.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 381' ' ' PRO . 1.7 mp -64.04 -64.0 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.725 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.45 -36.77 83.49 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -90.54 -35.23 15.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.534 0.606 . . . . 15.0 111.977 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 384' ' ' VAL . 55.6 m-85 -102.51 -42.08 6.07 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.357 1.243 . . . . 15.0 114.357 -171.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.7 p -67.45 -19.13 65.31 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.947 0.794 . . . . 15.0 111.843 -170.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.34 -5.24 59.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.765 0.826 . . . . 15.0 112.186 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -148.27 130.94 15.94 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.5 ttmt -59.17 -21.33 59.23 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.558 0.743 . . . . 15.0 112.224 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -29.83 -67.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.575 1.95 . . . . 15.0 113.075 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 tp -101.77 -7.94 22.13 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.382 -0.199 . . . . 15.0 110.969 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 9.5 tpt -75.11 -34.99 61.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.306 0.242 . . . . 15.0 111.245 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -76.53 -35.86 58.04 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.36 -29.99 70.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.428 0.691 . . . . 15.0 110.927 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 370' ' ' LEU . 49.7 tpp -68.7 -33.43 73.93 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.352 0.661 . . . . 15.0 109.66 176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.403 ' HG2' HG21 ' A' ' 367' ' ' VAL . 86.3 mtt-85 -74.32 -34.19 63.38 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.721 -1.127 . . . . 15.0 110.999 173.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' B' ' 106' ' ' TYR . 75.0 m-20 -72.78 -37.42 67.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.462 0.705 . . . . 15.0 111.269 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.548 ' HB ' ' HG2' ' B' ' 101' ' ' PRO . 7.7 p -76.35 -32.82 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.2 70.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.033 0.533 . . . . 15.0 109.766 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.99 -48.41 80.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.72 1.208 . . . . 15.0 111.057 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.14 -55.29 36.87 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 124.708 1.203 . . . . 15.0 111.418 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.576 ' HB2' HH21 ' A' ' 366' ' ' ARG . 66.9 mt-10 -68.75 -34.5 75.7 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.568 -0.742 . . . . 15.0 111.209 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -68.83 -32.73 72.64 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.709 0.803 . . . . 15.0 110.192 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.87 -48.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 124.375 1.047 . . . . 15.0 109.964 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.416 ' HA ' HD12 ' A' ' 412' ' ' LEU . 91.9 mt-10 -63.29 -29.04 70.43 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.279 0.844 . . . . 15.0 113.279 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.75 80.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.17 -0.307 . . . . 15.0 110.17 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.483 HG22 HD13 ' A' ' 120' ' ' LEU . 98.1 t -74.04 -32.67 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 417' ' ' VAL . 88.6 mt -67.69 -37.61 82.56 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.917 0.887 . . . . 15.0 110.848 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -69.38 -30.9 68.99 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.722 0.809 . . . . 15.0 110.874 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 26.2 mtpp -79.44 -30.01 42.06 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.783 0.833 . . . . 15.0 110.661 173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.99 -169.71 2.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.426 1.09 . . . . 15.0 111.602 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -116.3 88.96 3.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.192 0.997 . . . . 15.0 109.486 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 412' ' ' LEU . 52.9 t -89.27 95.61 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.866 0.466 . . . . 15.0 109.774 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -82.92 96.29 8.23 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.837 0.827 . . . . 15.0 110.529 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.62 124.86 29.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.125 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -144.57 164.96 29.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.909 . . . . 15.0 108.704 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.99 156.1 16.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.001 0.52 . . . . 15.0 110.141 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.6 t -150.05 174.05 13.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.808 0.443 . . . . 15.0 112.064 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.3 p -69.4 178.04 2.6 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.275 1.03 . . . . 15.0 111.394 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.583 ' HA ' HG13 ' A' ' 130' ' ' VAL . 86.3 t80 -68.54 -69.75 0.31 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.923 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 3.6 t-20 -79.01 6.31 9.66 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.51 0.724 . . . . 15.0 112.674 -164.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.06 -58.15 8.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.258 1.023 . . . . 15.0 111.103 171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.0 mp -87.54 -9.02 55.6 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.725 0.41 . . . . 15.0 110.978 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.725 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -99.64 32.02 2.99 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.402 0.681 . . . . 15.0 109.886 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.557 ' HA ' HE22 ' A' ' 431' ' ' GLN . 43.6 t-20 -80.39 51.45 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.335 1.054 . . . . 15.0 111.558 -173.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -127.32 88.89 2.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.829 1.251 . . . . 15.0 108.315 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.557 HE22 ' HA ' ' A' ' 429' ' ' ASN . 20.8 mp0 -97.87 -73.74 0.6 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.042 0.537 . . . . 15.0 109.728 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.943 0.897 . . . . 15.0 108.607 -178.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.477 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 23.6 tptm -129.19 -67.04 0.79 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.146 0.578 . . . . 0.0 110.313 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -129.44 148.39 51.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.503 0.721 . . . . 0.0 110.656 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -128.06 68.11 1.34 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 14.5 t -71.21 143.47 50.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.809 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.439 HD11 ' HE1' ' A' ' 222' ' ' HIS . 5.2 tt -78.41 111.11 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.213 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.14 89.82 6.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 166.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -86.08 143.44 28.07 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -161.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.09 170.22 12.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 113.197 -1.82 . . . . 0.0 108.297 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . 0.256 0.0 OUTLIER 25.35 96.64 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.289 1.835 . . . . 0.0 115.516 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.67 65.87 1.97 Allowed Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.793 1.237 . . . . 0.0 112.094 -173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -102.86 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.716 2.277 . . . . 0.0 111.324 158.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.463 HD13 ' HE2' ' A' ' 168' ' ' PHE . 75.7 mt -134.5 135.97 42.79 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.761 1.624 . . . . 0.0 106.868 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 2.1 tm? 70.16 100.44 0.06 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -160.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -138.04 49.12 1.96 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.952 1.358 . . . . 0.0 107.527 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.531 ' HB ' ' HE1' ' A' ' 185' ' ' PHE . 87.6 m -153.74 128.72 4.88 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.402 -172.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.74 109.86 1.34 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.787 1.658 . . . . 0.0 110.508 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.552 HG23 HG12 ' A' ' 186' ' ' VAL . 7.6 p -75.12 86.05 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-O 122.432 1.11 . . . . 0.0 110.044 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.1 m -117.68 88.36 2.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.885 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.53 92.24 1.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.178 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.95 159.97 29.98 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.431 0.692 . . . . 0.0 109.232 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 67.15 105.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.544 1.138 . . . . 0.0 109.892 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 p -81.74 145.81 55.03 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.415 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.96 93.07 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.301 2.667 . . . . 0.0 112.384 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.48 128.97 37.99 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.021 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -61.71 -37.15 37.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 117.841 -1.075 . . . . 0.0 112.583 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.69 -27.69 43.4 Favored 'Trans proline' 0 C--N 1.41 3.78 0 C-N-CA 122.387 2.058 . . . . 0.0 113.625 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.559 HG13 ' H ' ' B' ' 29' ' ' LEU 0.271 7.7 p 48.64 -75.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 126.986 2.114 . . . . 0.0 113.827 175.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.559 ' H ' HG13 ' B' ' 28' ' ' VAL . 1.7 tm? 55.66 -89.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.201 1.801 . . . . 0.0 112.052 171.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.0 -29.2 69.54 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.23 1.012 . . . . 0.0 111.716 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.63 108.34 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.526 0.73 . . . . 0.0 109.17 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -80.58 87.3 5.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.21 81.27 3.71 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.988 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.6 -62.89 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.061 1.344 . . . . 0.0 107.731 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.9 140.39 4.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.041 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.28 53.5 3.86 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.19 165.91 34.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.105 0.962 . . . . 0.0 109.106 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.9 mt 76.35 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.524 1.53 . . . . 0.0 110.221 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.0 m -75.04 -17.82 60.43 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.463 0.705 . . . . 0.0 111.017 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.35 138.35 85.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.43 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 124.024 3.149 . . . . 0.0 114.497 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.32 64.48 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.551 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.18 55.06 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-O 119.924 -0.375 . . . . 0.0 113.486 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.42 -2.83 51.26 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.631 0.772 . . . . 0.0 111.198 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' B' ' 45' ' ' ARG . 1.8 mmp_? -68.06 75.65 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.144 0.977 . . . . 0.0 110.715 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 59.2 -96.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.84 1.256 . . . . 0.0 110.804 -164.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' B' ' 53' ' ' ALA . 3.5 mm? 56.84 168.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.488 1.115 . . . . 0.0 111.7 -167.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.623 ' H ' ' HB2' ' B' ' 53' ' ' ALA . 55.3 m 73.35 -36.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.649 1.58 . . . . 0.0 112.851 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.01 -9.26 46.48 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.54 0.59 . . . . 0.0 114.528 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.553 ' HB3' HG22 ' B' ' 52' ' ' THR . 14.1 t70 -147.31 160.65 42.27 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.482 0.713 . . . . 0.0 109.56 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -63.18 -15.25 56.28 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.173 0.989 . . . . 0.0 112.963 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.553 HG22 ' HB3' ' B' ' 50' ' ' ASP . 11.7 t -66.09 -10.23 38.63 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.7 0.8 . . . . 0.0 111.629 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' B' ' 47' ' ' LEU . . . -67.1 -20.77 65.84 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 123.515 0.726 . . . . 0.0 112.154 173.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.77 47.0 6.51 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.588 1.155 . . . . 0.0 110.378 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 tt 67.04 92.08 0.08 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 109.38 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -143.74 26.18 1.58 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.789 0.836 . . . . 0.0 108.935 175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.51 ' HA ' HG23 ' B' ' 48' ' ' THR . 4.1 m-20 -59.0 -44.97 91.73 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.759 0.824 . . . . 0.0 111.551 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -148.2 149.11 31.35 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.401 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.6 OUTLIER -141.03 74.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.0 m -78.15 78.41 4.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.78 -51.45 0.56 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.235 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.77 150.84 82.02 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.81 118.83 5.77 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.405 2.07 . . . . 0.0 110.979 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 84.4 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.638 0.775 . . . . 0.0 111.415 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -123.41 91.07 3.4 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -89.7 -17.09 28.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.111 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 tp -68.94 90.96 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.069 0.937 . . . . 0.0 110.623 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.433 ' H ' HD13 ' B' ' 68' ' ' ILE . 0.2 OUTLIER -112.57 143.01 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.937 175.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -100.09 105.62 17.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.94 -48.56 0.13 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.019 0.528 . . . . 0.0 110.334 -172.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.3 mt -74.79 92.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.711 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.79 -12.4 82.95 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.426 171.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t70 69.21 -77.97 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.912 1.685 . . . . 0.0 111.564 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 170.55 118.26 0.45 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.7 mmt -90.49 -13.18 35.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.938 0.495 . . . . 0.0 110.433 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.29 -138.4 7.67 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -169.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.61 ' HB2' ' HB3' ' B' ' 83' ' ' ALA . 5.0 p-10 50.47 -69.89 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.814 2.046 . . . . 0.0 115.389 166.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 41.6 m -61.8 -45.9 91.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.734 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.13 -53.29 2.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.604 0.762 . . . . 0.0 110.814 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mm -84.05 122.62 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 4.4 t -53.87 110.11 0.55 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.819 0.848 . . . . 0.0 112.696 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' B' ' 77' ' ' ASP . . . -153.09 -60.63 0.14 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 0.0 109.382 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' B' ' 77' ' ' ASP . . . -119.77 100.8 7.46 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.48 ' H ' ' HB3' ' B' ' 87' ' ' ALA . 40.8 ttm180 -161.63 150.14 15.54 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 109.311 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.4 t30 61.52 71.29 0.56 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.325 1.05 . . . . 0.0 109.823 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 74.72 -5.4 2.14 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.149 1.38 . . . . 0.0 112.685 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.48 ' HB3' ' H ' ' B' ' 84' ' ' ARG . . . -77.29 -33.46 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.066 0.546 . . . . 0.0 110.013 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.69 -30.56 14.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.894 0.878 . . . . 0.0 110.813 170.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.81 -55.25 0.44 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.06 -76.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.597 1.559 . . . . 0.0 112.152 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.75 75.89 0.14 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.0 78.23 0.15 Allowed Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.745 0.688 . . . . 0.0 114.382 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -176.41 92.95 0.05 OUTLIER 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.7 16.8 16.41 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.901 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . 0.275 0.3 OUTLIER 63.09 -8.7 0.13 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.903 2.081 . . . . 0.0 116.604 165.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.97 33.66 64.25 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.766 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 35.3 pt 37.39 -172.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 C-N-CA 126.236 1.815 . . . . 0.0 115.524 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -166.55 109.42 0.73 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.89 164.02 22.94 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.22 0.533 . . . . 0.0 110.533 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.02 -48.08 0.8 Allowed Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.351 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 401' ' ' VAL . 27.8 Cg_exo -64.96 -76.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 121.988 1.792 . . . . 0.0 114.006 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 115' ' ' THR . 4.5 mm? 57.23 -134.15 1.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.579 1.152 . . . . 0.0 111.134 -174.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 4.1 m 60.93 28.13 17.93 Favored 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 123.959 0.904 . . . . 0.0 110.357 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.11 -112.9 5.38 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.822 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.06 86.63 2.96 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.499 ' HE1' ' HB3' ' B' ' 110' ' ' ALA . 88.1 t80 -65.32 101.46 0.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.824 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -83.22 20.47 1.27 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.075 0.95 . . . . 0.0 111.058 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 t60 78.25 -28.18 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.026 1.731 . . . . 0.0 111.551 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE1' HG13 ' A' ' 345' ' ' VAL . 82.5 t80 -74.23 89.03 2.01 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.869 1.268 . . . . 0.0 110.336 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' B' ' 113' ' ' LYS . . . -176.69 -58.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 108.058 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 291' ' ' ILE . 1.6 tm? 63.93 -80.78 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.528 1.531 . . . . 0.0 110.88 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 118' ' ' PRO . 27.5 t-20 -72.47 -20.65 61.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.762 1.225 . . . . 0.0 111.122 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.7 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 37.2 ttmt -82.56 93.94 7.4 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.623 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 101.41 13.12 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.307 0.643 . . . . 0.0 110.76 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.485 HG22 ' HB2' ' B' ' 102' ' ' LEU . 54.5 p 49.82 33.37 6.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.492 1.517 . . . . 0.0 113.869 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 99.15 -12.1 62.03 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.298 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 96.8 6.58 Favored Pre-proline 0 N--CA 1.477 0.885 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 170.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.708 ' HB2' HH12 ' A' ' 344' ' ' ARG . 10.1 Cg_endo -93.51 -60.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.922 2.415 . . . . 0.0 113.495 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.58 77.48 3.26 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.148 1.379 . . . . 0.0 111.579 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -166.42 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.783 1.233 . . . . 0.0 108.697 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.497 HG23 ' H ' ' B' ' 123' ' ' ASP . 10.5 m 53.26 -175.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 126.53 1.932 . . . . 0.0 112.868 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p -74.83 -31.38 61.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.664 0.786 . . . . 0.0 111.696 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.497 ' H ' HG23 ' B' ' 121' ' ' VAL . 3.7 m-20 -56.2 129.39 40.0 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.128 0.971 . . . . 0.0 113.109 -172.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 12.2 p -93.36 -176.77 4.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.726 1.21 . . . . 0.0 110.216 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.0 81.78 0.67 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 0.0 110.292 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.677 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -66.4 -54.08 28.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.157 0.983 . . . . 0.0 112.012 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.7 m -66.81 89.32 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.19 99.16 1.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.252 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.6 m -66.2 -37.5 85.73 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 160.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 75.58 -70.44 0.15 Allowed 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.997 1.719 . . . . 0.0 113.444 162.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.43 ' HZ2' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -90.4 149.09 22.41 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.347 0.659 . . . . 0.0 111.837 -163.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 71.0 m -151.03 11.59 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.109 0.963 . . . . 0.0 110.86 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 53.2 p -93.37 27.86 2.43 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.589 0.755 . . . . 0.0 111.966 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.02 -7.04 83.88 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 114.404 0.521 . . . . 0.0 114.404 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 34.8 m -78.18 -6.19 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.909 0.883 . . . . 0.0 112.056 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.31 77.76 1.34 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.749 0.819 . . . . 0.0 111.906 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.9 m -179.18 -42.18 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.982 2.113 . . . . 0.0 106.991 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -111.0 155.65 22.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.453 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.48 115.09 3.32 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.663 0.785 . . . . 0.0 109.496 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.2 55.75 2.84 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.93 7.84 6.45 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.47 1.508 . . . . 0.0 113.194 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -89.06 93.91 9.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.013 0.925 . . . . 0.0 109.474 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.71 60.65 1.14 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.14 154.12 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.429 1.092 . . . . 0.0 108.324 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -113.36 165.3 12.58 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.559 0.744 . . . . 0.0 109.028 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.69 149.23 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.454 0.702 . . . . 0.0 110.222 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -66.73 132.56 48.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.285 0.634 . . . . 0.0 111.098 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.9 166.02 16.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.673 0.389 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -85.64 139.97 30.95 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.803 0.841 . . . . 0.0 111.41 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.877 0.846 . . . . 15.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 9.1 tt0 -77.37 89.02 3.76 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.42 -0.809 . . . . 15.0 109.788 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 17' ' ' ILE . 16.3 m -86.0 154.65 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.46 0.704 . . . . 15.0 110.931 -175.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 p -155.96 111.21 2.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.203 0.601 . . . . 15.0 109.469 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.84 133.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.395 0.678 . . . . 15.0 110.564 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 40.1 mt-10 -141.06 101.77 4.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.261 1.024 . . . . 15.0 109.318 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 m -64.48 105.05 0.87 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.44 0.564 . . . . 15.0 110.166 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -78.02 -56.69 4.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.834 0.854 . . . . 15.0 111.33 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -151.1 93.98 1.99 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.663 0.385 . . . . 15.0 110.098 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.06 0.95 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.339 -0.846 . . . . 15.0 112.782 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 6.1 mp -75.45 -28.32 59.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.537 0.735 . . . . 15.0 109.964 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.98 112.85 5.32 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 124.308 1.005 . . . . 15.0 112.472 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -122.06 135.27 54.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.881 1.272 . . . . 15.0 108.867 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.1 ttm180 -105.78 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.411 1.084 . . . . 15.0 109.583 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.72 91.21 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -79.6 103.89 9.82 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.864 -1.062 . . . . 15.0 109.611 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 3' ' ' VAL . 38.3 mt -101.74 139.88 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.141 0.576 . . . . 15.0 109.726 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 64.1 m -115.42 109.55 18.04 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.312 -0.996 . . . . 15.0 108.312 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.51 128.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.15 57.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.099 0.96 . . . . 15.0 111.731 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.649 1.18 . . . . 15.0 112.023 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.71 -42.69 97.91 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.9 -1.045 . . . . 15.0 111.264 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 m -68.71 -31.66 70.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.269 0.628 . . . . 15.0 111.308 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.5 mt -67.2 -58.17 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.32 0.648 . . . . 15.0 109.386 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.54 -37.38 72.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.224 1.01 . . . . 15.0 111.667 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 86.4 m -78.44 -33.51 48.45 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.655 0.782 . . . . 15.0 111.619 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.855 0.462 . . . . 15.0 110.99 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG21 HH11 ' A' ' 63' ' ' ARG . 64.6 t -65.9 -40.76 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.767 . . . . 15.0 109.984 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.5 ttmp? -62.72 -43.96 97.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.069 0.948 . . . . 15.0 111.33 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -67.57 -25.14 65.64 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.599 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 tp10 -75.37 -41.11 57.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.187 175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 77.5 mt -68.49 -29.7 68.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.539 0.735 . . . . 15.0 112.133 -175.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.98 -29.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 110.322 -0.251 . . . . 15.0 110.322 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.73 -45.42 75.06 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 31' ' ' GLU . 48.3 t -61.06 -38.43 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 15.0 109.889 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.66 93.06 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 123.612 0.765 . . . . 15.0 110.8 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.12 -33.98 74.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.536 0.334 . . . . 15.0 111.246 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -68.01 -47.12 69.36 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.305 0.642 . . . . 15.0 110.898 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 41' ' ' ILE . 10.5 t -89.89 7.03 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.229 0.611 . . . . 15.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 60.8 16.0 6.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.516 1.526 . . . . 15.0 112.687 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.6 mt -57.82 -31.94 41.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 C-N-CA 125.317 1.447 . . . . 15.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.54 -41.28 76.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.719 0.808 . . . . 15.0 111.342 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.98 -10.28 85.2 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.782 -0.645 . . . . 15.0 113.349 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -110.47 -8.79 14.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.674 0.789 . . . . 15.0 111.081 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.6 HH12 HG11 ' A' ' 54' ' ' VAL . 46.2 ttt85 -71.97 105.79 4.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.311 0.645 . . . . 15.0 110.487 -173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.36 -26.47 63.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.547 0.739 . . . . 15.0 110.042 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.05 43.64 71.41 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 124.023 0.827 . . . . 15.0 113.406 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -68.13 -53.65 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.226 0.611 . . . . 15.0 109.742 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.36 118.41 69.58 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 108.138 -1.06 . . . . 15.0 108.138 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.79 149.33 41.74 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.587 2.858 . . . . 15.0 113.906 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HA ' HG22 ' A' ' 54' ' ' VAL . 15.7 tpt -67.62 -29.67 69.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.716 0.806 . . . . 15.0 112.158 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 29.6 p-10 -70.11 -26.85 64.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.63 0.372 . . . . 15.0 111.425 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -86.85 -37.33 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.162 0.985 . . . . 15.0 110.966 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG11 HH12 ' A' ' 45' ' ' ARG . 12.2 m -68.1 -24.78 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 122.496 0.319 . . . . 15.0 111.232 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -57.08 -40.88 77.79 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.613 1.165 . . . . 15.0 112.709 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.08 -18.79 19.13 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.3 -0.863 . . . . 15.0 111.64 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.44 -65.82 0.85 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.713 0.405 . . . . 15.0 110.588 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -77.69 -21.16 52.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 110.747 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 62' ' ' VAL . . . -89.51 -3.54 74.72 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.094 -0.837 . . . . 15.0 114.844 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.85 78.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.393 0.677 . . . . 15.0 112.123 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.5 p -81.36 -45.16 16.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.596 0.758 . . . . 15.0 110.471 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HA2' ' A' ' 59' ' ' GLY . 4.7 p -76.14 -0.83 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 122.811 0.445 . . . . 15.0 111.821 -174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.433 HH11 HG21 ' A' ' 28' ' ' VAL . 15.3 mmt180 -46.85 -41.46 15.69 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.822 0.849 . . . . 15.0 111.369 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -54.98 -58.63 6.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.254 1.022 . . . . 15.0 111.445 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.31 -39.74 89.51 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.248 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.45 -50.09 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 123.807 0.692 . . . . 15.0 110.167 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . 88.5 mt -61.96 -39.0 90.61 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.822 0.701 . . . . 15.0 111.204 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.31 99.48 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.866 0.729 . . . . 15.0 112.386 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.22 -40.57 82.06 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.869 0.868 . . . . 15.0 111.238 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.9 -36.71 84.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.215 0.606 . . . . 15.0 110.498 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 69.4 mtm -65.6 -42.42 91.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.105 0.562 . . . . 15.0 110.419 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 t -62.19 -49.04 77.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.042 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -79.13 -27.22 42.79 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.495 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -33.34 58.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.752 -0.462 . . . . 15.0 109.752 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.54 -57.42 10.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.912 0.485 . . . . 15.0 110.77 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 tt -59.76 -38.22 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.779 0.674 . . . . 15.0 110.711 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.33 -42.16 93.2 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.99 0.516 . . . . 15.0 110.499 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.8 -49.74 71.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.348 -0.842 . . . . 15.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.06 -25.73 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.064 0.394 . . . . 15.0 112.064 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -69.44 -51.16 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.663 0.385 . . . . 15.0 110.429 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -68.25 -40.29 82.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.354 0.261 . . . . 15.0 110.89 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -78.76 -13.91 59.56 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.372 0.669 . . . . 15.0 111.607 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 66.61 24.87 10.06 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.882 1.273 . . . . 15.0 111.58 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.5 mt -80.23 124.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.184 -1.043 . . . . 15.0 108.184 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 41.3 t30 -101.45 100.55 14.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.393 0.677 . . . . 15.0 109.595 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.2 164.38 34.23 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.976 2.451 . . . . 15.0 113.118 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.14 128.75 44.07 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.059 0.943 . . . . 15.0 109.901 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 70.65 -113.65 4.93 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.847 0.717 . . . . 15.0 112.586 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.91 135.85 27.63 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.457 0.703 . . . . 15.0 110.527 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.7 Cg_endo -76.69 120.53 5.56 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.74 2.293 . . . . 15.0 112.598 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -79.81 99.61 7.58 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.405 0.682 . . . . 15.0 109.931 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -76.03 100.53 4.94 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.59 101.38 2.01 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.847 -1.168 . . . . 15.0 107.847 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.74 113.52 3.81 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.194 1.929 . . . . 15.0 111.335 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.1 -73.62 0.49 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.36 -0.696 . . . . 15.0 111.36 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -176.03 158.14 1.96 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 15.0 110.755 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -118.95 140.2 50.39 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.352 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 85.3 mttt -120.18 132.24 55.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.841 -1.54 . . . . 15.0 106.841 172.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.8 tp -58.0 113.36 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.688 0.795 . . . . 15.0 111.01 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.36 -0.56 88.89 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.613 0.571 . . . . 15.0 114.041 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.5 mt-10 -113.6 174.22 6.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.193 0.997 . . . . 15.0 109.993 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.41 146.76 52.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.314 1.045 . . . . 15.0 112.351 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -109.73 127.15 54.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.079 0.952 . . . . 15.0 109.001 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -118.01 140.42 49.78 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.213 0.605 . . . . 15.0 109.696 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -152.76 135.32 15.22 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.717 0.807 . . . . 15.0 109.792 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.7 m -99.25 99.21 10.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.054 1.342 . . . . 15.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.59 102.72 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 122.295 -0.253 . . . . 15.0 110.442 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -94.61 124.56 38.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.865 0.866 . . . . 15.0 109.879 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 35.4 p90 -153.81 149.58 27.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.977 0.511 . . . . 15.0 109.95 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.57 171.47 15.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.273 0.358 . . . . 15.0 110.317 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 33.1 m -125.57 171.94 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.233 0.613 . . . . 15.0 110.62 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HE1' HD11 ' A' ' 306' ' ' LEU . 41.9 m-85 -103.63 106.79 53.9 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 123.368 0.667 . . . . 15.0 109.61 171.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.14 159.94 29.97 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.267 1.978 . . . . 15.0 111.519 171.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.0 115.88 13.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 15.0 109.752 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.86 98.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.346 0.658 . . . . 15.0 109.508 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -68.37 90.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.581 0.752 . . . . 15.0 109.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.18 105.28 0.86 Allowed 'General case' 0 C--N 1.355 0.814 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.565 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.59 -171.51 1.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.023 0.929 . . . . 15.0 110.501 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.25 115.6 8.13 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.052 0.22 . . . . 15.0 113.502 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 72.8 mt -100.01 8.54 43.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.36 0.664 . . . . 15.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.96 -31.66 45.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.029 0.932 . . . . 15.0 109.794 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.76 66.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.104 0.962 . . . . 15.0 112.336 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.582 HG23 ' HA3' ' A' ' 293' ' ' GLY . 42.4 mt -66.63 103.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.62 0.768 . . . . 15.0 109.701 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 48.8 mt-10 -90.66 97.39 11.15 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 123' ' ' ILE . 49.0 t -96.86 128.97 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.5 tt0 -84.75 126.92 33.83 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -101.4 100.5 13.94 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 107.935 -1.135 . . . . 15.0 107.935 167.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 97.6 Cg_endo -80.28 134.68 10.37 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.424 2.083 . . . . 15.0 111.932 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.7 mm -108.62 118.4 56.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' A' ' 278' ' ' LEU . 93.3 t -120.81 124.27 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.71 148.07 23.71 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG11 ' SD ' ' A' ' 274' ' ' MET . 18.7 t -117.33 100.93 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.6 p -78.31 171.24 15.36 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.3 -21.22 65.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.909 0.484 . . . . 15.0 110.302 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.8 64.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.918 0.887 . . . . 15.0 110.785 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -68.6 -41.6 79.34 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.845 0.458 . . . . 15.0 109.932 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.58 -45.11 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.705 0.402 . . . . 15.0 110.263 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.56 ' HB2' HH22 ' A' ' 267' ' ' ARG . 19.4 t70 -58.66 -52.84 63.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.148 0.905 . . . . 15.0 110.335 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.67 -33.15 86.47 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.536 -1.211 . . . . 15.0 113.281 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.6 tpp -72.85 -47.35 46.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.683 0.393 . . . . 15.0 111.268 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.57 -36.92 84.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.977 0.511 . . . . 15.0 110.064 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.09 -41.62 99.44 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.358 1.063 . . . . 15.0 110.814 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.556 HG21 HE21 ' A' ' 431' ' ' GLN . 90.6 m -62.41 -42.19 99.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.951 0.5 . . . . 15.0 110.614 175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 92.9 mt -59.67 -43.77 93.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.265 0.626 . . . . 15.0 109.998 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 77.5 mtp180 -64.92 -31.94 73.42 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.574 0.75 . . . . 15.0 111.725 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.457 ' HB3' HH11 ' A' ' 243' ' ' ARG . 92.6 mttt -84.46 -12.77 53.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.33 0.652 . . . . 15.0 112.182 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 143' ' ' THR . 99.1 mt-30 -82.97 -25.91 31.84 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.842 -0.799 . . . . 15.0 108.842 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 19.5 mm-40 -90.94 42.79 1.12 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.865 0.866 . . . . 15.0 109.034 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.86 96.64 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.567 1.147 . . . . 15.0 112.381 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 244' ' ' GLU . 57.5 m -84.68 115.28 22.58 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 108.644 -0.873 . . . . 15.0 108.644 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.82 148.04 26.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.43 0.633 . . . . 15.0 111.568 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 21.9 ttpt -147.4 139.2 24.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.799 1.639 . . . . 15.0 108.639 -173.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 51.4 mt-10 -68.38 155.59 39.51 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.768 0.794 . . . . 15.0 112.724 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 240' ' ' VAL . 60.2 pttt -156.98 178.53 10.26 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 113.801 -1.545 . . . . 15.0 109.366 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -134.39 148.59 50.69 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 207' ' ' ALA . . . 116.04 -129.8 8.69 Favored Glycine 0 C--O 1.235 0.173 0 CA-C-N 115.464 -0.789 . . . . 15.0 111.789 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.57 117.02 14.84 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.411 0.684 . . . . 15.0 111.924 -171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 202' ' ' ILE . 48.5 t -69.72 140.83 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.503 -0.771 . . . . 15.0 110.058 167.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 160.39 22.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.244 1.018 . . . . 15.0 108.693 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.21 -4.37 32.59 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.695 0.998 . . . . 15.0 113.695 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -116.98 18.41 14.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.491 0.716 . . . . 15.0 110.829 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -99.13 170.63 8.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.732 0.777 . . . . 15.0 111.64 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.9 32.58 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 106.591 -1.633 . . . . 15.0 106.591 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 202' ' ' ILE . 15.2 m -116.41 -174.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.545 0.572 . . . . 15.0 112.545 -164.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.5 m -142.27 112.06 6.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.898 1.279 . . . . 15.0 108.876 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 237' ' ' LEU . 32.8 pt -116.61 -174.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.563 0.697 . . . . 15.0 111.976 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.5 t70 -148.66 95.73 2.47 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.191 -1.781 . . . . 15.0 106.191 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 41.8 p90 -102.47 140.11 37.18 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.379 -0.826 . . . . 15.0 111.886 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.643 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m -88.14 100.48 12.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -59.45 114.29 6.07 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 124.08 0.862 . . . . 15.0 112.466 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.8 m -131.81 139.68 48.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.305 0.642 . . . . 15.0 110.95 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 177' ' ' PHE . 52.0 t -107.75 121.88 61.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.401 1.08 . . . . 15.0 108.234 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 15.8 t70 66.62 11.71 8.32 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 124.368 1.043 . . . . 15.0 112.166 172.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 105.61 -1.13 39.45 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.872 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -117.08 120.39 38.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 9.5 pt-20 -61.01 149.9 35.34 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.953 0.783 . . . . 15.0 112.06 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CE1' HG23 ' A' ' 172' ' ' VAL . 45.8 p90 -133.09 150.44 52.08 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.413 0.685 . . . . 15.0 110.503 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.01 141.52 54.86 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.466 -0.788 . . . . 15.0 111.409 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.35 -18.66 10.03 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.6 -0.727 . . . . 15.0 113.97 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.06 -0.34 88.66 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.641 0.617 . . . . 15.0 114.641 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 11.6 mptt -94.41 164.37 13.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.401 0.68 . . . . 15.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' B' ' 14' ' ' LEU . . . -154.0 120.38 5.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.406 -0.815 . . . . 15.0 110.159 171.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.0 p -99.89 131.98 45.53 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 125.073 1.349 . . . . 15.0 109.377 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.1 t70 62.49 29.13 17.05 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 124.115 0.884 . . . . 15.0 109.685 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 20.1 t80 -67.2 97.12 0.51 Allowed 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.991 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.76 84.66 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.59 -1.641 . . . . 15.0 109.899 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 57.0 tp -85.05 138.19 32.59 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.749 -1.114 . . . . 15.0 109.92 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -116.6 141.89 47.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.067 0.947 . . . . 15.0 108.869 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 47.2 mtt -88.59 151.31 22.57 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.405 0.682 . . . . 15.0 110.017 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.05 -37.32 3.6 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 116.175 -0.466 . . . . 15.0 112.434 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.66 110.48 8.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.44 0.638 . . . . 15.0 110.063 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.08 45.72 3.56 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.84 -0.618 . . . . 15.0 113.111 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -101.87 -17.28 16.25 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.143 0.977 . . . . 15.0 110.111 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 171.97 10.6 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 109.05 -0.722 . . . . 15.0 109.05 175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.468 HG23 ' HD3' ' A' ' 218' ' ' PRO . 76.0 mt -55.01 116.47 11.43 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.185 0.994 . . . . 15.0 109.415 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.12 113.04 1.36 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.133 2.555 . . . . 15.0 112.442 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.42 -11.18 36.25 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.585 -0.564 . . . . 15.0 113.11 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -61.46 -43.25 99.19 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.908 0.883 . . . . 15.0 111.464 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.33 -20.67 64.6 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.177 0.591 . . . . 15.0 112.177 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -46.42 -49.16 18.45 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.805 1.242 . . . . 15.0 111.674 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -49.61 -46.12 38.09 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 125.23 1.581 . . . . 15.0 113.642 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.692 HG22 HG11 ' A' ' 158' ' ' VAL . 4.6 mp -72.78 -44.33 59.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.037 -0.581 . . . . 15.0 109.914 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.79 3.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.857 1.428 . . . . 15.0 114.857 -167.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.07 35.88 1.34 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.58 0.627 . . . . 15.0 112.021 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -145.05 -177.29 5.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.565 0.746 . . . . 15.0 110.523 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -99.78 156.41 17.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.871 0.868 . . . . 15.0 110.473 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.672 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -76.41 13.92 0.86 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.95 1.463 . . . . 15.0 114.95 -165.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.8 47.29 0.59 Allowed Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.069 -0.812 . . . . 15.0 111.069 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -116.84 143.14 46.04 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 113.303 0.853 . . . . 15.0 113.303 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -98.55 120.4 38.91 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.096 -1.411 . . . . 15.0 108.169 167.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -156.84 162.28 39.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.863 0.465 . . . . 15.0 110.841 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 54.2 m -125.51 133.33 52.41 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.224 1.01 . . . . 15.0 108.89 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.481 HD13 ' HA3' ' A' ' 201' ' ' GLY . 47.0 pt -115.94 153.82 17.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 CA-C-O 121.175 0.512 . . . . 15.0 111.374 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -98.71 106.08 18.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.4 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.88 138.66 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.131 0.573 . . . . 15.0 109.624 172.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.7 m -84.74 140.45 31.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.467 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -57.57 162.43 4.77 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.008 0.923 . . . . 15.0 111.811 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 59.7 Cg_endo -82.19 157.83 17.53 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.028 1.819 . . . . 15.0 110.494 171.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 3.7 mp0 -77.17 -3.87 41.76 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.148 0.499 . . . . 15.0 110.643 172.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -91.57 -7.91 48.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.257 1.023 . . . . 15.0 111.042 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.51 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 34.5 t80 -60.44 133.39 56.05 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 123.738 0.815 . . . . 15.0 109.301 174.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -59.2 -39.15 81.7 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 15.0 112.139 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -71.0 118.4 13.72 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.454 0.302 . . . . 15.0 110.33 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.627 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 16.0 tp10 -68.17 -36.41 79.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.706 0.802 . . . . 15.0 111.44 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.24 -10.52 59.69 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.349 0.66 . . . . 15.0 111.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 54.5 mt -118.06 -8.59 10.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 118.949 -0.548 . . . . 15.0 112.327 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' A' ' 224' ' ' GLU . 18.0 ptpt -72.15 120.19 17.4 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.097 0.862 . . . . 15.0 109.347 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.21 31.17 69.09 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 116.206 -0.452 . . . . 15.0 112.895 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.592 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 6.2 tmtm? -103.74 134.9 46.28 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.069 -1.086 . . . . 15.0 108.069 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.41 7.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.209 0.603 . . . . 15.0 110.6 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.62 165.5 12.96 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.064 0.945 . . . . 15.0 110.774 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -116.94 143.92 45.16 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 173.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.412 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 81.4 m-85 -140.11 111.27 7.05 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.322 -0.622 . . . . 15.0 109.322 175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -80.87 84.78 6.3 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.614 0.721 . . . . 15.0 109.297 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 107.65 2.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 113.983 -1.462 . . . . 15.0 109.888 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -91.6 81.51 5.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.315 -1.365 . . . . 15.0 107.315 172.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 158' ' ' VAL . 10.9 tp -68.37 99.67 0.97 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.47 -1.241 . . . . 15.0 109.723 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -92.79 -35.14 13.58 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.584 0.754 . . . . 15.0 111.308 -171.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.2 mmmt -144.09 147.86 34.34 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.68 0.792 . . . . 15.0 110.803 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -123.6 133.51 69.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 161.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 50.1 mt-10 -119.79 121.93 40.23 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.244 0.545 . . . . 15.0 109.854 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.34 147.18 23.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.69 1.596 . . . . 15.0 111.09 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 146' ' ' LYS . 18.8 ptp180 -75.74 161.16 29.29 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.299 0.571 . . . . 15.0 110.62 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 150' ' ' THR . 8.5 mm-40 -122.09 153.59 38.47 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.084 0.954 . . . . 15.0 111.033 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.06 109.98 41.07 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 114.242 -1.345 . . . . 15.0 107.479 167.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 23.4 Cg_endo -59.05 174.82 0.78 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.911 2.407 . . . . 15.0 112.514 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.19 165.31 4.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.093 0.957 . . . . 15.0 113.518 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 20.4 tp -122.82 3.34 9.47 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 114.209 -1.36 . . . . 15.0 109.496 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 m -49.08 136.57 14.55 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.918 1.687 . . . . 15.0 110.771 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.45 61.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.964 0.906 . . . . 15.0 113.209 -167.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.98 -36.18 83.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.133 0.573 . . . . 15.0 112.06 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -79.47 -50.83 10.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.122 0.569 . . . . 15.0 110.627 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 266' ' ' LEU . 3.2 tt -57.82 -39.49 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.415 0.686 . . . . 15.0 110.787 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -18.16 61.26 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 111.964 0.357 . . . . 15.0 111.964 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -67.64 -24.86 65.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.868 0.467 . . . . 15.0 110.693 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.27 -0.16 16.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 15.0 111.948 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.64 48.44 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.927 -0.869 . . . . 15.0 110.927 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.0 94.81 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -59.96 -33.97 72.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.065 0.946 . . . . 15.0 109.809 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.01 67.95 2.69 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.975 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.22 51.33 2.47 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.752 -0.658 . . . . 15.0 114.28 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 m -106.1 163.69 12.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.022 1.329 . . . . 15.0 107.776 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 40.9 t -74.51 -67.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.37 0.532 . . . . 15.0 110.6 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.91 -30.62 66.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.606 0.763 . . . . 15.0 110.692 173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.02 89.78 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.864 -1.062 . . . . 15.0 113.101 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 253' ' ' ILE . 46.7 tp -68.49 -48.1 65.33 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.466 0.707 . . . . 15.0 109.195 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' A' ' 138' ' ' ASP . 58.9 mtp85 -56.38 -51.64 67.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.82 -1.082 . . . . 15.0 110.337 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.77 -43.0 90.17 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.124 -0.944 . . . . 15.0 111.555 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 272' ' ' LYS . 10.0 tp10 -57.65 -61.76 2.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.6 0.76 . . . . 15.0 110.706 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 274' ' ' MET . 59.5 t -60.8 -33.25 54.49 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.097 -1.411 . . . . 15.0 110.576 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.423 ' NH1' ' HG2' ' A' ' 275' ' ' GLU . 37.1 tpt85 -62.01 -48.86 78.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.772 0.429 . . . . 15.0 111.973 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 269' ' ' GLU . 44.6 mtmt -60.35 -41.85 94.52 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.283 0.563 . . . . 15.0 110.548 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -69.2 -28.45 66.39 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.007 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG11 ' A' ' 132' ' ' VAL . 57.0 mtt -68.76 -35.31 76.91 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-O 118.516 -0.755 . . . . 15.0 109.699 174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.423 ' HG2' ' NH1' ' A' ' 271' ' ' ARG . 37.2 mt-10 -60.26 -47.99 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.489 0.493 . . . . 15.0 111.347 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -58.74 -49.47 77.5 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.152 -0.931 . . . . 15.0 110.152 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.48 -34.7 78.82 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 123.905 0.753 . . . . 15.0 111.512 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 130' ' ' VAL . 49.8 tp -70.67 -52.18 22.83 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.359 1.064 . . . . 15.0 109.51 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -64.04 -34.66 78.52 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.34 0.4 . . . . 15.0 110.586 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 52.3 m -65.25 -40.01 93.43 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.083 0.553 . . . . 15.0 110.711 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.98 -49.9 72.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.351 0.661 . . . . 15.0 111.188 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.15 -41.98 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.17 0.588 . . . . 15.0 110.012 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.38 -50.39 73.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.787 0.435 . . . . 15.0 110.292 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.82 -38.49 86.55 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.43 -0.804 . . . . 15.0 111.178 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 3.8 tpt85 -62.01 -57.51 11.38 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.118 0.967 . . . . 15.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.35 -40.47 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.855 0.862 . . . . 15.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.9 tttt -63.3 -45.69 90.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.046 0.538 . . . . 15.0 111.017 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.5 p -69.71 -37.76 76.69 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.746 0.418 . . . . 15.0 111.608 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.52 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.3 mt-30 -66.04 -36.93 84.58 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 120.894 0.378 . . . . 15.0 110.452 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.93 -40.57 96.77 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.25 174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 287' ' ' LYS . 32.2 mm -61.38 -52.22 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 123.804 0.69 . . . . 15.0 110.342 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -49.8 -55.27 14.75 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 114.552 -1.204 . . . . 15.0 110.673 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.582 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -68.79 -30.41 72.61 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.87 -1.059 . . . . 15.0 113.604 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 411' ' ' VAL . 0.9 OUTLIER -65.13 -53.91 37.98 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' A' ' 343' ' ' ARG . 59.0 t -61.24 -44.86 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.145 -0.934 . . . . 15.0 109.659 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.54 -36.64 67.0 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 124.071 0.857 . . . . 15.0 111.932 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.16 -13.51 59.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.776 0.83 . . . . 15.0 112.573 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.503 HD21 HD21 ' A' ' 120' ' ' LEU . 51.8 m-80 -121.16 161.39 21.92 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.207 0.527 . . . . 15.0 111.837 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -135.67 120.48 18.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.657 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.4 tt -154.41 132.31 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -86.73 120.88 28.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.53 128.2 86.11 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.691 -0.671 . . . . 15.0 110.087 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.507 ' HB3' HD22 ' A' ' 11' ' ' LEU . 16.0 Cg_endo -58.78 151.49 63.77 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.215 2.61 . . . . 15.0 112.735 173.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.99 68.62 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.7 1.2 . . . . 15.0 112.687 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.481 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -66.46 -43.9 84.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.925 0.89 . . . . 15.0 112.101 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 349' ' ' LEU . 95.4 mt -68.38 -36.37 79.07 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.926 0.491 . . . . 15.0 110.482 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.575 HD11 ' HE3' ' A' ' 342' ' ' LYS . 47.0 mt -59.41 -49.38 83.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.32 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -55.67 -49.3 73.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.795 0.438 . . . . 15.0 110.29 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -58.1 -56.88 16.37 Favored 'General case' 0 CA--C 1.556 1.2 0 O-C-N 124.047 0.842 . . . . 15.0 113.039 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.566 ' HB3' HD22 ' B' ' 112' ' ' ASN . 22.0 mm-40 -73.88 -40.35 63.28 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.494 0.553 . . . . 15.0 112.494 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -61.36 -38.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.54 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.8 t70 -59.01 -46.71 87.5 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.541 0.736 . . . . 15.0 111.615 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' B' ' 113' ' ' LYS . 90.9 t -56.19 -44.91 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 123.67 0.606 . . . . 15.0 109.563 174.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 317' ' ' GLN . 75.2 mt -71.9 -19.52 61.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.54 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 52.6 mtm180 -73.8 -45.66 50.13 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.24 0.473 . . . . 15.0 110.198 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -64.75 -44.53 89.78 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.661 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 314' ' ' LEU . 8.3 tt0 -61.99 -37.92 86.64 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.454 -1.248 . . . . 15.0 111.369 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.04 12.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.081 0.552 . . . . 15.0 109.95 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.79 -38.35 75.33 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.633 1.208 . . . . 15.0 112.058 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -52.5 -40.68 62.67 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.372 1.045 . . . . 15.0 110.303 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -84.39 -39.01 19.56 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.994 0.902 . . . . 15.0 109.95 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -88.98 65.83 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.144 1.378 . . . . 15.0 109.378 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 78.9 -27.5 2.27 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.143 -0.935 . . . . 15.0 115.369 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 103.03 45.55 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-N 117.829 0.814 . . . . 15.0 112.003 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 9.1 m-80 -72.18 90.06 1.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.528 0.68 . . . . 15.0 110.45 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -84.5 127.07 33.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.378 1.071 . . . . 15.0 108.294 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.0 mtmm 75.62 -41.22 0.43 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.237 1.815 . . . . 15.0 112.021 -171.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.676 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 25.2 mm-40 -59.09 -28.46 66.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.238 1.015 . . . . 15.0 111.024 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.423 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.37 -60.8 2.73 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.468 1.105 . . . . 15.0 110.726 168.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 327' ' ' LYS . 1.7 mm? -69.06 -16.5 63.71 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.143 -0.935 . . . . 15.0 111.448 -170.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.54 -21.57 38.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.459 0.704 . . . . 15.0 111.498 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.23 119.56 39.93 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 336' ' ' LEU . 59.2 Cg_endo -69.62 162.95 40.0 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 121.892 1.728 . . . . 15.0 112.121 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.457 ' HA ' HG21 ' A' ' 311' ' ' ILE . 95.0 mtt180 -47.84 -51.13 24.01 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.885 1.274 . . . . 15.0 113.222 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.78 -5.9 10.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 15.0 113.545 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 333' ' ' PRO . 0.9 OUTLIER -61.14 -35.04 76.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.9 0.48 . . . . 15.0 110.431 170.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.41 -28.66 4.24 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.762 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.45 -27.02 5.73 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.019 1.328 . . . . 15.0 113.416 -166.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -45.88 -52.77 10.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.755 1.222 . . . . 15.0 111.57 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.4 OUTLIER -104.36 -25.63 12.77 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.747 0.819 . . . . 15.0 111.254 175.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -71.16 -41.38 70.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.136 0.575 . . . . 15.0 112.24 -170.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.575 ' HE3' HD11 ' A' ' 307' ' ' ILE . 84.1 tttt -63.02 -35.46 80.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.487 -0.56 . . . . 15.0 109.487 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 295' ' ' VAL . 27.9 ttt180 -64.03 -42.05 97.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.018 0.824 . . . . 15.0 110.599 174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' B' ' 112' ' ' ASN . 95.4 mtt180 -61.79 -35.12 77.24 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.386 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 341' ' ' ALA . 12.0 t -68.12 -43.4 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 89.7 t -52.31 -45.19 44.06 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 O-C-N 123.804 0.69 . . . . 15.0 110.296 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.6 t -47.24 -51.81 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 123.602 0.761 . . . . 15.0 111.086 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -72.5 -34.78 60.01 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 114.809 -1.087 . . . . 15.0 114.006 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 306' ' ' LEU . 74.0 mt -67.22 -39.38 86.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.806 0.442 . . . . 15.0 110.564 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 354' ' ' VAL . 88.3 mt -66.92 -47.64 71.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.69 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 355' ' ' ILE . 48.5 mt -74.98 -6.95 52.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.549 0.74 . . . . 15.0 112.669 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -86.68 -41.15 6.92 Favored Glycine 0 C--O 1.25 1.113 0 N-CA-C 110.144 -1.182 . . . . 15.0 110.144 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.72 -28.47 65.84 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.651 -0.775 . . . . 15.0 111.365 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 350' ' ' LEU . 72.9 t -60.84 -43.16 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 172.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -63.4 -48.43 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.918 0.487 . . . . 15.0 110.283 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -66.94 -65.09 0.73 Allowed 'General case' 0 CA--C 1.555 1.151 0 O-C-N 122.907 0.129 . . . . 15.0 110.937 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.8 m -54.5 -50.76 67.04 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.194 0.998 . . . . 15.0 112.804 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -89.3 14.31 11.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.506 0.322 . . . . 15.0 110.802 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 45.96 34.99 2.16 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 125.261 1.424 . . . . 15.0 112.061 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -84.04 129.04 34.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.071 -166.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 178.19 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.145 0.978 . . . . 15.0 109.332 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.54 121.69 14.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.01 0.524 . . . . 15.0 111.332 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 406' ' ' GLN . 25.3 t70 -70.28 122.91 20.44 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.438 0.695 . . . . 15.0 110.876 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.41 -44.4 76.19 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.539 1.15 . . . . 15.0 111.483 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -74.17 -22.87 59.23 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.834 -0.621 . . . . 15.0 111.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.408 HH11 ' HB3' ' A' ' 363' ' ' ASP . 21.9 ttm105 -77.86 -45.33 24.55 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.747 -0.835 . . . . 15.0 108.747 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 398' ' ' MET . 39.8 t -54.47 -66.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.852 1.261 . . . . 15.0 110.165 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.68 -38.2 84.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.749 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -56.71 -54.72 34.33 Favored Glycine 0 C--N 1.357 1.736 0 O-C-N 124.125 0.89 . . . . 15.0 113.594 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.631 HD11 ' SD ' ' A' ' 398' ' ' MET . 4.6 pp -68.52 -32.26 72.09 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.3 0.55 . . . . 15.0 110.894 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.07 -43.06 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.815 0.446 . . . . 15.0 110.596 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.99 -44.29 80.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.728 0.811 . . . . 15.0 111.096 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.71 -35.29 80.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.796 0.438 . . . . 15.0 111.171 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.7 ttp -72.33 -41.98 65.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.629 -0.714 . . . . 15.0 110.82 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.703 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -67.85 -46.92 70.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.906 0.882 . . . . 15.0 111.765 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 27.5 t -65.07 -18.23 65.13 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.997 -1.001 . . . . 15.0 112.245 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.62 61.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.569 0.748 . . . . 15.0 111.553 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -104.39 -178.51 3.68 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.379 0.672 . . . . 15.0 110.798 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.58 -52.64 60.09 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.709 0.804 . . . . 15.0 111.356 -169.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 381' ' ' PRO . 19.4 t70 -145.02 126.02 7.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.389 -0.823 . . . . 15.0 109.483 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 380' ' ' ASP . 31.8 Cg_exo -60.9 -22.54 74.52 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.512 2.808 . . . . 15.0 115.196 -172.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.67 -32.91 67.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.01 0.524 . . . . 15.0 112.201 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 14.9 pt-20 -58.47 -45.78 87.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.006 -0.739 . . . . 15.0 109.006 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 375' ' ' ALA . 19.3 t -69.71 -59.43 3.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.966 0.906 . . . . 15.0 109.727 -172.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.21 -54.59 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 114.35 -1.295 . . . . 15.0 110.468 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.68 -32.72 62.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.078 0.399 . . . . 15.0 112.078 -169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.18 -53.35 31.19 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 110.123 -0.325 . . . . 15.0 110.123 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.96 -32.81 57.56 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.185 1.18 . . . . 15.0 114.185 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.1 p -60.17 -27.34 67.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.008 0.433 . . . . 15.0 111.304 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -109.68 8.48 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 15.0 111.365 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -117.7 99.67 7.11 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.252 -0.647 . . . . 15.0 109.252 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -47.22 -42.89 21.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.418 1.487 . . . . 15.0 112.576 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -45.9 -45.79 15.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.771 1.628 . . . . 15.0 112.918 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 27.5 tp -101.24 -19.39 15.71 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.113 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 8.6 tpt -71.16 -38.58 72.19 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.559 0.618 . . . . 15.0 112.262 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.3 -36.01 34.95 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 110.13 -0.322 . . . . 15.0 110.13 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.22 -31.69 65.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.625 0.77 . . . . 15.0 111.148 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.631 ' SD ' HD11 ' A' ' 370' ' ' LEU . 45.5 tpp -66.9 -34.53 77.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.505 1.122 . . . . 15.0 110.199 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -75.74 -41.46 53.28 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.623 -1.171 . . . . 15.0 110.077 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -64.02 -41.04 97.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.599 ' HA ' HD22 ' B' ' 102' ' ' LEU . 7.4 p -65.73 -52.98 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.65 -30.56 71.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 15.0 111.509 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 355' ' ' ILE . 62.8 tp -60.21 -54.14 49.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.159 0.984 . . . . 15.0 110.406 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -71.65 -34.36 69.68 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.813 0.696 . . . . 15.0 111.368 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 92.2 mt-10 -61.29 -56.37 21.25 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.035 0.534 . . . . 15.0 109.601 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 363' ' ' ASP . 28.8 tt0 -66.52 -28.26 68.41 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.374 0.421 . . . . 15.0 111.092 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.28 66.15 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.92 0.488 . . . . 15.0 110.61 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.04 -43.84 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.164 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 412' ' ' LEU . 43.4 mt-10 -68.88 -21.25 64.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.551 0.741 . . . . 15.0 112.778 -175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.25 -28.5 59.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.906 0.483 . . . . 15.0 110.252 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 294' ' ' LEU . 92.1 t -77.89 -33.8 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.1 mt -66.25 -36.84 84.05 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.994 0.918 . . . . 15.0 110.839 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.37 -20.5 66.16 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.452 0.701 . . . . 15.0 112.007 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 24.6 mtpp -95.75 -30.84 13.5 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.995 0.918 . . . . 15.0 110.693 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.91 156.67 24.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 112.032 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 91.5 mttt -78.27 83.99 4.49 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.666 0.786 . . . . 15.0 109.272 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 412' ' ' LEU . 62.2 t -83.58 85.09 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.651 -0.87 . . . . 15.0 108.651 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -78.05 97.06 5.27 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.106 -0.952 . . . . 15.0 110.533 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.3 127.53 32.83 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.268 -0.878 . . . . 15.0 110.118 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -161.38 162.81 30.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.871 0.468 . . . . 15.0 109.802 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 48.0 mt-10 -71.33 151.38 44.2 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 123.607 0.567 . . . . 15.0 110.643 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -140.81 -177.28 5.0 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.673 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.7 p -65.01 155.45 34.61 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.326 0.651 . . . . 15.0 111.018 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.32 -58.15 8.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.645 0.778 . . . . 15.0 110.868 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.859 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 21.4 m120 -80.93 7.93 9.5 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.707 1.003 . . . . 15.0 113.707 -173.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.2 -38.64 63.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.008 0.923 . . . . 15.0 111.549 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.74 -22.77 11.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.63 0.772 . . . . 15.0 110.442 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.859 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 7.1 mmt -82.51 41.94 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.703 1.201 . . . . 15.0 110.319 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -68.26 2.86 1.96 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.94 71.62 10.49 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 119.8 1.182 . . . . 15.0 111.447 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.556 HE21 HG21 ' A' ' 143' ' ' THR . 9.7 mp0 -125.66 -58.59 1.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.325 1.05 . . . . 15.0 108.61 170.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 123.843 0.857 . . . . 15.0 109.382 -179.282 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -142.61 -168.11 2.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.423 1.089 . . . . 0.0 109.129 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.72 163.58 39.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.523 0.729 . . . . 0.0 110.16 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -140.96 144.23 35.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 0.0 109.884 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.1 t -150.5 171.57 16.85 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.2 148.65 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.739 0.816 . . . . 0.0 110.982 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.21 -30.69 10.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.631 0.772 . . . . 0.0 109.693 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp 54.95 157.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.831 2.452 . . . . 0.0 114.875 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.34 -40.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.038 1.335 . . . . 0.0 107.935 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -4.91 59.25 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.443 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -155.88 100.82 2.16 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.152 0.581 . . . . 0.0 109.66 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.1 146.84 6.58 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.707 2.271 . . . . 0.0 112.001 171.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.65 -23.98 59.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.186 0.594 . . . . 0.0 111.697 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.688 HD13 ' H ' ' B' ' 14' ' ' LEU . 0.0 OUTLIER -82.68 68.64 9.23 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.407 -174.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -70.03 -20.27 63.27 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.814 0.846 . . . . 0.0 112.548 -173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -94.35 111.39 53.44 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.033 0.533 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.45 171.34 8.77 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.028 2.485 . . . . 0.0 112.082 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -77.98 95.83 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 122.11 0.957 . . . . 0.0 109.448 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -73.9 -47.21 39.56 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.967 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -108.23 120.64 42.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.597 0.759 . . . . 0.0 109.53 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.23 90.08 2.49 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.725 0.81 . . . . 0.0 109.53 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -123.57 103.39 8.4 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' B' ' 25' ' ' GLU . 57.6 p -80.89 149.21 66.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 167.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -37.73 103.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.521 3.481 . . . . 0.0 115.593 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 23' ' ' THR . 0.0 OUTLIER -136.85 169.25 18.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.327 1.051 . . . . 0.0 109.907 174.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -110.59 142.77 26.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.591 0.757 . . . . 0.0 109.59 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.11 103.95 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.533 2.155 . . . . 0.0 111.093 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.77 97.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 CA-C-O 121.651 0.738 . . . . 0.0 109.811 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.2 tp -135.35 116.28 14.16 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -94.26 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.701 0.626 . . . . 0.0 110.924 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 56.7 23.34 7.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.823 1.249 . . . . 0.0 111.215 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -86.37 78.99 9.16 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.969 0.89 . . . . 0.0 108.641 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.95 73.39 10.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.621 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.81 -68.47 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.83 -73.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.812 1.645 . . . . 0.0 111.943 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.63 -137.59 3.67 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -162.1 148.6 13.54 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.404 1.082 . . . . 0.0 109.007 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -101.27 -8.05 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.364 0.666 . . . . 0.0 112.657 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m 59.23 77.73 0.3 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.66 1.184 . . . . 0.0 110.51 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.29 125.27 31.8 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.323 0.649 . . . . 0.0 110.91 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.26 -28.33 70.95 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 167.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.24 -121.31 6.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.22 52.82 0.02 OUTLIER Glycine 0 C--O 1.24 0.491 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.02 104.5 0.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.863 0.865 . . . . 0.0 111.078 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -98.82 -153.76 0.44 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.447 1.099 . . . . 0.0 110.295 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -62.92 91.8 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.613 0.765 . . . . 0.0 112.605 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp 70.95 -13.11 0.52 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.777 1.631 . . . . 0.0 114.205 165.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m 65.07 -75.75 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.463 1.505 . . . . 0.0 111.158 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.04 81.87 0.06 OUTLIER Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -125.86 -44.73 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.295 0.638 . . . . 0.0 111.004 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' B' ' 52' ' ' THR . 15.0 pt20 -50.65 -69.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.082 0.953 . . . . 0.0 112.844 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' B' ' 51' ' ' GLN . 80.6 m -108.21 -85.13 0.53 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.24 -71.33 0.75 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 171.87 173.21 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.473 1.909 . . . . 0.0 108.52 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.9 mt 64.02 -168.48 0.2 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.165 0.986 . . . . 0.0 113.131 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -133.98 99.84 4.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.957 0.903 . . . . 0.0 109.424 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.18 97.56 7.84 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.331 1.052 . . . . 0.0 109.571 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -98.07 175.34 6.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.268 0.627 . . . . 0.0 110.293 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.71 150.77 45.25 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.09 0.956 . . . . 0.0 109.559 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 62.4 p -93.39 105.9 17.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.46 -46.89 11.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.066 0.547 . . . . 0.0 110.253 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -172.04 165.95 3.87 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.786 0.834 . . . . 0.0 110.395 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -37.11 -40.6 0.65 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 124.708 3.606 . . . . 0.0 115.673 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.99 -79.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.142 1.377 . . . . 0.0 112.402 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -122.73 -44.58 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.659 0.784 . . . . 0.0 110.181 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.02 152.19 33.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.321 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.98 68.53 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.579 1.181 . . . . 0.0 108.97 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.45 169.39 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.315 1.446 . . . . 0.0 108.14 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -97.01 -58.44 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt 61.57 -166.45 0.21 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.544 1.152 . . . . 0.0 110.562 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tp 49.99 23.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 C-N-CA 125.68 1.592 . . . . 0.0 113.838 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.63 -107.26 0.37 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.43 -167.92 0.17 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.474 1.11 . . . . 0.0 112.675 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 168.56 30.23 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 67.2 mtt -102.77 94.23 5.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.252 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.83 80.3 1.22 Allowed Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.62 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.576 1.15 . . . . 0.0 110.895 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -102.52 -73.39 0.66 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.714 0.805 . . . . 0.0 109.423 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.86 -72.72 0.71 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.6 mm 61.21 -76.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.642 1.577 . . . . 0.0 112.154 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 25.8 m 62.38 -78.54 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.842 1.257 . . . . 0.0 110.76 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.34 -91.33 0.42 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 174.47 165.48 0.23 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.951 1.3 . . . . 0.0 109.453 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 63.62 111.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.743 1.217 . . . . 0.0 111.607 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.624 ' HB3' ' HA3' ' B' ' 140' ' ' GLY . 3.7 p-10 -72.0 107.84 4.92 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -76.94 82.31 3.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.24 134.37 0.08 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 126.213 1.805 . . . . 0.0 106.883 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.22 90.22 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.62 -48.88 2.25 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.9 -44.46 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.886 1.274 . . . . 0.0 108.951 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.84 -83.02 0.54 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.58 -73.35 0.78 Allowed Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.433 0.54 . . . . 0.0 113.349 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -67.3 -20.58 65.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.197 1.399 . . . . 0.0 111.03 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG22 ' A' ' 384' ' ' VAL . 84.3 t80 -134.96 152.77 52.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.818 0.847 . . . . 0.0 109.324 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' B' ' 95' ' ' LYS . 0.0 OUTLIER -145.72 145.62 30.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.454 1.101 . . . . 0.0 109.475 178.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.19 89.75 0.64 Allowed Glycine 0 C--N 1.345 1.07 0 O-C-N 123.774 0.672 . . . . 0.0 112.232 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.79 137.29 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 122.209 -0.583 . . . . 0.0 110.904 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.18 -68.76 0.19 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.772 1.229 . . . . 0.0 108.773 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.55 29.17 6.8 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.259 1.424 . . . . 0.0 112.991 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.38 88.54 0.12 Allowed Pre-proline 0 C--N 1.363 1.169 0 C-N-CA 124.599 1.159 . . . . 0.0 109.158 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.85 99.95 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.273 1.982 . . . . 0.0 112.328 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.599 HD22 ' HA ' ' A' ' 401' ' ' VAL . 10.9 mp -82.43 -156.44 0.17 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.684 0.794 . . . . 0.0 109.02 169.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 63.9 p -64.58 121.97 15.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.223 0.609 . . . . 0.0 109.707 172.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.11 -17.61 55.93 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 -168.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.634 ' HA ' HE21 ' B' ' 105' ' ' GLN . 0.0 OUTLIER -126.57 -179.38 4.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.028 0.531 . . . . 0.0 110.491 175.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -65.48 95.71 0.22 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 122.894 0.477 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 11.1 m -142.96 21.26 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.199 1.0 . . . . 0.0 109.682 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -75.96 85.28 2.87 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.356 0.598 . . . . 0.0 109.71 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -139.79 -28.33 0.75 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.694 1.198 . . . . 0.0 108.127 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.65 127.3 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.103 1.361 . . . . 0.0 108.278 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.57 HD13 ' H ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -78.92 1.4 23.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.493 0.717 . . . . 0.0 111.806 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.566 HD22 ' HB3' ' A' ' 310' ' ' GLU . 34.8 t30 -70.6 81.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.253 1.021 . . . . 0.0 110.619 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.42 ' HB3' HG11 ' A' ' 313' ' ' VAL . 4.1 ptpp? 174.73 -30.86 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.691 1.596 . . . . 0.0 109.3 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -81.25 95.54 6.99 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p 52.56 -78.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.577 1.951 . . . . 0.0 114.211 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.15 146.76 11.78 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.25 0.452 . . . . 0.0 113.625 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -81.63 -50.17 0.91 Allowed Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.303 1.041 . . . . 0.0 111.991 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.02 -6.63 17.56 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 121.63 1.554 . . . . 0.0 112.209 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.31 -32.24 24.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.238 1.015 . . . . 0.0 109.548 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 67.59 96.03 0.06 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 124.985 1.314 . . . . 0.0 111.332 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.81 -33.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.058 0.943 . . . . 0.0 108.774 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.5 m 81.53 -55.24 0.27 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.211 1.805 . . . . 0.0 112.039 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 71.91 -66.24 0.31 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.574 1.55 . . . . 0.0 110.392 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -157.51 142.94 17.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.8 27.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.203 0.601 . . . . 0.0 109.95 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.711 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . -74.49 179.59 4.56 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.049 0.54 . . . . 0.0 112.263 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 428' ' ' MET . 3.1 m 79.74 29.85 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.541 1.937 . . . . 0.0 110.593 -164.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.09 85.51 0.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.729 1.212 . . . . 0.0 112.325 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 46.8 m -70.66 138.77 50.98 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.78 158.95 26.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.419 0.628 . . . . 0.0 111.75 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -110.8 -74.32 0.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.068 -147.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' B' ' 135' ' ' VAL . 81.3 p 47.38 82.38 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.56 1.544 . . . . 0.0 112.435 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 3.1 m -68.58 -43.28 76.88 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.821 0.848 . . . . 0.0 110.592 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.46 -5.99 64.7 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.504 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.597 ' HA ' ' HB2' ' B' ' 132' ' ' SER . 5.7 m 56.63 4.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 127.236 2.214 . . . . 0.0 114.63 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 tttp 64.43 136.32 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.789 1.636 . . . . 0.0 112.238 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.4 m 77.27 -22.2 0.29 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.032 1.333 . . . . 0.0 113.496 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -57.07 128.16 35.58 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.696 0.68 . . . . 0.0 112.827 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -174.87 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.393 1.477 . . . . 0.0 109.323 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . 0.624 ' HA3' ' HB3' ' B' ' 85' ' ' ASN . . . 99.11 -51.28 1.14 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.459 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 -152.3 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.674 1.189 . . . . 0.0 111.512 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 59.6 mt 68.14 13.73 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.202 1.001 . . . . 0.0 111.586 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.25 32.37 12.27 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.575 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -82.99 60.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.406 1.098 . . . . 0.0 110.572 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.51 103.85 4.47 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.101 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.569 HD12 ' HD3' ' B' ' 149' ' ' LYS . 27.2 pt -123.35 150.21 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.598 0.759 . . . . 0.0 109.351 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -135.16 176.73 8.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.737 0.815 . . . . 0.0 110.815 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 40.3 32.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.495 1.918 . . . . 0.0 113.893 -172.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.569 ' HD3' HD12 ' B' ' 146' ' ' ILE . 89.1 tttt -125.38 102.08 7.25 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 123.742 0.817 . . . . 0.0 109.918 -178.571 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -104.3 111.97 24.81 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.926 -1.139 . . . . 15.0 107.926 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 17' ' ' ILE . 15.5 m -131.24 143.88 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.257 0.551 . . . . 15.0 111.545 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.6 p -144.89 164.03 32.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.126 1.37 . . . . 15.0 108.373 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -135.89 130.56 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.926 0.49 . . . . 15.0 111.203 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 42.9 mt-10 -126.22 128.36 47.1 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.271 1.028 . . . . 15.0 110.253 -178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m -82.74 98.52 9.13 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -85.16 -68.1 0.75 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.762 0.825 . . . . 15.0 111.72 -171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -133.49 96.05 3.63 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.63 -0.878 . . . . 15.0 108.63 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.78 -108.14 1.86 Allowed Glycine 0 C--N 1.349 1.293 0 O-C-N 123.841 0.713 . . . . 15.0 113.291 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 301' ' ' ASP . 5.7 mp -77.97 -20.99 51.65 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.365 1.066 . . . . 15.0 110.439 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.52 109.84 3.0 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.04 -0.982 . . . . 15.0 113.057 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' NH1' HG21 ' A' ' 111' ' ' VAL . 81.0 mtt85 -104.19 150.62 24.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.69 1.196 . . . . 15.0 110.139 171.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.9 ttm180 -120.02 101.6 7.96 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.732 1.213 . . . . 15.0 108.821 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.21 93.3 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.961 -1.126 . . . . 15.0 107.961 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 38.2 m -75.04 108.06 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.231 1.013 . . . . 15.0 109.487 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 3' ' ' VAL . 35.6 mt -110.75 131.43 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.767 0.827 . . . . 15.0 109.894 -174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 52.8 m -118.3 102.51 9.02 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.365 -1.346 . . . . 15.0 107.365 169.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.8 mt -76.21 112.38 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.338 -0.986 . . . . 15.0 108.338 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.96 39.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.694 0.798 . . . . 15.0 112.4 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.05 -33.09 66.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.638 1.175 . . . . 15.0 113.115 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.76 -41.63 91.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.838 0.455 . . . . 15.0 110.374 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -69.94 -39.93 75.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.232 1.013 . . . . 15.0 110.504 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 97' ' ' TYR . 57.0 mt -65.06 -55.24 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.54 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.66 -33.18 71.22 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.695 -1.139 . . . . 15.0 111.86 -173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.4 m -77.39 -48.75 16.46 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.72 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.68 91.01 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.0 0.52 . . . . 15.0 112.272 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.628 ' HA ' HG21 ' A' ' 66' ' ' VAL . 84.7 t -63.8 -43.44 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.232 0.613 . . . . 15.0 109.899 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -68.88 -30.77 69.34 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.297 1.039 . . . . 15.0 111.189 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.4 m -75.13 -26.47 59.22 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.276 -0.875 . . . . 15.0 110.108 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.7 tp10 -81.24 -30.3 34.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.288 0.635 . . . . 15.0 110.819 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 55' ' ' ALA . 83.5 mt -65.22 -39.55 92.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.995 0.518 . . . . 15.0 110.87 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 12.5 p -73.99 -24.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 123.718 0.636 . . . . 15.0 110.816 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 87.7 m-20 -64.66 -51.85 60.4 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.78 -0.452 . . . . 15.0 109.78 172.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.21 -37.69 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.477 -0.783 . . . . 15.0 110.077 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . . . -63.8 -45.1 91.18 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.623 -0.717 . . . . 15.0 111.265 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.16 -40.96 95.05 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.838 0.351 . . . . 15.0 110.598 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -61.82 -34.69 76.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.178 0.991 . . . . 15.0 111.739 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' HG13 ' A' ' 41' ' ' ILE . 22.1 t -108.51 0.22 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.805 0.842 . . . . 15.0 110.492 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 66.89 15.89 10.24 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.583 1.553 . . . . 15.0 112.9 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 69.9 mt -60.11 -32.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 124.629 1.172 . . . . 15.0 111.459 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -61.39 -31.64 71.55 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.544 0.738 . . . . 15.0 111.042 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.91 -28.55 72.95 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.756 -0.657 . . . . 15.0 113.046 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 97.4 m-85 -78.53 -17.85 55.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.2 0.6 . . . . 15.0 112.006 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -70.58 98.25 1.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.211 -0.663 . . . . 15.0 109.211 173.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -93.7 19.0 9.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.776 -0.647 . . . . 15.0 111.321 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.24 -17.8 58.17 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 119.765 -0.464 . . . . 15.0 112.905 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -70.54 -41.04 73.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.389 0.676 . . . . 15.0 111.141 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.8 115.63 51.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.375 0.67 . . . . 15.0 110.525 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 53' ' ' ILE . 23.7 Cg_exo -67.29 136.58 40.74 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.982 2.455 . . . . 15.0 112.534 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 61.7 tpp -72.23 -25.21 61.55 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.441 1.097 . . . . 15.0 111.896 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -74.67 -38.66 62.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.663 0.268 . . . . 15.0 111.07 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 57' ' ' ARG . 36.9 mt -67.44 -36.46 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.101 0.96 . . . . 15.0 111.377 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.79 -19.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 112.222 0.453 . . . . 15.0 112.222 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -85.98 -37.71 18.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.313 0.645 . . . . 15.0 112.089 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.4 pt20 -89.76 -36.3 15.24 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.755 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.628 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 95.3 mtt180 -103.55 -63.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.103 0.561 . . . . 15.0 111.411 -173.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -64.18 -45.51 88.04 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.636 0.775 . . . . 15.0 111.142 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -102.13 36.67 4.1 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.329 -0.851 . . . . 15.0 112.54 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.76 -38.36 88.86 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.937 0.895 . . . . 15.0 111.742 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 p -80.75 -23.75 39.19 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.279 0.631 . . . . 15.0 110.711 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 66' ' ' VAL . 42.8 t -67.04 -32.34 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 109.686 -0.487 . . . . 15.0 109.686 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG11 ' A' ' 28' ' ' VAL . 62.7 mtp85 -57.7 -35.83 71.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.115 0.566 . . . . 15.0 110.773 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.63 -49.23 63.99 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.066 0.854 . . . . 15.0 110.527 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -59.62 -45.04 93.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.217 0.607 . . . . 15.0 111.581 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 28' ' ' VAL . 60.4 t -68.25 -19.68 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.524 0.73 . . . . 15.0 111.38 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 70' ' ' LEU . 97.9 mt -56.97 -32.31 65.93 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.075 0.398 . . . . 15.0 111.11 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.02 -49.12 69.34 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.523 0.514 . . . . 15.0 111.829 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.29 -36.93 81.41 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.51 1.124 . . . . 15.0 111.609 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 19' ' ' ILE . 62.0 mt -68.08 -50.92 52.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.735 0.814 . . . . 15.0 110.261 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.0 mtm -63.36 -36.25 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.128 0.571 . . . . 15.0 111.18 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -60.12 -58.32 9.05 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.05 0.94 . . . . 15.0 110.691 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -69.96 -33.54 72.22 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.085 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.692 0.397 . . . . 15.0 110.933 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.74 -57.69 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.406 0.441 . . . . 15.0 110.723 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 tt -60.09 -37.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 123.878 0.736 . . . . 15.0 110.903 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.87 -39.31 72.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.247 0.619 . . . . 15.0 111.077 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -52.11 61.96 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.625 0.578 . . . . 15.0 111.239 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 pt -63.9 -27.8 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 112.453 0.538 . . . . 15.0 112.453 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.42 -54.56 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.028 0.531 . . . . 15.0 110.267 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.96 -31.32 67.86 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.475 0.31 . . . . 15.0 111.752 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.98 -3.94 59.05 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.288 0.635 . . . . 15.0 111.427 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm 68.08 20.19 9.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.394 1.077 . . . . 15.0 112.016 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 67.3 mt -91.45 140.66 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.126 0.97 . . . . 15.0 109.744 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 115.1 25.24 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 107.553 -1.277 . . . . 15.0 107.553 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.37 167.11 23.25 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.613 2.875 . . . . 15.0 114.045 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.8 105.56 8.1 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.77 1.228 . . . . 15.0 108.809 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.78 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.345 -0.302 . . . . 15.0 112.345 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.15 121.67 85.0 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.321 0.648 . . . . 15.0 110.835 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -69.38 132.97 25.1 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.196 2.598 . . . . 15.0 112.959 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -84.3 116.15 22.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.565 0.746 . . . . 15.0 110.111 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -84.92 124.67 31.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.587 0.755 . . . . 15.0 109.061 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.66 93.99 18.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.648 -1.242 . . . . 15.0 107.648 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.89 124.97 11.54 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.919 2.412 . . . . 15.0 111.604 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.19 -67.68 1.43 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 111.337 -0.705 . . . . 15.0 111.337 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -168.63 146.01 3.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.559 0.744 . . . . 15.0 111.31 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' HE1' HD13 ' A' ' 24' ' ' ILE . 62.8 t80 -127.59 137.47 52.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.543 1.137 . . . . 15.0 108.634 170.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.8 mttt -142.14 141.37 32.65 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.094 0.958 . . . . 15.0 109.668 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -65.75 110.38 2.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.817 0.847 . . . . 15.0 109.633 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.66 -24.1 26.42 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 116.06 -0.518 . . . . 15.0 112.63 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -107.51 171.12 7.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.65 0.78 . . . . 15.0 111.639 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.48 137.34 35.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.539 1.136 . . . . 15.0 110.789 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' HD2' HD12 ' A' ' 19' ' ' ILE . 18.7 t80 -79.03 99.87 7.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.351 0.661 . . . . 15.0 110.005 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 m -91.55 136.37 33.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.632 0.773 . . . . 15.0 110.31 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -167.81 -174.09 2.32 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.139 0.976 . . . . 15.0 110.02 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 56.6 p -153.97 128.57 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.672 0.789 . . . . 15.0 110.103 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -100.94 112.92 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.66 133.12 42.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.272 1.029 . . . . 15.0 109.29 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -166.19 149.11 7.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.682 0.793 . . . . 15.0 109.44 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.01 165.97 18.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.645 0.378 . . . . 15.0 110.099 171.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' NH1' ' A' ' 13' ' ' ARG . 22.7 m -119.56 167.53 12.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.58 0.752 . . . . 15.0 110.753 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -77.7 116.62 59.75 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.03 -1.1 . . . . 15.0 108.03 165.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 301' ' ' ASP . 71.0 Cg_endo -79.12 165.57 23.73 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.412 2.075 . . . . 15.0 111.577 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -76.61 111.35 12.01 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.511 -1.292 . . . . 15.0 107.511 167.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 300' ' ' ILE . 88.3 t -65.49 115.4 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.999 0.919 . . . . 15.0 111.012 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.25 83.61 1.04 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.696 0.798 . . . . 15.0 110.448 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.04 102.55 4.9 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.623 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.07 -178.07 4.8 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.169 -0.923 . . . . 15.0 109.268 168.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.73 116.68 9.62 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 113.963 0.345 . . . . 15.0 113.963 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.44 HD12 ' HD3' ' A' ' 414' ' ' LYS . 86.6 mt -75.5 -6.1 48.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.149 0.58 . . . . 15.0 110.768 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -68.96 -21.94 64.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.709 1.203 . . . . 15.0 110.376 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.49 -16.78 64.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.563 0.745 . . . . 15.0 112.375 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 23.4 mt -81.76 92.09 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.321 1.048 . . . . 15.0 109.202 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 41.1 mt-10 -92.97 91.14 7.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.253 0.621 . . . . 15.0 109.982 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.497 HG11 HG13 ' A' ' 286' ' ' VAL . 95.1 t -91.64 130.15 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.759 1.224 . . . . 15.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.59 106.74 17.34 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.426 1.09 . . . . 15.0 110.0 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 86.8 tttt -84.77 110.77 30.22 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.517 1.127 . . . . 15.0 109.394 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.562 ' HG2' HD11 ' A' ' 427' ' ' LEU . 10.3 Cg_endo -94.42 111.18 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.295 0 C-N-CA 123.513 2.809 . . . . 15.0 112.945 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.67 94.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 92.5 t -89.78 122.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.785 -1.098 . . . . 15.0 109.211 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -95.34 142.35 27.84 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.462 0.705 . . . . 15.0 110.088 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.58 133.92 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.7 p -130.36 175.41 8.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.85 0.86 . . . . 15.0 109.389 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.58 -21.71 65.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.186 0.594 . . . . 15.0 111.754 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.58 81.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.025 0.53 . . . . 15.0 110.484 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -76.02 -34.33 59.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.364 -0.834 . . . . 15.0 110.836 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.37 -52.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.91 -38.74 92.17 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.948 0.78 . . . . 15.0 110.753 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.96 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.873 0.733 . . . . 15.0 112.877 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 38.5 tpp -66.54 -46.68 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 15.0 110.577 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 270' ' ' VAL . 95.0 mt -62.49 -35.05 78.13 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.375 -0.83 . . . . 15.0 110.625 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.89 -39.05 79.98 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.3 1.04 . . . . 15.0 110.622 176.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.5 m -61.53 -43.07 99.54 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.367 0.417 . . . . 15.0 110.219 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.527 HD11 ' CZ2' ' B' ' 131' ' ' TRP . 76.0 mt -58.54 -45.39 89.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.345 0.658 . . . . 15.0 110.083 174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 78.8 mtp180 -67.07 -26.01 66.53 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.397 -0.819 . . . . 15.0 111.736 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -83.36 -27.16 29.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.919 0.488 . . . . 15.0 111.879 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -74.2 -39.41 63.16 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.001 0.52 . . . . 15.0 109.975 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -94.2 16.02 15.86 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 15.0 110.437 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.7 117.72 19.38 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.423 0.689 . . . . 15.0 111.401 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -84.6 131.42 34.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.365 1.066 . . . . 15.0 109.27 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -77.27 151.39 35.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.729 0.776 . . . . 15.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -153.6 138.68 17.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 113.894 -1.503 . . . . 15.0 108.591 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.38 142.56 57.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.457 0.646 . . . . 15.0 111.782 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.735 ' HG3' HG13 ' A' ' 240' ' ' VAL . 11.6 pttm -137.7 177.89 7.53 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.269 -1.332 . . . . 15.0 110.253 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.54 137.66 45.67 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.015 -1.105 . . . . 15.0 108.015 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.92 -158.28 17.54 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 123.502 0.573 . . . . 15.0 112.832 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.98 113.46 3.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.26 1.024 . . . . 15.0 111.931 -169.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 202' ' ' ILE . 58.3 t -58.67 130.48 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.64 1.576 . . . . 15.0 111.813 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -81.24 148.13 29.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 171.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.626 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -80.43 11.43 3.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.563 0.745 . . . . 15.0 112.594 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.57 6.67 4.43 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.88 1.272 . . . . 15.0 111.224 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -89.5 -171.06 3.07 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.045 0.926 . . . . 15.0 112.006 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -128.71 153.83 46.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.949 -1.501 . . . . 15.0 106.949 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG12 HG23 ' A' ' 240' ' ' VAL . 32.8 m -135.95 -171.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 15.0 110.929 -170.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 93.2 m -129.23 108.24 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.186 0.994 . . . . 15.0 108.708 168.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 237' ' ' LEU . 34.8 pt -106.77 -172.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.304 0.573 . . . . 15.0 111.877 171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 3.0 t70 -151.07 102.02 2.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 105.858 -1.904 . . . . 15.0 105.858 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 33.0 p90 -112.59 140.14 47.6 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.377 -0.827 . . . . 15.0 111.031 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -84.27 109.8 18.07 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -65.35 108.65 2.46 Favored Glycine 0 C--N 1.337 0.618 0 O-C-N 123.765 0.666 . . . . 15.0 111.995 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 13.0 m -127.53 140.44 52.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.693 0.797 . . . . 15.0 109.82 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.548 HG23 ' CE1' ' A' ' 177' ' ' PHE . 83.1 t -108.31 119.79 58.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.262 1.025 . . . . 15.0 108.551 173.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.486 ' HB2' ' HE3' ' A' ' 229' ' ' LYS . 20.4 t70 66.56 9.18 6.37 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.333 1.053 . . . . 15.0 112.391 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 118.61 -17.91 10.99 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.614 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -108.88 119.38 39.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.413 0.606 . . . . 15.0 109.859 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.0 pt-20 -69.18 152.0 45.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.267 0.627 . . . . 15.0 111.898 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.548 ' CE1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -131.81 161.41 32.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.939 -1.028 . . . . 15.0 110.119 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.66 150.47 48.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.849 0.86 . . . . 15.0 110.706 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.65 -43.63 3.1 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.365 -0.294 . . . . 15.0 112.365 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 177' ' ' PHE . . . -81.91 78.9 1.9 Allowed Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 111.266 -0.734 . . . . 15.0 111.266 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -156.14 140.6 16.78 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 105.556 -2.016 . . . . 15.0 105.556 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -137.67 102.43 4.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.3 p -92.87 130.53 38.43 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.025 1.73 . . . . 15.0 109.582 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.5 35.11 22.73 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.554 1.169 . . . . 15.0 109.784 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.434 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 22.1 t80 -83.42 125.23 31.48 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 113.968 -1.469 . . . . 15.0 111.649 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 8.5 p -77.01 129.3 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 122.975 0.51 . . . . 15.0 109.83 172.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.483 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.1 tm? -125.94 122.32 35.64 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.632 -0.877 . . . . 15.0 108.632 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.3 151.13 21.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.919 0.888 . . . . 15.0 110.703 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 37.4 mtt -105.01 158.5 16.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.0 0.92 . . . . 15.0 110.063 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.89 -24.37 5.27 Favored Glycine 0 N--CA 1.474 1.193 0 O-C-N 123.727 0.642 . . . . 15.0 113.512 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -64.14 131.31 47.07 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.582 0.753 . . . . 15.0 110.416 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.28 2.48 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 116.123 -0.489 . . . . 15.0 113.155 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -126.67 -27.39 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.773 0.829 . . . . 15.0 110.944 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.86 165.11 23.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.81 0.444 . . . . 15.0 110.552 -169.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.5 ' N ' ' SD ' ' A' ' 194' ' ' MET . 53.0 mt -57.16 115.0 9.23 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.895 0.878 . . . . 15.0 109.28 170.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.52 99.1 0.5 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.776 2.318 . . . . 15.0 111.943 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 132.2 -11.55 5.3 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 115.768 -0.651 . . . . 15.0 113.132 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' HA ' HG11 ' A' ' 215' ' ' VAL . 52.7 t80 -70.6 -52.14 23.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 15.0 110.435 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -24.77 60.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.513 -1.221 . . . . 15.0 112.323 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.59 -49.15 27.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.484 1.514 . . . . 15.0 112.453 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.22 -34.33 88.8 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.355 1.035 . . . . 15.0 113.692 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.557 HG22 HG11 ' A' ' 158' ' ' VAL . 3.9 mp -73.13 -39.62 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 C-N-CA 123.303 0.641 . . . . 15.0 110.359 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.626 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 54.0 mtpt -65.46 -1.13 2.29 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.336 1.606 . . . . 15.0 115.336 -166.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.76 42.06 0.89 Allowed Glycine 0 N--CA 1.468 0.775 0 CA-C-N 118.465 0.575 . . . . 15.0 112.262 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -145.5 -175.42 4.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.037 . . . . 15.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.05 167.98 11.26 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.225 1.01 . . . . 15.0 109.615 171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.71 25.7 0.19 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.279 1.214 . . . . 15.0 114.279 -166.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -138.37 41.95 1.32 Allowed Glycine 0 N--CA 1.475 1.236 0 O-C-N 121.623 -0.673 . . . . 15.0 112.954 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.06 155.74 48.66 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 114.903 1.445 . . . . 15.0 114.903 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -121.63 117.41 26.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 112.119 -2.31 . . . . 15.0 107.045 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -153.01 152.37 31.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.32 0.648 . . . . 15.0 110.304 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -116.21 120.95 40.61 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.34 1.056 . . . . 15.0 108.917 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 201' ' ' GLY . 45.9 pt -106.42 150.63 8.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 C-N-CA 123.055 0.542 . . . . 15.0 111.152 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.87 106.35 18.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.727 -1.124 . . . . 15.0 109.027 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 198' ' ' PHE . 34.9 m -119.12 -178.12 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.667 0.746 . . . . 15.0 110.591 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 73.0 m -146.9 130.68 17.02 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.795 1.638 . . . . 15.0 107.359 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -54.66 164.08 1.23 Allowed Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.986 1.314 . . . . 15.0 112.301 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.489 ' HD3' HG12 ' A' ' 195' ' ' ILE . 60.3 Cg_endo -81.33 149.31 16.92 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.936 1.757 . . . . 15.0 109.041 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 47.1 mt-10 -76.35 -1.49 27.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 122.285 -0.259 . . . . 15.0 111.191 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.03 -9.85 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.573 1.149 . . . . 15.0 111.407 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -56.65 135.29 55.01 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 122.971 0.508 . . . . 15.0 109.647 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.585 ' HB2' HD22 ' B' ' 10' ' ' LEU . 3.8 m-70 -57.23 -51.37 69.6 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.741 0.816 . . . . 15.0 112.167 -170.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' B' ' 6' ' ' ILE . . . -64.52 117.18 6.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.675 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 36.1 tt0 -63.47 -35.6 80.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.551 0.691 . . . . 15.0 110.87 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -61.47 -23.79 66.12 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.209 -1.36 . . . . 15.0 111.091 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 21.6 mt -113.11 -17.07 12.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.309 -0.853 . . . . 15.0 113.101 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.6 ptpt -69.77 118.92 13.23 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.649 1.113 . . . . 15.0 110.224 -173.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.95 29.87 75.24 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.616 -0.72 . . . . 15.0 113.11 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 173' ' ' ASP . 7.3 tmtm? -102.9 140.42 37.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.121 -1.066 . . . . 15.0 108.121 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.93 126.9 30.84 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.016 0.527 . . . . 15.0 111.632 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.36 152.7 39.9 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.152 0.981 . . . . 15.0 110.562 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.5 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 6.6 mmpt? -113.39 126.31 55.22 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.17 0.988 . . . . 15.0 108.598 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.407 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 29.6 m-85 -127.91 114.91 17.78 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.391 0.541 . . . . 15.0 109.566 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.01 84.23 4.28 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.418 0.687 . . . . 15.0 109.556 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.3 mm -71.78 101.92 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 125.237 1.415 . . . . 15.0 110.74 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -85.43 82.16 8.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.235 -1.024 . . . . 15.0 108.235 171.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 158' ' ' VAL . 25.1 tp -65.65 95.36 0.23 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.252 0.621 . . . . 15.0 109.401 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -91.34 -37.59 13.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.886 0.875 . . . . 15.0 111.377 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.78 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 29.8 mmmt -143.17 156.22 44.73 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.936 0.894 . . . . 15.0 109.759 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 154' ' ' LYS . 3.8 p -130.67 132.8 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.879 -1.156 . . . . 15.0 107.879 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -92.36 167.72 11.8 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 154' ' ' LYS . 41.2 tt0 -152.63 140.65 20.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.971 0.909 . . . . 15.0 108.576 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.655 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 12.0 ptp85 -74.75 152.2 39.09 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.34 0.59 . . . . 15.0 109.867 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.49 110.28 22.49 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.651 1.181 . . . . 15.0 108.273 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.4 108.35 2.05 Favored Pre-proline 0 C--O 1.242 0.686 0 N-CA-C 108.107 -1.072 . . . . 15.0 108.107 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.46 175.23 2.24 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.084 2.523 . . . . 15.0 112.07 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.5 138.58 41.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.457 -0.792 . . . . 15.0 111.137 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.4 19.7 5.03 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.503 -0.771 . . . . 15.0 108.942 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 26.4 m -68.33 145.2 54.41 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 124.192 0.997 . . . . 15.0 109.902 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.61 -33.31 21.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.854 1.262 . . . . 15.0 113.243 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.66 -33.82 75.84 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.348 1.03 . . . . 15.0 111.901 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -89.36 -36.88 15.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.768 0.427 . . . . 15.0 110.505 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 266' ' ' LEU . 66.9 mt -55.2 -45.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.367 0.667 . . . . 15.0 110.883 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.17 -16.99 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.663 -0.698 . . . . 15.0 112.453 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -70.49 -23.96 62.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.058 0.456 . . . . 15.0 109.989 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -82.83 15.83 2.52 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.552 0.741 . . . . 15.0 110.94 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.57 14.44 69.65 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 117.606 0.184 . . . . 15.0 113.496 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.41 103.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.326 -1.361 . . . . 15.0 107.326 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.78 -46.27 88.77 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.225 1.01 . . . . 15.0 111.75 -166.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.37 64.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.83 -1.174 . . . . 15.0 107.83 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -79.29 50.14 3.69 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.945 -166.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 83.3 p -85.89 175.81 8.43 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.367 1.083 . . . . 15.0 108.444 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.9 t -72.44 -59.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 118.373 0.533 . . . . 15.0 110.061 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -56.6 -34.71 67.47 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.918 0.887 . . . . 15.0 111.307 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.86 -30.77 67.76 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.423 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.475 HD13 HG23 ' A' ' 253' ' ' ILE . 66.4 tp -73.67 -38.13 65.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.429 0.692 . . . . 15.0 109.462 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -57.84 -49.85 75.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.188 0.595 . . . . 15.0 110.668 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.62 80.75 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.43 -0.805 . . . . 15.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.37 -47.65 66.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.906 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.597 HG21 HD21 ' A' ' 141' ' ' LEU . 73.3 t -63.67 -39.98 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 119.09 -0.481 . . . . 15.0 110.243 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -54.94 -45.18 74.81 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.673 0.608 . . . . 15.0 110.508 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -60.56 -52.54 64.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.15 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -65.77 -32.08 73.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.378 0.671 . . . . 15.0 111.125 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 37.2 mtt -64.28 -60.58 3.02 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.867 0.729 . . . . 15.0 109.392 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.45 -26.81 67.38 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 124.263 0.977 . . . . 15.0 111.988 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.25 -55.85 9.33 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.121 0.568 . . . . 15.0 109.663 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.39 -24.77 65.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.46 -0.791 . . . . 15.0 110.715 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.53 -36.81 60.4 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.41 0.684 . . . . 15.0 110.484 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 373' ' ' GLU . 31.3 ttpt -63.71 -39.2 93.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -67.68 -33.1 74.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.196 -0.911 . . . . 15.0 111.276 173.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.65 67.01 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.239 0.616 . . . . 15.0 110.644 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 128' ' ' PRO . 1.7 mp -65.34 -39.71 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.566 0.746 . . . . 15.0 109.425 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.573 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 20.9 tpt180 -63.1 -50.29 71.09 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.212 0.32 . . . . 15.0 110.658 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -70.27 -26.76 63.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.591 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 289' ' ' GLN . 8.7 tpp85 -63.64 -56.05 18.78 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.48 0.712 . . . . 15.0 110.221 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.497 HG13 HG11 ' A' ' 125' ' ' VAL . 76.8 t -63.62 -37.8 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.16 -0.927 . . . . 15.0 109.921 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.2 tttt -70.06 -39.37 75.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.98 0.912 . . . . 15.0 111.243 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.3 p -71.57 -41.82 68.56 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.265 0.226 . . . . 15.0 110.894 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' A' ' 285' ' ' ARG . 48.8 mt-30 -70.38 -29.72 66.44 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.274 0.359 . . . . 15.0 110.949 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.06 -54.68 43.08 Favored 'General case' 0 C--O 1.211 -0.947 0 O-C-N 123.602 0.563 . . . . 15.0 110.306 172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 287' ' ' LYS . 46.5 mm -64.97 -41.95 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 124.203 0.939 . . . . 15.0 111.329 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -58.47 -57.24 13.81 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.94 0.896 . . . . 15.0 110.252 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.67 -27.88 73.47 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.134 -1.393 . . . . 15.0 112.616 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.488 HD12 HG11 ' A' ' 411' ' ' VAL . 0.4 OUTLIER -62.42 -53.89 48.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.152 0.981 . . . . 15.0 109.972 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.585 HG21 ' HG3' ' A' ' 343' ' ' ARG . 69.0 t -59.88 -52.33 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -51.83 -37.11 50.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.108 1.363 . . . . 15.0 112.956 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.31 55.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.045 0.538 . . . . 15.0 111.892 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -126.77 109.76 12.37 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.028 0.376 . . . . 15.0 111.006 -164.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -79.03 140.98 37.82 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 166.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 115' ' ' VAL . 3.4 tt -149.9 136.8 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.457 0.703 . . . . 15.0 109.801 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 11' ' ' LEU . 5.0 m-20 -68.25 89.5 0.33 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.083 -0.71 . . . . 15.0 109.083 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 51.9 t -78.28 126.34 83.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.27 128.09 21.79 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.077 1.852 . . . . 15.0 110.788 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.33 59.59 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.265 1.426 . . . . 15.0 112.164 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -45.0 76.74 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.409 1.084 . . . . 15.0 111.988 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.05 -39.58 86.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.924 -0.58 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 311' ' ' ILE . 51.5 mt -61.19 -47.17 94.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.154 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -64.38 -33.06 74.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.726 0.81 . . . . 15.0 111.792 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -61.71 -48.35 81.13 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.774 0.671 . . . . 15.0 109.87 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -62.79 -41.0 99.07 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.109 -0.95 . . . . 15.0 111.97 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 338' ' ' GLU . 1.6 mp -54.95 -53.16 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 35.7 t70 -57.94 -52.66 64.58 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 124.657 1.223 . . . . 15.0 111.199 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.65 -40.71 90.02 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 O-C-N 123.677 0.61 . . . . 15.0 111.165 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.78 -32.11 73.19 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.024 0.53 . . . . 15.0 111.722 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 74.8 mtm180 -65.76 -47.73 74.23 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 57.9 mtt180 -54.4 -56.61 16.89 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.427 1.079 . . . . 15.0 110.124 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.84 -32.62 69.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.008 0.923 . . . . 15.0 111.796 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.73 -71.54 0.2 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.047 0.539 . . . . 15.0 110.351 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.97 -29.37 70.2 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.737 0.648 . . . . 15.0 112.317 -171.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.19 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.704 0.801 . . . . 15.0 110.959 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -91.11 -55.19 3.63 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.679 -0.489 . . . . 15.0 109.679 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -66.98 82.01 0.11 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.652 1.181 . . . . 15.0 110.179 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.65 -37.94 3.27 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.186 -0.915 . . . . 15.0 113.282 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.28 48.28 6.95 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 117.273 0.536 . . . . 15.0 111.985 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -84.09 152.56 24.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.265 0.626 . . . . 15.0 110.586 -175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -77.07 102.29 6.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.87 . . . . 15.0 111.546 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm 60.93 9.04 2.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 124.954 1.302 . . . . 15.0 114.377 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -71.64 -10.1 59.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 15.0 110.875 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 330' ' ' LEU . . . -51.92 -54.3 31.01 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.659 1.184 . . . . 15.0 110.226 165.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 329' ' ' ALA . 1.9 mm? -74.88 -5.29 42.83 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.021 -0.991 . . . . 15.0 111.796 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.07 -21.78 24.54 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.189 0.996 . . . . 15.0 110.836 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.1 mt -65.58 141.09 97.76 Favored Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.079 0.552 . . . . 15.0 110.453 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 86.9 Cg_endo -76.95 160.43 33.71 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.085 2.523 . . . . 15.0 113.198 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -57.65 -54.17 49.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.366 1.067 . . . . 15.0 110.844 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.82 -9.73 3.18 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.927 -1.488 . . . . 15.0 113.41 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.6 OUTLIER -70.14 -34.4 72.99 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -119.45 -13.61 9.22 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.869 -0.586 . . . . 15.0 112.042 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.597 ' HA ' HD11 ' A' ' 311' ' ' ILE . 35.1 tt0 -50.47 -35.47 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.189 1.181 . . . . 15.0 114.189 -171.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -63.95 -55.34 23.2 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.293 0.637 . . . . 15.0 111.393 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -74.35 -33.97 63.27 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.67 -45.74 77.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.918 0.887 . . . . 15.0 110.657 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 82.1 tttt -56.51 -48.09 77.93 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.299 0.999 . . . . 15.0 109.827 174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.585 ' HG3' HG21 ' A' ' 295' ' ' VAL . 22.1 ttt180 -52.46 -46.9 66.71 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.211 0.944 . . . . 15.0 110.92 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -59.57 -44.49 93.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.693 0.797 . . . . 15.0 111.888 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 341' ' ' ALA . 36.1 t -65.41 -42.19 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 123.525 0.516 . . . . 15.0 110.545 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 54.1 t -58.67 -44.85 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.14 0.976 . . . . 15.0 109.472 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 343' ' ' ARG . 89.4 t -56.9 -45.13 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.098 0.559 . . . . 15.0 110.61 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.42 96.16 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.154 -0.93 . . . . 15.0 114.176 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.86 -38.23 33.17 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.481 0.712 . . . . 15.0 111.422 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.6 mt -70.1 -51.86 28.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 15.0 109.749 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 68.3 mt -66.95 -26.76 66.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.051 0.541 . . . . 15.0 111.172 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 355' ' ' ILE . . . -66.44 -41.37 94.38 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.592 0.557 . . . . 15.0 112.169 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.53 -38.78 74.28 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.068 0.147 . . . . 15.0 111.026 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 75.5 t -61.42 -45.28 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 360' ' ' LEU . 1.9 tp -66.24 -36.25 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.443 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.15 -61.84 1.72 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 122.967 0.507 . . . . 15.0 110.874 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 62.0 m -58.27 -43.65 88.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.386 1.074 . . . . 15.0 112.18 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.32 3.72 42.22 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.14 36.59 1.0 Allowed 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 125.57 1.548 . . . . 15.0 112.005 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 355' ' ' ILE . 5.5 tt -70.59 131.13 43.5 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.05 -1.432 . . . . 15.0 110.417 -166.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.22 174.83 9.23 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.371 1.069 . . . . 15.0 110.126 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -70.6 138.69 51.05 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 123.594 0.559 . . . . 15.0 110.346 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -102.82 118.31 36.56 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.02 -35.18 66.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.071 0.948 . . . . 15.0 112.34 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.84 -33.27 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.115 -0.493 . . . . 15.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -75.0 -38.2 61.66 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.813 -0.81 . . . . 15.0 108.813 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' A' ' 398' ' ' MET . 35.6 t -60.8 -50.19 81.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 114.071 -1.422 . . . . 15.0 110.156 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.29 -37.86 88.88 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.524 0.515 . . . . 15.0 111.168 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 373' ' ' GLU . . . -58.77 -44.3 95.93 Favored Glycine 0 C--N 1.351 1.413 0 O-C-N 123.841 0.713 . . . . 15.0 112.777 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.3 -41.28 96.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.986 0.914 . . . . 15.0 110.051 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.1 mt -62.54 -35.62 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.114 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -69.41 -38.43 77.92 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.094 0.557 . . . . 15.0 111.499 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 369' ' ' GLY . 28.3 mm-40 -58.39 -42.02 86.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.96 0.504 . . . . 15.0 111.232 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 43.3 ttp -75.78 -33.05 60.14 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.229 -0.896 . . . . 15.0 110.999 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -77.19 -9.73 58.96 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.746 0.818 . . . . 15.0 111.26 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 47.5 t -58.64 -22.44 56.62 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 122.826 0.45 . . . . 15.0 111.271 167.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.07 -11.22 53.35 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.753 0.821 . . . . 15.0 111.905 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -130.86 116.65 18.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.821 0.848 . . . . 15.0 110.821 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.55 -38.0 85.86 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.846 0.858 . . . . 15.0 109.501 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -133.94 88.36 32.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-N 114.73 -1.123 . . . . 15.0 108.544 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.42 47.29 2.15 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.63 2.887 . . . . 15.0 114.847 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -53.24 -48.42 68.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.466 0.706 . . . . 15.0 110.992 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.59 -33.45 63.95 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.979 0.799 . . . . 15.0 111.791 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.84 -62.81 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.32 -42.83 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.534 -0.757 . . . . 15.0 109.884 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.92 -51.21 58.08 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.636 -0.697 . . . . 15.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -54.7 -42.98 72.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.302 0.501 . . . . 15.0 111.406 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.93 -62.07 2.14 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.793 0.437 . . . . 15.0 110.819 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 90.4 p -67.67 -8.49 35.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.437 0.903 . . . . 15.0 113.437 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.94 -19.02 13.65 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.383 0.673 . . . . 15.0 111.795 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -139.11 124.12 18.86 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -54.47 -46.04 73.27 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.132 0.973 . . . . 15.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -30.04 -73.44 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 125.665 1.853 . . . . 15.0 114.314 -170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.79 -25.82 23.17 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 119.475 -0.298 . . . . 15.0 111.49 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.5 -36.44 82.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.711 0.767 . . . . 15.0 110.225 175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.29 -54.57 6.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.266 -1.333 . . . . 15.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -63.12 -22.28 66.75 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.756 0.65 . . . . 15.0 112.756 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.586 ' HG3' HG13 ' A' ' 367' ' ' VAL . 38.0 tpp -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 15.0 110.506 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 367' ' ' VAL . 45.6 mtm180 -78.75 -22.55 46.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.622 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.72 -42.31 51.15 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 122.809 0.443 . . . . 15.0 110.682 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 9.6 p -66.4 -40.13 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.572 -0.529 . . . . 15.0 109.572 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.49 92.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.898 0.479 . . . . 15.0 110.585 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.3 tp -54.99 -53.03 60.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 15.0 111.28 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' B' ' 106' ' ' TYR . 11.2 tp10 -62.14 -45.33 93.94 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.573 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 61.1 mm-40 -63.54 -42.58 98.4 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.576 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -71.87 -30.67 65.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 15.0 110.909 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.412 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -59.33 -47.68 84.48 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.658 0.599 . . . . 15.0 109.779 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.16 -48.31 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 114.887 -1.051 . . . . 15.0 110.344 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 412' ' ' LEU . 46.0 mt-10 -67.28 -23.37 65.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.445 0.906 . . . . 15.0 113.445 -174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.08 -27.22 61.6 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 120.829 0.347 . . . . 15.0 110.835 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 294' ' ' LEU . 61.4 t -79.2 -35.2 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 108.232 -1.025 . . . . 15.0 108.232 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 290' ' ' ALA . 93.4 mt -67.15 -29.43 69.14 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.516 1.127 . . . . 15.0 111.502 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.69 -26.41 68.65 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.544 0.737 . . . . 15.0 111.712 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.44 ' HD3' HD12 ' A' ' 120' ' ' LEU . 25.2 mtpp -105.55 -14.3 15.33 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.555 0.742 . . . . 15.0 111.534 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -79.3 156.1 28.2 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.47 0.708 . . . . 15.0 111.559 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 99.5 mttt -81.2 79.59 7.82 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.247 0.619 . . . . 15.0 109.589 174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.16 81.5 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -76.77 167.26 22.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.653 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -138.18 137.23 37.41 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.775 0.43 . . . . 15.0 110.431 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 59.0 pttt -123.18 171.22 9.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.788 0.835 . . . . 15.0 109.589 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.72 140.15 48.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.484 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.9 t -158.19 169.68 23.96 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.078 0.551 . . . . 15.0 111.742 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.9 p -80.88 178.39 8.43 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.215 1.006 . . . . 15.0 111.752 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.419 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 84.5 t80 -63.84 -60.29 3.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.625 1.17 . . . . 15.0 113.222 -171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.795 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 9.3 t-20 -76.27 7.99 3.76 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -168.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.484 ' HG2' HG21 ' A' ' 422' ' ' THR . 36.5 tp10 -49.09 -65.42 0.57 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.636 1.174 . . . . 15.0 111.91 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.562 HD11 ' HG2' ' A' ' 128' ' ' PRO . 8.6 mp -82.36 -18.52 41.78 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.937 0.495 . . . . 15.0 110.475 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 10.7 mmt -84.28 34.61 0.52 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 15.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.49 16.48 0.48 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.07 0.948 . . . . 15.0 112.632 -164.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -106.49 102.21 11.62 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -90.53 -61.13 1.74 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.978 0.911 . . . . 15.0 109.483 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-N 115.647 -0.706 . . . . 15.0 109.52 -178.108 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -64.08 -57.36 9.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.655 0.782 . . . . 0.0 109.128 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -100.31 173.54 6.55 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.293 167.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -71.57 91.04 1.04 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.838 0.855 . . . . 0.0 109.631 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -79.9 78.34 6.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.749 0.819 . . . . 0.0 110.611 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 223' ' ' ALA . 3.5 mp -123.22 114.06 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.06 36.9 0.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.825 1.25 . . . . 0.0 111.384 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.859 HD23 HD23 ' B' ' 13' ' ' LEU . 1.2 pp 46.03 11.64 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 126.643 1.977 . . . . 0.0 115.608 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.52 -8.55 48.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.336 0.655 . . . . 0.0 112.329 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 222' ' ' HIS . 0.1 OUTLIER -66.32 -70.79 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 179.01 -64.31 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 124.472 1.109 . . . . 0.0 109.385 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.573 ' HD2' HD13 ' B' ' 10' ' ' LEU . 93.0 Cg_endo -72.86 146.13 41.81 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 121.909 1.74 . . . . 0.0 113.831 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.859 HD23 HD23 ' B' ' 8' ' ' LEU . 30.3 tp 169.4 -58.33 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.079 1.752 . . . . 0.0 108.277 164.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 14' ' ' LEU . 2.4 pt? -86.33 -44.64 11.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.418 -174.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.442 ' O ' ' HD2' ' B' ' 17' ' ' PRO . 90.1 m-85 57.69 -160.49 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.741 0.816 . . . . 0.0 111.277 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . 0.306 13.1 m 87.45 -89.57 0.0 OUTLIER Pre-proline 0 CA--C 1.584 2.287 0 CA-C-O 116.292 -1.813 . . . . 0.0 112.269 171.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 86.9 Cg_endo -77.76 -20.07 12.21 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 124.789 2.746 . . . . 0.0 111.941 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.483 HG13 HG22 ' B' ' 19' ' ' THR . 12.0 p -90.91 164.21 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 125.299 1.439 . . . . 0.0 110.309 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.483 HG22 HG13 ' B' ' 18' ' ' VAL . 10.9 t 50.05 82.59 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 126.452 1.901 . . . . 0.0 114.376 170.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.72 105.96 16.5 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 101.86 0.86 Allowed 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.483 1.113 . . . . 0.0 110.778 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? 57.41 67.83 0.93 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.711 1.257 . . . . 0.0 109.175 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.5 m -141.59 115.12 6.77 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.74 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.21 150.04 36.74 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.34 2.027 . . . . 0.0 111.323 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.32 -44.87 50.75 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 96.5 mmm 53.9 79.86 0.32 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.885 1.366 . . . . 0.0 111.316 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.33 -74.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.796 1.664 . . . . 0.0 112.108 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -179.65 -32.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.895 1.278 . . . . 0.0 108.811 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 75.12 -61.34 0.49 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 125.967 1.707 . . . . 0.0 110.576 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.36 163.55 37.18 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.153 0.981 . . . . 0.0 109.043 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.39 -153.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.554 0.742 . . . . 0.0 110.655 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 68.56 93.69 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -171.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 76.26 121.4 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.181 1.393 . . . . 0.0 108.889 -164.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 75.33 143.06 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.089 1.356 . . . . 0.0 110.906 -167.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -66.25 -63.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.003 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.7 11.2 0.1 Allowed Glycine 0 N--CA 1.468 0.771 0 O-C-N 123.432 0.458 . . . . 0.0 112.641 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.48 145.69 19.17 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.352 1.061 . . . . 0.0 109.118 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 20.7 tt -170.09 -36.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.853 0.861 . . . . 0.0 110.631 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m 59.15 -90.46 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 111.727 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.68 94.46 13.22 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.256 0.622 . . . . 0.0 109.527 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.24 22.75 0.84 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 123.572 2.848 . . . . 0.0 112.886 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.74 -138.1 26.7 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.513 0.508 . . . . 0.0 112.338 -175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.48 58.26 3.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.25 153.89 29.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.394 0.678 . . . . 0.0 110.782 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -81.57 -12.39 58.8 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.614 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 73.92 -46.93 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.786 1.634 . . . . 0.0 110.724 -170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.8 96.43 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 34.7 p -84.14 83.51 7.94 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.506 1.123 . . . . 0.0 110.263 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.03 75.28 0.11 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.216 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.15 160.49 31.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.35 1.06 . . . . 0.0 111.059 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.65 -35.54 80.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.754 0.822 . . . . 0.0 112.338 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.8 m -106.79 -84.24 0.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.76 0.424 . . . . 0.0 110.818 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.65 -71.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.99 0.916 . . . . 0.0 110.034 -174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.64 -59.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt 58.05 174.28 0.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.072 1.349 . . . . 0.0 113.803 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -117.46 -26.14 6.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.881 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.61 47.09 25.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.63 1.172 . . . . 0.0 110.333 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -54.51 110.72 0.67 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.834 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.697 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -76.75 179.4 6.1 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.236 176.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 47.9 m 70.16 118.52 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.54 1.136 . . . . 0.0 110.302 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 34.7 t70 75.5 -7.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.537 1.135 . . . . 0.0 111.833 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.76 108.18 2.45 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.893 0.877 . . . . 0.0 110.149 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -85.31 126.99 3.26 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.576 2.184 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 159.49 32.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.7 162.05 13.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.233 0.613 . . . . 0.0 110.135 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -59.95 -34.82 73.79 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.015 0.926 . . . . 0.0 111.007 -174.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 HG22 ' B' ' 68' ' ' ILE . 8.9 tp -166.86 -44.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.816 173.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.415 HG22 HG23 ' B' ' 67' ' ' ILE . 9.6 tp 176.7 -22.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.899 1.279 . . . . 0.0 109.655 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 tp 77.97 94.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.834 1.654 . . . . 0.0 109.144 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.6 tp -152.54 62.04 0.81 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.694 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -96.27 -20.26 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.427 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.82 41.56 0.06 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -104.71 146.85 28.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.532 1.133 . . . . 0.0 110.986 -168.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 171.55 37.21 Favored Glycine 0 C--O 1.244 0.771 0 C-N-CA 123.487 0.565 . . . . 0.0 111.774 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -89.58 62.05 5.75 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.89 76.77 0.07 OUTLIER Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.202 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -176.41 -67.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.676 1.19 . . . . 0.0 109.484 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 49.3 m -94.48 -21.71 18.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.508 0.723 . . . . 0.0 112.015 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.15 -24.58 65.91 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.34 -13.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -127.44 147.02 50.29 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 110.328 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.79 79.15 6.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.966 0.907 . . . . 0.0 108.621 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.41 82.89 8.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.301 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -97.56 114.59 26.52 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 169.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.558 ' HB3' ' HB2' ' B' ' 90' ' ' ALA . 40.5 t-20 -124.09 120.19 31.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -69.44 -30.49 68.42 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.763 0.825 . . . . 0.0 110.837 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.14 -175.51 5.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.246 1.018 . . . . 0.0 112.107 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -61.85 -36.95 82.7 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.67 1.188 . . . . 0.0 113.343 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.12 73.1 1.56 Allowed Glycine 0 C--N 1.35 1.352 0 O-C-N 123.944 0.778 . . . . 0.0 114.167 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' B' ' 85' ' ' ASN . . . -162.08 90.04 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.404 1.082 . . . . 0.0 108.809 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.64 121.93 5.19 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.591 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.83 -41.02 95.82 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -114.45 -64.8 1.26 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 167.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -154.59 -79.55 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' B' ' 95' ' ' LYS . 32.5 ttmt 179.79 -61.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.74 0.816 . . . . 0.0 109.016 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.71 85.41 0.06 OUTLIER Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 pt -132.46 147.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.4 1.08 . . . . 0.0 109.377 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.31 130.4 28.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.561 1.144 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.1 160.57 21.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.62 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 6.5 mt -64.98 -50.88 59.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 O-C-N 123.307 0.38 . . . . 0.0 110.004 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 52.9 Cg_endo -99.2 154.84 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.316 2.011 . . . . 0.0 110.543 153.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.34 176.52 9.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 110.341 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 71.4 p 54.8 76.01 0.27 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.05 1.74 . . . . 0.0 113.404 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.38 166.08 24.83 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.722 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.1 -17.64 42.39 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.237 1.015 . . . . 0.0 110.66 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.435 ' HD2' ' HB2' ' A' ' 404' ' ' GLU . 1.5 m-85 73.02 153.55 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.971 1.308 . . . . 0.0 111.421 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 14.3 t -160.8 9.18 0.09 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.387 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 73.35 -46.85 0.65 Allowed 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 125.136 1.374 . . . . 0.0 112.282 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.64 -35.41 74.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.917 1.287 . . . . 0.0 111.815 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.72 25.42 11.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.08 0.952 . . . . 0.0 111.825 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.95 -21.25 60.9 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.945 0.402 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -105.8 157.56 17.37 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.723 1.209 . . . . 0.0 109.211 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 68.54 170.2 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.37 1.468 . . . . 0.0 112.03 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' B' ' 115' ' ' THR . 1.6 tmmt? 69.08 -75.93 0.06 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.826 1.25 . . . . 0.0 110.172 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.613 HG23 ' HD2' ' B' ' 114' ' ' LYS . 7.5 p -100.52 -7.65 23.93 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.361 0.665 . . . . 0.0 110.655 171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.05 -35.86 64.44 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.85 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.643 ' HB3' ' HD2' ' B' ' 118' ' ' PRO . 99.2 mttt 61.86 -153.38 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.558 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' B' ' 117' ' ' LYS . 21.4 Cg_exo -41.8 95.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 123.39 2.246 . . . . 0.0 113.5 158.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.96 -17.27 64.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.73 1.212 . . . . 0.0 112.624 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -74.07 -28.43 61.39 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.929 0.491 . . . . 0.0 112.247 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.11 -26.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.576 0.35 . . . . 0.0 110.664 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.3 p 50.42 -86.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.763 1.625 . . . . 0.0 113.22 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -152.22 169.78 21.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.91 1.284 . . . . 0.0 109.359 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m 74.17 -77.57 0.05 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.573 1.549 . . . . 0.0 111.856 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 75.96 -34.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.014 1.326 . . . . 0.0 111.691 -171.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.712 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . 75.36 -172.8 0.11 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.435 1.094 . . . . 0.0 111.541 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m 57.48 43.27 23.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.518 1.127 . . . . 0.0 110.788 -161.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 78.33 -44.24 0.38 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.083 1.753 . . . . 0.0 112.44 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 24.8 m 60.83 -87.13 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.917 1.287 . . . . 0.0 108.866 -169.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.94 -162.73 0.14 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.488 1.115 . . . . 0.0 113.827 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.527 ' CZ2' HD11 ' A' ' 144' ' ' LEU . 6.0 m95 77.21 148.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.97 1.708 . . . . 0.0 113.979 163.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t 71.58 108.04 0.06 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.401 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -66.57 130.9 44.71 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.82 8.01 58.42 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 38.6 t 58.21 69.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.141 0 C-N-CA 125.13 1.372 . . . . 0.0 110.886 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 76.51 -33.02 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.521 1.529 . . . . 0.0 113.926 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 34.8 p 51.76 -151.28 0.26 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.144 1.378 . . . . 0.0 110.868 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.39 -173.69 4.59 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.542 HD21 ' HB3' ' B' ' 142' ' ' LEU . 25.3 t30 65.64 -101.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.907 0.883 . . . . 0.0 110.672 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.93 -44.19 1.52 Allowed Glycine 0 CA--C 1.543 1.797 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.77 -16.22 62.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -171.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.542 ' HB3' HD21 ' B' ' 139' ' ' ASN . 5.2 tt -84.98 107.23 17.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.7 -71.45 1.15 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 124.002 0.814 . . . . 0.0 111.927 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 p -168.63 153.12 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.666 0.786 . . . . 0.0 110.464 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -88.09 142.12 28.02 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.511 1.125 . . . . 0.0 110.219 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.33 115.58 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.056 0.943 . . . . 0.0 109.66 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -157.33 92.05 1.21 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 163.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -165.73 173.64 10.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.376 0.67 . . . . 0.0 110.277 -169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -61.6 80.09 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.202 1.001 . . . . 0.0 110.348 166.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.689 0.281 . . . . 15.0 110.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.36 107.37 3.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.136 -1.061 . . . . 15.0 108.136 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 17' ' ' ILE . 27.7 m -104.66 148.23 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.815 0.446 . . . . 15.0 110.859 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 p -136.8 108.1 6.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.765 -0.828 . . . . 15.0 108.765 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.65 98.44 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 122.58 1.181 . . . . 15.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.27 87.07 2.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.992 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 m -62.81 99.65 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.646 0.778 . . . . 15.0 110.103 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 p -81.35 -48.72 11.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.342 0.657 . . . . 15.0 111.23 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -141.52 91.35 2.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.75 0.42 . . . . 15.0 110.228 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -99.46 0.21 Allowed Glycine 0 C--N 1.349 1.277 0 O-C-N 123.886 0.741 . . . . 15.0 114.378 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.57 -31.99 36.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 15.0 109.957 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.01 95.68 0.17 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 124.319 1.012 . . . . 15.0 113.252 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' HD2' HG11 ' A' ' 111' ' ' VAL . 60.4 mtt85 -101.87 122.68 44.45 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 15.0 110.944 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 32.2 ttm180 -90.68 92.74 8.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.387 1.475 . . . . 15.0 109.679 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.4 89.22 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 15.0 108.2 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.7 m -76.57 103.43 6.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.84 -1.073 . . . . 15.0 110.045 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.653 HG12 HG12 ' A' ' 3' ' ' VAL . 34.1 mt -96.06 108.99 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.4 m -85.86 115.95 23.81 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.44 0.696 . . . . 15.0 109.321 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.97 120.95 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.67 159.66 31.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.684 0.793 . . . . 15.0 111.725 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.09 -32.97 74.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.472 1.109 . . . . 15.0 112.66 -171.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.0 -34.39 77.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.948 0.499 . . . . 15.0 110.99 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 -35.35 60.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.707 0.803 . . . . 15.0 110.861 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.75 -49.27 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.018 172.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -54.36 -40.08 67.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.709 1.203 . . . . 15.0 111.564 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.3 m -71.33 -51.51 23.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.007 0.923 . . . . 15.0 111.33 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.77 87.36 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.968 0.507 . . . . 15.0 112.282 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG11 ' NH2' ' A' ' 63' ' ' ARG . 96.1 t -61.2 -47.62 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.532 0.52 . . . . 15.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' HG3' ' A' ' 51' ' ' MET . 4.9 ttmp? -63.23 -35.54 80.66 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.068 -0.969 . . . . 15.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 m -69.98 -29.11 66.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.797 0.839 . . . . 15.0 110.621 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.9 -35.37 32.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.486 0.714 . . . . 15.0 110.827 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -71.45 -42.66 67.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.983 0.913 . . . . 15.0 111.499 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.5 p -64.75 -29.58 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 123.78 0.675 . . . . 15.0 110.608 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -58.5 -50.99 71.76 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.551 0.74 . . . . 15.0 110.527 173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.32 -40.67 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.136 -0.938 . . . . 15.0 110.342 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.53 74.28 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.587 0.755 . . . . 15.0 111.263 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.0 mttt -67.82 -45.92 73.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.745 0.418 . . . . 15.0 110.461 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.4 -45.75 91.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.146 0.904 . . . . 15.0 111.242 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.44 0.42 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.523 0.729 . . . . 15.0 110.641 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 67.09 14.69 9.9 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.448 1.499 . . . . 15.0 112.771 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.67 -24.64 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.465 1.106 . . . . 15.0 110.607 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.6 -34.1 75.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.468 0.707 . . . . 15.0 109.994 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.76 -42.62 12.9 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.347 -0.842 . . . . 15.0 112.302 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -68.84 -15.13 63.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.198 0.599 . . . . 15.0 111.96 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -61.55 123.25 17.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 15.0 110.363 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.89 7.98 24.16 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.759 0.824 . . . . 15.0 110.952 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.4 22.67 67.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 116.115 -0.493 . . . . 15.0 113.999 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -77.03 -44.68 29.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.284 0.634 . . . . 15.0 110.333 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.26 114.21 60.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.73 -0.652 . . . . 15.0 109.684 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.145 2.563 . . . . 15.0 113.167 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 54' ' ' VAL . 58.8 tpp -68.46 -22.11 64.59 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.586 1.155 . . . . 15.0 111.973 -169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -79.78 -33.23 40.75 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.992 0.517 . . . . 15.0 111.492 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 54.5 mt -75.13 -23.74 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.593 0.757 . . . . 15.0 111.4 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 51' ' ' MET . 10.5 m -69.06 -26.07 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 122.151 -0.343 . . . . 15.0 110.958 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -43.81 26.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.003 0.521 . . . . 15.0 111.827 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.9 pt20 -77.17 -25.59 52.07 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.906 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.611 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 96.9 mtt180 -117.43 -69.78 0.83 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.796 0.438 . . . . 15.0 111.657 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.75 -6.47 44.87 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.478 0.918 . . . . 15.0 113.478 -166.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -138.84 28.64 2.62 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.957 -0.457 . . . . 15.0 111.957 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.57 68.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.766 0.826 . . . . 15.0 111.526 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.2 p -67.96 -36.07 79.46 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.783 0.833 . . . . 15.0 111.467 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.12 83.06 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.817 0.818 . . . . 15.0 109.607 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' NH2' HG11 ' A' ' 28' ' ' VAL . 2.6 mmp_? -113.29 -52.82 2.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.808 -1.087 . . . . 15.0 109.065 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -58.46 -44.18 89.14 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.082 1.353 . . . . 15.0 111.901 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -57.7 -43.07 84.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.334 1.054 . . . . 15.0 110.83 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 28' ' ' VAL . 43.6 t -68.37 -36.08 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.633 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.16 -29.17 69.98 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.863 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.73 97.88 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.2 -0.36 . . . . 15.0 112.2 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -64.82 -48.75 73.24 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.013 0.925 . . . . 15.0 111.181 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.31 -59.78 4.76 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.282 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.3 mtm -62.05 -31.4 71.81 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.209 0.603 . . . . 15.0 112.324 -175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -69.47 -51.17 38.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.981 0.512 . . . . 15.0 111.138 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -65.22 -52.86 51.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.698 0.624 . . . . 15.0 110.733 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -60.82 -32.1 71.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.637 0.775 . . . . 15.0 112.253 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -66.28 -61.7 1.87 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.352 0.261 . . . . 15.0 110.791 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.02 -34.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.661 0.601 . . . . 15.0 110.879 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -69.64 -41.92 74.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.182 0.593 . . . . 15.0 110.278 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.13 -57.83 9.28 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 115.508 -0.769 . . . . 15.0 111.228 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -60.18 -27.45 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.7 mt -74.68 -50.55 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.151 0.58 . . . . 15.0 110.811 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.45 -35.22 75.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.118 0.167 . . . . 15.0 111.325 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.61 -9.73 59.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.786 0.834 . . . . 15.0 111.082 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 68.26 19.18 9.11 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.901 1.281 . . . . 15.0 111.923 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.17 129.84 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.602 0.761 . . . . 15.0 109.474 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 112' ' ' TYR . 32.2 t30 -101.88 88.7 1.32 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.336 1.055 . . . . 15.0 108.493 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.39 164.37 28.85 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.076 2.517 . . . . 15.0 112.858 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.63 20.71 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.306 1.042 . . . . 15.0 109.249 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.15 -167.76 53.58 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.6 0.562 . . . . 15.0 113.411 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.05 121.17 83.9 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.861 0.864 . . . . 15.0 111.551 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 57.0 Cg_endo -72.11 99.95 1.05 Allowed 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.055 1.836 . . . . 15.0 110.818 169.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -73.06 92.66 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.837 -0.62 . . . . 15.0 109.911 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -68.95 106.11 2.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.312 -0.995 . . . . 15.0 108.312 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.1 t -97.35 93.17 1.44 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.62 124.61 8.94 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.248 1.965 . . . . 15.0 111.701 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.47 -161.23 14.28 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.099 -0.5 . . . . 15.0 112.506 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.88 91.63 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.772 0.829 . . . . 15.0 110.998 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -74.34 132.69 42.27 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.674 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.9 172.07 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.188 0.995 . . . . 15.0 110.204 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -126.58 125.2 41.57 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.82 -41.28 2.31 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.112 -0.795 . . . . 15.0 111.112 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -90.3 156.23 18.42 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 168.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.71 153.21 37.23 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.897 . . . . 15.0 110.46 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -112.06 140.05 47.06 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 15.0 110.042 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.6 m -131.53 136.01 47.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.514 1.126 . . . . 15.0 109.105 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -141.0 138.13 33.5 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.315 0.646 . . . . 15.0 109.979 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 62.5 m -97.11 102.4 14.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.603 1.161 . . . . 15.0 110.809 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.403 HG12 ' HD2' ' A' ' 109' ' ' PHE . 14.5 t -83.45 94.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.518 -0.549 . . . . 15.0 109.518 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.71 118.09 30.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.883 0.873 . . . . 15.0 111.016 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.1 p90 -147.45 165.17 31.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.227 1.011 . . . . 15.0 109.281 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.48 179.29 5.89 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 13' ' ' ARG . 25.4 m -133.49 148.26 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 15.0 110.037 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.526 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 65.5 m-85 -74.48 113.82 27.78 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 108.784 -0.821 . . . . 15.0 108.784 171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 138.14 30.92 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.643 1.562 . . . . 15.0 110.138 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -64.76 107.61 1.49 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 353' ' ' GLU . 33.4 t -70.58 88.01 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.516 0.727 . . . . 15.0 110.181 -166.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.54 98.08 0.84 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.776 -0.453 . . . . 15.0 109.776 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.11 103.89 0.32 Allowed 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.021 -0.99 . . . . 15.0 111.07 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -67.61 153.86 42.74 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.882 -1.054 . . . . 15.0 108.766 170.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.26 115.35 1.47 Allowed Glycine 0 C--N 1.353 1.51 0 O-C-N 124.489 1.118 . . . . 15.0 115.4 -166.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.651 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 46.6 mt -83.08 6.32 19.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.035 0.534 . . . . 15.0 111.104 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -77.44 -23.82 50.46 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.225 1.01 . . . . 15.0 108.716 170.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.24 -17.72 64.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.02 0.928 . . . . 15.0 112.03 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.1 mt -74.11 129.53 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.696 -0.853 . . . . 15.0 108.696 173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.95 98.11 5.93 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.877 -1.156 . . . . 15.0 107.877 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 290' ' ' ALA . 25.7 t -86.66 145.43 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.55 0.74 . . . . 15.0 109.144 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 289' ' ' GLN . 35.5 tt0 -108.26 137.68 45.82 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -120.97 92.83 48.67 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.032 0.933 . . . . 15.0 108.766 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -73.91 108.62 2.69 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.472 2.114 . . . . 15.0 112.838 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 51.3 mm -76.2 92.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.483 -0.932 . . . . 15.0 108.483 169.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -81.33 107.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.235 -0.893 . . . . 15.0 109.94 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.6 126.86 32.25 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.278 -0.638 . . . . 15.0 109.278 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.8 t -122.43 104.3 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.788 -0.819 . . . . 15.0 108.788 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.5 p -98.16 163.51 12.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.82 -22.53 66.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.416 0.687 . . . . 15.0 110.733 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.15 72.88 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.462 -0.79 . . . . 15.0 111.132 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -70.53 -36.08 73.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.833 0.453 . . . . 15.0 110.665 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 59.8 t -58.23 -56.44 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.861 0.725 . . . . 15.0 109.351 173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.413 ' HB2' ' NH2' ' A' ' 267' ' ' ARG . 31.8 t70 -56.58 -42.89 79.42 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.46 1.104 . . . . 15.0 111.484 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.2 97.02 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.105 0.878 . . . . 15.0 112.936 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' B' ' 127' ' ' SER . 46.3 ttp -76.11 -29.22 57.79 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.455 0.168 . . . . 15.0 111.455 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.561 HD21 HG21 ' A' ' 270' ' ' VAL . 91.2 mt -61.37 -43.45 98.84 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.337 -0.616 . . . . 15.0 109.337 171.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.13 -38.37 90.92 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.693 1.197 . . . . 15.0 111.003 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -63.87 -38.82 92.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.158 0.583 . . . . 15.0 110.944 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 128' ' ' ALA . 90.1 mt -64.35 -46.26 84.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.245 0.618 . . . . 15.0 109.378 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -65.61 -26.45 67.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.744 -1.117 . . . . 15.0 111.54 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -78.96 -47.66 15.94 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.6 0.76 . . . . 15.0 111.122 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -72.6 -19.58 61.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.663 0.385 . . . . 15.0 111.271 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -112.63 28.25 8.94 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.829 0.852 . . . . 15.0 111.007 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -82.0 132.46 35.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.647 0.61 . . . . 15.0 112.647 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.1 m -72.13 123.62 23.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.876 1.27 . . . . 15.0 110.772 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -75.36 151.91 38.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.938 0.875 . . . . 15.0 111.462 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 24.9 ttpt -154.48 144.66 21.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 113.651 -1.613 . . . . 15.0 108.323 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.7 156.56 34.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.714 0.768 . . . . 15.0 111.224 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HG3' HG13 ' A' ' 240' ' ' VAL . 50.2 pttt -158.13 -177.83 6.84 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.384 -1.28 . . . . 15.0 108.429 172.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -143.62 133.22 23.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.61 -137.08 11.44 Favored Glycine 0 C--O 1.239 0.439 0 CA-C-N 115.572 -0.74 . . . . 15.0 112.205 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.31 1.47 Allowed 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.124 0.97 . . . . 15.0 112.817 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 237' ' ' LEU . 48.9 t -65.9 142.99 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.577 -1.192 . . . . 15.0 111.473 170.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.14 174.62 6.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.915 0.886 . . . . 15.0 109.83 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.45 6.73 47.74 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.04 0.536 . . . . 15.0 112.18 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.1 14.21 5.7 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.674 1.19 . . . . 15.0 109.331 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.7 176.47 8.53 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.688 -1.142 . . . . 15.0 111.181 -166.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -132.75 112.09 11.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.456 -1.312 . . . . 15.0 107.456 169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.59 HG12 HG23 ' A' ' 240' ' ' VAL . 17.2 m -108.21 179.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.148 0.499 . . . . 15.0 111.467 -175.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 96.7 m -130.36 107.3 9.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.791 -1.095 . . . . 15.0 109.394 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 237' ' ' LEU . 28.0 pt -103.72 -174.44 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.512 1.149 . . . . 15.0 112.282 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.5 t70 -139.3 166.77 23.66 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 104.137 -2.542 . . . . 15.0 104.137 165.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 50.9 p90 -171.3 149.84 2.84 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.856 1.207 . . . . 15.0 111.699 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 59.4 m -89.71 112.52 23.82 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.074 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 181' ' ' LYS . . . -68.87 104.61 1.28 Allowed Glycine 0 C--N 1.343 0.95 0 O-C-N 123.787 0.68 . . . . 15.0 112.3 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 20.3 m -128.06 152.28 48.16 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.89 . . . . 15.0 110.01 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 177' ' ' PHE . 94.9 t -118.58 122.52 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.316 -1.364 . . . . 15.0 107.316 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.6 t70 63.67 10.89 5.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.503 0.668 . . . . 15.0 111.873 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 102.85 2.34 49.26 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.316 -0.713 . . . . 15.0 114.007 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -114.17 117.51 31.4 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.958 0.879 . . . . 15.0 109.495 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 5.9 pt-20 -61.56 144.65 54.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.2 0.6 . . . . 15.0 112.315 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 172' ' ' VAL . 46.9 p90 -123.63 162.92 22.06 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 123.562 0.745 . . . . 15.0 109.328 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.467 ' HB3' HE21 ' B' ' 3' ' ' GLN . 1.2 pp20? -70.93 146.2 49.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.428 0.691 . . . . 15.0 111.87 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.91 21.08 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 124.009 0.818 . . . . 15.0 114.098 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.585 ' HA2' HD23 ' B' ' 13' ' ' LEU . . . -88.0 -15.53 60.9 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.043 0.377 . . . . 15.0 114.043 -170.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 10.3 mptt -92.09 159.13 15.84 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.568 0.747 . . . . 15.0 109.029 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -138.72 149.18 44.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.431 -0.804 . . . . 15.0 109.924 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 28.8 p -131.75 124.34 29.52 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.038 -0.983 . . . . 15.0 108.816 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.81 29.53 16.66 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.199 1.0 . . . . 15.0 110.029 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 16.0 t80 -72.85 109.22 6.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.541 -1.208 . . . . 15.0 110.632 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.29 121.44 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 115.427 -0.806 . . . . 15.0 110.137 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -115.99 132.45 56.65 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.528 0.731 . . . . 15.0 109.674 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.441 ' HB3' HE21 ' A' ' 191' ' ' GLN . . . -109.12 152.92 24.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.648 0.779 . . . . 15.0 109.312 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.401 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 42.5 mtt -103.27 152.07 21.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.349 0.66 . . . . 15.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.78 -43.45 1.68 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.582 -1.007 . . . . 15.0 110.582 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -68.89 107.24 3.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.637 0.732 . . . . 15.0 110.462 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.38 25.43 5.63 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.809 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -86.9 -21.29 26.41 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 15.0 110.279 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -78.07 167.6 21.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.295 0.638 . . . . 15.0 110.243 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.599 HG12 ' HD3' ' A' ' 218' ' ' PRO . 52.6 mt -50.21 120.3 11.87 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.692 1.197 . . . . 15.0 109.879 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.42 118.83 5.74 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.496 2.131 . . . . 15.0 111.134 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.79 -10.8 57.51 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.819 -0.628 . . . . 15.0 113.292 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 31.5 t80 -64.18 -42.37 96.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.297 0.639 . . . . 15.0 110.764 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.78 -25.33 66.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.541 0.736 . . . . 15.0 112.067 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -48.61 -49.53 36.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.159 1.384 . . . . 15.0 112.401 -173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.656 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -62.3 -43.77 98.61 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.385 1.053 . . . . 15.0 113.33 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -56.03 -44.97 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 15.0 110.748 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 54.1 mtpt -73.7 13.53 0.48 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.364 1.616 . . . . 15.0 115.364 -165.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.34 21.74 1.08 Allowed Glycine 0 N--CA 1.468 0.794 0 CA-C-N 118.998 0.817 . . . . 15.0 113.886 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.56 -166.5 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.568 0.684 . . . . 15.0 110.912 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -115.56 157.33 24.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.428 1.091 . . . . 15.0 110.491 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.0 35.18 0.31 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.924 1.29 . . . . 15.0 113.771 -172.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.77 44.16 0.66 Allowed Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.875 -0.89 . . . . 15.0 110.875 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -131.68 130.31 41.86 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -93.28 118.86 31.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.912 1.285 . . . . 15.0 107.683 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.57 150.8 30.74 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.491 0.716 . . . . 15.0 109.295 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.9 m -111.81 133.88 53.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.092 -0.958 . . . . 15.0 108.469 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.656 HG21 ' HA3' ' A' ' 201' ' ' GLY . 35.3 pt -118.94 147.78 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 121.133 0.492 . . . . 15.0 111.293 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.56 92.8 6.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.784 -1.098 . . . . 15.0 108.5 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.5 m -109.87 -171.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 114.994 -1.003 . . . . 15.0 110.475 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.8 m -142.36 128.71 19.99 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.435 ' HE2' HG22 ' A' ' 172' ' ' VAL . 32.7 m-85 -52.58 164.19 0.68 Allowed Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 125.185 1.394 . . . . 15.0 113.157 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.599 ' HD3' HG12 ' A' ' 195' ' ' ILE . 91.3 Cg_endo -85.02 161.45 11.7 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.287 1.991 . . . . 15.0 110.332 171.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 37.4 mt-10 -80.84 -1.71 44.33 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.802 0.441 . . . . 15.0 110.796 173.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -99.54 6.21 45.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.914 0.886 . . . . 15.0 111.058 171.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.55 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 32.6 t80 -62.32 153.91 29.47 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.144 0.497 . . . . 15.0 111.826 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' B' ' 11' ' ' LEU . 14.0 m-70 -85.2 31.52 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.5 1.12 . . . . 15.0 112.719 -175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -153.05 119.48 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.964 -1.495 . . . . 15.0 106.964 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 34.1 tt0 -74.04 -28.82 61.6 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.485 0.491 . . . . 15.0 110.7 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.04 -10.97 59.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.885 0.874 . . . . 15.0 111.066 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 73.2 mt -123.27 -1.62 8.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.394 0.678 . . . . 15.0 112.043 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.4 ptpt -75.04 125.08 28.16 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.523 1.056 . . . . 15.0 109.263 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.34 73.66 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.187 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -105.81 140.33 39.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.645 -1.242 . . . . 15.0 107.645 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.73 132.14 47.46 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.161 0.584 . . . . 15.0 111.479 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.24 159.64 33.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.773 0.829 . . . . 15.0 111.69 -170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 232' ' ' LYS . 8.5 mmpt? -117.21 119.67 35.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.522 -1.217 . . . . 15.0 109.031 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -124.68 116.67 22.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.181 -0.674 . . . . 15.0 109.181 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -83.21 74.61 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.728 0.775 . . . . 15.0 109.852 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 9.9 mm -67.21 103.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 113.751 -1.568 . . . . 15.0 111.506 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 22.1 m-80 -88.56 82.33 6.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 171.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 158' ' ' VAL . 19.9 tp -64.56 97.92 0.23 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.517 1.127 . . . . 15.0 109.63 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -94.98 -35.56 11.92 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 123.172 0.589 . . . . 15.0 111.614 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 30.2 mmmt -136.07 151.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.593 0.757 . . . . 15.0 109.47 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 154' ' ' LYS . 13.6 p -131.46 136.88 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 107.357 -1.349 . . . . 15.0 107.357 167.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -122.98 123.51 41.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.713 0.405 . . . . 15.0 111.719 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 43.3 tt0 -91.82 137.87 32.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.182 0.993 . . . . 15.0 110.89 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 15.1 ptp180 -79.97 145.94 32.32 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.778 -0.823 . . . . 15.0 108.778 169.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.42 126.62 44.12 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.983 0.513 . . . . 15.0 110.543 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.51 117.69 14.22 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.645 1.178 . . . . 15.0 109.112 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 27.4 Cg_endo -60.42 -169.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.87 3.047 . . . . 15.0 113.15 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.47 148.88 31.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.405 0.621 . . . . 15.0 112.593 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.0 tp -112.67 21.53 15.48 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 107.973 -1.121 . . . . 15.0 107.973 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.2 m -61.57 135.73 57.76 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.566 1.146 . . . . 15.0 109.936 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.04 68.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.092 0.87 . . . . 15.0 112.453 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 42.6 mt-10 -70.94 -17.16 62.69 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.3 -0.864 . . . . 15.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.74 -45.15 11.22 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.2 mt -55.63 -49.14 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.429 1.092 . . . . 15.0 110.013 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 251' ' ' GLU . 21.9 ptmt -72.68 -14.74 61.64 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.607 0.595 . . . . 15.0 112.607 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -65.86 -27.85 68.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.567 0.698 . . . . 15.0 109.836 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.0 -17.91 51.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.268 -1.333 . . . . 15.0 111.871 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.461 ' HA2' ' HA3' ' B' ' 134' ' ' GLY . . . 116.55 9.87 10.95 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-O 119.806 -0.441 . . . . 15.0 113.544 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 269' ' ' GLU . 86.8 t -71.08 108.79 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.571 -0.9 . . . . 15.0 108.571 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.71 -65.95 0.55 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.957 0.903 . . . . 15.0 111.49 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.6 71.23 8.87 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.059 -1.089 . . . . 15.0 108.059 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -71.59 51.97 1.16 Allowed Glycine 0 CA--C 1.537 1.442 0 N-CA-C 116.517 1.367 . . . . 15.0 116.517 -168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 49.8 p -93.72 -169.54 2.13 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.923 0.889 . . . . 15.0 108.636 166.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.13 -60.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 118.541 0.609 . . . . 15.0 110.162 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -22.14 66.77 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 117.93 0.332 . . . . 15.0 110.647 171.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.66 -36.69 91.67 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.813 0.696 . . . . 15.0 112.699 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 258' ' ' VAL . 41.9 tp -70.07 -44.49 69.0 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.722 0.809 . . . . 15.0 109.464 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.413 ' NH2' ' HB2' ' A' ' 138' ' ' ASP . 56.9 mtp85 -58.83 -49.57 77.21 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.106 -0.952 . . . . 15.0 109.907 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.97 72.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.738 . . . . 15.0 112.016 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 258' ' ' VAL . 12.3 tp10 -63.83 -55.52 22.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.811 0.444 . . . . 15.0 110.27 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.561 HG21 HD21 ' A' ' 141' ' ' LEU . 41.1 t -66.47 -29.83 47.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.78 -1.1 . . . . 15.0 109.745 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -61.1 -56.15 24.19 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.258 0.623 . . . . 15.0 111.924 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.475 ' HZ3' ' HA ' ' A' ' 269' ' ' GLU . 26.0 pttm -69.91 -25.95 63.92 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.786 0.327 . . . . 15.0 110.764 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.56 -31.39 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.267 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 41.3 mtt -62.74 -48.66 78.27 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 108.653 -0.869 . . . . 15.0 108.653 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 279' ' ' LYS . 43.5 mt-10 -61.46 -36.71 81.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.661 0.385 . . . . 15.0 111.214 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.424 HH21 ' HB2' ' A' ' 377' ' ' ALA . 11.2 tpp180 -71.65 -55.45 7.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.761 0.424 . . . . 15.0 111.116 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.1 -56.51 20.83 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.567 1.147 . . . . 15.0 110.146 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 281' ' ' ALA . 44.6 tp -65.0 -25.86 68.04 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 124.555 1.142 . . . . 15.0 112.231 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 275' ' ' GLU . 6.1 ttpt -61.72 -53.88 50.09 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 120.0 1.273 . . . . 15.0 109.497 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -68.78 -34.57 75.79 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.333 -0.849 . . . . 15.0 110.793 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 278' ' ' LEU . . . -70.15 -46.98 63.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.395 0.678 . . . . 15.0 110.068 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.34 -30.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 109.584 -0.524 . . . . 15.0 109.584 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -62.44 -52.25 64.27 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.786 0.679 . . . . 15.0 109.775 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 60.9 m-80 -78.79 -9.76 59.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.953 -0.546 . . . . 15.0 111.954 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -76.69 -58.74 3.11 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.49 -40.87 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.492 -1.231 . . . . 15.0 109.674 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 87.4 tttt -64.81 -47.45 78.02 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 118.887 -0.578 . . . . 15.0 111.396 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 80.6 p -60.96 -40.58 93.88 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.583 0.628 . . . . 15.0 111.144 -175.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 126' ' ' GLU . 46.7 mt-30 -71.92 -35.83 69.79 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.811 0.694 . . . . 15.0 111.178 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 125' ' ' VAL . . . -61.56 -50.92 70.69 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 15.0 111.674 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 287' ' ' LYS . 43.4 mm -72.8 -29.87 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.886 0.874 . . . . 15.0 110.114 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.03 -54.0 51.17 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.81 -27.76 73.47 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.462 -1.244 . . . . 15.0 113.294 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.611 HD22 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.99 -52.39 59.81 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.051 0.94 . . . . 15.0 109.724 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.91 -43.19 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.791 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -58.53 -34.66 71.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.544 0.738 . . . . 15.0 111.474 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.87 -10.38 59.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.77 0.828 . . . . 15.0 112.694 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -131.55 117.42 18.73 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.756 0.707 . . . . 15.0 111.907 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 119.89 33.25 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.869 0.868 . . . . 15.0 108.815 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 7.0 tt -150.77 118.67 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 123.676 0.79 . . . . 15.0 109.088 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.412 ' HA ' ' HE3' ' A' ' 342' ' ' LYS . 15.6 m-20 -77.84 95.65 4.77 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.57 143.33 86.43 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 113.309 -1.769 . . . . 15.0 111.211 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -46.9 132.18 17.19 Favored 'Trans proline' 0 C--N 1.39 2.717 0 C-N-CA 122.921 2.414 . . . . 15.0 111.555 167.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.35 -35.73 60.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.217 1.007 . . . . 15.0 111.575 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.89 77.7 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.967 1.307 . . . . 15.0 111.916 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.91 -41.88 90.88 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 115.498 -0.774 . . . . 15.0 110.486 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 311' ' ' ILE . 57.7 mt -58.51 -46.77 89.68 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.191 0 CA-C-N 115.182 -0.917 . . . . 15.0 108.93 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.04 -32.61 74.23 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.281 1.032 . . . . 15.0 112.096 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 313' ' ' VAL . 43.3 m -58.13 -57.21 13.84 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.073 0.858 . . . . 15.0 109.011 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' A' ' 345' ' ' VAL . 6.9 mm-40 -71.32 -22.14 61.97 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.186 -0.915 . . . . 15.0 112.433 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 307' ' ' ILE . 19.4 mm -61.44 -58.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 N-CA-C 106.967 -1.494 . . . . 15.0 106.967 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.0 -32.31 71.78 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.364 1.04 . . . . 15.0 111.989 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 309' ' ' SER . 70.0 t -56.88 -53.38 43.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.48 -26.92 68.15 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.713 0.633 . . . . 15.0 112.706 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 63.4 mtm180 -67.55 -57.04 7.17 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.381 0.537 . . . . 15.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -62.45 -46.65 87.55 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 124.117 0.886 . . . . 15.0 110.032 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.406 HE22 ' NH2' ' A' ' 344' ' ' ARG . 10.2 tt0 -64.59 -44.79 89.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.499 1.12 . . . . 15.0 111.986 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.32 -60.35 2.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -63.07 -26.41 68.82 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.104 0.877 . . . . 15.0 113.218 -170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 -39.68 70.08 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.441 0.697 . . . . 15.0 110.728 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -87.98 -47.48 8.51 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.421 0.688 . . . . 15.0 109.841 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.39 79.11 4.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.745 0.818 . . . . 15.0 110.148 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.83 -16.64 56.26 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.012 -0.994 . . . . 15.0 114.377 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.61 56.35 7.56 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 3.2 m-20 -70.17 92.03 0.74 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.685 0.794 . . . . 15.0 110.884 -172.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.31 98.49 0.47 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 15.0 109.5 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.536 ' HA ' HD23 ' A' ' 330' ' ' LEU . 36.7 mtmm 71.45 -22.39 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 125.983 1.713 . . . . 15.0 113.533 -173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 24.1 mm-40 -68.62 -17.71 64.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.931 0.892 . . . . 15.0 110.931 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.73 82.55 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.022 0.929 . . . . 15.0 110.358 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 327' ' ' LYS . 3.0 mm? -67.98 -8.39 36.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.996 -1.002 . . . . 15.0 111.722 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.64 -3.95 21.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.17 0.588 . . . . 15.0 111.613 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 319' ' ' ALA . 69.7 mt -56.33 132.78 76.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.415 0.552 . . . . 15.0 109.964 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 336' ' ' LEU . 20.3 Cg_endo -61.61 154.68 58.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.538 2.159 . . . . 15.0 112.883 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.409 ' NH2' ' HB ' ' A' ' 307' ' ' ILE . 59.0 ttt-85 -63.78 -45.89 87.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.802 -0.814 . . . . 15.0 108.802 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 338' ' ' GLU . 1.6 pm0 -62.95 -8.47 7.23 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.357 -1.292 . . . . 15.0 113.539 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 333' ' ' PRO . 0.4 OUTLIER -68.34 -36.37 79.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 336' ' ' LEU . 77.2 m-85 -125.75 2.96 7.47 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 118.51 -0.757 . . . . 15.0 112.281 -175.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.707 ' HB2' ' HA ' ' A' ' 335' ' ' GLU . 14.1 tp10 -35.16 -67.26 0.15 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.491 1.516 . . . . 15.0 114.936 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.75 -47.68 74.43 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.86 0.864 . . . . 15.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 12.1 pt20 -71.14 -26.07 62.84 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.685 0.615 . . . . 15.0 111.759 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -85.0 -38.07 19.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.282 0.633 . . . . 15.0 110.342 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.8 tttt -56.48 -53.57 55.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -54.06 -41.75 68.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.393 1.477 . . . . 15.0 111.363 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.696 ' HG2' ' HE3' ' B' ' 113' ' ' LYS . 22.1 ttt-85 -57.97 -42.66 85.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.518 1.127 . . . . 15.0 110.507 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 341' ' ' ALA . 11.4 t -69.62 -42.72 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.75 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.5 t -53.74 -44.09 57.9 Favored 'Isoleucine or valine' 0 C--N 1.363 1.169 0 O-C-N 124.006 0.816 . . . . 15.0 110.416 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 98.8 t -49.4 -49.68 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.365 0.666 . . . . 15.0 111.36 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -71.27 -39.33 62.31 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.112 -0.949 . . . . 15.0 113.792 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 345' ' ' VAL . 74.9 mt -69.75 -36.89 76.2 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.203 0.601 . . . . 15.0 110.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.611 HD13 HD22 ' A' ' 294' ' ' LEU . 87.5 mt -67.35 -56.16 10.87 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 123.708 0.63 . . . . 15.0 109.561 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 355' ' ' ILE . 81.7 mt -67.4 -12.0 59.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.37 0.508 . . . . 15.0 112.37 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -81.62 -48.54 5.83 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.172 -0.771 . . . . 15.0 111.172 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 115' ' ' VAL . 8.2 tp10 -72.05 -33.47 68.0 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.145 0.578 . . . . 15.0 111.871 -175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 66.2 t -57.82 -46.86 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.746 -0.835 . . . . 15.0 108.746 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 351' ' ' LEU . 1.5 mp -70.2 -40.27 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.616 0.766 . . . . 15.0 111.345 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -67.86 -60.09 2.79 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 122.914 0.134 . . . . 15.0 110.703 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.7 m -55.93 -41.74 75.06 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.265 1.026 . . . . 15.0 112.337 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -85.76 -0.13 54.41 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.042 0.537 . . . . 15.0 111.937 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 52.56 29.82 7.68 Favored 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 125.505 1.522 . . . . 15.0 112.046 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 7.1 tt -68.0 108.15 2.96 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.547 -1.206 . . . . 15.0 110.037 -171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 163.56 18.68 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 15.0 111.669 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -71.74 135.36 46.73 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.63 106.9 18.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.306 -0.246 . . . . 15.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.7 -29.18 67.93 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.192 0.997 . . . . 15.0 111.682 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -68.74 -32.1 71.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.305 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.525 ' NE ' ' HB3' ' A' ' 405' ' ' GLU . 21.9 ttt180 -89.64 -14.78 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.189 -0.3 . . . . 15.0 110.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.43 -56.44 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 107.815 -1.18 . . . . 15.0 107.815 164.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -49.86 -53.39 26.0 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 124.578 1.174 . . . . 15.0 110.3 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -60.76 -45.09 97.13 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.746 -1.115 . . . . 15.0 114.351 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.37 -44.83 77.97 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 123.466 0.706 . . . . 15.0 110.1 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.51 -42.21 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 123.816 0.698 . . . . 15.0 109.746 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 375' ' ' ALA . 42.7 mt-10 -72.53 -29.62 63.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.887 0.875 . . . . 15.0 112.84 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 53.6 mt-10 -60.99 -55.82 28.36 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.4 ttp -59.4 -40.47 86.72 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.461 -1.245 . . . . 15.0 110.733 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.53 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -65.77 -38.9 90.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.021 0.928 . . . . 15.0 112.905 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 26.1 t -63.77 -15.39 58.55 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.848 0.859 . . . . 15.0 112.369 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.424 ' HB2' HH21 ' A' ' 276' ' ' ARG . . . -71.59 -27.97 63.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.076 0.55 . . . . 15.0 112.182 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -95.31 -170.86 2.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.956 0.502 . . . . 15.0 110.554 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -79.88 -27.68 39.99 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 15.0 110.378 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -148.05 131.33 8.16 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.262 0.625 . . . . 15.0 110.873 -171.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 88.3 Cg_endo -76.04 -29.75 6.37 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.653 2.235 . . . . 15.0 113.19 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -59.3 -32.44 70.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.358 0.663 . . . . 15.0 111.309 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.6 -53.99 13.13 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.675 1.235 . . . . 15.0 110.059 170.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 375' ' ' ALA . 24.8 t -73.4 -54.08 16.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.082 0 CA-C-N 114.182 -1.372 . . . . 15.0 110.806 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.76 -54.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 124.548 1.155 . . . . 15.0 109.315 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.48 -40.95 76.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 119.199 -0.429 . . . . 15.0 111.825 -173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -59.14 -53.82 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.679 0.392 . . . . 15.0 111.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -77.51 -32.88 54.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.351 0.871 . . . . 15.0 113.351 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.0 p -61.77 -29.06 69.88 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.749 0.309 . . . . 15.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.5 -13.73 60.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.412 0.685 . . . . 15.0 111.835 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -122.48 114.28 20.48 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 110.039 -0.356 . . . . 15.0 110.039 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.7 ttmt -62.3 -19.13 62.97 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.696 1.198 . . . . 15.0 112.097 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -50.74 -65.49 0.55 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.456 1.102 . . . . 15.0 111.328 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' B' ' 100' ' ' LEU . 25.9 tp -84.67 -18.44 35.31 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.804 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 5.0 tpt -64.11 -47.76 78.75 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 118.196 0.453 . . . . 15.0 110.25 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 12.1 t70 -65.16 -49.59 69.27 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.721 0.808 . . . . 15.0 110.613 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.6 -25.67 68.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.251 -0.886 . . . . 15.0 111.822 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.57 ' HA ' HG12 ' A' ' 401' ' ' VAL . 47.9 tpp -74.1 -31.75 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.877 -0.416 . . . . 15.0 109.877 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 38.0 mtm180 -70.24 -39.61 74.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 173.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' B' ' 105' ' ' GLN . 71.5 m-20 -68.3 -38.15 81.34 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.468 -0.787 . . . . 15.0 111.807 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.1 p -82.11 -23.84 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.58 73.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.149 0.579 . . . . 15.0 110.275 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.2 tp -62.89 -47.19 84.36 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.861 -1.063 . . . . 15.0 109.33 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.623 ' HA ' ' HE1' ' B' ' 108' ' ' HIS . 14.3 tp10 -59.83 -42.16 92.95 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.31 1.006 . . . . 15.0 111.628 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.525 ' HB3' ' NE ' ' A' ' 366' ' ' ARG . 32.3 mm-40 -58.06 -59.92 4.54 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.749 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.72 -27.26 69.08 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.065 0.853 . . . . 15.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 355' ' ' ILE . . . -59.87 -55.53 33.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 15.0 110.579 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.9 t -62.73 -37.99 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 124.676 1.235 . . . . 15.0 110.222 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 6.1 mm-40 -58.27 -39.27 78.77 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 122.597 0.359 . . . . 15.0 111.914 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.0 -26.86 65.23 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.921 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.9 t -74.79 -41.09 47.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 108.33 -0.989 . . . . 15.0 108.33 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -69.69 -29.2 66.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.801 1.24 . . . . 15.0 110.654 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.19 80.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.729 0.812 . . . . 15.0 111.036 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' A' ' 120' ' ' LEU . 27.6 mtpp -92.57 -23.08 19.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.41 0.684 . . . . 15.0 111.73 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.54 149.7 22.06 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.467 0.707 . . . . 15.0 111.676 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -76.24 84.97 3.05 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.047 -0.978 . . . . 15.0 109.7 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.14 90.09 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -79.52 122.64 26.72 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -95.24 136.62 35.37 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.199 0.599 . . . . 15.0 109.872 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -127.34 131.86 50.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.401 -0.963 . . . . 15.0 108.401 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.581 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.0 mt-10 -87.04 110.25 19.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.448 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -124.64 173.86 8.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.295 1.038 . . . . 15.0 110.058 -171.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 59.8 p -88.57 -174.83 4.72 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.546 0.689 . . . . 15.0 112.227 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.65 -54.16 50.22 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.638 1.975 . . . . 15.0 114.095 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 428' ' ' MET . 4.9 t-20 -87.84 9.59 21.4 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 116.025 -0.534 . . . . 15.0 112.296 -163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 427' ' ' LEU . 16.2 tp10 -43.6 -60.75 1.63 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.555 1.542 . . . . 15.0 113.205 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 426' ' ' GLU . 10.4 mp -80.7 -21.54 41.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.119 0.485 . . . . 15.0 110.777 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.583 ' HG2' ' HB1' ' B' ' 126' ' ' ALA . 38.1 mtt -92.9 27.31 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.137 0.975 . . . . 15.0 111.251 -168.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.21 48.32 0.86 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.025 1.33 . . . . 15.0 111.607 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -123.29 39.74 3.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.791 0.836 . . . . 15.0 109.756 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.485 HE22 HD21 ' A' ' 425' ' ' ASN . 26.5 mp0 -76.04 119.25 19.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.246 0.618 . . . . 15.0 110.31 174.104 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.02 130.27 6.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 178' ' ' GLU . 13.7 pt20 -67.55 98.2 0.65 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.432 0.458 . . . . 0.0 110.035 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 31.3 t 69.93 -79.92 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.219 1.407 . . . . 0.0 111.945 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.1 t -161.94 -154.8 0.35 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.283 0.633 . . . . 0.0 110.458 -164.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 223' ' ' ALA 0.251 1.7 mp 71.84 -76.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.445 0 C-N-CA 125.596 1.558 . . . . 0.0 110.521 -173.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.11 48.11 23.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.655 0.782 . . . . 0.0 111.305 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.87 133.28 51.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.956 -166.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.46 170.04 16.79 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.491 1.117 . . . . 0.0 108.84 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tm? 72.12 -69.8 0.18 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.622 1.569 . . . . 0.0 109.408 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.553 ' HB3' ' NE2' ' A' ' 222' ' ' HIS . 30.0 tp -126.28 109.17 23.96 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.558 1.143 . . . . 0.0 109.025 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.29 -162.85 0.2 Allowed 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 124.076 3.184 . . . . 0.0 111.434 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.585 HD23 ' HA2' ' A' ' 180' ' ' GLY . 3.8 mm? -64.96 -2.23 2.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.607 0.763 . . . . 0.0 112.736 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 mt -86.85 80.54 8.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.521 0.729 . . . . 0.0 109.716 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 194' ' ' MET . 31.4 m-85 -82.93 -8.4 59.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.4 m -74.47 -54.47 3.09 Favored Pre-proline 0 CA--C 1.573 1.853 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.465 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.418 ' HB2' HG23 ' B' ' 19' ' ' THR . 94.4 Cg_endo -78.59 -30.27 3.21 Favored 'Trans proline' 0 C--N 1.392 2.823 0 CA-C-N 121.521 1.579 . . . . 0.0 114.026 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.528 HG12 HD13 ' B' ' 11' ' ' LEU . 30.1 m 38.51 57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 125.786 1.635 . . . . 0.0 113.377 -174.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.418 HG23 ' HB2' ' B' ' 17' ' ' PRO . 47.4 p -85.09 120.99 27.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.223 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.53 159.53 33.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.079 0.952 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.49 103.14 4.03 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.572 0.749 . . . . 0.0 110.055 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -123.46 -174.83 3.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.152 0.981 . . . . 0.0 110.534 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -62.77 143.82 96.74 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-O 117.75 -1.119 . . . . 0.0 109.68 167.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.66 97.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 1 C-N-CA 125.621 4.214 . . . . 0.0 114.971 -171.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.25 88.67 0.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.54 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.558 ' HG3' HG13 ' B' ' 28' ' ' VAL . 26.9 ptm -159.73 167.73 13.52 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.343 1.057 . . . . 0.0 109.172 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' B' ' 26' ' ' MET . 24.6 Cg_endo -61.21 85.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.472 2.115 . . . . 0.0 113.035 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' B' ' 26' ' ' MET . 19.0 m -121.59 -26.41 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.598 1.159 . . . . 0.0 109.749 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 62.9 mt -64.57 109.99 2.17 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 48.95 30.8 2.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.704 1.602 . . . . 0.0 112.988 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . 0.255 5.5 p30 46.25 -75.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.155 1.782 . . . . 0.0 111.789 -164.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.6 -22.8 0.09 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.179 0.591 . . . . 0.0 111.281 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -160.31 -47.0 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.15 85.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.354 0.662 . . . . 0.0 111.983 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 63.07 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.898 1.279 . . . . 0.0 110.193 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.76 26.94 0.02 OUTLIER Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -95.09 157.29 15.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.136 0.975 . . . . 0.0 110.093 -175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -66.18 89.8 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.758 0.789 . . . . 0.0 111.651 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -68.82 142.95 54.72 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.75 81.64 0.23 Allowed Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -161.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.03 -18.15 56.39 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.328 2.686 . . . . 0.0 113.472 -170.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.31 5.02 64.91 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.547 0.529 . . . . 0.0 113.103 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.32 48.0 11.73 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.32 0.486 . . . . 0.0 112.048 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.76 176.56 0.27 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.695 1.198 . . . . 0.0 112.396 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -82.77 72.42 9.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.763 0.825 . . . . 0.0 110.081 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -88.03 -62.87 1.4 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.253 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.681 HD23 ' H ' ' B' ' 47' ' ' LEU . 1.5 pt? -84.52 107.23 16.64 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.742 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 12.7 m -102.64 59.07 0.79 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.002 0.906 . . . . 0.0 109.252 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.33 146.45 6.75 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.791 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.61 95.19 7.7 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.124 0.487 . . . . 0.0 110.969 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -112.64 -24.26 9.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.058 0.943 . . . . 0.0 110.841 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.9 m -79.74 -15.04 58.24 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.591 0.756 . . . . 0.0 112.261 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.14 -17.71 56.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.691 -0.631 . . . . 0.0 111.432 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.35 -174.24 0.14 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.887 1.275 . . . . 0.0 111.981 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 pp -166.16 153.98 10.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.691 0.797 . . . . 0.0 110.602 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 61.61 12.01 4.25 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.908 1.283 . . . . 0.0 113.88 170.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.7 107.82 20.34 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.8 p 56.05 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.727 1.611 . . . . 0.0 112.119 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp 67.64 -80.08 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.482 1.513 . . . . 0.0 111.47 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.3 p -161.38 165.09 29.46 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.71 0.804 . . . . 0.0 109.772 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.26 -61.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.319 1.447 . . . . 0.0 111.218 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' B' ' 63' ' ' PRO . 2.6 tppp? -54.78 125.62 55.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.134 1.374 . . . . 0.0 110.506 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' B' ' 62' ' ' LYS . 20.8 Cg_exo -35.26 91.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 125.3 4.0 . . . . 0.0 115.305 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.07 -158.55 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 106.955 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 tttp 62.11 21.54 12.47 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.758 0.823 . . . . 0.0 111.401 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 18.5 m120 65.14 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 0.0 110.798 -169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 64.5 mt 59.95 -85.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.984 1.313 . . . . 0.0 111.47 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -83.57 -25.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.787 0.835 . . . . 0.0 110.021 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.8 mt -71.85 81.47 0.9 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.634 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.23 4.81 1.84 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.428 1.491 . . . . 0.0 108.558 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.8 tp -75.52 132.22 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.974 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.99 1.41 Allowed Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.49 -149.22 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.707 1.203 . . . . 0.0 110.654 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.42 97.62 0.05 OUTLIER Glycine 0 C--N 1.361 1.935 0 O-C-N 123.403 0.439 . . . . 0.0 112.748 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' B' ' 82' ' ' ALA . 54.3 tpp 58.72 92.52 0.04 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.384 1.474 . . . . 0.0 110.437 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.673 ' HA2' ' HB ' ' B' ' 80' ' ' ILE . . . -160.61 103.02 0.22 Allowed Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.336 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.61 -72.29 0.18 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.276 0.63 . . . . 0.0 109.341 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 39.0 m -96.86 -71.97 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -105.74 -78.8 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.673 ' HB ' ' HA2' ' B' ' 76' ' ' GLY . 38.7 mm 52.94 -76.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 125.962 1.705 . . . . 0.0 112.303 -171.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 38.6 p 57.45 82.48 0.12 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 125.976 1.71 . . . . 0.0 110.809 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' B' ' 75' ' ' MET . . . -85.07 12.01 8.55 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.003 -0.436 . . . . 0.0 111.932 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.74 156.81 26.01 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.883 0.873 . . . . 0.0 111.036 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 62.86 82.41 0.18 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.139 0.976 . . . . 0.0 111.668 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -137.44 -61.99 0.63 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.434 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 57.38 174.77 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.351 1.461 . . . . 0.0 113.71 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.72 -174.3 1.56 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.854 1.262 . . . . 0.0 108.257 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -125.75 86.72 2.58 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.04 107.41 2.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.144 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.07 178.96 6.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.751 0.821 . . . . 0.0 109.947 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.24 97.36 0.27 Allowed Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.28 -21.04 75.66 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.736 0.316 . . . . 0.0 113.699 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -80.41 -5.91 57.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.414 0.686 . . . . 0.0 110.896 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 77.2 t80 77.31 162.17 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.048 1.739 . . . . 0.0 111.426 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -59.2 152.3 20.94 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.053 1.741 . . . . 0.0 113.237 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.07 -82.22 0.18 Allowed Glycine 0 C--N 1.355 1.605 0 O-C-N 124.565 1.166 . . . . 0.0 115.04 165.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.504 HG23 HD13 ' B' ' 100' ' ' LEU . 37.3 mm 77.13 140.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.826 1.65 . . . . 0.0 111.835 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.64 -73.17 0.55 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.544 0.738 . . . . 0.0 110.801 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 401' ' ' VAL . . . -101.98 -81.28 0.49 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.315 0.646 . . . . 0.0 110.823 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.504 HD13 HG23 ' B' ' 97' ' ' ILE . 9.0 mp 65.97 -173.82 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 117.854 -1.07 . . . . 0.0 112.383 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 77.4 Cg_exo -50.7 29.54 0.02 OUTLIER 'Trans proline' 1 C--N 1.415 4.043 0 C-N-CA 123.897 3.065 . . . . 0.0 118.81 172.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' B' ' 120' ' ' TYR . 7.8 tt -50.54 -41.76 54.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.283 1.033 . . . . 0.0 108.864 155.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.539 HG22 HD13 ' B' ' 111' ' ' LEU . 66.0 p -105.58 156.32 18.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.461 1.105 . . . . 0.0 109.707 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.28 -128.8 1.71 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.449 ' HA ' ' ND2' ' A' ' 400' ' ' ASN . 9.7 mp0 -100.01 -171.22 2.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.466 0.706 . . . . 0.0 110.613 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -68.36 74.19 0.23 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.111 1.365 . . . . 0.0 110.417 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -146.95 -54.07 0.23 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.431 1.093 . . . . 0.0 109.912 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . 0.623 ' HE1' ' HA ' ' A' ' 404' ' ' GLU . 76.9 m-70 81.54 -13.7 0.87 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 126.549 1.939 . . . . 0.0 112.392 -171.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -69.36 -33.22 72.75 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.02 -8.99 58.23 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.69 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.539 HD13 HG22 ' B' ' 103' ' ' THR . 60.3 tp -66.1 102.7 0.85 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 168.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -80.5 143.94 32.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.696 ' HE3' ' HG2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -149.96 122.79 8.7 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.768 0.258 . . . . 0.0 111.09 -173.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' B' ' 119' ' ' ASP . 44.3 mmtm -67.98 179.29 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.496 0.665 . . . . 0.0 111.095 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -65.47 96.31 0.24 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 121.929 0.871 . . . . 0.0 108.898 165.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.65 -37.97 2.03 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -171.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 288' ' ' SER 0.34 4.2 ptpp? 110.22 -26.56 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 128.455 2.702 . . . . 0.0 116.019 169.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.83 99.42 0.97 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 CA-C-N 123.618 2.328 . . . . 0.0 111.277 168.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . 0.716 ' HA ' ' HG2' ' B' ' 114' ' ' LYS . 9.0 t70 -93.44 -31.41 14.61 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 122.778 0.431 . . . . 0.0 111.611 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.462 ' HB3' ' HG ' ' B' ' 102' ' ' LEU . 30.1 p90 -51.47 125.81 15.52 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.588 1.18 . . . . 0.0 111.713 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -71.6 83.31 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.288 1.035 . . . . 0.0 109.431 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.8 m -147.38 114.76 6.29 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.69 78.81 1.53 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.215 1.007 . . . . 0.0 109.467 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 47.5 t -81.6 85.25 6.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.219 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.06 -28.5 64.41 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.017 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 428' ' ' MET . . . 71.82 -57.3 0.62 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 125.167 1.542 . . . . 0.0 111.276 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.417 ' HA ' ' SD ' ' A' ' 140' ' ' MET . 31.7 m -64.09 102.56 0.51 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 122.789 0.436 . . . . 0.0 109.835 167.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 144' ' ' LEU . . . 80.15 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.081 1.752 . . . . 0.0 111.922 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.3 m 57.09 26.18 11.73 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.056 0.942 . . . . 0.0 111.339 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.3 22.34 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.241 1.016 . . . . 0.0 112.752 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -100.79 3.98 42.55 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.29 1.036 . . . . 0.0 109.96 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 10.5 m -60.25 -43.28 96.25 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.826 1.25 . . . . 0.0 113.784 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -91.15 -7.36 51.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.04 0.536 . . . . 0.0 111.859 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . 0.461 ' HA3' ' HA2' ' A' ' 257' ' ' GLY . . . -122.81 -165.14 12.31 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.678 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.5 t 50.26 43.1 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 122.644 1.211 . . . . 0.0 109.513 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -137.28 56.8 1.77 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.947 -167.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 40.7 m -120.53 123.59 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.238 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.1 -11.09 4.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 111.983 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -70.94 -21.66 62.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.895 0.478 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.47 -75.87 2.09 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' B' ' 144' ' ' VAL . . . -146.03 136.7 24.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.24 0.616 . . . . 0.0 110.813 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.7 124.41 50.5 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.577 1.151 . . . . 0.0 108.565 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.7 -63.55 4.25 Favored Glycine 0 C--N 1.347 1.152 0 O-C-N 123.455 0.472 . . . . 0.0 112.295 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.478 HG13 ' HB1' ' B' ' 141' ' ' ALA . 3.7 p -67.29 104.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.391 0.615 . . . . 0.0 110.006 175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -138.22 145.27 41.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.685 0.794 . . . . 0.0 109.173 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.72 107.17 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 109.355 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -157.36 75.64 0.81 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.623 0.725 . . . . 0.0 110.942 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.35 159.6 25.57 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.058 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -86.84 80.62 8.43 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 124.334 1.054 . . . . 0.0 111.311 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptm . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.6 tt0 -85.59 103.68 14.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.193 -0.669 . . . . 15.0 109.193 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 17' ' ' ILE . 33.5 m -107.67 141.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.399 0.679 . . . . 15.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 p -149.2 108.36 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.863 0.465 . . . . 15.0 110.093 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 13' ' ' ARG . 2.4 p -88.87 107.0 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.956 0.902 . . . . 15.0 110.158 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.12 112.04 24.34 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.492 1.117 . . . . 15.0 109.882 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -75.27 89.47 2.57 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 109.44 -0.578 . . . . 15.0 109.44 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -90.0 -62.48 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.815 0.846 . . . . 15.0 112.209 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -110.11 60.54 0.6 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.393 0.616 . . . . 15.0 110.515 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.72 -96.76 0.22 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.895 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 85.8 mt -64.72 -40.19 94.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.802 0.841 . . . . 15.0 110.611 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.51 107.87 1.82 Allowed Glycine 0 C--N 1.348 1.229 0 O-C-N 124.337 1.023 . . . . 15.0 113.223 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 5' ' ' VAL . 56.2 mtt85 -114.65 112.42 22.86 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.231 1.412 . . . . 15.0 109.971 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -78.4 90.23 4.42 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.521 1.128 . . . . 15.0 110.491 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 5' ' ' VAL . 94.6 t -77.91 87.9 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.499 -0.926 . . . . 15.0 108.499 171.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -76.86 118.9 19.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.179 -1.373 . . . . 15.0 109.464 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -118.31 116.18 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.104 0.562 . . . . 15.0 110.401 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 90.7 m -88.46 107.72 19.01 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.876 -0.787 . . . . 15.0 108.876 167.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 70' ' ' LEU . 53.0 mt -87.48 123.09 39.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.751 -1.203 . . . . 15.0 107.751 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.66 50.87 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.356 0.662 . . . . 15.0 110.947 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.62 87.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.417 1.087 . . . . 15.0 112.006 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.99 -32.32 69.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.533 -0.758 . . . . 15.0 110.626 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.8 m -66.95 -39.24 87.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.309 0.643 . . . . 15.0 111.193 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.548 HG21 ' HE1' ' A' ' 97' ' ' TYR . 54.5 mt -63.52 -46.3 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.217 -0.66 . . . . 15.0 109.217 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -59.12 -37.39 77.1 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.461 -1.245 . . . . 15.0 111.183 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -71.0 -38.26 72.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.577 0.751 . . . . 15.0 110.843 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.82 84.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.354 0.662 . . . . 15.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 ' HG2' ' A' ' 63' ' ' ARG . 57.6 t -64.29 -38.25 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.333 0.653 . . . . 15.0 110.144 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -68.35 -31.61 71.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.247 1.019 . . . . 15.0 111.753 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.6 m -80.73 -32.12 35.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.888 0.875 . . . . 15.0 109.813 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.7 -25.12 62.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.187 0.995 . . . . 15.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 68.5 mt -51.0 -51.67 50.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.329 1.052 . . . . 15.0 112.068 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG22 ' HE3' ' A' ' 37' ' ' LYS . 13.6 p -66.41 -29.32 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 O-C-N 123.944 0.778 . . . . 15.0 111.353 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -72.54 -49.3 33.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.163 0.585 . . . . 15.0 109.842 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.92 -33.15 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.198 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.52 -33.7 71.48 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 123.393 0.677 . . . . 15.0 110.929 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.0 mttt -78.07 -32.82 50.95 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.046 0.45 . . . . 15.0 110.635 174.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 15.0 111.341 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.41 1.16 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 C-N-CA 123.521 0.728 . . . . 15.0 109.533 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 62.23 19.1 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.225 1.41 . . . . 15.0 113.091 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.51 -35.69 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.897 0.879 . . . . 15.0 111.093 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.57 -34.41 69.17 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.547 0.739 . . . . 15.0 112.602 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.74 42.76 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 116.177 -0.465 . . . . 15.0 113.431 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -95.13 -25.63 16.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.441 0.697 . . . . 15.0 111.699 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -86.85 116.59 25.03 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.12 -28.34 69.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.235 1.014 . . . . 15.0 112.155 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 32.45 30.43 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.661 -0.699 . . . . 15.0 112.416 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -64.8 -48.83 73.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.429 0.692 . . . . 15.0 109.939 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -78.87 126.37 82.43 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -47.64 110.81 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.659 2.906 . . . . 15.0 113.264 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.457 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.1 tpt -60.03 -35.16 74.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.414 1.086 . . . . 15.0 111.175 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 8.5 p30 -59.74 -36.79 77.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.733 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mt -76.51 -30.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.027 0.531 . . . . 15.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 51' ' ' MET . 3.3 m -85.76 10.45 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 112.068 0.396 . . . . 15.0 112.068 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HA ' HD21 ' A' ' 32' ' ' LEU . . . -62.57 -34.99 78.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.519 0.727 . . . . 15.0 111.213 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 63' ' ' ARG . 3.3 pt20 -98.02 10.5 40.22 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.097 -0.956 . . . . 15.0 111.402 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -118.23 -73.45 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.785 0.834 . . . . 15.0 110.509 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -69.21 -36.13 76.94 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.133 0.573 . . . . 15.0 110.071 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -80.9 -3.01 90.6 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.398 -0.819 . . . . 15.0 113.593 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.37 -34.7 25.07 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.108 1.151 . . . . 15.0 114.108 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -80.65 -41.96 22.92 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.571 0.748 . . . . 15.0 111.603 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -72.82 -18.91 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 122.517 0.327 . . . . 15.0 111.398 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 73.9 mtp85 -54.58 -26.04 29.99 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.167 0.987 . . . . 15.0 112.525 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -59.86 -56.36 22.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.39 1.076 . . . . 15.0 110.354 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.7 -17.22 48.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.821 0.848 . . . . 15.0 112.165 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.4 t -64.51 -30.51 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.649 -0.5 . . . . 15.0 109.649 172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' MET . 96.3 mt -59.25 -43.34 92.43 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.786 0.434 . . . . 15.0 110.929 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.25 -40.75 98.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.542 0.526 . . . . 15.0 112.462 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.05 -42.69 99.45 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.429 1.092 . . . . 15.0 110.729 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 19' ' ' ILE . 61.5 mt -67.04 -48.18 69.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 66.9 mtm -62.44 -34.22 76.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 15.0 110.964 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 t -69.44 -52.64 24.83 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.32 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -73.29 -26.2 60.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.338 0.655 . . . . 15.0 112.432 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -75.58 -40.33 56.76 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.33 0.652 . . . . 15.0 110.007 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.58 -57.52 10.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.956 0.785 . . . . 15.0 111.373 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 tt -62.5 -36.98 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 123.808 0.693 . . . . 15.0 110.765 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -70.0 -37.84 75.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.367 0.667 . . . . 15.0 110.495 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.6 74.34 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.755 0.822 . . . . 15.0 111.848 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' A' ' 86' ' ' PRO . 30.5 pt -70.39 -25.97 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 112.074 0.398 . . . . 15.0 112.074 -175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.1 mt -76.26 -49.21 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.316 0.647 . . . . 15.0 110.484 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.7 -38.53 83.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.357 0.263 . . . . 15.0 111.051 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -87.31 -0.94 57.5 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.025 0.53 . . . . 15.0 111.805 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 61.28 30.55 19.21 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.417 1.087 . . . . 15.0 111.986 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.47 136.15 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -105.31 86.52 1.68 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.066 0.947 . . . . 15.0 109.237 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HG2' HD12 ' A' ' 79' ' ' ILE . 9.0 Cg_exo -74.27 153.79 45.87 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.596 2.864 . . . . 15.0 113.695 -167.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.84 167.67 28.89 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.542 1.137 . . . . 15.0 109.677 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.6 -112.35 3.52 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.757 -0.656 . . . . 15.0 112.68 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.01 126.48 4.55 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.614 0.766 . . . . 15.0 110.069 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 70.7 Cg_endo -73.18 108.63 2.65 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.777 2.318 . . . . 15.0 112.137 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 m -90.1 93.61 9.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.069 0.547 . . . . 15.0 110.477 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -75.17 127.37 33.04 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.62 0.768 . . . . 15.0 110.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.98 86.63 53.64 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 107.687 -1.227 . . . . 15.0 107.687 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.37 142.04 29.48 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.515 2.144 . . . . 15.0 112.411 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.76 -92.01 0.08 OUTLIER Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.109 -0.797 . . . . 15.0 111.109 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.89 143.57 4.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.782 0.833 . . . . 15.0 109.901 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' HE1' HG21 ' A' ' 24' ' ' ILE . 10.3 t80 -75.02 136.38 41.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 15.0 110.333 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 92.6 mttt -145.59 155.6 43.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.861 0.864 . . . . 15.0 110.674 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -112.49 104.98 13.11 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.117 -1.068 . . . . 15.0 108.117 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.78 -50.68 0.8 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.381 -0.688 . . . . 15.0 111.381 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 37.4 mt-10 -91.24 149.98 21.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.832 0.853 . . . . 15.0 109.611 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.72 151.23 27.6 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.175 0.99 . . . . 15.0 111.216 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -98.85 119.5 37.71 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.051 0.94 . . . . 15.0 109.671 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 m -117.64 145.38 44.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.507 0.723 . . . . 15.0 109.472 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -149.68 151.24 33.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.81 0.844 . . . . 15.0 109.842 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.0 m -109.79 121.8 46.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.999 0.92 . . . . 15.0 110.651 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.57 100.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.444 -0.576 . . . . 15.0 109.444 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -98.74 106.97 19.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.25 0.62 . . . . 15.0 109.942 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.5 p90 -131.82 156.62 45.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.78 0.832 . . . . 15.0 109.279 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.67 174.36 11.08 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.191 0.596 . . . . 15.0 110.03 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.6 m -133.41 163.73 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.422 0.689 . . . . 15.0 109.542 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -78.08 117.52 66.51 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.6 Cg_endo -81.48 165.45 18.42 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.954 1.769 . . . . 15.0 111.65 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -69.15 105.47 2.49 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 353' ' ' GLU . 46.1 t -65.3 121.73 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.459 0.703 . . . . 15.0 109.859 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -64.77 93.83 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.588 0.755 . . . . 15.0 111.106 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 105.07 14.74 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 169.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -92.42 -163.02 0.99 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.73 114.87 6.75 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.824 -0.51 . . . . 15.0 111.824 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -83.0 5.49 21.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.726 0.811 . . . . 15.0 110.947 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.75 -21.3 61.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.665 1.186 . . . . 15.0 110.01 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.21 -21.97 66.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.081 0.952 . . . . 15.0 112.03 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.729 HG23 ' HA3' ' A' ' 293' ' ' GLY . 72.1 mt -72.95 128.21 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.73 0.812 . . . . 15.0 109.677 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.47 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 46.0 mt-10 -107.25 111.71 24.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.713 0.805 . . . . 15.0 109.043 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.27 142.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 15.0 108.069 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.495 ' HB3' HH12 ' A' ' 285' ' ' ARG . 24.3 tt0 -114.95 138.08 51.24 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 61.6 tttm -112.35 94.52 27.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.182 -1.044 . . . . 15.0 108.182 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.0 114.89 1.98 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.325 2.017 . . . . 15.0 112.394 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 29.8 mm -77.33 89.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 172.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.48 116.65 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.958 -1.019 . . . . 15.0 109.703 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.32 135.36 33.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.285 0.634 . . . . 15.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 t -116.81 80.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.044 0.938 . . . . 15.0 108.578 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 p -70.8 165.04 23.97 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.793 -0.567 . . . . 15.0 109.654 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.67 -32.51 71.71 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.593 0.757 . . . . 15.0 111.113 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.73 -33.87 71.3 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.35 -0.841 . . . . 15.0 111.148 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.71 -46.72 52.23 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.265 0.626 . . . . 15.0 111.462 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 7.6 p -64.44 -40.88 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 123.365 0.415 . . . . 15.0 110.262 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.47 -34.65 78.78 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.724 0.41 . . . . 15.0 111.122 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.48 -32.75 82.65 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.497 -0.774 . . . . 15.0 112.22 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 47.8 tpp -74.47 -36.44 63.32 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.785 0.434 . . . . 15.0 110.597 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.0 mt -58.77 -41.37 86.45 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.473 -0.566 . . . . 15.0 109.473 172.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.016 1.326 . . . . 15.0 111.192 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.3 m -59.71 -40.06 86.7 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.316 0.646 . . . . 15.0 110.698 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.1 mt -65.43 -39.99 92.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.499 0.719 . . . . 15.0 110.513 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -62.52 -32.15 73.04 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.727 0.811 . . . . 15.0 111.16 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 -32.55 59.4 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.018 0.527 . . . . 15.0 111.574 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -77.01 -25.32 52.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.166 0.586 . . . . 15.0 111.022 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -106.05 21.91 16.55 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.898 0.879 . . . . 15.0 110.256 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.0 125.73 27.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.295 0.638 . . . . 15.0 111.273 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 m -89.13 129.21 35.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.379 1.072 . . . . 15.0 110.554 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -79.65 144.08 34.08 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.688 0.756 . . . . 15.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -150.81 138.34 19.62 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 113.796 -1.547 . . . . 15.0 108.281 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.3 mt-10 -67.94 156.31 37.53 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.027 0.831 . . . . 15.0 112.003 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HG3' HG13 ' A' ' 240' ' ' VAL . 55.3 pttt -158.9 -178.46 7.26 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.128 -1.396 . . . . 15.0 109.622 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.07 148.12 52.19 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.476 -1.238 . . . . 15.0 107.998 168.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.06 -157.56 16.79 Favored Glycine 0 N--CA 1.466 0.662 0 O-C-N 123.591 0.557 . . . . 15.0 112.571 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.93 106.87 0.54 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.065 0.946 . . . . 15.0 112.151 -171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.651 HG21 HD21 ' A' ' 237' ' ' LEU . 58.0 t -59.2 132.92 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.353 169.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -106.97 160.61 15.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.295 -0.632 . . . . 15.0 109.295 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.81 3.73 6.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.411 1.084 . . . . 15.0 113.4 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.24 12.39 7.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.274 1.03 . . . . 15.0 110.557 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -92.22 170.38 9.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.843 0.83 . . . . 15.0 111.568 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 188' ' ' ALA . 50.3 ttp180 -122.08 121.61 37.35 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.335 -1.728 . . . . 15.0 106.335 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.584 HG12 HG23 ' A' ' 240' ' ' VAL . 19.4 m -114.27 -176.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 122.997 0.519 . . . . 15.0 111.725 -172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 97.5 m -133.48 107.73 8.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.545 1.138 . . . . 15.0 109.043 170.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.9 pt -105.4 -172.74 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.01 0.524 . . . . 15.0 111.243 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -157.46 100.84 1.83 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.032 -1.84 . . . . 15.0 106.032 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 37.1 p90 -113.08 147.33 37.51 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.832 -0.543 . . . . 15.0 112.03 -171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -90.28 105.8 18.06 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.858 -0.793 . . . . 15.0 108.858 168.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.34 105.61 1.1 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.734 0.646 . . . . 15.0 111.675 173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 18.9 m -123.22 139.07 54.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.365 0.666 . . . . 15.0 110.313 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 177' ' ' PHE . 23.4 t -117.13 128.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.476 1.511 . . . . 15.0 108.53 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.71 25.99 14.37 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.004 0.922 . . . . 15.0 110.382 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.606 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 89.17 -6.37 83.58 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.403 -0.817 . . . . 15.0 114.1 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 118.006 0.903 . . . . 15.0 109.437 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 10.5 pt-20 -62.83 155.95 25.44 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.377 0.671 . . . . 15.0 111.737 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.421 ' HZ ' HD23 ' B' ' 13' ' ' LEU . 30.4 p90 -132.11 170.75 14.54 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.872 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.05 130.19 42.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.521 0.728 . . . . 15.0 112.143 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.44 -0.36 60.45 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 115.265 -0.88 . . . . 15.0 113.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -87.29 71.1 2.74 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 -169.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -159.59 168.99 24.76 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.745 1.618 . . . . 15.0 108.652 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -156.63 120.18 4.26 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 162.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.0 p -102.07 129.74 48.47 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.11 1.364 . . . . 15.0 109.82 -171.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 61.18 29.33 18.72 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.144 0.903 . . . . 15.0 110.074 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.58 109.32 3.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.796 1.238 . . . . 15.0 110.793 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.07 98.05 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.001 0.905 . . . . 15.0 109.835 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.6 tp -96.41 129.63 43.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.854 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . . . -112.13 148.95 32.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 15.0 109.571 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 36.7 mtt -101.34 164.42 11.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.48 0.712 . . . . 15.0 110.138 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.02 -51.9 3.19 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -172.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.92 123.54 21.76 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.171 0.588 . . . . 15.0 109.915 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.82 39.16 3.11 Favored Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.271 -0.422 . . . . 15.0 112.5 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.84 42.36 1.1 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.668 0.787 . . . . 15.0 110.611 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.406 ' HA ' ' HD1' ' B' ' 15' ' ' PHE . 93.2 mmm -149.88 -170.53 3.67 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.269 1.428 . . . . 15.0 108.159 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 57.2 mt -64.51 130.1 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.537 -0.912 . . . . 15.0 108.537 167.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.72 104.18 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.28 1.987 . . . . 15.0 111.054 170.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.69 -17.18 8.3 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 116.332 -0.395 . . . . 15.0 112.443 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 66.8 t80 -63.62 -42.2 98.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.471 0.708 . . . . 15.0 110.875 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -70.74 -18.65 62.78 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.522 -1.217 . . . . 15.0 112.068 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.7 -47.49 67.22 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.765 1.226 . . . . 15.0 111.476 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.78 -33.97 80.36 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.306 1.004 . . . . 15.0 113.429 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 158' ' ' VAL . 3.6 mp -69.39 -39.78 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 C-N-CA 123.392 0.677 . . . . 15.0 110.489 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -71.57 11.28 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.634 1.716 . . . . 15.0 115.634 -165.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.43 38.13 0.89 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 119.048 0.84 . . . . 15.0 112.004 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.805 ' HB3' ' HG3' ' A' ' 209' ' ' GLU . 62.4 m80 -142.35 -167.28 2.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.016 0.926 . . . . 15.0 109.768 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -127.64 -176.65 3.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.66 0.784 . . . . 15.0 110.633 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -86.68 36.89 0.72 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.727 0.811 . . . . 15.0 112.6 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.89 37.04 0.72 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.964 -0.46 . . . . 15.0 112.919 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.805 ' HG3' ' HB3' ' A' ' 205' ' ' HIS . 11.6 mm-40 -107.37 167.12 10.15 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.218 1.562 . . . . 15.0 115.218 -166.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -153.61 113.8 3.94 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 112.452 -2.158 . . . . 15.0 107.852 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -159.8 167.29 28.55 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.46 0.704 . . . . 15.0 109.97 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 95.5 m -133.8 119.13 18.83 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.998 0.919 . . . . 15.0 108.948 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.565 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.5 pt -104.53 150.47 7.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.226 0.536 . . . . 15.0 111.386 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -96.08 105.86 17.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.555 -1.202 . . . . 15.0 108.341 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.46 130.65 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.65 0.738 . . . . 15.0 110.715 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 68.2 m -80.85 130.58 35.13 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.174 -1.375 . . . . 15.0 109.68 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.445 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 36.3 m-85 -51.8 157.7 1.9 Allowed Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 124.826 1.25 . . . . 15.0 112.401 176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HD3' HG12 ' A' ' 195' ' ' ILE . 58.7 Cg_endo -80.79 158.01 21.3 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.101 1.868 . . . . 15.0 110.144 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 33.4 mt-10 -77.86 -6.22 53.5 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.092 0.472 . . . . 15.0 111.014 175.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.423 ' O ' HD21 ' B' ' 11' ' ' LEU . 7.8 mp0 -90.15 -13.45 35.63 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.948 0.899 . . . . 15.0 110.3 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.479 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 29.1 t80 -53.98 142.85 23.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.108 0.88 . . . . 15.0 111.205 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -55.02 -53.29 57.69 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.156 0.982 . . . . 15.0 111.553 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -66.39 117.93 9.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.622 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 227' ' ' LYS . 13.5 tp10 -66.06 -43.57 87.08 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.469 1.106 . . . . 15.0 110.783 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.16 -9.98 59.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.988 -1.005 . . . . 15.0 111.644 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 68.1 mt -116.82 -13.26 10.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.657 -0.687 . . . . 15.0 112.389 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 18.9 ptpt -69.57 119.89 14.52 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.385 0.993 . . . . 15.0 108.723 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.63 44.72 81.05 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 115.926 -0.579 . . . . 15.0 112.617 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.1 tmtm? -121.31 136.28 54.99 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -68.34 118.6 11.64 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.248 0.619 . . . . 15.0 110.606 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.59 159.46 21.26 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.803 0.841 . . . . 15.0 110.907 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.606 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -114.24 136.87 52.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.08 0.952 . . . . 15.0 109.505 177.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' B' ' 13' ' ' LEU . 72.7 m-85 -136.94 110.63 8.08 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.684 -0.487 . . . . 15.0 109.684 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PHE . . . -78.12 79.03 4.59 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.938 0.774 . . . . 15.0 109.621 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.3 mm -72.11 103.75 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 114.378 -1.283 . . . . 15.0 110.472 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.21 84.48 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.707 -1.22 . . . . 15.0 107.707 172.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 158' ' ' VAL . 27.0 tp -68.55 96.34 0.7 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.417 0.687 . . . . 15.0 109.935 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -88.01 -37.68 16.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.8 0.84 . . . . 15.0 111.863 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.666 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 28.1 mmmt -140.14 156.84 46.37 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 15.0 110.384 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.703 HG12 ' HB2' ' A' ' 207' ' ' ALA . 6.5 p -130.46 141.13 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.802 -1.184 . . . . 15.0 107.802 165.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 24.2 mt-10 -119.82 130.1 54.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.322 0.649 . . . . 15.0 109.802 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 33.9 tt0 -89.37 131.74 35.29 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.238 1.815 . . . . 15.0 110.91 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.432 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 13.7 ptp180 -74.98 146.44 41.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.735 -0.839 . . . . 15.0 108.735 167.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.76 119.02 25.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.042 0.537 . . . . 15.0 109.763 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.75 114.4 9.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 124.014 0.821 . . . . 15.0 108.832 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.7 -179.29 0.37 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.568 2.845 . . . . 15.0 112.402 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.41 155.64 21.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.568 0.699 . . . . 15.0 111.714 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 19.8 tp -127.46 29.83 5.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.443 -1.688 . . . . 15.0 106.443 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.5 m -81.64 154.84 25.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.702 -1.59 . . . . 15.0 109.384 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.95 14.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.842 1.257 . . . . 15.0 112.904 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.95 -30.79 71.41 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.94 0.775 . . . . 15.0 112.718 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -72.39 -54.79 8.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 266' ' ' LEU . 60.1 mt -52.62 -47.25 49.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 114.354 -1.294 . . . . 15.0 111.206 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' H ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.38 -18.16 55.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.891 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -59.9 -37.45 79.43 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.238 0.615 . . . . 15.0 110.665 -172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 132' ' ' SER . 35.7 m-85 -86.5 -21.14 27.15 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.561 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.91 62.46 0.21 Allowed Glycine 0 C--N 1.365 2.177 0 N-CA-C 115.28 0.872 . . . . 15.0 115.28 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.546 ' H ' ' HA ' ' A' ' 254' ' ' LYS . 98.8 t -135.95 84.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.007 -1.849 . . . . 15.0 106.007 162.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -34.7 71.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.083 0.953 . . . . 15.0 111.765 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -84.5 65.01 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.682 1.193 . . . . 15.0 108.885 168.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.18 45.51 2.56 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.024 -0.989 . . . . 15.0 115.443 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 38.5 m -79.94 156.33 27.29 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 167.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.75 -56.54 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.392 -0.596 . . . . 15.0 109.392 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.59 -32.34 65.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.812 0.845 . . . . 15.0 111.086 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -70.62 -36.47 67.74 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.122 -0.944 . . . . 15.0 112.3 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.493 HD13 HG23 ' A' ' 253' ' ' ILE . 65.1 tp -72.45 -36.22 68.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -62.14 -49.49 75.65 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.82 0.848 . . . . 15.0 109.681 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -35.98 80.91 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.096 0.558 . . . . 15.0 112.322 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -74.71 -45.05 46.77 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.106 0.562 . . . . 15.0 111.148 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.93 -30.28 31.85 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.998 -0.546 . . . . 15.0 109.921 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.18 -45.85 83.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 15.0 110.189 167.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -60.05 -44.29 94.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.355 0.662 . . . . 15.0 110.969 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -66.8 -32.94 74.55 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.662 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 137' ' ' VAL . 53.0 mtt -69.75 -35.11 74.68 Favored 'General case' 0 C--O 1.187 -2.21 0 CA-C-O 118.381 -0.819 . . . . 15.0 110.484 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.47 -42.66 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.229 0.612 . . . . 15.0 110.392 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -54.56 -49.94 69.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.601 1.16 . . . . 15.0 110.033 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -75.29 -35.03 61.34 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.32 -1.309 . . . . 15.0 111.996 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 282' ' ' ILE . 26.3 tp -77.48 -32.1 54.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.81 0.844 . . . . 15.0 110.583 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 37.9 ttpt -59.69 -45.35 92.38 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.61 -0.515 . . . . 15.0 109.61 172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 t -74.6 -23.5 58.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.08 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.23 38.77 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.199 0.6 . . . . 15.0 112.01 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.419 HD13 ' HG ' ' A' ' 278' ' ' LEU . 1.7 mp -65.59 -42.68 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 109.325 -0.62 . . . . 15.0 109.325 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 2.3 tpt180 -57.58 -50.09 74.27 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.165 -0.68 . . . . 15.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -53.11 -56.71 14.17 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.933 1.293 . . . . 15.0 110.522 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 126' ' ' GLU . 1.1 tpt85 -55.8 -61.34 2.43 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.933 1.293 . . . . 15.0 112.313 -174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.77 -45.82 97.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 123.813 0.845 . . . . 15.0 110.87 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.3 tttt -67.72 -39.28 84.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.882 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.9 p -74.27 -32.52 62.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.042 0.537 . . . . 15.0 111.174 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.58 -29.31 63.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.605 0.362 . . . . 15.0 110.508 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.12 82.32 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.334 0.396 . . . . 15.0 110.86 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.552 HD12 HG11 ' A' ' 347' ' ' VAL . 30.1 mm -64.41 -50.94 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.537 0.735 . . . . 15.0 109.619 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 10.8 tp10 -55.52 -49.45 72.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.609 -1.178 . . . . 15.0 110.706 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.729 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.21 -41.23 99.72 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.824 -1.08 . . . . 15.0 112.764 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.461 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.4 mt -59.62 -46.31 89.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 15.0 111.645 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.47 -55.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-O 121.243 0.545 . . . . 15.0 109.573 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.95 -30.39 65.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.905 1.282 . . . . 15.0 112.076 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.12 -20.54 21.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.877 0.871 . . . . 15.0 112.462 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -138.99 141.03 38.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.283 0.947 . . . . 15.0 112.976 -168.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -122.04 150.29 42.32 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.788 1.235 . . . . 15.0 109.882 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.678 HD11 ' HG2' ' A' ' 113' ' ' PRO . 3.3 tt -162.72 145.17 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.029 0.532 . . . . 15.0 110.984 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.01 96.99 3.29 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.508 0.723 . . . . 15.0 109.104 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 349' ' ' LEU . 61.8 t -77.06 134.75 67.5 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.397 1.079 . . . . 15.0 110.201 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.34 114.3 1.6 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.83 2.353 . . . . 15.0 112.02 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.94 97.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.167 1.387 . . . . 15.0 112.536 -170.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.77 73.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.215 0.606 . . . . 15.0 111.873 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.83 -42.54 97.61 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.325 0.39 . . . . 15.0 109.99 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.435 ' O ' HD13 ' A' ' 311' ' ' ILE . 61.8 mt -60.79 -46.66 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.317 -0.856 . . . . 15.0 109.336 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.9 -39.62 78.35 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.001 0.52 . . . . 15.0 111.793 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 313' ' ' VAL . 44.7 m -61.89 -45.84 92.0 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.911 0.757 . . . . 15.0 111.22 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 6.5 mm-40 -64.12 -50.19 69.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.148 0.579 . . . . 15.0 111.01 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.7 mp -48.63 -50.52 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 124.444 1.098 . . . . 15.0 109.734 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.599 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 16.9 t70 -55.16 -50.97 67.96 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.88 1.272 . . . . 15.0 111.977 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 309' ' ' SER . 96.2 t -57.02 -44.55 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 123.716 0.635 . . . . 15.0 110.62 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 47.8 mt -68.74 -28.91 67.23 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.941 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.599 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 77.2 mtm180 -68.28 -46.54 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.583 0.753 . . . . 15.0 110.054 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.433 ' HA ' ' HB1' ' A' ' 329' ' ' ALA . 58.4 mtt-85 -58.01 -51.81 68.13 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.541 -1.209 . . . . 15.0 110.022 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.65 -46.66 80.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.412 1.07 . . . . 15.0 111.551 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.55 -63.95 1.1 Allowed 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.026 0.829 . . . . 15.0 110.818 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -60.34 -32.35 71.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.849 0.718 . . . . 15.0 112.023 -175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -56.59 -41.28 76.7 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.504 0.722 . . . . 15.0 111.558 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.76 -59.82 2.07 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.315 0.579 . . . . 15.0 109.798 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -73.06 82.01 1.25 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.064 0.946 . . . . 15.0 110.037 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 108.91 -43.72 1.65 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.815 -1.084 . . . . 15.0 113.247 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.59 36.76 9.22 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.57 -1.012 . . . . 15.0 110.57 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 328' ' ' GLN . 2.1 m-20 -68.88 98.72 0.96 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.407 1.083 . . . . 15.0 111.0 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -67.05 118.7 10.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 15.0 111.335 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 73.47 -25.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.828 1.651 . . . . 15.0 113.174 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . 81.9 mt-30 -69.37 -11.6 60.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.485 0.714 . . . . 15.0 111.552 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 316' ' ' ARG . . . -57.1 -55.33 36.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.693 0.797 . . . . 15.0 109.985 166.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 330' ' ' LEU . 2.0 mm? -69.62 -12.95 62.05 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -89.39 -20.05 24.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.256 1.023 . . . . 15.0 111.371 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 92.2 mt -59.49 122.48 64.7 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.407 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 77.1 Cg_exo -53.46 146.02 43.87 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.841 2.361 . . . . 15.0 113.258 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.426 ' HA ' HG21 ' A' ' 311' ' ' ILE . 20.7 ttt180 -52.25 -38.69 58.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.509 1.123 . . . . 15.0 111.145 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 11.9 pt-20 -55.36 -21.61 16.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.229 1.411 . . . . 15.0 113.397 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.25 -36.83 71.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.297 0.639 . . . . 15.0 111.354 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 311' ' ' ILE . 70.8 m-85 -131.55 -4.23 3.74 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.541 -0.742 . . . . 15.0 111.72 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.433 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.2 tt0 -46.25 -67.57 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.077 0.951 . . . . 15.0 113.534 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.16 -44.18 80.4 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.725 0.81 . . . . 15.0 112.317 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 1.2 pp0? -69.14 -46.64 67.11 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.658 0.383 . . . . 15.0 110.749 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -67.79 -37.49 82.08 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.253 -0.431 . . . . 15.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.4 tttt -57.36 -45.62 84.2 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.737 0.815 . . . . 15.0 110.578 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 ttt180 -56.06 -46.6 78.89 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.394 1.059 . . . . 15.0 110.432 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 112' ' ' ASN . 32.1 mtt180 -64.47 -32.33 73.92 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 116.114 -0.493 . . . . 15.0 111.678 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 341' ' ' ALA . 40.1 t -74.96 -31.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.75 -0.463 . . . . 15.0 109.75 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 98.8 t -55.79 -51.69 56.97 Favored 'Isoleucine or valine' 0 C--N 1.367 1.328 0 N-CA-C 107.632 -1.247 . . . . 15.0 107.632 170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 291' ' ' ILE . 21.8 t -59.79 -34.82 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 124.203 0.94 . . . . 15.0 111.459 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.91 94.05 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.234 -0.439 . . . . 15.0 112.331 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 302' ' ' VAL . 88.0 mt -77.76 -34.32 52.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.473 0.709 . . . . 15.0 111.08 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 82.0 mt -66.09 -58.73 4.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.285 0.634 . . . . 15.0 109.518 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 355' ' ' ILE . 90.7 mt -68.38 -18.98 64.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.975 0.91 . . . . 15.0 111.941 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -72.51 -42.59 47.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 tp10 -72.04 -31.16 65.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.797 0.839 . . . . 15.0 111.117 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 358' ' ' ASN . 96.2 t -58.74 -48.66 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.116 -0.698 . . . . 15.0 109.116 172.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.5 mp -61.29 -41.74 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.351 0.66 . . . . 15.0 111.231 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -67.79 -74.73 0.11 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.562 0.745 . . . . 15.0 111.23 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 91.6 m -56.52 -43.22 79.57 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.13 0.972 . . . . 15.0 113.225 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 354' ' ' VAL . 59.9 t30 -89.61 12.29 17.2 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.407 0.283 . . . . 15.0 110.936 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 49.12 28.75 2.24 Favored 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.358 1.463 . . . . 15.0 112.462 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 4.8 tt -72.42 124.79 25.88 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.049 -0.978 . . . . 15.0 109.556 -164.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.49 157.93 39.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.401 1.08 . . . . 15.0 110.436 -175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -76.65 92.34 3.51 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.614 0.766 . . . . 15.0 110.238 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.37 151.08 35.02 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.554 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.28 -33.43 72.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.895 -1.048 . . . . 15.0 112.398 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.95 -22.91 60.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.764 0.426 . . . . 15.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HG2' ' HG3' ' A' ' 406' ' ' GLN . 7.4 tpm_? -85.98 -41.36 14.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.005 -0.369 . . . . 15.0 110.005 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 38.5 t -57.94 -49.76 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.591 0.557 . . . . 15.0 109.566 171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -56.08 -52.67 63.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.061 0.944 . . . . 15.0 111.467 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -55.3 -43.28 84.42 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 124.319 1.012 . . . . 15.0 113.353 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.87 -45.85 66.78 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.857 0.863 . . . . 15.0 109.906 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.09 -35.62 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.867 0.467 . . . . 15.0 110.933 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -80.1 -28.96 38.95 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 118.95 -0.548 . . . . 15.0 112.108 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 42.8 mt-10 -63.72 -44.58 93.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 169.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.606 ' HG3' ' HB3' ' B' ' 98' ' ' ASP . 32.5 ttp -58.51 -51.3 70.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.498 -1.228 . . . . 15.0 110.271 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -65.04 -40.32 94.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.297 1.039 . . . . 15.0 112.699 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 41.7 t -64.17 -24.44 67.68 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 15.0 111.78 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.18 -11.76 59.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.363 0.665 . . . . 15.0 111.659 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -100.65 159.24 15.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.961 0.886 . . . . 15.0 112.156 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -6.42 50.34 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.226 -1.807 . . . . 15.0 111.668 174.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -152.1 112.8 2.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 109.387 -0.598 . . . . 15.0 109.387 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.54 -30.65 9.66 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.232 2.622 . . . . 15.0 113.008 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -56.28 -43.18 78.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.504 0.721 . . . . 15.0 111.547 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.71 -36.35 83.35 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.78 0.675 . . . . 15.0 111.12 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 375' ' ' ALA . 28.4 t -67.97 -47.46 78.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 109.005 -0.739 . . . . 15.0 109.005 -172.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.12 -55.48 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.822 -1.081 . . . . 15.0 109.185 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.93 -4.78 34.23 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.34 -45.68 6.71 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.722 0.409 . . . . 15.0 110.601 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -95.41 -33.91 12.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.115 1.524 . . . . 15.0 115.115 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 81.6 p -55.93 -39.25 71.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 112.913 0.708 . . . . 15.0 112.913 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -111.98 14.96 20.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.804 0.842 . . . . 15.0 110.923 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -94.14 97.69 10.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.655 0.782 . . . . 15.0 108.953 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -47.82 -43.06 27.63 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.206 1.403 . . . . 15.0 111.817 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -47.61 -51.73 20.32 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 125.379 1.674 . . . . 15.0 112.034 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.8 tp -100.93 -4.18 28.15 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 118.765 -0.636 . . . . 15.0 111.379 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 2.5 tpt -70.48 -51.29 30.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.457 1.026 . . . . 15.0 110.455 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -67.88 -39.14 83.72 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.429 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.91 -30.14 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.966 0.507 . . . . 15.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.0 tpp -64.57 -41.46 96.27 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.84 -0.8 . . . . 15.0 108.84 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -67.26 -45.35 76.94 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.14 0.9 . . . . 15.0 110.853 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -67.4 -40.71 85.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.237 0.458 . . . . 15.0 112.237 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 11.7 p -72.64 -36.89 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.529 ' HB1' ' HG3' ' A' ' 366' ' ' ARG . . . -65.94 -30.93 71.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.613 0.765 . . . . 15.0 110.895 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 355' ' ' ILE . 58.9 tp -66.3 -43.13 87.15 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.536 1.134 . . . . 15.0 109.087 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.1 -33.18 71.54 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.831 . . . . 15.0 111.957 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 29.2 mm-40 -63.64 -48.54 76.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 366' ' ' ARG . 29.2 mt-30 -65.9 -33.37 75.68 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.135 0.897 . . . . 15.0 111.552 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.3 -48.45 78.89 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.643 0.59 . . . . 15.0 109.884 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 287' ' ' LYS . 97.1 t -64.58 -50.34 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.08 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.21 -26.74 67.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.27 1.028 . . . . 15.0 112.635 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -75.58 -32.66 60.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 15.0 110.165 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.35 -36.57 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.366 -0.833 . . . . 15.0 108.804 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 417' ' ' VAL . 95.6 mt -68.56 -41.62 79.5 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.295 1.038 . . . . 15.0 110.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -55.41 -27.82 50.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.935 0.894 . . . . 15.0 111.473 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -93.25 -37.32 12.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.927 0.891 . . . . 15.0 110.983 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -75.21 156.82 35.39 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.911 0.884 . . . . 15.0 112.796 -172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 95.4 mttt -68.92 82.18 0.3 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.195 0.998 . . . . 15.0 109.614 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 412' ' ' LEU . 59.2 t -93.87 87.87 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.67 0.748 . . . . 15.0 109.374 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -80.12 95.16 6.15 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.773 -1.103 . . . . 15.0 109.866 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 36.3 tt0 -79.11 111.07 14.96 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.533 -0.543 . . . . 15.0 109.533 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -123.66 135.16 53.75 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 44.0 mt-10 -79.21 131.55 36.23 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -150.2 169.74 20.61 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.296 0.569 . . . . 15.0 111.587 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.2 p -69.19 175.62 3.75 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.678 1.191 . . . . 15.0 111.661 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -69.51 -71.34 0.23 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.333 0.653 . . . . 15.0 112.62 -172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.93 0.26 13.98 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 112.202 0.445 . . . . 15.0 112.202 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -48.12 -58.38 4.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.759 1.624 . . . . 15.0 112.254 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.58 HD12 ' NE2' ' A' ' 430' ' ' GLN . 53.0 tp -65.88 -24.62 66.9 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.492 1.117 . . . . 15.0 112.684 -171.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.635 ' SD ' ' HB1' ' B' ' 126' ' ' ALA . 6.5 mmt -84.51 -39.9 18.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.644 -162.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.26 33.86 1.5 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.062 -171.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . 0.58 ' NE2' HD12 ' A' ' 427' ' ' LEU . 41.5 mt-30 -90.23 80.97 6.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.031 0.533 . . . . 15.0 110.039 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.27 -70.74 0.73 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 107.177 -1.416 . . . . 15.0 107.177 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.801 0.841 . . . . 15.0 108.997 176.076 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -175.31 156.3 2.01 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.799 0.84 . . . . 0.0 109.201 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -70.51 86.25 0.63 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -142.85 12.82 1.87 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.532 1.133 . . . . 0.0 109.048 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.563 HG22 HG13 ' B' ' 6' ' ' ILE . 88.0 m -148.38 142.99 26.52 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.364 1.465 . . . . 0.0 107.334 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.563 HG13 HG22 ' B' ' 5' ' ' THR . 5.4 mt 65.34 75.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.433 1.093 . . . . 0.0 110.061 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.6 34.26 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.822 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . 0.252 1.2 pp 33.83 58.51 0.57 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.326 1.85 . . . . 0.0 114.168 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.16 127.76 53.06 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.5 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 mp 60.08 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.245 1.418 . . . . 0.0 111.166 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.423 HD21 ' O ' ' A' ' 220' ' ' GLU . 28.3 tp 60.86 66.04 1.85 Allowed Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 123.988 0.915 . . . . 0.0 109.016 -171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.41 179.89 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.119 2.546 . . . . 0.0 112.568 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 233' ' ' PHE . 17.2 tp -85.81 58.94 5.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.005 0.907 . . . . 0.0 109.685 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 174.62 78.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.406 ' HD1' ' HA ' ' A' ' 194' ' ' MET . 4.1 m-85 -91.57 -1.37 57.52 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.479 ' N ' ' HD2' ' B' ' 17' ' ' PRO . 46.8 m -69.85 -41.67 16.19 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 16' ' ' THR . 8.5 Cg_endo -44.59 -70.54 0.07 OUTLIER 'Trans proline' 1 C--N 1.424 4.508 0 C-N-CA 123.656 2.904 . . . . 0.0 113.256 -169.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 56.5 t 51.55 -79.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 125.182 1.393 . . . . 0.0 111.976 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m 79.13 -44.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.636 1.974 . . . . 0.0 112.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 67.93 -77.22 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.002 1.321 . . . . 0.0 109.965 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.66 87.96 0.05 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.918 1.287 . . . . 0.0 111.623 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' B' ' 22' ' ' ARG . 1.9 mmp_? -127.51 103.72 7.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.665 0.786 . . . . 0.0 110.615 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -70.74 165.82 42.67 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.263 1.025 . . . . 0.0 109.275 167.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.475 ' HG3' ' HG3' ' B' ' 41' ' ' PRO . 10.5 Cg_endo -50.23 106.82 0.13 Allowed 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.106 2.538 . . . . 0.0 112.004 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.43 77.88 1.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.961 0.905 . . . . 0.0 110.338 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 64.8 mtt -94.17 -33.9 0.3 Allowed Pre-proline 0 CA--C 1.572 1.804 0 CA-C-O 117.179 -1.391 . . . . 0.0 112.941 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 26' ' ' MET . 1.9 Cg_exo -33.49 101.62 0.03 OUTLIER 'Trans proline' 1 C--N 1.42 4.304 0 C-N-CA 124.407 3.404 . . . . 0.0 115.749 176.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' B' ' 34' ' ' ALA . 13.8 p -144.7 157.58 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 125.022 1.329 . . . . 0.0 108.808 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -142.62 -56.18 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -120.52 179.99 4.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 0.0 110.528 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 72.22 166.37 0.3 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.511 1.525 . . . . 0.0 112.077 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -83.37 -171.72 3.74 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.228 174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 73.29 -66.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.404 1.482 . . . . 0.0 110.121 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' B' ' 28' ' ' VAL . . . 55.49 87.87 0.05 OUTLIER 'General case' 0 C--N 1.366 1.32 0 C-N-CA 125.357 1.463 . . . . 0.0 111.779 173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 77.98 -48.56 0.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.415 1.486 . . . . 0.0 110.82 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.28 -74.23 2.5 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -143.76 103.98 4.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.771 0.828 . . . . 0.0 109.133 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.452 HD13 ' H ' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -138.02 172.94 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.744 1.217 . . . . 0.0 109.342 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -138.51 166.49 24.15 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.989 0.916 . . . . 0.0 109.02 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.56 103.95 4.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.795 0.838 . . . . 0.0 109.099 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.475 ' HG3' ' HG3' ' B' ' 24' ' ' PRO . 29.5 Cg_endo -93.16 169.57 2.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.6 2.2 . . . . 0.0 113.1 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.64 -108.02 2.18 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.829 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.05 -31.8 82.07 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 124.137 0.551 . . . . 0.0 112.312 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.14 -78.11 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.214 1.406 . . . . 0.0 112.437 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.806 ' HG3' ' HA ' ' B' ' 63' ' ' PRO . 8.2 tmm_? 62.39 -82.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.196 1.398 . . . . 0.0 110.173 -171.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' B' ' 46' ' ' ARG . 2.5 tpm_? 176.17 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.019 0.928 . . . . 0.0 109.702 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.5 mt -130.03 70.36 1.44 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.0 m -66.78 -48.25 69.62 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.201 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.57 63.39 0.01 OUTLIER Glycine 0 C--O 1.244 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 62.12 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.456 1.502 . . . . 0.0 109.798 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -103.99 -72.95 0.69 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 166.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -111.2 -62.53 1.53 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.46 -48.83 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -161.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 106.24 0.9 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 -167.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.41 89.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.039 0.936 . . . . 0.0 111.941 -173.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.44 ' NH2' HD22 ' B' ' 59' ' ' LEU . 62.2 ttt180 65.59 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.699 1.2 . . . . 0.0 112.574 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.33 -37.66 13.89 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.72 1.208 . . . . 0.0 109.064 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -146.62 172.34 13.74 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.892 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.44 HD22 ' NH2' ' B' ' 56' ' ' ARG . 38.3 tp -132.2 -19.63 2.49 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.907 0.483 . . . . 0.0 111.519 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.29 -0.12 16.04 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.73 92.54 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.431 1.093 . . . . 0.0 110.637 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -66.28 151.93 95.06 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.482 1.113 . . . . 0.0 110.749 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.806 ' HA ' ' HG3' ' B' ' 45' ' ' ARG . 69.9 Cg_exo -40.27 -56.12 1.61 Allowed 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 124.255 3.304 . . . . 0.0 114.711 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.76 -169.96 3.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.714 0.806 . . . . 0.0 109.382 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 60.9 pttt 43.08 75.39 0.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 126.122 1.769 . . . . 0.0 114.03 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -86.15 141.32 29.45 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.907 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.437 HD12 ' H ' ' B' ' 69' ' ' LEU . 2.9 pp -62.27 -29.96 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 123.209 0.603 . . . . 0.0 112.605 -172.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' B' ' 73' ' ' ASP . 23.6 pt 41.13 29.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.95 2.1 . . . . 0.0 115.477 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.437 ' H ' HD12 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -98.77 25.98 6.08 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.539 0.736 . . . . 0.0 109.302 -177.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -163.16 112.42 1.32 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.484 HG23 ' H ' ' B' ' 72' ' ' GLY 0.265 13.9 tt 42.5 -76.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 127.179 2.192 . . . . 0.0 115.121 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.484 ' H ' HG23 ' B' ' 71' ' ' ILE . . . -126.25 -62.91 0.16 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' B' ' 68' ' ' ILE . 15.0 t70 65.67 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.705 1.202 . . . . 0.0 111.152 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.14 61.23 0.4 Allowed Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 28.0 ttt -138.92 106.76 5.65 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.524 0.729 . . . . 0.0 109.78 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.43 146.64 17.3 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . 0.271 2.0 p30 49.59 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.208 1.403 . . . . 0.0 111.758 -167.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.5 t -102.65 -79.5 0.53 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.497 1.119 . . . . 0.0 108.016 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.434 ' HG2' HG22 ' B' ' 80' ' ' ILE . 29.1 tt0 -113.75 -56.84 2.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.884 0.873 . . . . 0.0 108.678 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.434 HG22 ' HG2' ' B' ' 79' ' ' GLU . 13.4 tt -173.99 105.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.829 0.852 . . . . 0.0 110.96 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.3 m -76.08 110.32 10.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.7 -87.46 0.18 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.63 -166.66 1.22 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.91 0.484 . . . . 0.0 110.675 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 68.08 73.58 0.3 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.08 1.352 . . . . 0.0 110.095 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.83 -49.41 25.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.644 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -154.08 -53.26 0.1 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.75 0.42 . . . . 0.0 110.756 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 119.41 3.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.877 0.871 . . . . 0.0 109.401 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -172.68 142.93 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.363 1.065 . . . . 0.0 108.562 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.1 -106.62 0.64 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' HB3' HG11 ' B' ' 135' ' ' VAL . . . -160.87 120.02 2.61 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.893 0.877 . . . . 0.0 109.28 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.27 -160.89 52.72 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.699 0.625 . . . . 0.0 112.596 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.16 167.2 11.63 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 64.79 -78.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.426 1.49 . . . . 0.0 111.303 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -125.15 145.01 50.15 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.239 1.016 . . . . 0.0 109.65 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.39 106.73 18.69 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.3 -132.5 14.89 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.656 0.598 . . . . 0.0 111.906 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.82 -40.28 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.606 ' HB3' ' HG3' ' A' ' 374' ' ' MET . 14.9 t70 71.49 -63.12 0.43 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.17 1.788 . . . . 0.0 112.154 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.41 134.86 57.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.653 0.781 . . . . 0.0 110.367 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -94.79 107.27 29.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.82 0.848 . . . . 0.0 110.797 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -76.47 -31.23 4.55 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.25 2.633 . . . . 0.0 113.05 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' B' ' 107' ' ' THR . 6.2 mp 56.4 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.524 1.53 . . . . 0.0 110.945 -170.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' B' ' 107' ' ' THR . 25.8 m -82.4 -37.12 26.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.873 . . . . 0.0 110.514 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.34 145.03 10.34 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 62.23 -85.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.572 1.149 . . . . 0.0 110.115 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -120.68 110.41 16.37 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.433 HG23 ' HB2' ' B' ' 102' ' ' LEU . 6.9 m -78.55 -18.57 54.47 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.61 0.764 . . . . 0.0 112.909 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.72 1.13 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.625 0.77 . . . . 0.0 112.229 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 63.66 82.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.712 1.205 . . . . 0.0 109.646 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.57 68.03 0.73 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.129 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 132.48 48.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 171.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 344' ' ' ARG . 10.5 t30 60.68 102.88 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.234 0.959 . . . . 0.0 109.379 -163.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -147.64 98.95 3.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt 58.42 74.37 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.08 1.352 . . . . 0.0 110.393 -170.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.506 ' H ' ' HA ' ' B' ' 119' ' ' ASP . 78.6 m -86.4 95.03 9.54 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.238 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.03 3.76 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.418 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 22.1 tptm -108.23 -50.29 0.09 OUTLIER Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 124.219 1.008 . . . . 0.0 112.039 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 57.8 Cg_endo -67.49 -22.31 45.17 Favored 'Trans proline' 0 C--N 1.396 3.061 0 CA-C-N 121.478 1.563 . . . . 0.0 113.571 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . 0.506 ' HA ' ' H ' ' B' ' 115' ' ' THR . 42.7 t0 62.08 24.89 14.87 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.313 1.53 . . . . 0.0 110.37 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -168.93 172.98 7.28 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.676 -1.602 . . . . 0.0 107.312 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t 70.15 100.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 124.051 0.941 . . . . 0.0 110.911 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.4 m -66.97 -34.64 78.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.075 0.95 . . . . 0.0 110.898 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.22 -129.45 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.095 0.958 . . . . 0.0 108.95 169.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 52.6 p -159.81 -54.0 0.06 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.934 1.243 . . . . 0.0 111.314 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.62 -10.54 7.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.786 0.835 . . . . 0.0 111.747 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.635 ' HB1' ' SD ' ' A' ' 428' ' ' MET . . . 72.64 -60.92 0.52 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.629 1.572 . . . . 0.0 113.818 172.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.613 ' HB3' ' HG3' ' A' ' 428' ' ' MET . 22.0 p -101.77 -41.74 6.42 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.751 -0.593 . . . . 0.0 112.541 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.32 90.3 2.78 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.0 0.429 . . . . 0.0 111.954 -169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.2 p -86.97 8.17 24.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.694 0.798 . . . . 0.0 111.143 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 61.89 -144.72 0.42 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.423 1.089 . . . . 0.0 109.95 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.461 ' NE1' ' HB2' ' A' ' 256' ' ' PHE . 35.4 p90 -153.36 154.46 34.55 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.385 0.674 . . . . 0.0 110.259 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 32.9 t -162.95 148.17 11.78 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.01 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 34.9 m -67.85 151.39 47.24 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.53 24.39 Favored Glycine 0 N--CA 1.482 1.756 0 O-C-N 123.475 0.484 . . . . 0.0 113.787 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' B' ' 90' ' ' ALA . 7.4 p -160.55 123.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.111 0.964 . . . . 0.0 108.906 169.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -179.94 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.528 1.131 . . . . 0.0 108.889 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 37.0 p -68.82 131.18 44.71 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.985 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 71.18 -62.09 0.46 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.754 1.622 . . . . 0.0 111.842 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.11 83.98 0.72 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.646 0.779 . . . . 0.0 109.339 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.39 46.92 1.07 Allowed Glycine 0 C--N 1.336 0.577 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.39 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.072 0.949 . . . . 0.0 109.928 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 55.1 tp 64.86 -80.54 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.875 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.01 -69.77 1.23 Allowed Glycine 0 C--N 1.36 1.879 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.43 75.52 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.94 92.44 0.92 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.52 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 9.3 tp -111.2 137.2 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -101.74 158.33 16.19 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 72.2 142.49 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.403 1.481 . . . . 0.0 113.057 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -111.02 173.91 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.879 -169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.551 1.0 0 C-N-CA 123.819 0.847 . . . . 0.0 109.022 167.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.365 0.602 . . . . 15.0 110.035 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.657 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -73.68 92.17 1.95 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.243 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.518 HG12 HG12 ' A' ' 17' ' ' ILE . 27.6 m -93.26 71.41 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.603 0.761 . . . . 15.0 111.257 -174.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 p -70.47 93.13 0.86 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.888 0.475 . . . . 15.0 110.98 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 7.1 p -70.91 135.5 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.638 0.775 . . . . 15.0 110.528 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.09 97.12 4.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.212 1.005 . . . . 15.0 108.74 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.1 m -69.05 90.54 0.46 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -96.49 -56.27 2.66 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.817 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -103.92 37.77 1.98 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.503 0.721 . . . . 15.0 110.015 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.85 -97.31 0.42 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.926 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.32 -36.85 85.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.299 0.64 . . . . 15.0 110.082 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.21 0.47 Allowed Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.612 HH11 HG11 ' A' ' 111' ' ' VAL . 64.3 mtt180 -95.44 115.27 27.2 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 15.0 110.36 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -80.87 84.23 6.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.726 1.21 . . . . 15.0 110.352 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 67.3 t -77.32 91.19 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.4 m -75.2 97.1 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.626 -0.715 . . . . 15.0 110.153 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 74' ' ' ASN . 45.7 mt -82.06 136.61 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.382 -0.827 . . . . 15.0 109.316 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 57.7 m -123.18 104.75 9.36 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.72 -1.215 . . . . 15.0 107.72 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' LEU . 48.4 mt -83.3 135.51 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.049 -0.723 . . . . 15.0 109.049 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 131.13 46.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.298 0.639 . . . . 15.0 109.894 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.06 -28.75 69.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.386 0.674 . . . . 15.0 112.323 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.26 -40.03 86.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.173 0.589 . . . . 15.0 111.09 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.0 m -67.14 -32.73 74.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 15.0 110.697 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 97' ' ' TYR . 73.6 mt -65.95 -53.82 33.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 115.326 -0.852 . . . . 15.0 109.62 173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -58.85 -37.98 77.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.754 0.822 . . . . 15.0 111.794 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.1 m -70.64 -42.68 70.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.552 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.75 89.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.418 0.687 . . . . 15.0 111.576 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG11 ' HG2' ' A' ' 63' ' ' ARG . 75.6 t -63.24 -49.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 C-N-CA 123.852 0.861 . . . . 15.0 109.548 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -64.61 -31.31 72.47 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.681 0.792 . . . . 15.0 111.169 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -67.07 -42.4 84.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.668 0.787 . . . . 15.0 110.172 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.54 -38.81 74.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.023 0.529 . . . . 15.0 111.443 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.9 mt -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 111.721 -175.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.5 p -75.56 -25.78 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 110.048 -0.353 . . . . 15.0 110.048 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -63.27 -47.78 80.92 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.038 0.535 . . . . 15.0 109.747 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.12 -37.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.596 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.66 -39.36 93.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.22 0.608 . . . . 15.0 111.469 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 33' ' ' VAL . 85.2 mttt -70.64 -35.56 72.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.804 0.442 . . . . 15.0 110.865 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.7 -53.77 24.89 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.909 0.884 . . . . 15.0 111.229 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.44 -0.5 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 123.657 0.783 . . . . 15.0 110.162 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 71.4 12.81 6.6 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.36 1.464 . . . . 15.0 111.853 171.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.85 -32.07 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.452 1.501 . . . . 15.0 111.14 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -58.2 -34.51 70.45 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.682 0.793 . . . . 15.0 111.543 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -34.55 57.75 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 115.996 -0.547 . . . . 15.0 112.565 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.67 -21.03 52.71 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.1 0.56 . . . . 15.0 110.868 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -77.19 113.13 14.61 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.688 0.795 . . . . 15.0 109.239 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -84.14 -12.27 55.25 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.407 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 8.52 73.42 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.784 -0.644 . . . . 15.0 113.767 171.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -69.49 -46.35 66.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 15.0 110.213 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.12 125.84 89.73 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.19 -0.914 . . . . 15.0 108.642 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.81 131.37 41.68 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.385 2.723 . . . . 15.0 114.067 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.45 -34.21 77.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.83 0.852 . . . . 15.0 111.985 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -66.96 -37.05 83.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.817 0.447 . . . . 15.0 111.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 mt -73.6 -42.84 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.733 0.813 . . . . 15.0 111.35 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.7 m -69.53 -25.25 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 120.618 0.247 . . . . 15.0 111.136 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.95 -57.64 4.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.942 0.497 . . . . 15.0 111.366 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.584 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.8 pt20 -67.03 -31.87 72.7 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.657 -0.702 . . . . 15.0 112.165 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 77.8 mtt180 -98.1 -57.1 2.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.928 0.491 . . . . 15.0 111.736 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -76.29 -25.69 55.14 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.614 0.365 . . . . 15.0 111.433 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.4 19.92 43.94 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.476 -0.624 . . . . 15.0 112.765 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.79 86.4 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.887 0.875 . . . . 15.0 112.659 -174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.4 p -76.93 -30.78 56.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.228 0.611 . . . . 15.0 111.369 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.03 -16.39 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.541 0.736 . . . . 15.0 110.867 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.658 ' HG2' HG11 ' A' ' 28' ' ' VAL . 61.1 mtp85 -56.96 -28.06 61.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.907 0.883 . . . . 15.0 111.029 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -50.34 -59.18 4.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.31 1.444 . . . . 15.0 111.637 171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.46 -27.81 67.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.903 0.881 . . . . 15.0 111.893 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 28' ' ' VAL . 26.8 t -70.84 -29.43 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.497 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 97' ' ' TYR . 96.1 mt -60.29 -34.36 73.66 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.754 0.422 . . . . 15.0 111.149 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -48.19 83.91 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.415 0.447 . . . . 15.0 112.204 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.15 -48.85 75.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.457 1.103 . . . . 15.0 111.347 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' HB3' HD13 ' A' ' 19' ' ' ILE . 53.1 mt -57.77 -55.34 36.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.25 1.02 . . . . 15.0 111.071 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.8 mtm -63.59 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.765 0.826 . . . . 15.0 111.98 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -73.01 -45.23 58.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.212 0.605 . . . . 15.0 111.11 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -68.85 -38.46 79.78 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.165 0.586 . . . . 15.0 111.139 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.629 ' HB3' HG21 ' A' ' 17' ' ' ILE . 8.7 m-80 -67.96 -34.76 77.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.703 0.801 . . . . 15.0 110.694 177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.73 -53.55 15.16 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.732 0.413 . . . . 15.0 111.154 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -65.58 -41.58 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 123.484 0.49 . . . . 15.0 111.068 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.52 -33.51 74.25 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.04 -0.413 . . . . 15.0 111.553 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -55.18 32.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.92 0.488 . . . . 15.0 110.837 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.9 pt -62.47 -29.79 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.087 0.555 . . . . 15.0 112.047 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.9 mt -71.71 -57.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.427 0.691 . . . . 15.0 110.892 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -67.66 -33.86 75.78 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.091 0.556 . . . . 15.0 111.203 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -86.47 -6.05 59.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.601 0.76 . . . . 15.0 111.395 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 64.0 23.9 13.42 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.578 1.151 . . . . 15.0 111.852 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.22 119.39 28.4 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 C-N-CA 124.072 0.949 . . . . 15.0 108.697 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -91.18 97.28 1.25 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.37 162.43 9.73 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.216 2.611 . . . . 15.0 114.676 -165.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.79 166.41 27.64 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.415 1.086 . . . . 15.0 108.743 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.65 -142.34 20.11 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.64 139.19 34.84 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.71 96.79 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.33 2.02 . . . . 15.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -81.28 91.29 6.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.173 0.589 . . . . 15.0 109.44 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -72.37 119.77 17.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.311 0.645 . . . . 15.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 42.5 t -114.45 88.49 15.82 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.945 0.898 . . . . 15.0 108.714 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -83.91 171.93 10.22 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.073 2.516 . . . . 15.0 112.719 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.09 -53.45 0.09 OUTLIER Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.615 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -156.43 132.86 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.596 0.758 . . . . 15.0 110.924 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 24' ' ' ILE . 35.1 t80 -97.97 117.88 33.31 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -135.69 -178.94 5.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.908 0.883 . . . . 15.0 110.23 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.1 tp -126.97 142.41 51.56 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.636 1.174 . . . . 15.0 108.134 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.87 -51.96 4.36 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.049 -0.82 . . . . 15.0 111.049 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.08 138.67 32.93 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 15.0 109.401 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -75.56 155.37 36.09 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.911 0.884 . . . . 15.0 112.034 -172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.87 90.9 5.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.853 0.861 . . . . 15.0 109.524 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.3 m -88.06 125.53 34.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.965 0.906 . . . . 15.0 109.967 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.442 ' HE1' HG13 ' A' ' 19' ' ' ILE . 20.8 p90 -147.36 136.66 22.53 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.296 0.638 . . . . 15.0 109.799 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.9 m -87.37 115.19 24.62 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.208 1.003 . . . . 15.0 110.722 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -98.17 102.98 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -96.77 123.24 40.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.583 0.753 . . . . 15.0 110.039 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -156.88 160.2 38.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.502 0.721 . . . . 15.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.96 177.82 8.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.541 0.736 . . . . 15.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.612 HG11 HH11 ' A' ' 13' ' ' ARG . 32.7 m -134.13 160.28 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.74 . . . . 15.0 109.287 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.528 ' HE1' HD11 ' A' ' 306' ' ' LEU . 83.1 m-85 -79.55 120.71 81.17 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 166.4 28.73 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.475 2.117 . . . . 15.0 111.537 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.93 109.14 6.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.092 -0.707 . . . . 15.0 109.092 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 300' ' ' ILE . 64.8 t -71.36 120.66 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.462 -0.57 . . . . 15.0 109.462 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -101.62 110.43 22.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.133 0.573 . . . . 15.0 110.732 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.8 mt -85.56 100.14 11.73 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.592 -0.521 . . . . 15.0 109.592 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.4 -162.26 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.796 1.238 . . . . 15.0 109.839 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.7 113.92 6.35 Favored Glycine 0 C--N 1.353 1.475 0 C-N-CA 121.78 -0.248 . . . . 15.0 112.923 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.42 -3.18 58.77 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.039 0.935 . . . . 15.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.38 -14.38 58.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.847 1.259 . . . . 15.0 110.365 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.41 -26.18 63.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.708 0.803 . . . . 15.0 111.747 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 293' ' ' GLY . 52.6 mt -71.14 109.01 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.474 1.109 . . . . 15.0 110.108 -176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.25 104.48 14.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.113 0.565 . . . . 15.0 109.627 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.1 t -108.2 135.04 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.389 1.076 . . . . 15.0 109.284 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.5 129.81 39.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.082 -0.34 . . . . 15.0 110.082 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 84.4 tttt -109.82 95.9 22.17 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.904 -1.147 . . . . 15.0 107.904 168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.532 ' HG2' HD11 ' A' ' 427' ' ' LEU . 6.4 Cg_endo -87.76 107.96 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.326 2.017 . . . . 15.0 111.693 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 44.8 mm -72.1 89.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 108.286 -1.005 . . . . 15.0 108.286 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.1 t -84.46 130.33 36.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.681 -0.691 . . . . 15.0 109.463 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -97.98 130.87 44.81 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.398 -0.593 . . . . 15.0 109.398 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG23 HD22 ' A' ' 278' ' ' LEU . 46.1 t -115.58 132.39 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.889 -1.152 . . . . 15.0 107.889 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -126.19 171.63 10.73 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.272 1.029 . . . . 15.0 108.891 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.63 -16.37 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.322 -0.853 . . . . 15.0 111.689 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.87 62.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.571 0.748 . . . . 15.0 110.951 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -64.43 -44.94 89.61 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.027 0.531 . . . . 15.0 109.65 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.569 HG22 ' SD ' ' A' ' 274' ' ' MET . 85.8 t -61.4 -53.02 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 114.997 -1.002 . . . . 15.0 111.288 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -61.01 -44.31 97.6 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 15.0 110.772 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.68 -33.38 87.08 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 114.556 -1.202 . . . . 15.0 112.703 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 43.6 tpp -71.79 -36.57 70.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.374 0.67 . . . . 15.0 111.883 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 270' ' ' VAL . 77.9 mt -67.41 -39.65 85.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.46 0.648 . . . . 15.0 110.137 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.11 -44.61 94.73 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.312 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.9 m -60.77 -37.88 83.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.87 0.868 . . . . 15.0 111.671 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD21 ' HB1' ' B' ' 128' ' ' ALA . 55.0 mt -65.47 -39.76 92.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.335 0.654 . . . . 15.0 110.821 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -70.95 -23.39 62.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.623 0.769 . . . . 15.0 111.113 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.9 mttt -81.83 -23.83 36.2 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.612 0.765 . . . . 15.0 112.079 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -81.12 -30.03 34.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.768 -0.456 . . . . 15.0 109.768 171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -99.31 32.2 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.025 0.93 . . . . 15.0 109.261 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -77.38 97.3 4.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.151 0.58 . . . . 15.0 110.931 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.9 m -60.22 118.82 6.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.773 0.829 . . . . 15.0 109.602 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -76.33 153.78 35.58 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.869 0.842 . . . . 15.0 110.405 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -156.1 134.85 11.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.068 -1.424 . . . . 15.0 108.084 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.57 156.53 36.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.847 0.832 . . . . 15.0 112.193 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.708 ' HG3' HG13 ' A' ' 240' ' ' VAL . 58.6 pttt -153.9 -179.04 7.48 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 113.391 -1.731 . . . . 15.0 108.562 172.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -136.61 141.3 43.25 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.463 -0.94 . . . . 15.0 108.463 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.8 -152.21 16.88 Favored Glycine 0 C--O 1.239 0.468 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.297 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.81 114.85 3.26 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.297 1.039 . . . . 15.0 112.285 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 HG22 ' A' ' 202' ' ' ILE . 40.3 t -70.49 133.24 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.424 1.09 . . . . 15.0 110.505 172.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -97.63 162.07 13.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.783 0.833 . . . . 15.0 108.796 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.91 4.02 13.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.603 0.964 . . . . 15.0 113.603 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -124.04 4.79 8.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.369 1.067 . . . . 15.0 110.488 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -86.53 171.85 10.75 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.79 0.805 . . . . 15.0 111.7 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -116.08 137.09 52.43 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.393 -1.706 . . . . 15.0 106.393 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 202' ' ' ILE . 22.6 m -131.1 -175.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.076 0.398 . . . . 15.0 111.563 -169.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 86.9 m -137.73 109.85 7.28 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.492 1.117 . . . . 15.0 109.044 171.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.1 pt -111.12 -174.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.275 0.56 . . . . 15.0 112.165 175.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -152.04 96.2 2.17 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.354 -1.721 . . . . 15.0 106.354 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 47.3 p90 -106.38 137.03 45.07 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.284 -0.885 . . . . 15.0 111.409 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 234' ' ' ALA . 93.5 m -86.68 106.93 17.97 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 233' ' ' PHE . . . -58.94 115.16 6.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 15.0 112.856 173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 50.2 m -129.37 144.09 51.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.704 0.802 . . . . 15.0 110.569 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.1 t -116.77 126.85 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.112 1.365 . . . . 15.0 108.517 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.0 t70 65.42 15.95 10.28 Favored 'General case' 0 CA--C 1.556 1.19 0 O-C-N 124.146 0.904 . . . . 15.0 111.984 171.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 102.12 7.0 47.71 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-O 119.484 -0.62 . . . . 15.0 114.379 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.66 136.57 31.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.368 0.584 . . . . 15.0 110.608 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 13.9 pt-20 -60.61 150.65 31.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.451 1.1 . . . . 15.0 112.558 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.38 159.43 34.48 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.865 0.866 . . . . 15.0 109.804 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.84 130.84 44.49 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.182 0.593 . . . . 15.0 110.952 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' B' ' 8' ' ' LEU . . . 96.05 -16.89 60.3 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.447 -0.797 . . . . 15.0 112.826 -174.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.617 ' HA2' HD22 ' B' ' 13' ' ' LEU . . . -86.64 76.72 2.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 119.894 -0.392 . . . . 15.0 113.081 -161.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -157.35 164.97 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.87 0.868 . . . . 15.0 110.566 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -159.2 115.99 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.078 -0.964 . . . . 15.0 108.734 157.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.7 p -96.06 140.96 30.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.716 1.606 . . . . 15.0 109.739 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.6 t70 57.26 24.42 9.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.921 0.867 . . . . 15.0 110.627 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.77 108.03 2.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.842 1.257 . . . . 15.0 110.837 -172.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 7.4 p -79.58 90.25 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.45 1.119 . . . . 15.0 110.163 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.8 tp -91.6 133.69 35.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.765 -1.107 . . . . 15.0 110.441 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -114.19 145.66 41.4 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.911 0.884 . . . . 15.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.54 ' SD ' ' HG2' ' A' ' 203' ' ' LYS . 48.9 mtt -98.78 171.59 8.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.906 0.883 . . . . 15.0 111.228 -173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 85.55 -51.33 4.47 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.274 -0.73 . . . . 15.0 111.274 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 191' ' ' GLN . 8.3 pt20 -74.41 127.97 34.37 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.342 1.057 . . . . 15.0 110.72 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.9 43.05 2.6 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 116.122 -0.49 . . . . 15.0 112.689 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -96.04 62.79 2.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.471 -0.937 . . . . 15.0 108.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.521 ' HA ' ' HB2' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -168.18 -174.04 2.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.769 0.828 . . . . 15.0 108.968 -177.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 72.7 mt -62.51 133.86 94.86 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.419 1.088 . . . . 15.0 108.876 167.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.72 120.13 7.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.699 2.266 . . . . 15.0 111.39 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.27 15.52 78.34 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.654 -0.703 . . . . 15.0 113.552 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.3 t80 -70.01 -53.77 16.16 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.419 0.61 . . . . 15.0 110.975 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -23.05 55.02 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.747 0.819 . . . . 15.0 112.361 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -42.03 -49.27 4.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.005 1.722 . . . . 15.0 112.393 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.59 -35.33 90.97 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.293 -1.322 . . . . 15.0 114.385 -173.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 164' ' ' VAL . 4.6 mp -75.33 -39.54 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 122.775 0.43 . . . . 15.0 111.052 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HG2' ' SD ' ' A' ' 189' ' ' MET . 50.4 mtpt -64.07 -2.41 2.0 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.059 1.874 . . . . 15.0 116.059 -163.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -150.18 44.71 0.69 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.726 -0.549 . . . . 15.0 111.726 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -143.48 -177.0 5.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.415 1.086 . . . . 15.0 108.11 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 162.1 15.23 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.191 0.596 . . . . 15.0 110.682 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.613 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -80.23 36.49 0.36 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.753 1.221 . . . . 15.0 113.814 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.73 47.59 0.59 Allowed Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.454 -0.658 . . . . 15.0 111.454 175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.72 156.63 44.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.497 1.141 . . . . 15.0 113.974 -172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.84 120.19 31.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 112.162 -2.29 . . . . 15.0 107.06 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -156.56 154.42 30.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.302 0.641 . . . . 15.0 109.78 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 15.0 108.695 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.587 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.5 pt -112.75 153.26 14.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.332 0.587 . . . . 15.0 112.015 -171.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -93.25 98.97 11.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.348 -1.296 . . . . 15.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 198' ' ' PHE . 29.1 m -113.78 -176.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.702 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.9 m -140.6 130.51 24.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.706 -1.22 . . . . 15.0 107.706 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 20.5 m-85 -57.65 161.33 6.32 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.96 1.304 . . . . 15.0 113.49 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.21 162.47 13.31 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.834 2.356 . . . . 15.0 110.744 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 48.9 mt-10 -80.41 -3.39 49.6 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.565 0.346 . . . . 15.0 110.956 172.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -93.4 -0.44 56.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.396 0.679 . . . . 15.0 111.141 172.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' OH ' ' HB1' ' B' ' 7' ' ' ALA . 7.4 t80 -60.32 143.57 52.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.767 0.827 . . . . 15.0 110.822 173.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -64.14 -51.5 63.61 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.364 0.415 . . . . 15.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 7' ' ' ALA . . . -72.03 119.92 16.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.749 -0.66 . . . . 15.0 109.826 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.53 -36.57 60.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.951 0.782 . . . . 15.0 111.362 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.57 -23.02 65.69 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.423 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 97.3 mt -107.38 -12.44 15.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 123.846 0.858 . . . . 15.0 112.624 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.1 ptpt -72.45 117.56 14.27 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 120.125 1.329 . . . . 15.0 109.79 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.39 27.25 57.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.103 -0.953 . . . . 15.0 113.268 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 8.6 tmtm? -104.16 138.82 40.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.164 0.986 . . . . 15.0 108.902 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.08 110.93 3.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.397 0.679 . . . . 15.0 111.308 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.96 159.96 15.88 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.715 0.806 . . . . 15.0 111.806 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.5 mmpt? -115.24 138.28 51.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.847 -1.069 . . . . 15.0 108.218 175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 170' ' ' GLY . 69.5 m-85 -137.9 113.5 9.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 169' ' ' THR . . . -77.32 80.49 3.82 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 124.036 0.835 . . . . 15.0 109.808 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 mm -67.45 104.6 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 113.782 -1.554 . . . . 15.0 110.529 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.9 OUTLIER -88.48 82.03 7.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 170.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 158' ' ' VAL . 17.8 tp -64.27 96.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.831 -1.077 . . . . 15.0 109.489 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -89.17 -43.08 11.28 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 123.465 0.706 . . . . 15.0 111.131 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 31.7 mmmt -138.05 152.94 49.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.729 0.812 . . . . 15.0 110.17 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.708 HG13 ' HG3' ' A' ' 154' ' ' LYS . 6.6 p -126.13 142.84 41.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.639 -1.245 . . . . 15.0 107.639 164.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -116.16 132.84 56.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.121 0.568 . . . . 15.0 110.777 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.5 tt0 -91.42 164.35 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.209 1.404 . . . . 15.0 109.537 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.66 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.9 ptp85 -105.38 158.24 16.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.443 -0.577 . . . . 15.0 109.443 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -112.76 161.14 17.23 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.238 1.015 . . . . 15.0 110.225 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.48 79.24 15.43 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 108.942 -0.762 . . . . 15.0 108.942 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -93.37 -177.76 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.694 2.262 . . . . 15.0 112.044 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.98 65.61 0.69 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.748 -1.114 . . . . 15.0 112.172 167.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.9 11.83 2.88 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.405 -1.27 . . . . 15.0 109.126 170.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 90.7 m -68.68 136.5 53.02 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.279 0.632 . . . . 15.0 109.312 169.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.91 -38.0 54.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.31 1.044 . . . . 15.0 112.433 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -60.84 -34.4 74.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.352 1.061 . . . . 15.0 112.031 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.65 -46.84 24.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 266' ' ' LEU . 77.0 mt -56.74 -44.01 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.747 0.819 . . . . 15.0 111.882 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.43 -4.32 41.79 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.081 0.771 . . . . 15.0 113.081 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -60.33 -35.27 75.26 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.579 0.752 . . . . 15.0 110.144 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' B' ' 135' ' ' VAL . 88.5 m-85 -79.06 -5.14 53.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.695 -1.138 . . . . 15.0 111.808 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.88 27.72 28.12 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 120.178 -0.234 . . . . 15.0 112.769 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 261' ' ' GLY . 83.3 t -71.87 119.18 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -29.37 -76.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 127.403 2.281 . . . . 15.0 115.465 -172.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.68 30.07 5.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.016 0.526 . . . . 15.0 109.974 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 258' ' ' VAL . . . -25.67 55.46 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 120.157 2.823 . . . . 15.0 120.157 -156.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.0 p -86.33 -173.44 4.54 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.06 0.93 . . . . 15.0 109.385 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -56.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.81 -26.02 68.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.737 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.78 -32.23 73.87 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.914 -0.585 . . . . 15.0 112.521 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.576 HD13 HG23 ' A' ' 253' ' ' ILE . 29.7 tp -78.38 -34.0 48.52 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -64.46 -43.06 95.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.897 -0.592 . . . . 15.0 110.251 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.085 0.554 . . . . 15.0 110.616 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.83 -59.18 5.52 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.219 0.949 . . . . 15.0 110.812 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 141' ' ' LEU . 65.6 t -66.11 -21.72 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 115.68 -0.691 . . . . 15.0 110.32 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -62.46 -64.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.154 0.434 . . . . 15.0 110.848 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.6 ptmt -60.83 -32.0 71.41 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.719 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.476 HD21 ' HB ' ' B' ' 133' ' ' THR . 17.2 m-80 -80.25 -27.6 38.63 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.208 0.603 . . . . 15.0 112.163 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.569 ' SD ' HG22 ' A' ' 137' ' ' VAL . 43.9 mtt -66.67 -48.97 67.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 171.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.47 -40.77 88.01 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 124.044 0.84 . . . . 15.0 111.384 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -55.4 -58.62 6.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.005 1.322 . . . . 15.0 110.359 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.96 -20.23 61.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.975 -174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.513 HD22 HG23 ' A' ' 132' ' ' VAL . 20.1 tp -78.75 -43.29 25.95 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.729 0.812 . . . . 15.0 110.387 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.23 -39.65 93.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.611 -0.515 . . . . 15.0 109.611 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 24.2 t -68.53 -37.11 79.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.149 -0.932 . . . . 15.0 110.851 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.78 61.73 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.277 0.631 . . . . 15.0 111.124 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.87 -35.15 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 15.0 110.398 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -61.76 -51.36 68.63 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.841 0.353 . . . . 15.0 110.518 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -69.95 -28.64 65.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.006 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -59.63 3.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.865 0.866 . . . . 15.0 109.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.17 -39.71 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.443 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.755 ' HE2' HD11 ' B' ' 111' ' ' LEU . 83.9 tttt -64.87 -47.71 76.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.833 0.453 . . . . 15.0 110.732 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.6 p -69.29 -35.34 75.91 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.815 0.446 . . . . 15.0 111.919 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.4 mt-30 -71.48 -34.04 69.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.717 0.407 . . . . 15.0 110.418 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -60.76 -45.3 94.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.488 0.493 . . . . 15.0 110.608 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -62.95 -47.28 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.021 0.826 . . . . 15.0 111.28 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.42 -57.34 10.97 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 124.536 1.134 . . . . 15.0 110.551 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.07 -34.19 87.6 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.284 -1.325 . . . . 15.0 113.089 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.99 -52.89 62.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.411 0.685 . . . . 15.0 110.448 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.1 -50.51 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.123 -0.944 . . . . 15.0 112.472 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.23 -10.47 59.76 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.849 0.859 . . . . 15.0 112.544 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -127.02 146.45 50.35 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.397 0.544 . . . . 15.0 111.845 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -107.92 123.96 49.4 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 115' ' ' VAL . 5.8 tt -163.61 146.45 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.595 0.758 . . . . 15.0 110.275 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -108.03 145.28 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.7 133.41 20.29 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.868 0.867 . . . . 15.0 109.658 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.19 139.35 86.77 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.444 2.096 . . . . 15.0 110.713 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.27 -33.64 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.084 1.354 . . . . 15.0 112.931 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -50.3 -55.02 17.23 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.826 1.251 . . . . 15.0 112.416 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.528 HD11 ' HE1' ' A' ' 112' ' ' TYR . 81.5 mt -63.81 -36.38 83.73 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.268 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.62 -57.69 10.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 CA-C-N 114.919 -1.037 . . . . 15.0 109.465 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.64 0.776 . . . . 15.0 112.129 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.1 m -59.6 -49.39 77.94 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.067 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 25.4 mm-40 -59.35 -43.2 92.81 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.929 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.6 mp -53.62 -54.02 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.152 0.581 . . . . 15.0 109.495 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.527 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 37.8 t70 -57.94 -48.05 81.08 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.963 0.789 . . . . 15.0 111.821 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 309' ' ' SER . 87.8 t -56.39 -46.76 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.711 0.632 . . . . 15.0 111.038 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 74.1 mt -76.3 -21.06 56.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.639 -0.709 . . . . 15.0 111.847 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 70.1 mtm180 -69.57 -51.57 34.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.231 -0.655 . . . . 15.0 109.231 173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 15.0 mtm180 -60.21 -44.1 95.43 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.992 0.807 . . . . 15.0 109.788 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -65.7 -41.82 91.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.513 -1.221 . . . . 15.0 111.489 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.2 59.28 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.087 0.555 . . . . 15.0 109.903 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.14 67.54 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.384 1.052 . . . . 15.0 111.852 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -58.24 -39.64 79.63 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.618 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.73 -29.18 45.16 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.21 0.529 . . . . 15.0 109.946 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.41 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 32.3 t80 -87.56 43.63 1.12 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.55 1.14 . . . . 15.0 109.902 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 68.02 14.2 65.48 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.882 -1.054 . . . . 15.0 114.707 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.54 3.87 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 117.771 0.785 . . . . 15.0 112.111 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 322' ' ' PHE . 56.3 t30 -57.02 106.1 0.28 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.439 1.096 . . . . 15.0 109.421 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.485 ' HG3' HH21 ' B' ' 46' ' ' ARG . 0.1 OUTLIER -70.26 87.5 0.61 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.417 1.087 . . . . 15.0 113.188 -157.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm 59.59 12.76 2.99 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.287 1.435 . . . . 15.0 113.38 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -80.15 -5.71 56.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.987 0.915 . . . . 15.0 109.209 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.74 -54.07 16.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 15.0 110.622 164.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.87 -16.09 63.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.567 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.64 -23.76 42.35 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.616 0.766 . . . . 15.0 111.204 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 59.7 mt -62.59 127.52 90.29 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 335' ' ' GLU . 8.5 Cg_exo -72.65 167.86 25.99 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.019 2.479 . . . . 15.0 113.235 -177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -55.01 -50.91 67.85 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.67 0.788 . . . . 15.0 110.781 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 333' ' ' PRO . 12.1 pt-20 -55.37 -19.14 8.09 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.025 -1.443 . . . . 15.0 113.292 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -38.05 89.68 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.589 -0.523 . . . . 15.0 109.589 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.3 -18.3 8.0 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 118.676 -0.678 . . . . 15.0 112.044 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 311' ' ' ILE . 43.0 tt0 -45.74 -42.85 12.37 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.764 1.226 . . . . 15.0 113.806 -169.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -53.12 -59.27 4.75 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.419 1.087 . . . . 15.0 111.851 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 0.5 OUTLIER -80.88 -30.0 35.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.901 0.48 . . . . 15.0 111.867 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -69.03 -48.97 61.61 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.86 0.864 . . . . 15.0 111.546 -173.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -60.6 -35.09 75.26 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.274 -0.875 . . . . 15.0 110.666 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 43.2 ttt180 -65.74 -39.58 91.25 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.847 0.859 . . . . 15.0 110.731 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 48.3 mtt-85 -58.95 -44.84 91.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.949 0.499 . . . . 15.0 110.264 173.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -43.89 95.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.5 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 342' ' ' LYS . 63.4 t -51.7 -45.82 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 124.0 0.812 . . . . 15.0 110.56 174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 291' ' ' ILE . 66.5 t -51.24 -55.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 123.415 0.686 . . . . 15.0 111.62 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -72.83 -26.63 70.81 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.431 -0.804 . . . . 15.0 114.213 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 72.1 mt -72.09 -46.26 57.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.2 mt -64.66 -45.99 84.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.356 0.662 . . . . 15.0 110.942 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 48.8 mt -67.22 -38.45 85.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.825 0.45 . . . . 15.0 111.435 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.18 -34.26 89.49 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 121.552 0.529 . . . . 15.0 111.864 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -72.18 -28.86 63.49 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.971 -0.614 . . . . 15.0 110.851 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.2 t -60.53 -44.41 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 109.484 -0.561 . . . . 15.0 109.484 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.421 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 2.0 mp -60.45 -41.22 86.73 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.409 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -74.7 -69.98 0.43 Allowed 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 117.885 0.311 . . . . 15.0 111.75 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.5 m -47.7 -50.44 25.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.687 1.195 . . . . 15.0 113.101 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -92.85 9.45 35.27 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.296 0.239 . . . . 15.0 111.037 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 38.37 53.17 1.76 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 125.369 1.468 . . . . 15.0 112.552 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.9 tt -88.56 133.66 34.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.763 -1.108 . . . . 15.0 110.395 -170.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 162.34 18.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.161 0.984 . . . . 15.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.97 143.96 47.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.087 0.555 . . . . 15.0 109.519 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -116.86 118.94 33.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.969 0.35 . . . . 15.0 111.657 -170.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -52.91 -38.67 62.05 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.198 1.399 . . . . 15.0 113.143 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -77.19 -23.99 51.42 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.671 -0.695 . . . . 15.0 110.897 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.641 HH12 HD12 ' A' ' 370' ' ' LEU . 53.4 ttt-85 -83.39 -28.56 28.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.116 0.566 . . . . 15.0 109.476 177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' A' ' 398' ' ' MET . 38.6 t -67.11 -49.1 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.906 0.882 . . . . 15.0 109.058 171.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -50.22 -53.31 29.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.031 0.933 . . . . 15.0 110.625 170.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.7 -48.05 87.0 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 114.947 -1.024 . . . . 15.0 114.025 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.641 HD12 HH12 ' A' ' 366' ' ' ARG . 2.1 tt -64.98 -51.64 60.61 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.358 -0.608 . . . . 15.0 109.358 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.9 mt -54.24 -53.82 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.752 0.821 . . . . 15.0 111.0 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.08 -51.91 28.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.865 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -32.31 73.93 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.096 0.406 . . . . 15.0 112.096 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 47.2 ttp -74.11 -62.71 1.41 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.841 0.456 . . . . 15.0 110.551 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.68 -37.31 82.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.718 0.807 . . . . 15.0 113.067 -168.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.1 t -63.07 -27.7 69.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.939 0.495 . . . . 15.0 111.45 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.76 64.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.098 0.559 . . . . 15.0 111.688 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -84.32 179.32 7.48 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 15.0 112.223 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -59.89 -45.87 91.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.895 1.678 . . . . 15.0 110.694 -175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.88 108.22 4.33 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.15 -30.79 37.6 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.56 2.174 . . . . 15.0 112.418 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.74 -36.65 79.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.543 0.737 . . . . 15.0 112.734 -166.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -68.47 -30.49 69.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.254 0.622 . . . . 15.0 111.163 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.12 -46.06 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.299 -1.0 . . . . 15.0 108.299 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.46 -41.12 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.244 1.018 . . . . 15.0 110.374 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.96 -38.53 91.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.335 0.654 . . . . 15.0 110.624 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.7 -41.35 99.08 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.422 0.451 . . . . 15.0 110.714 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 395' ' ' MET . 93.4 m-85 -62.93 -58.03 8.75 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.458 0.647 . . . . 15.0 110.706 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 74.2 p -65.4 -23.51 66.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.455 0.909 . . . . 15.0 113.455 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -107.47 -1.15 21.7 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.327 0.651 . . . . 15.0 111.844 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -151.47 126.76 9.94 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 120.875 0.369 . . . . 15.0 110.116 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -77.04 -13.01 60.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.314 0.646 . . . . 15.0 111.643 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.06 -70.38 0.14 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.707 0.632 . . . . 15.0 112.707 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 397' ' ' ASN . 60.5 tp -72.92 -22.47 60.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.855 0.462 . . . . 15.0 110.863 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.411 ' HA ' ' HD1' ' A' ' 388' ' ' TYR . 6.3 tpt -64.61 -47.46 78.52 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.942 0.401 . . . . 15.0 110.126 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.413 ' HA ' ' NE ' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.65 -51.6 67.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.392 1.077 . . . . 15.0 109.406 172.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 394' ' ' LEU . 60.1 t30 -58.97 -28.56 66.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.681 1.192 . . . . 15.0 111.605 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.489 ' HG3' HG13 ' A' ' 367' ' ' VAL . 37.1 tpp -72.79 -38.51 67.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.223 0.609 . . . . 15.0 111.11 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 396' ' ' ASP . 51.7 mtm180 -63.38 -42.34 98.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.826 0.822 . . . . 15.0 109.35 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -74.16 -40.64 62.44 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.174 -1.376 . . . . 15.0 111.923 -172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.564 HG21 HD22 ' B' ' 102' ' ' LEU . 10.3 p -72.56 -30.1 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.54 ' HA ' ' NH1' ' A' ' 366' ' ' ARG . . . -55.99 -52.88 62.62 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -52.82 -50.06 64.45 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.418 1.087 . . . . 15.0 111.808 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 407' ' ' ALA . 39.7 tt0 -61.71 -63.29 1.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.819 0.847 . . . . 15.0 112.156 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.505 ' HG3' HH22 ' A' ' 366' ' ' ARG . 6.3 pt-20 -83.48 -3.36 57.54 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.783 0.661 . . . . 15.0 112.783 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -79.72 -35.58 38.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.469 -0.567 . . . . 15.0 109.469 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.477 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -60.54 -45.08 95.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.771 0.669 . . . . 15.0 109.9 169.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 82.4 t -55.91 -54.76 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 O-C-N 124.19 0.931 . . . . 15.0 110.256 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.468 ' HA ' HD12 ' A' ' 412' ' ' LEU . 50.2 mt-10 -61.31 -26.86 68.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 112.918 0.71 . . . . 15.0 112.918 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.29 -28.47 57.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.954 0.502 . . . . 15.0 110.576 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 407' ' ' ALA . 64.2 t -76.25 -33.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.259 -1.015 . . . . 15.0 108.259 174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 290' ' ' ALA . 95.3 mt -69.39 -36.47 76.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.676 1.191 . . . . 15.0 111.092 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.26 67.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.372 0.669 . . . . 15.0 111.605 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.16 -29.56 13.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 15.0 110.576 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -84.59 168.33 15.45 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.052 0.941 . . . . 15.0 111.664 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.35 85.43 7.16 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.223 -0.898 . . . . 15.0 110.233 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.43 86.43 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.673 -0.862 . . . . 15.0 108.673 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -71.84 87.69 1.0 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.959 0.885 . . . . 15.0 110.507 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 34.7 tt0 -75.22 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.915 -1.039 . . . . 15.0 109.281 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -139.61 142.99 37.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.6 mt-10 -77.79 147.77 35.1 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.45 -0.574 . . . . 15.0 109.45 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 426' ' ' GLU . 10.7 t -164.89 170.36 15.43 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.001 0.521 . . . . 15.0 110.927 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 42.7 p -92.52 -173.92 3.52 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.954 0.901 . . . . 15.0 111.134 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.405 ' HD1' HG22 ' A' ' 132' ' ' VAL . 55.9 t80 -56.51 -69.31 0.15 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.926 1.69 . . . . 15.0 113.494 -167.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.08 9.97 2.19 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.34 1.237 . . . . 15.0 114.34 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.418 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.3 tp10 -48.06 -60.31 2.72 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.371 0.669 . . . . 15.0 111.893 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.532 HD11 ' HG2' ' A' ' 128' ' ' PRO . 6.0 mp -77.17 -35.77 55.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.765 0.793 . . . . 15.0 109.619 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' B' ' 126' ' ' ALA . 48.8 mtm -98.95 34.04 2.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.14 -1.391 . . . . 15.0 111.108 -166.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.36 -10.15 58.63 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.707 -1.133 . . . . 15.0 109.574 167.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.32 86.37 5.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.177 0.991 . . . . 15.0 110.568 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -88.77 -72.77 0.53 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.531 -0.915 . . . . 15.0 108.531 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 123.922 0.889 . . . . 15.0 109.056 178.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -150.32 -161.6 1.38 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.368 0.667 . . . . 0.0 110.441 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -66.56 87.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.612 0.765 . . . . 0.0 111.791 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.6 t -92.27 78.58 5.11 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 32.1 p -127.32 120.29 28.23 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.523 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -74.8 -171.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.415 0.626 . . . . 0.0 110.884 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 223' ' ' ALA . . . -151.08 -7.47 0.25 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.46 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 179' ' ' GLY . 1.1 pp -160.33 159.25 31.01 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.554 -162.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -71.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.935 0.772 . . . . 0.0 109.927 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 -18.9 60.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.51 0.724 . . . . 0.0 110.504 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.477 HD13 ' H ' ' B' ' 11' ' ' LEU . 0.0 OUTLIER -117.7 145.82 37.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.23 1.012 . . . . 0.0 109.36 174.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.546 ' O ' HD22 ' B' ' 8' ' ' LEU . 25.0 Cg_exo -64.95 -40.59 20.28 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.617 HD22 ' HA2' ' A' ' 180' ' ' GLY . 16.7 tp 175.14 -45.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.569 1.548 . . . . 0.0 108.073 169.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 142.72 55.91 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 194' ' ' MET . 93.7 m-85 -107.58 25.55 11.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.903 0.881 . . . . 0.0 110.731 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' B' ' 17' ' ' PRO . 1.0 OUTLIER -114.18 23.08 0.08 OUTLIER Pre-proline 0 CA--C 1.588 2.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -174.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' B' ' 16' ' ' THR . 4.2 Cg_exo -78.47 85.93 1.76 Allowed 'Trans proline' 0 C--N 1.405 3.522 0 CA-C-N 123.698 2.356 . . . . 0.0 111.617 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t 44.65 -74.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 127.127 2.171 . . . . 0.0 115.119 168.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -69.77 -32.98 71.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -63.35 115.92 5.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.938 0.495 . . . . 0.0 111.569 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.24 34.23 18.78 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.455 1.097 . . . . 0.0 111.408 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.506 ' HG3' HG22 ' B' ' 23' ' ' THR . 10.1 tpt180 -58.8 -65.9 0.59 Allowed 'General case' 0 C--N 1.357 0.933 0 C-N-CA 123.913 0.885 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.506 HG22 ' HG3' ' B' ' 22' ' ' ARG . 3.7 t -169.77 102.22 0.46 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.222 1.009 . . . . 0.0 109.379 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.59 42.94 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.123 2.549 . . . . 0.0 112.533 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -153.7 -34.34 0.11 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.244 1.418 . . . . 0.0 109.184 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 41.44 86.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -53.01 104.56 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.392 2.728 . . . . 0.0 112.692 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.566 HG13 ' H ' ' B' ' 29' ' ' LEU 0.267 7.6 p 43.28 -79.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 126.505 1.922 . . . . 0.0 113.454 -171.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.566 ' H ' HG13 ' B' ' 28' ' ' VAL . 96.2 mt -134.57 125.44 27.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.681 1.192 . . . . 0.0 108.109 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.1 102.56 4.14 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.138 0.575 . . . . 0.0 110.04 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 60.4 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.067 1.347 . . . . 0.0 113.04 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -88.37 118.81 28.25 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.151 0.981 . . . . 0.0 110.13 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.73 47.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.318 0.647 . . . . 0.0 110.65 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.54 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.344 1.458 . . . . 0.0 111.842 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 69.85 -60.26 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.873 1.669 . . . . 0.0 112.927 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.89 64.26 1.0 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.45 103.31 15.4 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.911 0.884 . . . . 0.0 110.718 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.87 -45.06 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -152.37 114.47 4.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.314 1.046 . . . . 0.0 108.805 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.75 73.81 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.13 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.4 88.19 0.5 Allowed 'Trans proline' 0 C--N 1.39 2.759 0 CA-C-N 120.951 1.375 . . . . 0.0 110.844 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.53 -168.87 35.2 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.096 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -54.75 4.6 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.22 173.35 16.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.495 1.118 . . . . 0.0 109.845 173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -64.36 -56.96 10.89 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.581 0.752 . . . . 0.0 109.998 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 326' ' ' GLU . 20.2 ttm180 65.94 -84.28 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.311 1.044 . . . . 0.0 110.983 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.51 175.78 7.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.11 1.364 . . . . 0.0 108.941 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.4 m 68.34 83.85 0.16 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 112.232 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.7 99.82 0.7 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -55.98 108.23 0.43 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.978 0.911 . . . . 0.0 111.933 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.28 -9.91 59.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.939 0.896 . . . . 0.0 111.182 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 43.0 p -62.83 -25.56 68.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.839 0.856 . . . . 0.0 111.366 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.62 -22.23 65.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.289 1.036 . . . . 0.0 111.54 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.08 98.22 7.38 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.904 0.882 . . . . 0.0 109.052 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.13 83.71 1.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.569 0.748 . . . . 0.0 109.421 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.67 -16.11 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.244 1.018 . . . . 0.0 110.761 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.76 6.8 4.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.17 1.388 . . . . 0.0 114.291 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 72.1 p -90.57 18.18 6.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.558 0.743 . . . . 0.0 110.893 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.55 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -118.65 145.24 45.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.4 t 54.92 46.71 23.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.851 0.86 . . . . 0.0 109.472 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -47.51 -45.97 26.93 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.359 1.464 . . . . 0.0 113.276 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 63' ' ' PRO . 49.0 mtmt -102.28 126.48 33.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 62' ' ' LYS . 45.3 Cg_exo -57.5 -18.64 32.89 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 124.224 3.283 . . . . 0.0 115.249 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.72 -13.43 62.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.814 0.445 . . . . 0.0 112.14 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.91 8.84 34.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.533 0.733 . . . . 0.0 111.714 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.4 -170.26 2.88 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 tp 44.57 56.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 125.478 1.511 . . . . 0.0 112.006 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.441 HG12 HD13 ' B' ' 71' ' ' ILE . 38.7 pt -85.93 9.98 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.59 -170.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt 77.29 123.25 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.704 1.602 . . . . 0.0 109.099 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 44.6 tp 80.71 -51.74 0.32 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.052 1.741 . . . . 0.0 113.015 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 68' ' ' ILE . 37.3 mm 58.72 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 123.919 0.887 . . . . 0.0 109.045 -166.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.46 -163.7 37.12 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.343 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -151.07 -35.88 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.484 0.714 . . . . 0.0 109.721 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.97 87.79 0.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.401 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -87.45 -163.51 0.94 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.557 171.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 16.48 -133.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.0 t70 82.08 -174.72 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.418 1.487 . . . . 0.0 109.463 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 21.5 m -52.16 -46.45 65.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.407 1.083 . . . . 0.0 112.461 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -87.03 -13.36 44.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.424 0.69 . . . . 0.0 112.338 -173.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt 52.3 173.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 126.39 1.876 . . . . 0.0 114.357 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -83.32 -61.41 1.86 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.698 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -167.71 -51.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.84 10.24 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.716 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.48 163.03 12.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 110.962 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -158.3 -47.33 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.774 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 69.07 -72.06 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.308 1.443 . . . . 0.0 109.992 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.52 80.59 0.22 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.814 1.246 . . . . 0.0 113.12 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' B' ' 90' ' ' ALA . 34.7 tt0 -172.09 153.85 3.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.284 1.034 . . . . 0.0 109.476 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.63 -36.26 82.66 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' H ' ' HG2' ' B' ' 88' ' ' GLU . . . 67.85 -6.31 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 168.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.69 -47.78 3.87 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 122.909 0.29 . . . . 0.0 113.472 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.37 -6.35 75.32 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -70.55 105.24 3.03 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.94 83.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.993 0.917 . . . . 0.0 110.974 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -151.78 -46.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.487 1.515 . . . . 0.0 107.385 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.09 82.0 1.57 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.99 102.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.19 -19.92 52.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.14 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.82 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.604 1.562 . . . . 0.0 111.548 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 pp -159.93 177.32 2.11 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.542 0.737 . . . . 0.0 110.215 -168.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.14 107.17 0.24 Allowed 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.155 1.903 . . . . 0.0 112.24 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 401' ' ' VAL . 2.6 pp -159.76 151.18 19.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.18 0.992 . . . . 0.0 108.979 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.8 p -139.83 25.9 2.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.435 0.694 . . . . 0.0 109.597 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -53.83 119.59 11.76 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.615 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -156.39 -64.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.248 1.019 . . . . 0.0 108.402 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -156.66 -58.58 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.794 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.9 p -64.34 -58.3 6.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.159 0.584 . . . . 0.0 110.128 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 p80 36.16 42.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 126.627 1.971 . . . . 0.0 113.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.749 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 0.2 OUTLIER -89.87 27.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.312 -172.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 344' ' ' ARG . . . -168.89 75.9 0.1 Allowed 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.971 0.909 . . . . 0.0 109.4 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.755 HD11 ' HE2' ' A' ' 287' ' ' LYS . 8.4 tt -54.18 -39.66 66.81 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.819 1.248 . . . . 0.0 111.235 -176.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -85.23 128.51 34.71 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.482 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.66 ' HG3' ' H ' ' B' ' 114' ' ' LYS . 11.0 tppt? -174.49 -161.89 0.12 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.66 ' H ' ' HG3' ' B' ' 113' ' ' LYS . 32.0 mmtp 87.83 140.77 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.016 2.126 . . . . 0.0 112.03 164.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.7 t -61.08 -52.93 62.85 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.212 1.005 . . . . 0.0 111.489 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.14 47.35 1.99 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.091 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -167.98 116.53 0.64 Allowed Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.152 0.581 . . . . 0.0 109.55 -174.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.17 161.49 19.46 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.858 2.372 . . . . 0.0 112.564 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -82.03 6.19 16.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.921 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.28 167.27 20.69 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.582 0.753 . . . . 0.0 109.348 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.55 95.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.1 0.952 . . . . 0.0 111.515 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 123' ' ' ASP . 1.8 m -133.75 -164.98 1.57 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.59 ' H ' HG22 ' B' ' 122' ' ' THR . 6.5 m-20 73.75 -70.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.793 1.637 . . . . 0.0 110.694 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 91.76 0.69 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.237 1.015 . . . . 0.0 112.063 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.6 94.51 2.51 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.547 ' N ' ' SD ' ' A' ' 428' ' ' MET . . . -51.97 -21.08 2.74 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.751 1.221 . . . . 0.0 113.372 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -57.84 93.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 144' ' ' LEU . . . 74.54 -19.41 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.48 1.512 . . . . 0.0 114.637 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 8.5 m -77.68 90.05 3.98 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 273' ' ' ASN . . . -130.44 27.61 5.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.141 -172.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -105.44 15.38 27.25 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.212 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 33.2 t -72.87 -12.94 61.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.476 ' HB ' HD21 ' A' ' 273' ' ' ASN . 14.3 t -67.8 -18.48 64.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.442 0.697 . . . . 0.0 110.534 169.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.2 127.39 5.62 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 256' ' ' PHE . 41.4 t -73.99 81.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -70.04 -40.34 75.2 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.81 -170.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m 55.05 30.55 14.45 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 124.106 0.879 . . . . 0.0 111.1 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -60.73 -30.81 70.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.722 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -117.88 105.84 12.35 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.09 179.98 42.61 Favored Glycine 0 C--N 1.34 0.777 0 O-C-N 123.288 0.367 . . . . 0.0 113.033 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.14 100.65 3.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.28 1.032 . . . . 0.0 110.046 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.2 mp 63.69 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.086 1.354 . . . . 0.0 112.14 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.01 -75.73 1.49 Allowed Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -173.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 m -126.2 120.96 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 109.018 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.62 176.46 5.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.813 0.845 . . . . 0.0 110.605 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.85 99.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -125.91 173.54 9.04 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.685 0.794 . . . . 0.0 109.225 -171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 75.68 -68.92 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.22 129.83 35.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.119 0.568 . . . . 0.0 109.688 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 110.403 177.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.729 0.776 . . . . 15.0 110.6 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.56 91.36 0.59 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.8 -0.815 . . . . 15.0 108.8 173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 17' ' ' ILE . 35.4 m -96.22 162.17 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.03 0.932 . . . . 15.0 111.131 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 p -153.53 103.54 2.66 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.742 -1.207 . . . . 15.0 107.742 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.3 134.89 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.551 0.691 . . . . 15.0 111.417 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 54.8 mt-10 -126.6 177.82 6.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 125.114 1.366 . . . . 15.0 107.832 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 m -133.09 115.11 14.7 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 m -65.44 -57.02 9.32 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.462 -0.569 . . . . 15.0 109.462 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -167.69 118.98 0.86 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.718 0.807 . . . . 15.0 109.853 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -113.8 6.08 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 123.935 0.772 . . . . 15.0 113.917 172.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 2.7 mm? -71.88 -33.81 68.66 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.547 0.739 . . . . 15.0 109.203 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -67.55 104.07 1.07 Allowed Glycine 0 C--N 1.349 1.284 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.63 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 61.4 mtt85 -100.73 177.02 5.11 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.55 1.14 . . . . 15.0 110.833 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.8 ttm180 -146.53 92.75 2.2 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.12 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.77 98.94 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.96 -0.755 . . . . 15.0 108.96 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 m -82.51 101.3 10.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.692 0.797 . . . . 15.0 109.886 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.676 HG12 HG12 ' A' ' 3' ' ' VAL . 15.2 mt -99.45 131.91 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.657 0.783 . . . . 15.0 109.379 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.3 m -118.07 113.51 21.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.156 0.982 . . . . 15.0 108.607 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 70' ' ' LEU . 53.4 mt -96.64 127.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.689 0.796 . . . . 15.0 109.569 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.36 167.52 13.97 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.266 0.626 . . . . 15.0 111.08 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.75 64.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.069 1.348 . . . . 15.0 114.235 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.46 -42.08 91.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.282 0.633 . . . . 15.0 111.442 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.6 m -83.09 -38.59 22.27 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.933 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD13 ' HE1' ' A' ' 97' ' ' TYR . 66.1 mt -62.67 -52.84 54.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 116.003 -0.544 . . . . 15.0 109.968 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -58.67 -42.41 88.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.454 1.102 . . . . 15.0 111.83 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.7 m -67.46 -39.69 85.31 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.491 0.494 . . . . 15.0 111.043 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.73 75.37 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.359 0.663 . . . . 15.0 111.785 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 ' HD3' ' A' ' 63' ' ' ARG . 59.6 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.372 -0.603 . . . . 15.0 109.372 174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -62.69 -35.99 81.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.036 0.935 . . . . 15.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.8 m -66.22 -43.05 87.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.299 -0.864 . . . . 15.0 109.933 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.7 tp10 -64.27 -40.99 97.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 110.961 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.7 mt -63.32 -44.8 93.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.836 0.854 . . . . 15.0 112.288 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.3 p -68.88 -28.96 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 O-C-N 123.406 0.441 . . . . 15.0 110.125 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.74 -42.31 70.67 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.206 0.602 . . . . 15.0 111.145 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 31' ' ' GLU . 84.2 t -62.56 -42.11 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 15.0 109.495 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.77 97.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.125 -0.943 . . . . 15.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 94.5 mttt -68.16 -36.73 80.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.872 0.469 . . . . 15.0 111.474 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -69.02 -44.17 73.26 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.845 0.858 . . . . 15.0 110.762 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.06 10.15 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 C-N-CA 123.738 0.815 . . . . 15.0 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 67.11 5.82 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.125 1.37 . . . . 15.0 113.603 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.64 -28.75 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.027 1.331 . . . . 15.0 111.443 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.97 -32.13 73.17 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.225 1.01 . . . . 15.0 111.864 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 -24.08 72.61 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.275 -0.42 . . . . 15.0 112.426 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.39 -26.14 26.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.13 0.572 . . . . 15.0 109.804 172.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -80.67 113.23 18.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.851 0.86 . . . . 15.0 109.864 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -96.7 -4.01 41.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.455 0.702 . . . . 15.0 110.357 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.31 36.36 8.9 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.659 -0.7 . . . . 15.0 112.767 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -59.14 -61.11 2.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.814 0.846 . . . . 15.0 110.07 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.2 t -94.57 115.09 64.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.57 -1.27 . . . . 15.0 107.57 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.38 147.85 44.89 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.033 2.489 . . . . 15.0 112.45 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.499 ' HA ' HG22 ' A' ' 54' ' ' VAL . 61.2 tpp -59.94 -27.46 66.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.409 1.084 . . . . 15.0 112.799 -168.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -64.4 -36.99 85.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.876 0.471 . . . . 15.0 112.187 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -72.04 -45.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.204 0.602 . . . . 15.0 109.949 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 51' ' ' MET . 16.6 m -73.96 -14.15 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.54 -0.3 . . . . 15.0 111.224 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.33 -49.2 19.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.322 0.649 . . . . 15.0 112.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 4.0 pt20 -72.93 -15.5 61.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.969 -0.559 . . . . 15.0 111.42 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -108.72 -72.04 0.74 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.371 0.669 . . . . 15.0 111.306 -175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -70.8 -35.64 72.63 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.322 0.582 . . . . 15.0 110.066 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.39 13.38 66.64 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.256 -0.884 . . . . 15.0 113.512 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.36 65.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.271 0.629 . . . . 15.0 110.515 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.5 p -73.0 -43.86 61.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.123 0.969 . . . . 15.0 110.579 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.19 -23.66 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.16 1.384 . . . . 15.0 112.407 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HD3' HG21 ' A' ' 28' ' ' VAL . 24.9 mmt180 -46.91 -41.56 16.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.334 1.054 . . . . 15.0 112.179 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.33 -44.88 96.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.461 1.104 . . . . 15.0 112.094 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.18 -33.48 75.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.936 -0.574 . . . . 15.0 111.026 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 28' ' ' VAL . 51.2 t -74.54 -27.71 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 64.8 mt -58.77 -43.27 90.36 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.823 0.449 . . . . 15.0 111.156 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.57 99.72 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.828 -0.623 . . . . 15.0 112.638 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -60.82 -45.53 94.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.016 0.926 . . . . 15.0 110.585 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' HD12 ' A' ' 19' ' ' ILE . 73.6 mt -59.85 -47.78 84.36 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 15.0 111.234 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.1 mtm -60.96 -44.05 97.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.294 0.638 . . . . 15.0 111.917 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.8 t -70.81 -40.07 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.312 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.9 -49.57 74.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.492 1.117 . . . . 15.0 111.627 -173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.25 -24.41 57.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 116.071 -0.513 . . . . 15.0 111.285 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -68.9 -58.95 3.44 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.265 0.353 . . . . 15.0 111.305 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.74 -37.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 123.582 0.551 . . . . 15.0 110.309 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -66.73 -45.29 79.14 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.318 0.647 . . . . 15.0 110.901 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.5 64.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.531 0.733 . . . . 15.0 112.077 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -62.75 -34.83 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 112.506 0.558 . . . . 15.0 112.506 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.3 mt -67.25 -49.61 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.412 0.685 . . . . 15.0 111.052 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.28 -41.39 66.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.522 0.329 . . . . 15.0 111.002 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.63 -7.75 56.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.399 0.68 . . . . 15.0 111.248 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 68.57 17.72 8.96 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.723 1.209 . . . . 15.0 112.225 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.75 128.25 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.088 0.955 . . . . 15.0 109.19 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -104.62 112.19 65.31 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.48 136.71 21.95 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.138 2.559 . . . . 15.0 112.633 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -96.44 118.83 33.77 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.45 0.7 . . . . 15.0 109.346 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 -160.2 48.43 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.855 0.722 . . . . 15.0 112.85 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.19 133.96 56.47 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.506 0.722 . . . . 15.0 110.247 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.66 112.81 2.75 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.741 2.294 . . . . 15.0 112.013 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -75.33 86.19 2.51 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.216 0.607 . . . . 15.0 109.816 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -70.67 101.06 1.97 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.58 92.04 3.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 109.045 -0.724 . . . . 15.0 109.045 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 123.29 9.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.19 1.927 . . . . 15.0 111.638 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.5 -61.37 6.33 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 110.743 -0.943 . . . . 15.0 110.743 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -177.83 163.28 1.8 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.086 0.954 . . . . 15.0 110.2 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.526 ' HE1' HD13 ' A' ' 24' ' ' ILE . 35.9 t80 -107.73 140.02 41.42 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.62 171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -114.7 118.2 32.96 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.77 1.228 . . . . 15.0 107.766 171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.6 tp -56.9 103.56 0.12 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 124.195 0.935 . . . . 15.0 111.8 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.77 34.81 66.3 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.949 -1.023 . . . . 15.0 113.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.84 -75.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.242 0.617 . . . . 15.0 109.958 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -146.42 169.57 18.62 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.173 0.589 . . . . 15.0 111.178 -174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -150.2 95.5 2.28 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.561 1.144 . . . . 15.0 108.509 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 m -90.08 133.35 34.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.532 0.733 . . . . 15.0 109.55 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -152.23 152.78 32.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.03 0.932 . . . . 15.0 109.268 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 m -120.9 104.65 10.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.095 0.958 . . . . 15.0 109.509 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -83.37 104.93 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -93.81 127.59 39.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.867 0.867 . . . . 15.0 109.94 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -164.75 151.01 10.45 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.75 0.82 . . . . 15.0 109.077 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 45.5 mt-10 -84.75 171.66 12.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.874 0.47 . . . . 15.0 110.958 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 28.9 m -125.37 157.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.878 0.871 . . . . 15.0 109.232 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.72 119.03 69.92 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 123.052 0.541 . . . . 15.0 110.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -82.28 177.87 6.77 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.69 2.26 . . . . 15.0 112.077 171.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.7 136.28 33.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.18 0.592 . . . . 15.0 110.377 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 300' ' ' ILE . 95.8 t -80.86 118.91 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.845 0.858 . . . . 15.0 110.55 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.71 84.68 7.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.177 0.591 . . . . 15.0 111.12 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 117' ' ' LEU . 14.9 mt -75.75 99.86 4.53 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.779 170.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.7 -168.38 1.56 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.296 1.438 . . . . 15.0 109.905 172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.98 116.46 9.08 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.22 0.325 . . . . 15.0 113.421 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.71 1.01 31.98 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.357 0.663 . . . . 15.0 110.687 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -74.16 -20.74 60.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.649 1.18 . . . . 15.0 110.655 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -19.17 64.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.479 0.711 . . . . 15.0 112.064 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.501 HG23 ' HA3' ' A' ' 293' ' ' GLY . 29.5 mt -77.52 120.86 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.814 0.846 . . . . 15.0 109.562 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.51 103.89 13.65 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.883 -0.784 . . . . 15.0 108.883 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.37 125.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.81 0.844 . . . . 15.0 108.964 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.59 137.87 37.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.33 93.86 48.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.717 -0.846 . . . . 15.0 108.717 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.34 108.31 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.302 2.668 . . . . 15.0 112.051 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 42.9 mm -78.79 87.5 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 278' ' ' LEU . 67.3 t -76.44 105.14 5.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.664 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.54 96.29 8.01 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.482 0.658 . . . . 15.0 110.076 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -81.66 89.23 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.381 -0.97 . . . . 15.0 108.381 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 m -67.61 161.63 25.29 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.215 1.006 . . . . 15.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.05 -23.79 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.234 0.47 . . . . 15.0 111.439 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.04 91.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.792 0.837 . . . . 15.0 110.329 169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -68.23 -32.79 73.25 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.886 -0.597 . . . . 15.0 110.858 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.458 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 54.9 t -64.32 -53.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.921 0.889 . . . . 15.0 110.645 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.88 -34.64 78.22 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.35 -29.78 71.68 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.661 -0.699 . . . . 15.0 113.178 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -72.47 -41.65 65.8 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.478 1.111 . . . . 15.0 110.242 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 144' ' ' LEU . 79.7 mt -65.96 -37.41 85.93 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.322 173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.26 -31.76 71.46 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.061 0.944 . . . . 15.0 111.272 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 98.2 m -65.0 -46.14 82.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.028 0.531 . . . . 15.0 109.617 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HG ' ' HB1' ' B' ' 128' ' ' ALA . 18.4 mt -53.2 -45.57 68.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.66 0.784 . . . . 15.0 111.551 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -65.47 -34.33 78.04 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.663 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -77.2 -20.58 55.15 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.131 -0.356 . . . . 15.0 111.535 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' THR . 52.9 mt-30 -75.44 -38.98 59.4 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.039 0.536 . . . . 15.0 109.575 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -95.26 22.42 6.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.483 0.713 . . . . 15.0 111.294 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -71.43 103.9 3.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.728 0.811 . . . . 15.0 111.58 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.2 m -75.48 141.18 43.14 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.698 0.799 . . . . 15.0 109.309 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -77.88 160.07 28.51 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.955 0.883 . . . . 15.0 111.234 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -151.79 152.88 33.25 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 125.813 1.645 . . . . 15.0 107.394 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.12 148.25 32.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.742 0.782 . . . . 15.0 111.488 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.673 ' HG3' HG13 ' A' ' 240' ' ' VAL . 56.2 pttt -145.78 178.99 7.75 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.838 -1.528 . . . . 15.0 107.979 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.78 130.39 16.9 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 15.0 108.884 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.85 -133.01 8.9 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 123.945 0.778 . . . . 15.0 112.606 -177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.55 110.44 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.959 0.904 . . . . 15.0 112.522 -168.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 237' ' ' LEU . 32.9 t -68.36 143.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 114.564 -1.198 . . . . 15.0 110.16 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.04 -157.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.695 1.198 . . . . 15.0 108.988 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.17 -1.33 11.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.701 0.401 . . . . 15.0 112.036 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.17 2.66 7.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.21 0.604 . . . . 15.0 110.969 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -101.92 -162.01 0.9 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.032 0.533 . . . . 15.0 110.088 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -142.92 167.03 23.02 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.108 -0.701 . . . . 15.0 109.108 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.538 HG12 HG23 ' A' ' 240' ' ' VAL . 33.1 m -140.35 -176.2 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.307 0.643 . . . . 15.0 111.298 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 94.7 m -132.6 112.23 11.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.368 -1.345 . . . . 15.0 107.368 167.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.58 HD13 HD11 ' A' ' 202' ' ' ILE . 32.8 pt -114.27 -176.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-O 121.352 0.596 . . . . 15.0 111.623 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 236' ' ' ASN . 3.8 t70 -151.1 93.36 1.91 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.043 -1.466 . . . . 15.0 107.043 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 182' ' ' ALA . 49.3 p90 -105.19 139.02 40.47 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.335 -0.853 . . . . 15.0 112.284 -168.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.587 ' HA ' ' HG3' ' A' ' 181' ' ' LYS . 39.1 m -83.76 105.64 14.83 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.552 -0.749 . . . . 15.0 109.261 172.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.51 117.58 10.91 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 119.118 -0.823 . . . . 15.0 112.415 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 176' ' ' GLU . 6.8 m -140.24 141.76 35.84 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.357 0.663 . . . . 15.0 110.876 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 177' ' ' PHE . 76.9 t -115.67 126.61 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.296 1.438 . . . . 15.0 108.548 173.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.7 t70 60.26 24.55 13.97 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.658 0.783 . . . . 15.0 110.822 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 232' ' ' LYS . . . 88.11 -1.46 84.76 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.748 -0.66 . . . . 15.0 114.219 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.36 115.2 29.53 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.231 1.012 . . . . 15.0 108.752 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 171' ' ' SER . 8.0 pt-20 -56.58 152.04 12.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.509 0.724 . . . . 15.0 112.54 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 172' ' ' VAL . 44.2 p90 -140.68 150.33 43.35 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.474 0.71 . . . . 15.0 109.777 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 147.08 50.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 15.0 111.596 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.37 -29.38 4.4 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.753 -0.658 . . . . 15.0 112.446 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.693 ' HA2' HD21 ' B' ' 13' ' ' LEU . . . -73.77 -13.35 80.59 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.617 0.607 . . . . 15.0 114.617 -168.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.587 ' HG3' ' HA ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -91.32 148.41 22.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.789 0.836 . . . . 15.0 108.817 -178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -147.3 118.52 7.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.3 p -102.88 130.76 50.01 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.617 1.167 . . . . 15.0 110.235 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 t70 60.24 31.15 20.37 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.285 1.517 . . . . 15.0 109.867 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -74.01 111.11 8.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.055 -1.429 . . . . 15.0 110.72 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' B' ' 17' ' ' PRO . 5.4 p -73.5 106.44 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.562 -0.745 . . . . 15.0 109.957 173.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 194' ' ' MET . 3.3 tm? -98.42 129.99 45.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.035 0.934 . . . . 15.0 108.527 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -115.42 140.31 49.25 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.477 0.711 . . . . 15.0 110.513 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 42.7 mtt -90.87 -8.74 48.65 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.177 0.923 . . . . 15.0 110.752 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.9 35.87 3.06 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.574 -0.739 . . . . 15.0 112.415 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -153.65 122.67 6.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.392 1.077 . . . . 15.0 108.639 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.71 37.96 3.29 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.448 -0.661 . . . . 15.0 111.448 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.04 -22.58 14.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.775 1.23 . . . . 15.0 110.436 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.566 ' HG3' HD21 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -73.43 169.8 16.43 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.297 1.039 . . . . 15.0 111.739 -166.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' B' ' 13' ' ' LEU . 46.2 mt -53.11 128.11 47.68 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.973 0.909 . . . . 15.0 110.085 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.67 113.27 1.35 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.217 2.611 . . . . 15.0 112.551 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.04 -9.16 75.58 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.593 -0.73 . . . . 15.0 114.295 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.538 ' HA ' HG11 ' A' ' 215' ' ' VAL . 17.4 t80 -59.67 -48.51 81.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 117.642 0.721 . . . . 15.0 111.101 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 203' ' ' LYS . 12.5 pt-20 -65.46 -21.63 66.66 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.754 -0.657 . . . . 15.0 112.043 -175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 29.9 t70 -49.62 -50.43 42.91 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.639 1.176 . . . . 15.0 113.381 -171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.76 -43.32 99.4 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.249 -0.887 . . . . 15.0 113.153 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 166' ' ' ILE . 51.5 mt -54.0 -44.79 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.763 1.225 . . . . 15.0 111.831 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 199' ' ' GLU . 25.9 mtpp -67.43 -5.84 16.58 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.004 1.483 . . . . 15.0 115.004 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -146.66 46.22 0.75 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 118.523 0.601 . . . . 15.0 112.37 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -142.96 176.49 9.04 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.144 0.578 . . . . 15.0 110.716 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -90.69 151.33 21.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.398 1.479 . . . . 15.0 110.926 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 240' ' ' VAL . . . -77.36 26.5 0.16 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.965 1.306 . . . . 15.0 112.917 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.14 49.41 0.58 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.435 -1.066 . . . . 15.0 110.435 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 32.5 mt-10 -129.59 170.09 14.2 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 122.215 1.007 . . . . 15.0 113.01 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.36 126.43 18.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 112.689 -2.05 . . . . 15.0 107.258 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -155.36 146.07 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.961 0.41 . . . . 15.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.3 m -115.1 109.22 17.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.525 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.1 pt -102.37 145.69 11.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.62 -0.718 . . . . 15.0 110.653 -171.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.69 112.57 24.58 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.14 -0.936 . . . . 15.0 108.78 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 198' ' ' PHE . 35.2 m -127.92 -170.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.834 0.854 . . . . 15.0 109.538 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 90.7 m -140.39 134.51 30.94 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.489 ' HB2' ' H ' ' A' ' 229' ' ' LYS . 42.5 m-85 -57.78 166.08 2.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.304 1.042 . . . . 15.0 112.373 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HD3' HG12 ' A' ' 195' ' ' ILE . 72.6 Cg_endo -84.36 158.58 12.86 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.45 2.1 . . . . 15.0 110.024 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 227' ' ' LYS . 50.0 mt-10 -81.36 2.17 29.55 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.858 0.361 . . . . 15.0 110.918 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.59 -9.31 41.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.161 0.985 . . . . 15.0 111.073 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -58.95 123.1 15.42 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.14 -0.689 . . . . 15.0 109.14 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -32.25 73.21 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 -168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.13 101.21 0.86 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.451 -1.314 . . . . 15.0 107.451 168.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.35 -37.06 85.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.841 0.857 . . . . 15.0 111.488 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.62 -15.25 60.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.101 -0.954 . . . . 15.0 111.763 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.5 mt -116.66 -6.55 11.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.896 0.878 . . . . 15.0 112.008 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 219' ' ' GLU . 17.9 ptpt -72.92 118.22 15.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.469 1.031 . . . . 15.0 110.319 -176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.0 93.84 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.332 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 217' ' ' PHE . 7.9 tmtm? -115.54 138.51 50.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.151 0.98 . . . . 15.0 108.63 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.29 123.49 19.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.227 0.611 . . . . 15.0 111.643 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.11 25.38 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.907 0.883 . . . . 15.0 111.223 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 174' ' ' GLY . 8.0 mmpt? -115.17 139.67 49.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.298 1.039 . . . . 15.0 108.517 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -139.14 112.78 8.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.559 -0.534 . . . . 15.0 109.559 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.56 80.88 4.92 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-O 121.59 0.709 . . . . 15.0 109.633 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.7 mm -67.32 100.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 113.775 -1.557 . . . . 15.0 110.877 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 167' ' ' ASP . 8.0 m-80 -86.11 83.49 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.602 -0.888 . . . . 15.0 108.602 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.554 ' HA ' HG22 ' A' ' 166' ' ' ILE . 20.1 tp -63.95 94.79 0.1 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.387 1.075 . . . . 15.0 110.392 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -82.16 -42.85 18.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.508 1.123 . . . . 15.0 111.844 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 27.9 mmmt -146.03 167.29 23.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.056 0.943 . . . . 15.0 110.074 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 207' ' ' ALA . 7.2 p -142.39 138.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.706 -1.134 . . . . 15.0 109.998 167.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.18 157.66 16.98 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.574 1.15 . . . . 15.0 109.965 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -132.69 146.76 52.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.862 1.265 . . . . 15.0 109.159 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.572 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 3.4 ptp180 -84.11 155.15 22.77 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.565 0.697 . . . . 15.0 110.184 175.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -111.24 143.12 42.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.532 -1.213 . . . . 15.0 110.883 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 86.7 mt -78.98 106.63 4.64 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.516 -1.661 . . . . 15.0 106.516 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -61.25 -173.77 0.11 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 124.42 3.414 . . . . 15.0 112.703 -171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.68 141.3 55.38 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.229 0.538 . . . . 15.0 112.297 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.1 tp -97.16 -0.72 46.44 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.348 -0.842 . . . . 15.0 108.775 166.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.4 m -47.03 132.04 12.12 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.866 1.666 . . . . 15.0 111.309 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . -56.54 -36.03 68.8 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.015 0.822 . . . . 15.0 112.111 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.21 -34.29 77.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.003 0.921 . . . . 15.0 112.308 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.34 -48.65 8.84 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.936 0.494 . . . . 15.0 110.932 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 266' ' ' LEU . 5.0 tt -60.58 -33.08 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.335 0.654 . . . . 15.0 110.732 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -76.03 -18.69 59.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.894 0.701 . . . . 15.0 112.894 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -68.43 -21.47 64.65 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.238 0.615 . . . . 15.0 110.802 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.87 -24.2 66.1 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.116 -0.947 . . . . 15.0 111.784 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.41 1.74 12.23 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.093 -0.403 . . . . 15.0 112.093 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.76 77.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 107.652 -1.24 . . . . 15.0 107.652 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.04 -43.56 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.831 0.852 . . . . 15.0 111.059 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -82.74 70.19 9.68 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.009 1.324 . . . . 15.0 109.525 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.14 49.75 1.22 Allowed Glycine 0 C--N 1.357 1.706 0 N-CA-C 115.548 0.979 . . . . 15.0 115.548 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 57.4 p -95.01 160.51 14.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.361 1.065 . . . . 15.0 109.126 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.95 -45.38 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.22 -31.53 70.25 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.217 0.607 . . . . 15.0 110.807 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.69 -28.53 67.07 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.653 -0.703 . . . . 15.0 112.943 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 253' ' ' ILE . 47.3 tp -72.63 -46.49 53.8 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -51.2 -57.95 7.44 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.454 1.102 . . . . 15.0 111.571 172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.38 42.71 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.54 0.736 . . . . 15.0 111.963 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -66.29 -47.1 74.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.117 -0.492 . . . . 15.0 111.758 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 274' ' ' MET . 22.1 t -69.27 -29.13 41.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.037 0 CA-C-O 118.615 -0.707 . . . . 15.0 110.591 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -66.42 -44.65 82.35 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.847 0.749 . . . . 15.0 111.174 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -72.14 -16.85 61.99 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 119.837 -0.125 . . . . 15.0 111.24 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -80.65 -33.16 35.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 119.535 -0.269 . . . . 15.0 110.821 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 270' ' ' VAL . 54.8 mtt -65.16 -65.01 0.73 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.95 -32.0 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.814 0.696 . . . . 15.0 112.073 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 377' ' ' ALA . 49.7 ttp180 -67.2 -54.19 23.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.282 0.633 . . . . 15.0 110.817 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -77.18 -14.79 59.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.644 0.59 . . . . 15.0 110.649 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.644 HD11 ' HB ' ' A' ' 130' ' ' VAL . 30.0 tp -78.09 -50.79 11.36 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -60.61 -36.06 77.65 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.887 0.475 . . . . 15.0 110.403 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.6 t -62.77 -48.01 81.04 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.398 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.65 94.45 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.365 0.666 . . . . 15.0 111.662 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.47 -45.39 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.403 0.681 . . . . 15.0 109.722 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -62.65 -46.77 86.65 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.713 0.292 . . . . 15.0 110.764 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.61 -32.18 72.71 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.452 -0.795 . . . . 15.0 110.398 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -54.59 32.46 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.744 0.817 . . . . 15.0 110.792 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.134 -0.939 . . . . 15.0 110.214 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -67.41 -42.59 83.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.417 -0.81 . . . . 15.0 110.864 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 86.7 p -68.41 -39.12 81.72 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.54 0.336 . . . . 15.0 111.537 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -71.35 -34.01 70.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.498 0.319 . . . . 15.0 110.582 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -59.22 -47.84 83.84 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.708 0.63 . . . . 15.0 110.353 173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.2 mm -68.24 -52.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.963 0.905 . . . . 15.0 111.81 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.44 -51.0 70.05 Favored 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.336 1.054 . . . . 15.0 110.032 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.501 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -64.8 -36.64 93.35 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.18 -1.373 . . . . 15.0 113.136 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.5 tt -60.36 -54.25 47.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.465 0.706 . . . . 15.0 109.74 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 346' ' ' VAL . 62.3 t -60.2 -47.77 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.803 -0.635 . . . . 15.0 109.996 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -59.76 -29.91 68.5 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.51 0.724 . . . . 15.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.97 4.44 52.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.927 0.891 . . . . 15.0 113.044 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 21.0 m-80 -139.9 146.47 39.29 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.643 0.656 . . . . 15.0 112.302 -172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.74 145.15 30.76 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.002 -0.999 . . . . 15.0 108.992 171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.507 HD12 HG13 ' A' ' 115' ' ' VAL . 6.2 tt -167.3 139.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.519 0.728 . . . . 15.0 109.833 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.94 114.61 28.67 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.599 0.76 . . . . 15.0 109.009 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.68 132.72 30.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.162 0.985 . . . . 15.0 109.091 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.84 138.24 67.61 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.9 1.734 . . . . 15.0 109.835 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.29 65.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.236 1.014 . . . . 15.0 112.47 -170.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.32 -42.58 63.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.372 1.069 . . . . 15.0 113.004 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.86 -46.45 87.81 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.526 0.679 . . . . 15.0 110.848 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 311' ' ' ILE . 46.2 mt -61.19 -49.52 84.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 CA-C-N 113.942 -1.481 . . . . 15.0 109.299 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.7 -33.15 75.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.287 1.035 . . . . 15.0 112.32 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 313' ' ' VAL . 67.7 m -59.43 -54.83 42.17 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.799 -0.445 . . . . 15.0 109.799 171.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 16.8 mm-40 -63.87 -35.62 81.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.879 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 337' ' ' PHE . 95.5 mt -61.66 -49.27 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.598 0.759 . . . . 15.0 109.127 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.571 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 29.0 t70 -59.1 -42.72 91.16 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.246 0.966 . . . . 15.0 110.716 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 309' ' ' SER . 47.9 t -60.51 -44.27 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 123.429 0.456 . . . . 15.0 110.171 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.9 mt -65.16 -32.63 74.41 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.962 0.905 . . . . 15.0 111.91 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 76.7 mtm180 -73.55 -49.85 24.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.709 0.804 . . . . 15.0 110.419 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -63.77 -42.77 97.73 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.648 -0.706 . . . . 15.0 109.6 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.4 HE21 ' HA ' ' A' ' 314' ' ' LEU . 8.8 tt0 -60.14 -40.78 91.02 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.675 1.19 . . . . 15.0 111.365 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.58 -63.44 1.3 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 123.666 0.604 . . . . 15.0 109.898 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.9 71.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.149 0.98 . . . . 15.0 112.271 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -58.97 -38.43 79.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.86 0.864 . . . . 15.0 110.311 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -90.74 -18.58 24.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.17 0.509 . . . . 15.0 110.148 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -87.18 50.45 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.442 1.097 . . . . 15.0 108.118 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 73.1 7.52 71.57 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 114.917 -1.038 . . . . 15.0 114.76 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.7 45.22 13.42 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 118.208 1.004 . . . . 15.0 111.443 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.11 118.87 6.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.298 1.039 . . . . 15.0 110.713 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -59.93 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.886 1.274 . . . . 15.0 113.489 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm 61.76 6.04 1.5 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.634 1.346 . . . . 15.0 114.634 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.6 -12.05 60.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.785 0.434 . . . . 15.0 109.922 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.27 -49.88 31.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 125.465 1.506 . . . . 15.0 111.149 164.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.52 -22.33 66.71 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.118 -0.947 . . . . 15.0 111.036 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.49 -1.42 35.75 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.357 0.663 . . . . 15.0 111.791 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 73.4 mt -63.7 129.43 93.75 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 108.894 -0.78 . . . . 15.0 108.894 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.15 149.77 20.91 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.626 2.884 . . . . 15.0 114.089 -177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -54.79 -56.73 16.18 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.946 0.879 . . . . 15.0 109.853 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.44 -4.85 9.13 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.819 -1.537 . . . . 15.0 113.223 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -36.02 82.07 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.566 ' HB2' HG23 ' A' ' 311' ' ' ILE . 97.4 m-85 -124.6 -6.99 7.45 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 118.913 -0.565 . . . . 15.0 112.498 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.48 -42.54 67.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.7 -54.29 47.84 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.899 0.749 . . . . 15.0 110.875 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 7.4 pt20 -75.57 -35.31 60.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.616 -0.72 . . . . 15.0 111.797 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.82 -52.95 57.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.938 0.495 . . . . 15.0 110.513 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.9 tttt -55.39 -43.73 75.46 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.517 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.58 -45.57 81.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.111 0.965 . . . . 15.0 110.866 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 81.5 mtt-85 -65.33 -44.32 88.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.751 0.82 . . . . 15.0 111.03 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 341' ' ' ALA . 41.9 t -62.36 -40.09 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 123.254 0.346 . . . . 15.0 110.278 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 300' ' ' ILE . 38.2 t -61.51 -46.27 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.03 0.932 . . . . 15.0 110.192 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 343' ' ' ARG . 75.2 t -47.83 -47.94 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.417 0.687 . . . . 15.0 110.681 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' B' ' 109' ' ' TYR . . . -79.49 -28.15 52.91 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 114.444 -1.253 . . . . 15.0 115.61 -173.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.25 -33.5 43.51 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.236 0.518 . . . . 15.0 110.387 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.523 HD13 HD22 ' A' ' 294' ' ' LEU . 96.0 mt -66.53 -50.12 64.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.191 0.596 . . . . 15.0 109.412 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 355' ' ' ILE . 67.2 mt -67.41 -28.64 68.08 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.111 0.564 . . . . 15.0 111.756 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.91 -39.5 95.0 Favored Glycine 0 N--CA 1.471 1.009 0 N-CA-C 111.541 -0.624 . . . . 15.0 111.541 172.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.17 -30.49 63.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.249 0.619 . . . . 15.0 111.143 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.7 t -58.31 -50.88 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 15.0 108.851 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 360' ' ' LEU . 1.6 mp -61.03 -42.14 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.233 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -68.18 -66.5 0.56 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.027 0.204 . . . . 15.0 110.595 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.5 m -57.11 -41.77 79.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.012 0.925 . . . . 15.0 112.633 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.85 5.5 48.24 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.878 0.471 . . . . 15.0 111.71 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.76 37.22 2.15 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 124.807 1.243 . . . . 15.0 111.783 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 355' ' ' ILE . 6.4 tt -74.71 131.8 41.14 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.27 -1.332 . . . . 15.0 110.11 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.43 173.15 6.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.852 1.261 . . . . 15.0 110.774 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -85.86 87.19 7.37 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.004 -1.109 . . . . 15.0 108.004 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.68 144.2 57.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.657 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -56.45 -40.88 75.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.537 1.135 . . . . 15.0 111.118 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -67.99 -32.22 72.47 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.368 -0.833 . . . . 15.0 110.644 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -78.14 -42.48 31.68 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.925 -0.398 . . . . 15.0 109.925 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 398' ' ' MET . 49.1 t -64.2 -61.76 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.187 -0.671 . . . . 15.0 109.187 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -39.11 89.27 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.117 0.967 . . . . 15.0 110.861 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -66.46 -39.61 94.12 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.073 -0.512 . . . . 15.0 113.214 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.18 -31.64 69.2 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 116.709 0.254 . . . . 15.0 110.486 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -59.17 -46.66 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 171.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -66.52 -40.11 89.0 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.374 0.67 . . . . 15.0 112.103 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -68.79 -38.48 80.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.706 0.402 . . . . 15.0 111.657 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.468 ' SD ' HG23 ' B' ' 97' ' ' ILE . 53.6 ttp -73.04 -35.94 66.83 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.897 0.879 . . . . 15.0 110.461 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 384' ' ' VAL . . . -67.97 -45.55 73.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.21 0.604 . . . . 15.0 110.392 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -61.44 -31.56 71.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.222 1.009 . . . . 15.0 110.942 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' A' ' 276' ' ' ARG . . . -71.09 -33.74 70.47 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.923 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.407 ' HE2' HG12 ' B' ' 97' ' ' ILE . 5.2 m-30 -84.3 174.17 10.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.81 0.444 . . . . 15.0 110.299 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.44 -34.57 74.61 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.694 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 14.3 t70 -159.0 126.49 2.7 Favored Pre-proline 0 C--O 1.21 -1.022 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.6 -31.78 41.62 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 123.642 2.895 . . . . 15.0 115.377 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -53.21 -40.35 64.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.264 0.626 . . . . 15.0 112.0 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.3 pt-20 -58.84 -36.91 75.32 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 122.923 0.489 . . . . 15.0 111.116 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' B' ' 97' ' ' ILE . 69.6 t -73.11 -51.64 25.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 123.822 0.849 . . . . 15.0 109.817 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.68 -41.25 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 CA-C-N 115.624 -0.716 . . . . 15.0 110.754 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.29 -34.76 75.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.649 0.78 . . . . 15.0 111.422 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.477 ' HB2' ' HE1' ' B' ' 94' ' ' PHE . 29.5 t80 -60.55 -54.61 43.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.909 -0.404 . . . . 15.0 109.909 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -54.2 -49.71 68.77 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.274 0.63 . . . . 15.0 112.294 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.7 p -64.5 -14.28 56.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.88 2.26 11.55 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.102 -0.475 . . . . 15.0 111.463 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -142.74 101.44 3.86 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 15.0 111.372 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.72 -31.07 68.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.15 0.98 . . . . 15.0 110.593 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -52.64 -39.43 61.76 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.343 1.457 . . . . 15.0 112.091 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 59.4 tp -77.14 -40.48 45.42 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.195 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 14.1 tpt -64.79 -37.43 87.57 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.218 0.607 . . . . 15.0 112.128 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -73.89 -41.2 62.5 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 120.781 0.324 . . . . 15.0 110.15 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.06 -22.91 67.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 15.0 110.573 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.41 ' HG3' HG13 ' A' ' 367' ' ' VAL . 14.3 tpt -75.43 -37.58 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.339 1.055 . . . . 15.0 109.669 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -66.75 -39.32 87.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 15.0 109.561 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.83 -54.93 40.53 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.544 0.737 . . . . 15.0 111.249 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.02 -36.97 76.42 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.923 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -70.73 -34.15 71.59 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.88 0.472 . . . . 15.0 111.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.24 -49.99 75.15 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.534 0.734 . . . . 15.0 109.386 170.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.3 tt0 -68.57 -31.67 71.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.095 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 409' ' ' GLU . 14.0 mm-40 -67.94 -51.27 49.52 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.262 -0.644 . . . . 15.0 109.262 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.87 -27.88 67.05 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.395 0.434 . . . . 15.0 110.698 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -58.3 -48.63 79.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.262 0.625 . . . . 15.0 110.451 172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 287' ' ' LYS . 76.4 t -59.93 -45.95 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 O-C-N 124.3 1.0 . . . . 15.0 110.16 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 405' ' ' GLU . 3.4 mm-40 -58.71 -35.66 73.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 112.35 0.5 . . . . 15.0 112.35 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.82 68.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.11 0.564 . . . . 15.0 111.371 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 407' ' ' ALA . 76.4 t -76.29 -36.53 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.541 0.737 . . . . 15.0 109.052 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.5 -35.72 73.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.484 1.114 . . . . 15.0 110.673 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.65 -32.86 67.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.003 0.921 . . . . 15.0 111.005 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -97.07 -23.26 16.33 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.267 1.027 . . . . 15.0 111.666 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.45 154.3 22.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.32 0.648 . . . . 15.0 111.668 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.02 82.24 3.54 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.018 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.95 96.08 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.1 t -91.23 98.31 11.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.338 1.055 . . . . 15.0 109.346 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -89.79 126.01 35.52 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.298 -0.865 . . . . 15.0 109.427 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -148.71 150.75 33.7 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.617 0.246 . . . . 15.0 110.534 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 41.6 mt-10 -75.48 148.06 39.32 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.088 0.868 . . . . 15.0 110.371 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -152.28 171.62 17.69 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.786 0.434 . . . . 15.0 111.064 -175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 32.9 p -77.57 173.6 11.83 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.276 1.031 . . . . 15.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.89 -76.01 0.07 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.196 0.999 . . . . 15.0 113.299 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 428' ' ' MET . 10.8 t-20 -76.67 -3.04 35.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.133 0.42 . . . . 15.0 112.133 -167.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.54 -43.27 89.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.652 0.781 . . . . 15.0 111.413 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 26.7 tp -70.61 -30.78 67.54 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.419 0.628 . . . . 15.0 110.344 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 425' ' ' ASN . 6.6 mmt -86.58 3.77 42.95 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.367 -0.833 . . . . 15.0 110.765 -172.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.38 7.23 10.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.305 1.042 . . . . 15.0 111.487 173.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -105.1 86.9 2.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.884 0.874 . . . . 15.0 110.056 -176.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -96.45 -10.19 28.06 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.46 0.704 . . . . 15.0 110.718 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.472 1.109 . . . . 15.0 108.321 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? 56.84 32.02 20.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.733 1.213 . . . . 0.0 111.259 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.85 144.59 49.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.021 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.2 m -121.5 79.65 1.57 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 74.2 p -77.72 81.35 4.16 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -87.98 141.59 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.021 0.928 . . . . 0.0 109.446 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.07 65.29 5.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.367 1.079 . . . . 0.0 109.354 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -85.89 10.93 12.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.382 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.41 -9.84 45.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.116 0.967 . . . . 0.0 111.385 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.95 -150.86 0.46 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 125.179 1.392 . . . . 0.0 107.805 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.611 ' HB2' ' HD2' ' B' ' 12' ' ' PRO . 3.4 pp 59.42 177.3 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.412 1.485 . . . . 0.0 113.007 171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' HB2' ' B' ' 11' ' ' LEU . 37.8 Cg_endo -64.82 74.01 0.22 Allowed 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 122.013 1.809 . . . . 0.0 114.699 171.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.693 HD21 ' HA2' ' A' ' 180' ' ' GLY . 62.3 tp -128.79 -34.77 1.94 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.347 1.059 . . . . 0.0 108.657 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' A' ' 194' ' ' MET . 2.2 pt? -130.65 -59.2 1.02 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.969 -175.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 51.42 76.15 0.18 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.512 0.725 . . . . 0.0 111.7 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -91.81 140.97 25.08 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.555 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 186' ' ' VAL . 50.9 Cg_exo -55.41 -52.88 6.7 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.478 2.119 . . . . 0.0 111.205 171.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.99 136.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.093 1.357 . . . . 0.0 108.545 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 35.8 p -72.22 113.85 9.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 69.61 -73.16 0.09 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.379 1.472 . . . . 0.0 112.06 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.5 -80.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.026 1.33 . . . . 0.0 110.176 -171.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -166.55 76.81 0.2 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.615 1.166 . . . . 0.0 108.116 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 13.2 p -70.22 125.34 91.96 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.094 173.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 7.0 Cg_exo -75.39 14.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.206 2.604 . . . . 0.0 114.251 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.4 -45.95 84.01 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.697 0.799 . . . . 0.0 109.234 167.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -110.38 98.67 37.17 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.23 123.56 10.73 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.341 2.027 . . . . 0.0 111.332 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.67 90.71 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -78.66 89.17 4.55 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.054 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -80.97 139.78 35.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.682 0.793 . . . . 0.0 108.945 171.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -141.57 90.63 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 52.26 14.09 0.33 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 126.388 1.875 . . . . 0.0 115.062 170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.06 -9.88 27.19 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.092 0.557 . . . . 0.0 110.205 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.17 146.31 35.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.767 0.827 . . . . 0.0 110.466 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -117.05 171.9 7.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.834 0.854 . . . . 0.0 109.923 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.63 173.77 35.62 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.868 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 38' ' ' ILE . 20.6 t70 -58.98 120.93 10.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.799 0.84 . . . . 0.0 109.627 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.421 HG22 ' O ' ' B' ' 37' ' ' ASP . 6.7 tp 60.63 -0.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.454 1.902 . . . . 0.0 112.962 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m 51.45 -83.09 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.616 1.567 . . . . 0.0 112.043 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.09 107.91 27.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 109.508 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.96 10.98 3.41 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.624 2.216 . . . . 0.0 113.196 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.42 -85.4 0.73 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -172.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.02 22.09 59.95 Favored Glycine 0 C--N 1.353 1.513 0 O-C-N 124.234 0.608 . . . . 0.0 114.525 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.69 72.37 3.33 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.785 0.802 . . . . 0.0 109.437 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -168.43 -38.14 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.131 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 70.89 -46.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.547 1.539 . . . . 0.0 111.767 -169.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.38 178.19 9.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.181 0.993 . . . . 0.0 110.134 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 21.2 m -139.29 -53.3 0.56 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.68 -160.7 35.87 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.476 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.01 84.13 6.55 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 122.14 0.972 . . . . 0.0 111.017 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.455 ' HG3' ' HA ' ' B' ' 55' ' ' LEU . 0.4 OUTLIER -112.14 6.89 19.37 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.444 1.497 . . . . 0.0 110.168 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -57.04 -64.74 0.78 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.79 0.836 . . . . 0.0 113.027 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.98 -24.42 30.62 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.084 0.553 . . . . 0.0 111.623 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.61 78.29 1.78 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.48 0.712 . . . . 0.0 109.251 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.455 ' HA ' ' HG3' ' B' ' 51' ' ' GLN . 2.8 tm? -72.5 -61.44 1.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -169.18 163.47 10.98 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.587 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.06 71.57 1.62 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.884 0.85 . . . . 0.0 108.783 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m -75.5 -60.9 2.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.985 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 57.29 -78.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.17 1.388 . . . . 0.0 113.019 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t 68.91 25.38 6.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.258 1.023 . . . . 0.0 110.288 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 63.11 83.13 0.17 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.447 1.499 . . . . 0.0 110.829 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -127.27 143.16 46.18 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.54 79.74 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.631 2.221 . . . . 0.0 110.649 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -11.78 59.86 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.989 0.915 . . . . 0.0 111.254 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 66.25 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.413 1.485 . . . . 0.0 111.287 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -101.27 95.28 6.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -84.01 71.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.204 1.002 . . . . 0.0 109.02 177.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.16 -58.04 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.485 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt 60.32 -177.34 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.634 1.174 . . . . 0.0 111.721 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.536 ' HA ' ' HG3' ' B' ' 75' ' ' MET . 50.4 mt -71.63 -24.16 61.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.371 174.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 40.8 mt -98.61 101.3 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.613 0.765 . . . . 0.0 109.072 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.06 -131.47 1.35 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.17 -66.91 0.89 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 117.313 0.557 . . . . 0.0 109.666 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.21 -143.84 0.46 Allowed Glycine 0 C--N 1.348 1.224 0 O-C-N 124.174 0.921 . . . . 0.0 113.972 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' B' ' 70' ' ' LEU . 25.7 mmt 75.74 -57.57 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.038 1.335 . . . . 0.0 111.598 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.52 73.73 2.34 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.397 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' B' ' 80' ' ' ILE . 15.6 t70 74.77 156.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.769 1.628 . . . . 0.0 111.488 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -63.11 -67.22 0.44 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.372 1.069 . . . . 0.0 111.635 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.84 -14.7 59.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.125 0.57 . . . . 0.0 110.354 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.5 ' HA ' ' HB3' ' B' ' 77' ' ' ASP . 75.5 mt 66.6 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 125.387 1.475 . . . . 0.0 109.616 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.7 m -158.08 -45.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.134 1.374 . . . . 0.0 107.301 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.89 127.82 0.03 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.411 1.484 . . . . 0.0 110.642 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.82 4.68 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 123.537 0.523 . . . . 0.0 109.883 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.84 106.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -77.64 74.06 4.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.785 0.802 . . . . 0.0 110.861 -172.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -79.03 -38.41 36.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.78 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.85 23.0 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.358 1.063 . . . . 0.0 109.615 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -72.97 94.78 1.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.08 -58.72 0.69 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.83 66.54 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.459 0.703 . . . . 0.0 111.645 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.79 3.36 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.613 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.16 152.81 21.12 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -114.75 142.4 46.57 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.92 0.888 . . . . 0.0 110.615 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.477 ' HE1' ' HB2' ' A' ' 387' ' ' PHE . 42.1 p90 -69.69 -47.29 63.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 -176.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -165.92 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.23 157.62 9.92 Favored Glycine 0 N--CA 1.479 1.537 0 CA-C-O 119.883 -0.399 . . . . 0.0 112.853 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 384' ' ' VAL . 21.3 mt -123.65 132.85 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.483 0.713 . . . . 0.0 111.149 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.23 130.79 39.51 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.29 73.45 10.45 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.489 0.716 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . 0.292 3.1 mm? 61.07 -91.09 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.446 0 CA-C-O 116.336 -1.792 . . . . 0.0 112.224 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.9 -12.02 12.22 Favored 'Trans proline' 0 C--N 1.412 3.893 0 CA-C-N 125.38 2.957 . . . . 0.0 111.907 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 36.9 tp 53.87 84.89 0.06 Allowed 'General case' 0 C--N 1.354 0.783 0 C-N-CA 125.77 1.628 . . . . 0.0 111.05 -171.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -65.11 143.21 58.04 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.348 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.28 164.01 29.88 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.232 0.333 . . . . 0.0 113.308 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -63.5 103.51 0.53 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.355 0.662 . . . . 0.0 110.546 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 60.59 22.44 12.22 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.569 1.548 . . . . 0.0 111.713 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.9 m -85.71 52.61 2.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.777 1.275 . . . . 0.0 108.629 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.5 -14.51 45.76 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.143 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 348' ' ' GLY . 68.9 m-85 -87.57 8.14 26.45 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.616 1.167 . . . . 0.0 111.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.69 -44.8 0.24 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.719 0.807 . . . . 0.0 109.876 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt 66.07 -78.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.245 1.418 . . . . 0.0 108.781 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.02 132.21 35.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 108.259 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 22.6 tptm 179.63 -20.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.219 0.608 . . . . 0.0 110.892 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.74 -42.31 91.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.101 0.96 . . . . 0.0 112.562 -163.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -91.46 -22.5 20.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.752 0.421 . . . . 0.0 110.364 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.26 71.74 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.934 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -167.33 -66.12 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.525 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.471 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 68.5 Cg_endo -83.63 -55.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.39 2.757 0 CA-C-N 121.169 1.453 . . . . 0.0 113.776 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.58 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.588 1.555 . . . . 0.0 112.356 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.471 ' HE1' ' HB2' ' B' ' 118' ' ' PRO . 25.0 p90 35.28 -82.96 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 C-N-CA 125.952 1.701 . . . . 0.0 114.696 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.3 m -144.86 171.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.861 1.664 . . . . 0.0 108.082 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -148.72 139.72 23.03 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.922 -0.486 . . . . 0.0 111.376 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 69.81 -67.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.11 1.764 . . . . 0.0 113.346 173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -58.73 98.47 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.324 1.05 . . . . 0.0 112.335 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' B' ' 129' ' ' THR . . . -81.36 97.08 7.54 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 169.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.78 -13.54 15.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.684 1.194 . . . . 0.0 113.493 -171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 71.1 m -60.74 -46.23 91.22 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.293 0.637 . . . . 0.0 111.754 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.654 ' HB1' ' HG ' ' A' ' 144' ' ' LEU . . . -176.55 -41.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' B' ' 125' ' ' ALA . 21.4 m -67.33 115.24 6.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.329 0.651 . . . . 0.0 111.376 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.49 -150.28 0.3 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.873 0.869 . . . . 0.0 110.49 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.483 ' HH2' HD13 ' A' ' 144' ' ' LEU . 8.1 m-90 78.84 160.49 0.19 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.277 1.831 . . . . 0.0 112.854 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.2 p -168.87 90.59 0.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.154 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 9.3 t -70.47 139.65 51.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.855 0.462 . . . . 0.0 110.839 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.77 21.24 0.04 OUTLIER Glycine 0 N--CA 1.472 1.048 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.401 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.53 141.9 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.683 0.793 . . . . 0.0 110.015 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -10.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.241 0.616 . . . . 0.0 111.26 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 6.2 t 48.39 -159.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 126.094 1.757 . . . . 0.0 111.91 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -104.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.639 -0.663 . . . . 0.0 110.055 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.535 HD21 HD13 ' B' ' 142' ' ' LEU . 28.5 t-20 -58.97 -47.87 83.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.154 0.982 . . . . 0.0 110.468 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 60.7 57.55 18.33 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 124.007 0.817 . . . . 0.0 114.1 168.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.99 41.39 14.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.541 1.136 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.535 HD13 HD21 ' B' ' 139' ' ' ASN . 3.9 mm? 60.42 34.37 20.58 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.393 1.077 . . . . 0.0 110.178 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.78 119.57 16.87 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.972 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 23.1 t -67.44 89.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.501 0.721 . . . . 0.0 109.694 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.59 95.31 5.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.781 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.9 112.11 37.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -70.04 87.27 0.56 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.387 1.075 . . . . 0.0 110.15 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 60.21 87.94 0.08 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.277 1.431 . . . . 0.0 111.547 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -64.97 92.85 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 124.135 0.974 . . . . 0.0 108.514 -177.853 . . . . . . . . 0 0 . 1 stop_ save_